data_5xqm_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5xqm _Structure_validation_residue.Date_analyzed 2017-11-03 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 . . . . . 0 N--CA 1.441 -0.908 0 CA-C-O 120.979 0.419 . . . . 0.0 110.481 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.483 HG12 ' O ' ' A' ' 31' ' ' VAL . 11.9 pt -116.93 163.33 14.18 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.662 -176.086 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.429 ' HE2' ' HB3' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -96.31 141.54 29.53 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.2 179.644 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.457 HD13 ' CG2' ' A' ' 31' ' ' VAL . 83.7 mt -140.35 137.62 36.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.504 175.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 13.8 mtmm -102.02 106.32 17.2 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.599 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 92.8 t -82.45 119.87 32.82 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.62 178.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 59.1 t -110.81 118.77 58.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-O 120.91 0.386 . . . . 0.0 110.025 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.55 ' HA2' ' HB ' ' A' ' 83' ' ' VAL . . . -90.15 169.41 34.82 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.346 -0.93 . . . . 0.0 112.549 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.467 ' HG2' ' O ' ' A' ' 83' ' ' VAL . 89.8 mm-40 -69.16 -24.38 64.07 Favored 'General case' 0 CA--C 1.504 -0.799 0 CA-C-O 121.39 0.614 . . . . 0.0 110.689 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -69.85 1.6 4.25 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.644 175.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.446 ' H ' ' C ' ' A' ' 22' ' ' GLN . 47.4 m 69.49 27.82 4.8 Favored 'General case' 0 C--N 1.351 0.656 0 CA-C-O 121.994 0.902 . . . . 0.0 109.134 -176.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -98.86 107.1 19.45 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.354 -1.294 . . . . 0.0 111.049 -178.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.599 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 33.7 tt0 -99.3 133.27 43.83 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.418 177.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.6 p -133.8 139.78 47.9 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-N 115.91 -0.587 . . . . 0.0 109.88 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.424 ' HB3' ' HE3' ' A' ' 16' ' ' LYS . 19.0 m170 -96.48 113.28 24.85 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.345 0.593 . . . . 0.0 111.582 -176.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -111.99 150.4 30.63 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.473 179.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.471 ' HD3' ' O ' ' A' ' 15' ' ' ILE . 22.4 tpp180 -107.35 116.95 32.84 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 175.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.483 ' O ' HG12 ' A' ' 15' ' ' ILE . 35.0 m -138.66 169.02 18.53 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.304 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -178.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 53.9 tttp -89.33 160.1 17.03 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 -177.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -55.38 -38.29 68.66 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.016 0.436 . . . . 0.0 110.126 175.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -102.35 22.65 36.94 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.931 -0.577 . . . . 0.0 113.051 -178.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -62.39 142.36 57.87 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-O 121.323 0.582 . . . . 0.0 112.001 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 69.2 m -91.14 153.47 20.03 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.604 -179.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.401 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 27.3 ptt? -49.96 -33.19 16.92 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 112.897 0.702 . . . . 0.0 112.897 -177.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.46 -36.78 81.37 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -178.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -60.13 -40.04 88.41 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.91 0.386 . . . . 0.0 110.766 -176.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.557 HD11 ' CD2' ' A' ' 57' ' ' PHE . 0.2 OUTLIER -86.62 -45.49 10.98 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.928 -177.993 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.527 ' HG2' ' CD1' ' A' ' 57' ' ' PHE . 63.2 mtpt -63.83 -45.44 89.54 Favored 'General case' 0 CA--C 1.498 -1.024 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.639 -177.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -60.55 -44.37 96.19 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 176.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 39.5 t -64.96 -50.22 67.24 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.775 -176.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.532 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 48.8 t80 -68.18 -45.63 72.91 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.517 -179.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.473 ' HB3' ' O ' ' A' ' 50' ' ' VAL . . . -59.24 -36.27 75.15 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.413 0.625 . . . . 0.0 109.725 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -67.01 -47.01 72.74 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.413 -178.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.532 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 10.5 ptm85 -66.3 -24.74 66.6 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.334 -178.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.51 HG23 ' O ' ' A' ' 44' ' ' TYR . 14.6 t -99.36 -5.36 29.73 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.833 -178.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 69.3 30.94 71.38 Favored Glycine 0 C--N 1.336 0.53 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.762 178.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.473 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 83.2 t -118.75 150.19 21.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 C-N-CA 122.445 0.298 . . . . 0.0 110.803 -177.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.468 ' HB1' ' OG ' ' A' ' 54' ' ' SER . . . -51.34 134.72 27.89 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.296 176.059 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 74.7 t -61.63 -43.28 96.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.602 -178.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -71.82 -15.93 62.16 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.703 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.507 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 73.6 m -81.55 -12.62 58.73 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.645 178.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.498 ' C ' ' HD3' ' A' ' 56' ' ' ARG . 2.6 mm? -94.37 134.84 36.44 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.112 176.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.498 ' HD3' ' C ' ' A' ' 55' ' ' LEU . 0.7 OUTLIER -126.07 114.42 18.39 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.971 -177.658 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.557 ' CD2' HD11 ' A' ' 40' ' ' LEU . 20.0 m-85 -106.12 132.27 52.4 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.172 0.511 . . . . 0.0 111.856 -178.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.555 ' HG ' ' HA ' ' A' ' 63' ' ' ARG . 6.6 mp -129.3 139.98 51.58 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.701 178.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.719 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 88.9 t80 -111.14 121.89 46.46 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 177.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 19.4 t70 55.19 23.56 5.53 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 121.484 0.659 . . . . 0.0 111.544 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 94.85 8.46 59.23 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.793 -0.717 . . . . 0.0 113.16 177.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.719 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.1 OUTLIER -124.79 141.44 52.11 Favored 'General case' 0 CA--C 1.505 -0.758 0 CA-C-O 121.147 0.498 . . . . 0.0 109.759 176.456 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.555 ' HA ' ' HG ' ' A' ' 58' ' ' LEU . 29.5 ptt180 -68.23 139.38 56.03 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -174.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 83.7 mt -88.97 122.42 40.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-N 114.548 -1.206 . . . . 0.0 109.886 -178.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 -109.01 163.99 12.82 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.68 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -81.39 -7.7 59.62 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.142 0.496 . . . . 0.0 109.767 177.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -94.51 -19.25 20.7 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.164 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.503 ' CG ' HH12 ' A' ' 62' ' ' ARG . 39.3 m-20 -62.73 138.19 58.45 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-O 121.179 0.514 . . . . 0.0 111.746 -177.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.43 ' HB ' ' HD2' ' A' ' 70' ' ' PRO . 82.7 p -91.26 162.71 31.48 Favored Pre-proline 0 C--N 1.312 -1.039 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.195 -179.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.43 ' HD2' ' HB ' ' A' ' 69' ' ' THR . 17.9 Cg_endo -59.79 -25.99 80.9 Favored 'Trans proline' 0 CA--C 1.535 0.542 0 C-N-CA 122.107 1.871 . . . . 0.0 111.6 176.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.449 ' N ' ' HE2' ' A' ' 71' ' ' LYS . 0.2 OUTLIER -63.7 -47.01 82.87 Favored 'General case' 0 CA--C 1.483 -1.629 0 CA-C-O 121.96 0.886 . . . . 0.0 110.164 178.69 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.7 t -84.32 -27.14 27.98 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 113.975 -1.466 . . . . 0.0 112.09 -174.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 96.4 mt -82.77 -22.74 34.19 Favored 'General case' 0 C--O 1.216 -0.702 0 C-N-CA 120.289 -0.564 . . . . 0.0 110.798 177.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 38.08 34.27 0.06 Allowed 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 124.833 1.253 . . . . 0.0 113.616 178.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 64.9 mtt -75.35 150.57 38.39 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -152.54 -174.03 4.76 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -178.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -48.94 118.06 2.41 Favored 'General case' 0 C--N 1.32 -0.707 0 O-C-N 123.885 0.74 . . . . 0.0 112.763 -176.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.5 t70 58.42 34.55 24.07 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.23 -1.35 . . . . 0.0 111.479 173.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -69.89 178.13 2.81 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.3 m -114.77 148.77 17.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 CA-C-O 121.594 0.711 . . . . 0.0 112.092 -174.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.6 mt -131.85 137.79 54.17 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.1 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -105.1 133.88 49.13 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -178.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.55 ' HB ' ' HA2' ' A' ' 21' ' ' GLY . 92.6 t -124.08 136.43 60.38 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.874 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.527 ' CD1' HD13 ' A' ' 58' ' ' LEU . 69.8 m-85 -96.78 164.11 12.7 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 58.5 tp60 -67.24 128.7 37.39 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.304 0.573 . . . . 0.0 110.581 -171.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.507 ' HA ' ' O ' ' A' ' 54' ' ' SER . 13.7 pm0 -64.92 151.14 46.49 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 114.935 -1.029 . . . . 0.0 112.256 -177.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 61.8 tp60 -63.42 -50.91 67.95 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.366 -174.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 88.3 mt . . . . . 0 C--N 1.322 -0.609 0 CA-C-N 115.67 -0.696 . . . . 0.0 112.798 -179.873 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 . . . . . 0 N--CA 1.442 -0.869 0 CA-C-O 121.402 0.62 . . . . 0.0 112.466 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.493 ' O ' ' HD2' ' A' ' 30' ' ' ARG . 13.9 pt -124.25 164.17 22.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 114.535 -1.211 . . . . 0.0 108.035 -178.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.427 ' HB2' HH11 ' A' ' 30' ' ' ARG . 17.7 ttpp -99.69 143.41 29.95 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 119.997 -0.681 . . . . 0.0 110.202 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.43 HG23 HD13 ' A' ' 81' ' ' ILE . 74.3 mt -135.75 134.42 51.32 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 CA-C-O 120.87 0.367 . . . . 0.0 111.113 175.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 18.4 mtmt -96.04 107.18 19.45 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.642 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 71.4 t -81.29 117.38 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 177.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.3 t -110.75 118.11 56.5 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -82.52 178.53 53.33 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 120.5 -0.857 . . . . 0.0 111.747 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.539 ' C ' ' H ' ' A' ' 24' ' ' SER . 97.9 mt-30 -66.18 -37.02 84.61 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -178.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -79.29 22.19 0.44 Allowed 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.618 0.723 . . . . 0.0 109.294 177.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.539 ' H ' ' C ' ' A' ' 22' ' ' GLN . 85.0 p 58.97 30.43 20.22 Favored 'General case' 0 CA--C 1.512 -0.517 0 C-N-CA 124.807 1.243 . . . . 0.0 111.201 -179.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -83.6 105.68 14.72 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 114.836 -1.075 . . . . 0.0 109.866 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.642 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 36.5 tt0 -103.67 130.88 51.21 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.699 -177.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.5 p -135.79 140.75 43.7 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.091 177.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 18.4 m170 -96.24 117.13 30.17 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 121.525 0.679 . . . . 0.0 111.935 -175.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.402 ' HZ ' ' CD ' ' A' ' 47' ' ' ARG . 45.6 m-85 -109.6 149.21 30.0 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.604 -1.18 . . . . 0.0 111.039 177.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.493 ' HD2' ' O ' ' A' ' 15' ' ' ILE . 22.8 tpt180 -108.98 117.02 33.11 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 177.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.431 ' O ' HG12 ' A' ' 15' ' ' ILE . 33.0 m -137.69 170.5 17.33 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.35 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.008 -177.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.448 ' O ' ' HB ' ' A' ' 35' ' ' THR . 38.5 ttmt -89.83 156.29 18.59 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 110.453 -0.203 . . . . 0.0 110.453 -177.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -56.4 -38.91 72.16 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 121.142 0.496 . . . . 0.0 109.691 174.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -98.06 24.76 30.41 Favored Glycine 0 N--CA 1.443 -0.868 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.452 -178.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.448 ' HB ' ' O ' ' A' ' 32' ' ' LYS . 1.0 OUTLIER -65.83 140.51 58.39 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-O 121.426 0.631 . . . . 0.0 112.193 179.232 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 66.5 m -91.99 157.19 16.94 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.975 179.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.686 ' SD ' ' HA ' ' A' ' 65' ' ' ASN . 26.4 ptt? -51.47 -31.88 25.03 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -176.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.75 -38.06 86.6 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.198 -0.456 . . . . 0.0 112.097 -177.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.401 ' HB2' HG22 ' A' ' 35' ' ' THR . 75.5 mmtt -60.66 -38.25 84.25 Favored 'General case' 0 C--O 1.217 -0.645 0 CA-C-O 120.672 0.273 . . . . 0.0 111.183 -175.228 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.504 HD13 ' CG ' ' A' ' 57' ' ' PHE . 0.2 OUTLIER -86.59 -47.32 9.31 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.741 -178.528 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.408 ' HA ' ' HE1' ' A' ' 57' ' ' PHE . 94.3 mttt -62.95 -47.2 84.23 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.99 -177.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -64.27 -38.74 92.11 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.014 178.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 47.5 t -69.07 -53.55 19.75 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.68 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.688 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 45.3 t80 -65.89 -47.22 75.56 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-N 116.227 -0.442 . . . . 0.0 112.18 -178.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.75 -35.68 75.09 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.38 0.609 . . . . 0.0 109.895 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -65.99 -47.15 75.48 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.725 -178.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.688 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 8.7 ptm180 -65.9 -27.94 68.58 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.065 -178.252 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.531 HG22 ' O ' ' A' ' 44' ' ' TYR . 9.3 t -93.19 -6.74 47.07 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.072 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 69.67 33.16 71.17 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.902 178.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.6 p -117.7 167.29 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 CA-C-O 120.693 0.282 . . . . 0.0 110.827 -177.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.449 ' HB2' ' OG ' ' A' ' 54' ' ' SER . . . -61.48 128.22 35.25 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.389 178.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 77.2 t -64.24 -43.99 97.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.777 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -67.47 -29.67 69.18 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.708 -177.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.449 ' OG ' ' HB2' ' A' ' 51' ' ' ALA . 88.5 p -82.76 -17.16 45.18 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 119.891 -0.723 . . . . 0.0 111.135 -179.056 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.474 HD11 ' N ' ' A' ' 56' ' ' ARG . 0.9 OUTLIER -92.59 135.2 34.28 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 -177.183 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.516 ' NH1' ' HA ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -140.96 149.58 42.0 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-O 121.486 0.66 . . . . 0.0 111.693 -177.106 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.504 ' CG ' HD13 ' A' ' 40' ' ' LEU . 58.0 m-85 -117.94 138.8 51.92 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 114.554 -1.203 . . . . 0.0 109.824 179.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.577 HD23 ' CE1' ' A' ' 84' ' ' TYR . 9.2 mp -125.3 137.95 54.07 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.765 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.778 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 23.1 t80 -105.5 114.48 28.68 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 38.0 t70 53.86 29.29 9.57 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-O 121.697 0.761 . . . . 0.0 111.602 -177.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 95.07 -4.19 67.54 Favored Glycine 0 C--N 1.313 -0.704 0 CA-C-N 115.859 -0.609 . . . . 0.0 113.408 177.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.778 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.1 OUTLIER -106.5 138.88 41.88 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.355 0.598 . . . . 0.0 110.385 178.58 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.503 ' HA ' ' HG ' ' A' ' 58' ' ' LEU . 32.2 mtp-105 -69.01 135.64 51.21 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.882 -174.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 79.3 mt -93.3 121.52 44.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.985 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.686 ' HA ' ' SD ' ' A' ' 37' ' ' MET . 65.0 m-80 -117.31 161.72 19.06 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.486 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.475 ' OD2' ' HE1' ' A' ' 37' ' ' MET . 7.8 p-10 -71.75 -13.34 61.68 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.159 0.504 . . . . 0.0 109.826 178.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -76.74 -21.47 55.2 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.65 177.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -71.48 139.9 49.77 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 121.47 0.653 . . . . 0.0 111.444 -179.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.514 ' HB ' ' HD2' ' A' ' 70' ' ' PRO . 47.8 p -101.99 163.95 16.75 Favored Pre-proline 0 C--N 1.304 -1.396 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.92 -178.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.514 ' HD2' ' HB ' ' A' ' 69' ' ' THR . 12.7 Cg_endo -56.39 -37.44 97.07 Favored 'Trans proline' 0 C--N 1.357 1.024 0 C-N-CA 122.427 2.085 . . . . 0.0 113.436 -177.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.45 ' HD3' ' N ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -74.49 -19.5 60.34 Favored 'General case' 0 C--O 1.221 -0.438 0 CA-C-O 121.057 0.456 . . . . 0.0 112.028 179.277 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.45 ' N ' ' HD3' ' A' ' 71' ' ' LYS . 52.1 m -85.0 -45.17 12.4 Favored 'General case' 0 N--CA 1.408 -2.546 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.966 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 98.9 mt -71.2 -25.25 62.43 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.526 178.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 51.57 30.27 6.33 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.836 177.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.416 ' SD ' HD13 ' A' ' 15' ' ' ILE . 20.2 ptp -73.88 162.77 28.74 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.995 0.426 . . . . 0.0 111.464 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -151.56 175.41 12.36 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.724 -177.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -65.9 118.93 10.42 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 121.692 0.758 . . . . 0.0 111.634 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 21.5 t70 70.65 33.91 2.22 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 126.095 1.758 . . . . 0.0 111.587 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -77.86 178.72 7.2 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 176.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.1 m -113.36 146.79 17.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-O 121.7 0.762 . . . . 0.0 111.9 -175.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.482 ' CG2' ' HD2' ' A' ' 57' ' ' PHE . 1.2 mt -134.15 141.99 42.25 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.962 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -107.54 146.53 31.73 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.834 0.349 . . . . 0.0 111.473 -176.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.417 ' O ' ' HG3' ' A' ' 22' ' ' GLN . 97.5 t -125.31 132.41 71.13 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.66 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.102 179.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.577 ' CE1' HD23 ' A' ' 58' ' ' LEU . 63.6 m-85 -100.62 143.98 30.15 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.766 175.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 58.7 tp60 -69.85 134.64 48.71 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -176.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.516 ' HA ' ' NH1' ' A' ' 56' ' ' ARG . 1.3 pp20? -94.3 -155.79 0.47 Allowed 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -171.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -82.95 -55.94 4.1 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -171.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 85.3 mt . . . . . 0 C--N 1.321 -0.665 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -174.215 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 . . . . . 0 N--CA 1.442 -0.844 0 CA-C-O 120.818 0.342 . . . . 0.0 110.171 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.5 pt -125.39 162.34 28.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.442 -176.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.459 ' HE2' ' HB2' ' A' ' 78' ' ' ASP . 38.1 mtmm -97.42 144.47 27.13 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.963 176.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.473 HG21 HD13 ' A' ' 81' ' ' ILE . 45.2 mm -128.08 129.53 69.52 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.979 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.02 178.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 27.5 mtmt -96.67 104.58 16.58 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 174.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.552 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 89.6 t -81.95 111.92 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.863 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 177.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.0 t -108.49 117.72 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -93.84 164.79 26.58 Favored Glycine 0 N--CA 1.435 -1.42 0 C-N-CA 120.489 -0.862 . . . . 0.0 111.449 178.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.496 ' C ' ' H ' ' A' ' 24' ' ' SER . 98.3 mt-30 -67.95 -23.94 65.11 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.374 0.607 . . . . 0.0 110.44 179.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -70.87 8.92 0.77 Allowed 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.919 175.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.496 ' H ' ' C ' ' A' ' 22' ' ' GLN . 44.5 m 68.96 25.27 6.04 Favored 'General case' 0 C--N 1.348 0.531 0 C-N-CA 123.753 0.821 . . . . 0.0 110.315 -179.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 54.0 t-20 -96.03 107.27 19.54 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.946 -178.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.552 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 28.7 tt0 -105.46 125.77 51.37 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.426 175.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.2 p -137.65 140.94 40.45 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-O 121.099 0.476 . . . . 0.0 111.126 -179.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 62.5 m170 -89.83 118.65 29.58 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.066 -178.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -118.43 143.64 46.53 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.296 171.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 52.9 ttp180 -106.44 121.51 44.4 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 121.528 0.68 . . . . 0.0 110.466 177.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 33.8 m -136.57 172.58 15.02 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 CA-C-N 114.82 -1.082 . . . . 0.0 108.911 -177.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.458 ' O ' ' HB ' ' A' ' 35' ' ' THR . 50.3 tttm -89.55 160.58 16.63 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -179.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.407 ' C ' ' HB3' ' A' ' 70' ' ' PRO . 95.7 m-85 -54.08 -41.21 67.97 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.976 0.417 . . . . 0.0 110.228 176.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -97.65 22.33 41.38 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.844 -177.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.458 ' HB ' ' O ' ' A' ' 32' ' ' LYS . 0.9 OUTLIER -61.63 143.82 55.48 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-O 121.181 0.515 . . . . 0.0 112.109 179.222 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 65.5 m -91.59 150.72 21.05 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.967 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.405 ' HE3' ' OD1' ' A' ' 66' ' ' ASP . 26.5 ptt? -49.56 -33.03 13.83 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -177.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.88 -37.12 81.08 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.93 -177.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -61.32 -40.28 93.61 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.853 0.358 . . . . 0.0 110.646 -175.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.504 HD11 ' CD2' ' A' ' 57' ' ' PHE . 0.4 OUTLIER -87.26 -45.28 10.77 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.075 -0.512 . . . . 0.0 112.08 -179.269 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.543 ' HG2' ' CD1' ' A' ' 57' ' ' PHE . 61.4 mtpt -63.01 -45.98 89.8 Favored 'General case' 0 CA--C 1.496 -1.119 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.752 -177.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -62.13 -40.96 97.68 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 48.0 t -66.41 -51.34 57.96 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.168 -0.923 . . . . 0.0 111.326 -178.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.671 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 49.2 t80 -66.64 -45.82 77.78 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.85 -178.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' A' ' 50' ' ' VAL . . . -59.25 -36.03 74.75 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.502 0.668 . . . . 0.0 109.757 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -66.49 -46.34 76.62 Favored 'General case' 0 C--N 1.311 -1.109 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.193 -178.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.671 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 11.4 ptm85 -65.39 -26.84 68.17 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.176 -177.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.551 HG23 ' O ' ' A' ' 44' ' ' TYR . 10.1 t -95.55 -7.42 37.96 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.222 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.81 32.04 66.98 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.406 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.425 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 84.5 t -117.74 150.25 19.9 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 C-N-CA 122.6 0.36 . . . . 0.0 110.859 -177.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.439 ' HB3' ' OG ' ' A' ' 54' ' ' SER . . . -52.58 137.05 31.36 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.396 176.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 74.3 t -61.23 -42.97 95.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.14 -179.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -67.26 -25.04 65.87 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.118 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.439 ' OG ' ' HB3' ' A' ' 51' ' ' ALA . 74.0 m -74.76 -16.03 60.74 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.88 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -96.44 134.13 40.0 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.238 0.542 . . . . 0.0 110.823 177.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -132.93 125.29 29.51 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.626 178.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.543 ' CD1' ' HG2' ' A' ' 41' ' ' LYS . 12.3 m-85 -108.44 135.15 50.2 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.966 -179.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.581 HD11 ' CD1' ' A' ' 84' ' ' TYR . 6.2 mp -124.05 147.45 47.84 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.98 -178.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.651 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 31.2 t80 -128.96 128.83 44.51 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 176.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 34.7 t70 59.5 27.18 16.28 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 121.653 0.74 . . . . 0.0 110.4 179.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 78.51 17.97 76.69 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.667 178.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.651 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -130.87 151.73 50.97 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.91 178.587 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.426 ' HA ' ' HG ' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -68.06 135.64 52.55 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.807 -175.438 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 86.0 mt -88.1 117.47 31.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 177.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -107.36 153.85 22.16 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.499 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.405 ' OD1' ' HE3' ' A' ' 37' ' ' MET . 9.8 p-10 -68.98 -10.94 60.01 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.873 -179.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -85.78 -19.01 31.38 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.036 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.433 ' CG ' HH12 ' A' ' 62' ' ' ARG . 36.9 m-20 -67.43 148.74 51.17 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -175.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.442 ' HB ' ' HD2' ' A' ' 70' ' ' PRO . 31.7 p -96.9 162.29 23.49 Favored Pre-proline 0 N--CA 1.444 -0.755 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.212 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.442 ' HD2' ' HB ' ' A' ' 69' ' ' THR . 19.2 Cg_endo -59.28 -31.51 95.25 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.519 2.146 . . . . 0.0 113.06 -178.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.556 ' HG3' ' N ' ' A' ' 72' ' ' THR . 15.2 ptmt -70.46 -38.83 74.51 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -179.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.556 ' N ' ' HG3' ' A' ' 71' ' ' LYS . 13.4 t -82.09 -29.82 31.58 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 120.971 0.415 . . . . 0.0 110.437 -177.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 96.1 mt -73.25 -22.2 60.46 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 174.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 52.91 28.75 6.87 Favored 'General case' 0 C--N 1.348 0.509 0 O-C-N 124.037 0.836 . . . . 0.0 112.5 175.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 70.8 mtm -85.23 150.36 24.85 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.113 0.483 . . . . 0.0 111.834 -176.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -151.67 -176.61 5.69 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 176.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.415 ' HA ' ' H ' ' A' ' 16' ' ' LYS . 1.3 m-20 -57.33 119.5 6.55 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -177.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.459 ' HB2' ' HE2' ' A' ' 16' ' ' LYS . 18.5 t70 63.22 35.41 12.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 113.972 -1.467 . . . . 0.0 111.082 175.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -76.78 177.66 7.44 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.269 177.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 30.9 m -108.96 138.48 35.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 CA-C-O 121.772 0.796 . . . . 0.0 112.455 -174.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.473 HD13 HG21 ' A' ' 17' ' ' ILE . 1.6 mt -132.36 134.01 59.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.974 178.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -98.18 144.28 27.8 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.245 -174.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 84.6 t -129.13 133.98 64.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.993 178.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.581 ' CD1' HD11 ' A' ' 58' ' ' LEU . 57.4 m-85 -98.13 156.71 16.54 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.288 177.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 43.6 tp60 -68.0 133.14 48.53 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.195 0.522 . . . . 0.0 111.097 -171.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.2 pm0 -65.6 158.0 28.34 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.434 -0.803 . . . . 0.0 113.12 -174.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.426 ' H ' ' HB3' ' A' ' 54' ' ' SER . 82.7 mm-40 -72.53 -48.33 41.11 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.992 -177.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.416 ' HB3' HG12 ' A' ' 50' ' ' VAL . 60.5 tp . . . . . 0 C--N 1.312 -1.046 0 CA-C-N 114.708 -1.133 . . . . 0.0 111.758 -177.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 . . . . . 0 CA--C 1.5 -0.956 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.3 pt -120.12 162.46 18.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -176.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.488 ' HD2' ' CG ' ' A' ' 78' ' ' ASP . 38.9 ttmt -101.0 143.55 31.01 Favored 'General case' 0 C--N 1.286 -2.172 0 CA-C-O 121.006 0.432 . . . . 0.0 110.733 179.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.478 HG21 HD13 ' A' ' 81' ' ' ILE . 41.7 mm -127.58 129.56 70.33 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.783 177.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.5 mtmt -100.1 104.16 15.7 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 176.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.711 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 96.7 t -82.41 118.38 30.03 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.52 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.6 t -113.76 118.25 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 CA-C-O 120.927 0.394 . . . . 0.0 109.967 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -90.86 175.35 40.08 Favored Glycine 0 C--N 1.314 -0.693 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.49 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.528 ' C ' ' H ' ' A' ' 24' ' ' SER . 98.8 mt-30 -64.51 -34.18 77.63 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 121.235 0.541 . . . . 0.0 110.896 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -70.0 8.69 0.68 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.956 176.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.528 ' H ' ' C ' ' A' ' 22' ' ' GLN . 49.9 m 65.96 27.88 10.68 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.859 0.838 . . . . 0.0 109.059 -176.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -87.06 104.87 16.74 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.468 -177.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.711 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 42.6 tt0 -104.61 131.88 51.51 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.588 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.4 p -138.05 137.83 44.15 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.598 179.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 37.7 m170 -97.1 111.18 23.52 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.185 0.516 . . . . 0.0 111.644 -176.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -110.57 149.59 30.16 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.818 176.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 18.4 tpt180 -103.34 121.54 42.96 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 30.9 m -134.86 174.27 13.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.35 -177.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -88.11 155.28 19.87 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -52.98 -39.0 62.69 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 175.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.513 ' CA ' ' HG3' ' A' ' 70' ' ' PRO . . . -106.86 33.2 6.59 Favored Glycine 0 C--N 1.334 0.44 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.744 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.471 HG23 ' HB2' ' A' ' 39' ' ' LYS . 0.9 OUTLIER -64.38 136.5 57.18 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-O 121.526 0.679 . . . . 0.0 112.442 179.22 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 69.6 m -85.61 155.11 21.27 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.091 -0.958 . . . . 0.0 109.875 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.466 ' HB2' ' HZ3' ' A' ' 41' ' ' LYS . 25.7 ptt? -50.87 -30.49 14.68 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -176.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.49 -37.96 85.56 Favored 'General case' 0 C--O 1.217 -0.642 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 -178.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.471 ' HB2' HG23 ' A' ' 35' ' ' THR . 31.1 mmmt -60.6 -40.03 90.31 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.049 -176.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.425 HD12 ' CG ' ' A' ' 57' ' ' PHE . 0.2 OUTLIER -86.49 -46.05 10.54 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.782 -178.465 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.466 ' HZ3' ' HB2' ' A' ' 37' ' ' MET . 46.4 mttp -62.02 -46.61 88.41 Favored 'General case' 0 C--O 1.212 -0.892 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.43 -178.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -62.47 -42.53 99.55 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.079 0.466 . . . . 0.0 110.058 177.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 45.7 t -62.98 -50.07 72.2 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.289 -176.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.636 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 42.0 t80 -71.43 -43.81 66.01 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.787 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.59 ' HB2' ' O ' ' A' ' 50' ' ' VAL . . . -57.82 -33.26 68.42 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.364 0.602 . . . . 0.0 109.741 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -63.05 -47.72 81.78 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.188 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.636 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 3.5 ptm180 -68.62 -27.84 66.38 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.411 -177.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.476 HG21 ' O ' ' A' ' 44' ' ' TYR . 8.9 t -96.64 -10.77 26.33 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -177.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.56 35.26 67.75 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.248 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.59 ' O ' ' HB2' ' A' ' 45' ' ' ALA . 73.7 t -119.32 149.65 21.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 C-N-CA 122.713 0.405 . . . . 0.0 110.891 -177.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.455 ' HB3' ' OG ' ' A' ' 54' ' ' SER . . . -51.81 136.19 28.33 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.347 176.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 76.8 t -60.9 -44.3 97.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.277 -177.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -77.14 -10.01 59.12 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.093 0.473 . . . . 0.0 110.954 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.455 ' OG ' ' HB3' ' A' ' 51' ' ' ALA . 74.9 m -87.36 -10.51 51.95 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.18 176.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -96.34 130.05 43.53 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 177.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.458 ' HD3' ' O ' ' A' ' 85' ' ' GLN . 0.0 OUTLIER -122.49 117.06 25.04 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 121.423 0.63 . . . . 0.0 111.334 -176.696 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.569 ' HZ ' ' CB ' ' A' ' 44' ' ' TYR . 32.6 m-85 -106.14 128.36 53.84 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.529 178.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.493 ' HG ' ' HA ' ' A' ' 63' ' ' ARG . 7.8 mp -121.6 136.12 54.96 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.423 179.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.588 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 83.8 t80 -105.3 116.0 31.22 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 178.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 55.44 23.18 5.59 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.848 -0.614 . . . . 0.0 112.393 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 102.06 2.29 51.68 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 121.089 -0.577 . . . . 0.0 113.514 176.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.588 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -120.29 140.93 50.5 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 117.175 0.488 . . . . 0.0 109.98 176.702 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.493 ' HA ' ' HG ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -68.44 137.56 54.58 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.282 0.563 . . . . 0.0 112.05 -175.347 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 87.1 mt -82.66 125.16 39.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.581 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -99.21 162.94 12.77 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.495 -177.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -81.79 -6.52 59.14 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 174.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -101.65 -6.28 23.98 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.332 -178.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -62.2 148.77 43.62 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.253 0.549 . . . . 0.0 112.149 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 49.9 p -113.87 159.53 35.6 Favored Pre-proline 0 C--N 1.319 -0.749 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.531 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.513 ' HG3' ' CA ' ' A' ' 34' ' ' GLY . 77.8 Cg_exo -55.33 -39.38 91.29 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.904 2.403 . . . . 0.0 112.407 -178.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.529 ' HG3' ' H ' ' A' ' 72' ' ' THR . 17.3 ptmt -69.01 -46.76 67.2 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -177.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.529 ' H ' ' HG3' ' A' ' 71' ' ' LYS . 9.0 t -67.19 -27.01 66.91 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-O 120.924 0.393 . . . . 0.0 110.875 -177.263 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 93.7 mt -90.95 -22.55 20.8 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.676 178.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 43.4 47.8 5.91 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.927 -177.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 74.2 mtm -85.24 161.12 19.7 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.913 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -147.65 -178.39 6.23 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.376 178.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.432 ' HA ' ' H ' ' A' ' 16' ' ' LYS . 34.3 t70 -65.42 120.1 12.22 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.028 0.442 . . . . 0.0 111.357 -178.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.488 ' CG ' ' HD2' ' A' ' 16' ' ' LYS . 3.0 m-20 74.9 33.2 0.77 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.19 1.396 . . . . 0.0 111.783 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -70.43 176.4 4.05 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 177.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.9 t -118.36 136.66 54.84 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 CA-C-O 121.431 0.634 . . . . 0.0 111.163 -174.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.478 HD13 HG21 ' A' ' 17' ' ' ILE . 1.8 mt -131.64 138.85 51.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.307 -177.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -102.85 145.47 29.74 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.255 -173.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 90.7 t -126.59 131.01 71.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.26 178.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.436 ' CE1' HD22 ' A' ' 58' ' ' LEU . 78.6 m-85 -99.72 168.56 9.84 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.684 177.014 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.458 ' O ' ' HD3' ' A' ' 56' ' ' ARG . 43.9 tp60 -66.88 129.9 41.39 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.394 0.616 . . . . 0.0 111.188 -170.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.427 ' HB2' HG12 ' A' ' 50' ' ' VAL . 4.1 pm0 -65.66 154.1 39.8 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.958 -1.019 . . . . 0.0 112.714 -177.079 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.407 ' HB3' ' CB ' ' A' ' 54' ' ' SER . 61.0 tp60 -72.11 -42.76 65.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.98 -176.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.437 ' HB3' HG13 ' A' ' 50' ' ' VAL . 57.1 tp . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.009 -178.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 32' ' ' LYS . 98.4 m-85 . . . . . 0 N--CA 1.435 -1.184 0 CA-C-O 121.544 0.687 . . . . 0.0 111.438 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.473 ' HA ' ' OD1' ' A' ' 77' ' ' ASP . 21.8 pt -132.21 162.6 39.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 CA-C-N 114.588 -1.187 . . . . 0.0 108.552 -178.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.454 ' H ' ' HA ' ' A' ' 77' ' ' ASP . 56.5 mtmt -92.88 147.36 22.91 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 121.059 0.457 . . . . 0.0 110.664 175.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.473 ' CD1' HG22 ' A' ' 31' ' ' VAL . 9.4 mt -128.34 131.75 68.79 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.449 173.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.41 ' HD3' ' OD2' ' A' ' 78' ' ' ASP . 27.4 mtmt -98.93 104.71 16.78 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 176.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.624 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 98.5 t -82.29 115.54 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.1 t -106.06 116.56 50.09 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.461 ' HA2' ' HB ' ' A' ' 83' ' ' VAL . . . -85.16 174.3 49.13 Favored Glycine 0 C--N 1.309 -0.951 0 C-N-CA 120.191 -1.004 . . . . 0.0 112.0 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.411 ' C ' ' H ' ' A' ' 24' ' ' SER . 98.3 mt-30 -70.11 -21.88 63.07 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-O 121.447 0.641 . . . . 0.0 110.371 178.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -74.62 0.78 13.91 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.28 174.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.411 ' H ' ' C ' ' A' ' 22' ' ' GLN . 8.6 t 69.32 26.63 5.28 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -176.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -90.86 106.74 18.73 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-N 114.687 -1.142 . . . . 0.0 110.281 -179.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.624 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 29.4 tt0 -98.83 125.99 44.35 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.453 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.1 p -129.5 139.94 50.39 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.887 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 60.6 m170 -97.67 115.75 28.54 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.441 -175.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -111.55 148.39 33.36 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.706 175.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 26.2 tpt180 -99.22 120.27 39.25 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.473 HG22 ' CD1' ' A' ' 17' ' ' ILE . 33.0 m -135.86 172.45 15.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.537 -176.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 14' ' ' TYR . 36.9 tttm -90.38 160.76 15.92 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -54.21 -38.42 65.65 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-O 120.996 0.427 . . . . 0.0 110.275 175.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.642 ' CA ' ' HG3' ' A' ' 70' ' ' PRO . . . -98.82 25.88 26.36 Favored Glycine 0 CA--C 1.492 -1.389 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.858 -178.058 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.498 HG23 ' HB2' ' A' ' 39' ' ' LYS . 1.1 m -68.48 124.7 24.27 Favored 'General case' 0 N--CA 1.41 -2.457 0 CA-C-O 121.673 0.749 . . . . 0.0 111.773 178.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.547 ' HB3' ' HA ' ' A' ' 66' ' ' ASP . 41.2 m -91.82 167.53 12.08 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 114.482 -1.235 . . . . 0.0 109.537 178.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.452 ' HB2' ' CD ' ' A' ' 41' ' ' LYS . 25.2 ptt? -47.32 -39.32 14.53 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -175.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.84 -37.33 81.7 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -175.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.498 ' HB2' HG23 ' A' ' 35' ' ' THR . 29.9 mmmt -60.47 -41.64 94.61 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.273 -176.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.499 HD11 ' CD2' ' A' ' 57' ' ' PHE . 0.5 OUTLIER -88.95 -44.08 10.69 Favored 'General case' 0 C--O 1.22 -0.489 0 N-CA-C 112.438 0.532 . . . . 0.0 112.438 -178.964 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.617 ' HE3' ' O ' ' A' ' 55' ' ' LEU . 60.8 mtpt -61.74 -46.79 88.09 Favored 'General case' 0 CA--C 1.488 -1.439 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.798 -176.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.408 ' HA ' HG21 ' A' ' 52' ' ' VAL . 39.0 ttpt -62.12 -40.8 97.14 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 66.6 m -65.59 -49.05 70.22 Favored 'General case' 0 CA--C 1.552 1.021 0 CA-C-N 115.215 -0.902 . . . . 0.0 112.407 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.646 ' O ' ' HG3' ' A' ' 47' ' ' ARG . 59.7 t80 -71.08 -45.13 64.32 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.949 -179.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.622 ' HB1' ' O ' ' A' ' 50' ' ' VAL . . . -58.48 -34.19 70.63 Favored 'General case' 0 CA--C 1.501 -0.914 0 CA-C-O 121.443 0.639 . . . . 0.0 109.585 -178.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -63.08 -48.14 79.92 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.046 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.646 ' HG3' ' O ' ' A' ' 44' ' ' TYR . 0.0 OUTLIER -69.25 -22.66 63.83 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.967 -0.56 . . . . 0.0 112.19 -176.324 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.482 HG23 ' O ' ' A' ' 44' ' ' TYR . 8.8 t -103.3 -7.27 21.24 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.909 0.385 . . . . 0.0 111.939 -177.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.25 31.99 65.75 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.544 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.622 ' O ' ' HB1' ' A' ' 45' ' ' ALA . 80.6 t -113.53 147.29 17.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 C-N-CA 122.886 0.474 . . . . 0.0 110.343 -178.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.596 ' HB2' ' OG ' ' A' ' 54' ' ' SER . . . -56.49 136.52 54.09 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.316 -0.402 . . . . 0.0 109.995 176.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.408 HG21 ' HA ' ' A' ' 42' ' ' LYS . 73.1 t -62.12 -44.4 98.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.469 -176.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -69.29 -31.42 69.9 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.522 -177.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.596 ' OG ' ' HB2' ' A' ' 51' ' ' ALA . 89.8 p -87.42 2.82 49.35 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 120.664 -0.414 . . . . 0.0 111.481 -179.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.617 ' O ' ' HE3' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -94.83 121.73 36.72 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 174.147 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -117.15 117.89 30.83 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 119.875 -0.73 . . . . 0.0 112.343 -173.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.499 ' CD2' HD11 ' A' ' 40' ' ' LEU . 45.7 m-85 -108.91 130.03 55.43 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.595 176.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.567 HD11 ' CD1' ' A' ' 84' ' ' TYR . 8.0 mp -122.61 144.65 48.98 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 121.466 0.65 . . . . 0.0 111.226 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.67 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 64.5 t80 -118.37 115.1 23.99 Favored 'General case' 0 N--CA 1.426 -1.674 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.081 178.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 53.38 29.15 8.31 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.426 -178.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 96.01 -1.55 63.17 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.958 -0.564 . . . . 0.0 113.435 176.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.67 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -113.62 136.44 52.82 Favored 'General case' 0 CA--C 1.491 -1.326 0 CA-C-O 121.289 0.566 . . . . 0.0 109.672 177.5 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.507 ' HA ' ' HG ' ' A' ' 58' ' ' LEU . 30.1 ptt180 -72.38 133.74 45.08 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.168 -177.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.492 ' HA ' ' NH1' ' A' ' 62' ' ' ARG . 68.7 mt -75.61 132.83 32.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 CA-C-N 114.462 -1.244 . . . . 0.0 108.856 -178.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -109.57 169.82 8.46 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.09 0.471 . . . . 0.0 110.758 -175.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.547 ' HA ' ' HB3' ' A' ' 36' ' ' SER . 7.2 p-10 -82.9 -6.33 59.41 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.159 0.504 . . . . 0.0 109.667 175.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -101.3 -16.63 16.88 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.419 -0.809 . . . . 0.0 113.157 -175.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.6 p30 -68.78 161.57 28.18 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -175.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.439 ' O ' HG23 ' A' ' 72' ' ' THR . 72.0 p -129.9 166.72 24.19 Favored Pre-proline 0 CA--C 1.548 0.901 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.415 -174.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.642 ' HG3' ' CA ' ' A' ' 34' ' ' GLY . 57.2 Cg_exo -54.46 -39.91 85.71 Favored 'Trans proline' 0 C--N 1.369 1.623 0 C-N-CA 123.108 2.539 . . . . 0.0 113.318 -176.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.522 ' HD3' ' N ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -70.27 -23.77 62.94 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 -176.175 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.522 ' N ' ' HD3' ' A' ' 71' ' ' LYS . 5.1 t -95.34 -25.42 16.31 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.194 0.521 . . . . 0.0 110.117 -177.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.442 ' HB3' ' HG3' ' A' ' 75' ' ' MET . 92.7 mt -89.79 -24.34 21.49 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.936 178.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 46.5 30.96 1.19 Allowed 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.555 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.442 ' HG3' ' HB3' ' A' ' 73' ' ' LEU . 66.7 mtt -79.03 153.0 30.58 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.006 -179.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -150.54 -174.81 4.87 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.473 ' OD1' ' HA ' ' A' ' 15' ' ' ILE . 20.0 m-20 -55.0 126.1 23.16 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 -177.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.43 ' HB2' ' HE3' ' A' ' 16' ' ' LYS . 9.0 t70 67.21 35.42 4.47 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 113.882 -1.508 . . . . 0.0 111.489 173.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -70.63 176.38 4.19 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.845 177.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 30.7 m -110.11 136.52 45.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-O 121.588 0.708 . . . . 0.0 111.858 -175.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.453 HD13 HD11 ' A' ' 64' ' ' ILE . 10.8 mm -131.99 137.61 54.42 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.09 -178.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -107.33 142.75 36.63 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.361 -177.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.461 ' HB ' ' HA2' ' A' ' 21' ' ' GLY . 93.4 t -124.55 133.5 69.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-O 121.009 0.433 . . . . 0.0 111.29 178.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.567 ' CD1' HD11 ' A' ' 58' ' ' LEU . 46.7 m-85 -100.23 167.69 10.27 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.492 178.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -67.85 124.65 23.92 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.496 0.665 . . . . 0.0 110.691 -173.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.532 ' HG2' HD22 ' A' ' 55' ' ' LEU . 2.2 mp0 -82.59 162.02 22.07 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.6 -177.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -69.03 -40.09 78.82 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.105 177.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.491 ' HB2' HG11 ' A' ' 50' ' ' VAL . 10.9 mp . . . . . 0 C--N 1.332 -0.169 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.713 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 . . . . . 0 N--CA 1.45 -0.437 0 CA-C-O 121.19 0.519 . . . . 0.0 111.689 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.507 ' O ' ' HD2' ' A' ' 30' ' ' ARG . 23.7 pt -122.45 163.14 21.32 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.414 -176.116 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.543 ' HZ3' ' CG ' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -91.53 144.93 25.04 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.253 178.042 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.448 HD13 HG21 ' A' ' 31' ' ' VAL . 67.8 mt -139.12 133.9 40.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-O 120.87 0.367 . . . . 0.0 111.32 172.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 18.4 mtmt -96.43 106.15 18.34 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.649 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 81.1 t -81.25 116.76 26.1 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 176.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 59.9 t -112.63 117.76 56.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 120.929 0.395 . . . . 0.0 110.095 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.479 ' HA2' ' HB ' ' A' ' 83' ' ' VAL . . . -92.25 171.24 33.66 Favored Glycine 0 C--N 1.314 -0.665 0 C-N-CA 120.434 -0.888 . . . . 0.0 112.588 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.485 ' C ' ' H ' ' A' ' 24' ' ' SER . 97.7 mt-30 -66.45 -27.45 67.82 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 121.232 0.539 . . . . 0.0 110.674 179.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -69.86 4.17 2.17 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.917 175.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.485 ' H ' ' C ' ' A' ' 22' ' ' GLN . 50.9 m 67.54 27.79 7.76 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.878 0.847 . . . . 0.0 109.12 -176.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -91.95 104.83 17.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-N 114.576 -1.193 . . . . 0.0 110.952 -178.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.649 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 30.6 tt0 -100.73 129.53 46.64 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.851 176.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.402 ' CG1' ' HB ' ' A' ' 19' ' ' VAL . 7.5 p -133.26 140.18 47.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.041 179.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 51.4 m170 -94.73 112.87 24.59 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.164 -176.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -110.64 147.36 34.44 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.425 177.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.507 ' HD2' ' O ' ' A' ' 15' ' ' ILE . 12.4 tpt180 -105.17 116.0 31.21 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 175.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.448 HG21 HD13 ' A' ' 17' ' ' ILE . 35.3 m -137.86 172.72 13.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.918 -176.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -89.33 159.92 17.13 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 -177.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -55.04 -38.3 67.79 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.073 0.463 . . . . 0.0 109.753 173.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -100.04 25.92 26.44 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.767 -177.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.483 HG23 ' HB2' ' A' ' 39' ' ' LYS . 1.2 m -71.39 128.44 35.87 Favored 'General case' 0 N--CA 1.425 -1.682 0 CA-C-O 121.529 0.681 . . . . 0.0 112.418 179.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.504 ' HB3' ' HA ' ' A' ' 66' ' ' ASP . 66.9 m -93.11 164.15 13.37 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 114.759 -1.11 . . . . 0.0 111.045 -179.15 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.527 ' SD ' ' HA ' ' A' ' 65' ' ' ASN . 24.3 ptt? -47.14 -39.21 13.09 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -174.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.76 -37.18 80.94 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -175.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.483 ' HB2' HG23 ' A' ' 35' ' ' THR . 75.8 mmtt -61.1 -40.51 94.03 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.52 -176.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.547 HD12 ' CD2' ' A' ' 57' ' ' PHE . 0.3 OUTLIER -88.06 -44.49 10.92 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.376 -178.618 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.506 ' HG2' ' CD1' ' A' ' 57' ' ' PHE . 61.6 mtpt -62.87 -45.3 93.22 Favored 'General case' 0 CA--C 1.489 -1.376 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.71 -176.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -61.22 -43.3 99.1 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 176.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 44.5 t -65.78 -51.44 59.11 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.426 -0.806 . . . . 0.0 112.1 -176.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.534 ' O ' HG21 ' A' ' 48' ' ' THR . 41.9 t80 -66.85 -46.57 74.65 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 120.769 0.319 . . . . 0.0 111.488 -179.191 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.57 -35.08 75.19 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.413 0.625 . . . . 0.0 109.883 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -64.5 -47.37 79.16 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.343 -178.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.495 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 15.4 ptm180 -65.72 -28.5 69.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.539 -177.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.534 HG21 ' O ' ' A' ' 44' ' ' TYR . 7.0 t -93.57 -8.24 41.83 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.234 -179.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.12 30.99 69.33 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.941 -0.647 . . . . 0.0 113.12 178.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.5 p -115.09 169.28 6.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -178.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.421 ' HB3' ' HB3' ' A' ' 54' ' ' SER . . . -60.41 136.81 58.16 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.775 0.321 . . . . 0.0 110.666 178.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 79.7 t -61.96 -44.24 98.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-O 121.396 0.617 . . . . 0.0 109.857 179.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -71.33 -21.74 62.01 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.827 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.448 ' HB2' ' HB3' ' A' ' 87' ' ' GLN . 85.2 p -75.75 -12.59 60.21 Favored 'General case' 0 CA--C 1.52 -0.189 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.533 179.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.505 HD11 ' CE1' ' A' ' 57' ' ' PHE . 0.1 OUTLIER -94.45 132.72 38.8 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 177.469 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.72 120.11 25.85 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.125 0.488 . . . . 0.0 110.524 -179.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.547 ' CD2' HD12 ' A' ' 40' ' ' LEU . 32.9 m-85 -110.29 134.3 52.4 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.46 -179.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.523 HD11 ' CD1' ' A' ' 84' ' ' TYR . 7.1 mp -126.75 145.54 50.57 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.906 178.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.778 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 89.2 t80 -117.41 118.32 31.9 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 176.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 30.8 t70 54.05 29.74 10.73 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.738 0.78 . . . . 0.0 111.56 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 90.26 6.08 69.23 Favored Glycine 0 C--N 1.313 -0.741 0 CA-C-N 115.612 -0.722 . . . . 0.0 113.539 176.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.778 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -116.9 143.88 45.18 Favored 'General case' 0 CA--C 1.503 -0.838 0 CA-C-O 121.12 0.486 . . . . 0.0 109.752 177.102 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.492 ' HA ' ' HG ' ' A' ' 58' ' ' LEU . 34.6 mtp-105 -73.14 128.47 35.57 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.001 -175.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 74.6 mt -79.61 129.57 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 177.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.527 ' HA ' ' SD ' ' A' ' 37' ' ' MET . 93.7 m-20 -125.23 176.62 6.62 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 121.169 0.509 . . . . 0.0 111.443 -173.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.504 ' HA ' ' HB3' ' A' ' 36' ' ' SER . 8.9 p-10 -82.98 -6.58 59.54 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.571 177.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -102.16 -13.22 17.54 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.314 -176.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.402 ' HB3' HH22 ' A' ' 62' ' ' ARG . 20.2 p30 -70.97 165.29 23.73 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -176.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.478 ' O ' HG23 ' A' ' 72' ' ' THR . 42.5 p -123.56 159.63 54.47 Favored Pre-proline 0 N--CA 1.443 -0.78 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.056 -175.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.452 ' HD2' ' HB ' ' A' ' 69' ' ' THR . 19.3 Cg_endo -58.61 -31.15 94.04 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.927 2.418 . . . . 0.0 114.097 -176.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.68 -28.55 36.74 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 119.586 -0.845 . . . . 0.0 111.87 -177.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.478 HG23 ' O ' ' A' ' 69' ' ' THR . 12.1 t -79.24 -30.78 43.35 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 120.071 -0.652 . . . . 0.0 109.308 178.257 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 94.9 mt -76.65 -23.16 53.3 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.262 175.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 46.21 34.24 2.08 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.119 177.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 61.6 mtt -72.36 154.11 41.1 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.774 -177.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -151.13 175.22 12.34 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.543 ' CG ' ' HZ3' ' A' ' 16' ' ' LYS . 38.7 t70 -58.7 122.07 12.61 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.801 0.81 . . . . 0.0 112.76 -177.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.6 t70 66.45 34.74 6.01 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 113.788 -1.551 . . . . 0.0 111.701 177.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -74.8 178.45 5.48 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 175.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 36.0 m -117.26 147.77 20.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 CA-C-O 121.763 0.792 . . . . 0.0 112.87 -175.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 7.6 mt -128.73 138.25 55.1 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-N 114.318 -1.31 . . . . 0.0 110.164 178.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -104.52 140.45 37.96 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.813 0.34 . . . . 0.0 110.613 -176.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.479 ' HB ' ' HA2' ' A' ' 21' ' ' GLY . 98.4 t -126.42 134.37 66.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-O 121.221 0.534 . . . . 0.0 111.938 -178.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.523 ' CD1' HD11 ' A' ' 58' ' ' LEU . 78.3 m-85 -99.38 168.69 9.84 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.739 177.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -66.4 133.01 49.59 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.367 0.603 . . . . 0.0 111.499 -172.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.412 ' HA ' ' O ' ' A' ' 54' ' ' SER . 1.7 mp0 -61.68 151.89 32.44 Favored 'General case' 0 CA--C 1.497 -1.079 0 CA-C-N 115.125 -0.943 . . . . 0.0 112.021 -177.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.448 ' HB3' ' HB2' ' A' ' 54' ' ' SER . 60.5 tp60 -69.19 -40.06 78.29 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.533 179.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.0 mm? . . . . . 0 C--O 1.226 -0.184 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.212 -179.115 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 . . . . . 0 N--CA 1.439 -0.997 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.5 pt -114.98 161.44 13.73 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -176.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -103.61 142.82 33.64 Favored 'General case' 0 C--N 1.282 -2.326 0 C-N-CA 120.572 -0.451 . . . . 0.0 109.958 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.428 HG23 HD11 ' A' ' 81' ' ' ILE . 41.0 mm -123.59 127.99 74.32 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.169 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.799 177.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.1 mtmt -101.6 103.69 14.52 Favored 'General case' 0 N--CA 1.423 -1.802 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 177.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.767 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 91.3 t -81.69 121.98 35.9 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.87 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 62.0 t -109.99 121.48 62.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.16 0.505 . . . . 0.0 110.285 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -90.97 -174.11 43.94 Favored Glycine 0 CA--C 1.52 0.371 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.937 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.417 ' C ' ' H ' ' A' ' 24' ' ' SER . 16.6 mm100 -63.75 -38.59 91.68 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -177.074 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.612 ' HB2' ' OD1' ' A' ' 25' ' ' ASN . 16.0 m-20 -87.33 22.06 2.26 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 178.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.417 ' H ' ' C ' ' A' ' 22' ' ' GLN . 48.9 m 65.35 31.76 10.23 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.863 -178.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.612 ' OD1' ' HB2' ' A' ' 23' ' ' ASP . 14.9 m120 -78.67 106.74 10.86 Favored 'General case' 0 CA--C 1.501 -0.924 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.755 -178.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.767 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 36.6 tt0 -103.08 134.63 46.18 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-O 121.195 0.521 . . . . 0.0 111.279 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.7 p -136.12 141.92 40.2 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.198 178.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 35.6 m170 -101.69 115.14 29.86 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.264 0.554 . . . . 0.0 111.817 -176.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -115.51 148.07 39.92 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.37 175.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 21.4 tpp180 -103.11 120.56 40.91 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 177.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 32.5 m -134.58 172.22 16.5 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.449 -178.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -89.99 162.56 15.32 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.404 ' C ' ' HB3' ' A' ' 70' ' ' PRO . 83.3 m-85 -56.37 -39.85 73.59 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 175.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -101.22 33.06 6.77 Favored Glycine 0 N--CA 1.446 -0.651 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.388 -179.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.431 HG22 ' HB2' ' A' ' 39' ' ' LYS . 0.9 OUTLIER -68.75 133.42 48.35 Favored 'General case' 0 N--CA 1.428 -1.537 0 CA-C-O 121.47 0.652 . . . . 0.0 111.953 177.908 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.428 ' OG ' ' HG2' ' A' ' 39' ' ' LYS . 86.7 p -78.44 161.6 26.99 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.293 -179.359 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.629 ' SD ' ' HA ' ' A' ' 65' ' ' ASN . 26.2 ptt? -59.61 -32.29 70.27 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.898 0.38 . . . . 0.0 111.004 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.17 -36.87 83.19 Favored 'General case' 0 C--O 1.219 -0.537 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.628 -177.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.431 ' HB2' HG22 ' A' ' 35' ' ' THR . 32.4 mmmt -59.97 -40.86 90.56 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.609 -175.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.468 HD11 ' CG ' ' A' ' 57' ' ' PHE . 0.4 OUTLIER -87.82 -45.87 9.93 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -179.534 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -62.65 -45.32 93.36 Favored 'General case' 0 CA--C 1.501 -0.93 0 N-CA-C 111.798 0.295 . . . . 0.0 111.798 -176.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.512 ' O ' ' HB2' ' A' ' 46' ' ' ASP . 40.0 ttpt -61.95 -42.12 98.75 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.614 176.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.432 ' O ' ' HB3' ' A' ' 46' ' ' ASP . 38.2 t -68.75 -51.17 44.13 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.286 -176.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.473 ' O ' HG21 ' A' ' 48' ' ' THR . 48.7 t80 -68.3 -48.01 66.1 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.9 -178.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.21 -29.34 68.67 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 121.631 0.729 . . . . 0.0 109.679 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.512 ' HB2' ' O ' ' A' ' 42' ' ' LYS . 22.2 t70 -63.16 -46.74 85.76 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.749 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.469 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 25.9 ptt180 -69.09 -30.47 68.79 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.008 0.432 . . . . 0.0 110.926 -175.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.473 HG21 ' O ' ' A' ' 44' ' ' TYR . 4.8 t -92.46 -21.53 20.11 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.83 -175.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.3 23.32 57.08 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.39 -0.909 . . . . 0.0 112.985 179.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.423 HG11 HD22 ' A' ' 55' ' ' LEU . 7.8 p -98.74 158.94 3.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.002 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.536 ' HB3' ' OG ' ' A' ' 54' ' ' SER . . . -59.96 132.72 54.83 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 177.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 71.1 t -61.3 -44.19 97.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.158 0.504 . . . . 0.0 110.598 -178.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -66.63 -32.92 74.55 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.015 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.536 ' OG ' ' HB3' ' A' ' 51' ' ' ALA . 83.1 p -76.25 -13.21 60.17 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.302 -0.408 . . . . 0.0 112.066 -178.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.518 HD12 ' CE1' ' A' ' 57' ' ' PHE . 0.6 OUTLIER -95.56 128.5 42.47 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -178.196 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -121.82 126.86 49.74 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.906 -175.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.518 ' CE1' HD12 ' A' ' 55' ' ' LEU . 65.8 m-85 -106.14 129.83 54.14 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.094 173.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.506 ' HG ' ' HA ' ' A' ' 63' ' ' ARG . 8.1 mp -126.47 147.24 49.85 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 121.21 0.529 . . . . 0.0 111.103 -179.169 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.735 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 45.1 t80 -118.06 114.39 23.05 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 55.89 29.7 14.62 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.097 0.475 . . . . 0.0 112.258 -177.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 92.35 6.78 64.22 Favored Glycine 0 C--N 1.313 -0.717 0 C-N-CA 120.902 -0.666 . . . . 0.0 113.776 175.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.735 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.1 OUTLIER -120.84 136.6 54.87 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 117.204 0.502 . . . . 0.0 109.677 176.708 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.506 ' HA ' ' HG ' ' A' ' 58' ' ' LEU . 5.7 ptm180 -66.92 141.84 57.49 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.309 -0.86 . . . . 0.0 112.542 -175.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 77.7 mt -95.28 120.52 44.8 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.228 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.629 ' HA ' ' SD ' ' A' ' 37' ' ' MET . 21.3 m120 -119.56 164.75 15.37 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.065 0.459 . . . . 0.0 111.376 -178.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -70.66 -12.19 61.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.797 179.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -81.51 -21.01 38.91 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.083 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.441 ' CG ' HH12 ' A' ' 62' ' ' ARG . 66.0 m-20 -74.78 143.54 43.97 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -175.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.432 ' HB ' ' HD2' ' A' ' 70' ' ' PRO . 82.8 p -91.55 161.4 34.41 Favored Pre-proline 0 C--N 1.318 -0.792 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.872 177.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.432 ' HD2' ' HB ' ' A' ' 69' ' ' THR . 19.1 Cg_endo -60.04 -26.69 83.12 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.485 2.124 . . . . 0.0 111.766 177.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.07 -40.44 38.53 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.206 -177.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.1 t -75.83 -31.34 59.31 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.676 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 97.4 mt -71.98 -25.52 61.88 Favored 'General case' 0 C--O 1.213 -0.837 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.36 177.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 52.19 24.2 2.68 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 123.58 0.752 . . . . 0.0 112.926 174.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 23.4 ptp -79.62 161.1 26.1 Favored 'General case' 0 C--N 1.321 -0.643 0 O-C-N 122.123 -0.36 . . . . 0.0 110.982 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -143.74 -178.9 6.14 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -178.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -66.46 118.51 10.19 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.304 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 17.9 t70 71.27 33.54 1.95 Allowed 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.715 1.206 . . . . 0.0 110.475 178.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -84.02 177.36 8.3 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 176.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.5 m -110.47 149.27 13.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 CA-C-O 121.539 0.685 . . . . 0.0 111.836 -174.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.428 HD11 HG23 ' A' ' 17' ' ' ILE . 1.0 OUTLIER -137.61 138.93 44.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 CA-C-N 114.763 -1.108 . . . . 0.0 109.905 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -100.24 146.18 27.2 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.993 0.425 . . . . 0.0 111.499 -174.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 84.0 t -118.62 129.22 75.18 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.252 175.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.476 ' CE1' HD23 ' A' ' 58' ' ' LEU . 60.2 m-85 -100.55 169.42 9.07 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.224 177.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -67.36 148.81 51.14 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.439 0.637 . . . . 0.0 111.536 -173.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.489 ' HA ' ' O ' ' A' ' 54' ' ' SER . 0.7 OUTLIER -94.55 157.1 16.14 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 114.82 -1.082 . . . . 0.0 112.335 -175.052 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.474 ' H ' ' HB2' ' A' ' 54' ' ' SER . 53.1 tt0 -66.19 -41.78 89.78 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.112 178.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 58.8 tp . . . . . 0 C--N 1.328 -0.333 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 178.446 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 . . . . . 0 N--CA 1.443 -0.797 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.4 ' O ' ' HD3' ' A' ' 30' ' ' ARG . 4.3 pt -109.06 161.07 7.58 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -176.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.546 ' HE3' ' OD1' ' A' ' 78' ' ' ASP . 34.3 ttpt -109.82 144.69 37.9 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 -177.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.506 HG22 HD11 ' A' ' 81' ' ' ILE . 82.4 mt -130.29 133.04 64.61 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.183 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.395 178.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.0 mtmt -96.33 105.56 17.65 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 175.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.72 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 88.1 t -81.33 117.58 27.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.4 t -112.94 120.02 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 O-C-N 123.504 0.503 . . . . 0.0 109.769 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -86.42 -175.45 49.63 Favored Glycine 0 C--N 1.311 -0.821 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.746 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -62.68 -37.58 87.0 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -178.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -88.9 22.57 2.65 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 178.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 54.6 m 64.16 38.53 8.19 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.942 -178.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -79.91 102.34 9.11 Favored 'General case' 0 C--O 1.215 -0.739 0 CA-C-N 115.0 -1.0 . . . . 0.0 108.974 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.72 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 27.7 tt0 -104.35 128.41 52.18 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 120.986 0.422 . . . . 0.0 112.107 -176.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.6 p -141.65 144.07 26.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.283 177.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 61.0 m170 -91.43 117.64 29.86 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -178.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -111.76 144.95 40.21 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.859 172.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.4 ' HD3' ' O ' ' A' ' 15' ' ' ILE . 15.1 tpp180 -108.8 119.88 40.84 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 33.6 m -138.13 174.77 10.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.606 -178.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.529 ' O ' ' HB ' ' A' ' 35' ' ' THR . 36.1 ttpt -88.29 160.4 17.67 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.267 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.645 ' O ' ' HB3' ' A' ' 70' ' ' PRO . 96.7 m-85 -57.18 -44.11 83.27 Favored 'General case' 0 C--O 1.224 -0.244 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 176.379 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -93.18 21.04 42.37 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.464 -177.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.529 ' HB ' ' O ' ' A' ' 32' ' ' LYS . 0.9 OUTLIER -60.27 139.6 57.52 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-O 121.637 0.732 . . . . 0.0 112.154 179.363 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.9 m -91.35 158.42 16.55 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.433 178.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 25.3 ptt? -52.16 -33.35 39.98 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -176.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.42 -35.97 79.03 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -177.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.42 ' HB2' HG23 ' A' ' 35' ' ' THR . 75.1 mmtt -59.15 -41.3 88.01 Favored 'General case' 0 C--O 1.215 -0.749 0 CA-C-O 120.846 0.355 . . . . 0.0 110.691 -175.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.434 HD23 ' H ' ' A' ' 40' ' ' LEU . 0.4 OUTLIER -88.56 -44.19 10.84 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -179.575 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.609 ' HE3' ' O ' ' A' ' 55' ' ' LEU . 61.6 mtpt -62.52 -45.33 93.47 Favored 'General case' 0 CA--C 1.492 -1.279 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.803 -176.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -61.2 -43.58 98.65 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 176.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 58.0 m -62.84 -49.19 75.88 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.309 -176.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.477 ' CB ' ' HZ ' ' A' ' 57' ' ' PHE . 47.7 t80 -71.54 -45.93 60.97 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.735 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.518 ' HB2' ' O ' ' A' ' 50' ' ' VAL . . . -59.0 -33.36 70.62 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 121.301 0.572 . . . . 0.0 109.845 -178.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -63.02 -46.46 87.48 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.415 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 -70.84 -24.78 62.6 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.902 0.382 . . . . 0.0 111.616 -177.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.451 HG22 ' O ' ' A' ' 44' ' ' TYR . 9.9 t -97.29 -5.31 36.99 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.788 -178.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 68.52 30.56 73.13 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.312 178.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.518 ' O ' ' HB2' ' A' ' 45' ' ' ALA . 70.6 t -112.81 146.93 16.87 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 C-N-CA 122.628 0.371 . . . . 0.0 110.392 -178.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.513 ' HB3' ' OG ' ' A' ' 54' ' ' SER . . . -54.47 133.08 45.77 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.974 177.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 72.7 t -61.6 -42.86 95.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.991 -176.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 32.4 p-10 -73.73 -16.77 61.17 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.675 -177.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.513 ' OG ' ' HB3' ' A' ' 51' ' ' ALA . 96.8 p -93.82 -5.8 47.32 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.846 -0.342 . . . . 0.0 111.442 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.609 ' O ' ' HE3' ' A' ' 41' ' ' LYS . 0.1 OUTLIER -94.47 135.18 36.2 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.687 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.493 ' HD2' ' N ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -130.36 126.61 37.55 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 120.002 -0.679 . . . . 0.0 111.849 -175.844 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.477 ' HZ ' ' CB ' ' A' ' 44' ' ' TYR . 36.4 m-85 -110.27 133.14 53.54 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.39 177.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.504 HD23 ' CE1' ' A' ' 84' ' ' TYR . 9.8 mp -122.52 146.05 47.76 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.123 0.487 . . . . 0.0 111.113 -179.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.709 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 74.0 t80 -118.74 117.54 29.18 Favored 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 175.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 33.9 t70 58.17 28.3 16.3 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.741 0.781 . . . . 0.0 111.225 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 92.39 5.17 65.54 Favored Glycine 0 C--N 1.315 -0.585 0 CA-C-N 115.382 -0.826 . . . . 0.0 113.721 177.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.709 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.2 OUTLIER -122.37 134.47 54.63 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.313 0.578 . . . . 0.0 109.888 177.716 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.488 ' HA ' ' HG ' ' A' ' 58' ' ' LEU . 28.8 ptt180 -66.16 139.84 58.16 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 115.206 -0.906 . . . . 0.0 112.63 -175.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 76.5 mt -89.48 118.05 34.0 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.977 -178.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -105.71 159.85 15.67 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.514 -178.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -73.97 -14.47 61.04 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.244 0.545 . . . . 0.0 109.731 177.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -81.72 -19.16 42.06 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.78 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -72.88 147.47 45.32 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.197 0.522 . . . . 0.0 111.863 -178.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.418 ' HB ' ' HD2' ' A' ' 70' ' ' PRO . 23.3 p -97.12 160.74 28.3 Favored Pre-proline 0 N--CA 1.439 -1.013 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.545 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.645 ' HB3' ' O ' ' A' ' 33' ' ' TYR . 14.3 Cg_endo -58.21 -32.9 96.87 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.566 2.177 . . . . 0.0 112.535 -178.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.593 ' HG3' ' N ' ' A' ' 72' ' ' THR . 19.8 ptmt -69.0 -43.47 74.77 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.956 -0.565 . . . . 0.0 112.334 -179.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.593 ' N ' ' HG3' ' A' ' 71' ' ' LYS . 12.5 t -76.08 -28.75 57.71 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-O 121.248 0.547 . . . . 0.0 109.667 -178.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 96.1 mt -75.58 -21.59 57.71 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.681 175.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.526 ' HG2' ' O ' ' A' ' 71' ' ' LYS . 8.7 mm-40 52.4 34.03 14.25 Favored 'General case' 0 C--N 1.348 0.524 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 175.04 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 67.8 mtm -88.34 155.47 19.69 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 120.984 0.421 . . . . 0.0 111.526 -178.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -153.16 -175.19 5.23 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 177.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -63.85 125.25 23.76 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.758 0.79 . . . . 0.0 112.366 -176.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.546 ' OD1' ' HE3' ' A' ' 16' ' ' LYS . 24.2 t70 64.24 33.39 11.68 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.005 -1.452 . . . . 0.0 110.98 177.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -78.06 177.31 8.42 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.3 m -108.83 144.72 16.75 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 CA-C-O 121.547 0.689 . . . . 0.0 111.948 -174.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.506 HD11 HG22 ' A' ' 17' ' ' ILE . 1.2 mt -137.98 140.76 40.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.27 179.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -102.72 146.02 28.84 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.309 -175.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 97.4 t -126.44 132.37 70.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 121.081 0.467 . . . . 0.0 110.996 177.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.504 ' CE1' HD23 ' A' ' 58' ' ' LEU . 79.3 m-85 -108.47 168.75 9.1 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.452 178.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -68.05 141.66 56.11 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.7 0.762 . . . . 0.0 111.697 -173.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.493 ' HG3' HG13 ' A' ' 50' ' ' VAL . 0.5 OUTLIER -104.24 167.16 9.93 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 114.389 -1.278 . . . . 0.0 112.474 -172.621 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.478 ' HB3' ' HB2' ' A' ' 54' ' ' SER . 64.6 tt0 -64.14 -47.65 79.1 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.003 -177.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.495 HD12 ' H ' ' A' ' 51' ' ' ALA . 92.0 mt . . . . . 0 C--N 1.317 -0.813 0 CA-C-N 116.165 -0.47 . . . . 0.0 112.24 -177.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 . . . . . 0 CA--C 1.514 -0.424 0 CA-C-O 121.309 0.576 . . . . 0.0 111.1 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.2 pt -129.08 162.25 36.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.127 -177.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.513 ' HE3' ' HB2' ' A' ' 78' ' ' ASP . 55.7 mtmt -98.7 147.42 24.87 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-O 121.0 0.429 . . . . 0.0 110.308 176.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 61.3 mt -130.76 128.82 63.45 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.099 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.604 174.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.3 mtmt -95.61 104.45 16.36 Favored 'General case' 0 N--CA 1.426 -1.639 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 176.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.665 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 85.8 t -82.38 110.97 18.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 25' ' ' ASN . 5.5 p -121.66 121.68 65.04 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 CA-C-O 121.783 0.802 . . . . 0.0 111.385 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.433 ' HA2' ' HB ' ' A' ' 83' ' ' VAL . . . -91.26 169.03 32.81 Favored Glycine 0 N--CA 1.432 -1.595 0 CA-C-N 114.723 -1.126 . . . . 0.0 112.149 -179.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.513 ' C ' ' H ' ' A' ' 24' ' ' SER . 20.6 pt20 -68.15 -23.14 64.85 Favored 'General case' 0 CA--C 1.494 -1.179 0 CA-C-O 121.857 0.837 . . . . 0.0 110.859 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -70.23 7.52 0.98 Allowed 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 114.163 -1.38 . . . . 0.0 109.907 175.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.513 ' H ' ' C ' ' A' ' 22' ' ' GLN . 49.0 m 66.32 29.94 9.21 Favored 'General case' 0 C--N 1.347 0.463 0 C-N-CA 123.559 0.744 . . . . 0.0 110.363 -178.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.458 ' O ' ' HA ' ' A' ' 20' ' ' VAL . 54.7 t30 -104.59 105.57 15.73 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.564 -178.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.665 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 39.8 tt0 -108.0 132.73 53.21 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.437 0.637 . . . . 0.0 111.112 178.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.3 p -136.14 142.77 37.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.651 179.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 53.8 m170 -100.18 115.61 30.26 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 121.293 0.568 . . . . 0.0 111.791 -175.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -115.48 151.28 35.09 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.724 176.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 53.2 ttp180 -111.23 123.46 50.24 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 173.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 31.3 m -135.7 174.02 13.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.102 -176.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 24.4 ttpp -88.49 156.67 18.97 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.462 ' O ' ' HB3' ' A' ' 70' ' ' PRO . 90.1 m-85 -51.28 -41.36 60.38 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 176.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -100.27 25.49 28.11 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.844 -0.617 . . . . 0.0 113.244 -177.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.443 HG23 ' HB2' ' A' ' 39' ' ' LYS . 1.1 m -65.26 136.47 56.64 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 121.284 0.564 . . . . 0.0 111.855 178.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.441 ' HB3' ' HA ' ' A' ' 66' ' ' ASP . 49.3 m -84.85 153.95 22.61 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.06 -178.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.448 ' SD ' ' HA ' ' A' ' 65' ' ' ASN . 24.7 ptt? -48.2 -32.32 6.95 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.17 -37.79 84.18 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -176.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.443 ' HB2' HG23 ' A' ' 35' ' ' THR . 75.3 mmtt -62.16 -39.23 91.95 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.767 0.318 . . . . 0.0 110.972 -175.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.513 HD12 ' CD2' ' A' ' 57' ' ' PHE . 0.3 OUTLIER -86.88 -46.04 10.28 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 116.163 -0.471 . . . . 0.0 112.088 -178.564 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.437 ' HG2' ' CD1' ' A' ' 57' ' ' PHE . 59.0 mtpt -62.64 -48.53 78.96 Favored 'General case' 0 CA--C 1.496 -1.104 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 -177.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -63.04 -40.42 97.66 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.006 179.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 47.3 t -66.01 -51.4 58.66 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.078 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.455 ' O ' HG21 ' A' ' 48' ' ' THR . 45.2 t80 -65.34 -46.92 78.29 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.838 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.413 ' HB3' ' O ' ' A' ' 50' ' ' VAL . . . -58.53 -36.68 74.22 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-O 121.374 0.606 . . . . 0.0 109.805 -177.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -66.51 -47.94 71.37 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.227 -178.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.448 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 15.8 ptm180 -71.25 -24.35 62.16 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.73 -177.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.455 HG21 ' O ' ' A' ' 44' ' ' TYR . 12.9 t -95.67 -8.36 34.93 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.579 -178.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.73 30.94 65.5 Favored Glycine 0 C--N 1.336 0.552 0 C-N-CA 121.298 -0.477 . . . . 0.0 113.54 178.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.413 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 96.8 t -119.44 150.39 21.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 -178.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.449 ' HB1' ' OG ' ' A' ' 54' ' ' SER . . . -52.26 135.83 31.71 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.242 176.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 72.2 t -61.6 -43.41 96.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.243 -178.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -66.59 -27.24 67.56 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.52 178.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.45 ' OG ' ' HB3' ' A' ' 87' ' ' GLN . 74.2 m -75.09 -12.15 60.25 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.237 179.103 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -94.8 135.42 36.32 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.081 0.467 . . . . 0.0 110.28 177.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.46 119.25 17.23 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.127 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.513 ' CD2' HD12 ' A' ' 40' ' ' LEU . 11.0 m-85 -109.37 132.24 54.31 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.39 -179.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.477 ' HG ' ' HA ' ' A' ' 63' ' ' ARG . 9.1 mp -124.8 147.76 48.54 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 121.356 0.598 . . . . 0.0 111.654 -177.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.785 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 49.2 t80 -126.92 126.35 43.1 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 175.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 22.6 t70 58.78 24.56 12.46 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.719 0.771 . . . . 0.0 110.931 -179.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.07 5.83 87.16 Favored Glycine 0 C--N 1.312 -0.795 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.863 179.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.785 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.1 OUTLIER -113.97 144.47 43.03 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 178.046 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.477 ' HA ' ' HG ' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -71.65 132.1 44.11 Favored 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.699 -176.478 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 82.1 mt -74.68 130.72 35.88 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 N-CA-C 107.429 -1.322 . . . . 0.0 107.429 176.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.448 ' HA ' ' SD ' ' A' ' 37' ' ' MET . 15.6 m120 -112.9 165.74 12.04 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 121.236 0.541 . . . . 0.0 111.1 -173.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.441 ' HA ' ' HB3' ' A' ' 36' ' ' SER . 7.2 p-10 -82.66 -6.71 59.52 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 176.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -112.53 -2.4 14.65 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.668 -175.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 31.5 p30 -76.82 167.76 21.27 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.297 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.548 ' O ' HG23 ' A' ' 72' ' ' THR . 41.0 p -116.99 155.25 49.55 Favored Pre-proline 0 C--N 1.316 -0.857 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.702 -178.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.462 ' HB3' ' O ' ' A' ' 33' ' ' TYR . 18.5 Cg_endo -59.52 -31.22 94.23 Favored 'Trans proline' 0 C--O 1.217 -0.548 0 C-N-CA 122.375 2.05 . . . . 0.0 112.417 -178.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.571 ' HD3' ' N ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -75.53 -29.26 59.38 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -179.266 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.571 ' N ' ' HD3' ' A' ' 71' ' ' LYS . 4.9 t -76.08 -29.7 58.06 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.076 -0.65 . . . . 0.0 110.174 -178.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.532 HD22 ' NH1' ' A' ' 62' ' ' ARG . 97.7 mt -92.96 -23.72 18.62 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.355 177.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 40.19 59.14 2.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.506 -175.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 75.6 mtm -84.21 149.02 26.41 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.731 178.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -137.96 -179.29 5.68 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -178.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -64.17 118.19 8.22 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.528 0.68 . . . . 0.0 112.542 -175.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.513 ' HB2' ' HE3' ' A' ' 16' ' ' LYS . 11.8 t70 73.27 34.32 1.03 Allowed 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 113.951 -1.477 . . . . 0.0 111.17 176.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -74.84 177.22 6.39 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.638 177.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.8 t -111.85 130.69 65.0 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 CA-C-O 121.201 0.524 . . . . 0.0 110.939 -173.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.2 mp -118.69 135.1 60.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.434 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -97.59 135.86 38.81 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.589 -175.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.433 ' HB ' ' HA2' ' A' ' 21' ' ' GLY . 93.1 t -126.8 133.52 68.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 CA-C-O 121.163 0.506 . . . . 0.0 110.572 178.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -107.1 168.99 8.82 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.437 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -64.67 136.99 57.56 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-O 121.91 0.862 . . . . 0.0 111.64 -173.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.421 ' HA ' ' O ' ' A' ' 54' ' ' SER . 31.7 mp0 -70.7 156.56 39.33 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 114.169 -1.378 . . . . 0.0 112.286 -174.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.45 ' HB3' ' OG ' ' A' ' 54' ' ' SER . 61.7 tt0 -64.83 -43.98 91.31 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.015 175.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 52.8 tp . . . . . 0 N--CA 1.445 -0.721 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.101 -179.143 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 . . . . . 0 CA--C 1.495 -1.14 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.426 ' HB ' ' HA ' ' A' ' 77' ' ' ASP . 12.1 pt -116.49 160.76 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.21 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.247 -177.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -101.21 147.3 26.43 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.652 178.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 42.8 mm -127.13 126.47 68.13 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.312 176.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.7 mtmt -96.79 103.67 15.6 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 176.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.652 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 94.3 t -82.69 116.07 26.27 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.265 178.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 64.1 t -109.0 118.55 56.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -92.94 179.65 39.77 Favored Glycine 0 C--N 1.312 -0.805 0 C-N-CA 120.207 -0.997 . . . . 0.0 113.062 -178.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.404 ' C ' ' H ' ' A' ' 24' ' ' SER . 90.9 mm-40 -72.31 -20.2 61.53 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 121.468 0.651 . . . . 0.0 111.714 -178.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -83.37 10.77 7.94 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.324 -0.853 . . . . 0.0 108.963 176.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.404 ' H ' ' C ' ' A' ' 22' ' ' GLN . 40.8 m 63.65 28.47 15.03 Favored 'General case' 0 C--N 1.347 0.498 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -176.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 55.9 t-20 -93.32 106.94 18.84 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.513 -1.221 . . . . 0.0 110.42 -177.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.652 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 29.9 tt0 -99.28 132.02 44.9 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.13 177.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.7 p -136.74 139.94 43.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.461 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 60.1 m170 -98.66 114.55 27.08 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 121.376 0.608 . . . . 0.0 111.709 -176.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -110.63 145.31 38.13 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.284 174.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 57.6 ttp180 -105.33 125.71 51.29 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.1 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 32.6 m -136.44 175.7 9.72 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.516 -177.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.489 ' O ' ' HB ' ' A' ' 35' ' ' THR . 59.0 tttp -88.37 157.42 18.72 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.423 ' O ' ' HB3' ' A' ' 70' ' ' PRO . 66.2 m-85 -55.9 -41.08 73.95 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 173.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -97.98 31.57 7.79 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.141 -178.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.489 ' HB ' ' O ' ' A' ' 32' ' ' LYS . 0.9 OUTLIER -68.63 138.79 55.31 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-O 121.503 0.668 . . . . 0.0 112.378 179.009 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 87.7 p -83.09 163.55 20.83 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.705 177.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.691 ' SD ' ' HA ' ' A' ' 65' ' ' ASN . 25.3 ptt? -60.61 -31.89 71.04 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.748 0.309 . . . . 0.0 111.189 -179.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.63 -37.16 82.94 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.244 -178.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.429 ' HB2' HG21 ' A' ' 35' ' ' THR . 75.9 mmtt -59.93 -40.39 88.74 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.192 -175.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.422 ' H ' HD22 ' A' ' 40' ' ' LEU . 0.4 OUTLIER -87.96 -44.13 11.25 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 179.737 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -62.68 -45.29 93.45 Favored 'General case' 0 CA--C 1.493 -1.213 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.188 -177.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.404 ' O ' ' HB2' ' A' ' 46' ' ' ASP . 24.9 ttmm -62.98 -41.6 99.6 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 176.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 52.4 m -63.95 -46.19 85.82 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.202 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.685 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 45.6 t80 -71.11 -45.25 64.02 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.97 0.415 . . . . 0.0 110.871 178.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.47 -28.14 69.07 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.155 0.502 . . . . 0.0 110.008 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.404 ' HB2' ' O ' ' A' ' 42' ' ' LYS . 25.8 t70 -63.91 -45.95 87.0 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.374 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.685 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 15.3 ptm180 -65.82 -28.0 68.67 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.018 0.437 . . . . 0.0 111.047 -178.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.499 HG21 ' O ' ' A' ' 44' ' ' TYR . 2.0 t -97.27 -17.71 19.64 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.467 -178.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.04 30.36 67.82 Favored Glycine 0 C--O 1.236 0.23 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.04 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.575 ' CG1' ' HB2' ' A' ' 87' ' ' GLN . 2.4 p -108.76 176.46 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-O 120.676 0.274 . . . . 0.0 110.553 -177.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.423 ' HB3' ' HB2' ' A' ' 54' ' ' SER . . . -58.79 125.92 25.52 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.396 176.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 71.6 t -65.99 -45.46 90.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.379 0.609 . . . . 0.0 110.97 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -68.72 -31.74 71.03 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.456 -177.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.423 ' HB2' ' HB3' ' A' ' 51' ' ' ALA . 50.2 m -81.74 -4.44 56.31 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.979 -175.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.603 HD13 ' CE1' ' A' ' 57' ' ' PHE . 0.3 OUTLIER -90.14 128.71 36.41 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 177.108 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.45 ' HD3' ' CB ' ' A' ' 86' ' ' GLU . 3.2 mpt_? -106.12 118.95 37.95 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -173.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.603 ' CE1' HD13 ' A' ' 55' ' ' LEU . 61.0 m-85 -111.08 134.84 52.37 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.124 171.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.54 ' CD1' ' HA ' ' A' ' 63' ' ' ARG . 2.9 mm? -127.76 155.2 44.41 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.937 0.875 . . . . 0.0 111.746 -178.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.735 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 58.6 t80 -122.46 108.54 13.3 Favored 'General case' 0 C--N 1.286 -2.171 0 CA-C-N 113.941 -1.481 . . . . 0.0 108.264 176.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 55.19 22.52 4.72 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.183 0.516 . . . . 0.0 110.74 -174.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 93.85 -7.95 73.66 Favored Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.561 -179.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.735 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.1 OUTLIER -91.57 142.15 27.95 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.391 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.54 ' HA ' ' CD1' ' A' ' 58' ' ' LEU . 0.7 OUTLIER -64.81 139.2 58.74 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -174.795 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 78.9 mt -103.93 117.77 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 174.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.691 ' HA ' ' SD ' ' A' ' 37' ' ' MET . 48.0 m-80 -121.57 166.84 13.61 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 120.92 0.39 . . . . 0.0 110.6 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -70.61 -15.32 62.74 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.532 -177.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -92.12 -0.42 57.44 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 116.705 -0.225 . . . . 0.0 111.523 -179.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -80.33 140.58 36.06 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 120.906 0.384 . . . . 0.0 111.112 178.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.422 ' HB ' ' HD2' ' A' ' 70' ' ' PRO . 82.2 p -87.87 160.07 47.54 Favored Pre-proline 0 C--N 1.314 -0.97 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.993 -178.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.423 ' HB3' ' O ' ' A' ' 33' ' ' TYR . 21.0 Cg_endo -62.22 -25.61 76.99 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.626 2.217 . . . . 0.0 111.713 177.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.5 tmtt? -82.14 -37.65 25.9 Favored 'General case' 0 N--CA 1.423 -1.82 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.128 -177.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.7 t -74.07 -33.51 63.69 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 120.456 -0.497 . . . . 0.0 110.432 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 97.2 mt -79.06 -22.84 44.76 Favored 'General case' 0 C--O 1.217 -0.614 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.517 177.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 51.73 34.57 13.25 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.043 175.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 75.7 mtm -76.25 155.94 33.95 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 121.009 0.433 . . . . 0.0 111.342 -178.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -141.23 176.33 8.93 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.426 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 35.7 t70 -66.49 121.16 14.71 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 120.955 0.407 . . . . 0.0 111.089 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 24.5 t70 71.24 34.68 1.72 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.618 -1.174 . . . . 0.0 110.291 177.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -74.81 176.26 7.22 Favored 'General case' 0 N--CA 1.457 -0.09 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.95 178.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 24.5 m -106.97 138.38 33.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-O 121.57 0.7 . . . . 0.0 111.58 -176.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 6.8 mm -134.81 136.6 52.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.422 -177.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 53.6 mm-40 -101.88 141.88 34.05 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.862 -174.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 74.3 t -129.18 134.36 64.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-O 120.972 0.415 . . . . 0.0 110.953 177.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -99.98 151.76 20.98 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 175.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.526 ' O ' ' HG3' ' A' ' 86' ' ' GLU . 63.9 tt0 -71.51 96.45 1.52 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.219 0.533 . . . . 0.0 110.226 -176.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.563 ' O ' HD22 ' A' ' 55' ' ' LEU . 30.6 mt-10 -167.99 142.34 3.5 Favored 'General case' 0 CA--C 1.501 -0.929 0 C-N-CA 125.592 1.557 . . . . 0.0 109.486 -177.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.575 ' HB2' ' CG1' ' A' ' 50' ' ' VAL . 27.6 pt20 177.33 -29.41 0.0 OUTLIER 'General case' 0 N--CA 1.389 -3.483 0 C-N-CA 125.284 1.434 . . . . 0.0 108.315 -176.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 60.0 tp . . . . . 0 N--CA 1.428 -1.551 0 N-CA-C 103.696 -2.705 . . . . 0.0 103.696 -179.212 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 . . . . . 0 N--CA 1.433 -1.279 0 CA-C-O 121.163 0.506 . . . . 0.0 110.744 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.413 ' O ' ' HD2' ' A' ' 30' ' ' ARG . 12.1 pt -126.21 163.04 28.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -179.117 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.493 ' H ' ' HA ' ' A' ' 77' ' ' ASP . 37.0 ttpt -106.55 140.05 40.05 Favored 'General case' 0 C--N 1.282 -2.353 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.438 HG22 HD12 ' A' ' 81' ' ' ILE . 83.5 mt -133.5 132.97 57.69 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.118 0 CA-C-O 120.814 0.34 . . . . 0.0 111.29 177.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.3 mtmt -97.62 105.81 18.02 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.608 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 97.7 t -82.42 120.38 33.75 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 178.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 59.9 t -111.02 118.22 56.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 120.998 0.428 . . . . 0.0 110.11 179.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.502 ' HA2' ' HB ' ' A' ' 83' ' ' VAL . . . -87.27 169.51 39.83 Favored Glycine 0 N--CA 1.445 -0.764 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.704 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.491 ' HG2' ' O ' ' A' ' 83' ' ' VAL . 15.9 mm100 -68.71 -26.82 65.46 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 120.961 0.41 . . . . 0.0 111.92 -177.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -83.34 13.88 4.02 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.055 178.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.406 ' H ' ' C ' ' A' ' 22' ' ' GLN . 27.4 t 74.17 24.45 1.94 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.428 178.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -91.57 104.53 17.0 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.811 -178.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.608 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 30.4 tt0 -98.77 130.82 45.24 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.693 176.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.415 ' CG1' ' HB ' ' A' ' 19' ' ' VAL . 7.1 p -131.06 141.35 46.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.131 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 50.7 m170 -98.98 108.74 21.5 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 121.067 0.46 . . . . 0.0 110.702 -175.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -110.05 147.13 34.15 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.868 179.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.413 ' HD2' ' O ' ' A' ' 15' ' ' ILE . 23.4 tpt180 -108.38 118.74 37.56 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 176.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 33.7 m -133.21 171.6 17.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.767 -177.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.435 ' O ' ' HB ' ' A' ' 35' ' ' THR . 38.1 ttpt -88.83 156.93 18.65 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 -178.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -55.61 -39.58 70.97 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 174.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -97.42 24.6 30.77 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.56 -178.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.435 ' HB ' ' O ' ' A' ' 32' ' ' LYS . 1.0 OUTLIER -67.05 138.09 56.92 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-O 121.367 0.603 . . . . 0.0 112.068 179.032 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.8 m -92.1 158.89 15.95 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.685 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 25.9 ptt? -52.78 -34.38 53.01 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -176.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.55 -36.27 80.12 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.332 0.494 . . . . 0.0 112.332 -176.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -59.98 -40.91 90.76 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.664 0.268 . . . . 0.0 110.711 -174.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.428 HD13 ' CD2' ' A' ' 57' ' ' PHE . 0.4 OUTLIER -87.79 -45.81 10.0 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.213 -0.448 . . . . 0.0 112.0 -179.094 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.65 ' HG2' ' CD1' ' A' ' 57' ' ' PHE . 62.3 mtpt -62.83 -45.9 90.45 Favored 'General case' 0 CA--C 1.493 -1.22 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.501 -175.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -61.85 -41.68 98.12 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 177.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 47.9 t -63.98 -51.0 66.35 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.227 -178.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.577 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 46.6 t80 -70.21 -46.59 64.21 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.345 -179.089 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.419 ' HB2' ' O ' ' A' ' 50' ' ' VAL . . . -60.05 -36.76 78.02 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.393 0.616 . . . . 0.0 110.016 -178.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -66.03 -46.16 78.86 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.14 -178.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.577 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 14.6 ptm180 -68.07 -24.73 65.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.453 -177.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.48 HG21 ' O ' ' A' ' 44' ' ' TYR . 12.4 t -96.02 -8.61 33.16 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 120.769 0.318 . . . . 0.0 111.619 -179.126 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.72 31.2 60.73 Favored Glycine 0 C--N 1.339 0.727 0 C-N-CA 121.004 -0.617 . . . . 0.0 113.222 178.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.419 ' O ' ' HB2' ' A' ' 45' ' ' ALA . 94.7 t -119.47 148.76 22.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 C-N-CA 122.539 0.336 . . . . 0.0 110.806 -178.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.41 ' HB3' ' OG ' ' A' ' 54' ' ' SER . . . -51.76 134.24 30.8 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.456 176.355 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 74.0 t -61.05 -44.62 98.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.001 -177.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -70.56 -22.44 62.59 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.187 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.476 ' HB3' ' HB3' ' A' ' 87' ' ' GLN . 68.0 m -80.24 -10.96 59.77 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.169 179.129 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.08 129.3 40.67 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 177.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -117.94 115.12 24.27 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 120.999 0.428 . . . . 0.0 110.856 -177.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.65 ' CD1' ' HG2' ' A' ' 41' ' ' LYS . 27.6 m-85 -106.06 127.76 53.4 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.937 177.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.539 HD21 ' CE1' ' A' ' 84' ' ' TYR . 9.2 mp -124.59 140.22 53.15 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.922 -179.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.752 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 76.7 t80 -105.95 117.08 33.09 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 177.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 29.1 t70 56.53 19.84 4.46 Favored 'General case' 0 CA--C 1.548 0.879 0 CA-C-O 121.29 0.567 . . . . 0.0 111.625 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.94 1.32 51.95 Favored Glycine 0 CA--C 1.521 0.451 0 C-N-CA 121.081 -0.58 . . . . 0.0 113.224 178.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.752 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.2 OUTLIER -113.68 142.38 46.08 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 117.097 0.448 . . . . 0.0 109.866 177.668 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.516 ' HA ' ' HG ' ' A' ' 58' ' ' LEU . 9.7 mpt_? -65.45 139.09 58.49 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -175.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 80.5 mt -94.49 119.02 41.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.294 178.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -110.66 160.99 16.19 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.193 -178.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -72.18 -18.29 61.87 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.304 0.573 . . . . 0.0 109.718 176.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -81.4 -19.45 42.57 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.031 -179.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.51 ' CG ' HH12 ' A' ' 62' ' ' ARG . 47.3 m-20 -68.21 140.23 56.07 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 121.391 0.615 . . . . 0.0 111.854 -179.327 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.463 ' HB ' ' HD2' ' A' ' 70' ' ' PRO . 18.8 p -100.66 163.45 18.08 Favored Pre-proline 0 C--N 1.311 -1.065 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.909 -178.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.463 ' HD2' ' HB ' ' A' ' 69' ' ' THR . 17.1 Cg_endo -58.32 -28.86 86.16 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 122.703 2.269 . . . . 0.0 112.687 -178.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.561 ' HG3' ' H ' ' A' ' 72' ' ' THR . 15.2 ptmt -72.41 -49.82 30.92 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.561 ' H ' ' HG3' ' A' ' 71' ' ' LYS . 15.1 t -67.64 -34.26 76.61 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.981 0.42 . . . . 0.0 110.735 -177.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 97.5 mt -79.41 -22.84 43.74 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.541 177.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 36.35 36.52 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 124.639 1.176 . . . . 0.0 113.835 -179.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 65.9 mtt -75.42 151.81 38.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.47 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -147.98 -176.4 5.26 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.819 -178.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.493 ' HA ' ' H ' ' A' ' 16' ' ' LYS . 6.4 p-10 -59.42 121.91 12.66 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -174.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.448 ' OD1' ' HE3' ' A' ' 16' ' ' LYS . 26.5 t70 71.01 32.45 2.31 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 113.635 -1.621 . . . . 0.0 111.553 175.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -79.23 178.05 8.36 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 175.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 35.1 m -115.13 150.5 17.05 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 CA-C-O 121.815 0.817 . . . . 0.0 112.336 -174.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.438 HD12 HG22 ' A' ' 17' ' ' ILE . 1.6 mt -134.26 134.92 54.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.854 178.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -101.81 139.63 37.19 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.897 -178.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.502 ' HB ' ' HA2' ' A' ' 21' ' ' GLY . 95.2 t -122.11 130.94 74.15 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.548 177.092 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.539 ' CE1' HD21 ' A' ' 58' ' ' LEU . 66.8 m-85 -99.21 167.29 10.77 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.474 178.405 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -67.06 137.11 56.18 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.538 0.685 . . . . 0.0 110.677 -173.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.407 ' H ' ' CD ' ' A' ' 86' ' ' GLU . 0.9 OUTLIER -83.9 156.55 22.34 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.979 -1.009 . . . . 0.0 112.955 -171.574 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.476 ' HB3' ' HB3' ' A' ' 54' ' ' SER . 64.2 tt0 -66.36 -42.83 87.46 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.892 -1.049 . . . . 0.0 112.777 -177.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.466 HD22 ' OG ' ' A' ' 54' ' ' SER . 4.6 mm? . . . . . 0 C--N 1.322 -0.608 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -178.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 . . . . . 0 CA--C 1.505 -0.753 0 CA-C-O 121.87 0.843 . . . . 0.0 112.783 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.6 pt -134.01 162.73 38.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-N 114.152 -1.386 . . . . 0.0 107.931 -179.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.435 ' HD2' ' NH1' ' A' ' 30' ' ' ARG . 3.5 mppt? -99.99 148.67 24.26 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 121.147 0.499 . . . . 0.0 111.616 179.197 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.434 HG23 ' CG1' ' A' ' 81' ' ' ILE . 67.8 mt -124.96 131.83 72.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.796 176.151 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.0 mtmt -101.54 102.74 13.53 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 172.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.703 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 92.3 t -82.87 117.7 29.27 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 57.9 t -106.85 114.72 46.69 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.47 ' HA2' ' HB ' ' A' ' 83' ' ' VAL . . . -88.96 171.49 39.12 Favored Glycine 0 C--N 1.313 -0.721 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.597 -179.239 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 90.8 mm-40 -73.89 -11.83 60.48 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-O 121.719 0.771 . . . . 0.0 110.652 179.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -83.6 7.16 18.18 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 114.57 -1.195 . . . . 0.0 108.86 174.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.5 m 65.41 27.59 11.82 Favored 'General case' 0 C--N 1.347 0.46 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.002 -176.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -97.11 105.74 17.94 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.704 -177.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.703 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 39.0 tt0 -98.09 129.7 44.9 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.713 176.183 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.2 p -139.54 141.82 34.25 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.988 -178.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 31.7 m170 -88.65 116.91 27.24 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.747 -179.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -113.68 136.88 52.35 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 114.993 -1.003 . . . . 0.0 108.701 170.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.435 ' NH1' ' HD2' ' A' ' 16' ' ' LYS . 35.9 ttt85 -104.91 125.64 51.13 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.495 ' HB ' ' OG1' ' A' ' 35' ' ' THR . 22.7 m -135.12 -179.76 3.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.227 -174.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -89.77 157.04 18.12 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 178.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.426 ' O ' ' HB3' ' A' ' 70' ' ' PRO . 90.6 m-85 -53.93 -39.79 66.17 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 173.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -102.07 33.39 6.55 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.355 -179.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.495 ' OG1' ' HB ' ' A' ' 31' ' ' VAL . 0.9 OUTLIER -66.7 138.52 57.46 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 121.614 0.721 . . . . 0.0 112.2 179.263 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.458 ' HB3' ' HB2' ' A' ' 66' ' ' ASP . 67.2 m -82.87 151.99 25.77 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.94 178.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.599 ' SD ' ' HA ' ' A' ' 65' ' ' ASN . 26.7 ptt? -54.1 -30.58 49.16 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.935 0.398 . . . . 0.0 111.047 -179.44 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.17 -36.75 80.69 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.781 -178.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -60.14 -40.83 91.18 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.791 0.329 . . . . 0.0 111.149 -176.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.441 HD12 ' CD2' ' A' ' 57' ' ' PHE . 0.3 OUTLIER -86.87 -45.52 10.78 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 116.056 -0.52 . . . . 0.0 112.0 -179.787 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.407 ' HA ' ' CE1' ' A' ' 57' ' ' PHE . 24.8 mtpp -61.78 -47.32 85.68 Favored 'General case' 0 CA--C 1.5 -0.972 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.351 -177.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 40.6 ttpt -62.79 -42.07 99.54 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.072 0.463 . . . . 0.0 109.986 178.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 44.7 t -66.35 -50.88 62.07 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.866 -176.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.572 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 49.6 t80 -70.71 -45.53 64.78 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.142 -178.035 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.506 ' HB3' ' O ' ' A' ' 50' ' ' VAL . . . -59.13 -35.63 73.8 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.409 0.623 . . . . 0.0 109.77 -179.094 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -64.35 -47.16 80.4 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.531 -179.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.572 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 14.5 ptm180 -71.17 -21.91 62.1 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.671 -177.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.487 HG21 ' O ' ' A' ' 44' ' ' TYR . 13.7 t -101.13 -2.73 30.67 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-O 120.855 0.36 . . . . 0.0 111.699 -178.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 69.8 37.08 75.45 Favored Glycine 0 C--N 1.335 0.486 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.013 178.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.506 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 91.3 t -122.62 147.67 26.69 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 C-N-CA 122.825 0.45 . . . . 0.0 110.811 -178.008 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.412 ' HB3' ' HB2' ' A' ' 54' ' ' SER . . . -54.77 135.02 47.87 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 175.319 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 76.6 t -61.1 -45.86 97.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.312 -175.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -71.41 -27.79 63.55 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.356 -178.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.412 ' HB2' ' HB3' ' A' ' 51' ' ' ALA . 49.1 m -82.68 -5.43 58.85 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.464 -178.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.469 HD13 ' CE1' ' A' ' 57' ' ' PHE . 0.2 OUTLIER -95.34 122.42 38.03 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 177.414 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -108.02 117.39 34.01 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 120.33 -0.548 . . . . 0.0 112.222 -174.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.49 ' HZ ' ' CB ' ' A' ' 44' ' ' TYR . 44.3 m-85 -100.63 128.68 46.6 Favored 'General case' 0 CA--C 1.498 -1.058 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.569 174.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.507 HD13 ' HA ' ' A' ' 63' ' ' ARG . 4.2 mm? -119.06 155.89 30.66 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.384 -177.115 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.751 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 63.0 t80 -133.75 109.94 9.48 Favored 'General case' 0 C--N 1.279 -2.466 0 CA-C-N 114.289 -1.323 . . . . 0.0 109.385 174.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 27.9 t70 52.81 29.9 8.27 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.565 0.698 . . . . 0.0 111.562 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 94.58 4.98 61.87 Favored Glycine 0 C--N 1.31 -0.886 0 C-N-CA 120.856 -0.688 . . . . 0.0 113.65 176.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.751 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.2 OUTLIER -122.8 133.49 54.45 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 177.159 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.507 ' HA ' HD13 ' A' ' 58' ' ' LEU . 30.4 ptt180 -72.75 145.91 46.77 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.783 -172.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.426 ' CD1' HD11 ' A' ' 81' ' ' ILE . 73.6 mt -91.21 121.76 41.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.4 -176.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.599 ' HA ' ' SD ' ' A' ' 37' ' ' MET . 50.7 m-80 -111.09 157.54 19.88 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.769 -178.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.458 ' HB2' ' HB3' ' A' ' 36' ' ' SER . 4.8 p-10 -74.79 -11.98 60.28 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-O 121.179 0.514 . . . . 0.0 109.819 178.1 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -81.62 -20.37 39.86 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.913 179.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.449 ' CG ' HH12 ' A' ' 62' ' ' ARG . 50.5 m-20 -67.14 149.41 50.55 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.294 0.569 . . . . 0.0 112.087 -178.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 76.4 p -108.68 159.77 29.69 Favored Pre-proline 0 C--N 1.315 -0.933 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.634 178.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.426 ' HB3' ' O ' ' A' ' 33' ' ' TYR . 19.3 Cg_endo -60.49 -28.68 87.13 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.448 2.099 . . . . 0.0 111.721 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.818 ' C ' ' HD2' ' A' ' 71' ' ' LYS . 0.1 OUTLIER -65.6 -44.04 87.81 Favored 'General case' 0 N--CA 1.415 -2.176 0 CA-C-O 121.615 0.721 . . . . 0.0 109.496 178.819 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -80.22 -40.06 27.85 Favored 'General case' 0 N--CA 1.414 -2.265 0 CA-C-N 114.848 -1.069 . . . . 0.0 111.152 -174.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 98.6 mt -71.32 -23.24 61.9 Favored 'General case' 0 N--CA 1.44 -0.975 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 175.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.407 ' HG3' ' O ' ' A' ' 71' ' ' LYS . 38.5 mt-10 50.79 28.7 3.79 Favored 'General case' 0 C--N 1.349 0.553 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.462 -179.038 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 21.5 ptm -81.32 164.64 22.03 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.241 -178.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -151.37 -175.21 5.09 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-O 120.743 0.306 . . . . 0.0 110.252 -176.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -63.96 119.92 10.99 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.211 -179.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 33.1 t70 67.06 35.58 4.55 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.196 177.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -78.43 175.63 10.12 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 29.1 m -98.42 133.57 40.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 CA-C-O 121.807 0.813 . . . . 0.0 111.611 -176.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.434 ' CG1' HG23 ' A' ' 17' ' ' ILE . 18.1 mm -129.78 130.53 66.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 CA-C-N 114.634 -1.166 . . . . 0.0 109.86 179.137 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -102.56 148.25 25.77 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.094 0.473 . . . . 0.0 111.645 -175.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.47 ' HB ' ' HA2' ' A' ' 21' ' ' GLY . 79.4 t -123.34 129.86 74.57 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.858 174.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -101.77 170.84 7.9 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.571 178.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -64.51 136.94 57.56 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.776 0.798 . . . . 0.0 110.988 -172.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.459 ' CD ' ' H ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -108.93 160.21 16.19 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 114.512 -1.222 . . . . 0.0 111.614 -173.224 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -65.02 -46.14 82.57 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -175.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.401 ' HB2' HG11 ' A' ' 50' ' ' VAL . 3.3 mm? . . . . . 0 C--N 1.321 -0.666 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -175.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 . . . . . 0 CA--C 1.515 -0.382 0 CA-C-O 121.334 0.587 . . . . 0.0 111.479 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.44 ' O ' ' HD3' ' A' ' 30' ' ' ARG . 8.3 pt -111.27 163.08 8.33 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 -178.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.642 ' HE2' ' OD1' ' A' ' 78' ' ' ASP . 34.9 ttpt -113.78 145.33 41.55 Favored 'General case' 0 C--N 1.291 -1.955 0 C-N-CA 118.882 -1.127 . . . . 0.0 111.687 -179.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 84.6 mt -122.21 127.84 75.34 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.489 177.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.2 mtmt -99.19 104.68 16.66 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 176.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.662 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 96.1 t -82.55 119.2 31.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.989 -178.218 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.9 t -105.27 112.84 40.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -91.09 177.27 41.25 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.072 -1.061 . . . . 0.0 112.611 -178.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -82.54 -10.1 59.13 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 121.434 0.635 . . . . 0.0 111.621 -178.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -85.04 11.12 10.2 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 115.075 -0.966 . . . . 0.0 108.801 174.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.2 m 62.86 33.25 15.3 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.437 -178.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 -111.55 108.94 18.61 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.438 -179.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.662 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 30.0 tt0 -94.18 128.67 40.75 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.331 -0.849 . . . . 0.0 108.932 174.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.3 p -132.58 139.38 49.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -178.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 23.9 m170 -100.94 117.17 34.48 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.314 0.578 . . . . 0.0 111.963 -174.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -109.62 144.39 38.03 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.058 -0.973 . . . . 0.0 110.137 175.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.44 ' HD3' ' O ' ' A' ' 15' ' ' ILE . 20.2 tpp180 -103.2 119.32 38.66 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.217 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 32.9 m -134.63 167.99 24.7 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.803 -178.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.42 ' O ' ' HB ' ' A' ' 35' ' ' THR . 46.5 tttm -91.22 163.33 14.29 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 178.561 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -57.36 -38.67 74.53 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.752 174.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -93.94 19.0 55.55 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 121.175 -0.536 . . . . 0.0 112.428 -178.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.42 ' HB ' ' O ' ' A' ' 32' ' ' LYS . 1.1 m -63.85 136.81 57.69 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-O 121.394 0.616 . . . . 0.0 111.802 179.035 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 68.3 m -92.91 156.79 16.72 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.307 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.403 ' SD ' ' HA ' ' A' ' 65' ' ' ASN . 26.7 ptt? -51.38 -32.34 25.59 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -176.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.19 -37.39 82.8 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 -177.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 49.3 mmtm -60.21 -39.98 88.48 Favored 'General case' 0 C--O 1.216 -0.696 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.08 -176.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.668 HD12 ' CD1' ' A' ' 57' ' ' PHE . 0.2 OUTLIER -87.24 -44.06 11.73 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -178.848 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.453 ' HA ' ' HE1' ' A' ' 57' ' ' PHE . 57.3 mtpt -62.83 -45.63 91.72 Favored 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -178.239 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 28.9 ttpp -62.31 -41.98 98.98 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 177.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.415 ' O ' ' HB3' ' A' ' 46' ' ' ASP . 58.4 m -66.26 -48.17 71.34 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.73 -178.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.65 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 38.9 t80 -71.72 -44.25 64.46 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -179.584 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.35 -29.7 66.17 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 121.286 0.565 . . . . 0.0 109.809 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.415 ' HB3' ' O ' ' A' ' 43' ' ' SER . 31.3 t70 -62.72 -48.56 78.73 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.789 178.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.65 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 7.5 ptm180 -69.79 -24.16 63.45 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.192 -176.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.464 HG21 ' O ' ' A' ' 44' ' ' TYR . 7.3 t -100.66 -8.98 22.34 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.234 -0.439 . . . . 0.0 112.132 -178.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 67.43 40.6 91.39 Favored Glycine 0 C--N 1.336 0.531 0 C-N-CA 120.676 -0.774 . . . . 0.0 113.029 178.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.455 HG23 ' HG3' ' A' ' 86' ' ' GLU . 3.6 p -125.3 166.74 20.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 O-C-N 122.728 -0.277 . . . . 0.0 110.72 -177.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.434 ' HB2' ' OG ' ' A' ' 54' ' ' SER . . . -59.18 137.36 58.0 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 116.329 -0.396 . . . . 0.0 109.994 176.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 75.6 t -60.51 -44.04 95.65 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.57 -176.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -84.06 -12.15 55.57 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -179.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.462 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 85.5 p -79.75 -14.26 58.86 Favored 'General case' 0 CA--C 1.514 -0.417 0 C-N-CA 119.924 -0.711 . . . . 0.0 109.091 176.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.418 HD12 ' N ' ' A' ' 56' ' ' ARG . 1.9 tm? -99.61 129.59 45.77 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 177.061 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.418 ' N ' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -135.48 137.61 42.32 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 119.747 -0.781 . . . . 0.0 111.767 -176.599 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.668 ' CD1' HD12 ' A' ' 40' ' ' LEU . 96.3 m-85 -106.95 139.96 40.52 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.382 176.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.549 HD11 ' CD1' ' A' ' 84' ' ' TYR . 6.6 mp -128.68 139.7 52.11 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.703 176.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.66 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 34.4 t80 -107.78 119.04 38.32 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.129 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 32.5 t70 51.93 33.61 11.97 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.507 0.67 . . . . 0.0 111.395 179.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.19 13.8 73.25 Favored Glycine 0 CA--C 1.522 0.528 0 CA-C-N 115.647 -0.706 . . . . 0.0 113.739 177.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.66 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.2 OUTLIER -123.71 149.83 45.05 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 117.163 0.481 . . . . 0.0 110.406 178.822 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -67.88 139.7 56.5 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -176.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 75.5 mt -103.43 111.29 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 173.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.403 ' HA ' ' SD ' ' A' ' 37' ' ' MET . 95.1 m-20 -114.38 170.22 8.46 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-O 121.094 0.473 . . . . 0.0 111.439 -178.179 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 15.3 p-10 -72.25 -14.07 61.68 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.571 -178.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -94.15 -13.16 27.02 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.397 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.426 ' HB3' ' HG ' ' A' ' 73' ' ' LEU . 30.2 m-20 -72.56 149.62 43.86 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.269 0.557 . . . . 0.0 112.187 -178.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.441 ' HB ' ' HD2' ' A' ' 70' ' ' PRO . 81.8 p -108.88 161.45 23.62 Favored Pre-proline 0 C--N 1.315 -0.907 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.691 -179.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.441 ' HD2' ' HB ' ' A' ' 69' ' ' THR . 24.2 Cg_endo -61.34 -22.95 75.98 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.455 2.104 . . . . 0.0 111.639 178.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.796 ' C ' ' HD2' ' A' ' 71' ' ' LYS . 0.0 OUTLIER -67.65 -44.52 77.7 Favored 'General case' 0 N--CA 1.41 -2.441 0 C-N-CA 123.651 0.78 . . . . 0.0 109.635 -179.755 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.6 t -90.0 -32.57 16.72 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.927 -175.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.426 ' HG ' ' HB3' ' A' ' 68' ' ' ASP . 96.0 mt -72.7 -22.95 60.82 Favored 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 174.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 52.89 32.9 13.3 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 114.846 -1.07 . . . . 0.0 112.25 176.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 69.1 mtm -83.54 156.99 22.52 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.372 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -154.44 -176.04 5.7 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -58.48 122.6 13.75 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.949 0.88 . . . . 0.0 112.605 -177.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.642 ' OD1' ' HE2' ' A' ' 16' ' ' LYS . 1.4 m-20 63.14 33.61 14.31 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 113.884 -1.507 . . . . 0.0 111.614 176.495 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -74.92 176.74 6.85 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 178.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 31.5 m -112.71 144.26 20.78 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 CA-C-O 121.459 0.647 . . . . 0.0 111.335 -175.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -129.12 143.97 39.6 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.65 -179.204 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -107.7 141.44 39.23 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 120.817 0.342 . . . . 0.0 110.651 -177.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.425 HG21 ' CD2' ' A' ' 57' ' ' PHE . 99.5 t -117.13 133.44 63.88 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-O 121.096 0.474 . . . . 0.0 111.293 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.549 ' CD1' HD11 ' A' ' 58' ' ' LEU . 53.6 m-85 -98.91 168.45 10.1 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 115.366 -0.833 . . . . 0.0 109.669 176.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 60.1 tp60 -66.68 132.65 48.58 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.311 0.577 . . . . 0.0 111.766 -171.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.462 ' HA ' ' O ' ' A' ' 54' ' ' SER . 19.5 pm0 -82.2 144.72 30.49 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.43 -179.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.451 ' HB3' ' HB2' ' A' ' 54' ' ' SER . 6.8 tp-100 -64.6 -45.61 86.19 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -174.46 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 87.8 mt . . . . . 0 C--N 1.315 -0.914 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -175.668 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 . . . . . 0 N--CA 1.441 -0.88 0 CA-C-O 121.11 0.481 . . . . 0.0 110.624 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.6 pt -114.03 160.84 13.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.091 -175.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.42 ' H ' ' HA ' ' A' ' 77' ' ' ASP . 23.4 ttmt -100.76 145.39 28.56 Favored 'General case' 0 C--N 1.283 -2.324 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.622 -179.175 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.454 HG22 HD13 ' A' ' 81' ' ' ILE . 39.7 mm -126.21 127.57 70.89 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.357 175.137 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.401 ' HG3' ' O ' ' A' ' 79' ' ' ASP . 15.1 mtmt -96.36 104.98 16.98 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 176.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.661 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 85.0 t -81.7 109.45 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.591 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.223 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.1 t -112.24 118.36 57.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -178.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.432 ' HA2' ' HB ' ' A' ' 83' ' ' VAL . . . -96.28 160.47 22.13 Favored Glycine 0 C--N 1.304 -1.196 0 C-N-CA 120.074 -1.06 . . . . 0.0 112.293 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.515 ' C ' ' H ' ' A' ' 24' ' ' SER . 16.4 pt20 -66.52 -20.35 66.01 Favored 'General case' 0 CA--C 1.495 -1.163 0 CA-C-O 122.427 1.108 . . . . 0.0 109.67 177.277 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -69.33 5.41 1.31 Allowed 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 113.122 -1.853 . . . . 0.0 109.507 173.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.515 ' H ' ' C ' ' A' ' 22' ' ' GLN . 50.2 m 63.13 31.59 15.68 Favored 'General case' 0 C--N 1.35 0.625 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.154 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -110.39 108.07 17.99 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 114.843 -1.071 . . . . 0.0 111.042 -177.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.661 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 30.8 tt0 -103.82 133.85 48.11 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.522 175.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.3 p -139.23 139.39 39.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-N 115.663 -0.698 . . . . 0.0 109.52 177.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 63.6 m170 -98.04 117.17 31.8 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.205 0.526 . . . . 0.0 111.433 -176.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -112.73 146.52 38.61 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.298 175.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 23.8 tpp180 -103.31 120.53 40.94 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.45 ' HB ' ' OG1' ' A' ' 35' ' ' THR . 29.0 m -132.07 167.82 25.5 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -177.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.586 ' O ' ' HB ' ' A' ' 35' ' ' THR . 43.0 tttm -91.06 161.38 15.14 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.656 ' O ' ' HB3' ' A' ' 70' ' ' PRO . 97.1 m-85 -58.96 -38.23 78.6 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 171.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.615 ' HA2' ' CG ' ' A' ' 70' ' ' PRO . . . -85.64 21.81 13.13 Favored Glycine 0 N--CA 1.433 -1.547 0 CA-C-N 114.621 -1.172 . . . . 0.0 112.167 -178.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.586 ' HB ' ' O ' ' A' ' 32' ' ' LYS . 0.9 OUTLIER -68.56 141.01 55.61 Favored 'General case' 0 N--CA 1.425 -1.699 0 CA-C-O 121.384 0.611 . . . . 0.0 111.684 179.775 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.4 ' HB3' ' HE3' ' A' ' 37' ' ' MET . 48.7 m -88.47 143.37 27.02 Favored 'General case' 0 N--CA 1.416 -2.148 0 CA-C-N 115.405 -0.816 . . . . 0.0 108.939 177.381 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.798 ' SD ' ' HA ' ' A' ' 66' ' ' ASP . 0.2 OUTLIER -51.65 -40.1 59.37 Favored 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 123.575 0.75 . . . . 0.0 111.482 179.647 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.508 ' N ' ' HG2' ' A' ' 37' ' ' MET . . . -62.35 -27.02 68.77 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.152 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -60.47 -40.43 91.21 Favored 'General case' 0 C--O 1.21 -0.995 0 C-N-CA 121.111 -0.235 . . . . 0.0 110.84 -178.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.496 HD12 ' CD1' ' A' ' 57' ' ' PHE . 0.3 OUTLIER -85.47 -39.12 17.84 Favored 'General case' 0 C--N 1.309 -1.183 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.889 -176.764 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.445 ' HA ' ' HE1' ' A' ' 57' ' ' PHE . 61.7 mtpt -65.49 -44.86 85.79 Favored 'General case' 0 CA--C 1.493 -1.225 0 CA-C-O 120.728 0.299 . . . . 0.0 110.773 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.459 ' HD3' HG22 ' A' ' 52' ' ' VAL . 15.5 tppt? -62.97 -43.23 99.35 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 176.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 58.1 m -69.53 -50.25 46.79 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.366 -0.833 . . . . 0.0 113.196 -176.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.611 ' O ' ' HG3' ' A' ' 47' ' ' ARG . 62.4 t80 -64.67 -47.23 79.18 Favored 'General case' 0 CA--C 1.496 -1.116 0 CA-C-O 120.674 0.273 . . . . 0.0 111.233 -179.143 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.25 -36.5 77.91 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 121.367 0.603 . . . . 0.0 109.471 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -66.21 -45.59 80.22 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.315 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.611 ' HG3' ' O ' ' A' ' 44' ' ' TYR . 5.1 ppt_? -67.27 -25.01 65.85 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.347 -178.099 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.547 HG21 ' O ' ' A' ' 44' ' ' TYR . 10.2 t -99.07 -17.81 18.06 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 120.815 0.341 . . . . 0.0 111.61 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.1 32.59 35.22 Favored Glycine 0 C--O 1.227 -0.298 0 C-N-CA 120.471 -0.871 . . . . 0.0 113.021 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.465 HG22 ' HG3' ' A' ' 86' ' ' GLU . 4.3 p -115.13 160.96 14.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 O-C-N 122.555 -0.379 . . . . 0.0 110.292 -179.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.463 ' HB1' ' OG ' ' A' ' 54' ' ' SER . . . -57.91 129.31 41.34 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 178.126 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.459 HG22 ' HD3' ' A' ' 42' ' ' LYS . 78.6 t -61.53 -43.65 97.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.648 -178.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -64.53 -33.98 77.18 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.541 -179.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.463 ' OG ' ' HB1' ' A' ' 51' ' ' ALA . 90.6 p -78.82 -12.56 60.03 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.96 0.41 . . . . 0.0 110.975 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.4 HD11 ' N ' ' A' ' 56' ' ' ARG . 2.8 tm? -95.86 132.8 40.74 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -178.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.4 ' N ' HD11 ' A' ' 55' ' ' LEU . 5.6 ptt180 -144.33 145.8 32.19 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-O 121.259 0.552 . . . . 0.0 112.351 -173.375 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.512 ' CD2' HG22 ' A' ' 83' ' ' VAL . 95.7 m-85 -119.06 147.2 44.38 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.737 176.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 6.7 mp -124.31 138.24 54.4 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.792 175.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.592 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 32.2 t80 -117.84 125.93 51.46 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 179.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 33.4 t70 58.74 26.86 15.19 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.888 0.852 . . . . 0.0 110.163 -179.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 81.33 15.77 75.69 Favored Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.735 177.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.592 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 4.4 ppt_? -132.08 155.32 48.3 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-O 121.277 0.56 . . . . 0.0 112.042 179.242 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 16.4 mmm180 -58.68 137.59 57.5 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -175.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.417 HG21 ' HB3' ' A' ' 37' ' ' MET . 75.7 mt -102.09 109.0 25.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 168.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.53 ' C ' ' HG3' ' A' ' 37' ' ' MET . 88.6 m-20 -120.53 161.59 21.04 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 120.638 0.256 . . . . 0.0 111.039 -174.332 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.798 ' HA ' ' SD ' ' A' ' 37' ' ' MET . 4.7 t70 -58.38 -9.75 1.73 Allowed 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 179.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -84.14 -15.49 47.03 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.242 177.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -71.86 149.78 44.87 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -175.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.533 ' O ' HG23 ' A' ' 72' ' ' THR . 35.3 p -117.69 155.29 50.78 Favored Pre-proline 0 N--CA 1.437 -1.11 0 CA-C-N 114.439 -1.255 . . . . 0.0 109.358 177.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.656 ' HB3' ' O ' ' A' ' 33' ' ' TYR . 58.5 Cg_exo -54.83 -40.56 84.54 Favored 'Trans proline' 0 N--CA 1.477 0.502 0 C-N-CA 122.803 2.335 . . . . 0.0 113.75 -176.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.622 ' HD2' ' N ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -70.92 -30.0 66.21 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -177.482 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.622 ' N ' ' HD2' ' A' ' 71' ' ' LYS . 4.7 t -81.69 -28.64 33.4 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.484 -177.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 97.9 mt -70.26 -24.78 63.12 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 176.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 47.11 30.35 1.33 Allowed 'General case' 0 CA--C 1.551 1.016 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.488 177.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 20.5 ptp -75.49 160.23 30.43 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.938 0.399 . . . . 0.0 111.513 -179.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -147.52 -177.64 5.81 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.588 -178.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.42 ' HA ' ' H ' ' A' ' 16' ' ' LYS . 36.8 t70 -66.14 120.16 12.72 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -176.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 20.4 t70 69.19 33.66 3.24 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 114.381 -1.282 . . . . 0.0 110.441 177.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.401 ' O ' ' HG3' ' A' ' 18' ' ' LYS . 4.6 t70 -78.19 177.36 8.44 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.612 177.453 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 16.9 t -110.0 135.06 50.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 CA-C-O 121.481 0.658 . . . . 0.0 111.686 -171.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.454 HD13 HG22 ' A' ' 17' ' ' ILE . 1.8 mt -132.57 132.46 60.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.703 178.305 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -98.79 141.93 30.96 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.442 -174.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.512 HG22 ' CD2' ' A' ' 57' ' ' PHE . 87.6 t -125.88 129.14 72.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-O 121.346 0.593 . . . . 0.0 110.57 177.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -107.75 169.18 8.76 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.869 178.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -64.8 138.31 58.3 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.411 0.625 . . . . 0.0 111.303 -172.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.465 ' HG3' HG22 ' A' ' 50' ' ' VAL . 0.2 OUTLIER -96.93 160.74 14.18 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.706 -178.496 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.418 ' H ' ' HB2' ' A' ' 54' ' ' SER . 6.5 tp-100 -61.22 -46.02 92.17 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.025 0.441 . . . . 0.0 112.063 -174.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 87.4 mt . . . . . 0 C--N 1.31 -1.146 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.892 -176.781 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 . . . . . 0 CA--C 1.507 -0.696 0 CA-C-O 121.189 0.518 . . . . 0.0 111.135 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.4 pt -125.39 161.63 29.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 CA-C-N 115.183 -0.917 . . . . 0.0 108.576 -179.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.496 ' HE3' ' HB3' ' A' ' 78' ' ' ASP . 59.6 mtmt -101.29 143.08 31.79 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-O 120.999 0.428 . . . . 0.0 110.535 177.176 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 75.9 mt -124.3 126.67 72.43 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.152 174.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 31.0 mtmt -94.83 104.46 16.36 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 177.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.645 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 97.5 t -85.26 112.05 21.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -179.274 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.443 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 5.2 p -115.62 123.41 71.01 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 CA-C-O 121.461 0.648 . . . . 0.0 110.331 179.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -85.96 176.68 49.16 Favored Glycine 0 N--CA 1.435 -1.387 0 CA-C-N 115.223 -0.899 . . . . 0.0 112.095 -178.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.56 ' NE2' ' HA ' ' A' ' 84' ' ' TYR . 78.4 mt-30 -77.36 -13.1 60.0 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.382 0.611 . . . . 0.0 111.333 -177.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -87.95 13.51 10.79 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.18 174.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 46.5 m 66.06 32.79 8.05 Favored 'General case' 0 C--N 1.343 0.294 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.378 179.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.437 ' O ' ' HA ' ' A' ' 20' ' ' VAL . 94.4 m-20 -105.47 111.71 24.52 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.952 179.255 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.645 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 31.2 tt0 -108.78 132.97 53.46 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.399 -179.389 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.2 p -134.36 143.36 38.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.196 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 27.4 m170 -101.98 113.28 26.36 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.403 0.621 . . . . 0.0 112.105 -175.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -111.18 148.86 31.86 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.072 175.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -111.8 123.82 51.04 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.901 178.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 32.9 m -136.99 174.3 12.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.229 -179.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.468 ' O ' ' HB ' ' A' ' 35' ' ' THR . 35.4 ttmt -89.73 160.95 16.31 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 -179.573 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -54.65 -38.69 67.19 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 120.918 0.39 . . . . 0.0 110.365 177.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -100.77 21.92 41.8 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 116.066 -0.516 . . . . 0.0 112.826 -178.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.468 ' HB ' ' O ' ' A' ' 32' ' ' LYS . 0.9 OUTLIER -60.53 143.08 54.45 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-O 121.376 0.607 . . . . 0.0 112.552 179.8 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 56.1 m -85.97 157.03 20.22 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.285 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.696 ' SD ' ' HA ' ' A' ' 65' ' ' ASN . 25.5 ptm -53.27 -32.73 50.0 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -178.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.34 -37.04 84.1 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -178.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.415 ' HB2' HG23 ' A' ' 35' ' ' THR . 49.7 mmtm -59.15 -40.65 86.22 Favored 'General case' 0 C--O 1.206 -1.222 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.25 -175.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.431 HD21 ' H ' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -86.42 -43.68 12.62 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -179.163 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp -62.15 -46.97 86.61 Favored 'General case' 0 CA--C 1.502 -0.873 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.05 -177.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 29.6 ttpp -63.64 -40.08 95.96 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.136 0.493 . . . . 0.0 110.003 178.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 50.9 m -63.66 -49.72 72.08 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.591 -0.732 . . . . 0.0 112.352 -178.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.507 ' CB ' ' HZ ' ' A' ' 57' ' ' PHE . 44.0 t80 -71.86 -45.59 60.86 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.743 0.306 . . . . 0.0 111.611 -179.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.559 ' HB1' ' O ' ' A' ' 50' ' ' VAL . . . -58.27 -32.49 68.45 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.133 -178.142 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -62.88 -45.0 94.6 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.353 -0.839 . . . . 0.0 112.223 -179.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.465 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 24.0 ptt180 -69.54 -25.17 63.89 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.202 0.525 . . . . 0.0 110.779 -176.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.447 HG21 ' O ' ' A' ' 44' ' ' TYR . 7.9 t -102.59 -7.26 21.96 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -174.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 68.76 28.31 73.2 Favored Glycine 0 N--CA 1.46 0.268 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.237 178.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.559 ' O ' ' HB1' ' A' ' 45' ' ' ALA . 86.9 t -106.53 146.52 12.96 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 C-N-CA 122.613 0.365 . . . . 0.0 110.167 -178.216 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -52.52 133.54 35.62 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 176.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 76.9 t -60.48 -43.99 95.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.79 -177.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -66.08 -32.4 73.83 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.166 179.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.424 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 68.0 m -76.06 -10.81 59.72 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.446 -178.467 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.546 HD12 ' CE1' ' A' ' 57' ' ' PHE . 0.1 OUTLIER -92.68 123.38 35.92 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -179.947 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 28.0 mmm180 -104.47 110.74 23.13 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.757 -170.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.546 ' CE1' HD12 ' A' ' 55' ' ' LEU . 69.2 m-85 -110.48 126.95 54.9 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-O 121.043 0.449 . . . . 0.0 110.622 175.507 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.537 HD22 ' CE1' ' A' ' 84' ' ' TYR . 7.7 mp -129.1 144.94 51.37 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.184 178.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.737 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 62.5 t80 -111.41 116.46 30.96 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.054 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 58.71 18.7 6.15 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 122.673 0.389 . . . . 0.0 111.907 -179.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 98.98 6.72 55.9 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.774 -0.727 . . . . 0.0 113.234 178.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.737 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.1 OUTLIER -118.33 146.6 44.24 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.01 0.433 . . . . 0.0 110.06 176.815 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.493 ' HA ' ' HG ' ' A' ' 58' ' ' LEU . 38.9 mtp180 -68.4 134.96 51.01 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.525 -0.762 . . . . 0.0 112.51 -174.302 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 90.8 mt -91.15 119.86 39.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 115.399 -0.819 . . . . 0.0 108.828 178.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.696 ' HA ' ' SD ' ' A' ' 37' ' ' MET . 65.5 m-80 -118.6 159.36 23.73 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.635 -178.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -71.07 -12.96 61.81 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.191 0.52 . . . . 0.0 110.433 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -83.62 -19.45 35.43 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.097 -179.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -62.31 145.25 54.31 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.316 0.579 . . . . 0.0 112.263 -177.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.417 ' O ' HG22 ' A' ' 72' ' ' THR . 69.4 p -103.38 158.06 32.57 Favored Pre-proline 0 N--CA 1.44 -0.951 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.18 179.221 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -61.63 -21.59 72.42 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.578 2.185 . . . . 0.0 112.51 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.62 -22.47 32.21 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.437 -178.029 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.417 HG22 ' O ' ' A' ' 69' ' ' THR . 4.7 t -95.35 -32.77 12.79 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -179.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 96.1 mt -71.99 -25.96 62.05 Favored 'General case' 0 C--O 1.218 -0.554 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.025 177.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 48.74 33.34 4.22 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 176.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 65.2 mtt -87.21 158.88 19.02 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.293 -179.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -149.58 -179.42 7.08 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 177.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -56.33 127.88 33.09 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.259 0.552 . . . . 0.0 112.123 -176.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.496 ' HB3' ' HE3' ' A' ' 16' ' ' LYS . 1.0 OUTLIER 67.27 32.63 5.88 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.591 1.556 . . . . 0.0 114.117 174.204 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -78.78 178.68 7.72 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 176.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.6 m -112.35 151.71 14.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 CA-C-O 121.271 0.558 . . . . 0.0 111.784 -174.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -131.44 144.81 36.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 CA-C-N 115.453 -0.794 . . . . 0.0 108.878 178.023 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -104.55 139.29 39.65 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.964 -178.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 87.4 t -121.31 130.42 74.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 CA-C-O 121.235 0.54 . . . . 0.0 110.958 -179.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.56 ' HA ' ' NE2' ' A' ' 22' ' ' GLN . 77.4 m-85 -101.11 168.5 9.55 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.198 178.024 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 80.9 mm-40 -67.83 133.52 49.34 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.608 0.718 . . . . 0.0 111.821 -171.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.424 ' HA ' ' O ' ' A' ' 54' ' ' SER . 3.2 pm0 -79.85 157.52 26.97 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.488 -1.233 . . . . 0.0 112.224 -176.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -79.32 -52.18 8.45 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -177.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 50' ' ' VAL . 56.4 tp . . . . . 0 C--N 1.33 -0.274 0 CA-C-O 120.876 0.37 . . . . 0.0 111.432 -178.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 . . . . . 0 N--CA 1.432 -1.358 0 CA-C-O 121.338 0.59 . . . . 0.0 110.496 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.0 pt -110.5 161.54 8.83 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.048 -174.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.502 ' HB2' ' NH1' ' A' ' 30' ' ' ARG . 34.5 ttpt -109.1 144.22 37.43 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -179.231 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.445 HG23 HD11 ' A' ' 81' ' ' ILE . 82.2 mt -132.33 133.61 59.96 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.161 0 CA-C-O 120.775 0.322 . . . . 0.0 111.598 178.142 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.8 mtmt -94.87 105.23 17.14 Favored 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.694 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 75.0 t -82.28 117.64 28.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 175.36 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.536 ' HA ' ' O ' ' A' ' 25' ' ' ASN . 7.6 p -122.05 122.11 65.77 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 CA-C-O 121.727 0.775 . . . . 0.0 111.453 179.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.404 ' HA2' ' HB ' ' A' ' 83' ' ' VAL . . . -91.2 171.98 35.99 Favored Glycine 0 N--CA 1.436 -1.355 0 CA-C-N 114.867 -1.06 . . . . 0.0 111.535 179.451 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.479 ' C ' ' H ' ' A' ' 24' ' ' SER . 88.1 mm-40 -70.76 -27.32 63.85 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 120.933 0.397 . . . . 0.0 111.895 -176.143 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -79.63 21.84 0.5 Allowed 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.362 175.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.479 ' H ' ' C ' ' A' ' 22' ' ' GLN . 21.2 m 68.59 27.09 6.19 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.687 176.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.536 ' O ' ' HA ' ' A' ' 20' ' ' VAL . 58.2 t30 -93.85 102.09 14.2 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 119.895 -0.722 . . . . 0.0 111.167 -179.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.694 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 35.6 tt0 -112.84 127.49 56.19 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.47 177.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.7 p -136.4 145.0 31.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.712 -177.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 63.5 m170 -92.41 117.59 30.07 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.308 0.575 . . . . 0.0 111.917 -178.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -109.5 141.76 41.49 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.805 174.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.502 ' NH1' ' HB2' ' A' ' 16' ' ' LYS . 23.9 tpp180 -102.57 116.35 32.42 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 177.019 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.472 ' HB ' ' OG1' ' A' ' 35' ' ' THR . 34.5 m -134.43 174.86 12.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.212 -176.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.473 ' O ' ' HB ' ' A' ' 35' ' ' THR . 38.0 ttmt -88.54 158.83 18.18 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -55.43 -40.57 71.66 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 174.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -101.99 33.81 6.21 Favored Glycine 0 N--CA 1.449 -0.462 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.163 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.473 ' HB ' ' O ' ' A' ' 32' ' ' LYS . 0.6 OUTLIER -65.69 140.32 58.46 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 121.317 0.58 . . . . 0.0 111.936 179.356 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.485 ' OG ' ' HG2' ' A' ' 39' ' ' LYS . 85.9 p -81.08 160.03 24.59 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.137 178.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.594 ' SD ' ' HA ' ' A' ' 65' ' ' ASN . 26.5 ptt? -60.82 -32.49 71.87 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.933 0.397 . . . . 0.0 110.687 178.096 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.74 -36.27 80.49 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.45 -177.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.485 ' HG2' ' OG ' ' A' ' 36' ' ' SER . 75.6 mmtt -59.63 -41.82 91.31 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.999 -176.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.453 HD13 ' CD2' ' A' ' 57' ' ' PHE . 0.5 OUTLIER -89.42 -47.87 7.72 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -179.738 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.602 ' HG2' ' CD1' ' A' ' 57' ' ' PHE . 61.8 mtpt -62.37 -47.93 82.02 Favored 'General case' 0 CA--C 1.492 -1.271 0 CA-C-N 116.282 -0.417 . . . . 0.0 112.09 -174.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -61.69 -43.3 99.12 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 178.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 42.7 t -64.98 -51.51 61.31 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.371 -0.832 . . . . 0.0 111.294 -176.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.518 ' O ' HG21 ' A' ' 48' ' ' THR . 62.9 t80 -65.99 -49.06 69.12 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.937 -179.486 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.482 ' HB2' ' O ' ' A' ' 50' ' ' VAL . . . -59.74 -35.17 74.04 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.521 0.676 . . . . 0.0 109.788 -178.324 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -65.31 -47.0 78.08 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.248 -178.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -68.35 -26.39 65.57 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.568 -178.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.518 HG21 ' O ' ' A' ' 44' ' ' TYR . 8.8 t -96.71 -3.51 42.42 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -178.194 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 68.51 35.56 81.66 Favored Glycine 0 C--N 1.335 0.5 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.706 178.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.482 ' O ' ' HB2' ' A' ' 45' ' ' ALA . 78.2 t -118.83 144.54 26.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 C-N-CA 122.406 0.282 . . . . 0.0 111.346 -177.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.423 ' HB2' ' HB2' ' A' ' 54' ' ' SER . . . -51.25 129.31 24.32 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.968 176.008 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 77.0 t -61.42 -43.94 97.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.019 -177.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -65.75 -32.43 73.96 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.016 -179.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.441 ' HB3' ' HB3' ' A' ' 87' ' ' GLN . 51.5 m -83.57 -6.17 59.37 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.687 -178.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.492 HD11 ' CE1' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -96.43 121.17 37.95 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 176.617 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.21 126.47 52.26 Favored 'General case' 0 CA--C 1.499 -1.012 0 C-N-CA 120.112 -0.635 . . . . 0.0 110.834 -176.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.602 ' CD1' ' HG2' ' A' ' 41' ' ' LYS . 22.2 m-85 -106.98 131.04 54.5 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 176.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.507 HD12 ' C ' ' A' ' 62' ' ' ARG . 2.9 mm? -120.88 155.06 34.96 Favored 'General case' 0 N--CA 1.417 -2.075 0 CA-C-O 122.29 1.043 . . . . 0.0 113.068 -174.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.618 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 54.1 t80 -122.79 105.99 10.52 Favored 'General case' 0 C--N 1.282 -2.339 0 CA-C-N 113.289 -1.778 . . . . 0.0 108.103 174.536 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 54.26 28.46 9.24 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.805 -176.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 96.4 -7.83 66.43 Favored Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.543 -0.753 . . . . 0.0 113.117 177.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.618 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 4.1 ppt_? -104.34 147.15 27.84 Favored 'General case' 0 N--CA 1.438 -1.034 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.078 179.287 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.458 ' HA ' HD11 ' A' ' 58' ' ' LEU . 0.1 OUTLIER -67.9 143.77 55.56 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -171.4 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 81.9 mt -102.87 121.42 54.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.273 -0.876 . . . . 0.0 108.709 174.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.594 ' HA ' ' SD ' ' A' ' 37' ' ' MET . 66.4 m-80 -121.41 172.41 8.07 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 120.916 0.389 . . . . 0.0 110.997 -178.177 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -70.21 -13.21 62.08 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.076 0.465 . . . . 0.0 110.96 -178.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -82.29 -14.82 54.8 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.011 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.422 ' CG ' HH12 ' A' ' 62' ' ' ARG . 4.6 m-20 -65.17 153.73 40.07 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 -177.048 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 70.2 p -126.28 159.35 63.11 Favored Pre-proline 0 N--CA 1.435 -1.206 0 CA-C-N 114.156 -1.384 . . . . 0.0 109.54 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -63.71 -19.49 67.33 Favored 'Trans proline' 0 C--O 1.224 -0.183 0 C-N-CA 122.515 2.143 . . . . 0.0 112.688 -179.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.49 -26.99 37.88 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-O 120.81 0.338 . . . . 0.0 111.143 -178.219 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.3 t -94.82 -36.75 11.54 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 120.861 0.362 . . . . 0.0 110.181 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 95.8 mt -75.33 -23.14 57.22 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 175.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 52.94 29.03 7.22 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.728 178.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.437 ' HA ' ' OD2' ' A' ' 79' ' ' ASP . 66.2 mtt -85.71 157.18 20.36 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.166 -178.081 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -152.79 -173.57 4.62 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.157 -178.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -57.66 120.84 9.05 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.709 0.766 . . . . 0.0 112.569 -176.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.466 ' OD1' ' HE3' ' A' ' 16' ' ' LYS . 29.5 t70 65.86 34.16 7.49 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.442 1.497 . . . . 0.0 111.054 178.464 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.437 ' OD2' ' HA ' ' A' ' 75' ' ' MET . 31.9 t0 -75.06 176.3 7.37 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.413 177.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 35.3 m -111.87 143.24 22.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 CA-C-O 121.847 0.832 . . . . 0.0 112.883 -174.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.445 HD11 HG23 ' A' ' 17' ' ' ILE . 3.3 mt -128.47 134.15 65.27 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 CA-C-N 114.234 -1.348 . . . . 0.0 109.425 176.026 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -101.7 138.16 39.06 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.105 0.478 . . . . 0.0 110.677 -177.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.404 ' HB ' ' HA2' ' A' ' 21' ' ' GLY . 88.6 t -123.5 133.76 68.26 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.644 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -99.5 152.48 19.95 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 175.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 10.5 mm100 -68.32 129.24 39.34 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 122.004 0.907 . . . . 0.0 112.568 -169.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.448 ' HG3' HG11 ' A' ' 50' ' ' VAL . 1.4 pm0 -64.05 160.87 17.12 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 113.473 -1.694 . . . . 0.0 113.548 -172.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.441 ' HB3' ' HB3' ' A' ' 54' ' ' SER . 6.6 tp-100 -64.96 -48.72 73.01 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.404 -178.212 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' A' ' 50' ' ' VAL . 56.7 tp . . . . . 0 C--N 1.322 -0.604 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.868 -179.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 . . . . . 0 N--CA 1.439 -1.021 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.403 ' HB ' ' HA ' ' A' ' 77' ' ' ASP . 18.3 pt -127.16 161.95 33.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -177.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.505 ' HE3' ' HB2' ' A' ' 78' ' ' ASP . 59.3 mtmt -97.55 146.47 25.23 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-O 121.045 0.45 . . . . 0.0 110.599 176.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.457 HG21 HD13 ' A' ' 81' ' ' ILE . 40.7 mm -128.1 127.37 67.64 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 CA-C-N 115.498 -0.773 . . . . 0.0 109.833 174.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.9 mtmt -96.75 104.77 16.8 Favored 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 177.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.696 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 98.8 t -82.21 116.88 27.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.6 t -113.03 117.61 55.82 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-O 121.082 0.467 . . . . 0.0 110.738 -178.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -88.49 168.58 36.59 Favored Glycine 0 N--CA 1.436 -1.317 0 C-N-CA 120.431 -0.89 . . . . 0.0 111.378 177.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.426 ' C ' ' H ' ' A' ' 24' ' ' SER . 78.5 mt-30 -67.89 -23.78 65.15 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.191 0.52 . . . . 0.0 111.902 -178.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -79.5 11.27 3.14 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.124 178.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.426 ' H ' ' C ' ' A' ' 22' ' ' GLN . 23.1 m 69.0 27.29 5.44 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.811 -178.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -95.66 104.63 16.55 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.737 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.696 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 37.7 tt0 -105.02 135.37 46.48 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.673 178.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.1 p -137.17 140.22 42.74 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.457 178.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 55.1 m170 -99.05 113.14 25.18 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 121.307 0.575 . . . . 0.0 111.156 -176.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -110.65 145.38 38.04 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.718 176.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 11.1 tpt180 -99.95 118.07 35.59 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.429 ' HB ' HG22 ' A' ' 35' ' ' THR . 33.3 m -133.56 167.75 25.69 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -178.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 46.0 tttm -90.82 162.96 14.61 Favored 'General case' 0 C--N 1.284 -2.247 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.52 ' O ' ' HB3' ' A' ' 70' ' ' PRO . 94.2 m-85 -55.09 -39.18 69.01 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 176.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.435 ' HA2' ' HG3' ' A' ' 70' ' ' PRO . . . -96.38 19.26 55.35 Favored Glycine 0 N--CA 1.444 -0.805 0 CA-C-N 115.728 -0.669 . . . . 0.0 113.337 -177.135 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.429 HG22 ' HB ' ' A' ' 31' ' ' VAL . 1.3 m -67.47 136.69 55.03 Favored 'General case' 0 N--CA 1.428 -1.535 0 CA-C-O 121.125 0.488 . . . . 0.0 111.73 179.088 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.55 ' HA ' ' O ' ' A' ' 65' ' ' ASN . 47.0 m -86.28 151.97 23.16 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.497 -178.063 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.445 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 24.2 ptt? -50.01 -32.27 14.84 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -179.161 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.95 -35.96 78.12 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -178.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -59.44 -40.89 88.24 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.083 0.468 . . . . 0.0 110.137 -177.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.65 HD11 ' CD2' ' A' ' 57' ' ' PHE . 0.2 OUTLIER -86.8 -43.96 12.1 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.544 -177.684 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 61.6 mtpt -62.79 -47.03 85.24 Favored 'General case' 0 CA--C 1.491 -1.293 0 N-CA-C 111.868 0.321 . . . . 0.0 111.868 -177.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -63.72 -40.68 97.35 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 46.6 t -63.73 -48.77 75.69 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.03 -179.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.687 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 43.1 t80 -70.18 -44.84 67.93 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.874 -179.108 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.413 ' CB ' ' HA ' ' A' ' 52' ' ' VAL . . . -59.47 -34.57 72.71 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.229 0.538 . . . . 0.0 109.822 179.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -66.43 -45.81 78.6 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.331 -0.849 . . . . 0.0 111.613 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.687 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 10.9 ptm85 -65.59 -28.71 69.33 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.898 -178.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.504 HG22 ' O ' ' A' ' 44' ' ' TYR . 9.9 t -93.23 -5.82 49.07 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.718 179.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 66.92 35.4 89.46 Favored Glycine 0 C--N 1.335 0.483 0 CA-C-N 116.036 -0.529 . . . . 0.0 113.277 177.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.462 HG22 ' HG3' ' A' ' 86' ' ' GLU . 1.5 p -121.54 166.16 16.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 116.927 0.364 . . . . 0.0 110.967 -177.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.46 128.72 38.47 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.51 179.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.413 ' HA ' ' CB ' ' A' ' 45' ' ' ALA . 73.4 t -61.36 -46.24 96.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.553 -0.748 . . . . 0.0 111.585 -177.037 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -77.33 -14.76 59.67 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.987 -176.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.432 ' HB3' ' HB3' ' A' ' 87' ' ' GLN . 70.0 m -85.43 -15.6 42.47 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.528 178.511 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -95.03 135.03 37.06 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.43 141.42 50.53 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 120.132 -0.627 . . . . 0.0 111.404 -175.203 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.65 ' CD2' HD11 ' A' ' 40' ' ' LEU . 13.7 m-85 -115.5 136.71 52.8 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-N 115.21 -0.904 . . . . 0.0 108.95 177.228 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.659 HD21 ' CD1' ' A' ' 84' ' ' TYR . 0.9 OUTLIER -129.99 151.12 50.9 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-O 121.589 0.709 . . . . 0.0 111.268 178.773 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.711 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 49.5 t80 -113.89 103.47 11.2 Favored 'General case' 0 C--N 1.284 -2.265 0 CA-C-N 114.921 -1.036 . . . . 0.0 108.713 175.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.7 t70 54.92 24.29 5.72 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.748 -177.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 102.34 -5.7 52.47 Favored Glycine 0 C--N 1.333 0.4 0 CA-C-N 115.601 -0.727 . . . . 0.0 113.663 177.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.711 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.2 OUTLIER -108.4 150.16 27.75 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 117.362 0.581 . . . . 0.0 109.856 178.578 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.497 ' HA ' ' CD1' ' A' ' 58' ' ' LEU . 11.8 mpt_? -66.96 142.86 57.11 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -171.053 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.1 mm -74.59 144.9 11.77 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 CA-C-N 114.816 -1.084 . . . . 0.0 109.502 176.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.58 ' HA ' ' HB2' ' A' ' 68' ' ' ASP . 1.0 OUTLIER -68.35 106.12 2.39 Favored 'General case' 0 N--CA 1.406 -2.655 0 N-CA-C 115.089 1.515 . . . . 0.0 115.089 -170.415 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.441 ' HB2' ' HG2' ' A' ' 37' ' ' MET . 4.1 t70 -91.07 -39.65 12.06 Favored 'General case' 0 C--N 1.257 -3.453 0 N-CA-C 102.834 -3.024 . . . . 0.0 102.834 153.494 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -117.7 -17.9 9.78 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 110.82 -2.9 . . . . 0.0 110.927 -176.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.58 ' HB2' ' HA ' ' A' ' 65' ' ' ASN . 2.7 m-20 -72.76 168.58 18.5 Favored 'General case' 0 C--N 1.342 0.269 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.964 -176.073 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.68 ' O ' HG22 ' A' ' 72' ' ' THR . 88.8 m -97.47 130.49 29.23 Favored Pre-proline 0 C--N 1.306 -1.324 0 C-N-CA 120.799 -0.361 . . . . 0.0 110.687 -172.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.52 ' HB3' ' O ' ' A' ' 33' ' ' TYR . 88.6 Cg_exo -52.62 -37.68 74.93 Favored 'Trans proline' 0 CA--C 1.53 0.295 0 C-N-CA 122.756 2.304 . . . . 0.0 112.127 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.02 -25.06 37.49 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.554 179.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.68 HG22 ' O ' ' A' ' 69' ' ' THR . 2.1 t -70.15 -32.81 70.96 Favored 'General case' 0 C--N 1.347 0.473 0 C-N-CA 120.026 -0.67 . . . . 0.0 109.47 178.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 60.4 mt -72.2 -24.99 61.49 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.185 174.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 57.22 40.52 27.93 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.359 179.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 24.7 mmt -72.55 155.62 39.87 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.834 -179.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -151.59 175.75 12.03 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 176.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.403 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 37.6 t70 -58.26 121.35 10.54 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.456 0.646 . . . . 0.0 112.335 -178.057 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.505 ' HB2' ' HE3' ' A' ' 16' ' ' LYS . 13.5 t70 74.19 34.28 0.85 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.351 1.461 . . . . 0.0 111.982 176.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -75.71 177.51 6.79 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.597 -0.441 . . . . 0.0 109.984 177.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 33.1 m -110.23 147.63 14.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 CA-C-O 121.546 0.689 . . . . 0.0 112.28 -173.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.457 HD13 HG21 ' A' ' 17' ' ' ILE . 0.3 OUTLIER -140.61 144.82 26.61 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.302 -179.85 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -110.28 143.08 40.99 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.169 -175.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 86.6 t -125.4 132.43 71.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.131 0.491 . . . . 0.0 111.479 179.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.659 ' CD1' HD21 ' A' ' 58' ' ' LEU . 90.5 m-85 -100.44 162.49 12.91 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.784 177.165 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 53.3 tp60 -69.45 143.97 53.42 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -176.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.462 ' HG3' HG22 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -90.0 171.15 9.77 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 112.991 0.738 . . . . 0.0 112.991 -175.12 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.432 ' HB3' ' HB3' ' A' ' 54' ' ' SER . 51.9 tt0 -62.06 -50.01 73.69 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.044 -0.98 . . . . 0.0 112.613 -178.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.8 mp . . . . . 0 C--N 1.32 -0.712 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.022 -178.009 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 . . . . . 0 N--CA 1.442 -0.871 0 CA-C-O 121.098 0.475 . . . . 0.0 111.769 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.625 HG12 ' O ' ' A' ' 31' ' ' VAL . 17.1 pt -109.56 163.62 6.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.326 -174.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.533 ' C ' HD13 ' A' ' 17' ' ' ILE . 38.0 mtmm -90.28 145.88 24.65 Favored 'General case' 0 CA--C 1.5 -0.95 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.653 HD12 ' CG2' ' A' ' 31' ' ' VAL . 1.5 mp -135.18 137.04 50.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.632 173.179 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 18.6 mtmm -97.29 104.53 16.56 Favored 'General case' 0 N--CA 1.437 -1.083 0 C-N-CA 119.979 -0.688 . . . . 0.0 109.191 178.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.619 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 85.3 t -82.64 116.17 26.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.422 179.309 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.8 t -107.69 118.85 56.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-O 120.833 0.349 . . . . 0.0 110.077 179.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.451 ' HA2' ' HB ' ' A' ' 83' ' ' VAL . . . -87.97 177.06 46.13 Favored Glycine 0 C--N 1.314 -0.663 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.414 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.545 ' C ' ' H ' ' A' ' 24' ' ' SER . 91.0 mm-40 -65.62 -36.75 84.63 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -178.102 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.64 18.85 0.22 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.954 0.407 . . . . 0.0 109.99 176.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.545 ' H ' ' C ' ' A' ' 22' ' ' GLN . 51.0 m 62.12 30.41 17.77 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.153 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -92.06 107.07 18.94 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.947 -178.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.619 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 32.2 tt0 -97.4 132.3 43.25 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.892 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.4 p -135.76 139.82 45.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.522 178.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 61.7 m170 -95.91 114.0 25.68 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 121.17 0.51 . . . . 0.0 110.916 -176.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -110.37 153.41 24.98 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.583 177.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 11.7 tpp180 -108.74 115.59 30.39 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.66 179.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.653 ' CG2' HD12 ' A' ' 17' ' ' ILE . 30.3 m -140.36 -178.94 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.412 -178.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.516 ' O ' ' HB ' ' A' ' 35' ' ' THR . 83.6 tttt -88.68 155.22 19.72 Favored 'General case' 0 C--N 1.313 -1.001 0 O-C-N 122.361 -0.212 . . . . 0.0 110.674 -177.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -51.79 -45.41 63.83 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-O 121.381 0.61 . . . . 0.0 110.123 176.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -109.84 35.43 4.88 Favored Glycine 0 N--CA 1.441 -1.012 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.967 179.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.645 ' O ' HD12 ' A' ' 73' ' ' LEU . 0.5 OUTLIER -57.19 143.43 39.12 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 121.475 0.655 . . . . 0.0 110.893 -177.164 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 59.3 m -79.85 150.02 30.79 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.757 -179.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.644 ' SD ' ' HA ' ' A' ' 65' ' ' ASN . 26.6 ptt? -49.64 -32.31 12.79 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -177.541 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.24 -36.07 82.42 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -179.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -59.19 -41.48 88.59 Favored 'General case' 0 C--O 1.217 -0.65 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.165 -175.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.642 HD12 ' CG ' ' A' ' 57' ' ' PHE . 0.5 OUTLIER -86.25 -45.64 11.09 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.168 -176.87 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -62.45 -47.92 81.92 Favored 'General case' 0 CA--C 1.492 -1.257 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.761 -176.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -65.72 -39.67 91.41 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.166 178.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 44.9 t -64.35 -51.45 63.27 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.34 -178.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.59 ' O ' ' HG3' ' A' ' 47' ' ' ARG . 47.6 t80 -66.82 -44.0 82.3 Favored 'General case' 0 CA--C 1.499 -1.002 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.45 179.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.411 ' HA ' HG13 ' A' ' 50' ' ' VAL . . . -58.58 -36.16 73.53 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.01 0.434 . . . . 0.0 109.855 -179.202 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -67.58 -44.79 77.33 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.778 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.59 ' HG3' ' O ' ' A' ' 44' ' ' TYR . 2.1 ppt_? -64.33 -25.87 68.23 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.65 -178.05 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.537 HG23 ' O ' ' A' ' 44' ' ' TYR . 10.1 t -104.17 -9.33 18.76 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.815 -178.148 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 68.92 39.56 85.14 Favored Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.737 -0.744 . . . . 0.0 113.036 179.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.491 HG22 ' HG3' ' A' ' 86' ' ' GLU . 5.2 p -118.21 164.32 14.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 120.981 0.419 . . . . 0.0 111.026 -178.01 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.585 ' HB3' ' OG ' ' A' ' 54' ' ' SER . . . -59.99 128.55 37.39 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.991 175.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 73.4 t -64.39 -40.96 90.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 121.131 0.491 . . . . 0.0 110.401 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 32.2 p-10 -67.24 -27.83 67.55 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.36 -177.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.585 ' OG ' ' HB3' ' A' ' 51' ' ' ALA . 88.4 p -97.58 1.18 48.55 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.079 0.466 . . . . 0.0 111.618 179.314 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -96.85 133.49 41.4 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 175.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.75 144.16 35.35 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -174.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.642 ' CG ' HD12 ' A' ' 40' ' ' LEU . 63.4 m-85 -119.14 142.86 47.56 Favored 'General case' 0 CA--C 1.501 -0.921 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.618 176.419 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.613 HD22 ' CE1' ' A' ' 84' ' ' TYR . 8.1 mp -130.84 133.87 46.31 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.628 178.248 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.768 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 0.3 OUTLIER -109.33 114.63 28.47 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.945 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 38.7 t70 66.27 22.48 10.91 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 122.044 0.926 . . . . 0.0 110.674 -177.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 89.9 9.53 65.86 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.41 -0.814 . . . . 0.0 113.055 176.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.768 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.2 OUTLIER -117.62 148.62 41.77 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.753 179.588 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 26.1 mmt85 -65.41 133.26 50.96 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.245 -175.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.401 HD11 ' HB3' ' A' ' 57' ' ' PHE . 87.9 mt -93.67 120.55 43.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.213 -178.317 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.644 ' HA ' ' SD ' ' A' ' 37' ' ' MET . 22.1 m120 -115.83 162.48 17.25 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.773 177.019 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -70.1 -15.0 62.92 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.214 0.53 . . . . 0.0 110.573 -179.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -84.12 -18.83 35.52 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.701 -178.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.628 ' CG ' HH12 ' A' ' 62' ' ' ARG . 65.9 m-20 -71.21 171.49 10.95 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 115.413 1.635 . . . . 0.0 115.413 -172.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.69 ' O ' ' HG ' ' A' ' 73' ' ' LEU . 71.8 p -93.57 156.39 39.76 Favored Pre-proline 0 C--N 1.346 0.449 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.352 -172.036 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.524 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 9.6 Cg_endo -49.77 -26.51 13.6 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 123.352 2.702 . . . . 0.0 113.793 -175.047 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.845 ' HA ' ' CG ' ' A' ' 75' ' ' MET . 0.0 OUTLIER -74.04 -24.35 59.53 Favored 'General case' 0 C--O 1.214 -0.775 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 -179.558 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.549 ' CG2' ' HB3' ' A' ' 68' ' ' ASP . 0.5 OUTLIER -101.85 -6.8 23.12 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 176.126 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.83 ' O ' ' HB2' ' A' ' 74' ' ' GLU . 0.7 OUTLIER -101.44 24.58 9.43 Favored 'General case' 0 CA--C 1.444 -3.098 0 CA-C-N 111.807 -2.451 . . . . 0.0 115.409 -172.661 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.83 ' HB2' ' O ' ' A' ' 73' ' ' LEU . 35.7 mt-10 76.26 65.62 0.05 Allowed 'General case' 0 C--N 1.303 -1.413 0 CA-C-O 122.903 1.335 . . . . 0.0 111.35 174.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.845 ' CG ' ' HA ' ' A' ' 71' ' ' LYS . 90.1 mtp -39.58 -179.31 0.0 OUTLIER 'General case' 0 C--N 1.267 -2.984 0 CA-C-N 111.812 -2.449 . . . . 0.0 116.201 171.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.513 ' HA ' HD12 ' A' ' 15' ' ' ILE . 14.9 pt-20 -71.74 -178.05 2.14 Favored 'General case' 0 CA--C 1.486 -1.508 0 C-N-CA 124.812 1.245 . . . . 0.0 113.13 -156.488 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -35.34 99.76 0.02 OUTLIER 'General case' 0 CA--C 1.506 -0.74 0 O-C-N 124.862 1.351 . . . . 0.0 113.932 -168.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 14.0 t70 82.42 33.23 0.08 Allowed 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 112.181 -2.281 . . . . 0.0 112.566 171.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -70.44 178.9 2.71 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 119.828 -0.749 . . . . 0.0 109.57 172.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 29.3 m -110.92 151.02 13.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -172.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.453 ' CG1' ' HG2' ' A' ' 74' ' ' GLU . 1.3 mm -138.87 145.93 26.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.017 -0.992 . . . . 0.0 111.674 -178.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -112.16 138.8 48.34 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 116.114 -0.493 . . . . 0.0 109.83 178.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.451 ' HB ' ' HA2' ' A' ' 21' ' ' GLY . 78.3 t -125.83 132.8 70.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 CA-C-O 121.063 0.459 . . . . 0.0 111.092 179.54 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.613 ' CE1' HD22 ' A' ' 58' ' ' LEU . 70.7 m-85 -98.84 140.88 32.35 Favored 'General case' 0 N--CA 1.418 -2.056 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 174.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -68.15 127.12 31.75 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 121.806 0.812 . . . . 0.0 112.152 -164.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.491 ' HG3' HG22 ' A' ' 50' ' ' VAL . 13.2 pm0 -64.54 157.44 26.82 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 113.84 -1.527 . . . . 0.0 113.029 -175.262 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 57.9 tp60 -66.23 -45.22 81.42 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.999 -1.001 . . . . 0.0 112.928 -174.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 93.4 mt . . . . . 0 C--N 1.315 -0.898 0 CA-C-N 116.13 -0.487 . . . . 0.0 112.292 -174.656 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 . . . . . 0 CA--C 1.511 -0.549 0 CA-C-O 121.51 0.672 . . . . 0.0 112.343 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 18.2 pt -126.89 162.89 30.62 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.285 -175.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.403 ' HB2' ' N ' ' A' ' 78' ' ' ASP . 28.3 mtpp -92.27 145.35 24.55 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.048 178.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 31.2 mm -135.02 129.8 51.26 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 CA-C-O 120.856 0.36 . . . . 0.0 111.305 175.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 22.3 mtmt -100.34 108.13 20.09 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 177.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.637 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 77.5 t -81.69 117.76 28.25 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 177.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 59.4 t -112.29 118.78 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 CA-C-O 121.189 0.519 . . . . 0.0 110.571 -178.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -86.89 168.24 39.11 Favored Glycine 0 N--CA 1.436 -1.344 0 C-N-CA 120.494 -0.86 . . . . 0.0 111.44 177.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.441 ' HG2' ' O ' ' A' ' 83' ' ' VAL . 87.7 mm-40 -70.87 -20.29 62.54 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.566 0.698 . . . . 0.0 111.498 -178.134 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -84.46 13.84 5.09 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.354 178.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.9 m 67.18 28.73 8.06 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.083 -178.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -95.58 103.28 15.15 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.063 -179.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.637 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 35.4 tt0 -104.03 135.44 45.53 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.03 179.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.2 p -135.64 142.38 39.52 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.389 178.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 27.9 m170 -102.08 117.61 35.17 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 121.252 0.548 . . . . 0.0 112.285 -175.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.427 ' HZ ' ' CD ' ' A' ' 47' ' ' ARG . 81.0 m-85 -116.33 146.87 42.1 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.49 175.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 49.5 ttp180 -104.45 123.02 46.72 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 174.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 33.4 m -133.43 174.34 13.37 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.374 -175.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.4 ttpp -88.41 157.7 18.6 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -178.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.508 ' O ' ' HB3' ' A' ' 70' ' ' PRO . 90.8 m-85 -52.3 -41.22 62.74 Favored 'General case' 0 C--O 1.224 -0.268 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 175.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -104.97 32.31 7.64 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.954 -178.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.453 HG22 ' HB2' ' A' ' 39' ' ' LYS . 1.1 m -67.76 134.57 51.25 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 121.28 0.562 . . . . 0.0 111.913 178.438 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.51 ' HB3' ' HA ' ' A' ' 66' ' ' ASP . 69.9 m -91.26 156.31 17.91 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.528 -179.688 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 24.9 ptt? -45.67 -35.75 4.38 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -178.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.69 -37.74 85.22 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -176.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.453 ' HB2' HG22 ' A' ' 35' ' ' THR . 76.0 mmtt -59.99 -39.87 87.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.778 0.323 . . . . 0.0 110.205 -175.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.572 HD12 ' CD1' ' A' ' 57' ' ' PHE . 0.4 OUTLIER -87.58 -42.79 12.47 Favored 'General case' 0 C--O 1.217 -0.629 0 N-CA-C 112.665 0.616 . . . . 0.0 112.665 -177.545 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.438 ' HA ' ' HE1' ' A' ' 57' ' ' PHE . 61.3 mtpt -62.88 -46.24 88.8 Favored 'General case' 0 CA--C 1.493 -1.22 0 CA-C-O 120.574 0.226 . . . . 0.0 111.514 -178.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.514 ' O ' ' HB2' ' A' ' 46' ' ' ASP . 40.5 ttpt -62.81 -41.28 99.24 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.638 176.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 46.9 t -69.08 -52.19 30.97 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.63 -177.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.653 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 40.3 t80 -64.4 -47.83 77.73 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-O 120.694 0.283 . . . . 0.0 110.935 -178.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.429 ' CB ' ' HA ' ' A' ' 52' ' ' VAL . . . -60.13 -33.68 72.48 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.397 0.617 . . . . 0.0 109.968 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.514 ' HB2' ' O ' ' A' ' 42' ' ' LYS . 20.4 t70 -64.02 -47.15 81.36 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.214 -178.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.653 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 7.8 ptm180 -69.76 -29.25 66.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.392 -177.163 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.54 HG23 ' O ' ' A' ' 44' ' ' TYR . 7.6 t -88.44 -12.75 42.23 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.965 0.412 . . . . 0.0 110.425 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 69.76 31.58 70.34 Favored Glycine 0 CA--C 1.505 -0.558 0 C-N-CA 121.003 -0.618 . . . . 0.0 111.906 179.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 87' ' ' GLN . 0.5 OUTLIER -115.2 175.12 2.73 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 CA-C-O 120.435 0.16 . . . . 0.0 110.605 -176.064 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.443 ' HB1' ' HB2' ' A' ' 54' ' ' SER . . . -59.16 125.64 24.45 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.912 179.021 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.429 ' HA ' ' CB ' ' A' ' 45' ' ' ALA . 70.2 t -67.1 -44.14 88.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.284 0.564 . . . . 0.0 110.253 178.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -66.16 -34.23 77.57 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.847 -178.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.443 ' HB2' ' HB1' ' A' ' 51' ' ' ALA . 59.2 m -84.98 -13.83 49.4 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.885 -175.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.495 HD23 ' HB3' ' A' ' 87' ' ' GLN . 2.7 tm? -92.98 123.2 36.06 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 179.01 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.416 ' HG3' ' C ' ' A' ' 55' ' ' LEU . 20.4 mtt180 -135.74 146.09 47.3 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.117 -170.091 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.572 ' CD1' HD12 ' A' ' 40' ' ' LEU . 95.2 m-85 -119.97 148.11 43.94 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.965 -179.329 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.3 mp -129.07 148.31 51.01 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.517 176.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.655 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 18.0 t80 -121.88 120.81 35.59 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 177.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 33.6 t70 61.04 24.05 14.18 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 121.517 0.675 . . . . 0.0 110.707 179.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 87.92 8.38 72.77 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.846 179.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.655 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 6.0 ppt_? -120.44 152.59 37.77 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 120.356 -0.538 . . . . 0.0 111.274 178.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 18.0 mmm180 -65.3 133.95 52.54 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.458 -176.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 87.0 mt -85.18 129.37 37.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 173.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -109.96 162.23 14.72 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.25 0.547 . . . . 0.0 111.034 -172.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.51 ' HA ' ' HB3' ' A' ' 36' ' ' SER . 10.9 p-10 -83.47 -7.67 59.5 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.178 0.513 . . . . 0.0 109.688 174.048 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -102.81 -13.02 17.17 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 115.361 -0.836 . . . . 0.0 112.324 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.417 ' OD2' HD21 ' A' ' 73' ' ' LEU . 35.9 p30 -71.62 167.08 20.55 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 113.034 0.754 . . . . 0.0 113.034 -174.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.464 ' HB ' ' HD2' ' A' ' 70' ' ' PRO . 53.0 p -120.59 160.23 45.03 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.012 -176.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.508 ' HB3' ' O ' ' A' ' 33' ' ' TYR . 12.7 Cg_endo -56.84 -31.34 88.52 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.125 2.55 . . . . 0.0 113.701 -177.129 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.422 ' HE2' ' HB3' ' A' ' 71' ' ' LYS . 2.8 ptpt -70.18 -48.77 55.77 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.645 0.259 . . . . 0.0 111.066 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.0 t -70.87 -27.87 64.14 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 121.007 0.432 . . . . 0.0 109.928 178.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.485 ' HB3' ' HG3' ' A' ' 75' ' ' MET . 74.9 mt -70.84 -27.42 63.84 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 174.286 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 53.84 29.38 9.67 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.223 176.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.485 ' HG3' ' HB3' ' A' ' 73' ' ' LEU . 88.2 mtp -81.9 150.85 27.55 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.411 -177.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -146.73 178.65 8.15 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 177.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -60.58 123.49 17.55 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.729 0.775 . . . . 0.0 112.224 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.403 ' N ' ' HB2' ' A' ' 16' ' ' LYS . 15.4 t70 64.8 33.93 9.8 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 113.865 -1.516 . . . . 0.0 111.033 176.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -76.98 177.84 7.43 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 175.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.0 m -114.43 148.6 17.12 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 CA-C-O 121.742 0.782 . . . . 0.0 112.382 -174.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.1 mp -125.75 136.74 59.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 CA-C-N 114.508 -1.224 . . . . 0.0 108.232 177.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -99.97 139.4 35.69 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.143 0.497 . . . . 0.0 110.892 -176.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.525 HG23 ' CD2' ' A' ' 57' ' ' PHE . 86.6 t -123.36 130.45 74.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.114 178.294 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -99.28 149.07 23.5 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 174.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -69.31 107.26 3.2 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 121.553 0.692 . . . . 0.0 111.017 -171.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.486 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 1.3 mm-40 176.04 114.65 0.02 OUTLIER 'General case' 0 CA--C 1.476 -1.901 0 C-N-CA 125.984 1.714 . . . . 0.0 110.966 -174.198 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.582 ' O ' HG23 ' A' ' 50' ' ' VAL . 27.8 pt20 -157.18 13.35 0.24 Allowed 'General case' 0 N--CA 1.384 -3.768 0 CA-C-N 113.425 -1.716 . . . . 0.0 108.337 176.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 52.3 tp . . . . . 0 C--N 1.309 -1.167 0 CA-C-N 112.857 -1.974 . . . . 0.0 107.624 -170.036 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 . . . . . 0 N--CA 1.444 -0.758 0 CA-C-O 120.947 0.403 . . . . 0.0 111.072 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.55 HD11 ' O ' ' A' ' 75' ' ' MET . 11.7 pt -109.05 163.01 6.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-O 121.49 0.662 . . . . 0.0 111.369 -173.107 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.527 ' HD3' ' OD2' ' A' ' 77' ' ' ASP . 42.5 mtpt -92.1 147.67 22.77 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.727 -178.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.56 HG13 ' HB3' ' A' ' 74' ' ' GLU . 8.4 mm -139.5 139.34 38.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.613 175.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.5 mtmt -101.92 105.25 16.03 Favored 'General case' 0 N--CA 1.431 -1.388 0 C-N-CA 120.105 -0.638 . . . . 0.0 109.638 177.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.622 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 76.0 t -80.71 114.06 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 176.347 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 59.2 t -109.34 118.65 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.013 0 CA-C-O 121.154 0.502 . . . . 0.0 110.482 -178.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -84.62 173.34 49.35 Favored Glycine 0 N--CA 1.436 -1.318 0 C-N-CA 120.321 -0.942 . . . . 0.0 111.013 176.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 86.7 mm-40 -73.36 -19.18 61.07 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.368 0.604 . . . . 0.0 111.83 -176.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -85.5 12.53 8.33 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.161 176.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 51.0 m 67.3 27.13 8.36 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.063 -177.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -89.31 103.4 16.03 Favored 'General case' 0 CA--C 1.495 -1.14 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.876 179.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.622 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 36.3 tt0 -104.89 133.44 49.69 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.978 -177.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.3 p -136.57 141.9 39.73 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.466 178.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 63.5 m170 -95.37 119.04 33.19 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 121.405 0.622 . . . . 0.0 111.429 -176.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -109.51 150.74 27.69 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.508 175.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 17.1 tpp180 -103.36 118.09 35.97 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 176.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.548 ' O ' HG12 ' A' ' 15' ' ' ILE . 34.6 m -136.75 173.13 14.08 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.715 -175.381 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -90.13 156.76 18.12 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -55.49 -38.86 69.71 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 121.327 0.584 . . . . 0.0 109.518 175.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -104.45 33.69 6.37 Favored Glycine 0 N--CA 1.44 -1.037 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.395 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.549 ' O ' HD11 ' A' ' 73' ' ' LEU . 0.9 OUTLIER -63.77 131.7 48.67 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-O 121.695 0.759 . . . . 0.0 111.833 179.568 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 69.9 m -81.15 151.88 28.03 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.254 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.666 ' SD ' ' HA ' ' A' ' 65' ' ' ASN . 27.3 ptt? -48.34 -33.5 9.07 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -178.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.52 -36.53 82.87 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 112.203 0.445 . . . . 0.0 112.203 -178.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.428 ' HB2' HG22 ' A' ' 35' ' ' THR . 75.8 mmtt -60.74 -41.19 94.87 Favored 'General case' 0 C--O 1.217 -0.622 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.822 -174.416 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.493 HD13 ' CG ' ' A' ' 57' ' ' PHE . 0.9 OUTLIER -87.71 -45.14 10.63 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -178.2 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.409 ' HA ' ' HE1' ' A' ' 57' ' ' PHE . 61.1 mtpt -62.65 -46.09 89.84 Favored 'General case' 0 CA--C 1.494 -1.175 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -177.055 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 41.7 ttmt -62.76 -41.49 99.25 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 121.231 0.539 . . . . 0.0 109.593 176.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 58.8 m -69.16 -51.91 33.4 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -177.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.582 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 43.4 t80 -66.41 -47.51 73.04 Favored 'General case' 0 CA--C 1.505 -0.776 0 N-CA-C 111.779 0.289 . . . . 0.0 111.779 -179.118 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.401 ' CB ' ' HA ' ' A' ' 52' ' ' VAL . . . -59.98 -35.47 75.07 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.318 0.58 . . . . 0.0 110.347 -178.419 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -66.15 -47.1 75.16 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.517 -178.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.582 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 10.6 ptm85 -68.91 -25.72 64.73 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.242 -176.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.471 HG21 ' O ' ' A' ' 44' ' ' TYR . 10.2 t -93.04 -9.9 38.08 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 120.956 0.408 . . . . 0.0 111.123 -179.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.6 40.14 59.6 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.975 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.507 HG23 ' HG3' ' A' ' 86' ' ' GLU . 2.7 p -126.4 162.46 30.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.47 ' HB3' ' OG ' ' A' ' 54' ' ' SER . . . -59.81 130.67 47.92 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 178.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.401 ' HA ' ' CB ' ' A' ' 45' ' ' ALA . 74.8 t -61.63 -44.64 99.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.694 -177.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -66.37 -33.21 75.2 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.673 -178.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.47 ' OG ' ' HB3' ' A' ' 51' ' ' ALA . 90.5 p -76.72 -14.45 59.94 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.68 -178.423 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.474 HD12 ' N ' ' A' ' 56' ' ' ARG . 1.0 OUTLIER -95.89 136.97 35.62 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -179.509 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.474 ' N ' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -140.99 145.48 36.01 Favored 'General case' 0 N--CA 1.436 -1.129 0 C-N-CA 119.853 -0.739 . . . . 0.0 111.509 -176.798 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.493 ' CG ' HD13 ' A' ' 40' ' ' LEU . 92.8 m-85 -118.84 140.96 49.11 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 114.922 -1.035 . . . . 0.0 109.267 176.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.58 HD23 ' CE1' ' A' ' 84' ' ' TYR . 9.2 mp -126.26 145.54 50.37 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.856 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.693 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 0.4 OUTLIER -128.84 117.38 20.96 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 177.157 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 68.13 24.14 7.77 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.387 0.613 . . . . 0.0 110.987 -175.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.1 14.08 77.77 Favored Glycine 0 N--CA 1.438 -1.185 0 CA-C-N 115.414 -0.812 . . . . 0.0 113.001 176.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.693 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.1 OUTLIER -124.2 146.45 48.69 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.232 179.462 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 10.9 mpt_? -67.6 130.1 41.97 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.836 -176.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 83.9 mt -80.09 125.86 39.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.384 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.666 ' HA ' ' SD ' ' A' ' 37' ' ' MET . 20.7 m120 -116.69 171.18 8.04 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 123.343 0.657 . . . . 0.0 109.489 177.255 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -78.8 -8.76 59.07 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -175.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -114.97 16.62 17.14 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 120.229 -0.588 . . . . 0.0 112.162 -178.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.571 ' HB2' HD22 ' A' ' 73' ' ' LEU . 72.0 m-20 -84.22 172.06 12.22 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.582 ' O ' ' HG ' ' A' ' 73' ' ' LEU . 69.2 p -82.91 156.13 67.5 Favored Pre-proline 0 CA--C 1.509 -0.599 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -173.362 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.538 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 17.4 Cg_endo -54.84 -18.68 16.93 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 123.131 2.554 . . . . 0.0 112.61 -176.427 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.856 ' HA ' ' CG ' ' A' ' 75' ' ' MET . 2.1 tmmm? -70.5 -40.54 73.51 Favored 'General case' 0 N--CA 1.413 -2.312 0 C-N-CA 122.888 0.475 . . . . 0.0 111.812 -179.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.464 ' OG1' ' HD2' ' A' ' 62' ' ' ARG . 1.4 t -96.72 -6.84 35.45 Favored 'General case' 0 CA--C 1.477 -1.839 0 CA-C-O 123.34 1.543 . . . . 0.0 107.021 -178.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.826 ' O ' ' HB2' ' A' ' 74' ' ' GLU . 0.3 OUTLIER -96.53 24.97 5.42 Favored 'General case' 0 CA--C 1.432 -3.587 0 CA-C-N 111.514 -2.585 . . . . 0.0 114.407 -176.761 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.826 ' HB2' ' O ' ' A' ' 73' ' ' LEU . 32.7 mt-10 76.23 66.04 0.06 Allowed 'General case' 0 C--N 1.305 -1.327 0 O-C-N 124.747 1.28 . . . . 0.0 111.66 173.067 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.856 ' CG ' ' HA ' ' A' ' 71' ' ' LYS . 76.4 mtm -39.84 -179.32 0.0 OUTLIER 'General case' 0 C--N 1.269 -2.897 0 CA-C-N 112.418 -2.174 . . . . 0.0 116.764 172.46 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.483 ' HA ' HD11 ' A' ' 15' ' ' ILE . 13.6 pt-20 -72.18 178.75 3.68 Favored 'General case' 0 CA--C 1.478 -1.819 0 C-N-CA 124.369 1.068 . . . . 0.0 112.295 -157.052 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.527 ' OD2' ' HD3' ' A' ' 16' ' ' LYS . 7.0 t70 -25.67 97.74 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.705 0 O-C-N 125.392 1.683 . . . . 0.0 114.269 -171.023 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.9 t70 80.23 33.04 0.17 Allowed 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 112.05 -2.341 . . . . 0.0 113.076 168.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -72.04 178.27 3.88 Favored 'General case' 0 C--N 1.36 1.056 0 C-N-CA 119.193 -1.003 . . . . 0.0 109.489 171.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 29.8 m -107.76 152.19 9.56 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -170.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.414 HD12 ' HA ' ' A' ' 81' ' ' ILE . 4.7 mm -135.91 138.88 46.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.499 -179.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -103.34 140.41 37.46 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.198 -179.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 95.6 t -125.69 133.72 68.41 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-O 120.975 0.417 . . . . 0.0 111.227 178.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.58 ' CE1' HD23 ' A' ' 58' ' ' LEU . 79.0 m-85 -107.59 159.3 16.55 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.604 176.207 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 37.5 tp60 -68.62 144.05 54.62 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.19 0.519 . . . . 0.0 111.649 -170.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.507 ' HG3' HG23 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -95.87 161.41 14.02 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.547 -175.589 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.446 ' H ' ' HB2' ' A' ' 54' ' ' SER . 58.3 tp60 -66.75 -44.39 81.56 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.379 -0.828 . . . . 0.0 113.232 -177.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.2 mm? . . . . . 0 C--N 1.32 -0.708 0 CA-C-O 120.881 0.372 . . . . 0.0 111.958 -175.795 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.7 mtp . . . . . 0 N--CA 1.474 0.762 0 N-CA-C 110.421 -0.214 . . . . 0.0 110.421 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.98 149.67 46.42 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.35 178.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -60.89 141.59 57.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.199 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -62.11 -40.98 97.74 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.143 -176.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 62.64 11.79 5.07 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.484 178.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 66.91 126.29 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.516 0.726 . . . . 0.0 112.341 178.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 19.4 pm0 -69.29 165.14 21.25 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.206 178.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.47 -40.77 97.74 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.567 -178.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 89.3 -6.86 83.1 Favored Glycine 0 N--CA 1.445 -0.759 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 -178.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -84.55 83.09 8.13 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 114.469 -0.865 . . . . 0.0 109.681 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 31.1 p30 -162.89 178.39 8.44 Favored 'General case' 0 N--CA 1.424 -1.768 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -177.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -165.84 -74.41 0.03 OUTLIER 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.006 177.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -110.96 -13.68 14.07 Favored 'General case' 0 CA--C 1.496 -1.108 0 CA-C-O 122.303 1.049 . . . . 0.0 109.701 177.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -137.73 160.66 38.62 Favored 'General case' 0 C--N 1.28 -2.443 0 CA-C-N 113.41 -1.723 . . . . 0.0 110.481 -177.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.483 HG12 ' O ' ' A' ' 31' ' ' VAL . 11.9 pt -116.93 163.33 14.18 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.662 -176.086 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.429 ' HE2' ' HB3' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -96.31 141.54 29.53 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.2 179.644 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.457 HD13 ' CG2' ' A' ' 31' ' ' VAL . 83.7 mt -140.35 137.62 36.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.504 175.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 13.8 mtmm -102.02 106.32 17.2 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.599 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 92.8 t -82.45 119.87 32.82 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.62 178.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 59.1 t -110.81 118.77 58.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-O 120.91 0.386 . . . . 0.0 110.025 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.55 ' HA2' ' HB ' ' A' ' 83' ' ' VAL . . . -90.15 169.41 34.82 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.346 -0.93 . . . . 0.0 112.549 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.467 ' HG2' ' O ' ' A' ' 83' ' ' VAL . 89.8 mm-40 -69.16 -24.38 64.07 Favored 'General case' 0 CA--C 1.504 -0.799 0 CA-C-O 121.39 0.614 . . . . 0.0 110.689 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -69.85 1.6 4.25 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.644 175.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.446 ' H ' ' C ' ' A' ' 22' ' ' GLN . 47.4 m 69.49 27.82 4.8 Favored 'General case' 0 C--N 1.351 0.656 0 CA-C-O 121.994 0.902 . . . . 0.0 109.134 -176.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -98.86 107.1 19.45 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.354 -1.294 . . . . 0.0 111.049 -178.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.599 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 33.7 tt0 -99.3 133.27 43.83 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.418 177.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.6 p -133.8 139.78 47.9 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-N 115.91 -0.587 . . . . 0.0 109.88 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.424 ' HB3' ' HE3' ' A' ' 16' ' ' LYS . 19.0 m170 -96.48 113.28 24.85 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.345 0.593 . . . . 0.0 111.582 -176.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -111.99 150.4 30.63 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.473 179.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.471 ' HD3' ' O ' ' A' ' 15' ' ' ILE . 22.4 tpp180 -107.35 116.95 32.84 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 175.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.483 ' O ' HG12 ' A' ' 15' ' ' ILE . 35.0 m -138.66 169.02 18.53 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.304 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -178.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 53.9 tttp -89.33 160.1 17.03 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 -177.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -55.38 -38.29 68.66 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.016 0.436 . . . . 0.0 110.126 175.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -102.35 22.65 36.94 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.931 -0.577 . . . . 0.0 113.051 -178.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -62.39 142.36 57.87 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-O 121.323 0.582 . . . . 0.0 112.001 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 69.2 m -91.14 153.47 20.03 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.604 -179.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.401 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 27.3 ptt? -49.96 -33.19 16.92 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 112.897 0.702 . . . . 0.0 112.897 -177.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.46 -36.78 81.37 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -178.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -60.13 -40.04 88.41 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.91 0.386 . . . . 0.0 110.766 -176.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.557 HD11 ' CD2' ' A' ' 57' ' ' PHE . 0.2 OUTLIER -86.62 -45.49 10.98 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.928 -177.993 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.527 ' HG2' ' CD1' ' A' ' 57' ' ' PHE . 63.2 mtpt -63.83 -45.44 89.54 Favored 'General case' 0 CA--C 1.498 -1.024 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.639 -177.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -60.55 -44.37 96.19 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 176.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 39.5 t -64.96 -50.22 67.24 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.775 -176.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.532 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 48.8 t80 -68.18 -45.63 72.91 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.517 -179.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.473 ' HB3' ' O ' ' A' ' 50' ' ' VAL . . . -59.24 -36.27 75.15 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.413 0.625 . . . . 0.0 109.725 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -67.01 -47.01 72.74 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.413 -178.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.532 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 10.5 ptm85 -66.3 -24.74 66.6 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.334 -178.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.51 HG23 ' O ' ' A' ' 44' ' ' TYR . 14.6 t -99.36 -5.36 29.73 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.833 -178.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 69.3 30.94 71.38 Favored Glycine 0 C--N 1.336 0.53 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.762 178.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.473 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 83.2 t -118.75 150.19 21.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 C-N-CA 122.445 0.298 . . . . 0.0 110.803 -177.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.468 ' HB1' ' OG ' ' A' ' 54' ' ' SER . . . -51.34 134.72 27.89 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.296 176.059 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 74.7 t -61.63 -43.28 96.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.602 -178.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -71.82 -15.93 62.16 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.703 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.507 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 73.6 m -81.55 -12.62 58.73 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.645 178.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.498 ' C ' ' HD3' ' A' ' 56' ' ' ARG . 2.6 mm? -94.37 134.84 36.44 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.112 176.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.498 ' HD3' ' C ' ' A' ' 55' ' ' LEU . 0.7 OUTLIER -126.07 114.42 18.39 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.971 -177.658 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.557 ' CD2' HD11 ' A' ' 40' ' ' LEU . 20.0 m-85 -106.12 132.27 52.4 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.172 0.511 . . . . 0.0 111.856 -178.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.555 ' HG ' ' HA ' ' A' ' 63' ' ' ARG . 6.6 mp -129.3 139.98 51.58 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.701 178.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.719 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 88.9 t80 -111.14 121.89 46.46 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 177.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 19.4 t70 55.19 23.56 5.53 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 121.484 0.659 . . . . 0.0 111.544 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 94.85 8.46 59.23 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.793 -0.717 . . . . 0.0 113.16 177.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.719 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.1 OUTLIER -124.79 141.44 52.11 Favored 'General case' 0 CA--C 1.505 -0.758 0 CA-C-O 121.147 0.498 . . . . 0.0 109.759 176.456 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.555 ' HA ' ' HG ' ' A' ' 58' ' ' LEU . 29.5 ptt180 -68.23 139.38 56.03 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -174.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 83.7 mt -88.97 122.42 40.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-N 114.548 -1.206 . . . . 0.0 109.886 -178.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 -109.01 163.99 12.82 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.68 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -81.39 -7.7 59.62 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.142 0.496 . . . . 0.0 109.767 177.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -94.51 -19.25 20.7 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.164 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.503 ' CG ' HH12 ' A' ' 62' ' ' ARG . 39.3 m-20 -62.73 138.19 58.45 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-O 121.179 0.514 . . . . 0.0 111.746 -177.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.43 ' HB ' ' HD2' ' A' ' 70' ' ' PRO . 82.7 p -91.26 162.71 31.48 Favored Pre-proline 0 C--N 1.312 -1.039 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.195 -179.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.43 ' HD2' ' HB ' ' A' ' 69' ' ' THR . 17.9 Cg_endo -59.79 -25.99 80.9 Favored 'Trans proline' 0 CA--C 1.535 0.542 0 C-N-CA 122.107 1.871 . . . . 0.0 111.6 176.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.449 ' N ' ' HE2' ' A' ' 71' ' ' LYS . 0.2 OUTLIER -63.7 -47.01 82.87 Favored 'General case' 0 CA--C 1.483 -1.629 0 CA-C-O 121.96 0.886 . . . . 0.0 110.164 178.69 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.7 t -84.32 -27.14 27.98 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 113.975 -1.466 . . . . 0.0 112.09 -174.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 96.4 mt -82.77 -22.74 34.19 Favored 'General case' 0 C--O 1.216 -0.702 0 C-N-CA 120.289 -0.564 . . . . 0.0 110.798 177.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 38.08 34.27 0.06 Allowed 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 124.833 1.253 . . . . 0.0 113.616 178.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 64.9 mtt -75.35 150.57 38.39 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -152.54 -174.03 4.76 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -178.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -48.94 118.06 2.41 Favored 'General case' 0 C--N 1.32 -0.707 0 O-C-N 123.885 0.74 . . . . 0.0 112.763 -176.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.5 t70 58.42 34.55 24.07 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.23 -1.35 . . . . 0.0 111.479 173.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -69.89 178.13 2.81 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.3 m -114.77 148.77 17.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 CA-C-O 121.594 0.711 . . . . 0.0 112.092 -174.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.6 mt -131.85 137.79 54.17 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.1 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -105.1 133.88 49.13 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -178.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.55 ' HB ' ' HA2' ' A' ' 21' ' ' GLY . 92.6 t -124.08 136.43 60.38 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.874 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.527 ' CD1' HD13 ' A' ' 58' ' ' LEU . 69.8 m-85 -96.78 164.11 12.7 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 58.5 tp60 -67.24 128.7 37.39 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.304 0.573 . . . . 0.0 110.581 -171.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.507 ' HA ' ' O ' ' A' ' 54' ' ' SER . 13.7 pm0 -64.92 151.14 46.49 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 114.935 -1.029 . . . . 0.0 112.256 -177.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 61.8 tp60 -63.42 -50.91 67.95 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.366 -174.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 88.3 mt -72.79 -34.54 66.99 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.67 -0.696 . . . . 0.0 112.798 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -62.14 -42.28 99.72 Favored Glycine 0 CA--C 1.516 0.109 0 C-N-CA 120.215 -0.993 . . . . 0.0 112.16 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.563 0 CA-C-O 118.622 -1.099 . . . . 0.0 112.385 178.403 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.3 tpp . . . . . 0 N--CA 1.471 0.593 0 CA-C-O 120.616 0.246 . . . . 0.0 110.485 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.64 150.12 31.68 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.655 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -82.58 133.49 35.18 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.79 177.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -65.82 -19.45 65.89 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -178.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 76.56 17.69 1.84 Allowed 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.85 0.86 . . . . 0.0 109.915 -176.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -143.81 134.1 24.5 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 177.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 67.3 mm-40 -116.52 178.07 4.47 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 -176.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.7 -40.82 93.66 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.959 0.409 . . . . 0.0 110.254 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -87.39 -48.07 4.41 Favored Glycine 0 N--CA 1.438 -1.202 0 C-N-CA 120.426 -0.893 . . . . 0.0 110.91 175.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 28.1 t70 56.82 33.31 22.86 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.585 0.754 . . . . 0.0 111.147 178.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 31.7 p-10 -111.93 26.14 10.91 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.564 0.697 . . . . 0.0 110.325 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -143.6 148.69 36.26 Favored 'General case' 0 N--CA 1.418 -2.043 0 CA-C-N 115.034 -0.984 . . . . 0.0 109.195 -177.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.562 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 23.5 mt-10 -125.55 38.3 4.2 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.665 -176.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -129.39 160.32 33.45 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 115.747 -0.66 . . . . 0.0 112.466 -173.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.493 ' O ' ' HD2' ' A' ' 30' ' ' ARG . 13.9 pt -124.25 164.17 22.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 114.535 -1.211 . . . . 0.0 108.035 -178.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.427 ' HB2' HH11 ' A' ' 30' ' ' ARG . 17.7 ttpp -99.69 143.41 29.95 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 119.997 -0.681 . . . . 0.0 110.202 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.43 HG23 HD13 ' A' ' 81' ' ' ILE . 74.3 mt -135.75 134.42 51.32 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 CA-C-O 120.87 0.367 . . . . 0.0 111.113 175.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 18.4 mtmt -96.04 107.18 19.45 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.642 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 71.4 t -81.29 117.38 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 177.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.3 t -110.75 118.11 56.5 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -82.52 178.53 53.33 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 120.5 -0.857 . . . . 0.0 111.747 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.539 ' C ' ' H ' ' A' ' 24' ' ' SER . 97.9 mt-30 -66.18 -37.02 84.61 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -178.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -79.29 22.19 0.44 Allowed 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.618 0.723 . . . . 0.0 109.294 177.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.539 ' H ' ' C ' ' A' ' 22' ' ' GLN . 85.0 p 58.97 30.43 20.22 Favored 'General case' 0 CA--C 1.512 -0.517 0 C-N-CA 124.807 1.243 . . . . 0.0 111.201 -179.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -83.6 105.68 14.72 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 114.836 -1.075 . . . . 0.0 109.866 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.642 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 36.5 tt0 -103.67 130.88 51.21 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.699 -177.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.5 p -135.79 140.75 43.7 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.091 177.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 18.4 m170 -96.24 117.13 30.17 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 121.525 0.679 . . . . 0.0 111.935 -175.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.402 ' HZ ' ' CD ' ' A' ' 47' ' ' ARG . 45.6 m-85 -109.6 149.21 30.0 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.604 -1.18 . . . . 0.0 111.039 177.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.493 ' HD2' ' O ' ' A' ' 15' ' ' ILE . 22.8 tpt180 -108.98 117.02 33.11 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 177.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.431 ' O ' HG12 ' A' ' 15' ' ' ILE . 33.0 m -137.69 170.5 17.33 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.35 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.008 -177.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.562 ' HG3' ' O ' ' A' ' 13' ' ' GLU . 38.5 ttmt -89.83 156.29 18.59 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 110.453 -0.203 . . . . 0.0 110.453 -177.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -56.4 -38.91 72.16 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 121.142 0.496 . . . . 0.0 109.691 174.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -98.06 24.76 30.41 Favored Glycine 0 N--CA 1.443 -0.868 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.452 -178.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.448 ' HB ' ' O ' ' A' ' 32' ' ' LYS . 1.0 OUTLIER -65.83 140.51 58.39 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-O 121.426 0.631 . . . . 0.0 112.193 179.232 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 66.5 m -91.99 157.19 16.94 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.975 179.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.686 ' SD ' ' HA ' ' A' ' 65' ' ' ASN . 26.4 ptt? -51.47 -31.88 25.03 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -176.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.75 -38.06 86.6 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.198 -0.456 . . . . 0.0 112.097 -177.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.401 ' HB2' HG22 ' A' ' 35' ' ' THR . 75.5 mmtt -60.66 -38.25 84.25 Favored 'General case' 0 C--O 1.217 -0.645 0 CA-C-O 120.672 0.273 . . . . 0.0 111.183 -175.228 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.504 HD13 ' CG ' ' A' ' 57' ' ' PHE . 0.2 OUTLIER -86.59 -47.32 9.31 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.741 -178.528 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.408 ' HA ' ' HE1' ' A' ' 57' ' ' PHE . 94.3 mttt -62.95 -47.2 84.23 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.99 -177.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -64.27 -38.74 92.11 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.014 178.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 47.5 t -69.07 -53.55 19.75 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.68 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.688 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 45.3 t80 -65.89 -47.22 75.56 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-N 116.227 -0.442 . . . . 0.0 112.18 -178.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.75 -35.68 75.09 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.38 0.609 . . . . 0.0 109.895 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -65.99 -47.15 75.48 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.725 -178.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.688 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 8.7 ptm180 -65.9 -27.94 68.58 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.065 -178.252 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.531 HG22 ' O ' ' A' ' 44' ' ' TYR . 9.3 t -93.19 -6.74 47.07 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.072 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 69.67 33.16 71.17 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.902 178.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.6 p -117.7 167.29 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 CA-C-O 120.693 0.282 . . . . 0.0 110.827 -177.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.449 ' HB2' ' OG ' ' A' ' 54' ' ' SER . . . -61.48 128.22 35.25 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.389 178.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 77.2 t -64.24 -43.99 97.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.777 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -67.47 -29.67 69.18 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.708 -177.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.449 ' OG ' ' HB2' ' A' ' 51' ' ' ALA . 88.5 p -82.76 -17.16 45.18 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 119.891 -0.723 . . . . 0.0 111.135 -179.056 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.474 HD11 ' N ' ' A' ' 56' ' ' ARG . 0.9 OUTLIER -92.59 135.2 34.28 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 -177.183 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.516 ' NH1' ' HA ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -140.96 149.58 42.0 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-O 121.486 0.66 . . . . 0.0 111.693 -177.106 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.504 ' CG ' HD13 ' A' ' 40' ' ' LEU . 58.0 m-85 -117.94 138.8 51.92 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 114.554 -1.203 . . . . 0.0 109.824 179.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.577 HD23 ' CE1' ' A' ' 84' ' ' TYR . 9.2 mp -125.3 137.95 54.07 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.765 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.778 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 23.1 t80 -105.5 114.48 28.68 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 38.0 t70 53.86 29.29 9.57 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-O 121.697 0.761 . . . . 0.0 111.602 -177.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 95.07 -4.19 67.54 Favored Glycine 0 C--N 1.313 -0.704 0 CA-C-N 115.859 -0.609 . . . . 0.0 113.408 177.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.778 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.1 OUTLIER -106.5 138.88 41.88 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.355 0.598 . . . . 0.0 110.385 178.58 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.503 ' HA ' ' HG ' ' A' ' 58' ' ' LEU . 32.2 mtp-105 -69.01 135.64 51.21 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.882 -174.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 79.3 mt -93.3 121.52 44.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.985 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.686 ' HA ' ' SD ' ' A' ' 37' ' ' MET . 65.0 m-80 -117.31 161.72 19.06 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.486 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.475 ' OD2' ' HE1' ' A' ' 37' ' ' MET . 7.8 p-10 -71.75 -13.34 61.68 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.159 0.504 . . . . 0.0 109.826 178.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -76.74 -21.47 55.2 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.65 177.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -71.48 139.9 49.77 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 121.47 0.653 . . . . 0.0 111.444 -179.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.514 ' HB ' ' HD2' ' A' ' 70' ' ' PRO . 47.8 p -101.99 163.95 16.75 Favored Pre-proline 0 C--N 1.304 -1.396 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.92 -178.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.514 ' HD2' ' HB ' ' A' ' 69' ' ' THR . 12.7 Cg_endo -56.39 -37.44 97.07 Favored 'Trans proline' 0 C--N 1.357 1.024 0 C-N-CA 122.427 2.085 . . . . 0.0 113.436 -177.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.45 ' HD3' ' N ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -74.49 -19.5 60.34 Favored 'General case' 0 C--O 1.221 -0.438 0 CA-C-O 121.057 0.456 . . . . 0.0 112.028 179.277 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.45 ' N ' ' HD3' ' A' ' 71' ' ' LYS . 52.1 m -85.0 -45.17 12.4 Favored 'General case' 0 N--CA 1.408 -2.546 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.966 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 98.9 mt -71.2 -25.25 62.43 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.526 178.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 51.57 30.27 6.33 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.836 177.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.416 ' SD ' HD13 ' A' ' 15' ' ' ILE . 20.2 ptp -73.88 162.77 28.74 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.995 0.426 . . . . 0.0 111.464 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -151.56 175.41 12.36 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.724 -177.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -65.9 118.93 10.42 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 121.692 0.758 . . . . 0.0 111.634 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 21.5 t70 70.65 33.91 2.22 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 126.095 1.758 . . . . 0.0 111.587 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -77.86 178.72 7.2 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 176.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.1 m -113.36 146.79 17.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-O 121.7 0.762 . . . . 0.0 111.9 -175.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.482 ' CG2' ' HD2' ' A' ' 57' ' ' PHE . 1.2 mt -134.15 141.99 42.25 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.962 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -107.54 146.53 31.73 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.834 0.349 . . . . 0.0 111.473 -176.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.417 ' O ' ' HG3' ' A' ' 22' ' ' GLN . 97.5 t -125.31 132.41 71.13 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.66 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.102 179.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.577 ' CE1' HD23 ' A' ' 58' ' ' LEU . 63.6 m-85 -100.62 143.98 30.15 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.766 175.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 58.7 tp60 -69.85 134.64 48.71 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -176.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.516 ' HA ' ' NH1' ' A' ' 56' ' ' ARG . 1.3 pp20? -94.3 -155.79 0.47 Allowed 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -171.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -82.95 -55.94 4.1 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -171.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 85.3 mt -65.49 -39.65 92.14 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -174.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -103.72 5.19 47.1 Favored Glycine 0 C--N 1.307 -1.075 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.087 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.408 ' HA3' ' O ' ' A' ' 86' ' ' GLU . . . . . . . . 0 N--CA 1.439 -1.119 0 CA-C-O 118.763 -1.02 . . . . 0.0 112.571 -178.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.5 ttp . . . . . 0 N--CA 1.476 0.87 0 CA-C-O 120.813 0.34 . . . . 0.0 110.758 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -141.93 126.07 17.41 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.374 178.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -85.22 106.7 16.84 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -60.81 -49.54 77.07 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.997 -176.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 53.26 25.83 4.71 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 177.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -125.44 137.02 53.98 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 121.006 0.432 . . . . 0.0 110.457 -178.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -132.29 144.92 50.93 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.629 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.6 -24.55 62.77 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.108 0.48 . . . . 0.0 110.392 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 78.81 15.67 80.33 Favored Glycine 0 CA--C 1.497 -1.043 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -179.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -132.89 97.74 4.11 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 114.964 -0.618 . . . . 0.0 110.186 -178.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -105.88 100.62 10.16 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 177.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -150.47 153.25 35.54 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.892 -176.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.442 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 40.4 mt-10 -123.59 44.38 2.71 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 121.617 0.722 . . . . 0.0 112.026 -176.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -120.36 157.25 29.64 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.171 177.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.5 pt -125.39 162.34 28.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.442 -176.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.459 ' HE2' ' HB2' ' A' ' 78' ' ' ASP . 38.1 mtmm -97.42 144.47 27.13 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.963 176.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.473 HG21 HD13 ' A' ' 81' ' ' ILE . 45.2 mm -128.08 129.53 69.52 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.979 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.02 178.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 27.5 mtmt -96.67 104.58 16.58 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 174.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.552 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 89.6 t -81.95 111.92 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.863 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 177.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.0 t -108.49 117.72 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -93.84 164.79 26.58 Favored Glycine 0 N--CA 1.435 -1.42 0 C-N-CA 120.489 -0.862 . . . . 0.0 111.449 178.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.496 ' C ' ' H ' ' A' ' 24' ' ' SER . 98.3 mt-30 -67.95 -23.94 65.11 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.374 0.607 . . . . 0.0 110.44 179.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -70.87 8.92 0.77 Allowed 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.919 175.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.496 ' H ' ' C ' ' A' ' 22' ' ' GLN . 44.5 m 68.96 25.27 6.04 Favored 'General case' 0 C--N 1.348 0.531 0 C-N-CA 123.753 0.821 . . . . 0.0 110.315 -179.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 54.0 t-20 -96.03 107.27 19.54 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.946 -178.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.552 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 28.7 tt0 -105.46 125.77 51.37 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.426 175.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.2 p -137.65 140.94 40.45 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-O 121.099 0.476 . . . . 0.0 111.126 -179.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 62.5 m170 -89.83 118.65 29.58 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.066 -178.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -118.43 143.64 46.53 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.296 171.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 52.9 ttp180 -106.44 121.51 44.4 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 121.528 0.68 . . . . 0.0 110.466 177.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 33.8 m -136.57 172.58 15.02 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 CA-C-N 114.82 -1.082 . . . . 0.0 108.911 -177.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.458 ' O ' ' HB ' ' A' ' 35' ' ' THR . 50.3 tttm -89.55 160.58 16.63 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -179.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.407 ' C ' ' HB3' ' A' ' 70' ' ' PRO . 95.7 m-85 -54.08 -41.21 67.97 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.976 0.417 . . . . 0.0 110.228 176.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -97.65 22.33 41.38 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.844 -177.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.458 ' HB ' ' O ' ' A' ' 32' ' ' LYS . 0.9 OUTLIER -61.63 143.82 55.48 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-O 121.181 0.515 . . . . 0.0 112.109 179.222 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 65.5 m -91.59 150.72 21.05 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.967 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.405 ' HE3' ' OD1' ' A' ' 66' ' ' ASP . 26.5 ptt? -49.56 -33.03 13.83 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -177.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.88 -37.12 81.08 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.93 -177.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -61.32 -40.28 93.61 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.853 0.358 . . . . 0.0 110.646 -175.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.504 HD11 ' CD2' ' A' ' 57' ' ' PHE . 0.4 OUTLIER -87.26 -45.28 10.77 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.075 -0.512 . . . . 0.0 112.08 -179.269 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.543 ' HG2' ' CD1' ' A' ' 57' ' ' PHE . 61.4 mtpt -63.01 -45.98 89.8 Favored 'General case' 0 CA--C 1.496 -1.119 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.752 -177.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -62.13 -40.96 97.68 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 48.0 t -66.41 -51.34 57.96 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.168 -0.923 . . . . 0.0 111.326 -178.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.671 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 49.2 t80 -66.64 -45.82 77.78 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.85 -178.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' A' ' 50' ' ' VAL . . . -59.25 -36.03 74.75 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.502 0.668 . . . . 0.0 109.757 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -66.49 -46.34 76.62 Favored 'General case' 0 C--N 1.311 -1.109 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.193 -178.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.671 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 11.4 ptm85 -65.39 -26.84 68.17 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.176 -177.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.551 HG23 ' O ' ' A' ' 44' ' ' TYR . 10.1 t -95.55 -7.42 37.96 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.222 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.81 32.04 66.98 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.406 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.425 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 84.5 t -117.74 150.25 19.9 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 C-N-CA 122.6 0.36 . . . . 0.0 110.859 -177.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.439 ' HB3' ' OG ' ' A' ' 54' ' ' SER . . . -52.58 137.05 31.36 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.396 176.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 74.3 t -61.23 -42.97 95.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.14 -179.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -67.26 -25.04 65.87 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.118 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.439 ' OG ' ' HB3' ' A' ' 51' ' ' ALA . 74.0 m -74.76 -16.03 60.74 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.88 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -96.44 134.13 40.0 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.238 0.542 . . . . 0.0 110.823 177.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -132.93 125.29 29.51 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.626 178.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.543 ' CD1' ' HG2' ' A' ' 41' ' ' LYS . 12.3 m-85 -108.44 135.15 50.2 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.966 -179.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.581 HD11 ' CD1' ' A' ' 84' ' ' TYR . 6.2 mp -124.05 147.45 47.84 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.98 -178.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.651 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 31.2 t80 -128.96 128.83 44.51 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 176.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 34.7 t70 59.5 27.18 16.28 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 121.653 0.74 . . . . 0.0 110.4 179.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 78.51 17.97 76.69 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.667 178.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.651 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -130.87 151.73 50.97 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.91 178.587 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.426 ' HA ' ' HG ' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -68.06 135.64 52.55 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.807 -175.438 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 86.0 mt -88.1 117.47 31.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 177.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -107.36 153.85 22.16 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.499 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.405 ' OD1' ' HE3' ' A' ' 37' ' ' MET . 9.8 p-10 -68.98 -10.94 60.01 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.873 -179.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -85.78 -19.01 31.38 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.036 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.433 ' CG ' HH12 ' A' ' 62' ' ' ARG . 36.9 m-20 -67.43 148.74 51.17 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -175.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.442 ' HB ' ' HD2' ' A' ' 70' ' ' PRO . 31.7 p -96.9 162.29 23.49 Favored Pre-proline 0 N--CA 1.444 -0.755 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.212 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.442 ' HD2' ' HB ' ' A' ' 69' ' ' THR . 19.2 Cg_endo -59.28 -31.51 95.25 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.519 2.146 . . . . 0.0 113.06 -178.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.556 ' HG3' ' N ' ' A' ' 72' ' ' THR . 15.2 ptmt -70.46 -38.83 74.51 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -179.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.556 ' N ' ' HG3' ' A' ' 71' ' ' LYS . 13.4 t -82.09 -29.82 31.58 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 120.971 0.415 . . . . 0.0 110.437 -177.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 96.1 mt -73.25 -22.2 60.46 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 174.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 52.91 28.75 6.87 Favored 'General case' 0 C--N 1.348 0.509 0 O-C-N 124.037 0.836 . . . . 0.0 112.5 175.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 70.8 mtm -85.23 150.36 24.85 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.113 0.483 . . . . 0.0 111.834 -176.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -151.67 -176.61 5.69 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 176.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.415 ' HA ' ' H ' ' A' ' 16' ' ' LYS . 1.3 m-20 -57.33 119.5 6.55 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -177.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.459 ' HB2' ' HE2' ' A' ' 16' ' ' LYS . 18.5 t70 63.22 35.41 12.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 113.972 -1.467 . . . . 0.0 111.082 175.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -76.78 177.66 7.44 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.269 177.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 30.9 m -108.96 138.48 35.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 CA-C-O 121.772 0.796 . . . . 0.0 112.455 -174.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.473 HD13 HG21 ' A' ' 17' ' ' ILE . 1.6 mt -132.36 134.01 59.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.974 178.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -98.18 144.28 27.8 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.245 -174.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 84.6 t -129.13 133.98 64.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.993 178.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.581 ' CD1' HD11 ' A' ' 58' ' ' LEU . 57.4 m-85 -98.13 156.71 16.54 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.288 177.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 43.6 tp60 -68.0 133.14 48.53 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.195 0.522 . . . . 0.0 111.097 -171.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.556 ' HG2' ' H ' ' A' ' 89' ' ' GLY . 4.2 pm0 -65.6 158.0 28.34 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.434 -0.803 . . . . 0.0 113.12 -174.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.426 ' H ' ' HB3' ' A' ' 54' ' ' SER . 82.7 mm-40 -72.53 -48.33 41.11 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.992 -177.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.416 ' HB3' HG12 ' A' ' 50' ' ' VAL . 60.5 tp -66.89 -43.26 83.93 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 114.708 -1.133 . . . . 0.0 111.758 -177.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.556 ' H ' ' HG2' ' A' ' 86' ' ' GLU . . . -65.3 -41.62 96.58 Favored Glycine 0 C--N 1.318 -0.438 0 CA-C-N 115.644 -0.707 . . . . 0.0 113.446 -178.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.67 -1.072 . . . . 0.0 112.426 -179.886 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 79.9 mtm . . . . . 0 N--CA 1.476 0.831 0 N-CA-C 110.291 -0.263 . . . . 0.0 110.291 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 59.5 34.84 22.65 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.649 0.737 . . . . 0.0 110.338 -177.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -143.7 -177.3 5.34 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.219 -177.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -64.24 -37.47 87.59 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -74.04 -4.35 34.88 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 121.119 0.485 . . . . 0.0 110.831 -178.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -81.55 116.88 21.53 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.433 178.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -150.07 158.71 44.45 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.442 -177.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -72.54 -23.28 60.97 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.41 0.624 . . . . 0.0 110.045 178.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 100.79 -20.26 48.75 Favored Glycine 0 N--CA 1.437 -1.251 0 CA-C-N 115.157 -0.929 . . . . 0.0 112.073 178.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 31.2 t70 55.26 40.98 31.74 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.922 0.867 . . . . 0.0 109.871 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -158.15 91.71 1.12 Allowed 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -177.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 13' ' ' GLU . . . -81.13 159.55 24.64 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.37 -175.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.401 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 51.3 mt-10 72.9 29.98 1.77 Allowed 'General case' 0 CA--C 1.508 -0.669 0 C-N-CA 124.174 0.99 . . . . 0.0 110.205 -177.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -132.78 160.21 37.51 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 113.789 -1.551 . . . . 0.0 109.699 178.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.3 pt -120.12 162.46 18.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -176.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.488 ' HD2' ' CG ' ' A' ' 78' ' ' ASP . 38.9 ttmt -101.0 143.55 31.01 Favored 'General case' 0 C--N 1.286 -2.172 0 CA-C-O 121.006 0.432 . . . . 0.0 110.733 179.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.478 HG21 HD13 ' A' ' 81' ' ' ILE . 41.7 mm -127.58 129.56 70.33 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.783 177.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.5 mtmt -100.1 104.16 15.7 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 176.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.711 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 96.7 t -82.41 118.38 30.03 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.52 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.6 t -113.76 118.25 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 CA-C-O 120.927 0.394 . . . . 0.0 109.967 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -90.86 175.35 40.08 Favored Glycine 0 C--N 1.314 -0.693 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.49 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.528 ' C ' ' H ' ' A' ' 24' ' ' SER . 98.8 mt-30 -64.51 -34.18 77.63 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 121.235 0.541 . . . . 0.0 110.896 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -70.0 8.69 0.68 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.956 176.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.528 ' H ' ' C ' ' A' ' 22' ' ' GLN . 49.9 m 65.96 27.88 10.68 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.859 0.838 . . . . 0.0 109.059 -176.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -87.06 104.87 16.74 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.468 -177.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.711 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 42.6 tt0 -104.61 131.88 51.51 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.588 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.4 p -138.05 137.83 44.15 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.598 179.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 37.7 m170 -97.1 111.18 23.52 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.185 0.516 . . . . 0.0 111.644 -176.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -110.57 149.59 30.16 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.818 176.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 18.4 tpt180 -103.34 121.54 42.96 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 30.9 m -134.86 174.27 13.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.35 -177.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -88.11 155.28 19.87 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -52.98 -39.0 62.69 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 175.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.513 ' CA ' ' HG3' ' A' ' 70' ' ' PRO . . . -106.86 33.2 6.59 Favored Glycine 0 C--N 1.334 0.44 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.744 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.471 HG23 ' HB2' ' A' ' 39' ' ' LYS . 0.9 OUTLIER -64.38 136.5 57.18 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-O 121.526 0.679 . . . . 0.0 112.442 179.22 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 69.6 m -85.61 155.11 21.27 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.091 -0.958 . . . . 0.0 109.875 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.466 ' HB2' ' HZ3' ' A' ' 41' ' ' LYS . 25.7 ptt? -50.87 -30.49 14.68 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -176.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.49 -37.96 85.56 Favored 'General case' 0 C--O 1.217 -0.642 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 -178.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.471 ' HB2' HG23 ' A' ' 35' ' ' THR . 31.1 mmmt -60.6 -40.03 90.31 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.049 -176.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.425 HD12 ' CG ' ' A' ' 57' ' ' PHE . 0.2 OUTLIER -86.49 -46.05 10.54 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.782 -178.465 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.466 ' HZ3' ' HB2' ' A' ' 37' ' ' MET . 46.4 mttp -62.02 -46.61 88.41 Favored 'General case' 0 C--O 1.212 -0.892 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.43 -178.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -62.47 -42.53 99.55 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.079 0.466 . . . . 0.0 110.058 177.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 45.7 t -62.98 -50.07 72.2 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.289 -176.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.636 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 42.0 t80 -71.43 -43.81 66.01 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.787 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.59 ' HB2' ' O ' ' A' ' 50' ' ' VAL . . . -57.82 -33.26 68.42 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.364 0.602 . . . . 0.0 109.741 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -63.05 -47.72 81.78 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.188 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.636 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 3.5 ptm180 -68.62 -27.84 66.38 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.411 -177.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.476 HG21 ' O ' ' A' ' 44' ' ' TYR . 8.9 t -96.64 -10.77 26.33 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -177.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.56 35.26 67.75 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.248 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.59 ' O ' ' HB2' ' A' ' 45' ' ' ALA . 73.7 t -119.32 149.65 21.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 C-N-CA 122.713 0.405 . . . . 0.0 110.891 -177.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.455 ' HB3' ' OG ' ' A' ' 54' ' ' SER . . . -51.81 136.19 28.33 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.347 176.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 76.8 t -60.9 -44.3 97.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.277 -177.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -77.14 -10.01 59.12 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.093 0.473 . . . . 0.0 110.954 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.455 ' OG ' ' HB3' ' A' ' 51' ' ' ALA . 74.9 m -87.36 -10.51 51.95 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.18 176.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -96.34 130.05 43.53 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 177.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.458 ' HD3' ' O ' ' A' ' 85' ' ' GLN . 0.0 OUTLIER -122.49 117.06 25.04 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 121.423 0.63 . . . . 0.0 111.334 -176.696 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.569 ' HZ ' ' CB ' ' A' ' 44' ' ' TYR . 32.6 m-85 -106.14 128.36 53.84 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.529 178.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.493 ' HG ' ' HA ' ' A' ' 63' ' ' ARG . 7.8 mp -121.6 136.12 54.96 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.423 179.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.588 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 83.8 t80 -105.3 116.0 31.22 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 178.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 55.44 23.18 5.59 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.848 -0.614 . . . . 0.0 112.393 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 102.06 2.29 51.68 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 121.089 -0.577 . . . . 0.0 113.514 176.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.588 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -120.29 140.93 50.5 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 117.175 0.488 . . . . 0.0 109.98 176.702 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.493 ' HA ' ' HG ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -68.44 137.56 54.58 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.282 0.563 . . . . 0.0 112.05 -175.347 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 87.1 mt -82.66 125.16 39.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.581 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -99.21 162.94 12.77 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.495 -177.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -81.79 -6.52 59.14 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 174.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -101.65 -6.28 23.98 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.332 -178.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -62.2 148.77 43.62 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.253 0.549 . . . . 0.0 112.149 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 49.9 p -113.87 159.53 35.6 Favored Pre-proline 0 C--N 1.319 -0.749 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.531 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.513 ' HG3' ' CA ' ' A' ' 34' ' ' GLY . 77.8 Cg_exo -55.33 -39.38 91.29 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.904 2.403 . . . . 0.0 112.407 -178.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.529 ' HG3' ' H ' ' A' ' 72' ' ' THR . 17.3 ptmt -69.01 -46.76 67.2 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -177.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.529 ' H ' ' HG3' ' A' ' 71' ' ' LYS . 9.0 t -67.19 -27.01 66.91 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-O 120.924 0.393 . . . . 0.0 110.875 -177.263 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 93.7 mt -90.95 -22.55 20.8 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.676 178.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 43.4 47.8 5.91 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.927 -177.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 74.2 mtm -85.24 161.12 19.7 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.913 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -147.65 -178.39 6.23 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.376 178.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.432 ' HA ' ' H ' ' A' ' 16' ' ' LYS . 34.3 t70 -65.42 120.1 12.22 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.028 0.442 . . . . 0.0 111.357 -178.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.488 ' CG ' ' HD2' ' A' ' 16' ' ' LYS . 3.0 m-20 74.9 33.2 0.77 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.19 1.396 . . . . 0.0 111.783 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -70.43 176.4 4.05 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 177.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.9 t -118.36 136.66 54.84 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 CA-C-O 121.431 0.634 . . . . 0.0 111.163 -174.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.478 HD13 HG21 ' A' ' 17' ' ' ILE . 1.8 mt -131.64 138.85 51.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.307 -177.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -102.85 145.47 29.74 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.255 -173.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 90.7 t -126.59 131.01 71.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.26 178.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.436 ' CE1' HD22 ' A' ' 58' ' ' LEU . 78.6 m-85 -99.72 168.56 9.84 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.684 177.014 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.458 ' O ' ' HD3' ' A' ' 56' ' ' ARG . 43.9 tp60 -66.88 129.9 41.39 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.394 0.616 . . . . 0.0 111.188 -170.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.554 ' HG2' ' H ' ' A' ' 89' ' ' GLY . 4.1 pm0 -65.66 154.1 39.8 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.958 -1.019 . . . . 0.0 112.714 -177.079 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.407 ' HB3' ' CB ' ' A' ' 54' ' ' SER . 61.0 tp60 -72.11 -42.76 65.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.98 -176.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.437 ' HB3' HG13 ' A' ' 50' ' ' VAL . 57.1 tp -67.43 -39.54 85.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.009 -178.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.554 ' H ' ' HG2' ' A' ' 86' ' ' GLU . . . -87.03 -105.03 0.83 Allowed Glycine 0 C--N 1.315 -0.601 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.521 -178.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.92 -0.933 . . . . 0.0 111.399 -178.875 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 79.4 mtm . . . . . 0 N--CA 1.471 0.615 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.17 135.09 55.09 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 120.924 0.392 . . . . 0.0 111.324 -177.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -95.38 110.11 22.18 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.176 178.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -62.08 -36.18 80.91 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.609 178.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 73.29 25.34 2.23 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.403 -179.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 61.43 67.42 0.78 Allowed 'General case' 0 C--O 1.246 0.902 0 CA-C-N 114.876 -1.056 . . . . 0.0 111.821 179.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 59.35 -161.86 0.26 Allowed 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.71 177.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -82.02 -0.93 46.54 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.023 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 128.06 47.95 0.17 Allowed Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -178.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -115.14 122.35 45.82 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.665 -0.267 . . . . 0.0 110.607 -177.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -108.29 100.9 10.15 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.031 0.443 . . . . 0.0 109.979 177.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -153.11 -49.16 0.1 Allowed 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.772 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 63.84 49.36 2.9 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 114.84 -1.073 . . . . 0.0 112.33 176.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 32' ' ' LYS . 98.4 m-85 -110.54 154.97 22.95 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 121.544 0.687 . . . . 0.0 111.438 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.473 ' HA ' ' OD1' ' A' ' 77' ' ' ASP . 21.8 pt -132.21 162.6 39.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 CA-C-N 114.588 -1.187 . . . . 0.0 108.552 -178.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.454 ' H ' ' HA ' ' A' ' 77' ' ' ASP . 56.5 mtmt -92.88 147.36 22.91 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 121.059 0.457 . . . . 0.0 110.664 175.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.473 ' CD1' HG22 ' A' ' 31' ' ' VAL . 9.4 mt -128.34 131.75 68.79 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.449 173.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.41 ' HD3' ' OD2' ' A' ' 78' ' ' ASP . 27.4 mtmt -98.93 104.71 16.78 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 176.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.624 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 98.5 t -82.29 115.54 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.1 t -106.06 116.56 50.09 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.461 ' HA2' ' HB ' ' A' ' 83' ' ' VAL . . . -85.16 174.3 49.13 Favored Glycine 0 C--N 1.309 -0.951 0 C-N-CA 120.191 -1.004 . . . . 0.0 112.0 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.411 ' C ' ' H ' ' A' ' 24' ' ' SER . 98.3 mt-30 -70.11 -21.88 63.07 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-O 121.447 0.641 . . . . 0.0 110.371 178.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -74.62 0.78 13.91 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.28 174.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.411 ' H ' ' C ' ' A' ' 22' ' ' GLN . 8.6 t 69.32 26.63 5.28 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -176.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -90.86 106.74 18.73 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-N 114.687 -1.142 . . . . 0.0 110.281 -179.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.624 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 29.4 tt0 -98.83 125.99 44.35 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.453 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.1 p -129.5 139.94 50.39 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.887 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 60.6 m170 -97.67 115.75 28.54 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.441 -175.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -111.55 148.39 33.36 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.706 175.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 26.2 tpt180 -99.22 120.27 39.25 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.473 HG22 ' CD1' ' A' ' 17' ' ' ILE . 33.0 m -135.86 172.45 15.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.537 -176.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 14' ' ' TYR . 36.9 tttm -90.38 160.76 15.92 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -54.21 -38.42 65.65 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-O 120.996 0.427 . . . . 0.0 110.275 175.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.642 ' CA ' ' HG3' ' A' ' 70' ' ' PRO . . . -98.82 25.88 26.36 Favored Glycine 0 CA--C 1.492 -1.389 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.858 -178.058 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.498 HG23 ' HB2' ' A' ' 39' ' ' LYS . 1.1 m -68.48 124.7 24.27 Favored 'General case' 0 N--CA 1.41 -2.457 0 CA-C-O 121.673 0.749 . . . . 0.0 111.773 178.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.547 ' HB3' ' HA ' ' A' ' 66' ' ' ASP . 41.2 m -91.82 167.53 12.08 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 114.482 -1.235 . . . . 0.0 109.537 178.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.452 ' HB2' ' CD ' ' A' ' 41' ' ' LYS . 25.2 ptt? -47.32 -39.32 14.53 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -175.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.84 -37.33 81.7 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -175.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.498 ' HB2' HG23 ' A' ' 35' ' ' THR . 29.9 mmmt -60.47 -41.64 94.61 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.273 -176.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.499 HD11 ' CD2' ' A' ' 57' ' ' PHE . 0.5 OUTLIER -88.95 -44.08 10.69 Favored 'General case' 0 C--O 1.22 -0.489 0 N-CA-C 112.438 0.532 . . . . 0.0 112.438 -178.964 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.617 ' HE3' ' O ' ' A' ' 55' ' ' LEU . 60.8 mtpt -61.74 -46.79 88.09 Favored 'General case' 0 CA--C 1.488 -1.439 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.798 -176.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.408 ' HA ' HG21 ' A' ' 52' ' ' VAL . 39.0 ttpt -62.12 -40.8 97.14 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 66.6 m -65.59 -49.05 70.22 Favored 'General case' 0 CA--C 1.552 1.021 0 CA-C-N 115.215 -0.902 . . . . 0.0 112.407 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.646 ' O ' ' HG3' ' A' ' 47' ' ' ARG . 59.7 t80 -71.08 -45.13 64.32 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.949 -179.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.622 ' HB1' ' O ' ' A' ' 50' ' ' VAL . . . -58.48 -34.19 70.63 Favored 'General case' 0 CA--C 1.501 -0.914 0 CA-C-O 121.443 0.639 . . . . 0.0 109.585 -178.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -63.08 -48.14 79.92 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.046 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.646 ' HG3' ' O ' ' A' ' 44' ' ' TYR . 0.0 OUTLIER -69.25 -22.66 63.83 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.967 -0.56 . . . . 0.0 112.19 -176.324 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.482 HG23 ' O ' ' A' ' 44' ' ' TYR . 8.8 t -103.3 -7.27 21.24 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.909 0.385 . . . . 0.0 111.939 -177.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.25 31.99 65.75 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.544 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.622 ' O ' ' HB1' ' A' ' 45' ' ' ALA . 80.6 t -113.53 147.29 17.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 C-N-CA 122.886 0.474 . . . . 0.0 110.343 -178.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.596 ' HB2' ' OG ' ' A' ' 54' ' ' SER . . . -56.49 136.52 54.09 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.316 -0.402 . . . . 0.0 109.995 176.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.408 HG21 ' HA ' ' A' ' 42' ' ' LYS . 73.1 t -62.12 -44.4 98.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.469 -176.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -69.29 -31.42 69.9 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.522 -177.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.596 ' OG ' ' HB2' ' A' ' 51' ' ' ALA . 89.8 p -87.42 2.82 49.35 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 120.664 -0.414 . . . . 0.0 111.481 -179.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.617 ' O ' ' HE3' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -94.83 121.73 36.72 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 174.147 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -117.15 117.89 30.83 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 119.875 -0.73 . . . . 0.0 112.343 -173.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.499 ' CD2' HD11 ' A' ' 40' ' ' LEU . 45.7 m-85 -108.91 130.03 55.43 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.595 176.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.567 HD11 ' CD1' ' A' ' 84' ' ' TYR . 8.0 mp -122.61 144.65 48.98 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 121.466 0.65 . . . . 0.0 111.226 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.67 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 64.5 t80 -118.37 115.1 23.99 Favored 'General case' 0 N--CA 1.426 -1.674 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.081 178.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 53.38 29.15 8.31 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.426 -178.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 96.01 -1.55 63.17 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.958 -0.564 . . . . 0.0 113.435 176.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.67 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -113.62 136.44 52.82 Favored 'General case' 0 CA--C 1.491 -1.326 0 CA-C-O 121.289 0.566 . . . . 0.0 109.672 177.5 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.507 ' HA ' ' HG ' ' A' ' 58' ' ' LEU . 30.1 ptt180 -72.38 133.74 45.08 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.168 -177.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.492 ' HA ' ' NH1' ' A' ' 62' ' ' ARG . 68.7 mt -75.61 132.83 32.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 CA-C-N 114.462 -1.244 . . . . 0.0 108.856 -178.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -109.57 169.82 8.46 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.09 0.471 . . . . 0.0 110.758 -175.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.547 ' HA ' ' HB3' ' A' ' 36' ' ' SER . 7.2 p-10 -82.9 -6.33 59.41 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.159 0.504 . . . . 0.0 109.667 175.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -101.3 -16.63 16.88 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.419 -0.809 . . . . 0.0 113.157 -175.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.6 p30 -68.78 161.57 28.18 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -175.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.439 ' O ' HG23 ' A' ' 72' ' ' THR . 72.0 p -129.9 166.72 24.19 Favored Pre-proline 0 CA--C 1.548 0.901 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.415 -174.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.642 ' HG3' ' CA ' ' A' ' 34' ' ' GLY . 57.2 Cg_exo -54.46 -39.91 85.71 Favored 'Trans proline' 0 C--N 1.369 1.623 0 C-N-CA 123.108 2.539 . . . . 0.0 113.318 -176.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.522 ' HD3' ' N ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -70.27 -23.77 62.94 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 -176.175 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.522 ' N ' ' HD3' ' A' ' 71' ' ' LYS . 5.1 t -95.34 -25.42 16.31 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.194 0.521 . . . . 0.0 110.117 -177.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.442 ' HB3' ' HG3' ' A' ' 75' ' ' MET . 92.7 mt -89.79 -24.34 21.49 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.936 178.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 46.5 30.96 1.19 Allowed 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.555 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.442 ' HG3' ' HB3' ' A' ' 73' ' ' LEU . 66.7 mtt -79.03 153.0 30.58 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.006 -179.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -150.54 -174.81 4.87 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.473 ' OD1' ' HA ' ' A' ' 15' ' ' ILE . 20.0 m-20 -55.0 126.1 23.16 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 -177.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.43 ' HB2' ' HE3' ' A' ' 16' ' ' LYS . 9.0 t70 67.21 35.42 4.47 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 113.882 -1.508 . . . . 0.0 111.489 173.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -70.63 176.38 4.19 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.845 177.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 30.7 m -110.11 136.52 45.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-O 121.588 0.708 . . . . 0.0 111.858 -175.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.453 HD13 HD11 ' A' ' 64' ' ' ILE . 10.8 mm -131.99 137.61 54.42 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.09 -178.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -107.33 142.75 36.63 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.361 -177.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.461 ' HB ' ' HA2' ' A' ' 21' ' ' GLY . 93.4 t -124.55 133.5 69.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-O 121.009 0.433 . . . . 0.0 111.29 178.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.567 ' CD1' HD11 ' A' ' 58' ' ' LEU . 46.7 m-85 -100.23 167.69 10.27 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.492 178.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -67.85 124.65 23.92 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.496 0.665 . . . . 0.0 110.691 -173.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.532 ' HG2' HD22 ' A' ' 55' ' ' LEU . 2.2 mp0 -82.59 162.02 22.07 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.6 -177.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -69.03 -40.09 78.82 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.105 177.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.491 ' HB2' HG11 ' A' ' 50' ' ' VAL . 10.9 mp -102.74 3.97 37.5 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.713 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -92.26 -163.6 37.94 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.56 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.357 0 CA-C-O 118.66 -1.078 . . . . 0.0 111.86 179.457 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.9 tpp . . . . . 0 N--CA 1.471 0.6 0 CA-C-O 121.13 0.491 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -154.27 158.02 39.57 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.266 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -79.63 176.61 9.55 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -69.31 -34.37 74.58 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.792 0.329 . . . . 0.0 110.825 -178.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 61.41 30.48 18.96 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.549 178.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -96.65 131.43 43.32 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.64 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 26.5 pt20 -146.99 161.42 40.84 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.877 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.56 -37.22 85.3 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.43 0.633 . . . . 0.0 110.305 177.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 97.28 -7.66 64.23 Favored Glycine 0 CA--C 1.497 -1.036 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.455 -179.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -62.93 -39.35 94.34 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.229 -0.486 . . . . 0.0 110.707 178.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 65.2 t30 55.92 47.3 20.33 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-O 122.264 1.03 . . . . 0.0 108.656 -175.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -114.66 179.43 3.95 Favored 'General case' 0 N--CA 1.399 -3.002 0 CA-C-N 114.288 -1.324 . . . . 0.0 108.54 -175.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -105.71 27.87 8.04 Favored 'General case' 0 C--N 1.281 -2.394 0 CA-C-O 121.395 0.617 . . . . 0.0 111.448 -175.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -133.06 155.67 48.78 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.689 -178.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.507 ' O ' ' HD2' ' A' ' 30' ' ' ARG . 23.7 pt -122.45 163.14 21.32 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.414 -176.116 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.543 ' HZ3' ' CG ' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -91.53 144.93 25.04 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.253 178.042 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.448 HD13 HG21 ' A' ' 31' ' ' VAL . 67.8 mt -139.12 133.9 40.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-O 120.87 0.367 . . . . 0.0 111.32 172.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 18.4 mtmt -96.43 106.15 18.34 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.649 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 81.1 t -81.25 116.76 26.1 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 176.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 59.9 t -112.63 117.76 56.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 120.929 0.395 . . . . 0.0 110.095 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.479 ' HA2' ' HB ' ' A' ' 83' ' ' VAL . . . -92.25 171.24 33.66 Favored Glycine 0 C--N 1.314 -0.665 0 C-N-CA 120.434 -0.888 . . . . 0.0 112.588 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.485 ' C ' ' H ' ' A' ' 24' ' ' SER . 97.7 mt-30 -66.45 -27.45 67.82 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 121.232 0.539 . . . . 0.0 110.674 179.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -69.86 4.17 2.17 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.917 175.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.485 ' H ' ' C ' ' A' ' 22' ' ' GLN . 50.9 m 67.54 27.79 7.76 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.878 0.847 . . . . 0.0 109.12 -176.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -91.95 104.83 17.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-N 114.576 -1.193 . . . . 0.0 110.952 -178.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.649 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 30.6 tt0 -100.73 129.53 46.64 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.851 176.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.402 ' CG1' ' HB ' ' A' ' 19' ' ' VAL . 7.5 p -133.26 140.18 47.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.041 179.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 51.4 m170 -94.73 112.87 24.59 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.164 -176.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -110.64 147.36 34.44 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.425 177.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.507 ' HD2' ' O ' ' A' ' 15' ' ' ILE . 12.4 tpt180 -105.17 116.0 31.21 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 175.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.448 HG21 HD13 ' A' ' 17' ' ' ILE . 35.3 m -137.86 172.72 13.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.918 -176.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -89.33 159.92 17.13 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 -177.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -55.04 -38.3 67.79 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.073 0.463 . . . . 0.0 109.753 173.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -100.04 25.92 26.44 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.767 -177.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.483 HG23 ' HB2' ' A' ' 39' ' ' LYS . 1.2 m -71.39 128.44 35.87 Favored 'General case' 0 N--CA 1.425 -1.682 0 CA-C-O 121.529 0.681 . . . . 0.0 112.418 179.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.504 ' HB3' ' HA ' ' A' ' 66' ' ' ASP . 66.9 m -93.11 164.15 13.37 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 114.759 -1.11 . . . . 0.0 111.045 -179.15 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.527 ' SD ' ' HA ' ' A' ' 65' ' ' ASN . 24.3 ptt? -47.14 -39.21 13.09 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -174.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.76 -37.18 80.94 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -175.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.483 ' HB2' HG23 ' A' ' 35' ' ' THR . 75.8 mmtt -61.1 -40.51 94.03 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.52 -176.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.547 HD12 ' CD2' ' A' ' 57' ' ' PHE . 0.3 OUTLIER -88.06 -44.49 10.92 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.376 -178.618 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.506 ' HG2' ' CD1' ' A' ' 57' ' ' PHE . 61.6 mtpt -62.87 -45.3 93.22 Favored 'General case' 0 CA--C 1.489 -1.376 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.71 -176.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -61.22 -43.3 99.1 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 176.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 44.5 t -65.78 -51.44 59.11 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.426 -0.806 . . . . 0.0 112.1 -176.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.534 ' O ' HG21 ' A' ' 48' ' ' THR . 41.9 t80 -66.85 -46.57 74.65 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 120.769 0.319 . . . . 0.0 111.488 -179.191 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.57 -35.08 75.19 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.413 0.625 . . . . 0.0 109.883 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -64.5 -47.37 79.16 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.343 -178.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.495 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 15.4 ptm180 -65.72 -28.5 69.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.539 -177.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.534 HG21 ' O ' ' A' ' 44' ' ' TYR . 7.0 t -93.57 -8.24 41.83 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.234 -179.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.12 30.99 69.33 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.941 -0.647 . . . . 0.0 113.12 178.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.5 p -115.09 169.28 6.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -178.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.421 ' HB3' ' HB3' ' A' ' 54' ' ' SER . . . -60.41 136.81 58.16 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.775 0.321 . . . . 0.0 110.666 178.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 79.7 t -61.96 -44.24 98.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-O 121.396 0.617 . . . . 0.0 109.857 179.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -71.33 -21.74 62.01 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.827 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.448 ' HB2' ' HB3' ' A' ' 87' ' ' GLN . 85.2 p -75.75 -12.59 60.21 Favored 'General case' 0 CA--C 1.52 -0.189 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.533 179.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.505 HD11 ' CE1' ' A' ' 57' ' ' PHE . 0.1 OUTLIER -94.45 132.72 38.8 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 177.469 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.72 120.11 25.85 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.125 0.488 . . . . 0.0 110.524 -179.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.547 ' CD2' HD12 ' A' ' 40' ' ' LEU . 32.9 m-85 -110.29 134.3 52.4 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.46 -179.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.523 HD11 ' CD1' ' A' ' 84' ' ' TYR . 7.1 mp -126.75 145.54 50.57 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.906 178.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.778 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 89.2 t80 -117.41 118.32 31.9 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 176.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 30.8 t70 54.05 29.74 10.73 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.738 0.78 . . . . 0.0 111.56 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 90.26 6.08 69.23 Favored Glycine 0 C--N 1.313 -0.741 0 CA-C-N 115.612 -0.722 . . . . 0.0 113.539 176.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.778 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -116.9 143.88 45.18 Favored 'General case' 0 CA--C 1.503 -0.838 0 CA-C-O 121.12 0.486 . . . . 0.0 109.752 177.102 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.492 ' HA ' ' HG ' ' A' ' 58' ' ' LEU . 34.6 mtp-105 -73.14 128.47 35.57 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.001 -175.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 74.6 mt -79.61 129.57 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 177.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.527 ' HA ' ' SD ' ' A' ' 37' ' ' MET . 93.7 m-20 -125.23 176.62 6.62 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 121.169 0.509 . . . . 0.0 111.443 -173.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.504 ' HA ' ' HB3' ' A' ' 36' ' ' SER . 8.9 p-10 -82.98 -6.58 59.54 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.571 177.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -102.16 -13.22 17.54 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.314 -176.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.402 ' HB3' HH22 ' A' ' 62' ' ' ARG . 20.2 p30 -70.97 165.29 23.73 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -176.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.478 ' O ' HG23 ' A' ' 72' ' ' THR . 42.5 p -123.56 159.63 54.47 Favored Pre-proline 0 N--CA 1.443 -0.78 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.056 -175.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.452 ' HD2' ' HB ' ' A' ' 69' ' ' THR . 19.3 Cg_endo -58.61 -31.15 94.04 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.927 2.418 . . . . 0.0 114.097 -176.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.68 -28.55 36.74 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 119.586 -0.845 . . . . 0.0 111.87 -177.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.478 HG23 ' O ' ' A' ' 69' ' ' THR . 12.1 t -79.24 -30.78 43.35 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 120.071 -0.652 . . . . 0.0 109.308 178.257 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 94.9 mt -76.65 -23.16 53.3 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.262 175.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 46.21 34.24 2.08 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.119 177.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 61.6 mtt -72.36 154.11 41.1 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.774 -177.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -151.13 175.22 12.34 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.543 ' CG ' ' HZ3' ' A' ' 16' ' ' LYS . 38.7 t70 -58.7 122.07 12.61 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.801 0.81 . . . . 0.0 112.76 -177.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.6 t70 66.45 34.74 6.01 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 113.788 -1.551 . . . . 0.0 111.701 177.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -74.8 178.45 5.48 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 175.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 36.0 m -117.26 147.77 20.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 CA-C-O 121.763 0.792 . . . . 0.0 112.87 -175.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 7.6 mt -128.73 138.25 55.1 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-N 114.318 -1.31 . . . . 0.0 110.164 178.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -104.52 140.45 37.96 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.813 0.34 . . . . 0.0 110.613 -176.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.479 ' HB ' ' HA2' ' A' ' 21' ' ' GLY . 98.4 t -126.42 134.37 66.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-O 121.221 0.534 . . . . 0.0 111.938 -178.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.523 ' CD1' HD11 ' A' ' 58' ' ' LEU . 78.3 m-85 -99.38 168.69 9.84 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.739 177.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.437 ' HG3' ' HA2' ' A' ' 90' ' ' GLY . 64.1 tt0 -66.4 133.01 49.59 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.367 0.603 . . . . 0.0 111.499 -172.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.412 ' HA ' ' O ' ' A' ' 54' ' ' SER . 1.7 mp0 -61.68 151.89 32.44 Favored 'General case' 0 CA--C 1.497 -1.079 0 CA-C-N 115.125 -0.943 . . . . 0.0 112.021 -177.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.448 ' HB3' ' HB2' ' A' ' 54' ' ' SER . 60.5 tp60 -69.19 -40.06 78.29 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.533 179.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -111.62 -1.5 15.73 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.212 -179.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -103.2 -123.41 5.27 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.437 ' HA2' ' HG3' ' A' ' 85' ' ' GLN . . . . . . . . 0 N--CA 1.435 -1.415 0 CA-C-O 118.515 -1.158 . . . . 0.0 112.354 178.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 N--CA 1.475 0.785 0 CA-C-O 120.772 0.32 . . . . 0.0 110.487 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -110.67 123.4 49.95 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 177.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -68.38 -26.07 65.38 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -62.35 -42.45 99.4 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.724 174.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 62.79 74.21 0.44 Allowed 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.099 -0.955 . . . . 0.0 112.055 178.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -81.21 112.52 18.62 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 58.47 -176.39 0.08 Allowed 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.586 -176.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -105.53 -3.22 22.67 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.939 177.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 107.15 73.79 0.85 Allowed Glycine 0 N--CA 1.443 -0.878 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -178.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -133.64 163.0 30.41 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -176.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -119.07 12.12 12.62 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 120.805 0.336 . . . . 0.0 111.426 -178.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -144.98 162.4 37.0 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.337 -179.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -130.5 124.68 32.49 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-O 121.661 0.744 . . . . 0.0 111.996 -177.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -129.39 157.24 42.5 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.82 178.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.5 pt -114.98 161.44 13.73 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -176.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -103.61 142.82 33.64 Favored 'General case' 0 C--N 1.282 -2.326 0 C-N-CA 120.572 -0.451 . . . . 0.0 109.958 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.428 HG23 HD11 ' A' ' 81' ' ' ILE . 41.0 mm -123.59 127.99 74.32 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.169 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.799 177.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.1 mtmt -101.6 103.69 14.52 Favored 'General case' 0 N--CA 1.423 -1.802 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 177.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.767 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 91.3 t -81.69 121.98 35.9 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.87 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 62.0 t -109.99 121.48 62.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.16 0.505 . . . . 0.0 110.285 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -90.97 -174.11 43.94 Favored Glycine 0 CA--C 1.52 0.371 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.937 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.417 ' C ' ' H ' ' A' ' 24' ' ' SER . 16.6 mm100 -63.75 -38.59 91.68 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -177.074 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.612 ' HB2' ' OD1' ' A' ' 25' ' ' ASN . 16.0 m-20 -87.33 22.06 2.26 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 178.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.417 ' H ' ' C ' ' A' ' 22' ' ' GLN . 48.9 m 65.35 31.76 10.23 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.863 -178.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.612 ' OD1' ' HB2' ' A' ' 23' ' ' ASP . 14.9 m120 -78.67 106.74 10.86 Favored 'General case' 0 CA--C 1.501 -0.924 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.755 -178.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.767 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 36.6 tt0 -103.08 134.63 46.18 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-O 121.195 0.521 . . . . 0.0 111.279 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.7 p -136.12 141.92 40.2 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.198 178.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 35.6 m170 -101.69 115.14 29.86 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.264 0.554 . . . . 0.0 111.817 -176.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -115.51 148.07 39.92 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.37 175.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 21.4 tpp180 -103.11 120.56 40.91 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 177.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 32.5 m -134.58 172.22 16.5 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.449 -178.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -89.99 162.56 15.32 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.404 ' C ' ' HB3' ' A' ' 70' ' ' PRO . 83.3 m-85 -56.37 -39.85 73.59 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 175.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -101.22 33.06 6.77 Favored Glycine 0 N--CA 1.446 -0.651 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.388 -179.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.431 HG22 ' HB2' ' A' ' 39' ' ' LYS . 0.9 OUTLIER -68.75 133.42 48.35 Favored 'General case' 0 N--CA 1.428 -1.537 0 CA-C-O 121.47 0.652 . . . . 0.0 111.953 177.908 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.428 ' OG ' ' HG2' ' A' ' 39' ' ' LYS . 86.7 p -78.44 161.6 26.99 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.293 -179.359 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.629 ' SD ' ' HA ' ' A' ' 65' ' ' ASN . 26.2 ptt? -59.61 -32.29 70.27 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.898 0.38 . . . . 0.0 111.004 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.17 -36.87 83.19 Favored 'General case' 0 C--O 1.219 -0.537 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.628 -177.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.431 ' HB2' HG22 ' A' ' 35' ' ' THR . 32.4 mmmt -59.97 -40.86 90.56 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.609 -175.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.468 HD11 ' CG ' ' A' ' 57' ' ' PHE . 0.4 OUTLIER -87.82 -45.87 9.93 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -179.534 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -62.65 -45.32 93.36 Favored 'General case' 0 CA--C 1.501 -0.93 0 N-CA-C 111.798 0.295 . . . . 0.0 111.798 -176.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.512 ' O ' ' HB2' ' A' ' 46' ' ' ASP . 40.0 ttpt -61.95 -42.12 98.75 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.614 176.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.432 ' O ' ' HB3' ' A' ' 46' ' ' ASP . 38.2 t -68.75 -51.17 44.13 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.286 -176.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.473 ' O ' HG21 ' A' ' 48' ' ' THR . 48.7 t80 -68.3 -48.01 66.1 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.9 -178.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.21 -29.34 68.67 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 121.631 0.729 . . . . 0.0 109.679 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.512 ' HB2' ' O ' ' A' ' 42' ' ' LYS . 22.2 t70 -63.16 -46.74 85.76 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.749 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.469 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 25.9 ptt180 -69.09 -30.47 68.79 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.008 0.432 . . . . 0.0 110.926 -175.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.473 HG21 ' O ' ' A' ' 44' ' ' TYR . 4.8 t -92.46 -21.53 20.11 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.83 -175.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.3 23.32 57.08 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.39 -0.909 . . . . 0.0 112.985 179.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.423 HG11 HD22 ' A' ' 55' ' ' LEU . 7.8 p -98.74 158.94 3.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.002 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.536 ' HB3' ' OG ' ' A' ' 54' ' ' SER . . . -59.96 132.72 54.83 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 177.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 71.1 t -61.3 -44.19 97.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.158 0.504 . . . . 0.0 110.598 -178.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -66.63 -32.92 74.55 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.015 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.536 ' OG ' ' HB3' ' A' ' 51' ' ' ALA . 83.1 p -76.25 -13.21 60.17 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.302 -0.408 . . . . 0.0 112.066 -178.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.518 HD12 ' CE1' ' A' ' 57' ' ' PHE . 0.6 OUTLIER -95.56 128.5 42.47 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -178.196 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -121.82 126.86 49.74 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.906 -175.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.518 ' CE1' HD12 ' A' ' 55' ' ' LEU . 65.8 m-85 -106.14 129.83 54.14 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.094 173.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.506 ' HG ' ' HA ' ' A' ' 63' ' ' ARG . 8.1 mp -126.47 147.24 49.85 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 121.21 0.529 . . . . 0.0 111.103 -179.169 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.735 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 45.1 t80 -118.06 114.39 23.05 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 55.89 29.7 14.62 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.097 0.475 . . . . 0.0 112.258 -177.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 92.35 6.78 64.22 Favored Glycine 0 C--N 1.313 -0.717 0 C-N-CA 120.902 -0.666 . . . . 0.0 113.776 175.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.735 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.1 OUTLIER -120.84 136.6 54.87 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 117.204 0.502 . . . . 0.0 109.677 176.708 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.506 ' HA ' ' HG ' ' A' ' 58' ' ' LEU . 5.7 ptm180 -66.92 141.84 57.49 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.309 -0.86 . . . . 0.0 112.542 -175.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 77.7 mt -95.28 120.52 44.8 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.228 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.629 ' HA ' ' SD ' ' A' ' 37' ' ' MET . 21.3 m120 -119.56 164.75 15.37 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.065 0.459 . . . . 0.0 111.376 -178.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -70.66 -12.19 61.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.797 179.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -81.51 -21.01 38.91 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.083 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.441 ' CG ' HH12 ' A' ' 62' ' ' ARG . 66.0 m-20 -74.78 143.54 43.97 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -175.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.432 ' HB ' ' HD2' ' A' ' 70' ' ' PRO . 82.8 p -91.55 161.4 34.41 Favored Pre-proline 0 C--N 1.318 -0.792 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.872 177.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.432 ' HD2' ' HB ' ' A' ' 69' ' ' THR . 19.1 Cg_endo -60.04 -26.69 83.12 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.485 2.124 . . . . 0.0 111.766 177.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.07 -40.44 38.53 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.206 -177.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.1 t -75.83 -31.34 59.31 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.676 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 97.4 mt -71.98 -25.52 61.88 Favored 'General case' 0 C--O 1.213 -0.837 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.36 177.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 52.19 24.2 2.68 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 123.58 0.752 . . . . 0.0 112.926 174.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 23.4 ptp -79.62 161.1 26.1 Favored 'General case' 0 C--N 1.321 -0.643 0 O-C-N 122.123 -0.36 . . . . 0.0 110.982 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -143.74 -178.9 6.14 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -178.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -66.46 118.51 10.19 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.304 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 17.9 t70 71.27 33.54 1.95 Allowed 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.715 1.206 . . . . 0.0 110.475 178.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -84.02 177.36 8.3 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 176.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.5 m -110.47 149.27 13.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 CA-C-O 121.539 0.685 . . . . 0.0 111.836 -174.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.428 HD11 HG23 ' A' ' 17' ' ' ILE . 1.0 OUTLIER -137.61 138.93 44.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 CA-C-N 114.763 -1.108 . . . . 0.0 109.905 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -100.24 146.18 27.2 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.993 0.425 . . . . 0.0 111.499 -174.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 84.0 t -118.62 129.22 75.18 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.252 175.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.476 ' CE1' HD23 ' A' ' 58' ' ' LEU . 60.2 m-85 -100.55 169.42 9.07 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.224 177.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -67.36 148.81 51.14 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.439 0.637 . . . . 0.0 111.536 -173.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.557 ' HG2' ' H ' ' A' ' 89' ' ' GLY . 0.7 OUTLIER -94.55 157.1 16.14 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 114.82 -1.082 . . . . 0.0 112.335 -175.052 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.474 ' H ' ' HB2' ' A' ' 54' ' ' SER . 53.1 tt0 -66.19 -41.78 89.78 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.112 178.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 58.8 tp -63.08 -40.55 97.99 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 178.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.557 ' H ' ' HG2' ' A' ' 86' ' ' GLU . . . 103.24 154.95 24.56 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.89 177.169 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.102 0 CA-C-O 119.041 -0.866 . . . . 0.0 111.08 178.687 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 ptp . . . . . 0 N--CA 1.471 0.587 0 CA-C-O 120.892 0.377 . . . . 0.0 111.046 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -109.15 128.04 54.69 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 174.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 31.6 t70 67.01 -179.75 0.22 Allowed 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -174.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -66.35 -37.42 85.27 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.325 -0.55 . . . . 0.0 109.719 177.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 55.42 33.68 21.39 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.411 177.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.58 87.8 5.73 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-O 121.543 0.687 . . . . 0.0 109.703 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -91.5 162.74 14.42 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.429 -177.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -94.3 125.4 38.91 Favored 'General case' 0 N--CA 1.425 -1.725 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 174.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -71.99 61.29 1.35 Allowed Glycine 0 C--N 1.308 -1.004 0 C-N-CA 120.613 -0.803 . . . . 0.0 113.98 -176.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -85.77 66.82 9.81 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.577 0.703 . . . . 0.0 109.807 177.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -171.34 42.26 0.02 OUTLIER 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.27 162.08 26.79 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.662 -1.154 . . . . 0.0 111.163 -178.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 70.4 35.67 1.94 Allowed 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 122.3 1.048 . . . . 0.0 110.23 -177.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -132.21 167.51 19.67 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 113.644 -1.617 . . . . 0.0 109.417 178.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.4 ' O ' ' HD3' ' A' ' 30' ' ' ARG . 4.3 pt -109.06 161.07 7.58 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -176.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.546 ' HE3' ' OD1' ' A' ' 78' ' ' ASP . 34.3 ttpt -109.82 144.69 37.9 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 -177.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.506 HG22 HD11 ' A' ' 81' ' ' ILE . 82.4 mt -130.29 133.04 64.61 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.183 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.395 178.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.0 mtmt -96.33 105.56 17.65 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 175.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.72 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 88.1 t -81.33 117.58 27.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.4 t -112.94 120.02 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 O-C-N 123.504 0.503 . . . . 0.0 109.769 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -86.42 -175.45 49.63 Favored Glycine 0 C--N 1.311 -0.821 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.746 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -62.68 -37.58 87.0 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -178.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -88.9 22.57 2.65 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 178.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 54.6 m 64.16 38.53 8.19 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.942 -178.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -79.91 102.34 9.11 Favored 'General case' 0 C--O 1.215 -0.739 0 CA-C-N 115.0 -1.0 . . . . 0.0 108.974 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.72 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 27.7 tt0 -104.35 128.41 52.18 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 120.986 0.422 . . . . 0.0 112.107 -176.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.6 p -141.65 144.07 26.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.283 177.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 61.0 m170 -91.43 117.64 29.86 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -178.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -111.76 144.95 40.21 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.859 172.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.4 ' HD3' ' O ' ' A' ' 15' ' ' ILE . 15.1 tpp180 -108.8 119.88 40.84 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 33.6 m -138.13 174.77 10.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.606 -178.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.529 ' O ' ' HB ' ' A' ' 35' ' ' THR . 36.1 ttpt -88.29 160.4 17.67 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.267 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.645 ' O ' ' HB3' ' A' ' 70' ' ' PRO . 96.7 m-85 -57.18 -44.11 83.27 Favored 'General case' 0 C--O 1.224 -0.244 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 176.379 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -93.18 21.04 42.37 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.464 -177.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.529 ' HB ' ' O ' ' A' ' 32' ' ' LYS . 0.9 OUTLIER -60.27 139.6 57.52 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-O 121.637 0.732 . . . . 0.0 112.154 179.363 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.9 m -91.35 158.42 16.55 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.433 178.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 25.3 ptt? -52.16 -33.35 39.98 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -176.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.42 -35.97 79.03 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -177.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.42 ' HB2' HG23 ' A' ' 35' ' ' THR . 75.1 mmtt -59.15 -41.3 88.01 Favored 'General case' 0 C--O 1.215 -0.749 0 CA-C-O 120.846 0.355 . . . . 0.0 110.691 -175.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.434 HD23 ' H ' ' A' ' 40' ' ' LEU . 0.4 OUTLIER -88.56 -44.19 10.84 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -179.575 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.609 ' HE3' ' O ' ' A' ' 55' ' ' LEU . 61.6 mtpt -62.52 -45.33 93.47 Favored 'General case' 0 CA--C 1.492 -1.279 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.803 -176.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -61.2 -43.58 98.65 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 176.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 58.0 m -62.84 -49.19 75.88 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.309 -176.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.477 ' CB ' ' HZ ' ' A' ' 57' ' ' PHE . 47.7 t80 -71.54 -45.93 60.97 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.735 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.518 ' HB2' ' O ' ' A' ' 50' ' ' VAL . . . -59.0 -33.36 70.62 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 121.301 0.572 . . . . 0.0 109.845 -178.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -63.02 -46.46 87.48 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.415 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 -70.84 -24.78 62.6 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.902 0.382 . . . . 0.0 111.616 -177.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.451 HG22 ' O ' ' A' ' 44' ' ' TYR . 9.9 t -97.29 -5.31 36.99 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.788 -178.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 68.52 30.56 73.13 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.312 178.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.518 ' O ' ' HB2' ' A' ' 45' ' ' ALA . 70.6 t -112.81 146.93 16.87 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 C-N-CA 122.628 0.371 . . . . 0.0 110.392 -178.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.513 ' HB3' ' OG ' ' A' ' 54' ' ' SER . . . -54.47 133.08 45.77 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.974 177.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 72.7 t -61.6 -42.86 95.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.991 -176.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 32.4 p-10 -73.73 -16.77 61.17 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.675 -177.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.513 ' OG ' ' HB3' ' A' ' 51' ' ' ALA . 96.8 p -93.82 -5.8 47.32 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.846 -0.342 . . . . 0.0 111.442 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.609 ' O ' ' HE3' ' A' ' 41' ' ' LYS . 0.1 OUTLIER -94.47 135.18 36.2 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.687 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.493 ' HD2' ' N ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -130.36 126.61 37.55 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 120.002 -0.679 . . . . 0.0 111.849 -175.844 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.477 ' HZ ' ' CB ' ' A' ' 44' ' ' TYR . 36.4 m-85 -110.27 133.14 53.54 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.39 177.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.504 HD23 ' CE1' ' A' ' 84' ' ' TYR . 9.8 mp -122.52 146.05 47.76 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.123 0.487 . . . . 0.0 111.113 -179.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.709 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 74.0 t80 -118.74 117.54 29.18 Favored 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 175.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 33.9 t70 58.17 28.3 16.3 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.741 0.781 . . . . 0.0 111.225 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 92.39 5.17 65.54 Favored Glycine 0 C--N 1.315 -0.585 0 CA-C-N 115.382 -0.826 . . . . 0.0 113.721 177.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.709 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.2 OUTLIER -122.37 134.47 54.63 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.313 0.578 . . . . 0.0 109.888 177.716 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.488 ' HA ' ' HG ' ' A' ' 58' ' ' LEU . 28.8 ptt180 -66.16 139.84 58.16 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 115.206 -0.906 . . . . 0.0 112.63 -175.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 76.5 mt -89.48 118.05 34.0 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.977 -178.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -105.71 159.85 15.67 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.514 -178.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -73.97 -14.47 61.04 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.244 0.545 . . . . 0.0 109.731 177.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -81.72 -19.16 42.06 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.78 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -72.88 147.47 45.32 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.197 0.522 . . . . 0.0 111.863 -178.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.418 ' HB ' ' HD2' ' A' ' 70' ' ' PRO . 23.3 p -97.12 160.74 28.3 Favored Pre-proline 0 N--CA 1.439 -1.013 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.545 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.645 ' HB3' ' O ' ' A' ' 33' ' ' TYR . 14.3 Cg_endo -58.21 -32.9 96.87 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.566 2.177 . . . . 0.0 112.535 -178.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.593 ' HG3' ' N ' ' A' ' 72' ' ' THR . 19.8 ptmt -69.0 -43.47 74.77 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.956 -0.565 . . . . 0.0 112.334 -179.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.593 ' N ' ' HG3' ' A' ' 71' ' ' LYS . 12.5 t -76.08 -28.75 57.71 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-O 121.248 0.547 . . . . 0.0 109.667 -178.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 96.1 mt -75.58 -21.59 57.71 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.681 175.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.526 ' HG2' ' O ' ' A' ' 71' ' ' LYS . 8.7 mm-40 52.4 34.03 14.25 Favored 'General case' 0 C--N 1.348 0.524 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 175.04 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 67.8 mtm -88.34 155.47 19.69 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 120.984 0.421 . . . . 0.0 111.526 -178.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -153.16 -175.19 5.23 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 177.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -63.85 125.25 23.76 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.758 0.79 . . . . 0.0 112.366 -176.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.546 ' OD1' ' HE3' ' A' ' 16' ' ' LYS . 24.2 t70 64.24 33.39 11.68 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.005 -1.452 . . . . 0.0 110.98 177.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -78.06 177.31 8.42 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.3 m -108.83 144.72 16.75 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 CA-C-O 121.547 0.689 . . . . 0.0 111.948 -174.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.506 HD11 HG22 ' A' ' 17' ' ' ILE . 1.2 mt -137.98 140.76 40.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.27 179.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -102.72 146.02 28.84 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.309 -175.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 97.4 t -126.44 132.37 70.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 121.081 0.467 . . . . 0.0 110.996 177.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.504 ' CE1' HD23 ' A' ' 58' ' ' LEU . 79.3 m-85 -108.47 168.75 9.1 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.452 178.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -68.05 141.66 56.11 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.7 0.762 . . . . 0.0 111.697 -173.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.493 ' HG3' HG13 ' A' ' 50' ' ' VAL . 0.5 OUTLIER -104.24 167.16 9.93 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 114.389 -1.278 . . . . 0.0 112.474 -172.621 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.478 ' HB3' ' HB2' ' A' ' 54' ' ' SER . 64.6 tt0 -64.14 -47.65 79.1 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.003 -177.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.495 HD12 ' H ' ' A' ' 51' ' ' ALA . 92.0 mt -91.02 -2.4 57.68 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.165 -0.47 . . . . 0.0 112.24 -177.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.444 ' N ' ' HG2' ' A' ' 86' ' ' GLU . . . -106.55 -110.12 3.45 Favored Glycine 0 N--CA 1.442 -0.951 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 176.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.213 0 CA-C-O 118.44 -1.2 . . . . 0.0 111.633 -179.916 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.0 mtm . . . . . 0 N--CA 1.474 0.74 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.69 97.33 7.87 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-O 120.868 0.366 . . . . 0.0 111.123 -178.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -90.19 5.72 45.8 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.602 0.715 . . . . 0.0 109.204 177.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -61.36 -36.57 80.58 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.507 -1.224 . . . . 0.0 110.44 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 71.89 20.23 4.54 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.882 178.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.449 ' O ' ' HB2' ' A' ' 7' ' ' GLN . . . -65.46 138.26 57.99 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 176.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.449 ' HB2' ' O ' ' A' ' 6' ' ' ALA . 98.8 mt-30 68.2 125.14 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.535 0.734 . . . . 0.0 110.742 -175.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.36 -40.57 94.75 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.099 0.476 . . . . 0.0 110.623 -178.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -178.69 29.6 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.839 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 177.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -63.79 -40.7 97.29 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -176.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -125.73 116.14 21.16 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-O 121.568 0.699 . . . . 0.0 111.227 -173.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -138.45 148.59 44.56 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.575 178.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 61.94 42.34 10.33 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.759 0.79 . . . . 0.0 109.659 -175.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -110.75 164.75 12.44 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.1 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.2 pt -129.08 162.25 36.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.127 -177.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.513 ' HE3' ' HB2' ' A' ' 78' ' ' ASP . 55.7 mtmt -98.7 147.42 24.87 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-O 121.0 0.429 . . . . 0.0 110.308 176.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 61.3 mt -130.76 128.82 63.45 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.099 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.604 174.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.3 mtmt -95.61 104.45 16.36 Favored 'General case' 0 N--CA 1.426 -1.639 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 176.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.665 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 85.8 t -82.38 110.97 18.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 25' ' ' ASN . 5.5 p -121.66 121.68 65.04 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 CA-C-O 121.783 0.802 . . . . 0.0 111.385 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.433 ' HA2' ' HB ' ' A' ' 83' ' ' VAL . . . -91.26 169.03 32.81 Favored Glycine 0 N--CA 1.432 -1.595 0 CA-C-N 114.723 -1.126 . . . . 0.0 112.149 -179.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.513 ' C ' ' H ' ' A' ' 24' ' ' SER . 20.6 pt20 -68.15 -23.14 64.85 Favored 'General case' 0 CA--C 1.494 -1.179 0 CA-C-O 121.857 0.837 . . . . 0.0 110.859 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -70.23 7.52 0.98 Allowed 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 114.163 -1.38 . . . . 0.0 109.907 175.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.513 ' H ' ' C ' ' A' ' 22' ' ' GLN . 49.0 m 66.32 29.94 9.21 Favored 'General case' 0 C--N 1.347 0.463 0 C-N-CA 123.559 0.744 . . . . 0.0 110.363 -178.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.458 ' O ' ' HA ' ' A' ' 20' ' ' VAL . 54.7 t30 -104.59 105.57 15.73 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.564 -178.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.665 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 39.8 tt0 -108.0 132.73 53.21 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.437 0.637 . . . . 0.0 111.112 178.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.3 p -136.14 142.77 37.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.651 179.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 53.8 m170 -100.18 115.61 30.26 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 121.293 0.568 . . . . 0.0 111.791 -175.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -115.48 151.28 35.09 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.724 176.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 53.2 ttp180 -111.23 123.46 50.24 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 173.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 31.3 m -135.7 174.02 13.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.102 -176.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 24.4 ttpp -88.49 156.67 18.97 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.462 ' O ' ' HB3' ' A' ' 70' ' ' PRO . 90.1 m-85 -51.28 -41.36 60.38 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 176.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -100.27 25.49 28.11 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.844 -0.617 . . . . 0.0 113.244 -177.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.443 HG23 ' HB2' ' A' ' 39' ' ' LYS . 1.1 m -65.26 136.47 56.64 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 121.284 0.564 . . . . 0.0 111.855 178.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.441 ' HB3' ' HA ' ' A' ' 66' ' ' ASP . 49.3 m -84.85 153.95 22.61 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.06 -178.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.448 ' SD ' ' HA ' ' A' ' 65' ' ' ASN . 24.7 ptt? -48.2 -32.32 6.95 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.17 -37.79 84.18 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -176.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.443 ' HB2' HG23 ' A' ' 35' ' ' THR . 75.3 mmtt -62.16 -39.23 91.95 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.767 0.318 . . . . 0.0 110.972 -175.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.513 HD12 ' CD2' ' A' ' 57' ' ' PHE . 0.3 OUTLIER -86.88 -46.04 10.28 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 116.163 -0.471 . . . . 0.0 112.088 -178.564 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.437 ' HG2' ' CD1' ' A' ' 57' ' ' PHE . 59.0 mtpt -62.64 -48.53 78.96 Favored 'General case' 0 CA--C 1.496 -1.104 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 -177.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -63.04 -40.42 97.66 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.006 179.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 47.3 t -66.01 -51.4 58.66 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.078 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.455 ' O ' HG21 ' A' ' 48' ' ' THR . 45.2 t80 -65.34 -46.92 78.29 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.838 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.413 ' HB3' ' O ' ' A' ' 50' ' ' VAL . . . -58.53 -36.68 74.22 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-O 121.374 0.606 . . . . 0.0 109.805 -177.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -66.51 -47.94 71.37 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.227 -178.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.448 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 15.8 ptm180 -71.25 -24.35 62.16 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.73 -177.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.455 HG21 ' O ' ' A' ' 44' ' ' TYR . 12.9 t -95.67 -8.36 34.93 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.579 -178.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.73 30.94 65.5 Favored Glycine 0 C--N 1.336 0.552 0 C-N-CA 121.298 -0.477 . . . . 0.0 113.54 178.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.413 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 96.8 t -119.44 150.39 21.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 -178.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.449 ' HB1' ' OG ' ' A' ' 54' ' ' SER . . . -52.26 135.83 31.71 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.242 176.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 72.2 t -61.6 -43.41 96.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.243 -178.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -66.59 -27.24 67.56 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.52 178.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.45 ' OG ' ' HB3' ' A' ' 87' ' ' GLN . 74.2 m -75.09 -12.15 60.25 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.237 179.103 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -94.8 135.42 36.32 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.081 0.467 . . . . 0.0 110.28 177.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.46 119.25 17.23 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.127 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.513 ' CD2' HD12 ' A' ' 40' ' ' LEU . 11.0 m-85 -109.37 132.24 54.31 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.39 -179.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.477 ' HG ' ' HA ' ' A' ' 63' ' ' ARG . 9.1 mp -124.8 147.76 48.54 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 121.356 0.598 . . . . 0.0 111.654 -177.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.785 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 49.2 t80 -126.92 126.35 43.1 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 175.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 22.6 t70 58.78 24.56 12.46 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.719 0.771 . . . . 0.0 110.931 -179.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.07 5.83 87.16 Favored Glycine 0 C--N 1.312 -0.795 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.863 179.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.785 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.1 OUTLIER -113.97 144.47 43.03 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 178.046 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.477 ' HA ' ' HG ' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -71.65 132.1 44.11 Favored 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.699 -176.478 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 82.1 mt -74.68 130.72 35.88 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 N-CA-C 107.429 -1.322 . . . . 0.0 107.429 176.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.448 ' HA ' ' SD ' ' A' ' 37' ' ' MET . 15.6 m120 -112.9 165.74 12.04 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 121.236 0.541 . . . . 0.0 111.1 -173.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.441 ' HA ' ' HB3' ' A' ' 36' ' ' SER . 7.2 p-10 -82.66 -6.71 59.52 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 176.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -112.53 -2.4 14.65 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.668 -175.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 31.5 p30 -76.82 167.76 21.27 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.297 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.548 ' O ' HG23 ' A' ' 72' ' ' THR . 41.0 p -116.99 155.25 49.55 Favored Pre-proline 0 C--N 1.316 -0.857 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.702 -178.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.462 ' HB3' ' O ' ' A' ' 33' ' ' TYR . 18.5 Cg_endo -59.52 -31.22 94.23 Favored 'Trans proline' 0 C--O 1.217 -0.548 0 C-N-CA 122.375 2.05 . . . . 0.0 112.417 -178.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.571 ' HD3' ' N ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -75.53 -29.26 59.38 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -179.266 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.571 ' N ' ' HD3' ' A' ' 71' ' ' LYS . 4.9 t -76.08 -29.7 58.06 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.076 -0.65 . . . . 0.0 110.174 -178.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.532 HD22 ' NH1' ' A' ' 62' ' ' ARG . 97.7 mt -92.96 -23.72 18.62 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.355 177.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 40.19 59.14 2.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.506 -175.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 75.6 mtm -84.21 149.02 26.41 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.731 178.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -137.96 -179.29 5.68 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -178.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -64.17 118.19 8.22 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.528 0.68 . . . . 0.0 112.542 -175.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.513 ' HB2' ' HE3' ' A' ' 16' ' ' LYS . 11.8 t70 73.27 34.32 1.03 Allowed 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 113.951 -1.477 . . . . 0.0 111.17 176.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -74.84 177.22 6.39 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.638 177.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.8 t -111.85 130.69 65.0 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 CA-C-O 121.201 0.524 . . . . 0.0 110.939 -173.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.2 mp -118.69 135.1 60.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.434 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -97.59 135.86 38.81 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.589 -175.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.433 ' HB ' ' HA2' ' A' ' 21' ' ' GLY . 93.1 t -126.8 133.52 68.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 CA-C-O 121.163 0.506 . . . . 0.0 110.572 178.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -107.1 168.99 8.82 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.437 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -64.67 136.99 57.56 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-O 121.91 0.862 . . . . 0.0 111.64 -173.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.421 ' HA ' ' O ' ' A' ' 54' ' ' SER . 31.7 mp0 -70.7 156.56 39.33 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 114.169 -1.378 . . . . 0.0 112.286 -174.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.45 ' HB3' ' OG ' ' A' ' 54' ' ' SER . 61.7 tt0 -64.83 -43.98 91.31 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.015 175.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 52.8 tp -93.35 -30.47 15.1 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.101 -179.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -89.92 0.09 78.78 Favored Glycine 0 C--O 1.236 0.251 0 C-N-CA 121.094 -0.574 . . . . 0.0 113.497 -177.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.581 -1.122 . . . . 0.0 111.391 179.009 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.7 ttt . . . . . 0 N--CA 1.47 0.559 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -118.34 133.77 55.61 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 120.649 0.262 . . . . 0.0 110.312 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.549 ' OD1' ' HB1' ' A' ' 6' ' ' ALA . 35.6 t70 -81.38 110.39 16.77 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.008 0.432 . . . . 0.0 111.29 -178.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -65.42 -40.97 93.98 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.8 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -170.76 -30.99 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -177.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.549 ' HB1' ' OD1' ' A' ' 3' ' ' ASP . . . 58.3 39.26 25.74 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.062 -178.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -94.91 146.8 23.98 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.46 -178.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -84.85 -6.35 59.35 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.234 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 143.22 -22.25 2.25 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.345 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 22.1 t70 64.48 27.23 13.49 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.494 0.664 . . . . 0.0 111.114 178.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -101.11 -1.17 34.74 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.36 0.6 . . . . 0.0 110.11 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.65 -44.07 97.2 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 115.222 1.564 . . . . 0.0 115.222 -173.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -117.18 16.26 14.92 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 115.002 1.482 . . . . 0.0 115.002 -171.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -138.05 159.83 40.99 Favored 'General case' 0 C--N 1.283 -2.305 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.426 ' HB ' ' HA ' ' A' ' 77' ' ' ASP . 12.1 pt -116.49 160.76 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.21 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.247 -177.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -101.21 147.3 26.43 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.652 178.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 42.8 mm -127.13 126.47 68.13 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.312 176.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.7 mtmt -96.79 103.67 15.6 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 176.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.652 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 94.3 t -82.69 116.07 26.27 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.265 178.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 64.1 t -109.0 118.55 56.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -92.94 179.65 39.77 Favored Glycine 0 C--N 1.312 -0.805 0 C-N-CA 120.207 -0.997 . . . . 0.0 113.062 -178.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.404 ' C ' ' H ' ' A' ' 24' ' ' SER . 90.9 mm-40 -72.31 -20.2 61.53 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 121.468 0.651 . . . . 0.0 111.714 -178.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -83.37 10.77 7.94 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.324 -0.853 . . . . 0.0 108.963 176.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.404 ' H ' ' C ' ' A' ' 22' ' ' GLN . 40.8 m 63.65 28.47 15.03 Favored 'General case' 0 C--N 1.347 0.498 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -176.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 55.9 t-20 -93.32 106.94 18.84 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.513 -1.221 . . . . 0.0 110.42 -177.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.652 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 29.9 tt0 -99.28 132.02 44.9 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.13 177.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.7 p -136.74 139.94 43.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.461 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 60.1 m170 -98.66 114.55 27.08 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 121.376 0.608 . . . . 0.0 111.709 -176.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -110.63 145.31 38.13 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.284 174.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 57.6 ttp180 -105.33 125.71 51.29 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.1 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 32.6 m -136.44 175.7 9.72 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.516 -177.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.489 ' O ' ' HB ' ' A' ' 35' ' ' THR . 59.0 tttp -88.37 157.42 18.72 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.423 ' O ' ' HB3' ' A' ' 70' ' ' PRO . 66.2 m-85 -55.9 -41.08 73.95 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 173.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -97.98 31.57 7.79 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.141 -178.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.489 ' HB ' ' O ' ' A' ' 32' ' ' LYS . 0.9 OUTLIER -68.63 138.79 55.31 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-O 121.503 0.668 . . . . 0.0 112.378 179.009 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 87.7 p -83.09 163.55 20.83 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.705 177.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.691 ' SD ' ' HA ' ' A' ' 65' ' ' ASN . 25.3 ptt? -60.61 -31.89 71.04 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.748 0.309 . . . . 0.0 111.189 -179.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.63 -37.16 82.94 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.244 -178.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.429 ' HB2' HG21 ' A' ' 35' ' ' THR . 75.9 mmtt -59.93 -40.39 88.74 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.192 -175.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.422 ' H ' HD22 ' A' ' 40' ' ' LEU . 0.4 OUTLIER -87.96 -44.13 11.25 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 179.737 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -62.68 -45.29 93.45 Favored 'General case' 0 CA--C 1.493 -1.213 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.188 -177.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.404 ' O ' ' HB2' ' A' ' 46' ' ' ASP . 24.9 ttmm -62.98 -41.6 99.6 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 176.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 52.4 m -63.95 -46.19 85.82 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.202 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.685 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 45.6 t80 -71.11 -45.25 64.02 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.97 0.415 . . . . 0.0 110.871 178.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.47 -28.14 69.07 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.155 0.502 . . . . 0.0 110.008 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.404 ' HB2' ' O ' ' A' ' 42' ' ' LYS . 25.8 t70 -63.91 -45.95 87.0 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.374 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.685 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 15.3 ptm180 -65.82 -28.0 68.67 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.018 0.437 . . . . 0.0 111.047 -178.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.499 HG21 ' O ' ' A' ' 44' ' ' TYR . 2.0 t -97.27 -17.71 19.64 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.467 -178.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.04 30.36 67.82 Favored Glycine 0 C--O 1.236 0.23 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.04 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.575 ' CG1' ' HB2' ' A' ' 87' ' ' GLN . 2.4 p -108.76 176.46 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-O 120.676 0.274 . . . . 0.0 110.553 -177.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.423 ' HB3' ' HB2' ' A' ' 54' ' ' SER . . . -58.79 125.92 25.52 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.396 176.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 71.6 t -65.99 -45.46 90.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.379 0.609 . . . . 0.0 110.97 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -68.72 -31.74 71.03 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.456 -177.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.423 ' HB2' ' HB3' ' A' ' 51' ' ' ALA . 50.2 m -81.74 -4.44 56.31 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.979 -175.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.603 HD13 ' CE1' ' A' ' 57' ' ' PHE . 0.3 OUTLIER -90.14 128.71 36.41 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 177.108 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.45 ' HD3' ' CB ' ' A' ' 86' ' ' GLU . 3.2 mpt_? -106.12 118.95 37.95 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -173.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.603 ' CE1' HD13 ' A' ' 55' ' ' LEU . 61.0 m-85 -111.08 134.84 52.37 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.124 171.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.54 ' CD1' ' HA ' ' A' ' 63' ' ' ARG . 2.9 mm? -127.76 155.2 44.41 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.937 0.875 . . . . 0.0 111.746 -178.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.735 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 58.6 t80 -122.46 108.54 13.3 Favored 'General case' 0 C--N 1.286 -2.171 0 CA-C-N 113.941 -1.481 . . . . 0.0 108.264 176.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 55.19 22.52 4.72 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.183 0.516 . . . . 0.0 110.74 -174.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 93.85 -7.95 73.66 Favored Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.561 -179.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.735 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.1 OUTLIER -91.57 142.15 27.95 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.391 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.54 ' HA ' ' CD1' ' A' ' 58' ' ' LEU . 0.7 OUTLIER -64.81 139.2 58.74 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -174.795 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 78.9 mt -103.93 117.77 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 174.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.691 ' HA ' ' SD ' ' A' ' 37' ' ' MET . 48.0 m-80 -121.57 166.84 13.61 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 120.92 0.39 . . . . 0.0 110.6 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -70.61 -15.32 62.74 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.532 -177.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -92.12 -0.42 57.44 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 116.705 -0.225 . . . . 0.0 111.523 -179.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -80.33 140.58 36.06 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 120.906 0.384 . . . . 0.0 111.112 178.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.422 ' HB ' ' HD2' ' A' ' 70' ' ' PRO . 82.2 p -87.87 160.07 47.54 Favored Pre-proline 0 C--N 1.314 -0.97 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.993 -178.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.423 ' HB3' ' O ' ' A' ' 33' ' ' TYR . 21.0 Cg_endo -62.22 -25.61 76.99 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.626 2.217 . . . . 0.0 111.713 177.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.5 tmtt? -82.14 -37.65 25.9 Favored 'General case' 0 N--CA 1.423 -1.82 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.128 -177.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.7 t -74.07 -33.51 63.69 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 120.456 -0.497 . . . . 0.0 110.432 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 97.2 mt -79.06 -22.84 44.76 Favored 'General case' 0 C--O 1.217 -0.614 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.517 177.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 51.73 34.57 13.25 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.043 175.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 75.7 mtm -76.25 155.94 33.95 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 121.009 0.433 . . . . 0.0 111.342 -178.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -141.23 176.33 8.93 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.426 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 35.7 t70 -66.49 121.16 14.71 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 120.955 0.407 . . . . 0.0 111.089 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 24.5 t70 71.24 34.68 1.72 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.618 -1.174 . . . . 0.0 110.291 177.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -74.81 176.26 7.22 Favored 'General case' 0 N--CA 1.457 -0.09 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.95 178.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 24.5 m -106.97 138.38 33.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-O 121.57 0.7 . . . . 0.0 111.58 -176.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 6.8 mm -134.81 136.6 52.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.422 -177.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 53.6 mm-40 -101.88 141.88 34.05 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.862 -174.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 74.3 t -129.18 134.36 64.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-O 120.972 0.415 . . . . 0.0 110.953 177.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -99.98 151.76 20.98 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 175.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.526 ' O ' ' HG3' ' A' ' 86' ' ' GLU . 63.9 tt0 -71.51 96.45 1.52 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.219 0.533 . . . . 0.0 110.226 -176.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.563 ' O ' HD22 ' A' ' 55' ' ' LEU . 30.6 mt-10 -167.99 142.34 3.5 Favored 'General case' 0 CA--C 1.501 -0.929 0 C-N-CA 125.592 1.557 . . . . 0.0 109.486 -177.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.575 ' HB2' ' CG1' ' A' ' 50' ' ' VAL . 27.6 pt20 177.33 -29.41 0.0 OUTLIER 'General case' 0 N--CA 1.389 -3.483 0 C-N-CA 125.284 1.434 . . . . 0.0 108.315 -176.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 60.0 tp 178.44 -37.6 0.01 OUTLIER 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 103.696 -2.705 . . . . 0.0 103.696 -179.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 141.05 95.18 0.25 Allowed Glycine 0 N--CA 1.44 -1.077 0 CA-C-N 113.182 -1.826 . . . . 0.0 112.047 172.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.469 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 -179.065 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.9 mtt . . . . . 0 N--CA 1.474 0.747 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -133.37 154.78 50.45 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.321 -178.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -70.77 160.31 32.94 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.167 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -63.13 -34.33 77.38 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 175.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 77.63 -71.96 0.1 Allowed 'General case' 0 CA--C 1.508 -0.641 0 CA-C-N 114.756 -1.111 . . . . 0.0 112.77 176.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -121.45 116.81 25.42 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-O 121.056 0.455 . . . . 0.0 112.208 -177.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -137.27 158.67 43.92 Favored 'General case' 0 CA--C 1.496 -1.122 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.07 175.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -106.85 120.98 43.49 Favored 'General case' 0 N--CA 1.413 -2.294 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 175.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -66.91 -12.71 60.39 Favored Glycine 0 CA--C 1.496 -1.141 0 C-N-CA 120.522 -0.847 . . . . 0.0 111.364 -178.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 27.7 t70 53.23 67.03 1.06 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.734 0.778 . . . . 0.0 109.772 -179.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -93.84 13.1 23.56 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.663 -174.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -146.8 144.92 29.7 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.115 -178.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -129.88 15.7 5.8 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.928 0.871 . . . . 0.0 110.449 -178.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -136.89 159.83 40.69 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 114.301 -1.318 . . . . 0.0 110.744 -177.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.413 ' O ' ' HD2' ' A' ' 30' ' ' ARG . 12.1 pt -126.21 163.04 28.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -179.117 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.493 ' H ' ' HA ' ' A' ' 77' ' ' ASP . 37.0 ttpt -106.55 140.05 40.05 Favored 'General case' 0 C--N 1.282 -2.353 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.438 HG22 HD12 ' A' ' 81' ' ' ILE . 83.5 mt -133.5 132.97 57.69 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.118 0 CA-C-O 120.814 0.34 . . . . 0.0 111.29 177.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.3 mtmt -97.62 105.81 18.02 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.608 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 97.7 t -82.42 120.38 33.75 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 178.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 59.9 t -111.02 118.22 56.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 120.998 0.428 . . . . 0.0 110.11 179.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.502 ' HA2' ' HB ' ' A' ' 83' ' ' VAL . . . -87.27 169.51 39.83 Favored Glycine 0 N--CA 1.445 -0.764 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.704 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.491 ' HG2' ' O ' ' A' ' 83' ' ' VAL . 15.9 mm100 -68.71 -26.82 65.46 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 120.961 0.41 . . . . 0.0 111.92 -177.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -83.34 13.88 4.02 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.055 178.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.406 ' H ' ' C ' ' A' ' 22' ' ' GLN . 27.4 t 74.17 24.45 1.94 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.428 178.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -91.57 104.53 17.0 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.811 -178.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.608 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 30.4 tt0 -98.77 130.82 45.24 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.693 176.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.415 ' CG1' ' HB ' ' A' ' 19' ' ' VAL . 7.1 p -131.06 141.35 46.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.131 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 50.7 m170 -98.98 108.74 21.5 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 121.067 0.46 . . . . 0.0 110.702 -175.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -110.05 147.13 34.15 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.868 179.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.413 ' HD2' ' O ' ' A' ' 15' ' ' ILE . 23.4 tpt180 -108.38 118.74 37.56 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 176.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 33.7 m -133.21 171.6 17.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.767 -177.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.435 ' O ' ' HB ' ' A' ' 35' ' ' THR . 38.1 ttpt -88.83 156.93 18.65 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 -178.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -55.61 -39.58 70.97 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 174.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -97.42 24.6 30.77 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.56 -178.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.435 ' HB ' ' O ' ' A' ' 32' ' ' LYS . 1.0 OUTLIER -67.05 138.09 56.92 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-O 121.367 0.603 . . . . 0.0 112.068 179.032 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.8 m -92.1 158.89 15.95 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.685 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 25.9 ptt? -52.78 -34.38 53.01 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -176.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.55 -36.27 80.12 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.332 0.494 . . . . 0.0 112.332 -176.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -59.98 -40.91 90.76 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.664 0.268 . . . . 0.0 110.711 -174.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.428 HD13 ' CD2' ' A' ' 57' ' ' PHE . 0.4 OUTLIER -87.79 -45.81 10.0 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.213 -0.448 . . . . 0.0 112.0 -179.094 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.65 ' HG2' ' CD1' ' A' ' 57' ' ' PHE . 62.3 mtpt -62.83 -45.9 90.45 Favored 'General case' 0 CA--C 1.493 -1.22 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.501 -175.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -61.85 -41.68 98.12 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 177.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 47.9 t -63.98 -51.0 66.35 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.227 -178.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.577 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 46.6 t80 -70.21 -46.59 64.21 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.345 -179.089 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.419 ' HB2' ' O ' ' A' ' 50' ' ' VAL . . . -60.05 -36.76 78.02 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.393 0.616 . . . . 0.0 110.016 -178.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -66.03 -46.16 78.86 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.14 -178.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.577 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 14.6 ptm180 -68.07 -24.73 65.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.453 -177.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.48 HG21 ' O ' ' A' ' 44' ' ' TYR . 12.4 t -96.02 -8.61 33.16 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 120.769 0.318 . . . . 0.0 111.619 -179.126 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.72 31.2 60.73 Favored Glycine 0 C--N 1.339 0.727 0 C-N-CA 121.004 -0.617 . . . . 0.0 113.222 178.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.419 ' O ' ' HB2' ' A' ' 45' ' ' ALA . 94.7 t -119.47 148.76 22.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 C-N-CA 122.539 0.336 . . . . 0.0 110.806 -178.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.41 ' HB3' ' OG ' ' A' ' 54' ' ' SER . . . -51.76 134.24 30.8 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.456 176.355 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 74.0 t -61.05 -44.62 98.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.001 -177.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -70.56 -22.44 62.59 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.187 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.476 ' HB3' ' HB3' ' A' ' 87' ' ' GLN . 68.0 m -80.24 -10.96 59.77 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.169 179.129 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.08 129.3 40.67 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 177.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -117.94 115.12 24.27 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 120.999 0.428 . . . . 0.0 110.856 -177.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.65 ' CD1' ' HG2' ' A' ' 41' ' ' LYS . 27.6 m-85 -106.06 127.76 53.4 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.937 177.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.539 HD21 ' CE1' ' A' ' 84' ' ' TYR . 9.2 mp -124.59 140.22 53.15 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.922 -179.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.752 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 76.7 t80 -105.95 117.08 33.09 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 177.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 29.1 t70 56.53 19.84 4.46 Favored 'General case' 0 CA--C 1.548 0.879 0 CA-C-O 121.29 0.567 . . . . 0.0 111.625 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.94 1.32 51.95 Favored Glycine 0 CA--C 1.521 0.451 0 C-N-CA 121.081 -0.58 . . . . 0.0 113.224 178.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.752 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.2 OUTLIER -113.68 142.38 46.08 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 117.097 0.448 . . . . 0.0 109.866 177.668 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.516 ' HA ' ' HG ' ' A' ' 58' ' ' LEU . 9.7 mpt_? -65.45 139.09 58.49 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -175.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 80.5 mt -94.49 119.02 41.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.294 178.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -110.66 160.99 16.19 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.193 -178.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -72.18 -18.29 61.87 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.304 0.573 . . . . 0.0 109.718 176.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -81.4 -19.45 42.57 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.031 -179.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.51 ' CG ' HH12 ' A' ' 62' ' ' ARG . 47.3 m-20 -68.21 140.23 56.07 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 121.391 0.615 . . . . 0.0 111.854 -179.327 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.463 ' HB ' ' HD2' ' A' ' 70' ' ' PRO . 18.8 p -100.66 163.45 18.08 Favored Pre-proline 0 C--N 1.311 -1.065 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.909 -178.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.463 ' HD2' ' HB ' ' A' ' 69' ' ' THR . 17.1 Cg_endo -58.32 -28.86 86.16 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 122.703 2.269 . . . . 0.0 112.687 -178.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.561 ' HG3' ' H ' ' A' ' 72' ' ' THR . 15.2 ptmt -72.41 -49.82 30.92 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.561 ' H ' ' HG3' ' A' ' 71' ' ' LYS . 15.1 t -67.64 -34.26 76.61 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.981 0.42 . . . . 0.0 110.735 -177.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 97.5 mt -79.41 -22.84 43.74 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.541 177.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 36.35 36.52 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 124.639 1.176 . . . . 0.0 113.835 -179.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 65.9 mtt -75.42 151.81 38.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.47 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -147.98 -176.4 5.26 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.819 -178.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.493 ' HA ' ' H ' ' A' ' 16' ' ' LYS . 6.4 p-10 -59.42 121.91 12.66 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -174.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.448 ' OD1' ' HE3' ' A' ' 16' ' ' LYS . 26.5 t70 71.01 32.45 2.31 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 113.635 -1.621 . . . . 0.0 111.553 175.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -79.23 178.05 8.36 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 175.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 35.1 m -115.13 150.5 17.05 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 CA-C-O 121.815 0.817 . . . . 0.0 112.336 -174.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.438 HD12 HG22 ' A' ' 17' ' ' ILE . 1.6 mt -134.26 134.92 54.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.854 178.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -101.81 139.63 37.19 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.897 -178.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.502 ' HB ' ' HA2' ' A' ' 21' ' ' GLY . 95.2 t -122.11 130.94 74.15 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.548 177.092 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.539 ' CE1' HD21 ' A' ' 58' ' ' LEU . 66.8 m-85 -99.21 167.29 10.77 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.474 178.405 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -67.06 137.11 56.18 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.538 0.685 . . . . 0.0 110.677 -173.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.461 ' HG2' ' HA3' ' A' ' 89' ' ' GLY . 0.9 OUTLIER -83.9 156.55 22.34 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.979 -1.009 . . . . 0.0 112.955 -171.574 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.476 ' HB3' ' HB3' ' A' ' 54' ' ' SER . 64.2 tt0 -66.36 -42.83 87.46 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.892 -1.049 . . . . 0.0 112.777 -177.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.466 HD22 ' OG ' ' A' ' 54' ' ' SER . 4.6 mm? -91.56 -15.58 28.44 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -178.084 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.461 ' HA3' ' HG2' ' A' ' 86' ' ' GLU . . . -62.67 -41.82 99.77 Favored Glycine 0 CA--C 1.509 -0.327 0 C-N-CA 120.249 -0.977 . . . . 0.0 111.645 178.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.124 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 176.686 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.5 mtp . . . . . 0 N--CA 1.474 0.771 0 CA-C-O 120.958 0.409 . . . . 0.0 110.711 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -135.47 162.18 33.37 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -78.2 179.63 6.78 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.149 -178.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -65.07 -40.12 94.23 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.641 0.258 . . . . 0.0 111.652 -176.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 63.23 23.48 13.87 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.543 0.737 . . . . 0.0 112.682 178.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -145.36 148.26 33.18 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.265 178.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 54.34 -159.2 0.17 Allowed 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.33 0.586 . . . . 0.0 111.415 179.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -71.53 -18.57 62.26 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.662 177.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 90.53 -7.77 80.85 Favored Glycine 0 CA--C 1.501 -0.821 0 N-CA-C 111.138 -0.785 . . . . 0.0 111.138 -178.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -115.21 145.62 42.24 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.825 -0.688 . . . . 0.0 111.144 -179.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 -155.51 96.14 1.75 Allowed 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -79.68 -70.39 0.52 Allowed 'General case' 0 N--CA 1.428 -1.562 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.529 ' C ' ' HD1' ' A' ' 14' ' ' TYR . 11.1 pt-20 -174.2 -55.36 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.266 0 CA-C-O 121.463 0.649 . . . . 0.0 111.227 173.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.529 ' HD1' ' C ' ' A' ' 13' ' ' GLU . 2.0 m-85 -122.43 155.98 34.98 Favored 'General case' 0 C--N 1.273 -2.735 0 CA-C-N 115.122 -0.944 . . . . 0.0 112.783 -177.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.6 pt -134.01 162.73 38.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-N 114.152 -1.386 . . . . 0.0 107.931 -179.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.435 ' HD2' ' NH1' ' A' ' 30' ' ' ARG . 3.5 mppt? -99.99 148.67 24.26 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 121.147 0.499 . . . . 0.0 111.616 179.197 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.434 HG23 ' CG1' ' A' ' 81' ' ' ILE . 67.8 mt -124.96 131.83 72.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.796 176.151 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.0 mtmt -101.54 102.74 13.53 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 172.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.703 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 92.3 t -82.87 117.7 29.27 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 57.9 t -106.85 114.72 46.69 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.47 ' HA2' ' HB ' ' A' ' 83' ' ' VAL . . . -88.96 171.49 39.12 Favored Glycine 0 C--N 1.313 -0.721 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.597 -179.239 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 90.8 mm-40 -73.89 -11.83 60.48 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-O 121.719 0.771 . . . . 0.0 110.652 179.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -83.6 7.16 18.18 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 114.57 -1.195 . . . . 0.0 108.86 174.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.5 m 65.41 27.59 11.82 Favored 'General case' 0 C--N 1.347 0.46 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.002 -176.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -97.11 105.74 17.94 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.704 -177.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.703 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 39.0 tt0 -98.09 129.7 44.9 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.713 176.183 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.2 p -139.54 141.82 34.25 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.988 -178.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 31.7 m170 -88.65 116.91 27.24 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.747 -179.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -113.68 136.88 52.35 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 114.993 -1.003 . . . . 0.0 108.701 170.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.435 ' NH1' ' HD2' ' A' ' 16' ' ' LYS . 35.9 ttt85 -104.91 125.64 51.13 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.495 ' HB ' ' OG1' ' A' ' 35' ' ' THR . 22.7 m -135.12 -179.76 3.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.227 -174.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -89.77 157.04 18.12 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 178.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.426 ' O ' ' HB3' ' A' ' 70' ' ' PRO . 90.6 m-85 -53.93 -39.79 66.17 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 173.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -102.07 33.39 6.55 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.355 -179.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.495 ' OG1' ' HB ' ' A' ' 31' ' ' VAL . 0.9 OUTLIER -66.7 138.52 57.46 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 121.614 0.721 . . . . 0.0 112.2 179.263 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.458 ' HB3' ' HB2' ' A' ' 66' ' ' ASP . 67.2 m -82.87 151.99 25.77 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.94 178.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.599 ' SD ' ' HA ' ' A' ' 65' ' ' ASN . 26.7 ptt? -54.1 -30.58 49.16 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.935 0.398 . . . . 0.0 111.047 -179.44 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.17 -36.75 80.69 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.781 -178.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -60.14 -40.83 91.18 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.791 0.329 . . . . 0.0 111.149 -176.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.441 HD12 ' CD2' ' A' ' 57' ' ' PHE . 0.3 OUTLIER -86.87 -45.52 10.78 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 116.056 -0.52 . . . . 0.0 112.0 -179.787 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.407 ' HA ' ' CE1' ' A' ' 57' ' ' PHE . 24.8 mtpp -61.78 -47.32 85.68 Favored 'General case' 0 CA--C 1.5 -0.972 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.351 -177.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 40.6 ttpt -62.79 -42.07 99.54 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.072 0.463 . . . . 0.0 109.986 178.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 44.7 t -66.35 -50.88 62.07 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.866 -176.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.572 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 49.6 t80 -70.71 -45.53 64.78 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.142 -178.035 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.506 ' HB3' ' O ' ' A' ' 50' ' ' VAL . . . -59.13 -35.63 73.8 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.409 0.623 . . . . 0.0 109.77 -179.094 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -64.35 -47.16 80.4 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.531 -179.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.572 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 14.5 ptm180 -71.17 -21.91 62.1 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.671 -177.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.487 HG21 ' O ' ' A' ' 44' ' ' TYR . 13.7 t -101.13 -2.73 30.67 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-O 120.855 0.36 . . . . 0.0 111.699 -178.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 69.8 37.08 75.45 Favored Glycine 0 C--N 1.335 0.486 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.013 178.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.506 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 91.3 t -122.62 147.67 26.69 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 C-N-CA 122.825 0.45 . . . . 0.0 110.811 -178.008 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.412 ' HB3' ' HB2' ' A' ' 54' ' ' SER . . . -54.77 135.02 47.87 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 175.319 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 76.6 t -61.1 -45.86 97.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.312 -175.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -71.41 -27.79 63.55 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.356 -178.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.412 ' HB2' ' HB3' ' A' ' 51' ' ' ALA . 49.1 m -82.68 -5.43 58.85 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.464 -178.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.469 HD13 ' CE1' ' A' ' 57' ' ' PHE . 0.2 OUTLIER -95.34 122.42 38.03 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 177.414 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -108.02 117.39 34.01 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 120.33 -0.548 . . . . 0.0 112.222 -174.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.49 ' HZ ' ' CB ' ' A' ' 44' ' ' TYR . 44.3 m-85 -100.63 128.68 46.6 Favored 'General case' 0 CA--C 1.498 -1.058 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.569 174.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.507 HD13 ' HA ' ' A' ' 63' ' ' ARG . 4.2 mm? -119.06 155.89 30.66 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.384 -177.115 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.751 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 63.0 t80 -133.75 109.94 9.48 Favored 'General case' 0 C--N 1.279 -2.466 0 CA-C-N 114.289 -1.323 . . . . 0.0 109.385 174.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 27.9 t70 52.81 29.9 8.27 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.565 0.698 . . . . 0.0 111.562 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 94.58 4.98 61.87 Favored Glycine 0 C--N 1.31 -0.886 0 C-N-CA 120.856 -0.688 . . . . 0.0 113.65 176.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.751 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.2 OUTLIER -122.8 133.49 54.45 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 177.159 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.507 ' HA ' HD13 ' A' ' 58' ' ' LEU . 30.4 ptt180 -72.75 145.91 46.77 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.783 -172.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.426 ' CD1' HD11 ' A' ' 81' ' ' ILE . 73.6 mt -91.21 121.76 41.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.4 -176.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.599 ' HA ' ' SD ' ' A' ' 37' ' ' MET . 50.7 m-80 -111.09 157.54 19.88 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.769 -178.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.458 ' HB2' ' HB3' ' A' ' 36' ' ' SER . 4.8 p-10 -74.79 -11.98 60.28 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-O 121.179 0.514 . . . . 0.0 109.819 178.1 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -81.62 -20.37 39.86 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.913 179.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.449 ' CG ' HH12 ' A' ' 62' ' ' ARG . 50.5 m-20 -67.14 149.41 50.55 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.294 0.569 . . . . 0.0 112.087 -178.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 76.4 p -108.68 159.77 29.69 Favored Pre-proline 0 C--N 1.315 -0.933 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.634 178.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.426 ' HB3' ' O ' ' A' ' 33' ' ' TYR . 19.3 Cg_endo -60.49 -28.68 87.13 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.448 2.099 . . . . 0.0 111.721 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.818 ' C ' ' HD2' ' A' ' 71' ' ' LYS . 0.1 OUTLIER -65.6 -44.04 87.81 Favored 'General case' 0 N--CA 1.415 -2.176 0 CA-C-O 121.615 0.721 . . . . 0.0 109.496 178.819 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -80.22 -40.06 27.85 Favored 'General case' 0 N--CA 1.414 -2.265 0 CA-C-N 114.848 -1.069 . . . . 0.0 111.152 -174.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 98.6 mt -71.32 -23.24 61.9 Favored 'General case' 0 N--CA 1.44 -0.975 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 175.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.407 ' HG3' ' O ' ' A' ' 71' ' ' LYS . 38.5 mt-10 50.79 28.7 3.79 Favored 'General case' 0 C--N 1.349 0.553 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.462 -179.038 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 21.5 ptm -81.32 164.64 22.03 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.241 -178.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -151.37 -175.21 5.09 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-O 120.743 0.306 . . . . 0.0 110.252 -176.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -63.96 119.92 10.99 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.211 -179.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 33.1 t70 67.06 35.58 4.55 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.196 177.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -78.43 175.63 10.12 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 29.1 m -98.42 133.57 40.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 CA-C-O 121.807 0.813 . . . . 0.0 111.611 -176.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.434 ' CG1' HG23 ' A' ' 17' ' ' ILE . 18.1 mm -129.78 130.53 66.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 CA-C-N 114.634 -1.166 . . . . 0.0 109.86 179.137 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -102.56 148.25 25.77 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.094 0.473 . . . . 0.0 111.645 -175.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.47 ' HB ' ' HA2' ' A' ' 21' ' ' GLY . 79.4 t -123.34 129.86 74.57 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.858 174.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -101.77 170.84 7.9 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.571 178.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -64.51 136.94 57.56 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.776 0.798 . . . . 0.0 110.988 -172.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.481 ' HG2' ' N ' ' A' ' 89' ' ' GLY . 0.0 OUTLIER -108.93 160.21 16.19 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 114.512 -1.222 . . . . 0.0 111.614 -173.224 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -65.02 -46.14 82.57 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -175.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.401 ' HB2' HG11 ' A' ' 50' ' ' VAL . 3.3 mm? -98.24 3.48 48.86 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -175.363 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.481 ' N ' ' HG2' ' A' ' 86' ' ' GLU . . . -101.05 -155.72 27.05 Favored Glycine 0 C--N 1.313 -0.709 0 C-N-CA 120.193 -1.003 . . . . 0.0 112.934 -178.084 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.362 0 CA-C-O 118.536 -1.147 . . . . 0.0 111.547 -178.174 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.8 mtp . . . . . 0 N--CA 1.469 0.52 0 CA-C-O 120.95 0.405 . . . . 0.0 110.597 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.71 153.58 37.17 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.479 179.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 43.4 m-20 -81.65 157.35 24.69 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 177.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -61.0 -40.73 94.63 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.71 -179.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 54.99 30.55 14.34 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.512 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -105.75 135.43 47.18 Favored 'General case' 0 N--CA 1.426 -1.633 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.868 -177.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -125.18 160.88 28.1 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.34 -39.4 92.96 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 121.415 0.626 . . . . 0.0 109.537 -178.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 87.54 -10.7 68.53 Favored Glycine 0 CA--C 1.485 -1.814 0 N-CA-C 109.971 -1.251 . . . . 0.0 109.971 -178.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 25.6 t70 50.08 45.24 25.65 Favored 'General case' 0 C--O 1.216 -0.66 0 CA-C-N 114.112 -1.044 . . . . 0.0 108.909 -179.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 32.3 p-10 -88.42 11.57 16.57 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.34 -1.3 . . . . 0.0 112.422 -172.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.58 -40.63 95.46 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.267 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -110.58 25.95 11.22 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.333 0.587 . . . . 0.0 111.324 -178.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -133.5 157.34 45.89 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.479 -178.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.44 ' O ' ' HD3' ' A' ' 30' ' ' ARG . 8.3 pt -111.27 163.08 8.33 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 -178.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.642 ' HE2' ' OD1' ' A' ' 78' ' ' ASP . 34.9 ttpt -113.78 145.33 41.55 Favored 'General case' 0 C--N 1.291 -1.955 0 C-N-CA 118.882 -1.127 . . . . 0.0 111.687 -179.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 84.6 mt -122.21 127.84 75.34 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.489 177.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.2 mtmt -99.19 104.68 16.66 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 176.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.662 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 96.1 t -82.55 119.2 31.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.989 -178.218 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.9 t -105.27 112.84 40.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -91.09 177.27 41.25 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.072 -1.061 . . . . 0.0 112.611 -178.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -82.54 -10.1 59.13 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 121.434 0.635 . . . . 0.0 111.621 -178.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -85.04 11.12 10.2 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 115.075 -0.966 . . . . 0.0 108.801 174.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.2 m 62.86 33.25 15.3 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.437 -178.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 -111.55 108.94 18.61 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.438 -179.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.662 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 30.0 tt0 -94.18 128.67 40.75 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.331 -0.849 . . . . 0.0 108.932 174.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.3 p -132.58 139.38 49.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -178.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 23.9 m170 -100.94 117.17 34.48 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.314 0.578 . . . . 0.0 111.963 -174.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -109.62 144.39 38.03 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.058 -0.973 . . . . 0.0 110.137 175.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.44 ' HD3' ' O ' ' A' ' 15' ' ' ILE . 20.2 tpp180 -103.2 119.32 38.66 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.217 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 32.9 m -134.63 167.99 24.7 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.803 -178.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.42 ' O ' ' HB ' ' A' ' 35' ' ' THR . 46.5 tttm -91.22 163.33 14.29 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 178.561 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -57.36 -38.67 74.53 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.752 174.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -93.94 19.0 55.55 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 121.175 -0.536 . . . . 0.0 112.428 -178.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.42 ' HB ' ' O ' ' A' ' 32' ' ' LYS . 1.1 m -63.85 136.81 57.69 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-O 121.394 0.616 . . . . 0.0 111.802 179.035 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 68.3 m -92.91 156.79 16.72 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.307 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.403 ' SD ' ' HA ' ' A' ' 65' ' ' ASN . 26.7 ptt? -51.38 -32.34 25.59 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -176.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.19 -37.39 82.8 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 -177.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 49.3 mmtm -60.21 -39.98 88.48 Favored 'General case' 0 C--O 1.216 -0.696 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.08 -176.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.668 HD12 ' CD1' ' A' ' 57' ' ' PHE . 0.2 OUTLIER -87.24 -44.06 11.73 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -178.848 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.453 ' HA ' ' HE1' ' A' ' 57' ' ' PHE . 57.3 mtpt -62.83 -45.63 91.72 Favored 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -178.239 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 28.9 ttpp -62.31 -41.98 98.98 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 177.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.415 ' O ' ' HB3' ' A' ' 46' ' ' ASP . 58.4 m -66.26 -48.17 71.34 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.73 -178.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.65 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 38.9 t80 -71.72 -44.25 64.46 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -179.584 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.35 -29.7 66.17 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 121.286 0.565 . . . . 0.0 109.809 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.415 ' HB3' ' O ' ' A' ' 43' ' ' SER . 31.3 t70 -62.72 -48.56 78.73 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.789 178.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.65 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 7.5 ptm180 -69.79 -24.16 63.45 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.192 -176.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.464 HG21 ' O ' ' A' ' 44' ' ' TYR . 7.3 t -100.66 -8.98 22.34 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.234 -0.439 . . . . 0.0 112.132 -178.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 67.43 40.6 91.39 Favored Glycine 0 C--N 1.336 0.531 0 C-N-CA 120.676 -0.774 . . . . 0.0 113.029 178.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.455 HG23 ' HG3' ' A' ' 86' ' ' GLU . 3.6 p -125.3 166.74 20.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 O-C-N 122.728 -0.277 . . . . 0.0 110.72 -177.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.434 ' HB2' ' OG ' ' A' ' 54' ' ' SER . . . -59.18 137.36 58.0 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 116.329 -0.396 . . . . 0.0 109.994 176.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 75.6 t -60.51 -44.04 95.65 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.57 -176.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -84.06 -12.15 55.57 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -179.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.462 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 85.5 p -79.75 -14.26 58.86 Favored 'General case' 0 CA--C 1.514 -0.417 0 C-N-CA 119.924 -0.711 . . . . 0.0 109.091 176.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.418 HD12 ' N ' ' A' ' 56' ' ' ARG . 1.9 tm? -99.61 129.59 45.77 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 177.061 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.418 ' N ' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -135.48 137.61 42.32 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 119.747 -0.781 . . . . 0.0 111.767 -176.599 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.668 ' CD1' HD12 ' A' ' 40' ' ' LEU . 96.3 m-85 -106.95 139.96 40.52 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.382 176.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.549 HD11 ' CD1' ' A' ' 84' ' ' TYR . 6.6 mp -128.68 139.7 52.11 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.703 176.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.66 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 34.4 t80 -107.78 119.04 38.32 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.129 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 32.5 t70 51.93 33.61 11.97 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.507 0.67 . . . . 0.0 111.395 179.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.19 13.8 73.25 Favored Glycine 0 CA--C 1.522 0.528 0 CA-C-N 115.647 -0.706 . . . . 0.0 113.739 177.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.66 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.2 OUTLIER -123.71 149.83 45.05 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 117.163 0.481 . . . . 0.0 110.406 178.822 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -67.88 139.7 56.5 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -176.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 75.5 mt -103.43 111.29 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 173.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.403 ' HA ' ' SD ' ' A' ' 37' ' ' MET . 95.1 m-20 -114.38 170.22 8.46 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-O 121.094 0.473 . . . . 0.0 111.439 -178.179 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 15.3 p-10 -72.25 -14.07 61.68 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.571 -178.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -94.15 -13.16 27.02 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.397 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.426 ' HB3' ' HG ' ' A' ' 73' ' ' LEU . 30.2 m-20 -72.56 149.62 43.86 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.269 0.557 . . . . 0.0 112.187 -178.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.441 ' HB ' ' HD2' ' A' ' 70' ' ' PRO . 81.8 p -108.88 161.45 23.62 Favored Pre-proline 0 C--N 1.315 -0.907 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.691 -179.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.441 ' HD2' ' HB ' ' A' ' 69' ' ' THR . 24.2 Cg_endo -61.34 -22.95 75.98 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.455 2.104 . . . . 0.0 111.639 178.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.796 ' C ' ' HD2' ' A' ' 71' ' ' LYS . 0.0 OUTLIER -67.65 -44.52 77.7 Favored 'General case' 0 N--CA 1.41 -2.441 0 C-N-CA 123.651 0.78 . . . . 0.0 109.635 -179.755 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.6 t -90.0 -32.57 16.72 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.927 -175.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.426 ' HG ' ' HB3' ' A' ' 68' ' ' ASP . 96.0 mt -72.7 -22.95 60.82 Favored 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 174.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 52.89 32.9 13.3 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 114.846 -1.07 . . . . 0.0 112.25 176.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 69.1 mtm -83.54 156.99 22.52 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.372 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -154.44 -176.04 5.7 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -58.48 122.6 13.75 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.949 0.88 . . . . 0.0 112.605 -177.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.642 ' OD1' ' HE2' ' A' ' 16' ' ' LYS . 1.4 m-20 63.14 33.61 14.31 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 113.884 -1.507 . . . . 0.0 111.614 176.495 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -74.92 176.74 6.85 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 178.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 31.5 m -112.71 144.26 20.78 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 CA-C-O 121.459 0.647 . . . . 0.0 111.335 -175.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -129.12 143.97 39.6 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.65 -179.204 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -107.7 141.44 39.23 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 120.817 0.342 . . . . 0.0 110.651 -177.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.425 HG21 ' CD2' ' A' ' 57' ' ' PHE . 99.5 t -117.13 133.44 63.88 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-O 121.096 0.474 . . . . 0.0 111.293 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.549 ' CD1' HD11 ' A' ' 58' ' ' LEU . 53.6 m-85 -98.91 168.45 10.1 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 115.366 -0.833 . . . . 0.0 109.669 176.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 60.1 tp60 -66.68 132.65 48.58 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.311 0.577 . . . . 0.0 111.766 -171.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.472 ' CG ' ' HA3' ' A' ' 89' ' ' GLY . 19.5 pm0 -82.2 144.72 30.49 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.43 -179.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.451 ' HB3' ' HB2' ' A' ' 54' ' ' SER . 6.8 tp-100 -64.6 -45.61 86.19 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -174.46 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 87.8 mt -92.48 -13.03 30.5 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -175.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.472 ' HA3' ' CG ' ' A' ' 86' ' ' GLU . . . -65.72 -43.43 94.2 Favored Glycine 0 CA--C 1.503 -0.703 0 C-N-CA 120.056 -1.069 . . . . 0.0 111.822 178.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.383 0 CA-C-O 118.731 -1.038 . . . . 0.0 111.563 177.871 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.1 mtt . . . . . 0 N--CA 1.475 0.793 0 CA-C-O 120.641 0.258 . . . . 0.0 110.586 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.33 150.41 43.53 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.94 177.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -81.05 111.01 17.13 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 120.947 0.403 . . . . 0.0 111.034 -179.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -75.06 -26.46 59.4 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.77 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 59.24 63.47 1.58 Allowed 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.416 -178.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -88.85 108.09 19.34 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.949 -178.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 56.9 -172.09 0.08 Allowed 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.452 0.701 . . . . 0.0 112.229 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.11 -39.72 94.66 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.487 -179.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 79.7 14.52 80.97 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 110.436 -1.066 . . . . 0.0 110.436 -176.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -110.19 133.22 53.45 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 114.587 -0.807 . . . . 0.0 109.716 -179.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 31.8 p30 -119.76 19.11 12.55 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -176.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -150.85 152.02 33.09 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.491 -178.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -99.55 23.56 9.31 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.453 0.644 . . . . 0.0 111.198 -179.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -100.8 155.31 18.0 Favored 'General case' 0 C--N 1.284 -2.259 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.624 -178.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.6 pt -114.03 160.84 13.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.091 -175.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.42 ' H ' ' HA ' ' A' ' 77' ' ' ASP . 23.4 ttmt -100.76 145.39 28.56 Favored 'General case' 0 C--N 1.283 -2.324 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.622 -179.175 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.454 HG22 HD13 ' A' ' 81' ' ' ILE . 39.7 mm -126.21 127.57 70.89 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.357 175.137 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.401 ' HG3' ' O ' ' A' ' 79' ' ' ASP . 15.1 mtmt -96.36 104.98 16.98 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 176.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.661 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 85.0 t -81.7 109.45 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.591 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.223 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.1 t -112.24 118.36 57.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -178.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.432 ' HA2' ' HB ' ' A' ' 83' ' ' VAL . . . -96.28 160.47 22.13 Favored Glycine 0 C--N 1.304 -1.196 0 C-N-CA 120.074 -1.06 . . . . 0.0 112.293 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.515 ' C ' ' H ' ' A' ' 24' ' ' SER . 16.4 pt20 -66.52 -20.35 66.01 Favored 'General case' 0 CA--C 1.495 -1.163 0 CA-C-O 122.427 1.108 . . . . 0.0 109.67 177.277 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -69.33 5.41 1.31 Allowed 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 113.122 -1.853 . . . . 0.0 109.507 173.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.515 ' H ' ' C ' ' A' ' 22' ' ' GLN . 50.2 m 63.13 31.59 15.68 Favored 'General case' 0 C--N 1.35 0.625 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.154 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -110.39 108.07 17.99 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 114.843 -1.071 . . . . 0.0 111.042 -177.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.661 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 30.8 tt0 -103.82 133.85 48.11 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.522 175.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.3 p -139.23 139.39 39.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-N 115.663 -0.698 . . . . 0.0 109.52 177.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 63.6 m170 -98.04 117.17 31.8 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.205 0.526 . . . . 0.0 111.433 -176.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -112.73 146.52 38.61 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.298 175.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 23.8 tpp180 -103.31 120.53 40.94 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.45 ' HB ' ' OG1' ' A' ' 35' ' ' THR . 29.0 m -132.07 167.82 25.5 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -177.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.586 ' O ' ' HB ' ' A' ' 35' ' ' THR . 43.0 tttm -91.06 161.38 15.14 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.656 ' O ' ' HB3' ' A' ' 70' ' ' PRO . 97.1 m-85 -58.96 -38.23 78.6 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 171.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.615 ' HA2' ' CG ' ' A' ' 70' ' ' PRO . . . -85.64 21.81 13.13 Favored Glycine 0 N--CA 1.433 -1.547 0 CA-C-N 114.621 -1.172 . . . . 0.0 112.167 -178.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.586 ' HB ' ' O ' ' A' ' 32' ' ' LYS . 0.9 OUTLIER -68.56 141.01 55.61 Favored 'General case' 0 N--CA 1.425 -1.699 0 CA-C-O 121.384 0.611 . . . . 0.0 111.684 179.775 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.4 ' HB3' ' HE3' ' A' ' 37' ' ' MET . 48.7 m -88.47 143.37 27.02 Favored 'General case' 0 N--CA 1.416 -2.148 0 CA-C-N 115.405 -0.816 . . . . 0.0 108.939 177.381 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.798 ' SD ' ' HA ' ' A' ' 66' ' ' ASP . 0.2 OUTLIER -51.65 -40.1 59.37 Favored 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 123.575 0.75 . . . . 0.0 111.482 179.647 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.508 ' N ' ' HG2' ' A' ' 37' ' ' MET . . . -62.35 -27.02 68.77 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.152 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -60.47 -40.43 91.21 Favored 'General case' 0 C--O 1.21 -0.995 0 C-N-CA 121.111 -0.235 . . . . 0.0 110.84 -178.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.496 HD12 ' CD1' ' A' ' 57' ' ' PHE . 0.3 OUTLIER -85.47 -39.12 17.84 Favored 'General case' 0 C--N 1.309 -1.183 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.889 -176.764 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.445 ' HA ' ' HE1' ' A' ' 57' ' ' PHE . 61.7 mtpt -65.49 -44.86 85.79 Favored 'General case' 0 CA--C 1.493 -1.225 0 CA-C-O 120.728 0.299 . . . . 0.0 110.773 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.459 ' HD3' HG22 ' A' ' 52' ' ' VAL . 15.5 tppt? -62.97 -43.23 99.35 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 176.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 58.1 m -69.53 -50.25 46.79 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.366 -0.833 . . . . 0.0 113.196 -176.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.611 ' O ' ' HG3' ' A' ' 47' ' ' ARG . 62.4 t80 -64.67 -47.23 79.18 Favored 'General case' 0 CA--C 1.496 -1.116 0 CA-C-O 120.674 0.273 . . . . 0.0 111.233 -179.143 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.25 -36.5 77.91 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 121.367 0.603 . . . . 0.0 109.471 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -66.21 -45.59 80.22 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.315 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.611 ' HG3' ' O ' ' A' ' 44' ' ' TYR . 5.1 ppt_? -67.27 -25.01 65.85 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.347 -178.099 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.547 HG21 ' O ' ' A' ' 44' ' ' TYR . 10.2 t -99.07 -17.81 18.06 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 120.815 0.341 . . . . 0.0 111.61 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.1 32.59 35.22 Favored Glycine 0 C--O 1.227 -0.298 0 C-N-CA 120.471 -0.871 . . . . 0.0 113.021 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.465 HG22 ' HG3' ' A' ' 86' ' ' GLU . 4.3 p -115.13 160.96 14.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 O-C-N 122.555 -0.379 . . . . 0.0 110.292 -179.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.463 ' HB1' ' OG ' ' A' ' 54' ' ' SER . . . -57.91 129.31 41.34 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 178.126 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.459 HG22 ' HD3' ' A' ' 42' ' ' LYS . 78.6 t -61.53 -43.65 97.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.648 -178.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -64.53 -33.98 77.18 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.541 -179.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.463 ' OG ' ' HB1' ' A' ' 51' ' ' ALA . 90.6 p -78.82 -12.56 60.03 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.96 0.41 . . . . 0.0 110.975 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.4 HD11 ' N ' ' A' ' 56' ' ' ARG . 2.8 tm? -95.86 132.8 40.74 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -178.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.4 ' N ' HD11 ' A' ' 55' ' ' LEU . 5.6 ptt180 -144.33 145.8 32.19 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-O 121.259 0.552 . . . . 0.0 112.351 -173.375 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.512 ' CD2' HG22 ' A' ' 83' ' ' VAL . 95.7 m-85 -119.06 147.2 44.38 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.737 176.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 6.7 mp -124.31 138.24 54.4 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.792 175.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.592 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 32.2 t80 -117.84 125.93 51.46 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 179.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 33.4 t70 58.74 26.86 15.19 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.888 0.852 . . . . 0.0 110.163 -179.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 81.33 15.77 75.69 Favored Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.735 177.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.592 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 4.4 ppt_? -132.08 155.32 48.3 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-O 121.277 0.56 . . . . 0.0 112.042 179.242 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 16.4 mmm180 -58.68 137.59 57.5 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -175.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.417 HG21 ' HB3' ' A' ' 37' ' ' MET . 75.7 mt -102.09 109.0 25.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 168.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.53 ' C ' ' HG3' ' A' ' 37' ' ' MET . 88.6 m-20 -120.53 161.59 21.04 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 120.638 0.256 . . . . 0.0 111.039 -174.332 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.798 ' HA ' ' SD ' ' A' ' 37' ' ' MET . 4.7 t70 -58.38 -9.75 1.73 Allowed 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 179.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -84.14 -15.49 47.03 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.242 177.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -71.86 149.78 44.87 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -175.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.533 ' O ' HG23 ' A' ' 72' ' ' THR . 35.3 p -117.69 155.29 50.78 Favored Pre-proline 0 N--CA 1.437 -1.11 0 CA-C-N 114.439 -1.255 . . . . 0.0 109.358 177.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.656 ' HB3' ' O ' ' A' ' 33' ' ' TYR . 58.5 Cg_exo -54.83 -40.56 84.54 Favored 'Trans proline' 0 N--CA 1.477 0.502 0 C-N-CA 122.803 2.335 . . . . 0.0 113.75 -176.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.622 ' HD2' ' N ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -70.92 -30.0 66.21 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -177.482 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.622 ' N ' ' HD2' ' A' ' 71' ' ' LYS . 4.7 t -81.69 -28.64 33.4 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.484 -177.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 97.9 mt -70.26 -24.78 63.12 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 176.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 47.11 30.35 1.33 Allowed 'General case' 0 CA--C 1.551 1.016 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.488 177.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 20.5 ptp -75.49 160.23 30.43 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.938 0.399 . . . . 0.0 111.513 -179.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -147.52 -177.64 5.81 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.588 -178.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.42 ' HA ' ' H ' ' A' ' 16' ' ' LYS . 36.8 t70 -66.14 120.16 12.72 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -176.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 20.4 t70 69.19 33.66 3.24 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 114.381 -1.282 . . . . 0.0 110.441 177.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.401 ' O ' ' HG3' ' A' ' 18' ' ' LYS . 4.6 t70 -78.19 177.36 8.44 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.612 177.453 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 16.9 t -110.0 135.06 50.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 CA-C-O 121.481 0.658 . . . . 0.0 111.686 -171.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.454 HD13 HG22 ' A' ' 17' ' ' ILE . 1.8 mt -132.57 132.46 60.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.703 178.305 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -98.79 141.93 30.96 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.442 -174.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.512 HG22 ' CD2' ' A' ' 57' ' ' PHE . 87.6 t -125.88 129.14 72.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-O 121.346 0.593 . . . . 0.0 110.57 177.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -107.75 169.18 8.76 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.869 178.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -64.8 138.31 58.3 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.411 0.625 . . . . 0.0 111.303 -172.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.465 ' HG3' HG22 ' A' ' 50' ' ' VAL . 0.2 OUTLIER -96.93 160.74 14.18 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.706 -178.496 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.418 ' H ' ' HB2' ' A' ' 54' ' ' SER . 6.5 tp-100 -61.22 -46.02 92.17 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.025 0.441 . . . . 0.0 112.063 -174.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 87.4 mt -91.7 -7.23 50.42 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.892 -176.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.445 ' N ' ' HG2' ' A' ' 86' ' ' GLU . . . -65.89 -40.34 95.41 Favored Glycine 0 CA--C 1.509 -0.291 0 C-N-CA 120.848 -0.691 . . . . 0.0 111.988 178.015 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.236 0 CA-C-O 118.161 -1.355 . . . . 0.0 111.147 179.898 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.2 mtp . . . . . 0 N--CA 1.47 0.547 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.26 112.21 18.77 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.88 0.371 . . . . 0.0 110.306 178.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -86.5 -5.0 59.26 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.612 -179.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -64.93 -39.89 94.2 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -178.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 56.21 64.31 1.74 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.25 0.548 . . . . 0.0 109.586 -176.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -64.13 114.29 4.09 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.55 -175.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 57.46 102.91 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.981 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -76.61 -3.61 38.65 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.772 -176.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 82.04 21.3 61.32 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.924 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -81.72 112.82 19.24 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 -179.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -118.5 -1.95 11.12 Favored 'General case' 0 CA--C 1.498 -1.019 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -178.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.407 ' O ' ' HB2' ' A' ' 13' ' ' GLU . . . 67.17 178.69 0.23 Allowed 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.794 -176.636 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.6 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 45.0 mt-10 68.49 40.92 1.85 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.339 0.59 . . . . 0.0 111.548 -177.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -131.67 158.65 40.54 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.135 178.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.4 pt -125.39 161.63 29.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 CA-C-N 115.183 -0.917 . . . . 0.0 108.576 -179.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.496 ' HE3' ' HB3' ' A' ' 78' ' ' ASP . 59.6 mtmt -101.29 143.08 31.79 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-O 120.999 0.428 . . . . 0.0 110.535 177.176 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 75.9 mt -124.3 126.67 72.43 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.152 174.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 31.0 mtmt -94.83 104.46 16.36 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 177.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.645 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 97.5 t -85.26 112.05 21.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -179.274 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.443 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 5.2 p -115.62 123.41 71.01 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 CA-C-O 121.461 0.648 . . . . 0.0 110.331 179.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -85.96 176.68 49.16 Favored Glycine 0 N--CA 1.435 -1.387 0 CA-C-N 115.223 -0.899 . . . . 0.0 112.095 -178.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.56 ' NE2' ' HA ' ' A' ' 84' ' ' TYR . 78.4 mt-30 -77.36 -13.1 60.0 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.382 0.611 . . . . 0.0 111.333 -177.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -87.95 13.51 10.79 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.18 174.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 46.5 m 66.06 32.79 8.05 Favored 'General case' 0 C--N 1.343 0.294 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.378 179.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.437 ' O ' ' HA ' ' A' ' 20' ' ' VAL . 94.4 m-20 -105.47 111.71 24.52 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.952 179.255 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.645 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 31.2 tt0 -108.78 132.97 53.46 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.399 -179.389 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.2 p -134.36 143.36 38.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.196 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 27.4 m170 -101.98 113.28 26.36 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.403 0.621 . . . . 0.0 112.105 -175.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -111.18 148.86 31.86 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.072 175.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -111.8 123.82 51.04 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.901 178.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 32.9 m -136.99 174.3 12.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.229 -179.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.6 ' HG3' ' O ' ' A' ' 13' ' ' GLU . 35.4 ttmt -89.73 160.95 16.31 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 -179.573 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -54.65 -38.69 67.19 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 120.918 0.39 . . . . 0.0 110.365 177.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -100.77 21.92 41.8 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 116.066 -0.516 . . . . 0.0 112.826 -178.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.468 ' HB ' ' O ' ' A' ' 32' ' ' LYS . 0.9 OUTLIER -60.53 143.08 54.45 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-O 121.376 0.607 . . . . 0.0 112.552 179.8 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 56.1 m -85.97 157.03 20.22 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.285 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.696 ' SD ' ' HA ' ' A' ' 65' ' ' ASN . 25.5 ptm -53.27 -32.73 50.0 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -178.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.34 -37.04 84.1 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -178.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.415 ' HB2' HG23 ' A' ' 35' ' ' THR . 49.7 mmtm -59.15 -40.65 86.22 Favored 'General case' 0 C--O 1.206 -1.222 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.25 -175.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.431 HD21 ' H ' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -86.42 -43.68 12.62 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -179.163 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp -62.15 -46.97 86.61 Favored 'General case' 0 CA--C 1.502 -0.873 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.05 -177.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 29.6 ttpp -63.64 -40.08 95.96 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.136 0.493 . . . . 0.0 110.003 178.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 50.9 m -63.66 -49.72 72.08 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.591 -0.732 . . . . 0.0 112.352 -178.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.507 ' CB ' ' HZ ' ' A' ' 57' ' ' PHE . 44.0 t80 -71.86 -45.59 60.86 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.743 0.306 . . . . 0.0 111.611 -179.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.559 ' HB1' ' O ' ' A' ' 50' ' ' VAL . . . -58.27 -32.49 68.45 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.133 -178.142 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -62.88 -45.0 94.6 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.353 -0.839 . . . . 0.0 112.223 -179.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.465 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 24.0 ptt180 -69.54 -25.17 63.89 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.202 0.525 . . . . 0.0 110.779 -176.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.447 HG21 ' O ' ' A' ' 44' ' ' TYR . 7.9 t -102.59 -7.26 21.96 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -174.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 68.76 28.31 73.2 Favored Glycine 0 N--CA 1.46 0.268 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.237 178.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.559 ' O ' ' HB1' ' A' ' 45' ' ' ALA . 86.9 t -106.53 146.52 12.96 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 C-N-CA 122.613 0.365 . . . . 0.0 110.167 -178.216 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -52.52 133.54 35.62 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 176.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 76.9 t -60.48 -43.99 95.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.79 -177.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -66.08 -32.4 73.83 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.166 179.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.424 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 68.0 m -76.06 -10.81 59.72 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.446 -178.467 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.546 HD12 ' CE1' ' A' ' 57' ' ' PHE . 0.1 OUTLIER -92.68 123.38 35.92 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -179.947 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 28.0 mmm180 -104.47 110.74 23.13 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.757 -170.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.546 ' CE1' HD12 ' A' ' 55' ' ' LEU . 69.2 m-85 -110.48 126.95 54.9 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-O 121.043 0.449 . . . . 0.0 110.622 175.507 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.537 HD22 ' CE1' ' A' ' 84' ' ' TYR . 7.7 mp -129.1 144.94 51.37 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.184 178.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.737 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 62.5 t80 -111.41 116.46 30.96 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.054 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 58.71 18.7 6.15 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 122.673 0.389 . . . . 0.0 111.907 -179.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 98.98 6.72 55.9 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.774 -0.727 . . . . 0.0 113.234 178.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.737 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.1 OUTLIER -118.33 146.6 44.24 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.01 0.433 . . . . 0.0 110.06 176.815 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.493 ' HA ' ' HG ' ' A' ' 58' ' ' LEU . 38.9 mtp180 -68.4 134.96 51.01 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.525 -0.762 . . . . 0.0 112.51 -174.302 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 90.8 mt -91.15 119.86 39.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 115.399 -0.819 . . . . 0.0 108.828 178.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.696 ' HA ' ' SD ' ' A' ' 37' ' ' MET . 65.5 m-80 -118.6 159.36 23.73 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.635 -178.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -71.07 -12.96 61.81 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.191 0.52 . . . . 0.0 110.433 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -83.62 -19.45 35.43 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.097 -179.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -62.31 145.25 54.31 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.316 0.579 . . . . 0.0 112.263 -177.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.417 ' O ' HG22 ' A' ' 72' ' ' THR . 69.4 p -103.38 158.06 32.57 Favored Pre-proline 0 N--CA 1.44 -0.951 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.18 179.221 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -61.63 -21.59 72.42 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.578 2.185 . . . . 0.0 112.51 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.62 -22.47 32.21 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.437 -178.029 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.417 HG22 ' O ' ' A' ' 69' ' ' THR . 4.7 t -95.35 -32.77 12.79 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -179.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 96.1 mt -71.99 -25.96 62.05 Favored 'General case' 0 C--O 1.218 -0.554 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.025 177.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 48.74 33.34 4.22 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 176.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 65.2 mtt -87.21 158.88 19.02 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.293 -179.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -149.58 -179.42 7.08 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 177.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -56.33 127.88 33.09 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.259 0.552 . . . . 0.0 112.123 -176.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.496 ' HB3' ' HE3' ' A' ' 16' ' ' LYS . 1.0 OUTLIER 67.27 32.63 5.88 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.591 1.556 . . . . 0.0 114.117 174.204 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -78.78 178.68 7.72 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 176.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.6 m -112.35 151.71 14.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 CA-C-O 121.271 0.558 . . . . 0.0 111.784 -174.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -131.44 144.81 36.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 CA-C-N 115.453 -0.794 . . . . 0.0 108.878 178.023 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -104.55 139.29 39.65 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.964 -178.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 87.4 t -121.31 130.42 74.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 CA-C-O 121.235 0.54 . . . . 0.0 110.958 -179.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.56 ' HA ' ' NE2' ' A' ' 22' ' ' GLN . 77.4 m-85 -101.11 168.5 9.55 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.198 178.024 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 80.9 mm-40 -67.83 133.52 49.34 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.608 0.718 . . . . 0.0 111.821 -171.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.424 ' HA ' ' O ' ' A' ' 54' ' ' SER . 3.2 pm0 -79.85 157.52 26.97 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.488 -1.233 . . . . 0.0 112.224 -176.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -79.32 -52.18 8.45 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -177.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 50' ' ' VAL . 56.4 tp -65.04 -40.7 95.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.876 0.37 . . . . 0.0 111.432 -178.056 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.419 ' H ' ' HG2' ' A' ' 86' ' ' GLU . . . 114.77 119.08 3.31 Favored Glycine 0 C--N 1.319 -0.387 0 C-N-CA 120.518 -0.849 . . . . 0.0 113.0 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.787 0 CA-C-O 118.839 -0.978 . . . . 0.0 111.862 178.985 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 75.7 mtm . . . . . 0 N--CA 1.478 0.962 0 CA-C-O 120.915 0.388 . . . . 0.0 110.99 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.33 159.9 29.21 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.807 -179.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -78.52 -2.65 39.71 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.208 0.528 . . . . 0.0 109.745 179.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.431 ' C ' ' H ' ' A' ' 6' ' ' ALA . 8.6 m-20 -62.91 -38.1 89.61 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.194 175.327 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 77.72 -24.87 0.21 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.431 1.092 . . . . 0.0 111.597 -177.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.431 ' H ' ' C ' ' A' ' 4' ' ' ASP . . . 54.95 84.53 0.07 Allowed 'General case' 0 C--O 1.238 0.485 0 O-C-N 123.852 0.72 . . . . 0.0 111.749 178.305 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 61.49 -171.12 0.15 Allowed 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.329 -178.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -92.1 -4.63 54.08 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 71.79 19.0 77.84 Favored Glycine 0 N--CA 1.436 -1.331 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -176.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 27.5 t70 55.07 51.62 13.11 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.949 0.88 . . . . 0.0 109.078 -175.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 12.5 t30 -62.4 -45.18 94.28 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-N 114.649 -1.159 . . . . 0.0 109.482 -177.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 56.9 -160.41 0.23 Allowed 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.7 178.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 52.03 68.31 0.83 Allowed 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.226 0.536 . . . . 0.0 112.106 177.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -100.66 151.15 21.97 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-O 121.338 0.59 . . . . 0.0 110.496 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.0 pt -110.5 161.54 8.83 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.048 -174.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.502 ' HB2' ' NH1' ' A' ' 30' ' ' ARG . 34.5 ttpt -109.1 144.22 37.43 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -179.231 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.445 HG23 HD11 ' A' ' 81' ' ' ILE . 82.2 mt -132.33 133.61 59.96 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.161 0 CA-C-O 120.775 0.322 . . . . 0.0 111.598 178.142 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.8 mtmt -94.87 105.23 17.14 Favored 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.694 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 75.0 t -82.28 117.64 28.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 175.36 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.536 ' HA ' ' O ' ' A' ' 25' ' ' ASN . 7.6 p -122.05 122.11 65.77 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 CA-C-O 121.727 0.775 . . . . 0.0 111.453 179.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.404 ' HA2' ' HB ' ' A' ' 83' ' ' VAL . . . -91.2 171.98 35.99 Favored Glycine 0 N--CA 1.436 -1.355 0 CA-C-N 114.867 -1.06 . . . . 0.0 111.535 179.451 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.479 ' C ' ' H ' ' A' ' 24' ' ' SER . 88.1 mm-40 -70.76 -27.32 63.85 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 120.933 0.397 . . . . 0.0 111.895 -176.143 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -79.63 21.84 0.5 Allowed 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.362 175.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.479 ' H ' ' C ' ' A' ' 22' ' ' GLN . 21.2 m 68.59 27.09 6.19 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.687 176.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.536 ' O ' ' HA ' ' A' ' 20' ' ' VAL . 58.2 t30 -93.85 102.09 14.2 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 119.895 -0.722 . . . . 0.0 111.167 -179.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.694 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 35.6 tt0 -112.84 127.49 56.19 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.47 177.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.7 p -136.4 145.0 31.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.712 -177.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 63.5 m170 -92.41 117.59 30.07 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.308 0.575 . . . . 0.0 111.917 -178.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -109.5 141.76 41.49 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.805 174.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.502 ' NH1' ' HB2' ' A' ' 16' ' ' LYS . 23.9 tpp180 -102.57 116.35 32.42 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 177.019 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.472 ' HB ' ' OG1' ' A' ' 35' ' ' THR . 34.5 m -134.43 174.86 12.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.212 -176.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.473 ' O ' ' HB ' ' A' ' 35' ' ' THR . 38.0 ttmt -88.54 158.83 18.18 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -55.43 -40.57 71.66 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 174.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -101.99 33.81 6.21 Favored Glycine 0 N--CA 1.449 -0.462 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.163 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.473 ' HB ' ' O ' ' A' ' 32' ' ' LYS . 0.6 OUTLIER -65.69 140.32 58.46 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 121.317 0.58 . . . . 0.0 111.936 179.356 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.485 ' OG ' ' HG2' ' A' ' 39' ' ' LYS . 85.9 p -81.08 160.03 24.59 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.137 178.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.594 ' SD ' ' HA ' ' A' ' 65' ' ' ASN . 26.5 ptt? -60.82 -32.49 71.87 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.933 0.397 . . . . 0.0 110.687 178.096 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.74 -36.27 80.49 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.45 -177.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.485 ' HG2' ' OG ' ' A' ' 36' ' ' SER . 75.6 mmtt -59.63 -41.82 91.31 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.999 -176.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.453 HD13 ' CD2' ' A' ' 57' ' ' PHE . 0.5 OUTLIER -89.42 -47.87 7.72 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -179.738 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.602 ' HG2' ' CD1' ' A' ' 57' ' ' PHE . 61.8 mtpt -62.37 -47.93 82.02 Favored 'General case' 0 CA--C 1.492 -1.271 0 CA-C-N 116.282 -0.417 . . . . 0.0 112.09 -174.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -61.69 -43.3 99.12 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 178.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 42.7 t -64.98 -51.51 61.31 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.371 -0.832 . . . . 0.0 111.294 -176.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.518 ' O ' HG21 ' A' ' 48' ' ' THR . 62.9 t80 -65.99 -49.06 69.12 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.937 -179.486 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.482 ' HB2' ' O ' ' A' ' 50' ' ' VAL . . . -59.74 -35.17 74.04 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.521 0.676 . . . . 0.0 109.788 -178.324 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -65.31 -47.0 78.08 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.248 -178.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -68.35 -26.39 65.57 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.568 -178.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.518 HG21 ' O ' ' A' ' 44' ' ' TYR . 8.8 t -96.71 -3.51 42.42 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -178.194 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 68.51 35.56 81.66 Favored Glycine 0 C--N 1.335 0.5 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.706 178.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.482 ' O ' ' HB2' ' A' ' 45' ' ' ALA . 78.2 t -118.83 144.54 26.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 C-N-CA 122.406 0.282 . . . . 0.0 111.346 -177.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.423 ' HB2' ' HB2' ' A' ' 54' ' ' SER . . . -51.25 129.31 24.32 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.968 176.008 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 77.0 t -61.42 -43.94 97.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.019 -177.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -65.75 -32.43 73.96 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.016 -179.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.441 ' HB3' ' HB3' ' A' ' 87' ' ' GLN . 51.5 m -83.57 -6.17 59.37 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.687 -178.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.492 HD11 ' CE1' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -96.43 121.17 37.95 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 176.617 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.21 126.47 52.26 Favored 'General case' 0 CA--C 1.499 -1.012 0 C-N-CA 120.112 -0.635 . . . . 0.0 110.834 -176.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.602 ' CD1' ' HG2' ' A' ' 41' ' ' LYS . 22.2 m-85 -106.98 131.04 54.5 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 176.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.507 HD12 ' C ' ' A' ' 62' ' ' ARG . 2.9 mm? -120.88 155.06 34.96 Favored 'General case' 0 N--CA 1.417 -2.075 0 CA-C-O 122.29 1.043 . . . . 0.0 113.068 -174.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.618 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 54.1 t80 -122.79 105.99 10.52 Favored 'General case' 0 C--N 1.282 -2.339 0 CA-C-N 113.289 -1.778 . . . . 0.0 108.103 174.536 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 54.26 28.46 9.24 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.805 -176.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 96.4 -7.83 66.43 Favored Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.543 -0.753 . . . . 0.0 113.117 177.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.618 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 4.1 ppt_? -104.34 147.15 27.84 Favored 'General case' 0 N--CA 1.438 -1.034 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.078 179.287 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.458 ' HA ' HD11 ' A' ' 58' ' ' LEU . 0.1 OUTLIER -67.9 143.77 55.56 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -171.4 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 81.9 mt -102.87 121.42 54.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.273 -0.876 . . . . 0.0 108.709 174.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.594 ' HA ' ' SD ' ' A' ' 37' ' ' MET . 66.4 m-80 -121.41 172.41 8.07 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 120.916 0.389 . . . . 0.0 110.997 -178.177 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -70.21 -13.21 62.08 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.076 0.465 . . . . 0.0 110.96 -178.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -82.29 -14.82 54.8 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.011 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.422 ' CG ' HH12 ' A' ' 62' ' ' ARG . 4.6 m-20 -65.17 153.73 40.07 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 -177.048 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 70.2 p -126.28 159.35 63.11 Favored Pre-proline 0 N--CA 1.435 -1.206 0 CA-C-N 114.156 -1.384 . . . . 0.0 109.54 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -63.71 -19.49 67.33 Favored 'Trans proline' 0 C--O 1.224 -0.183 0 C-N-CA 122.515 2.143 . . . . 0.0 112.688 -179.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.49 -26.99 37.88 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-O 120.81 0.338 . . . . 0.0 111.143 -178.219 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.3 t -94.82 -36.75 11.54 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 120.861 0.362 . . . . 0.0 110.181 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 95.8 mt -75.33 -23.14 57.22 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 175.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 52.94 29.03 7.22 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.728 178.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.437 ' HA ' ' OD2' ' A' ' 79' ' ' ASP . 66.2 mtt -85.71 157.18 20.36 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.166 -178.081 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -152.79 -173.57 4.62 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.157 -178.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -57.66 120.84 9.05 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.709 0.766 . . . . 0.0 112.569 -176.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.466 ' OD1' ' HE3' ' A' ' 16' ' ' LYS . 29.5 t70 65.86 34.16 7.49 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.442 1.497 . . . . 0.0 111.054 178.464 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.437 ' OD2' ' HA ' ' A' ' 75' ' ' MET . 31.9 t0 -75.06 176.3 7.37 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.413 177.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 35.3 m -111.87 143.24 22.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 CA-C-O 121.847 0.832 . . . . 0.0 112.883 -174.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.445 HD11 HG23 ' A' ' 17' ' ' ILE . 3.3 mt -128.47 134.15 65.27 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 CA-C-N 114.234 -1.348 . . . . 0.0 109.425 176.026 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -101.7 138.16 39.06 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.105 0.478 . . . . 0.0 110.677 -177.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.404 ' HB ' ' HA2' ' A' ' 21' ' ' GLY . 88.6 t -123.5 133.76 68.26 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.644 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -99.5 152.48 19.95 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 175.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 10.5 mm100 -68.32 129.24 39.34 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 122.004 0.907 . . . . 0.0 112.568 -169.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.448 ' HG3' HG11 ' A' ' 50' ' ' VAL . 1.4 pm0 -64.05 160.87 17.12 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 113.473 -1.694 . . . . 0.0 113.548 -172.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.441 ' HB3' ' HB3' ' A' ' 54' ' ' SER . 6.6 tp-100 -64.96 -48.72 73.01 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.404 -178.212 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' A' ' 50' ' ' VAL . 56.7 tp -68.91 -39.89 79.43 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.868 -179.05 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 104.18 133.98 8.0 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.55 -178.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.541 -1.144 . . . . 0.0 111.858 -178.854 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.9 ttp . . . . . 0 N--CA 1.471 0.595 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -142.17 172.72 12.31 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.002 -177.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -65.98 122.85 18.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.228 179.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -70.91 -38.26 72.96 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.511 -179.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 74.21 -52.66 0.69 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.125 0.97 . . . . 0.0 110.571 -176.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -104.91 112.06 25.04 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.483 177.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -133.05 146.49 51.75 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.485 -179.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.04 -46.31 81.81 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.435 177.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -70.57 -43.51 60.56 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.739 177.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 25.0 t70 66.74 -54.8 0.43 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.472 1.109 . . . . 0.0 113.736 177.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -65.25 -38.98 92.02 Favored 'General case' 0 CA--C 1.488 -1.431 0 CA-C-O 121.485 0.659 . . . . 0.0 111.041 -178.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -113.07 125.13 54.04 Favored 'General case' 0 N--CA 1.398 -3.033 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.565 -176.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -114.37 3.07 14.9 Favored 'General case' 0 C--N 1.282 -2.339 0 CA-C-O 122.344 1.069 . . . . 0.0 110.622 -175.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -140.13 159.46 42.14 Favored 'General case' 0 C--N 1.282 -2.338 0 CA-C-N 113.353 -1.749 . . . . 0.0 108.457 177.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.403 ' HB ' ' HA ' ' A' ' 77' ' ' ASP . 18.3 pt -127.16 161.95 33.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -177.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.505 ' HE3' ' HB2' ' A' ' 78' ' ' ASP . 59.3 mtmt -97.55 146.47 25.23 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-O 121.045 0.45 . . . . 0.0 110.599 176.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.457 HG21 HD13 ' A' ' 81' ' ' ILE . 40.7 mm -128.1 127.37 67.64 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 CA-C-N 115.498 -0.773 . . . . 0.0 109.833 174.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.9 mtmt -96.75 104.77 16.8 Favored 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 177.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.696 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 98.8 t -82.21 116.88 27.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.6 t -113.03 117.61 55.82 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-O 121.082 0.467 . . . . 0.0 110.738 -178.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -88.49 168.58 36.59 Favored Glycine 0 N--CA 1.436 -1.317 0 C-N-CA 120.431 -0.89 . . . . 0.0 111.378 177.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.426 ' C ' ' H ' ' A' ' 24' ' ' SER . 78.5 mt-30 -67.89 -23.78 65.15 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.191 0.52 . . . . 0.0 111.902 -178.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -79.5 11.27 3.14 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.124 178.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.426 ' H ' ' C ' ' A' ' 22' ' ' GLN . 23.1 m 69.0 27.29 5.44 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.811 -178.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -95.66 104.63 16.55 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.737 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.696 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 37.7 tt0 -105.02 135.37 46.48 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.673 178.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.1 p -137.17 140.22 42.74 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.457 178.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 55.1 m170 -99.05 113.14 25.18 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 121.307 0.575 . . . . 0.0 111.156 -176.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -110.65 145.38 38.04 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.718 176.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 11.1 tpt180 -99.95 118.07 35.59 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.429 ' HB ' HG22 ' A' ' 35' ' ' THR . 33.3 m -133.56 167.75 25.69 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -178.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 46.0 tttm -90.82 162.96 14.61 Favored 'General case' 0 C--N 1.284 -2.247 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.52 ' O ' ' HB3' ' A' ' 70' ' ' PRO . 94.2 m-85 -55.09 -39.18 69.01 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 176.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.435 ' HA2' ' HG3' ' A' ' 70' ' ' PRO . . . -96.38 19.26 55.35 Favored Glycine 0 N--CA 1.444 -0.805 0 CA-C-N 115.728 -0.669 . . . . 0.0 113.337 -177.135 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.429 HG22 ' HB ' ' A' ' 31' ' ' VAL . 1.3 m -67.47 136.69 55.03 Favored 'General case' 0 N--CA 1.428 -1.535 0 CA-C-O 121.125 0.488 . . . . 0.0 111.73 179.088 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.55 ' HA ' ' O ' ' A' ' 65' ' ' ASN . 47.0 m -86.28 151.97 23.16 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.497 -178.063 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.445 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 24.2 ptt? -50.01 -32.27 14.84 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -179.161 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.95 -35.96 78.12 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -178.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -59.44 -40.89 88.24 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.083 0.468 . . . . 0.0 110.137 -177.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.65 HD11 ' CD2' ' A' ' 57' ' ' PHE . 0.2 OUTLIER -86.8 -43.96 12.1 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.544 -177.684 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 61.6 mtpt -62.79 -47.03 85.24 Favored 'General case' 0 CA--C 1.491 -1.293 0 N-CA-C 111.868 0.321 . . . . 0.0 111.868 -177.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -63.72 -40.68 97.35 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 46.6 t -63.73 -48.77 75.69 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.03 -179.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.687 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 43.1 t80 -70.18 -44.84 67.93 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.874 -179.108 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.413 ' CB ' ' HA ' ' A' ' 52' ' ' VAL . . . -59.47 -34.57 72.71 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.229 0.538 . . . . 0.0 109.822 179.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -66.43 -45.81 78.6 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.331 -0.849 . . . . 0.0 111.613 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.687 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 10.9 ptm85 -65.59 -28.71 69.33 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.898 -178.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.504 HG22 ' O ' ' A' ' 44' ' ' TYR . 9.9 t -93.23 -5.82 49.07 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.718 179.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 66.92 35.4 89.46 Favored Glycine 0 C--N 1.335 0.483 0 CA-C-N 116.036 -0.529 . . . . 0.0 113.277 177.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.462 HG22 ' HG3' ' A' ' 86' ' ' GLU . 1.5 p -121.54 166.16 16.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 116.927 0.364 . . . . 0.0 110.967 -177.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.46 128.72 38.47 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.51 179.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.413 ' HA ' ' CB ' ' A' ' 45' ' ' ALA . 73.4 t -61.36 -46.24 96.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.553 -0.748 . . . . 0.0 111.585 -177.037 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -77.33 -14.76 59.67 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.987 -176.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.432 ' HB3' ' HB3' ' A' ' 87' ' ' GLN . 70.0 m -85.43 -15.6 42.47 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.528 178.511 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -95.03 135.03 37.06 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.43 141.42 50.53 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 120.132 -0.627 . . . . 0.0 111.404 -175.203 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.65 ' CD2' HD11 ' A' ' 40' ' ' LEU . 13.7 m-85 -115.5 136.71 52.8 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-N 115.21 -0.904 . . . . 0.0 108.95 177.228 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.659 HD21 ' CD1' ' A' ' 84' ' ' TYR . 0.9 OUTLIER -129.99 151.12 50.9 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-O 121.589 0.709 . . . . 0.0 111.268 178.773 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.711 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 49.5 t80 -113.89 103.47 11.2 Favored 'General case' 0 C--N 1.284 -2.265 0 CA-C-N 114.921 -1.036 . . . . 0.0 108.713 175.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.7 t70 54.92 24.29 5.72 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.748 -177.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 102.34 -5.7 52.47 Favored Glycine 0 C--N 1.333 0.4 0 CA-C-N 115.601 -0.727 . . . . 0.0 113.663 177.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.711 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.2 OUTLIER -108.4 150.16 27.75 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 117.362 0.581 . . . . 0.0 109.856 178.578 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.497 ' HA ' ' CD1' ' A' ' 58' ' ' LEU . 11.8 mpt_? -66.96 142.86 57.11 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -171.053 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.1 mm -74.59 144.9 11.77 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 CA-C-N 114.816 -1.084 . . . . 0.0 109.502 176.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.58 ' HA ' ' HB2' ' A' ' 68' ' ' ASP . 1.0 OUTLIER -68.35 106.12 2.39 Favored 'General case' 0 N--CA 1.406 -2.655 0 N-CA-C 115.089 1.515 . . . . 0.0 115.089 -170.415 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.441 ' HB2' ' HG2' ' A' ' 37' ' ' MET . 4.1 t70 -91.07 -39.65 12.06 Favored 'General case' 0 C--N 1.257 -3.453 0 N-CA-C 102.834 -3.024 . . . . 0.0 102.834 153.494 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -117.7 -17.9 9.78 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 110.82 -2.9 . . . . 0.0 110.927 -176.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.58 ' HB2' ' HA ' ' A' ' 65' ' ' ASN . 2.7 m-20 -72.76 168.58 18.5 Favored 'General case' 0 C--N 1.342 0.269 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.964 -176.073 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.68 ' O ' HG22 ' A' ' 72' ' ' THR . 88.8 m -97.47 130.49 29.23 Favored Pre-proline 0 C--N 1.306 -1.324 0 C-N-CA 120.799 -0.361 . . . . 0.0 110.687 -172.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.52 ' HB3' ' O ' ' A' ' 33' ' ' TYR . 88.6 Cg_exo -52.62 -37.68 74.93 Favored 'Trans proline' 0 CA--C 1.53 0.295 0 C-N-CA 122.756 2.304 . . . . 0.0 112.127 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.02 -25.06 37.49 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.554 179.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.68 HG22 ' O ' ' A' ' 69' ' ' THR . 2.1 t -70.15 -32.81 70.96 Favored 'General case' 0 C--N 1.347 0.473 0 C-N-CA 120.026 -0.67 . . . . 0.0 109.47 178.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 60.4 mt -72.2 -24.99 61.49 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.185 174.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 57.22 40.52 27.93 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.359 179.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 24.7 mmt -72.55 155.62 39.87 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.834 -179.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -151.59 175.75 12.03 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 176.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.403 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 37.6 t70 -58.26 121.35 10.54 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.456 0.646 . . . . 0.0 112.335 -178.057 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.505 ' HB2' ' HE3' ' A' ' 16' ' ' LYS . 13.5 t70 74.19 34.28 0.85 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.351 1.461 . . . . 0.0 111.982 176.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -75.71 177.51 6.79 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.597 -0.441 . . . . 0.0 109.984 177.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 33.1 m -110.23 147.63 14.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 CA-C-O 121.546 0.689 . . . . 0.0 112.28 -173.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.457 HD13 HG21 ' A' ' 17' ' ' ILE . 0.3 OUTLIER -140.61 144.82 26.61 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.302 -179.85 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -110.28 143.08 40.99 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.169 -175.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 86.6 t -125.4 132.43 71.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.131 0.491 . . . . 0.0 111.479 179.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.659 ' CD1' HD21 ' A' ' 58' ' ' LEU . 90.5 m-85 -100.44 162.49 12.91 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.784 177.165 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 53.3 tp60 -69.45 143.97 53.42 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -176.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.562 ' OE1' ' HA3' ' A' ' 89' ' ' GLY . 0.1 OUTLIER -90.0 171.15 9.77 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 112.991 0.738 . . . . 0.0 112.991 -175.12 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.432 ' HB3' ' HB3' ' A' ' 54' ' ' SER . 51.9 tt0 -62.06 -50.01 73.69 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.044 -0.98 . . . . 0.0 112.613 -178.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.8 mp -68.56 -36.63 79.03 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.022 -178.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.562 ' HA3' ' OE1' ' A' ' 86' ' ' GLU . . . -63.34 -41.12 99.55 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.953 -0.642 . . . . 0.0 113.05 -178.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.054 0 CA-C-O 118.555 -1.136 . . . . 0.0 111.644 179.445 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.9 tpt . . . . . 0 N--CA 1.475 0.784 0 CA-C-O 120.725 0.298 . . . . 0.0 110.359 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -88.02 87.42 7.33 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.106 0.479 . . . . 0.0 110.787 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -88.2 -172.65 3.89 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.502 178.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -61.15 -40.26 93.19 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.771 -178.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 54.34 36.84 26.27 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.101 0.476 . . . . 0.0 110.444 -176.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -160.04 159.59 32.19 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.115 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 26.6 pt20 -124.6 146.68 48.92 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.838 0.352 . . . . 0.0 110.374 178.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.81 -40.24 96.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.573 -175.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.0 16.84 73.78 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.501 -0.857 . . . . 0.0 111.401 -177.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -85.52 99.87 11.53 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.033 -0.583 . . . . 0.0 109.632 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.638 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 10.2 p30 -143.12 20.98 1.93 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -175.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.51 -45.99 91.76 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -177.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -115.37 60.34 0.7 Allowed 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 120.995 0.426 . . . . 0.0 110.264 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.638 ' CD1' ' HA ' ' A' ' 11' ' ' ASN . 90.7 m-85 -134.45 167.85 20.0 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.769 -175.436 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.625 HG12 ' O ' ' A' ' 31' ' ' VAL . 17.1 pt -109.56 163.62 6.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.326 -174.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.533 ' C ' HD13 ' A' ' 17' ' ' ILE . 38.0 mtmm -90.28 145.88 24.65 Favored 'General case' 0 CA--C 1.5 -0.95 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.653 HD12 ' CG2' ' A' ' 31' ' ' VAL . 1.5 mp -135.18 137.04 50.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.632 173.179 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 18.6 mtmm -97.29 104.53 16.56 Favored 'General case' 0 N--CA 1.437 -1.083 0 C-N-CA 119.979 -0.688 . . . . 0.0 109.191 178.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.619 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 85.3 t -82.64 116.17 26.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.422 179.309 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.8 t -107.69 118.85 56.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-O 120.833 0.349 . . . . 0.0 110.077 179.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.451 ' HA2' ' HB ' ' A' ' 83' ' ' VAL . . . -87.97 177.06 46.13 Favored Glycine 0 C--N 1.314 -0.663 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.414 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.545 ' C ' ' H ' ' A' ' 24' ' ' SER . 91.0 mm-40 -65.62 -36.75 84.63 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -178.102 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.64 18.85 0.22 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.954 0.407 . . . . 0.0 109.99 176.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.545 ' H ' ' C ' ' A' ' 22' ' ' GLN . 51.0 m 62.12 30.41 17.77 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.153 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -92.06 107.07 18.94 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.947 -178.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.619 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 32.2 tt0 -97.4 132.3 43.25 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.892 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.4 p -135.76 139.82 45.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.522 178.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 61.7 m170 -95.91 114.0 25.68 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 121.17 0.51 . . . . 0.0 110.916 -176.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -110.37 153.41 24.98 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.583 177.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.444 ' HG2' ' HB2' ' A' ' 11' ' ' ASN . 11.7 tpp180 -108.74 115.59 30.39 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.66 179.3 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.653 ' CG2' HD12 ' A' ' 17' ' ' ILE . 30.3 m -140.36 -178.94 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.412 -178.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.516 ' O ' ' HB ' ' A' ' 35' ' ' THR . 83.6 tttt -88.68 155.22 19.72 Favored 'General case' 0 C--N 1.313 -1.001 0 O-C-N 122.361 -0.212 . . . . 0.0 110.674 -177.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -51.79 -45.41 63.83 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-O 121.381 0.61 . . . . 0.0 110.123 176.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -109.84 35.43 4.88 Favored Glycine 0 N--CA 1.441 -1.012 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.967 179.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.645 ' O ' HD12 ' A' ' 73' ' ' LEU . 0.5 OUTLIER -57.19 143.43 39.12 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 121.475 0.655 . . . . 0.0 110.893 -177.164 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 59.3 m -79.85 150.02 30.79 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.757 -179.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.644 ' SD ' ' HA ' ' A' ' 65' ' ' ASN . 26.6 ptt? -49.64 -32.31 12.79 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -177.541 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.24 -36.07 82.42 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -179.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -59.19 -41.48 88.59 Favored 'General case' 0 C--O 1.217 -0.65 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.165 -175.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.642 HD12 ' CG ' ' A' ' 57' ' ' PHE . 0.5 OUTLIER -86.25 -45.64 11.09 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.168 -176.87 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -62.45 -47.92 81.92 Favored 'General case' 0 CA--C 1.492 -1.257 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.761 -176.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -65.72 -39.67 91.41 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.166 178.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 44.9 t -64.35 -51.45 63.27 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.34 -178.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.59 ' O ' ' HG3' ' A' ' 47' ' ' ARG . 47.6 t80 -66.82 -44.0 82.3 Favored 'General case' 0 CA--C 1.499 -1.002 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.45 179.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.411 ' HA ' HG13 ' A' ' 50' ' ' VAL . . . -58.58 -36.16 73.53 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.01 0.434 . . . . 0.0 109.855 -179.202 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -67.58 -44.79 77.33 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.778 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.59 ' HG3' ' O ' ' A' ' 44' ' ' TYR . 2.1 ppt_? -64.33 -25.87 68.23 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.65 -178.05 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.537 HG23 ' O ' ' A' ' 44' ' ' TYR . 10.1 t -104.17 -9.33 18.76 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.815 -178.148 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 68.92 39.56 85.14 Favored Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.737 -0.744 . . . . 0.0 113.036 179.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.491 HG22 ' HG3' ' A' ' 86' ' ' GLU . 5.2 p -118.21 164.32 14.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 120.981 0.419 . . . . 0.0 111.026 -178.01 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.585 ' HB3' ' OG ' ' A' ' 54' ' ' SER . . . -59.99 128.55 37.39 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.991 175.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 73.4 t -64.39 -40.96 90.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 121.131 0.491 . . . . 0.0 110.401 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 32.2 p-10 -67.24 -27.83 67.55 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.36 -177.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.585 ' OG ' ' HB3' ' A' ' 51' ' ' ALA . 88.4 p -97.58 1.18 48.55 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.079 0.466 . . . . 0.0 111.618 179.314 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -96.85 133.49 41.4 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 175.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.75 144.16 35.35 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -174.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.642 ' CG ' HD12 ' A' ' 40' ' ' LEU . 63.4 m-85 -119.14 142.86 47.56 Favored 'General case' 0 CA--C 1.501 -0.921 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.618 176.419 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.613 HD22 ' CE1' ' A' ' 84' ' ' TYR . 8.1 mp -130.84 133.87 46.31 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.628 178.248 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.768 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 0.3 OUTLIER -109.33 114.63 28.47 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.945 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 38.7 t70 66.27 22.48 10.91 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 122.044 0.926 . . . . 0.0 110.674 -177.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 89.9 9.53 65.86 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.41 -0.814 . . . . 0.0 113.055 176.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.768 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.2 OUTLIER -117.62 148.62 41.77 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.753 179.588 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 26.1 mmt85 -65.41 133.26 50.96 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.245 -175.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.401 HD11 ' HB3' ' A' ' 57' ' ' PHE . 87.9 mt -93.67 120.55 43.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.213 -178.317 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.644 ' HA ' ' SD ' ' A' ' 37' ' ' MET . 22.1 m120 -115.83 162.48 17.25 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.773 177.019 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -70.1 -15.0 62.92 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.214 0.53 . . . . 0.0 110.573 -179.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -84.12 -18.83 35.52 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.701 -178.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.628 ' CG ' HH12 ' A' ' 62' ' ' ARG . 65.9 m-20 -71.21 171.49 10.95 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 115.413 1.635 . . . . 0.0 115.413 -172.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.69 ' O ' ' HG ' ' A' ' 73' ' ' LEU . 71.8 p -93.57 156.39 39.76 Favored Pre-proline 0 C--N 1.346 0.449 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.352 -172.036 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.524 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 9.6 Cg_endo -49.77 -26.51 13.6 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 123.352 2.702 . . . . 0.0 113.793 -175.047 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.845 ' HA ' ' CG ' ' A' ' 75' ' ' MET . 0.0 OUTLIER -74.04 -24.35 59.53 Favored 'General case' 0 C--O 1.214 -0.775 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 -179.558 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.549 ' CG2' ' HB3' ' A' ' 68' ' ' ASP . 0.5 OUTLIER -101.85 -6.8 23.12 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 176.126 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.83 ' O ' ' HB2' ' A' ' 74' ' ' GLU . 0.7 OUTLIER -101.44 24.58 9.43 Favored 'General case' 0 CA--C 1.444 -3.098 0 CA-C-N 111.807 -2.451 . . . . 0.0 115.409 -172.661 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.83 ' HB2' ' O ' ' A' ' 73' ' ' LEU . 35.7 mt-10 76.26 65.62 0.05 Allowed 'General case' 0 C--N 1.303 -1.413 0 CA-C-O 122.903 1.335 . . . . 0.0 111.35 174.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.845 ' CG ' ' HA ' ' A' ' 71' ' ' LYS . 90.1 mtp -39.58 -179.31 0.0 OUTLIER 'General case' 0 C--N 1.267 -2.984 0 CA-C-N 111.812 -2.449 . . . . 0.0 116.201 171.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.513 ' HA ' HD12 ' A' ' 15' ' ' ILE . 14.9 pt-20 -71.74 -178.05 2.14 Favored 'General case' 0 CA--C 1.486 -1.508 0 C-N-CA 124.812 1.245 . . . . 0.0 113.13 -156.488 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -35.34 99.76 0.02 OUTLIER 'General case' 0 CA--C 1.506 -0.74 0 O-C-N 124.862 1.351 . . . . 0.0 113.932 -168.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 14.0 t70 82.42 33.23 0.08 Allowed 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 112.181 -2.281 . . . . 0.0 112.566 171.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -70.44 178.9 2.71 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 119.828 -0.749 . . . . 0.0 109.57 172.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 29.3 m -110.92 151.02 13.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -172.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.453 ' CG1' ' HG2' ' A' ' 74' ' ' GLU . 1.3 mm -138.87 145.93 26.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.017 -0.992 . . . . 0.0 111.674 -178.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -112.16 138.8 48.34 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 116.114 -0.493 . . . . 0.0 109.83 178.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.451 ' HB ' ' HA2' ' A' ' 21' ' ' GLY . 78.3 t -125.83 132.8 70.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 CA-C-O 121.063 0.459 . . . . 0.0 111.092 179.54 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.613 ' CE1' HD22 ' A' ' 58' ' ' LEU . 70.7 m-85 -98.84 140.88 32.35 Favored 'General case' 0 N--CA 1.418 -2.056 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 174.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -68.15 127.12 31.75 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 121.806 0.812 . . . . 0.0 112.152 -164.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.491 ' HG3' HG22 ' A' ' 50' ' ' VAL . 13.2 pm0 -64.54 157.44 26.82 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 113.84 -1.527 . . . . 0.0 113.029 -175.262 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 57.9 tp60 -66.23 -45.22 81.42 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.999 -1.001 . . . . 0.0 112.928 -174.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 93.4 mt -105.89 4.14 29.32 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 116.13 -0.487 . . . . 0.0 112.292 -174.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -121.99 -144.49 6.82 Favored Glycine 0 C--N 1.31 -0.873 0 C-N-CA 120.382 -0.914 . . . . 0.0 111.858 -178.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.494 0 CA-C-O 118.461 -1.188 . . . . 0.0 111.709 -179.796 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.4 tpp . . . . . 0 N--CA 1.476 0.843 0 CA-C-O 120.526 0.203 . . . . 0.0 111.403 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 51.02 44.69 28.48 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.338 0.655 . . . . 0.0 112.504 177.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.5 t70 53.99 53.31 11.36 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.47 0.653 . . . . 0.0 111.581 -179.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -62.27 -39.81 94.17 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.484 176.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 67.52 36.47 3.76 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.927 178.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -66.04 125.44 25.48 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 175.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.7 mp0 53.53 87.65 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 121.943 0.878 . . . . 0.0 110.771 -173.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -79.14 0.03 29.86 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 114.834 -1.076 . . . . 0.0 111.232 -177.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 123.54 -8.71 8.82 Favored Glycine 0 CA--C 1.498 -0.974 0 N-CA-C 111.476 -0.65 . . . . 0.0 111.476 -178.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -147.1 172.95 12.97 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -100.85 10.9 40.57 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.537 0.684 . . . . 0.0 110.099 -179.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -154.1 159.58 41.56 Favored 'General case' 0 N--CA 1.422 -1.84 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.701 -179.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.434 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 1.3 pm0 -95.31 47.91 1.14 Allowed 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.685 -176.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -123.92 153.36 41.29 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.51 0.672 . . . . 0.0 112.343 -178.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 18.2 pt -126.89 162.89 30.62 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.285 -175.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.403 ' HB2' ' N ' ' A' ' 78' ' ' ASP . 28.3 mtpp -92.27 145.35 24.55 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.048 178.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 31.2 mm -135.02 129.8 51.26 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 CA-C-O 120.856 0.36 . . . . 0.0 111.305 175.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 22.3 mtmt -100.34 108.13 20.09 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 177.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.637 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 77.5 t -81.69 117.76 28.25 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 177.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 59.4 t -112.29 118.78 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 CA-C-O 121.189 0.519 . . . . 0.0 110.571 -178.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -86.89 168.24 39.11 Favored Glycine 0 N--CA 1.436 -1.344 0 C-N-CA 120.494 -0.86 . . . . 0.0 111.44 177.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.441 ' HG2' ' O ' ' A' ' 83' ' ' VAL . 87.7 mm-40 -70.87 -20.29 62.54 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.566 0.698 . . . . 0.0 111.498 -178.134 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -84.46 13.84 5.09 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.354 178.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.9 m 67.18 28.73 8.06 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.083 -178.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -95.58 103.28 15.15 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.063 -179.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.637 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 35.4 tt0 -104.03 135.44 45.53 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.03 179.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.2 p -135.64 142.38 39.52 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.389 178.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 27.9 m170 -102.08 117.61 35.17 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 121.252 0.548 . . . . 0.0 112.285 -175.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.427 ' HZ ' ' CD ' ' A' ' 47' ' ' ARG . 81.0 m-85 -116.33 146.87 42.1 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.49 175.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 49.5 ttp180 -104.45 123.02 46.72 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 174.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 33.4 m -133.43 174.34 13.37 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.374 -175.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.434 ' HG3' ' O ' ' A' ' 13' ' ' GLU . 22.4 ttpp -88.41 157.7 18.6 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -178.298 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.508 ' O ' ' HB3' ' A' ' 70' ' ' PRO . 90.8 m-85 -52.3 -41.22 62.74 Favored 'General case' 0 C--O 1.224 -0.268 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 175.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -104.97 32.31 7.64 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.954 -178.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.453 HG22 ' HB2' ' A' ' 39' ' ' LYS . 1.1 m -67.76 134.57 51.25 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 121.28 0.562 . . . . 0.0 111.913 178.438 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.51 ' HB3' ' HA ' ' A' ' 66' ' ' ASP . 69.9 m -91.26 156.31 17.91 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.528 -179.688 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 24.9 ptt? -45.67 -35.75 4.38 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -178.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.69 -37.74 85.22 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -176.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.453 ' HB2' HG22 ' A' ' 35' ' ' THR . 76.0 mmtt -59.99 -39.87 87.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.778 0.323 . . . . 0.0 110.205 -175.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.572 HD12 ' CD1' ' A' ' 57' ' ' PHE . 0.4 OUTLIER -87.58 -42.79 12.47 Favored 'General case' 0 C--O 1.217 -0.629 0 N-CA-C 112.665 0.616 . . . . 0.0 112.665 -177.545 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.438 ' HA ' ' HE1' ' A' ' 57' ' ' PHE . 61.3 mtpt -62.88 -46.24 88.8 Favored 'General case' 0 CA--C 1.493 -1.22 0 CA-C-O 120.574 0.226 . . . . 0.0 111.514 -178.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.514 ' O ' ' HB2' ' A' ' 46' ' ' ASP . 40.5 ttpt -62.81 -41.28 99.24 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.638 176.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 46.9 t -69.08 -52.19 30.97 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.63 -177.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.653 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 40.3 t80 -64.4 -47.83 77.73 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-O 120.694 0.283 . . . . 0.0 110.935 -178.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.429 ' CB ' ' HA ' ' A' ' 52' ' ' VAL . . . -60.13 -33.68 72.48 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.397 0.617 . . . . 0.0 109.968 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.514 ' HB2' ' O ' ' A' ' 42' ' ' LYS . 20.4 t70 -64.02 -47.15 81.36 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.214 -178.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.653 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 7.8 ptm180 -69.76 -29.25 66.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.392 -177.163 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.54 HG23 ' O ' ' A' ' 44' ' ' TYR . 7.6 t -88.44 -12.75 42.23 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.965 0.412 . . . . 0.0 110.425 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 69.76 31.58 70.34 Favored Glycine 0 CA--C 1.505 -0.558 0 C-N-CA 121.003 -0.618 . . . . 0.0 111.906 179.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 87' ' ' GLN . 0.5 OUTLIER -115.2 175.12 2.73 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 CA-C-O 120.435 0.16 . . . . 0.0 110.605 -176.064 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.443 ' HB1' ' HB2' ' A' ' 54' ' ' SER . . . -59.16 125.64 24.45 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.912 179.021 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.429 ' HA ' ' CB ' ' A' ' 45' ' ' ALA . 70.2 t -67.1 -44.14 88.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.284 0.564 . . . . 0.0 110.253 178.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -66.16 -34.23 77.57 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.847 -178.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.443 ' HB2' ' HB1' ' A' ' 51' ' ' ALA . 59.2 m -84.98 -13.83 49.4 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.885 -175.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.495 HD23 ' HB3' ' A' ' 87' ' ' GLN . 2.7 tm? -92.98 123.2 36.06 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 179.01 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.416 ' HG3' ' C ' ' A' ' 55' ' ' LEU . 20.4 mtt180 -135.74 146.09 47.3 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.117 -170.091 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.572 ' CD1' HD12 ' A' ' 40' ' ' LEU . 95.2 m-85 -119.97 148.11 43.94 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.965 -179.329 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.3 mp -129.07 148.31 51.01 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.517 176.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.655 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 18.0 t80 -121.88 120.81 35.59 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 177.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 33.6 t70 61.04 24.05 14.18 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 121.517 0.675 . . . . 0.0 110.707 179.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 87.92 8.38 72.77 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.846 179.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.655 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 6.0 ppt_? -120.44 152.59 37.77 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 120.356 -0.538 . . . . 0.0 111.274 178.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 18.0 mmm180 -65.3 133.95 52.54 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.458 -176.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 87.0 mt -85.18 129.37 37.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 173.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -109.96 162.23 14.72 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.25 0.547 . . . . 0.0 111.034 -172.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.51 ' HA ' ' HB3' ' A' ' 36' ' ' SER . 10.9 p-10 -83.47 -7.67 59.5 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.178 0.513 . . . . 0.0 109.688 174.048 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -102.81 -13.02 17.17 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 115.361 -0.836 . . . . 0.0 112.324 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.417 ' OD2' HD21 ' A' ' 73' ' ' LEU . 35.9 p30 -71.62 167.08 20.55 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 113.034 0.754 . . . . 0.0 113.034 -174.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.464 ' HB ' ' HD2' ' A' ' 70' ' ' PRO . 53.0 p -120.59 160.23 45.03 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.012 -176.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.508 ' HB3' ' O ' ' A' ' 33' ' ' TYR . 12.7 Cg_endo -56.84 -31.34 88.52 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.125 2.55 . . . . 0.0 113.701 -177.129 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.422 ' HE2' ' HB3' ' A' ' 71' ' ' LYS . 2.8 ptpt -70.18 -48.77 55.77 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.645 0.259 . . . . 0.0 111.066 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.0 t -70.87 -27.87 64.14 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 121.007 0.432 . . . . 0.0 109.928 178.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.485 ' HB3' ' HG3' ' A' ' 75' ' ' MET . 74.9 mt -70.84 -27.42 63.84 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 174.286 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 53.84 29.38 9.67 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.223 176.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.485 ' HG3' ' HB3' ' A' ' 73' ' ' LEU . 88.2 mtp -81.9 150.85 27.55 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.411 -177.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -146.73 178.65 8.15 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 177.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -60.58 123.49 17.55 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.729 0.775 . . . . 0.0 112.224 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.403 ' N ' ' HB2' ' A' ' 16' ' ' LYS . 15.4 t70 64.8 33.93 9.8 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 113.865 -1.516 . . . . 0.0 111.033 176.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -76.98 177.84 7.43 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 175.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.0 m -114.43 148.6 17.12 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 CA-C-O 121.742 0.782 . . . . 0.0 112.382 -174.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.1 mp -125.75 136.74 59.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 CA-C-N 114.508 -1.224 . . . . 0.0 108.232 177.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -99.97 139.4 35.69 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.143 0.497 . . . . 0.0 110.892 -176.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.525 HG23 ' CD2' ' A' ' 57' ' ' PHE . 86.6 t -123.36 130.45 74.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.114 178.294 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -99.28 149.07 23.5 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 174.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -69.31 107.26 3.2 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 121.553 0.692 . . . . 0.0 111.017 -171.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.486 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 1.3 mm-40 176.04 114.65 0.02 OUTLIER 'General case' 0 CA--C 1.476 -1.901 0 C-N-CA 125.984 1.714 . . . . 0.0 110.966 -174.198 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.582 ' O ' HG23 ' A' ' 50' ' ' VAL . 27.8 pt20 -157.18 13.35 0.24 Allowed 'General case' 0 N--CA 1.384 -3.768 0 CA-C-N 113.425 -1.716 . . . . 0.0 108.337 176.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 52.3 tp 90.44 -7.21 0.32 Allowed 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 112.857 -1.974 . . . . 0.0 107.624 -170.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -60.78 -41.39 99.09 Favored Glycine 0 N--CA 1.441 -0.989 0 CA-C-N 114.416 -1.265 . . . . 0.0 111.656 174.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.895 0 CA-C-O 118.227 -1.318 . . . . 0.0 111.449 178.584 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.9 ttm . . . . . 0 N--CA 1.472 0.672 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.84 102.77 10.24 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 177.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -83.98 -172.91 4.42 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.551 -178.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -60.55 -38.44 84.52 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.098 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 62.44 29.74 17.18 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.198 0.523 . . . . 0.0 110.535 -178.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -152.4 157.94 41.96 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.45 -179.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -124.45 151.38 44.61 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.06 -37.95 86.92 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.786 0.327 . . . . 0.0 110.94 -178.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 82.05 19.06 65.87 Favored Glycine 0 CA--C 1.5 -0.903 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 -177.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -81.96 -178.54 7.04 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 114.524 -0.838 . . . . 0.0 109.804 -178.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 56.32 44.51 24.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.824 0.821 . . . . 0.0 110.158 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.7 -37.18 80.79 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.338 -1.301 . . . . 0.0 111.735 -178.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -86.59 26.64 1.06 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.644 0.735 . . . . 0.0 110.824 -179.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -125.32 168.67 13.2 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 115.076 -0.965 . . . . 0.0 111.072 -177.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.55 HD11 ' O ' ' A' ' 75' ' ' MET . 11.7 pt -109.05 163.01 6.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-O 121.49 0.662 . . . . 0.0 111.369 -173.107 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.527 ' HD3' ' OD2' ' A' ' 77' ' ' ASP . 42.5 mtpt -92.1 147.67 22.77 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.727 -178.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.56 HG13 ' HB3' ' A' ' 74' ' ' GLU . 8.4 mm -139.5 139.34 38.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.613 175.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.5 mtmt -101.92 105.25 16.03 Favored 'General case' 0 N--CA 1.431 -1.388 0 C-N-CA 120.105 -0.638 . . . . 0.0 109.638 177.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.622 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 76.0 t -80.71 114.06 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 176.347 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 59.2 t -109.34 118.65 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.013 0 CA-C-O 121.154 0.502 . . . . 0.0 110.482 -178.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -84.62 173.34 49.35 Favored Glycine 0 N--CA 1.436 -1.318 0 C-N-CA 120.321 -0.942 . . . . 0.0 111.013 176.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 86.7 mm-40 -73.36 -19.18 61.07 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.368 0.604 . . . . 0.0 111.83 -176.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -85.5 12.53 8.33 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.161 176.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 51.0 m 67.3 27.13 8.36 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.063 -177.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -89.31 103.4 16.03 Favored 'General case' 0 CA--C 1.495 -1.14 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.876 179.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.622 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 36.3 tt0 -104.89 133.44 49.69 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.978 -177.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.3 p -136.57 141.9 39.73 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.466 178.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 63.5 m170 -95.37 119.04 33.19 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 121.405 0.622 . . . . 0.0 111.429 -176.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -109.51 150.74 27.69 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.508 175.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 17.1 tpp180 -103.36 118.09 35.97 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 176.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.548 ' O ' HG12 ' A' ' 15' ' ' ILE . 34.6 m -136.75 173.13 14.08 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.715 -175.381 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -90.13 156.76 18.12 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -55.49 -38.86 69.71 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 121.327 0.584 . . . . 0.0 109.518 175.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -104.45 33.69 6.37 Favored Glycine 0 N--CA 1.44 -1.037 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.395 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.549 ' O ' HD11 ' A' ' 73' ' ' LEU . 0.9 OUTLIER -63.77 131.7 48.67 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-O 121.695 0.759 . . . . 0.0 111.833 179.568 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 69.9 m -81.15 151.88 28.03 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.254 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.666 ' SD ' ' HA ' ' A' ' 65' ' ' ASN . 27.3 ptt? -48.34 -33.5 9.07 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -178.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.52 -36.53 82.87 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 112.203 0.445 . . . . 0.0 112.203 -178.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.428 ' HB2' HG22 ' A' ' 35' ' ' THR . 75.8 mmtt -60.74 -41.19 94.87 Favored 'General case' 0 C--O 1.217 -0.622 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.822 -174.416 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.493 HD13 ' CG ' ' A' ' 57' ' ' PHE . 0.9 OUTLIER -87.71 -45.14 10.63 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -178.2 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.409 ' HA ' ' HE1' ' A' ' 57' ' ' PHE . 61.1 mtpt -62.65 -46.09 89.84 Favored 'General case' 0 CA--C 1.494 -1.175 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -177.055 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 41.7 ttmt -62.76 -41.49 99.25 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 121.231 0.539 . . . . 0.0 109.593 176.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 58.8 m -69.16 -51.91 33.4 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -177.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.582 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 43.4 t80 -66.41 -47.51 73.04 Favored 'General case' 0 CA--C 1.505 -0.776 0 N-CA-C 111.779 0.289 . . . . 0.0 111.779 -179.118 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.401 ' CB ' ' HA ' ' A' ' 52' ' ' VAL . . . -59.98 -35.47 75.07 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.318 0.58 . . . . 0.0 110.347 -178.419 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -66.15 -47.1 75.16 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.517 -178.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.582 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 10.6 ptm85 -68.91 -25.72 64.73 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.242 -176.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.471 HG21 ' O ' ' A' ' 44' ' ' TYR . 10.2 t -93.04 -9.9 38.08 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 120.956 0.408 . . . . 0.0 111.123 -179.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.6 40.14 59.6 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.975 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.507 HG23 ' HG3' ' A' ' 86' ' ' GLU . 2.7 p -126.4 162.46 30.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.47 ' HB3' ' OG ' ' A' ' 54' ' ' SER . . . -59.81 130.67 47.92 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 178.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.401 ' HA ' ' CB ' ' A' ' 45' ' ' ALA . 74.8 t -61.63 -44.64 99.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.694 -177.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -66.37 -33.21 75.2 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.673 -178.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.47 ' OG ' ' HB3' ' A' ' 51' ' ' ALA . 90.5 p -76.72 -14.45 59.94 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.68 -178.423 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.474 HD12 ' N ' ' A' ' 56' ' ' ARG . 1.0 OUTLIER -95.89 136.97 35.62 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -179.509 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.474 ' N ' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -140.99 145.48 36.01 Favored 'General case' 0 N--CA 1.436 -1.129 0 C-N-CA 119.853 -0.739 . . . . 0.0 111.509 -176.798 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.493 ' CG ' HD13 ' A' ' 40' ' ' LEU . 92.8 m-85 -118.84 140.96 49.11 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 114.922 -1.035 . . . . 0.0 109.267 176.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.58 HD23 ' CE1' ' A' ' 84' ' ' TYR . 9.2 mp -126.26 145.54 50.37 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.856 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.693 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 0.4 OUTLIER -128.84 117.38 20.96 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 177.157 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 68.13 24.14 7.77 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.387 0.613 . . . . 0.0 110.987 -175.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.1 14.08 77.77 Favored Glycine 0 N--CA 1.438 -1.185 0 CA-C-N 115.414 -0.812 . . . . 0.0 113.001 176.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.693 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.1 OUTLIER -124.2 146.45 48.69 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.232 179.462 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 10.9 mpt_? -67.6 130.1 41.97 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.836 -176.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 83.9 mt -80.09 125.86 39.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.384 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.666 ' HA ' ' SD ' ' A' ' 37' ' ' MET . 20.7 m120 -116.69 171.18 8.04 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 123.343 0.657 . . . . 0.0 109.489 177.255 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -78.8 -8.76 59.07 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -175.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -114.97 16.62 17.14 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 120.229 -0.588 . . . . 0.0 112.162 -178.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.571 ' HB2' HD22 ' A' ' 73' ' ' LEU . 72.0 m-20 -84.22 172.06 12.22 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.582 ' O ' ' HG ' ' A' ' 73' ' ' LEU . 69.2 p -82.91 156.13 67.5 Favored Pre-proline 0 CA--C 1.509 -0.599 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -173.362 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.538 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 17.4 Cg_endo -54.84 -18.68 16.93 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 123.131 2.554 . . . . 0.0 112.61 -176.427 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.856 ' HA ' ' CG ' ' A' ' 75' ' ' MET . 2.1 tmmm? -70.5 -40.54 73.51 Favored 'General case' 0 N--CA 1.413 -2.312 0 C-N-CA 122.888 0.475 . . . . 0.0 111.812 -179.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.464 ' OG1' ' HD2' ' A' ' 62' ' ' ARG . 1.4 t -96.72 -6.84 35.45 Favored 'General case' 0 CA--C 1.477 -1.839 0 CA-C-O 123.34 1.543 . . . . 0.0 107.021 -178.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.826 ' O ' ' HB2' ' A' ' 74' ' ' GLU . 0.3 OUTLIER -96.53 24.97 5.42 Favored 'General case' 0 CA--C 1.432 -3.587 0 CA-C-N 111.514 -2.585 . . . . 0.0 114.407 -176.761 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.826 ' HB2' ' O ' ' A' ' 73' ' ' LEU . 32.7 mt-10 76.23 66.04 0.06 Allowed 'General case' 0 C--N 1.305 -1.327 0 O-C-N 124.747 1.28 . . . . 0.0 111.66 173.067 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.856 ' CG ' ' HA ' ' A' ' 71' ' ' LYS . 76.4 mtm -39.84 -179.32 0.0 OUTLIER 'General case' 0 C--N 1.269 -2.897 0 CA-C-N 112.418 -2.174 . . . . 0.0 116.764 172.46 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.483 ' HA ' HD11 ' A' ' 15' ' ' ILE . 13.6 pt-20 -72.18 178.75 3.68 Favored 'General case' 0 CA--C 1.478 -1.819 0 C-N-CA 124.369 1.068 . . . . 0.0 112.295 -157.052 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.527 ' OD2' ' HD3' ' A' ' 16' ' ' LYS . 7.0 t70 -25.67 97.74 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.705 0 O-C-N 125.392 1.683 . . . . 0.0 114.269 -171.023 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.9 t70 80.23 33.04 0.17 Allowed 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 112.05 -2.341 . . . . 0.0 113.076 168.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -72.04 178.27 3.88 Favored 'General case' 0 C--N 1.36 1.056 0 C-N-CA 119.193 -1.003 . . . . 0.0 109.489 171.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 29.8 m -107.76 152.19 9.56 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -170.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.414 HD12 ' HA ' ' A' ' 81' ' ' ILE . 4.7 mm -135.91 138.88 46.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.499 -179.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -103.34 140.41 37.46 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.198 -179.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 95.6 t -125.69 133.72 68.41 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-O 120.975 0.417 . . . . 0.0 111.227 178.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.58 ' CE1' HD23 ' A' ' 58' ' ' LEU . 79.0 m-85 -107.59 159.3 16.55 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.604 176.207 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 37.5 tp60 -68.62 144.05 54.62 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.19 0.519 . . . . 0.0 111.649 -170.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.507 ' HG3' HG23 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -95.87 161.41 14.02 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.547 -175.589 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.446 ' H ' ' HB2' ' A' ' 54' ' ' SER . 58.3 tp60 -66.75 -44.39 81.56 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.379 -0.828 . . . . 0.0 113.232 -177.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -85.98 -7.06 58.92 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.881 0.372 . . . . 0.0 111.958 -175.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.437 ' H ' ' HG2' ' A' ' 86' ' ' GLU . . . -101.68 -84.4 1.8 Allowed Glycine 0 N--CA 1.436 -1.352 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 178.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.048 0 CA-C-O 118.692 -1.06 . . . . 0.0 112.481 178.447 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 . . . . . 0 N--CA 1.441 -0.908 0 CA-C-O 120.979 0.419 . . . . 0.0 110.481 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.497 HG12 ' O ' ' A' ' 31' ' ' VAL . 11.9 pt -116.93 163.33 14.18 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.662 -176.086 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.465 ' HE2' ' HB3' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -96.31 141.54 29.53 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.2 179.644 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.508 HD12 ' CG2' ' A' ' 31' ' ' VAL . 83.7 mt -140.35 137.62 36.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.504 175.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 13.8 mtmm -102.02 106.32 17.2 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.058 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.608 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 92.8 t -82.45 119.87 32.82 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.62 178.428 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 59.1 t -110.81 118.77 58.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-O 120.91 0.386 . . . . 0.0 110.025 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.586 ' HA2' ' HB ' ' A' ' 83' ' ' VAL . . . -90.15 169.41 34.82 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.346 -0.93 . . . . 0.0 112.549 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.472 ' HG2' ' O ' ' A' ' 83' ' ' VAL . 89.8 mm-40 -69.16 -24.38 64.07 Favored 'General case' 0 CA--C 1.504 -0.799 0 CA-C-O 121.39 0.614 . . . . 0.0 110.689 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -69.85 1.6 4.25 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.644 175.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.428 ' H ' ' C ' ' A' ' 22' ' ' GLN . 47.4 m 69.49 27.82 4.8 Favored 'General case' 0 C--N 1.351 0.656 0 CA-C-O 121.994 0.902 . . . . 0.0 109.134 -176.461 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -98.86 107.1 19.45 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.354 -1.294 . . . . 0.0 111.049 -178.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.608 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 33.7 tt0 -99.3 133.27 43.83 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.418 177.728 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.6 p -133.8 139.78 47.9 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-N 115.91 -0.587 . . . . 0.0 109.88 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.415 ' HB3' ' HE3' ' A' ' 16' ' ' LYS . 19.0 m170 -96.48 113.28 24.85 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.345 0.593 . . . . 0.0 111.582 -176.502 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -111.99 150.4 30.63 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.473 179.044 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.485 ' HD3' ' O ' ' A' ' 15' ' ' ILE . 22.4 tpp180 -107.35 116.95 32.84 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 175.346 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.508 ' CG2' HD12 ' A' ' 17' ' ' ILE . 35.0 m -138.66 169.02 18.53 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.304 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -178.414 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 53.9 tttp -89.33 160.1 17.03 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 -177.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -55.38 -38.29 68.66 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.016 0.436 . . . . 0.0 110.126 175.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -102.35 22.65 36.94 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.931 -0.577 . . . . 0.0 113.051 -178.096 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -62.39 142.36 57.87 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-O 121.323 0.582 . . . . 0.0 112.001 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 69.2 m -91.14 153.47 20.03 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.604 -179.175 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.407 ' HA ' HD21 ' A' ' 40' ' ' LEU . 27.3 ptt? -49.96 -33.19 16.92 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 112.897 0.702 . . . . 0.0 112.897 -177.194 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.46 -36.78 81.37 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -178.103 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -60.13 -40.04 88.41 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.91 0.386 . . . . 0.0 110.766 -176.225 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.567 HD12 ' CD2' ' A' ' 57' ' ' PHE . 0.2 OUTLIER -86.62 -45.49 10.98 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.928 -177.993 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.554 ' HG2' ' CD1' ' A' ' 57' ' ' PHE . 63.2 mtpt -63.83 -45.44 89.54 Favored 'General case' 0 CA--C 1.498 -1.024 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.639 -177.054 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -60.55 -44.37 96.19 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 176.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 39.5 t -64.96 -50.22 67.24 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.775 -176.315 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.554 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 48.8 t80 -68.18 -45.63 72.91 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.517 -179.073 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.486 ' HB1' ' O ' ' A' ' 50' ' ' VAL . . . -59.24 -36.27 75.15 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.413 0.625 . . . . 0.0 109.725 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -67.01 -47.01 72.74 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.413 -178.339 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.554 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 10.5 ptm85 -66.3 -24.74 66.6 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.334 -178.487 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.485 HG22 ' O ' ' A' ' 44' ' ' TYR . 14.6 t -99.36 -5.36 29.73 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.833 -178.212 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 69.3 30.94 71.38 Favored Glycine 0 C--N 1.336 0.53 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.762 178.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.486 ' O ' ' HB1' ' A' ' 45' ' ' ALA . 83.2 t -118.75 150.19 21.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 C-N-CA 122.445 0.298 . . . . 0.0 110.803 -177.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.497 ' HB3' ' OG ' ' A' ' 54' ' ' SER . . . -51.34 134.72 27.89 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.296 176.059 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 74.7 t -61.63 -43.28 96.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.602 -178.356 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -71.82 -15.93 62.16 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.703 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.52 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 73.6 m -81.55 -12.62 58.73 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.645 178.302 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.495 ' C ' ' HD3' ' A' ' 56' ' ' ARG . 2.6 mm? -94.37 134.84 36.44 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.112 176.526 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.495 ' HD3' ' C ' ' A' ' 55' ' ' LEU . 0.7 OUTLIER -126.07 114.42 18.39 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.971 -177.658 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.567 ' CD2' HD12 ' A' ' 40' ' ' LEU . 20.0 m-85 -106.12 132.27 52.4 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.172 0.511 . . . . 0.0 111.856 -178.577 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.564 ' HG ' ' HA ' ' A' ' 63' ' ' ARG . 6.6 mp -129.3 139.98 51.58 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.701 178.594 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.724 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 88.9 t80 -111.14 121.89 46.46 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 177.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 19.4 t70 55.19 23.56 5.53 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 121.484 0.659 . . . . 0.0 111.544 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 94.85 8.46 59.23 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.793 -0.717 . . . . 0.0 113.16 177.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.724 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.1 OUTLIER -124.79 141.44 52.11 Favored 'General case' 0 CA--C 1.505 -0.758 0 CA-C-O 121.147 0.498 . . . . 0.0 109.759 176.456 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.564 ' HA ' ' HG ' ' A' ' 58' ' ' LEU . 29.5 ptt180 -68.23 139.38 56.03 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -174.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.439 HD12 ' HB3' ' A' ' 57' ' ' PHE . 83.7 mt -88.97 122.42 40.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-N 114.548 -1.206 . . . . 0.0 109.886 -178.764 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 -109.01 163.99 12.82 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.68 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -81.39 -7.7 59.62 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.142 0.496 . . . . 0.0 109.767 177.263 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -94.51 -19.25 20.7 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.164 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.514 ' CG ' HH12 ' A' ' 62' ' ' ARG . 39.3 m-20 -62.73 138.19 58.45 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-O 121.179 0.514 . . . . 0.0 111.746 -177.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.442 ' HB ' ' HD2' ' A' ' 70' ' ' PRO . 82.7 p -91.26 162.71 31.48 Favored Pre-proline 0 C--N 1.312 -1.039 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.195 -179.009 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.442 ' HD2' ' HB ' ' A' ' 69' ' ' THR . 17.9 Cg_endo -59.79 -25.99 80.9 Favored 'Trans proline' 0 CA--C 1.535 0.542 0 C-N-CA 122.107 1.871 . . . . 0.0 111.6 176.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.441 ' N ' ' HE2' ' A' ' 71' ' ' LYS . 0.2 OUTLIER -63.7 -47.01 82.87 Favored 'General case' 0 CA--C 1.483 -1.629 0 CA-C-O 121.96 0.886 . . . . 0.0 110.164 178.69 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.7 t -84.32 -27.14 27.98 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 113.975 -1.466 . . . . 0.0 112.09 -174.569 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 96.4 mt -82.77 -22.74 34.19 Favored 'General case' 0 C--O 1.216 -0.702 0 C-N-CA 120.289 -0.564 . . . . 0.0 110.798 177.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 38.08 34.27 0.06 Allowed 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 124.833 1.253 . . . . 0.0 113.616 178.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 64.9 mtt -75.35 150.57 38.39 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -152.54 -174.03 4.76 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -178.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -48.94 118.06 2.41 Favored 'General case' 0 C--N 1.32 -0.707 0 O-C-N 123.885 0.74 . . . . 0.0 112.763 -176.238 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.5 t70 58.42 34.55 24.07 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.23 -1.35 . . . . 0.0 111.479 173.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -69.89 178.13 2.81 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.3 m -114.77 148.77 17.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 CA-C-O 121.594 0.711 . . . . 0.0 112.092 -174.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.483 HD12 HG21 ' A' ' 17' ' ' ILE . 2.6 mt -131.85 137.79 54.17 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.1 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -105.1 133.88 49.13 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -178.303 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.586 ' HB ' ' HA2' ' A' ' 21' ' ' GLY . 92.6 t -124.08 136.43 60.38 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.874 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.554 ' CD1' HD13 ' A' ' 58' ' ' LEU . 69.8 m-85 -96.78 164.11 12.7 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.792 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 58.5 tp60 -67.24 128.7 37.39 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.304 0.573 . . . . 0.0 110.581 -171.183 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.52 ' HA ' ' O ' ' A' ' 54' ' ' SER . 13.7 pm0 -64.92 151.14 46.49 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 114.935 -1.029 . . . . 0.0 112.256 -177.002 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 61.8 tp60 -63.42 -50.91 67.95 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.366 -174.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 88.3 mt . . . . . 0 C--N 1.322 -0.609 0 CA-C-N 115.67 -0.696 . . . . 0.0 112.798 -179.873 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 . . . . . 0 N--CA 1.442 -0.869 0 CA-C-O 121.402 0.62 . . . . 0.0 112.466 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.493 ' O ' ' HD2' ' A' ' 30' ' ' ARG . 13.9 pt -124.25 164.17 22.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 114.535 -1.211 . . . . 0.0 108.035 -178.595 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.441 ' HB2' HH11 ' A' ' 30' ' ' ARG . 17.7 ttpp -99.69 143.41 29.95 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 119.997 -0.681 . . . . 0.0 110.202 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.562 HG21 HD12 ' A' ' 81' ' ' ILE . 74.3 mt -135.75 134.42 51.32 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 CA-C-O 120.87 0.367 . . . . 0.0 111.113 175.337 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 18.4 mtmt -96.04 107.18 19.45 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.655 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 71.4 t -81.29 117.38 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 177.719 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.3 t -110.75 118.11 56.5 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -82.52 178.53 53.33 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 120.5 -0.857 . . . . 0.0 111.747 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.511 ' C ' ' H ' ' A' ' 24' ' ' SER . 97.9 mt-30 -66.18 -37.02 84.61 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -178.739 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -79.29 22.19 0.44 Allowed 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.618 0.723 . . . . 0.0 109.294 177.277 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.511 ' H ' ' C ' ' A' ' 22' ' ' GLN . 85.0 p 58.97 30.43 20.22 Favored 'General case' 0 CA--C 1.512 -0.517 0 C-N-CA 124.807 1.243 . . . . 0.0 111.201 -179.093 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -83.6 105.68 14.72 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 114.836 -1.075 . . . . 0.0 109.866 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.655 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 36.5 tt0 -103.67 130.88 51.21 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.699 -177.184 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.5 p -135.79 140.75 43.7 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.091 177.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 18.4 m170 -96.24 117.13 30.17 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 121.525 0.679 . . . . 0.0 111.935 -175.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.406 ' HZ ' ' CD ' ' A' ' 47' ' ' ARG . 45.6 m-85 -109.6 149.21 30.0 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.604 -1.18 . . . . 0.0 111.039 177.018 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.493 ' HD2' ' O ' ' A' ' 15' ' ' ILE . 22.8 tpt180 -108.98 117.02 33.11 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 177.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.443 ' O ' HG12 ' A' ' 15' ' ' ILE . 33.0 m -137.69 170.5 17.33 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.35 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.008 -177.356 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.432 ' O ' ' HB ' ' A' ' 35' ' ' THR . 38.5 ttmt -89.83 156.29 18.59 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 110.453 -0.203 . . . . 0.0 110.453 -177.619 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -56.4 -38.91 72.16 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 121.142 0.496 . . . . 0.0 109.691 174.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -98.06 24.76 30.41 Favored Glycine 0 N--CA 1.443 -0.868 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.452 -178.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.48 HG23 ' HB2' ' A' ' 39' ' ' LYS . 1.0 OUTLIER -65.83 140.51 58.39 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-O 121.426 0.631 . . . . 0.0 112.193 179.232 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 66.5 m -91.99 157.19 16.94 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.975 179.071 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.694 ' SD ' ' HA ' ' A' ' 65' ' ' ASN . 26.4 ptt? -51.47 -31.88 25.03 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -176.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.75 -38.06 86.6 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.198 -0.456 . . . . 0.0 112.097 -177.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.48 ' HB2' HG23 ' A' ' 35' ' ' THR . 75.5 mmtt -60.66 -38.25 84.25 Favored 'General case' 0 C--O 1.217 -0.645 0 CA-C-O 120.672 0.273 . . . . 0.0 111.183 -175.228 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.514 HD12 ' CG ' ' A' ' 57' ' ' PHE . 0.2 OUTLIER -86.59 -47.32 9.31 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.741 -178.528 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.441 ' HA ' ' HE1' ' A' ' 57' ' ' PHE . 94.3 mttt -62.95 -47.2 84.23 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.99 -177.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -64.27 -38.74 92.11 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.014 178.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 47.5 t -69.07 -53.55 19.75 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.68 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.705 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 45.3 t80 -65.89 -47.22 75.56 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-N 116.227 -0.442 . . . . 0.0 112.18 -178.214 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.75 -35.68 75.09 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.38 0.609 . . . . 0.0 109.895 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -65.99 -47.15 75.48 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.725 -178.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.705 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 8.7 ptm180 -65.9 -27.94 68.58 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.065 -178.252 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.517 HG22 ' O ' ' A' ' 44' ' ' TYR . 9.3 t -93.19 -6.74 47.07 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.072 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 69.67 33.16 71.17 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.902 178.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.421 HG22 ' H ' ' A' ' 51' ' ' ALA . 1.6 p -117.7 167.29 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 CA-C-O 120.693 0.282 . . . . 0.0 110.827 -177.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.543 ' HB3' ' OG ' ' A' ' 54' ' ' SER . . . -61.48 128.22 35.25 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.389 178.631 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 77.2 t -64.24 -43.99 97.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.777 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -67.47 -29.67 69.18 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.708 -177.527 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.543 ' OG ' ' HB3' ' A' ' 51' ' ' ALA . 88.5 p -82.76 -17.16 45.18 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 119.891 -0.723 . . . . 0.0 111.135 -179.056 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.503 HD13 ' N ' ' A' ' 56' ' ' ARG . 0.9 OUTLIER -92.59 135.2 34.28 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 -177.183 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.509 ' NH1' ' HA ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -140.96 149.58 42.0 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-O 121.486 0.66 . . . . 0.0 111.693 -177.106 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.514 ' CG ' HD12 ' A' ' 40' ' ' LEU . 58.0 m-85 -117.94 138.8 51.92 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 114.554 -1.203 . . . . 0.0 109.824 179.117 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.602 HD22 ' CE1' ' A' ' 84' ' ' TYR . 9.2 mp -125.3 137.95 54.07 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.765 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.782 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 23.1 t80 -105.5 114.48 28.68 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 38.0 t70 53.86 29.29 9.57 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-O 121.697 0.761 . . . . 0.0 111.602 -177.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.416 ' O ' HD23 ' A' ' 58' ' ' LEU . . . 95.07 -4.19 67.54 Favored Glycine 0 C--N 1.313 -0.704 0 CA-C-N 115.859 -0.609 . . . . 0.0 113.408 177.439 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.782 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.1 OUTLIER -106.5 138.88 41.88 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.355 0.598 . . . . 0.0 110.385 178.58 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.507 ' HA ' ' HG ' ' A' ' 58' ' ' LEU . 32.2 mtp-105 -69.01 135.64 51.21 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.882 -174.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 79.3 mt -93.3 121.52 44.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.985 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.694 ' HA ' ' SD ' ' A' ' 37' ' ' MET . 65.0 m-80 -117.31 161.72 19.06 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.486 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -71.75 -13.34 61.68 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.159 0.504 . . . . 0.0 109.826 178.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -76.74 -21.47 55.2 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.65 177.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.415 ' CG ' HH12 ' A' ' 62' ' ' ARG . 66.0 m-20 -71.48 139.9 49.77 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 121.47 0.653 . . . . 0.0 111.444 -179.201 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.545 ' HB ' ' HD2' ' A' ' 70' ' ' PRO . 47.8 p -101.99 163.95 16.75 Favored Pre-proline 0 C--N 1.304 -1.396 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.92 -178.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.545 ' HD2' ' HB ' ' A' ' 69' ' ' THR . 12.7 Cg_endo -56.39 -37.44 97.07 Favored 'Trans proline' 0 C--N 1.357 1.024 0 C-N-CA 122.427 2.085 . . . . 0.0 113.436 -177.018 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.446 ' HD3' ' N ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -74.49 -19.5 60.34 Favored 'General case' 0 C--O 1.221 -0.438 0 CA-C-O 121.057 0.456 . . . . 0.0 112.028 179.277 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.446 ' N ' ' HD3' ' A' ' 71' ' ' LYS . 52.1 m -85.0 -45.17 12.4 Favored 'General case' 0 N--CA 1.408 -2.546 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.966 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 98.9 mt -71.2 -25.25 62.43 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.526 178.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 51.57 30.27 6.33 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.836 177.565 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 20.2 ptp -73.88 162.77 28.74 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.995 0.426 . . . . 0.0 111.464 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -151.56 175.41 12.36 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.724 -177.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -65.9 118.93 10.42 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 121.692 0.758 . . . . 0.0 111.634 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 21.5 t70 70.65 33.91 2.22 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 126.095 1.758 . . . . 0.0 111.587 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -77.86 178.72 7.2 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 176.081 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.1 m -113.36 146.79 17.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-O 121.7 0.762 . . . . 0.0 111.9 -175.054 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.562 HD12 HG21 ' A' ' 17' ' ' ILE . 1.2 mt -134.15 141.99 42.25 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.962 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -107.54 146.53 31.73 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.834 0.349 . . . . 0.0 111.473 -176.246 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.428 ' O ' ' HG3' ' A' ' 22' ' ' GLN . 97.5 t -125.31 132.41 71.13 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.66 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.102 179.278 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.602 ' CE1' HD22 ' A' ' 58' ' ' LEU . 63.6 m-85 -100.62 143.98 30.15 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.766 175.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 58.7 tp60 -69.85 134.64 48.71 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -176.311 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.509 ' HA ' ' NH1' ' A' ' 56' ' ' ARG . 1.3 pp20? -94.3 -155.79 0.47 Allowed 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -171.226 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -82.95 -55.94 4.1 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -171.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.406 HD12 ' H ' ' A' ' 51' ' ' ALA . 85.3 mt . . . . . 0 C--N 1.321 -0.665 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -174.215 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 . . . . . 0 N--CA 1.442 -0.844 0 CA-C-O 120.818 0.342 . . . . 0.0 110.171 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.5 pt -125.39 162.34 28.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.442 -176.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.484 ' HE2' ' HB2' ' A' ' 78' ' ' ASP . 38.1 mtmm -97.42 144.47 27.13 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.963 176.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.669 HG21 HD12 ' A' ' 81' ' ' ILE . 45.2 mm -128.08 129.53 69.52 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.979 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.02 178.565 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 27.5 mtmt -96.67 104.58 16.58 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 174.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.557 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 89.6 t -81.95 111.92 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.863 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 177.208 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.0 t -108.49 117.72 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.414 ' HA2' ' HB ' ' A' ' 83' ' ' VAL . . . -93.84 164.79 26.58 Favored Glycine 0 N--CA 1.435 -1.42 0 C-N-CA 120.489 -0.862 . . . . 0.0 111.449 178.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.455 ' C ' ' H ' ' A' ' 24' ' ' SER . 98.3 mt-30 -67.95 -23.94 65.11 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.374 0.607 . . . . 0.0 110.44 179.525 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -70.87 8.92 0.77 Allowed 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.919 175.109 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.455 ' H ' ' C ' ' A' ' 22' ' ' GLN . 44.5 m 68.96 25.27 6.04 Favored 'General case' 0 C--N 1.348 0.531 0 C-N-CA 123.753 0.821 . . . . 0.0 110.315 -179.352 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 54.0 t-20 -96.03 107.27 19.54 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.946 -178.226 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.557 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 28.7 tt0 -105.46 125.77 51.37 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.426 175.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.2 p -137.65 140.94 40.45 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-O 121.099 0.476 . . . . 0.0 111.126 -179.109 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 62.5 m170 -89.83 118.65 29.58 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.066 -178.354 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -118.43 143.64 46.53 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.296 171.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 52.9 ttp180 -106.44 121.51 44.4 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 121.528 0.68 . . . . 0.0 110.466 177.239 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 33.8 m -136.57 172.58 15.02 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 CA-C-N 114.82 -1.082 . . . . 0.0 108.911 -177.194 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.436 ' O ' ' HB ' ' A' ' 35' ' ' THR . 50.3 tttm -89.55 160.58 16.63 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -179.195 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.409 ' C ' ' HB3' ' A' ' 70' ' ' PRO . 95.7 m-85 -54.08 -41.21 67.97 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.976 0.417 . . . . 0.0 110.228 176.531 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -97.65 22.33 41.38 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.844 -177.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.436 ' HB ' ' O ' ' A' ' 32' ' ' LYS . 0.9 OUTLIER -61.63 143.82 55.48 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-O 121.181 0.515 . . . . 0.0 112.109 179.222 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 65.5 m -91.59 150.72 21.05 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.967 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -49.56 -33.03 13.83 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -177.315 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.88 -37.12 81.08 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.93 -177.089 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -61.32 -40.28 93.61 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.853 0.358 . . . . 0.0 110.646 -175.145 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.514 HD12 ' CD2' ' A' ' 57' ' ' PHE . 0.4 OUTLIER -87.26 -45.28 10.77 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.075 -0.512 . . . . 0.0 112.08 -179.269 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.572 ' HG2' ' CD1' ' A' ' 57' ' ' PHE . 61.4 mtpt -63.01 -45.98 89.8 Favored 'General case' 0 CA--C 1.496 -1.119 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.752 -177.185 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -62.13 -40.96 97.68 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.165 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 48.0 t -66.41 -51.34 57.96 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.168 -0.923 . . . . 0.0 111.326 -178.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.689 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 49.2 t80 -66.64 -45.82 77.78 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.85 -178.158 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.443 ' HB1' ' O ' ' A' ' 50' ' ' VAL . . . -59.25 -36.03 74.75 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.502 0.668 . . . . 0.0 109.757 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -66.49 -46.34 76.62 Favored 'General case' 0 C--N 1.311 -1.109 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.193 -178.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.689 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 11.4 ptm85 -65.39 -26.84 68.17 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.176 -177.494 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.528 HG22 ' O ' ' A' ' 44' ' ' TYR . 10.1 t -95.55 -7.42 37.96 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.222 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.81 32.04 66.98 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.406 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.456 HG13 ' HB3' ' A' ' 88' ' ' LEU . 84.5 t -117.74 150.25 19.9 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 C-N-CA 122.6 0.36 . . . . 0.0 110.859 -177.634 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.443 ' HB3' ' OG ' ' A' ' 54' ' ' SER . . . -52.58 137.05 31.36 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.396 176.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 74.3 t -61.23 -42.97 95.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.14 -179.186 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -67.26 -25.04 65.87 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.118 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.45 ' HB3' ' H ' ' A' ' 87' ' ' GLN . 74.0 m -74.76 -16.03 60.74 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.88 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -96.44 134.13 40.0 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.238 0.542 . . . . 0.0 110.823 177.315 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -132.93 125.29 29.51 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.626 178.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.572 ' CD1' ' HG2' ' A' ' 41' ' ' LYS . 12.3 m-85 -108.44 135.15 50.2 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.966 -179.376 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.58 HD13 ' CD1' ' A' ' 84' ' ' TYR . 6.2 mp -124.05 147.45 47.84 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.98 -178.525 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.652 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 31.2 t80 -128.96 128.83 44.51 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 176.746 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 34.7 t70 59.5 27.18 16.28 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 121.653 0.74 . . . . 0.0 110.4 179.392 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 78.51 17.97 76.69 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.667 178.46 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.652 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -130.87 151.73 50.97 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.91 178.587 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.449 ' HA ' ' HG ' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -68.06 135.64 52.55 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.807 -175.438 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 86.0 mt -88.1 117.47 31.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 177.204 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -107.36 153.85 22.16 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.499 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -68.98 -10.94 60.01 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.873 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -85.78 -19.01 31.38 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.036 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.442 ' CG ' HH12 ' A' ' 62' ' ' ARG . 36.9 m-20 -67.43 148.74 51.17 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -175.274 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.461 ' HB ' ' HD2' ' A' ' 70' ' ' PRO . 31.7 p -96.9 162.29 23.49 Favored Pre-proline 0 N--CA 1.444 -0.755 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.212 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.461 ' HD2' ' HB ' ' A' ' 69' ' ' THR . 19.2 Cg_endo -59.28 -31.51 95.25 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.519 2.146 . . . . 0.0 113.06 -178.503 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.564 ' HG3' ' N ' ' A' ' 72' ' ' THR . 15.2 ptmt -70.46 -38.83 74.51 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -179.017 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.564 ' N ' ' HG3' ' A' ' 71' ' ' LYS . 13.4 t -82.09 -29.82 31.58 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 120.971 0.415 . . . . 0.0 110.437 -177.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 96.1 mt -73.25 -22.2 60.46 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 174.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 52.91 28.75 6.87 Favored 'General case' 0 C--N 1.348 0.509 0 O-C-N 124.037 0.836 . . . . 0.0 112.5 175.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 70.8 mtm -85.23 150.36 24.85 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.113 0.483 . . . . 0.0 111.834 -176.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -151.67 -176.61 5.69 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 176.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.438 ' HA ' ' H ' ' A' ' 16' ' ' LYS . 1.3 m-20 -57.33 119.5 6.55 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -177.287 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.484 ' HB2' ' HE2' ' A' ' 16' ' ' LYS . 18.5 t70 63.22 35.41 12.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 113.972 -1.467 . . . . 0.0 111.082 175.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -76.78 177.66 7.44 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.269 177.082 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 30.9 m -108.96 138.48 35.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 CA-C-O 121.772 0.796 . . . . 0.0 112.455 -174.134 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.669 HD12 HG21 ' A' ' 17' ' ' ILE . 1.6 mt -132.36 134.01 59.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.974 178.238 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -98.18 144.28 27.8 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.245 -174.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.414 ' HB ' ' HA2' ' A' ' 21' ' ' GLY . 84.6 t -129.13 133.98 64.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.993 178.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.58 ' CD1' HD13 ' A' ' 58' ' ' LEU . 57.4 m-85 -98.13 156.71 16.54 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.288 177.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 43.6 tp60 -68.0 133.14 48.53 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.195 0.522 . . . . 0.0 111.097 -171.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.418 ' HB2' HG11 ' A' ' 50' ' ' VAL . 4.2 pm0 -65.6 158.0 28.34 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.434 -0.803 . . . . 0.0 113.12 -174.582 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.45 ' H ' ' HB3' ' A' ' 54' ' ' SER . 82.7 mm-40 -72.53 -48.33 41.11 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.992 -177.542 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.456 ' HB3' HG13 ' A' ' 50' ' ' VAL . 60.5 tp . . . . . 0 C--N 1.312 -1.046 0 CA-C-N 114.708 -1.133 . . . . 0.0 111.758 -177.454 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 . . . . . 0 CA--C 1.5 -0.956 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.3 pt -120.12 162.46 18.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -176.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.499 ' HD2' ' CG ' ' A' ' 78' ' ' ASP . 38.9 ttmt -101.0 143.55 31.01 Favored 'General case' 0 C--N 1.286 -2.172 0 CA-C-O 121.006 0.432 . . . . 0.0 110.733 179.257 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.719 HG21 HD12 ' A' ' 81' ' ' ILE . 41.7 mm -127.58 129.56 70.33 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.783 177.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.5 mtmt -100.1 104.16 15.7 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 176.315 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.723 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 96.7 t -82.41 118.38 30.03 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.52 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.6 t -113.76 118.25 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 CA-C-O 120.927 0.394 . . . . 0.0 109.967 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.414 ' HA2' ' HB ' ' A' ' 83' ' ' VAL . . . -90.86 175.35 40.08 Favored Glycine 0 C--N 1.314 -0.693 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.49 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.498 ' C ' ' H ' ' A' ' 24' ' ' SER . 98.8 mt-30 -64.51 -34.18 77.63 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 121.235 0.541 . . . . 0.0 110.896 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -70.0 8.69 0.68 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.956 176.48 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.498 ' H ' ' C ' ' A' ' 22' ' ' GLN . 49.9 m 65.96 27.88 10.68 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.859 0.838 . . . . 0.0 109.059 -176.253 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -87.06 104.87 16.74 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.468 -177.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.723 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 42.6 tt0 -104.61 131.88 51.51 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.588 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.4 p -138.05 137.83 44.15 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.598 179.159 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 37.7 m170 -97.1 111.18 23.52 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.185 0.516 . . . . 0.0 111.644 -176.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -110.57 149.59 30.16 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.818 176.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 18.4 tpt180 -103.34 121.54 42.96 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.338 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.406 HG22 HG12 ' A' ' 17' ' ' ILE . 30.9 m -134.86 174.27 13.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.35 -177.44 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -88.11 155.28 19.87 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -52.98 -39.0 62.69 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 175.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.52 ' CA ' ' HG3' ' A' ' 70' ' ' PRO . . . -106.86 33.2 6.59 Favored Glycine 0 C--N 1.334 0.44 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.744 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.605 HG23 ' HB2' ' A' ' 39' ' ' LYS . 0.9 OUTLIER -64.38 136.5 57.18 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-O 121.526 0.679 . . . . 0.0 112.442 179.22 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 69.6 m -85.61 155.11 21.27 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.091 -0.958 . . . . 0.0 109.875 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.498 ' HA ' HD21 ' A' ' 40' ' ' LEU . 25.7 ptt? -50.87 -30.49 14.68 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -176.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.49 -37.96 85.56 Favored 'General case' 0 C--O 1.217 -0.642 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 -178.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.605 ' HB2' HG23 ' A' ' 35' ' ' THR . 31.1 mmmt -60.6 -40.03 90.31 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.049 -176.444 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.498 HD21 ' HA ' ' A' ' 37' ' ' MET . 0.2 OUTLIER -86.49 -46.05 10.54 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.782 -178.465 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 46.4 mttp -62.02 -46.61 88.41 Favored 'General case' 0 C--O 1.212 -0.892 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.43 -178.404 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.461 ' HA ' HG22 ' A' ' 52' ' ' VAL . 25.0 ttmm -62.47 -42.53 99.55 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.079 0.466 . . . . 0.0 110.058 177.027 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 45.7 t -62.98 -50.07 72.2 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.289 -176.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.655 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 42.0 t80 -71.43 -43.81 66.01 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.787 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.605 ' HB1' ' O ' ' A' ' 50' ' ' VAL . . . -57.82 -33.26 68.42 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.364 0.602 . . . . 0.0 109.741 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -63.05 -47.72 81.78 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.188 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.655 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 3.5 ptm180 -68.62 -27.84 66.38 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.411 -177.197 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.459 HG22 ' O ' ' A' ' 44' ' ' TYR . 8.9 t -96.64 -10.77 26.33 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -177.257 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.56 35.26 67.75 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.248 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.625 HG13 ' HB3' ' A' ' 88' ' ' LEU . 73.7 t -119.32 149.65 21.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 C-N-CA 122.713 0.405 . . . . 0.0 110.891 -177.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.456 ' HB3' ' OG ' ' A' ' 54' ' ' SER . . . -51.81 136.19 28.33 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.347 176.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.461 HG22 ' HA ' ' A' ' 42' ' ' LYS . 76.8 t -60.9 -44.3 97.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.277 -177.031 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -77.14 -10.01 59.12 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.093 0.473 . . . . 0.0 110.954 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.456 ' OG ' ' HB3' ' A' ' 51' ' ' ALA . 74.9 m -87.36 -10.51 51.95 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.18 176.561 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -96.34 130.05 43.53 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 177.307 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.473 ' HD3' ' O ' ' A' ' 85' ' ' GLN . 0.0 OUTLIER -122.49 117.06 25.04 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 121.423 0.63 . . . . 0.0 111.334 -176.696 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.576 ' HZ ' ' CB ' ' A' ' 44' ' ' TYR . 32.6 m-85 -106.14 128.36 53.84 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.529 178.426 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.534 ' HG ' ' HA ' ' A' ' 63' ' ' ARG . 7.8 mp -121.6 136.12 54.96 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.423 179.274 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.587 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 83.8 t80 -105.3 116.0 31.22 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 178.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 55.44 23.18 5.59 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.848 -0.614 . . . . 0.0 112.393 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 102.06 2.29 51.68 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 121.089 -0.577 . . . . 0.0 113.514 176.476 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.587 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -120.29 140.93 50.5 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 117.175 0.488 . . . . 0.0 109.98 176.702 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.534 ' HA ' ' HG ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -68.44 137.56 54.58 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.282 0.563 . . . . 0.0 112.05 -175.347 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.404 HD12 ' HB3' ' A' ' 57' ' ' PHE . 87.1 mt -82.66 125.16 39.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.581 -179.252 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -99.21 162.94 12.77 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.495 -177.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.415 ' HB3' ' HG2' ' A' ' 37' ' ' MET . 7.1 p-10 -81.79 -6.52 59.14 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 174.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -101.65 -6.28 23.98 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.332 -178.336 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -62.2 148.77 43.62 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.253 0.549 . . . . 0.0 112.149 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.403 ' H ' HG22 ' A' ' 72' ' ' THR . 49.9 p -113.87 159.53 35.6 Favored Pre-proline 0 C--N 1.319 -0.749 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.531 -179.253 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.52 ' HG3' ' CA ' ' A' ' 34' ' ' GLY . 77.8 Cg_exo -55.33 -39.38 91.29 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.904 2.403 . . . . 0.0 112.407 -178.521 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.507 ' HG3' ' H ' ' A' ' 72' ' ' THR . 17.3 ptmt -69.01 -46.76 67.2 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -177.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.507 ' H ' ' HG3' ' A' ' 71' ' ' LYS . 9.0 t -67.19 -27.01 66.91 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-O 120.924 0.393 . . . . 0.0 110.875 -177.263 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 93.7 mt -90.95 -22.55 20.8 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.676 178.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 43.4 47.8 5.91 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.927 -177.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 74.2 mtm -85.24 161.12 19.7 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.913 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -147.65 -178.39 6.23 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.376 178.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.484 ' HA ' ' H ' ' A' ' 16' ' ' LYS . 34.3 t70 -65.42 120.1 12.22 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.028 0.442 . . . . 0.0 111.357 -178.321 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.499 ' CG ' ' HD2' ' A' ' 16' ' ' LYS . 3.0 m-20 74.9 33.2 0.77 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.19 1.396 . . . . 0.0 111.783 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -70.43 176.4 4.05 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 177.083 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.9 t -118.36 136.66 54.84 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 CA-C-O 121.431 0.634 . . . . 0.0 111.163 -174.191 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.719 HD12 HG21 ' A' ' 17' ' ' ILE . 1.8 mt -131.64 138.85 51.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.307 -177.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -102.85 145.47 29.74 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.255 -173.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.414 ' HB ' ' HA2' ' A' ' 21' ' ' GLY . 90.7 t -126.59 131.01 71.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.26 178.431 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.465 ' CE1' HD22 ' A' ' 58' ' ' LEU . 78.6 m-85 -99.72 168.56 9.84 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.684 177.014 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.473 ' O ' ' HD3' ' A' ' 56' ' ' ARG . 43.9 tp60 -66.88 129.9 41.39 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.394 0.616 . . . . 0.0 111.188 -170.791 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.473 ' HB2' HG11 ' A' ' 50' ' ' VAL . 4.1 pm0 -65.66 154.1 39.8 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.958 -1.019 . . . . 0.0 112.714 -177.079 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.425 ' HB3' ' CB ' ' A' ' 54' ' ' SER . 61.0 tp60 -72.11 -42.76 65.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.98 -176.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.625 ' HB3' HG13 ' A' ' 50' ' ' VAL . 57.1 tp . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.009 -178.213 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 32' ' ' LYS . 98.4 m-85 . . . . . 0 N--CA 1.435 -1.184 0 CA-C-O 121.544 0.687 . . . . 0.0 111.438 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.475 ' HA ' ' OD1' ' A' ' 77' ' ' ASP . 21.8 pt -132.21 162.6 39.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 CA-C-N 114.588 -1.187 . . . . 0.0 108.552 -178.157 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.468 ' H ' ' HA ' ' A' ' 77' ' ' ASP . 56.5 mtmt -92.88 147.36 22.91 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 121.059 0.457 . . . . 0.0 110.664 175.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.652 HD12 HG21 ' A' ' 31' ' ' VAL . 9.4 mt -128.34 131.75 68.79 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.449 173.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.416 ' HD3' ' OD2' ' A' ' 78' ' ' ASP . 27.4 mtmt -98.93 104.71 16.78 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 176.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.632 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 98.5 t -82.29 115.54 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.1 t -106.06 116.56 50.09 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.495 ' HA2' ' HB ' ' A' ' 83' ' ' VAL . . . -85.16 174.3 49.13 Favored Glycine 0 C--N 1.309 -0.951 0 C-N-CA 120.191 -1.004 . . . . 0.0 112.0 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.425 ' HG3' ' O ' ' A' ' 83' ' ' VAL . 98.3 mt-30 -70.11 -21.88 63.07 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-O 121.447 0.641 . . . . 0.0 110.371 178.726 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -74.62 0.78 13.91 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.28 174.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.6 t 69.32 26.63 5.28 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -176.282 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -90.86 106.74 18.73 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-N 114.687 -1.142 . . . . 0.0 110.281 -179.014 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.632 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 29.4 tt0 -98.83 125.99 44.35 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.453 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.1 p -129.5 139.94 50.39 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.887 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 60.6 m170 -97.67 115.75 28.54 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.441 -175.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -111.55 148.39 33.36 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.706 175.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 26.2 tpt180 -99.22 120.27 39.25 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.652 HG21 HD12 ' A' ' 17' ' ' ILE . 33.0 m -135.86 172.45 15.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.537 -176.194 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 14' ' ' TYR . 36.9 tttm -90.38 160.76 15.92 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -54.21 -38.42 65.65 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-O 120.996 0.427 . . . . 0.0 110.275 175.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.65 ' CA ' ' HG3' ' A' ' 70' ' ' PRO . . . -98.82 25.88 26.36 Favored Glycine 0 CA--C 1.492 -1.389 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.858 -178.058 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.756 HG23 ' HB2' ' A' ' 39' ' ' LYS . 1.1 m -68.48 124.7 24.27 Favored 'General case' 0 N--CA 1.41 -2.457 0 CA-C-O 121.673 0.749 . . . . 0.0 111.773 178.491 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.583 ' HB3' ' HA ' ' A' ' 66' ' ' ASP . 41.2 m -91.82 167.53 12.08 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 114.482 -1.235 . . . . 0.0 109.537 178.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.456 ' HB2' ' CD ' ' A' ' 41' ' ' LYS . 25.2 ptt? -47.32 -39.32 14.53 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -175.323 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.84 -37.33 81.7 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -175.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.756 ' HB2' HG23 ' A' ' 35' ' ' THR . 29.9 mmmt -60.47 -41.64 94.61 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.273 -176.01 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.543 HD23 ' H ' ' A' ' 40' ' ' LEU . 0.5 OUTLIER -88.95 -44.08 10.69 Favored 'General case' 0 C--O 1.22 -0.489 0 N-CA-C 112.438 0.532 . . . . 0.0 112.438 -178.964 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.629 ' HE3' ' O ' ' A' ' 55' ' ' LEU . 60.8 mtpt -61.74 -46.79 88.09 Favored 'General case' 0 CA--C 1.488 -1.439 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.798 -176.317 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.496 ' HA ' HG22 ' A' ' 52' ' ' VAL . 39.0 ttpt -62.12 -40.8 97.14 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.14 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 66.6 m -65.59 -49.05 70.22 Favored 'General case' 0 CA--C 1.552 1.021 0 CA-C-N 115.215 -0.902 . . . . 0.0 112.407 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.649 ' O ' ' HG3' ' A' ' 47' ' ' ARG . 59.7 t80 -71.08 -45.13 64.32 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.949 -179.309 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.635 ' HB1' ' O ' ' A' ' 50' ' ' VAL . . . -58.48 -34.19 70.63 Favored 'General case' 0 CA--C 1.501 -0.914 0 CA-C-O 121.443 0.639 . . . . 0.0 109.585 -178.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -63.08 -48.14 79.92 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.046 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.649 ' HG3' ' O ' ' A' ' 44' ' ' TYR . 0.0 OUTLIER -69.25 -22.66 63.83 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.967 -0.56 . . . . 0.0 112.19 -176.324 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.466 HG22 ' O ' ' A' ' 44' ' ' TYR . 8.8 t -103.3 -7.27 21.24 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.909 0.385 . . . . 0.0 111.939 -177.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.25 31.99 65.75 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.544 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.635 ' O ' ' HB1' ' A' ' 45' ' ' ALA . 80.6 t -113.53 147.29 17.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 C-N-CA 122.886 0.474 . . . . 0.0 110.343 -178.391 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.588 ' HB3' ' OG ' ' A' ' 54' ' ' SER . . . -56.49 136.52 54.09 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.316 -0.402 . . . . 0.0 109.995 176.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.496 HG22 ' HA ' ' A' ' 42' ' ' LYS . 73.1 t -62.12 -44.4 98.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.469 -176.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -69.29 -31.42 69.9 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.522 -177.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.588 ' OG ' ' HB3' ' A' ' 51' ' ' ALA . 89.8 p -87.42 2.82 49.35 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 120.664 -0.414 . . . . 0.0 111.481 -179.097 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.713 HD22 ' HG2' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -94.83 121.73 36.72 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 174.147 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -117.15 117.89 30.83 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 119.875 -0.73 . . . . 0.0 112.343 -173.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.517 ' CD1' ' HG2' ' A' ' 41' ' ' LYS . 45.7 m-85 -108.91 130.03 55.43 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.595 176.407 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.575 HD13 ' CD1' ' A' ' 84' ' ' TYR . 8.0 mp -122.61 144.65 48.98 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 121.466 0.65 . . . . 0.0 111.226 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.676 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 64.5 t80 -118.37 115.1 23.99 Favored 'General case' 0 N--CA 1.426 -1.674 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.081 178.462 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 53.38 29.15 8.31 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.426 -178.137 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 96.01 -1.55 63.17 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.958 -0.564 . . . . 0.0 113.435 176.486 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.676 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -113.62 136.44 52.82 Favored 'General case' 0 CA--C 1.491 -1.326 0 CA-C-O 121.289 0.566 . . . . 0.0 109.672 177.5 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.508 ' HA ' ' HG ' ' A' ' 58' ' ' LEU . 30.1 ptt180 -72.38 133.74 45.08 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.168 -177.121 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.503 HD11 HD12 ' A' ' 81' ' ' ILE . 68.7 mt -75.61 132.83 32.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 CA-C-N 114.462 -1.244 . . . . 0.0 108.856 -178.056 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -109.57 169.82 8.46 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.09 0.471 . . . . 0.0 110.758 -175.297 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.583 ' HA ' ' HB3' ' A' ' 36' ' ' SER . 7.2 p-10 -82.9 -6.33 59.41 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.159 0.504 . . . . 0.0 109.667 175.421 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -101.3 -16.63 16.88 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.419 -0.809 . . . . 0.0 113.157 -175.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.6 p30 -68.78 161.57 28.18 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -175.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.454 ' HB ' ' HD2' ' A' ' 70' ' ' PRO . 72.0 p -129.9 166.72 24.19 Favored Pre-proline 0 CA--C 1.548 0.901 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.415 -174.03 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.65 ' HG3' ' CA ' ' A' ' 34' ' ' GLY . 57.2 Cg_exo -54.46 -39.91 85.71 Favored 'Trans proline' 0 C--N 1.369 1.623 0 C-N-CA 123.108 2.539 . . . . 0.0 113.318 -176.52 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.509 ' HD3' ' N ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -70.27 -23.77 62.94 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 -176.175 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.509 ' N ' ' HD3' ' A' ' 71' ' ' LYS . 5.1 t -95.34 -25.42 16.31 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.194 0.521 . . . . 0.0 110.117 -177.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.471 ' HB3' ' HG3' ' A' ' 75' ' ' MET . 92.7 mt -89.79 -24.34 21.49 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.936 178.487 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 46.5 30.96 1.19 Allowed 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.555 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.471 ' HG3' ' HB3' ' A' ' 73' ' ' LEU . 66.7 mtt -79.03 153.0 30.58 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.006 -179.016 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -150.54 -174.81 4.87 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.475 ' OD1' ' HA ' ' A' ' 15' ' ' ILE . 20.0 m-20 -55.0 126.1 23.16 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 -177.084 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.442 ' HB2' ' HE3' ' A' ' 16' ' ' LYS . 9.0 t70 67.21 35.42 4.47 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 113.882 -1.508 . . . . 0.0 111.489 173.466 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -70.63 176.38 4.19 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.845 177.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 30.7 m -110.11 136.52 45.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-O 121.588 0.708 . . . . 0.0 111.858 -175.083 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.503 HD12 HD11 ' A' ' 64' ' ' ILE . 10.8 mm -131.99 137.61 54.42 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.09 -178.153 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -107.33 142.75 36.63 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.361 -177.389 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.495 ' HB ' ' HA2' ' A' ' 21' ' ' GLY . 93.4 t -124.55 133.5 69.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-O 121.009 0.433 . . . . 0.0 111.29 178.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.575 ' CD1' HD13 ' A' ' 58' ' ' LEU . 46.7 m-85 -100.23 167.69 10.27 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.492 178.476 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -67.85 124.65 23.92 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.496 0.665 . . . . 0.0 110.691 -173.154 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.713 ' HG2' HD22 ' A' ' 55' ' ' LEU . 2.2 mp0 -82.59 162.02 22.07 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.6 -177.072 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -69.03 -40.09 78.82 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.105 177.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.532 ' HB2' HG13 ' A' ' 50' ' ' VAL . 10.9 mp . . . . . 0 C--N 1.332 -0.169 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.713 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 . . . . . 0 N--CA 1.45 -0.437 0 CA-C-O 121.19 0.519 . . . . 0.0 111.689 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.499 ' O ' ' HD2' ' A' ' 30' ' ' ARG . 23.7 pt -122.45 163.14 21.32 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.414 -176.116 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.434 ' HZ2' ' CG ' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -91.53 144.93 25.04 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.253 178.042 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.52 HD12 HG21 ' A' ' 31' ' ' VAL . 67.8 mt -139.12 133.9 40.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-O 120.87 0.367 . . . . 0.0 111.32 172.653 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 18.4 mtmt -96.43 106.15 18.34 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.647 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 81.1 t -81.25 116.76 26.1 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 176.678 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 59.9 t -112.63 117.76 56.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 120.929 0.395 . . . . 0.0 110.095 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.529 ' HA2' ' HB ' ' A' ' 83' ' ' VAL . . . -92.25 171.24 33.66 Favored Glycine 0 C--N 1.314 -0.665 0 C-N-CA 120.434 -0.888 . . . . 0.0 112.588 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.437 ' C ' ' H ' ' A' ' 24' ' ' SER . 97.7 mt-30 -66.45 -27.45 67.82 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 121.232 0.539 . . . . 0.0 110.674 179.35 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -69.86 4.17 2.17 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.917 175.02 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.437 ' H ' ' C ' ' A' ' 22' ' ' GLN . 50.9 m 67.54 27.79 7.76 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.878 0.847 . . . . 0.0 109.12 -176.656 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -91.95 104.83 17.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-N 114.576 -1.193 . . . . 0.0 110.952 -178.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.647 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 30.6 tt0 -100.73 129.53 46.64 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.851 176.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.411 ' CG1' ' HB ' ' A' ' 19' ' ' VAL . 7.5 p -133.26 140.18 47.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.041 179.049 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 51.4 m170 -94.73 112.87 24.59 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.164 -176.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -110.64 147.36 34.44 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.425 177.256 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.499 ' HD2' ' O ' ' A' ' 15' ' ' ILE . 12.4 tpt180 -105.17 116.0 31.21 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 175.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.52 HG21 HD12 ' A' ' 17' ' ' ILE . 35.3 m -137.86 172.72 13.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.918 -176.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -89.33 159.92 17.13 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 -177.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -55.04 -38.3 67.79 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.073 0.463 . . . . 0.0 109.753 173.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -100.04 25.92 26.44 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.767 -177.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.594 HG23 ' HB2' ' A' ' 39' ' ' LYS . 1.2 m -71.39 128.44 35.87 Favored 'General case' 0 N--CA 1.425 -1.682 0 CA-C-O 121.529 0.681 . . . . 0.0 112.418 179.102 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.535 ' HB3' ' HA ' ' A' ' 66' ' ' ASP . 66.9 m -93.11 164.15 13.37 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 114.759 -1.11 . . . . 0.0 111.045 -179.15 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.541 ' SD ' ' HA ' ' A' ' 65' ' ' ASN . 24.3 ptt? -47.14 -39.21 13.09 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -174.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.76 -37.18 80.94 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -175.164 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.594 ' HB2' HG23 ' A' ' 35' ' ' THR . 75.8 mmtt -61.1 -40.51 94.03 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.52 -176.106 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.559 HD12 ' CD2' ' A' ' 57' ' ' PHE . 0.3 OUTLIER -88.06 -44.49 10.92 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.376 -178.618 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.546 ' HG2' ' CD1' ' A' ' 57' ' ' PHE . 61.6 mtpt -62.87 -45.3 93.22 Favored 'General case' 0 CA--C 1.489 -1.376 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.71 -176.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.407 ' O ' ' HB2' ' A' ' 46' ' ' ASP . 24.4 ttmm -61.22 -43.3 99.1 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 176.31 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 44.5 t -65.78 -51.44 59.11 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.426 -0.806 . . . . 0.0 112.1 -176.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.521 ' O ' HG22 ' A' ' 48' ' ' THR . 41.9 t80 -66.85 -46.57 74.65 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 120.769 0.319 . . . . 0.0 111.488 -179.191 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.57 -35.08 75.19 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.413 0.625 . . . . 0.0 109.883 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' A' ' 42' ' ' LYS . 32.3 t70 -64.5 -47.37 79.16 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.343 -178.155 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.518 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 15.4 ptm180 -65.72 -28.5 69.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.539 -177.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.521 HG22 ' O ' ' A' ' 44' ' ' TYR . 7.0 t -93.57 -8.24 41.83 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.234 -179.428 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.12 30.99 69.33 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.941 -0.647 . . . . 0.0 113.12 178.137 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.412 HG12 HG23 ' A' ' 48' ' ' THR . 2.5 p -115.09 169.28 6.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -178.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.428 ' HB3' ' HB3' ' A' ' 54' ' ' SER . . . -60.41 136.81 58.16 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.775 0.321 . . . . 0.0 110.666 178.046 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 79.7 t -61.96 -44.24 98.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-O 121.396 0.617 . . . . 0.0 109.857 179.4 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -71.33 -21.74 62.01 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.827 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.509 ' HB2' ' HB3' ' A' ' 87' ' ' GLN . 85.2 p -75.75 -12.59 60.21 Favored 'General case' 0 CA--C 1.52 -0.189 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.533 179.276 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.532 HD12 ' CE1' ' A' ' 57' ' ' PHE . 0.1 OUTLIER -94.45 132.72 38.8 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 177.469 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.72 120.11 25.85 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.125 0.488 . . . . 0.0 110.524 -179.288 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.559 ' CD2' HD12 ' A' ' 40' ' ' LEU . 32.9 m-85 -110.29 134.3 52.4 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.46 -179.482 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.534 HD13 ' CD1' ' A' ' 84' ' ' TYR . 7.1 mp -126.75 145.54 50.57 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.906 178.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.785 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 89.2 t80 -117.41 118.32 31.9 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 176.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 30.8 t70 54.05 29.74 10.73 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.738 0.78 . . . . 0.0 111.56 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 90.26 6.08 69.23 Favored Glycine 0 C--N 1.313 -0.741 0 CA-C-N 115.612 -0.722 . . . . 0.0 113.539 176.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.785 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -116.9 143.88 45.18 Favored 'General case' 0 CA--C 1.503 -0.838 0 CA-C-O 121.12 0.486 . . . . 0.0 109.752 177.102 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.491 ' HA ' ' HG ' ' A' ' 58' ' ' LEU . 34.6 mtp-105 -73.14 128.47 35.57 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.001 -175.39 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 74.6 mt -79.61 129.57 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 177.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.541 ' HA ' ' SD ' ' A' ' 37' ' ' MET . 93.7 m-20 -125.23 176.62 6.62 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 121.169 0.509 . . . . 0.0 111.443 -173.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.535 ' HA ' ' HB3' ' A' ' 36' ' ' SER . 8.9 p-10 -82.98 -6.58 59.54 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.571 177.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -102.16 -13.22 17.54 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.314 -176.287 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.444 ' HB3' HH22 ' A' ' 62' ' ' ARG . 20.2 p30 -70.97 165.29 23.73 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -176.103 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.474 ' O ' HG22 ' A' ' 72' ' ' THR . 42.5 p -123.56 159.63 54.47 Favored Pre-proline 0 N--CA 1.443 -0.78 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.056 -175.616 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.47 ' HD2' ' HB ' ' A' ' 69' ' ' THR . 19.3 Cg_endo -58.61 -31.15 94.04 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.927 2.418 . . . . 0.0 114.097 -176.584 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.68 -28.55 36.74 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 119.586 -0.845 . . . . 0.0 111.87 -177.635 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.474 HG22 ' O ' ' A' ' 69' ' ' THR . 12.1 t -79.24 -30.78 43.35 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 120.071 -0.652 . . . . 0.0 109.308 178.257 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.432 ' HB3' ' HG3' ' A' ' 75' ' ' MET . 94.9 mt -76.65 -23.16 53.3 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.262 175.55 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 46.21 34.24 2.08 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.119 177.54 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.432 ' HG3' ' HB3' ' A' ' 73' ' ' LEU . 61.6 mtt -72.36 154.11 41.1 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.774 -177.774 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -151.13 175.22 12.34 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.222 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.434 ' CG ' ' HZ2' ' A' ' 16' ' ' LYS . 38.7 t70 -58.7 122.07 12.61 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.801 0.81 . . . . 0.0 112.76 -177.258 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.6 t70 66.45 34.74 6.01 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 113.788 -1.551 . . . . 0.0 111.701 177.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -74.8 178.45 5.48 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 175.308 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 36.0 m -117.26 147.77 20.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 CA-C-O 121.763 0.792 . . . . 0.0 112.87 -175.005 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.498 HD12 HG21 ' A' ' 17' ' ' ILE . 7.6 mt -128.73 138.25 55.1 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-N 114.318 -1.31 . . . . 0.0 110.164 178.333 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -104.52 140.45 37.96 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.813 0.34 . . . . 0.0 110.613 -176.045 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.529 ' HB ' ' HA2' ' A' ' 21' ' ' GLY . 98.4 t -126.42 134.37 66.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-O 121.221 0.534 . . . . 0.0 111.938 -178.483 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.534 ' CD1' HD13 ' A' ' 58' ' ' LEU . 78.3 m-85 -99.38 168.69 9.84 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.739 177.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -66.4 133.01 49.59 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.367 0.603 . . . . 0.0 111.499 -172.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -61.68 151.89 32.44 Favored 'General case' 0 CA--C 1.497 -1.079 0 CA-C-N 115.125 -0.943 . . . . 0.0 112.021 -177.491 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.509 ' HB3' ' HB2' ' A' ' 54' ' ' SER . 60.5 tp60 -69.19 -40.06 78.29 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.533 179.36 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.0 mm? . . . . . 0 C--O 1.226 -0.184 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.212 -179.115 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 . . . . . 0 N--CA 1.439 -0.997 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.5 pt -114.98 161.44 13.73 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -176.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.403 ' H ' ' HA ' ' A' ' 77' ' ' ASP . 23.0 ttmm -103.61 142.82 33.64 Favored 'General case' 0 C--N 1.282 -2.326 0 C-N-CA 120.572 -0.451 . . . . 0.0 109.958 179.398 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.629 HG21 HD12 ' A' ' 81' ' ' ILE . 41.0 mm -123.59 127.99 74.32 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.169 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.799 177.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.1 mtmt -101.6 103.69 14.52 Favored 'General case' 0 N--CA 1.423 -1.802 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 177.199 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.776 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 91.3 t -81.69 121.98 35.9 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.87 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 62.0 t -109.99 121.48 62.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.16 0.505 . . . . 0.0 110.285 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -90.97 -174.11 43.94 Favored Glycine 0 CA--C 1.52 0.371 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.937 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -63.75 -38.59 91.68 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -177.074 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.614 ' HB2' ' OD1' ' A' ' 25' ' ' ASN . 16.0 m-20 -87.33 22.06 2.26 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 178.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 48.9 m 65.35 31.76 10.23 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.863 -178.191 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.614 ' OD1' ' HB2' ' A' ' 23' ' ' ASP . 14.9 m120 -78.67 106.74 10.86 Favored 'General case' 0 CA--C 1.501 -0.924 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.755 -178.439 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.776 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 36.6 tt0 -103.08 134.63 46.18 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-O 121.195 0.521 . . . . 0.0 111.279 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.7 p -136.12 141.92 40.2 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.198 178.276 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 35.6 m170 -101.69 115.14 29.86 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.264 0.554 . . . . 0.0 111.817 -176.026 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -115.51 148.07 39.92 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.37 175.4 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 21.4 tpp180 -103.11 120.56 40.91 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 177.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.424 HG22 HG12 ' A' ' 17' ' ' ILE . 32.5 m -134.58 172.22 16.5 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.449 -178.158 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -89.99 162.56 15.32 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.411 ' C ' ' HB3' ' A' ' 70' ' ' PRO . 83.3 m-85 -56.37 -39.85 73.59 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 175.009 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -101.22 33.06 6.77 Favored Glycine 0 N--CA 1.446 -0.651 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.388 -179.076 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.508 HG23 ' HB2' ' A' ' 39' ' ' LYS . 0.9 OUTLIER -68.75 133.42 48.35 Favored 'General case' 0 N--CA 1.428 -1.537 0 CA-C-O 121.47 0.652 . . . . 0.0 111.953 177.908 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.459 ' OG ' ' HG2' ' A' ' 39' ' ' LYS . 86.7 p -78.44 161.6 26.99 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.293 -179.359 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.638 ' SD ' ' HA ' ' A' ' 65' ' ' ASN . 26.2 ptt? -59.61 -32.29 70.27 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.898 0.38 . . . . 0.0 111.004 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.17 -36.87 83.19 Favored 'General case' 0 C--O 1.219 -0.537 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.628 -177.289 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.508 ' HB2' HG23 ' A' ' 35' ' ' THR . 32.4 mmmt -59.97 -40.86 90.56 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.609 -175.588 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.513 HD23 ' H ' ' A' ' 40' ' ' LEU . 0.4 OUTLIER -87.82 -45.87 9.93 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -179.534 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -62.65 -45.32 93.36 Favored 'General case' 0 CA--C 1.501 -0.93 0 N-CA-C 111.798 0.295 . . . . 0.0 111.798 -176.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.531 ' O ' ' HB2' ' A' ' 46' ' ' ASP . 40.0 ttpt -61.95 -42.12 98.75 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.614 176.776 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.448 ' O ' ' HB3' ' A' ' 46' ' ' ASP . 38.2 t -68.75 -51.17 44.13 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.286 -176.196 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.487 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 48.7 t80 -68.3 -48.01 66.1 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.9 -178.166 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.21 -29.34 68.67 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 121.631 0.729 . . . . 0.0 109.679 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.531 ' HB2' ' O ' ' A' ' 42' ' ' LYS . 22.2 t70 -63.16 -46.74 85.76 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.749 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.487 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 25.9 ptt180 -69.09 -30.47 68.79 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.008 0.432 . . . . 0.0 110.926 -175.579 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.595 HG23 HG12 ' A' ' 50' ' ' VAL . 4.8 t -92.46 -21.53 20.11 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.83 -175.661 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.3 23.32 57.08 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.39 -0.909 . . . . 0.0 112.985 179.163 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.72 HG11 HD23 ' A' ' 55' ' ' LEU . 7.8 p -98.74 158.94 3.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.002 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.543 ' HB3' ' OG ' ' A' ' 54' ' ' SER . . . -59.96 132.72 54.83 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 177.703 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 71.1 t -61.3 -44.19 97.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.158 0.504 . . . . 0.0 110.598 -178.053 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -66.63 -32.92 74.55 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.015 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.543 ' OG ' ' HB3' ' A' ' 51' ' ' ALA . 83.1 p -76.25 -13.21 60.17 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.302 -0.408 . . . . 0.0 112.066 -178.374 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.72 HD23 HG11 ' A' ' 50' ' ' VAL . 0.6 OUTLIER -95.56 128.5 42.47 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -178.196 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -121.82 126.86 49.74 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.906 -175.314 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.546 ' CE1' HD12 ' A' ' 55' ' ' LEU . 65.8 m-85 -106.14 129.83 54.14 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.094 173.423 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.514 ' HG ' ' HA ' ' A' ' 63' ' ' ARG . 8.1 mp -126.47 147.24 49.85 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 121.21 0.529 . . . . 0.0 111.103 -179.169 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.75 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 45.1 t80 -118.06 114.39 23.05 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.697 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 55.89 29.7 14.62 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.097 0.475 . . . . 0.0 112.258 -177.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 92.35 6.78 64.22 Favored Glycine 0 C--N 1.313 -0.717 0 C-N-CA 120.902 -0.666 . . . . 0.0 113.776 175.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.75 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.1 OUTLIER -120.84 136.6 54.87 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 117.204 0.502 . . . . 0.0 109.677 176.708 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.514 ' HA ' ' HG ' ' A' ' 58' ' ' LEU . 5.7 ptm180 -66.92 141.84 57.49 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.309 -0.86 . . . . 0.0 112.542 -175.674 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 77.7 mt -95.28 120.52 44.8 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.228 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.638 ' HA ' ' SD ' ' A' ' 37' ' ' MET . 21.3 m120 -119.56 164.75 15.37 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.065 0.459 . . . . 0.0 111.376 -178.807 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -70.66 -12.19 61.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.797 179.089 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -81.51 -21.01 38.91 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.083 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.458 ' CG ' HH12 ' A' ' 62' ' ' ARG . 66.0 m-20 -74.78 143.54 43.97 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -175.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.447 ' HB ' ' HD2' ' A' ' 70' ' ' PRO . 82.8 p -91.55 161.4 34.41 Favored Pre-proline 0 C--N 1.318 -0.792 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.872 177.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.447 ' HD2' ' HB ' ' A' ' 69' ' ' THR . 19.1 Cg_endo -60.04 -26.69 83.12 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.485 2.124 . . . . 0.0 111.766 177.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.07 -40.44 38.53 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.206 -177.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.1 t -75.83 -31.34 59.31 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.676 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.405 ' HB3' ' HE3' ' A' ' 75' ' ' MET . 97.4 mt -71.98 -25.52 61.88 Favored 'General case' 0 C--O 1.213 -0.837 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.36 177.338 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 52.19 24.2 2.68 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 123.58 0.752 . . . . 0.0 112.926 174.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.405 ' HE3' ' HB3' ' A' ' 73' ' ' LEU . 23.4 ptp -79.62 161.1 26.1 Favored 'General case' 0 C--N 1.321 -0.643 0 O-C-N 122.123 -0.36 . . . . 0.0 110.982 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -143.74 -178.9 6.14 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -178.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.403 ' HA ' ' H ' ' A' ' 16' ' ' LYS . 34.2 t70 -66.46 118.51 10.19 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.304 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 17.9 t70 71.27 33.54 1.95 Allowed 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.715 1.206 . . . . 0.0 110.475 178.304 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -84.02 177.36 8.3 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 176.305 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.5 m -110.47 149.27 13.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 CA-C-O 121.539 0.685 . . . . 0.0 111.836 -174.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.629 HD12 HG21 ' A' ' 17' ' ' ILE . 1.0 OUTLIER -137.61 138.93 44.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 CA-C-N 114.763 -1.108 . . . . 0.0 109.905 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -100.24 146.18 27.2 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.993 0.425 . . . . 0.0 111.499 -174.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 84.0 t -118.62 129.22 75.18 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.252 175.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.503 ' CE1' HD22 ' A' ' 58' ' ' LEU . 60.2 m-85 -100.55 169.42 9.07 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.224 177.478 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -67.36 148.81 51.14 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.439 0.637 . . . . 0.0 111.536 -173.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.549 ' HG3' HG21 ' A' ' 50' ' ' VAL . 0.7 OUTLIER -94.55 157.1 16.14 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 114.82 -1.082 . . . . 0.0 112.335 -175.052 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.537 ' H ' ' HB2' ' A' ' 54' ' ' SER . 53.1 tt0 -66.19 -41.78 89.78 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.112 178.472 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.41 ' HB3' HG23 ' A' ' 50' ' ' VAL . 58.8 tp . . . . . 0 C--N 1.328 -0.333 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 178.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 . . . . . 0 N--CA 1.443 -0.797 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.424 ' O ' ' HD3' ' A' ' 30' ' ' ARG . 4.3 pt -109.06 161.07 7.58 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -176.52 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.559 ' HE3' ' OD1' ' A' ' 78' ' ' ASP . 34.3 ttpt -109.82 144.69 37.9 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 -177.628 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.761 HG21 HD12 ' A' ' 81' ' ' ILE . 82.4 mt -130.29 133.04 64.61 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.183 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.395 178.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.0 mtmt -96.33 105.56 17.65 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 175.553 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.739 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 88.1 t -81.33 117.58 27.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.061 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.4 t -112.94 120.02 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 O-C-N 123.504 0.503 . . . . 0.0 109.769 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.405 ' HA2' ' HB ' ' A' ' 83' ' ' VAL . . . -86.42 -175.45 49.63 Favored Glycine 0 C--N 1.311 -0.821 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.746 -179.531 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -62.68 -37.58 87.0 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -178.044 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -88.9 22.57 2.65 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 178.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 54.6 m 64.16 38.53 8.19 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.942 -178.278 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -79.91 102.34 9.11 Favored 'General case' 0 C--O 1.215 -0.739 0 CA-C-N 115.0 -1.0 . . . . 0.0 108.974 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.739 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 27.7 tt0 -104.35 128.41 52.18 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 120.986 0.422 . . . . 0.0 112.107 -176.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.6 p -141.65 144.07 26.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.283 177.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 61.0 m170 -91.43 117.64 29.86 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -178.501 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -111.76 144.95 40.21 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.859 172.001 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.424 ' HD3' ' O ' ' A' ' 15' ' ' ILE . 15.1 tpp180 -108.8 119.88 40.84 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.251 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 33.6 m -138.13 174.77 10.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.606 -178.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.513 ' O ' ' HB ' ' A' ' 35' ' ' THR . 36.1 ttpt -88.29 160.4 17.67 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.267 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.641 ' O ' ' HB3' ' A' ' 70' ' ' PRO . 96.7 m-85 -57.18 -44.11 83.27 Favored 'General case' 0 C--O 1.224 -0.244 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 176.379 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -93.18 21.04 42.37 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.464 -177.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.513 ' HB ' ' O ' ' A' ' 32' ' ' LYS . 0.9 OUTLIER -60.27 139.6 57.52 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-O 121.637 0.732 . . . . 0.0 112.154 179.363 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.9 m -91.35 158.42 16.55 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.433 178.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.405 ' HG2' ' HB3' ' A' ' 66' ' ' ASP . 25.3 ptt? -52.16 -33.35 39.98 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -176.63 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.42 -35.97 79.03 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -177.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.505 ' HB2' HG23 ' A' ' 35' ' ' THR . 75.1 mmtt -59.15 -41.3 88.01 Favored 'General case' 0 C--O 1.215 -0.749 0 CA-C-O 120.846 0.355 . . . . 0.0 110.691 -175.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.519 HD23 ' H ' ' A' ' 40' ' ' LEU . 0.4 OUTLIER -88.56 -44.19 10.84 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -179.575 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.624 ' HE3' ' O ' ' A' ' 55' ' ' LEU . 61.6 mtpt -62.52 -45.33 93.47 Favored 'General case' 0 CA--C 1.492 -1.279 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.803 -176.464 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.502 ' HA ' HG22 ' A' ' 52' ' ' VAL . 40.4 ttmt -61.2 -43.58 98.65 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 176.358 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 58.0 m -62.84 -49.19 75.88 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.309 -176.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.479 ' CB ' ' HZ ' ' A' ' 57' ' ' PHE . 47.7 t80 -71.54 -45.93 60.97 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.735 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.532 ' HB1' ' O ' ' A' ' 50' ' ' VAL . . . -59.0 -33.36 70.62 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 121.301 0.572 . . . . 0.0 109.845 -178.677 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -63.02 -46.46 87.48 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.415 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 -70.84 -24.78 62.6 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.902 0.382 . . . . 0.0 111.616 -177.185 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.429 HG22 ' O ' ' A' ' 44' ' ' TYR . 9.9 t -97.29 -5.31 36.99 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.788 -178.409 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 68.52 30.56 73.13 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.312 178.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.712 HG11 ' HG3' ' A' ' 86' ' ' GLU . 70.6 t -112.81 146.93 16.87 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 C-N-CA 122.628 0.371 . . . . 0.0 110.392 -178.443 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.561 ' H ' HD12 ' A' ' 88' ' ' LEU . . . -54.47 133.08 45.77 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.974 177.117 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.502 HG22 ' HA ' ' A' ' 42' ' ' LYS . 72.7 t -61.6 -42.86 95.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.991 -176.632 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 32.4 p-10 -73.73 -16.77 61.17 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.675 -177.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.547 ' HB2' ' HB3' ' A' ' 87' ' ' GLN . 96.8 p -93.82 -5.8 47.32 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.846 -0.342 . . . . 0.0 111.442 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.624 ' O ' ' HE3' ' A' ' 41' ' ' LYS . 0.1 OUTLIER -94.47 135.18 36.2 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.687 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.479 ' HD2' ' N ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -130.36 126.61 37.55 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 120.002 -0.679 . . . . 0.0 111.849 -175.844 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.498 ' CE1' HD12 ' A' ' 55' ' ' LEU . 36.4 m-85 -110.27 133.14 53.54 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.39 177.297 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.518 HD22 ' CE1' ' A' ' 84' ' ' TYR . 9.8 mp -122.52 146.05 47.76 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.123 0.487 . . . . 0.0 111.113 -179.156 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.72 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 74.0 t80 -118.74 117.54 29.18 Favored 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 175.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 33.9 t70 58.17 28.3 16.3 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.741 0.781 . . . . 0.0 111.225 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 92.39 5.17 65.54 Favored Glycine 0 C--N 1.315 -0.585 0 CA-C-N 115.382 -0.826 . . . . 0.0 113.721 177.255 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.72 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.2 OUTLIER -122.37 134.47 54.63 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.313 0.578 . . . . 0.0 109.888 177.716 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.487 ' HA ' ' HG ' ' A' ' 58' ' ' LEU . 28.8 ptt180 -66.16 139.84 58.16 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 115.206 -0.906 . . . . 0.0 112.63 -175.498 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 76.5 mt -89.48 118.05 34.0 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.977 -178.404 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -105.71 159.85 15.67 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.514 -178.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.405 ' HB3' ' HG2' ' A' ' 37' ' ' MET . 6.9 p-10 -73.97 -14.47 61.04 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.244 0.545 . . . . 0.0 109.731 177.311 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -81.72 -19.16 42.06 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.78 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -72.88 147.47 45.32 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.197 0.522 . . . . 0.0 111.863 -178.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.431 ' HB ' ' HD2' ' A' ' 70' ' ' PRO . 23.3 p -97.12 160.74 28.3 Favored Pre-proline 0 N--CA 1.439 -1.013 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.545 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.641 ' HB3' ' O ' ' A' ' 33' ' ' TYR . 14.3 Cg_endo -58.21 -32.9 96.87 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.566 2.177 . . . . 0.0 112.535 -178.352 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.598 ' HG3' ' N ' ' A' ' 72' ' ' THR . 19.8 ptmt -69.0 -43.47 74.77 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.956 -0.565 . . . . 0.0 112.334 -179.376 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.598 ' N ' ' HG3' ' A' ' 71' ' ' LYS . 12.5 t -76.08 -28.75 57.71 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-O 121.248 0.547 . . . . 0.0 109.667 -178.219 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 96.1 mt -75.58 -21.59 57.71 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.681 175.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.519 ' HG2' ' O ' ' A' ' 71' ' ' LYS . 8.7 mm-40 52.4 34.03 14.25 Favored 'General case' 0 C--N 1.348 0.524 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 175.04 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 67.8 mtm -88.34 155.47 19.69 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 120.984 0.421 . . . . 0.0 111.526 -178.116 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -153.16 -175.19 5.23 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 177.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.444 ' HA ' ' H ' ' A' ' 16' ' ' LYS . 3.5 p-10 -63.85 125.25 23.76 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.758 0.79 . . . . 0.0 112.366 -176.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.559 ' OD1' ' HE3' ' A' ' 16' ' ' LYS . 24.2 t70 64.24 33.39 11.68 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.005 -1.452 . . . . 0.0 110.98 177.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -78.06 177.31 8.42 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.135 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.3 m -108.83 144.72 16.75 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 CA-C-O 121.547 0.689 . . . . 0.0 111.948 -174.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.761 HD12 HG21 ' A' ' 17' ' ' ILE . 1.2 mt -137.98 140.76 40.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.27 179.335 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -102.72 146.02 28.84 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.309 -175.46 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.405 ' HB ' ' HA2' ' A' ' 21' ' ' GLY . 97.4 t -126.44 132.37 70.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 121.081 0.467 . . . . 0.0 110.996 177.491 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.518 ' CE1' HD22 ' A' ' 58' ' ' LEU . 79.3 m-85 -108.47 168.75 9.1 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.452 178.698 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -68.05 141.66 56.11 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.7 0.762 . . . . 0.0 111.697 -173.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.712 ' HG3' HG11 ' A' ' 50' ' ' VAL . 0.5 OUTLIER -104.24 167.16 9.93 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 114.389 -1.278 . . . . 0.0 112.474 -172.621 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.547 ' HB3' ' HB2' ' A' ' 54' ' ' SER . 64.6 tt0 -64.14 -47.65 79.1 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.003 -177.741 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.561 HD12 ' H ' ' A' ' 51' ' ' ALA . 92.0 mt . . . . . 0 C--N 1.317 -0.813 0 CA-C-N 116.165 -0.47 . . . . 0.0 112.24 -177.196 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 . . . . . 0 CA--C 1.514 -0.424 0 CA-C-O 121.309 0.576 . . . . 0.0 111.1 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.2 pt -129.08 162.25 36.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.127 -177.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.539 ' HE3' ' HB2' ' A' ' 78' ' ' ASP . 55.7 mtmt -98.7 147.42 24.87 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-O 121.0 0.429 . . . . 0.0 110.308 176.425 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.56 HD12 HG21 ' A' ' 31' ' ' VAL . 61.3 mt -130.76 128.82 63.45 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.099 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.604 174.229 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.3 mtmt -95.61 104.45 16.36 Favored 'General case' 0 N--CA 1.426 -1.639 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 176.246 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.673 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 85.8 t -82.38 110.97 18.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.467 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 5.5 p -121.66 121.68 65.04 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 CA-C-O 121.783 0.802 . . . . 0.0 111.385 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.48 ' HA2' ' HB ' ' A' ' 83' ' ' VAL . . . -91.26 169.03 32.81 Favored Glycine 0 N--CA 1.432 -1.595 0 CA-C-N 114.723 -1.126 . . . . 0.0 112.149 -179.213 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.475 ' C ' ' H ' ' A' ' 24' ' ' SER . 20.6 pt20 -68.15 -23.14 64.85 Favored 'General case' 0 CA--C 1.494 -1.179 0 CA-C-O 121.857 0.837 . . . . 0.0 110.859 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -70.23 7.52 0.98 Allowed 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 114.163 -1.38 . . . . 0.0 109.907 175.001 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.475 ' H ' ' C ' ' A' ' 22' ' ' GLN . 49.0 m 66.32 29.94 9.21 Favored 'General case' 0 C--N 1.347 0.463 0 C-N-CA 123.559 0.744 . . . . 0.0 110.363 -178.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.458 ' O ' ' HA ' ' A' ' 20' ' ' VAL . 54.7 t30 -104.59 105.57 15.73 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.564 -178.674 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.673 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 39.8 tt0 -108.0 132.73 53.21 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.437 0.637 . . . . 0.0 111.112 178.72 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.3 p -136.14 142.77 37.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.651 179.09 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 53.8 m170 -100.18 115.61 30.26 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 121.293 0.568 . . . . 0.0 111.791 -175.158 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -115.48 151.28 35.09 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.724 176.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 53.2 ttp180 -111.23 123.46 50.24 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 173.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.56 HG21 HD12 ' A' ' 17' ' ' ILE . 31.3 m -135.7 174.02 13.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.102 -176.717 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 24.4 ttpp -88.49 156.67 18.97 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.472 ' C ' ' HB3' ' A' ' 70' ' ' PRO . 90.1 m-85 -51.28 -41.36 60.38 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 176.371 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -100.27 25.49 28.11 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.844 -0.617 . . . . 0.0 113.244 -177.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.518 HG23 ' HB2' ' A' ' 39' ' ' LYS . 1.1 m -65.26 136.47 56.64 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 121.284 0.564 . . . . 0.0 111.855 178.507 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.463 ' HB3' ' HA ' ' A' ' 66' ' ' ASP . 49.3 m -84.85 153.95 22.61 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.06 -178.498 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.462 ' SD ' ' HA ' ' A' ' 65' ' ' ASN . 24.7 ptt? -48.2 -32.32 6.95 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.17 -37.79 84.18 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -176.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.518 ' HB2' HG23 ' A' ' 35' ' ' THR . 75.3 mmtt -62.16 -39.23 91.95 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.767 0.318 . . . . 0.0 110.972 -175.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.523 HD12 ' CD2' ' A' ' 57' ' ' PHE . 0.3 OUTLIER -86.88 -46.04 10.28 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 116.163 -0.471 . . . . 0.0 112.088 -178.564 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.467 ' HG2' ' CD1' ' A' ' 57' ' ' PHE . 59.0 mtpt -62.64 -48.53 78.96 Favored 'General case' 0 CA--C 1.496 -1.104 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 -177.364 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -63.04 -40.42 97.66 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.006 179.001 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 47.3 t -66.01 -51.4 58.66 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.078 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.471 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 45.2 t80 -65.34 -46.92 78.29 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.838 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.427 ' HB1' ' O ' ' A' ' 50' ' ' VAL . . . -58.53 -36.68 74.22 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-O 121.374 0.606 . . . . 0.0 109.805 -177.707 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -66.51 -47.94 71.37 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.227 -178.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.471 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 15.8 ptm180 -71.25 -24.35 62.16 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.73 -177.578 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.439 HG22 ' O ' ' A' ' 44' ' ' TYR . 12.9 t -95.67 -8.36 34.93 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.579 -178.459 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.73 30.94 65.5 Favored Glycine 0 C--N 1.336 0.552 0 C-N-CA 121.298 -0.477 . . . . 0.0 113.54 178.175 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.456 HG11 ' HG2' ' A' ' 86' ' ' GLU . 96.8 t -119.44 150.39 21.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 -178.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.446 ' HB3' ' OG ' ' A' ' 54' ' ' SER . . . -52.26 135.83 31.71 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.242 176.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 72.2 t -61.6 -43.41 96.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.243 -178.092 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -66.59 -27.24 67.56 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.52 178.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.455 ' OG ' ' HB3' ' A' ' 87' ' ' GLN . 74.2 m -75.09 -12.15 60.25 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.237 179.103 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.412 HD13 ' HA ' ' A' ' 55' ' ' LEU . 1.4 mm? -94.8 135.42 36.32 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.081 0.467 . . . . 0.0 110.28 177.035 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.46 119.25 17.23 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.127 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.523 ' CD2' HD12 ' A' ' 40' ' ' LEU . 11.0 m-85 -109.37 132.24 54.31 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.39 -179.351 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.523 ' HG ' ' HA ' ' A' ' 63' ' ' ARG . 9.1 mp -124.8 147.76 48.54 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 121.356 0.598 . . . . 0.0 111.654 -177.489 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.794 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 49.2 t80 -126.92 126.35 43.1 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 175.676 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 22.6 t70 58.78 24.56 12.46 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.719 0.771 . . . . 0.0 110.931 -179.018 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.07 5.83 87.16 Favored Glycine 0 C--N 1.312 -0.795 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.863 179.095 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.794 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.1 OUTLIER -113.97 144.47 43.03 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 178.046 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.523 ' HA ' ' HG ' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -71.65 132.1 44.11 Favored 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.699 -176.478 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 82.1 mt -74.68 130.72 35.88 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 N-CA-C 107.429 -1.322 . . . . 0.0 107.429 176.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.462 ' HA ' ' SD ' ' A' ' 37' ' ' MET . 15.6 m120 -112.9 165.74 12.04 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 121.236 0.541 . . . . 0.0 111.1 -173.807 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.463 ' HA ' ' HB3' ' A' ' 36' ' ' SER . 7.2 p-10 -82.66 -6.71 59.52 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 176.214 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -112.53 -2.4 14.65 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.668 -175.346 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 31.5 p30 -76.82 167.76 21.27 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.297 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.559 ' O ' HG22 ' A' ' 72' ' ' THR . 41.0 p -116.99 155.25 49.55 Favored Pre-proline 0 C--N 1.316 -0.857 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.702 -178.022 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.472 ' HB3' ' C ' ' A' ' 33' ' ' TYR . 18.5 Cg_endo -59.52 -31.22 94.23 Favored 'Trans proline' 0 C--O 1.217 -0.548 0 C-N-CA 122.375 2.05 . . . . 0.0 112.417 -178.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.56 ' HD3' ' N ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -75.53 -29.26 59.38 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -179.266 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.56 ' N ' ' HD3' ' A' ' 71' ' ' LYS . 4.9 t -76.08 -29.7 58.06 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.076 -0.65 . . . . 0.0 110.174 -178.725 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.552 HD21 ' NH1' ' A' ' 62' ' ' ARG . 97.7 mt -92.96 -23.72 18.62 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.355 177.484 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 40.19 59.14 2.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.506 -175.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 75.6 mtm -84.21 149.02 26.41 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.731 178.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -137.96 -179.29 5.68 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -178.077 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -64.17 118.19 8.22 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.528 0.68 . . . . 0.0 112.542 -175.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.539 ' HB2' ' HE3' ' A' ' 16' ' ' LYS . 11.8 t70 73.27 34.32 1.03 Allowed 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 113.951 -1.477 . . . . 0.0 111.17 176.214 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -74.84 177.22 6.39 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.638 177.536 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.8 t -111.85 130.69 65.0 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 CA-C-O 121.201 0.524 . . . . 0.0 110.939 -173.098 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.447 HD13 HG23 ' A' ' 17' ' ' ILE . 1.2 mp -118.69 135.1 60.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.434 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -97.59 135.86 38.81 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.589 -175.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.48 ' HB ' ' HA2' ' A' ' 21' ' ' GLY . 93.1 t -126.8 133.52 68.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 CA-C-O 121.163 0.506 . . . . 0.0 110.572 178.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -107.1 168.99 8.82 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.437 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -64.67 136.99 57.56 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-O 121.91 0.862 . . . . 0.0 111.64 -173.327 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.456 ' HG2' HG11 ' A' ' 50' ' ' VAL . 31.7 mp0 -70.7 156.56 39.33 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 114.169 -1.378 . . . . 0.0 112.286 -174.312 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.455 ' HB3' ' OG ' ' A' ' 54' ' ' SER . 61.7 tt0 -64.83 -43.98 91.31 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.015 175.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 52.8 tp . . . . . 0 N--CA 1.445 -0.721 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.101 -179.143 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 . . . . . 0 CA--C 1.495 -1.14 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.47 ' HB ' ' HA ' ' A' ' 77' ' ' ASP . 12.1 pt -116.49 160.76 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.21 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.247 -177.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.402 ' H ' ' HA ' ' A' ' 77' ' ' ASP . 58.8 mtpt -101.21 147.3 26.43 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.652 178.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.423 HG12 HG22 ' A' ' 31' ' ' VAL . 42.8 mm -127.13 126.47 68.13 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.312 176.695 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.7 mtmt -96.79 103.67 15.6 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 176.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.653 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 94.3 t -82.69 116.07 26.27 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.265 178.339 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 64.1 t -109.0 118.55 56.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -92.94 179.65 39.77 Favored Glycine 0 C--N 1.312 -0.805 0 C-N-CA 120.207 -0.997 . . . . 0.0 113.062 -178.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 90.9 mm-40 -72.31 -20.2 61.53 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 121.468 0.651 . . . . 0.0 111.714 -178.366 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -83.37 10.77 7.94 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.324 -0.853 . . . . 0.0 108.963 176.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 40.8 m 63.65 28.47 15.03 Favored 'General case' 0 C--N 1.347 0.498 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -176.224 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 55.9 t-20 -93.32 106.94 18.84 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.513 -1.221 . . . . 0.0 110.42 -177.134 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.653 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 29.9 tt0 -99.28 132.02 44.9 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.13 177.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.7 p -136.74 139.94 43.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.461 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 60.1 m170 -98.66 114.55 27.08 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 121.376 0.608 . . . . 0.0 111.709 -176.124 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -110.63 145.31 38.13 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.284 174.121 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 57.6 ttp180 -105.33 125.71 51.29 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.1 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.423 HG22 HG12 ' A' ' 17' ' ' ILE . 32.6 m -136.44 175.7 9.72 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.516 -177.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.476 ' O ' ' HB ' ' A' ' 35' ' ' THR . 59.0 tttp -88.37 157.42 18.72 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.075 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.418 ' O ' ' HB3' ' A' ' 70' ' ' PRO . 66.2 m-85 -55.9 -41.08 73.95 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 173.684 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -97.98 31.57 7.79 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.141 -178.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.522 HG23 ' HB2' ' A' ' 39' ' ' LYS . 0.9 OUTLIER -68.63 138.79 55.31 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-O 121.503 0.668 . . . . 0.0 112.378 179.009 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.415 ' OG ' ' HG2' ' A' ' 39' ' ' LYS . 87.7 p -83.09 163.55 20.83 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.705 177.44 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.703 ' SD ' ' HA ' ' A' ' 65' ' ' ASN . 25.3 ptt? -60.61 -31.89 71.04 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.748 0.309 . . . . 0.0 111.189 -179.598 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.63 -37.16 82.94 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.244 -178.087 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.522 ' HB2' HG23 ' A' ' 35' ' ' THR . 75.9 mmtt -59.93 -40.39 88.74 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.192 -175.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.506 HD23 ' H ' ' A' ' 40' ' ' LEU . 0.4 OUTLIER -87.96 -44.13 11.25 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 179.737 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.4 ' HG2' ' HD1' ' A' ' 57' ' ' PHE . 61.3 mtpt -62.68 -45.29 93.45 Favored 'General case' 0 CA--C 1.493 -1.213 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.188 -177.518 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.422 ' O ' ' HB2' ' A' ' 46' ' ' ASP . 24.9 ttmm -62.98 -41.6 99.6 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 176.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 52.4 m -63.95 -46.19 85.82 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.202 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.707 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 45.6 t80 -71.11 -45.25 64.02 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.97 0.415 . . . . 0.0 110.871 178.585 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.47 -28.14 69.07 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.155 0.502 . . . . 0.0 110.008 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.422 ' HB2' ' O ' ' A' ' 42' ' ' LYS . 25.8 t70 -63.91 -45.95 87.0 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.374 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.707 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 15.3 ptm180 -65.82 -28.0 68.67 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.018 0.437 . . . . 0.0 111.047 -178.34 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.501 HG22 ' O ' ' A' ' 44' ' ' TYR . 2.0 t -97.27 -17.71 19.64 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.467 -178.516 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.04 30.36 67.82 Favored Glycine 0 C--O 1.236 0.23 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.04 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.872 HG11 ' HB2' ' A' ' 87' ' ' GLN . 2.4 p -108.76 176.46 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-O 120.676 0.274 . . . . 0.0 110.553 -177.173 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.626 ' H ' HG22 ' A' ' 50' ' ' VAL . . . -58.79 125.92 25.52 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.396 176.31 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 71.6 t -65.99 -45.46 90.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.379 0.609 . . . . 0.0 110.97 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -68.72 -31.74 71.03 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.456 -177.179 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.567 ' HB2' ' HB3' ' A' ' 51' ' ' ALA . 50.2 m -81.74 -4.44 56.31 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.979 -175.656 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.651 HD12 ' CE1' ' A' ' 57' ' ' PHE . 0.3 OUTLIER -90.14 128.71 36.41 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 177.108 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.465 ' HD3' ' CB ' ' A' ' 86' ' ' GLU . 3.2 mpt_? -106.12 118.95 37.95 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -173.436 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.651 ' CE1' HD12 ' A' ' 55' ' ' LEU . 61.0 m-85 -111.08 134.84 52.37 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.124 171.632 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.723 HD23 ' HD1' ' A' ' 84' ' ' TYR . 2.9 mm? -127.76 155.2 44.41 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.937 0.875 . . . . 0.0 111.746 -178.502 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.746 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 58.6 t80 -122.46 108.54 13.3 Favored 'General case' 0 C--N 1.286 -2.171 0 CA-C-N 113.941 -1.481 . . . . 0.0 108.264 176.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 55.19 22.52 4.72 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.183 0.516 . . . . 0.0 110.74 -174.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 93.85 -7.95 73.66 Favored Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.561 -179.375 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.746 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.1 OUTLIER -91.57 142.15 27.95 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.391 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.548 ' HA ' ' CD1' ' A' ' 58' ' ' LEU . 0.7 OUTLIER -64.81 139.2 58.74 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -174.795 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 78.9 mt -103.93 117.77 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 174.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.703 ' HA ' ' SD ' ' A' ' 37' ' ' MET . 48.0 m-80 -121.57 166.84 13.61 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 120.92 0.39 . . . . 0.0 110.6 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -70.61 -15.32 62.74 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.532 -177.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -92.12 -0.42 57.44 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 116.705 -0.225 . . . . 0.0 111.523 -179.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -80.33 140.58 36.06 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 120.906 0.384 . . . . 0.0 111.112 178.365 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.437 ' HB ' ' HD2' ' A' ' 70' ' ' PRO . 82.2 p -87.87 160.07 47.54 Favored Pre-proline 0 C--N 1.314 -0.97 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.993 -178.712 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.437 ' HD2' ' HB ' ' A' ' 69' ' ' THR . 21.0 Cg_endo -62.22 -25.61 76.99 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.626 2.217 . . . . 0.0 111.713 177.402 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.5 tmtt? -82.14 -37.65 25.9 Favored 'General case' 0 N--CA 1.423 -1.82 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.128 -177.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.7 t -74.07 -33.51 63.69 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 120.456 -0.497 . . . . 0.0 110.432 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 97.2 mt -79.06 -22.84 44.76 Favored 'General case' 0 C--O 1.217 -0.614 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.517 177.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 51.73 34.57 13.25 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.043 175.013 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 75.7 mtm -76.25 155.94 33.95 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 121.009 0.433 . . . . 0.0 111.342 -178.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -141.23 176.33 8.93 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.47 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 35.7 t70 -66.49 121.16 14.71 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 120.955 0.407 . . . . 0.0 111.089 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 24.5 t70 71.24 34.68 1.72 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.618 -1.174 . . . . 0.0 110.291 177.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -74.81 176.26 7.22 Favored 'General case' 0 N--CA 1.457 -0.09 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.95 178.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 24.5 m -106.97 138.38 33.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-O 121.57 0.7 . . . . 0.0 111.58 -176.547 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.412 HD13 ' HA ' ' A' ' 81' ' ' ILE . 6.8 mm -134.81 136.6 52.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.422 -177.479 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 53.6 mm-40 -101.88 141.88 34.05 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.862 -174.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 74.3 t -129.18 134.36 64.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-O 120.972 0.415 . . . . 0.0 110.953 177.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.723 ' HD1' HD23 ' A' ' 58' ' ' LEU . 74.4 m-85 -99.98 151.76 20.98 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 175.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.523 ' O ' ' HG3' ' A' ' 86' ' ' GLU . 63.9 tt0 -71.51 96.45 1.52 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.219 0.533 . . . . 0.0 110.226 -176.39 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.577 ' O ' HD22 ' A' ' 55' ' ' LEU . 30.6 mt-10 -167.99 142.34 3.5 Favored 'General case' 0 CA--C 1.501 -0.929 0 C-N-CA 125.592 1.557 . . . . 0.0 109.486 -177.437 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.872 ' HB2' HG11 ' A' ' 50' ' ' VAL . 27.6 pt20 177.33 -29.41 0.0 OUTLIER 'General case' 0 N--CA 1.389 -3.483 0 C-N-CA 125.284 1.434 . . . . 0.0 108.315 -176.692 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 60.0 tp . . . . . 0 N--CA 1.428 -1.551 0 N-CA-C 103.696 -2.705 . . . . 0.0 103.696 -179.212 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 . . . . . 0 N--CA 1.433 -1.279 0 CA-C-O 121.163 0.506 . . . . 0.0 110.744 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.411 ' O ' ' HD2' ' A' ' 30' ' ' ARG . 12.1 pt -126.21 163.04 28.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -179.117 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.535 ' H ' ' HA ' ' A' ' 77' ' ' ASP . 37.0 ttpt -106.55 140.05 40.05 Favored 'General case' 0 C--N 1.282 -2.353 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.621 HG21 HD12 ' A' ' 81' ' ' ILE . 83.5 mt -133.5 132.97 57.69 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.118 0 CA-C-O 120.814 0.34 . . . . 0.0 111.29 177.608 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.3 mtmt -97.62 105.81 18.02 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.148 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.61 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 97.7 t -82.42 120.38 33.75 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 178.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 59.9 t -111.02 118.22 56.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 120.998 0.428 . . . . 0.0 110.11 179.248 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.534 ' HA2' ' HB ' ' A' ' 83' ' ' VAL . . . -87.27 169.51 39.83 Favored Glycine 0 N--CA 1.445 -0.764 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.704 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.493 ' HG2' ' O ' ' A' ' 83' ' ' VAL . 15.9 mm100 -68.71 -26.82 65.46 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 120.961 0.41 . . . . 0.0 111.92 -177.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -83.34 13.88 4.02 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.055 178.512 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 27.4 t 74.17 24.45 1.94 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.428 178.277 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -91.57 104.53 17.0 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.811 -178.176 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.61 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 30.4 tt0 -98.77 130.82 45.24 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.693 176.637 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.423 ' CG1' ' HB ' ' A' ' 19' ' ' VAL . 7.1 p -131.06 141.35 46.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.131 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 50.7 m170 -98.98 108.74 21.5 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 121.067 0.46 . . . . 0.0 110.702 -175.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -110.05 147.13 34.15 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.868 179.239 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.411 ' HD2' ' O ' ' A' ' 15' ' ' ILE . 23.4 tpt180 -108.38 118.74 37.56 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 176.344 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.497 HG21 HD12 ' A' ' 17' ' ' ILE . 33.7 m -133.21 171.6 17.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.767 -177.684 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.422 ' O ' ' HB ' ' A' ' 35' ' ' THR . 38.1 ttpt -88.83 156.93 18.65 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 -178.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -55.61 -39.58 70.97 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 174.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -97.42 24.6 30.77 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.56 -178.335 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.422 ' HB ' ' O ' ' A' ' 32' ' ' LYS . 1.0 OUTLIER -67.05 138.09 56.92 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-O 121.367 0.603 . . . . 0.0 112.068 179.032 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.8 m -92.1 158.89 15.95 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.685 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 25.9 ptt? -52.78 -34.38 53.01 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -176.345 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.55 -36.27 80.12 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.332 0.494 . . . . 0.0 112.332 -176.489 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -59.98 -40.91 90.76 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.664 0.268 . . . . 0.0 110.711 -174.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.501 HD23 ' H ' ' A' ' 40' ' ' LEU . 0.4 OUTLIER -87.79 -45.81 10.0 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.213 -0.448 . . . . 0.0 112.0 -179.094 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.672 ' HG2' ' CD1' ' A' ' 57' ' ' PHE . 62.3 mtpt -62.83 -45.9 90.45 Favored 'General case' 0 CA--C 1.493 -1.22 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.501 -175.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -61.85 -41.68 98.12 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 177.249 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 47.9 t -63.98 -51.0 66.35 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.227 -178.052 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.596 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 46.6 t80 -70.21 -46.59 64.21 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.345 -179.089 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.437 ' HB1' ' O ' ' A' ' 50' ' ' VAL . . . -60.05 -36.76 78.02 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.393 0.616 . . . . 0.0 110.016 -178.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -66.03 -46.16 78.86 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.14 -178.34 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.596 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 14.6 ptm180 -68.07 -24.73 65.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.453 -177.668 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.459 HG22 ' O ' ' A' ' 44' ' ' TYR . 12.4 t -96.02 -8.61 33.16 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 120.769 0.318 . . . . 0.0 111.619 -179.126 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.72 31.2 60.73 Favored Glycine 0 C--N 1.339 0.727 0 C-N-CA 121.004 -0.617 . . . . 0.0 113.222 178.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.443 HG11 ' HG3' ' A' ' 86' ' ' GLU . 94.7 t -119.47 148.76 22.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 C-N-CA 122.539 0.336 . . . . 0.0 110.806 -178.409 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.417 ' HB3' ' OG ' ' A' ' 54' ' ' SER . . . -51.76 134.24 30.8 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.456 176.355 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 74.0 t -61.05 -44.62 98.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.001 -177.446 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -70.56 -22.44 62.59 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.187 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.484 ' HB3' ' HB3' ' A' ' 87' ' ' GLN . 68.0 m -80.24 -10.96 59.77 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.169 179.129 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.08 129.3 40.67 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 177.554 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -117.94 115.12 24.27 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 120.999 0.428 . . . . 0.0 110.856 -177.465 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.672 ' CD1' ' HG2' ' A' ' 41' ' ' LYS . 27.6 m-85 -106.06 127.76 53.4 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.937 177.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.556 HD22 ' CE1' ' A' ' 84' ' ' TYR . 9.2 mp -124.59 140.22 53.15 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.922 -179.353 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.767 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 76.7 t80 -105.95 117.08 33.09 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 177.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 29.1 t70 56.53 19.84 4.46 Favored 'General case' 0 CA--C 1.548 0.879 0 CA-C-O 121.29 0.567 . . . . 0.0 111.625 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.94 1.32 51.95 Favored Glycine 0 CA--C 1.521 0.451 0 C-N-CA 121.081 -0.58 . . . . 0.0 113.224 178.435 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.767 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.2 OUTLIER -113.68 142.38 46.08 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 117.097 0.448 . . . . 0.0 109.866 177.668 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.553 ' HA ' ' HG ' ' A' ' 58' ' ' LEU . 9.7 mpt_? -65.45 139.09 58.49 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -175.671 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 80.5 mt -94.49 119.02 41.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.294 178.284 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -110.66 160.99 16.19 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.193 -178.707 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -72.18 -18.29 61.87 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.304 0.573 . . . . 0.0 109.718 176.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -81.4 -19.45 42.57 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.031 -179.418 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.522 ' CG ' HH12 ' A' ' 62' ' ' ARG . 47.3 m-20 -68.21 140.23 56.07 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 121.391 0.615 . . . . 0.0 111.854 -179.327 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.488 ' HB ' ' HD2' ' A' ' 70' ' ' PRO . 18.8 p -100.66 163.45 18.08 Favored Pre-proline 0 C--N 1.311 -1.065 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.909 -178.277 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.488 ' HD2' ' HB ' ' A' ' 69' ' ' THR . 17.1 Cg_endo -58.32 -28.86 86.16 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 122.703 2.269 . . . . 0.0 112.687 -178.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.554 ' HG3' ' H ' ' A' ' 72' ' ' THR . 15.2 ptmt -72.41 -49.82 30.92 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.554 ' H ' ' HG3' ' A' ' 71' ' ' LYS . 15.1 t -67.64 -34.26 76.61 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.981 0.42 . . . . 0.0 110.735 -177.402 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 97.5 mt -79.41 -22.84 43.74 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.541 177.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 36.35 36.52 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 124.639 1.176 . . . . 0.0 113.835 -179.009 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 65.9 mtt -75.42 151.81 38.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.47 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -147.98 -176.4 5.26 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.819 -178.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.535 ' HA ' ' H ' ' A' ' 16' ' ' LYS . 6.4 p-10 -59.42 121.91 12.66 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -174.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.459 ' OD1' ' HE3' ' A' ' 16' ' ' LYS . 26.5 t70 71.01 32.45 2.31 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 113.635 -1.621 . . . . 0.0 111.553 175.321 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -79.23 178.05 8.36 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 175.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 35.1 m -115.13 150.5 17.05 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 CA-C-O 121.815 0.817 . . . . 0.0 112.336 -174.068 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.621 HD12 HG21 ' A' ' 17' ' ' ILE . 1.6 mt -134.26 134.92 54.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.854 178.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -101.81 139.63 37.19 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.897 -178.4 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.534 ' HB ' ' HA2' ' A' ' 21' ' ' GLY . 95.2 t -122.11 130.94 74.15 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.548 177.092 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.556 ' CE1' HD22 ' A' ' 58' ' ' LEU . 66.8 m-85 -99.21 167.29 10.77 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.474 178.405 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -67.06 137.11 56.18 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.538 0.685 . . . . 0.0 110.677 -173.052 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.493 ' H ' ' CD ' ' A' ' 86' ' ' GLU . 0.9 OUTLIER -83.9 156.55 22.34 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.979 -1.009 . . . . 0.0 112.955 -171.574 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.484 ' HB3' ' HB3' ' A' ' 54' ' ' SER . 64.2 tt0 -66.36 -42.83 87.46 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.892 -1.049 . . . . 0.0 112.777 -177.74 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.476 HD23 ' OG ' ' A' ' 54' ' ' SER . 4.6 mm? . . . . . 0 C--N 1.322 -0.608 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -178.084 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 . . . . . 0 CA--C 1.505 -0.753 0 CA-C-O 121.87 0.843 . . . . 0.0 112.783 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.6 pt -134.01 162.73 38.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-N 114.152 -1.386 . . . . 0.0 107.931 -179.021 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.456 ' HD2' ' NH1' ' A' ' 30' ' ' ARG . 3.5 mppt? -99.99 148.67 24.26 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 121.147 0.499 . . . . 0.0 111.616 179.197 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.468 HG23 ' CG1' ' A' ' 81' ' ' ILE . 67.8 mt -124.96 131.83 72.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.796 176.151 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.0 mtmt -101.54 102.74 13.53 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 172.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.701 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 92.3 t -82.87 117.7 29.27 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.614 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 57.9 t -106.85 114.72 46.69 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.513 ' HA2' ' HB ' ' A' ' 83' ' ' VAL . . . -88.96 171.49 39.12 Favored Glycine 0 C--N 1.313 -0.721 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.597 -179.239 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 90.8 mm-40 -73.89 -11.83 60.48 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-O 121.719 0.771 . . . . 0.0 110.652 179.385 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -83.6 7.16 18.18 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 114.57 -1.195 . . . . 0.0 108.86 174.19 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.5 m 65.41 27.59 11.82 Favored 'General case' 0 C--N 1.347 0.46 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.002 -176.242 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -97.11 105.74 17.94 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.704 -177.086 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.701 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 39.0 tt0 -98.09 129.7 44.9 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.713 176.183 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.2 p -139.54 141.82 34.25 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.988 -178.524 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 31.7 m170 -88.65 116.91 27.24 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.747 -179.132 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -113.68 136.88 52.35 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 114.993 -1.003 . . . . 0.0 108.701 170.676 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.456 ' NH1' ' HD2' ' A' ' 16' ' ' LYS . 35.9 ttt85 -104.91 125.64 51.13 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.57 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.503 ' HB ' ' OG1' ' A' ' 35' ' ' THR . 22.7 m -135.12 -179.76 3.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.227 -174.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -89.77 157.04 18.12 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 178.478 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.422 ' O ' ' HB3' ' A' ' 70' ' ' PRO . 90.6 m-85 -53.93 -39.79 66.17 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 173.725 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -102.07 33.39 6.55 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.355 -179.037 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.503 ' OG1' ' HB ' ' A' ' 31' ' ' VAL . 0.9 OUTLIER -66.7 138.52 57.46 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 121.614 0.721 . . . . 0.0 112.2 179.263 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.507 ' HB3' ' HB2' ' A' ' 66' ' ' ASP . 67.2 m -82.87 151.99 25.77 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.94 178.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.612 ' SD ' ' HA ' ' A' ' 65' ' ' ASN . 26.7 ptt? -54.1 -30.58 49.16 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.935 0.398 . . . . 0.0 111.047 -179.44 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.17 -36.75 80.69 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.781 -178.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -60.14 -40.83 91.18 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.791 0.329 . . . . 0.0 111.149 -176.245 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.491 HD23 ' H ' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -86.87 -45.52 10.78 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 116.056 -0.52 . . . . 0.0 112.0 -179.787 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.426 ' HA ' ' CE1' ' A' ' 57' ' ' PHE . 24.8 mtpp -61.78 -47.32 85.68 Favored 'General case' 0 CA--C 1.5 -0.972 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.351 -177.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.489 ' HA ' HG22 ' A' ' 52' ' ' VAL . 40.6 ttpt -62.79 -42.07 99.54 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.072 0.463 . . . . 0.0 109.986 178.546 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 44.7 t -66.35 -50.88 62.07 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.866 -176.693 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.592 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 49.6 t80 -70.71 -45.53 64.78 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.142 -178.035 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.525 ' HB1' ' O ' ' A' ' 50' ' ' VAL . . . -59.13 -35.63 73.8 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.409 0.623 . . . . 0.0 109.77 -179.094 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -64.35 -47.16 80.4 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.531 -179.347 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.592 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 14.5 ptm180 -71.17 -21.91 62.1 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.671 -177.671 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.466 HG22 ' O ' ' A' ' 44' ' ' TYR . 13.7 t -101.13 -2.73 30.67 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-O 120.855 0.36 . . . . 0.0 111.699 -178.753 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 69.8 37.08 75.45 Favored Glycine 0 C--N 1.335 0.486 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.013 178.375 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.525 ' O ' ' HB1' ' A' ' 45' ' ' ALA . 91.3 t -122.62 147.67 26.69 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 C-N-CA 122.825 0.45 . . . . 0.0 110.811 -178.008 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.456 ' HB3' ' HB2' ' A' ' 54' ' ' SER . . . -54.77 135.02 47.87 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 175.319 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.489 HG22 ' HA ' ' A' ' 42' ' ' LYS . 76.6 t -61.1 -45.86 97.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.312 -175.358 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -71.41 -27.79 63.55 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.356 -178.524 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.456 ' HB2' ' HB3' ' A' ' 51' ' ' ALA . 49.1 m -82.68 -5.43 58.85 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.464 -178.68 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.485 HD12 ' CE1' ' A' ' 57' ' ' PHE . 0.2 OUTLIER -95.34 122.42 38.03 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 177.414 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -108.02 117.39 34.01 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 120.33 -0.548 . . . . 0.0 112.222 -174.091 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.494 ' HZ ' ' CB ' ' A' ' 44' ' ' TYR . 44.3 m-85 -100.63 128.68 46.6 Favored 'General case' 0 CA--C 1.498 -1.058 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.569 174.024 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.595 HD13 ' HA ' ' A' ' 63' ' ' ARG . 4.2 mm? -119.06 155.89 30.66 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.384 -177.115 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.764 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 63.0 t80 -133.75 109.94 9.48 Favored 'General case' 0 C--N 1.279 -2.466 0 CA-C-N 114.289 -1.323 . . . . 0.0 109.385 174.245 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 27.9 t70 52.81 29.9 8.27 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.565 0.698 . . . . 0.0 111.562 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 94.58 4.98 61.87 Favored Glycine 0 C--N 1.31 -0.886 0 C-N-CA 120.856 -0.688 . . . . 0.0 113.65 176.627 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.764 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.2 OUTLIER -122.8 133.49 54.45 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 177.159 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.595 ' HA ' HD13 ' A' ' 58' ' ' LEU . 30.4 ptt180 -72.75 145.91 46.77 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.783 -172.716 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.448 HD11 HD12 ' A' ' 81' ' ' ILE . 73.6 mt -91.21 121.76 41.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.4 -176.57 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.612 ' HA ' ' SD ' ' A' ' 37' ' ' MET . 50.7 m-80 -111.09 157.54 19.88 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.769 -178.548 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.507 ' HB2' ' HB3' ' A' ' 36' ' ' SER . 4.8 p-10 -74.79 -11.98 60.28 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-O 121.179 0.514 . . . . 0.0 109.819 178.1 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -81.62 -20.37 39.86 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.913 179.193 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.461 ' CG ' HH12 ' A' ' 62' ' ' ARG . 50.5 m-20 -67.14 149.41 50.55 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.294 0.569 . . . . 0.0 112.087 -178.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.404 ' HB ' ' HD2' ' A' ' 70' ' ' PRO . 76.4 p -108.68 159.77 29.69 Favored Pre-proline 0 C--N 1.315 -0.933 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.634 178.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.422 ' HB3' ' O ' ' A' ' 33' ' ' TYR . 19.3 Cg_endo -60.49 -28.68 87.13 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.448 2.099 . . . . 0.0 111.721 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.738 ' C ' ' HD2' ' A' ' 71' ' ' LYS . 0.1 OUTLIER -65.6 -44.04 87.81 Favored 'General case' 0 N--CA 1.415 -2.176 0 CA-C-O 121.615 0.721 . . . . 0.0 109.496 178.819 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -80.22 -40.06 27.85 Favored 'General case' 0 N--CA 1.414 -2.265 0 CA-C-N 114.848 -1.069 . . . . 0.0 111.152 -174.463 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 98.6 mt -71.32 -23.24 61.9 Favored 'General case' 0 N--CA 1.44 -0.975 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 175.656 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.425 ' HG3' ' O ' ' A' ' 71' ' ' LYS . 38.5 mt-10 50.79 28.7 3.79 Favored 'General case' 0 C--N 1.349 0.553 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.462 -179.038 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.441 ' HE1' HD11 ' A' ' 17' ' ' ILE . 21.5 ptm -81.32 164.64 22.03 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.241 -178.369 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -151.37 -175.21 5.09 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-O 120.743 0.306 . . . . 0.0 110.252 -176.465 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -63.96 119.92 10.99 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.211 -179.679 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 33.1 t70 67.06 35.58 4.55 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.196 177.553 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -78.43 175.63 10.12 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.082 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 29.1 m -98.42 133.57 40.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 CA-C-O 121.807 0.813 . . . . 0.0 111.611 -176.052 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.468 ' CG1' HG23 ' A' ' 17' ' ' ILE . 18.1 mm -129.78 130.53 66.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 CA-C-N 114.634 -1.166 . . . . 0.0 109.86 179.137 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -102.56 148.25 25.77 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.094 0.473 . . . . 0.0 111.645 -175.059 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.513 ' HB ' ' HA2' ' A' ' 21' ' ' GLY . 79.4 t -123.34 129.86 74.57 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.858 174.603 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -101.77 170.84 7.9 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.571 178.472 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -64.51 136.94 57.56 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.776 0.798 . . . . 0.0 110.988 -172.111 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.523 ' CD ' ' H ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -108.93 160.21 16.19 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 114.512 -1.222 . . . . 0.0 111.614 -173.224 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.423 ' HB3' ' HB3' ' A' ' 54' ' ' SER . 64.3 tt0 -65.02 -46.14 82.57 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -175.771 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.473 ' HB2' HG13 ' A' ' 50' ' ' VAL . 3.3 mm? . . . . . 0 C--N 1.321 -0.666 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -175.363 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 . . . . . 0 CA--C 1.515 -0.382 0 CA-C-O 121.334 0.587 . . . . 0.0 111.479 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.464 ' O ' ' HD3' ' A' ' 30' ' ' ARG . 8.3 pt -111.27 163.08 8.33 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 -178.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.656 ' HE2' ' OD1' ' A' ' 78' ' ' ASP . 34.9 ttpt -113.78 145.33 41.55 Favored 'General case' 0 C--N 1.291 -1.955 0 C-N-CA 118.882 -1.127 . . . . 0.0 111.687 -179.221 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 84.6 mt -122.21 127.84 75.34 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.489 177.009 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.2 mtmt -99.19 104.68 16.66 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 176.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.668 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 96.1 t -82.55 119.2 31.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.989 -178.218 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.9 t -105.27 112.84 40.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.328 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -91.09 177.27 41.25 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.072 -1.061 . . . . 0.0 112.611 -178.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -82.54 -10.1 59.13 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 121.434 0.635 . . . . 0.0 111.621 -178.347 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -85.04 11.12 10.2 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 115.075 -0.966 . . . . 0.0 108.801 174.464 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.2 m 62.86 33.25 15.3 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.437 -178.095 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 -111.55 108.94 18.61 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.438 -179.364 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.668 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 30.0 tt0 -94.18 128.67 40.75 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.331 -0.849 . . . . 0.0 108.932 174.694 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.3 p -132.58 139.38 49.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -178.818 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 23.9 m170 -100.94 117.17 34.48 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.314 0.578 . . . . 0.0 111.963 -174.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -109.62 144.39 38.03 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.058 -0.973 . . . . 0.0 110.137 175.688 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.464 ' HD3' ' O ' ' A' ' 15' ' ' ILE . 20.2 tpp180 -103.2 119.32 38.66 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.217 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.401 ' HB ' HG21 ' A' ' 35' ' ' THR . 32.9 m -134.63 167.99 24.7 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.803 -178.062 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.403 ' O ' ' HB ' ' A' ' 35' ' ' THR . 46.5 tttm -91.22 163.33 14.29 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 178.561 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -57.36 -38.67 74.53 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.752 174.546 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -93.94 19.0 55.55 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 121.175 -0.536 . . . . 0.0 112.428 -178.063 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.403 ' HB ' ' O ' ' A' ' 32' ' ' LYS . 1.1 m -63.85 136.81 57.69 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-O 121.394 0.616 . . . . 0.0 111.802 179.035 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 68.3 m -92.91 156.79 16.72 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.307 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.414 ' SD ' ' HA ' ' A' ' 65' ' ' ASN . 26.7 ptt? -51.38 -32.34 25.59 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -176.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.19 -37.39 82.8 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 -177.434 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 49.3 mmtm -60.21 -39.98 88.48 Favored 'General case' 0 C--O 1.216 -0.696 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.08 -176.609 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.678 HD12 ' CD1' ' A' ' 57' ' ' PHE . 0.2 OUTLIER -87.24 -44.06 11.73 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -178.848 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.496 ' HA ' ' HE1' ' A' ' 57' ' ' PHE . 57.3 mtpt -62.83 -45.63 91.72 Favored 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -178.239 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 28.9 ttpp -62.31 -41.98 98.98 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 177.409 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.429 ' O ' ' HB3' ' A' ' 46' ' ' ASP . 58.4 m -66.26 -48.17 71.34 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.73 -178.475 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.664 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 38.9 t80 -71.72 -44.25 64.46 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -179.584 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.35 -29.7 66.17 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 121.286 0.565 . . . . 0.0 109.809 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.429 ' HB3' ' O ' ' A' ' 43' ' ' SER . 31.3 t70 -62.72 -48.56 78.73 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.789 178.489 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.664 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 7.5 ptm180 -69.79 -24.16 63.45 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.192 -176.353 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.47 HG23 HG12 ' A' ' 50' ' ' VAL . 7.3 t -100.66 -8.98 22.34 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.234 -0.439 . . . . 0.0 112.132 -178.333 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 67.43 40.6 91.39 Favored Glycine 0 C--N 1.336 0.531 0 C-N-CA 120.676 -0.774 . . . . 0.0 113.029 178.403 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.471 HG21 ' HG3' ' A' ' 86' ' ' GLU . 3.6 p -125.3 166.74 20.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 O-C-N 122.728 -0.277 . . . . 0.0 110.72 -177.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.441 ' HB3' ' OG ' ' A' ' 54' ' ' SER . . . -59.18 137.36 58.0 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 116.329 -0.396 . . . . 0.0 109.994 176.693 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 75.6 t -60.51 -44.04 95.65 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.57 -176.034 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -84.06 -12.15 55.57 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -179.108 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.512 ' HB2' ' HB3' ' A' ' 87' ' ' GLN . 85.5 p -79.75 -14.26 58.86 Favored 'General case' 0 CA--C 1.514 -0.417 0 C-N-CA 119.924 -0.711 . . . . 0.0 109.091 176.687 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.423 HD13 ' N ' ' A' ' 56' ' ' ARG . 1.9 tm? -99.61 129.59 45.77 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 177.061 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.423 ' N ' HD13 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -135.48 137.61 42.32 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 119.747 -0.781 . . . . 0.0 111.767 -176.599 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.678 ' CD1' HD12 ' A' ' 40' ' ' LEU . 96.3 m-85 -106.95 139.96 40.52 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.382 176.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.557 HD13 ' CD1' ' A' ' 84' ' ' TYR . 6.6 mp -128.68 139.7 52.11 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.703 176.517 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.675 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 34.4 t80 -107.78 119.04 38.32 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.129 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 32.5 t70 51.93 33.61 11.97 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.507 0.67 . . . . 0.0 111.395 179.53 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.19 13.8 73.25 Favored Glycine 0 CA--C 1.522 0.528 0 CA-C-N 115.647 -0.706 . . . . 0.0 113.739 177.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.675 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.2 OUTLIER -123.71 149.83 45.05 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 117.163 0.481 . . . . 0.0 110.406 178.822 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 63' ' ' ARG . 10.2 mmm180 -67.88 139.7 56.5 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -176.142 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 75.5 mt -103.43 111.29 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 173.19 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.414 ' HA ' ' SD ' ' A' ' 37' ' ' MET . 95.1 m-20 -114.38 170.22 8.46 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-O 121.094 0.473 . . . . 0.0 111.439 -178.179 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 15.3 p-10 -72.25 -14.07 61.68 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.571 -178.311 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -94.15 -13.16 27.02 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.397 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.443 ' HB3' ' HG ' ' A' ' 73' ' ' LEU . 30.2 m-20 -72.56 149.62 43.86 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.269 0.557 . . . . 0.0 112.187 -178.724 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.459 ' HB ' ' HD2' ' A' ' 70' ' ' PRO . 81.8 p -108.88 161.45 23.62 Favored Pre-proline 0 C--N 1.315 -0.907 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.691 -179.509 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.459 ' HD2' ' HB ' ' A' ' 69' ' ' THR . 24.2 Cg_endo -61.34 -22.95 75.98 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.455 2.104 . . . . 0.0 111.639 178.736 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.695 ' C ' ' HD2' ' A' ' 71' ' ' LYS . 0.0 OUTLIER -67.65 -44.52 77.7 Favored 'General case' 0 N--CA 1.41 -2.441 0 C-N-CA 123.651 0.78 . . . . 0.0 109.635 -179.755 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.6 t -90.0 -32.57 16.72 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.927 -175.292 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.443 ' HG ' ' HB3' ' A' ' 68' ' ' ASP . 96.0 mt -72.7 -22.95 60.82 Favored 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 174.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 52.89 32.9 13.3 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 114.846 -1.07 . . . . 0.0 112.25 176.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.406 ' HG3' ' HB3' ' A' ' 73' ' ' LEU . 69.1 mtm -83.54 156.99 22.52 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.372 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -154.44 -176.04 5.7 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -58.48 122.6 13.75 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.949 0.88 . . . . 0.0 112.605 -177.192 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.656 ' OD1' ' HE2' ' A' ' 16' ' ' LYS . 1.4 m-20 63.14 33.61 14.31 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 113.884 -1.507 . . . . 0.0 111.614 176.495 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -74.92 176.74 6.85 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 178.539 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 31.5 m -112.71 144.26 20.78 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 CA-C-O 121.459 0.647 . . . . 0.0 111.335 -175.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -129.12 143.97 39.6 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.65 -179.204 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -107.7 141.44 39.23 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 120.817 0.342 . . . . 0.0 110.651 -177.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.438 HG22 ' CD2' ' A' ' 57' ' ' PHE . 99.5 t -117.13 133.44 63.88 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-O 121.096 0.474 . . . . 0.0 111.293 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.557 ' CD1' HD13 ' A' ' 58' ' ' LEU . 53.6 m-85 -98.91 168.45 10.1 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 115.366 -0.833 . . . . 0.0 109.669 176.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 60.1 tp60 -66.68 132.65 48.58 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.311 0.577 . . . . 0.0 111.766 -171.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.489 ' HA ' ' O ' ' A' ' 54' ' ' SER . 19.5 pm0 -82.2 144.72 30.49 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.43 -179.142 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.512 ' HB3' ' HB2' ' A' ' 54' ' ' SER . 6.8 tp-100 -64.6 -45.61 86.19 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -174.46 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.436 HD12 ' HB2' ' A' ' 51' ' ' ALA . 87.8 mt . . . . . 0 C--N 1.315 -0.914 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -175.668 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 . . . . . 0 N--CA 1.441 -0.88 0 CA-C-O 121.11 0.481 . . . . 0.0 110.624 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.427 ' O ' ' HD3' ' A' ' 30' ' ' ARG . 11.6 pt -114.03 160.84 13.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.091 -175.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.458 ' H ' ' HA ' ' A' ' 77' ' ' ASP . 23.4 ttmt -100.76 145.39 28.56 Favored 'General case' 0 C--N 1.283 -2.324 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.622 -179.175 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.678 HG21 HD12 ' A' ' 81' ' ' ILE . 39.7 mm -126.21 127.57 70.89 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.357 175.137 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.451 ' HE2' HG22 ' A' ' 80' ' ' VAL . 15.1 mtmt -96.36 104.98 16.98 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 176.415 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.656 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 85.0 t -81.7 109.45 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.591 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.223 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.1 t -112.24 118.36 57.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -178.653 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.48 ' HA2' ' HB ' ' A' ' 83' ' ' VAL . . . -96.28 160.47 22.13 Favored Glycine 0 C--N 1.304 -1.196 0 C-N-CA 120.074 -1.06 . . . . 0.0 112.293 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.468 ' C ' ' H ' ' A' ' 24' ' ' SER . 16.4 pt20 -66.52 -20.35 66.01 Favored 'General case' 0 CA--C 1.495 -1.163 0 CA-C-O 122.427 1.108 . . . . 0.0 109.67 177.277 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -69.33 5.41 1.31 Allowed 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 113.122 -1.853 . . . . 0.0 109.507 173.377 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.468 ' H ' ' C ' ' A' ' 22' ' ' GLN . 50.2 m 63.13 31.59 15.68 Favored 'General case' 0 C--N 1.35 0.625 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.154 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -110.39 108.07 17.99 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 114.843 -1.071 . . . . 0.0 111.042 -177.286 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.656 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 30.8 tt0 -103.82 133.85 48.11 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.522 175.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.3 p -139.23 139.39 39.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-N 115.663 -0.698 . . . . 0.0 109.52 177.503 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 63.6 m170 -98.04 117.17 31.8 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.205 0.526 . . . . 0.0 111.433 -176.6 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -112.73 146.52 38.61 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.298 175.102 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.427 ' HD3' ' O ' ' A' ' 15' ' ' ILE . 23.8 tpp180 -103.31 120.53 40.94 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.458 ' HB ' ' OG1' ' A' ' 35' ' ' THR . 29.0 m -132.07 167.82 25.5 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -177.449 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.57 ' O ' ' HB ' ' A' ' 35' ' ' THR . 43.0 tttm -91.06 161.38 15.14 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.847 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.644 ' O ' ' HB3' ' A' ' 70' ' ' PRO . 97.1 m-85 -58.96 -38.23 78.6 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 171.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.626 ' HA2' ' CG ' ' A' ' 70' ' ' PRO . . . -85.64 21.81 13.13 Favored Glycine 0 N--CA 1.433 -1.547 0 CA-C-N 114.621 -1.172 . . . . 0.0 112.167 -178.105 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.57 ' HB ' ' O ' ' A' ' 32' ' ' LYS . 0.9 OUTLIER -68.56 141.01 55.61 Favored 'General case' 0 N--CA 1.425 -1.699 0 CA-C-O 121.384 0.611 . . . . 0.0 111.684 179.775 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.477 ' HB3' ' HE1' ' A' ' 37' ' ' MET . 48.7 m -88.47 143.37 27.02 Favored 'General case' 0 N--CA 1.416 -2.148 0 CA-C-N 115.405 -0.816 . . . . 0.0 108.939 177.381 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.807 ' SD ' ' HA ' ' A' ' 66' ' ' ASP . 0.2 OUTLIER -51.65 -40.1 59.37 Favored 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 123.575 0.75 . . . . 0.0 111.482 179.647 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.505 ' N ' ' HG2' ' A' ' 37' ' ' MET . . . -62.35 -27.02 68.77 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.152 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -60.47 -40.43 91.21 Favored 'General case' 0 C--O 1.21 -0.995 0 C-N-CA 121.111 -0.235 . . . . 0.0 110.84 -178.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.508 HD23 ' H ' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -85.47 -39.12 17.84 Favored 'General case' 0 C--N 1.309 -1.183 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.889 -176.764 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.492 ' HA ' ' HE1' ' A' ' 57' ' ' PHE . 61.7 mtpt -65.49 -44.86 85.79 Favored 'General case' 0 CA--C 1.493 -1.225 0 CA-C-O 120.728 0.299 . . . . 0.0 110.773 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.604 ' HD3' HG21 ' A' ' 52' ' ' VAL . 15.5 tppt? -62.97 -43.23 99.35 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 176.847 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 58.1 m -69.53 -50.25 46.79 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.366 -0.833 . . . . 0.0 113.196 -176.536 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.62 ' O ' ' HG3' ' A' ' 47' ' ' ARG . 62.4 t80 -64.67 -47.23 79.18 Favored 'General case' 0 CA--C 1.496 -1.116 0 CA-C-O 120.674 0.273 . . . . 0.0 111.233 -179.143 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.25 -36.5 77.91 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 121.367 0.603 . . . . 0.0 109.471 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -66.21 -45.59 80.22 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.315 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.62 ' HG3' ' O ' ' A' ' 44' ' ' TYR . 5.1 ppt_? -67.27 -25.01 65.85 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.347 -178.099 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.544 HG22 ' O ' ' A' ' 44' ' ' TYR . 10.2 t -99.07 -17.81 18.06 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 120.815 0.341 . . . . 0.0 111.61 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.1 32.59 35.22 Favored Glycine 0 C--O 1.227 -0.298 0 C-N-CA 120.471 -0.871 . . . . 0.0 113.021 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.579 HG21 ' HG3' ' A' ' 86' ' ' GLU . 4.3 p -115.13 160.96 14.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 O-C-N 122.555 -0.379 . . . . 0.0 110.292 -179.49 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.488 ' HB3' ' OG ' ' A' ' 54' ' ' SER . . . -57.91 129.31 41.34 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 178.126 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.604 HG21 ' HD3' ' A' ' 42' ' ' LYS . 78.6 t -61.53 -43.65 97.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.648 -178.27 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -64.53 -33.98 77.18 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.541 -179.539 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.488 ' OG ' ' HB3' ' A' ' 51' ' ' ALA . 90.6 p -78.82 -12.56 60.03 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.96 0.41 . . . . 0.0 110.975 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.405 HD13 ' N ' ' A' ' 56' ' ' ARG . 2.8 tm? -95.86 132.8 40.74 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -178.753 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.405 ' N ' HD13 ' A' ' 55' ' ' LEU . 5.6 ptt180 -144.33 145.8 32.19 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-O 121.259 0.552 . . . . 0.0 112.351 -173.375 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.524 ' CD2' HG22 ' A' ' 83' ' ' VAL . 95.7 m-85 -119.06 147.2 44.38 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.737 176.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 6.7 mp -124.31 138.24 54.4 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.792 175.423 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.594 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 32.2 t80 -117.84 125.93 51.46 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 179.147 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 33.4 t70 58.74 26.86 15.19 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.888 0.852 . . . . 0.0 110.163 -179.427 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 81.33 15.77 75.69 Favored Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.735 177.762 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.594 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 4.4 ppt_? -132.08 155.32 48.3 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-O 121.277 0.56 . . . . 0.0 112.042 179.242 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 16.4 mmm180 -58.68 137.59 57.5 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -175.159 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.487 HD11 ' HB2' ' A' ' 59' ' ' PHE . 75.7 mt -102.09 109.0 25.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 168.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.536 ' C ' ' HG3' ' A' ' 37' ' ' MET . 88.6 m-20 -120.53 161.59 21.04 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 120.638 0.256 . . . . 0.0 111.039 -174.332 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.807 ' HA ' ' SD ' ' A' ' 37' ' ' MET . 4.7 t70 -58.38 -9.75 1.73 Allowed 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 179.355 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -84.14 -15.49 47.03 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.242 177.06 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -71.86 149.78 44.87 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -175.468 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.53 ' O ' HG22 ' A' ' 72' ' ' THR . 35.3 p -117.69 155.29 50.78 Favored Pre-proline 0 N--CA 1.437 -1.11 0 CA-C-N 114.439 -1.255 . . . . 0.0 109.358 177.529 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.644 ' HB3' ' O ' ' A' ' 33' ' ' TYR . 58.5 Cg_exo -54.83 -40.56 84.54 Favored 'Trans proline' 0 N--CA 1.477 0.502 0 C-N-CA 122.803 2.335 . . . . 0.0 113.75 -176.483 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.599 ' C ' ' HD2' ' A' ' 71' ' ' LYS . 0.0 OUTLIER -70.92 -30.0 66.21 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -177.482 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.583 ' N ' ' HD2' ' A' ' 71' ' ' LYS . 4.7 t -81.69 -28.64 33.4 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.484 -177.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 97.9 mt -70.26 -24.78 63.12 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 176.178 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 47.11 30.35 1.33 Allowed 'General case' 0 CA--C 1.551 1.016 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.488 177.262 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 20.5 ptp -75.49 160.23 30.43 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.938 0.399 . . . . 0.0 111.513 -179.401 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -147.52 -177.64 5.81 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.588 -178.499 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.458 ' HA ' ' H ' ' A' ' 16' ' ' LYS . 36.8 t70 -66.14 120.16 12.72 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -176.737 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 20.4 t70 69.19 33.66 3.24 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 114.381 -1.282 . . . . 0.0 110.441 177.157 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.4 ' O ' ' HG3' ' A' ' 18' ' ' LYS . 4.6 t70 -78.19 177.36 8.44 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.612 177.453 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.451 HG22 ' HE2' ' A' ' 18' ' ' LYS . 16.9 t -110.0 135.06 50.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 CA-C-O 121.481 0.658 . . . . 0.0 111.686 -171.5 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.678 HD12 HG21 ' A' ' 17' ' ' ILE . 1.8 mt -132.57 132.46 60.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.703 178.305 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -98.79 141.93 30.96 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.442 -174.424 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.524 HG22 ' CD2' ' A' ' 57' ' ' PHE . 87.6 t -125.88 129.14 72.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-O 121.346 0.593 . . . . 0.0 110.57 177.605 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -107.75 169.18 8.76 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.869 178.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -64.8 138.31 58.3 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.411 0.625 . . . . 0.0 111.303 -172.035 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.579 ' HG3' HG21 ' A' ' 50' ' ' VAL . 0.2 OUTLIER -96.93 160.74 14.18 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.706 -178.496 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.47 ' H ' ' HB2' ' A' ' 54' ' ' SER . 6.5 tp-100 -61.22 -46.02 92.17 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.025 0.441 . . . . 0.0 112.063 -174.296 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 87.4 mt . . . . . 0 C--N 1.31 -1.146 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.892 -176.781 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 . . . . . 0 CA--C 1.507 -0.696 0 CA-C-O 121.189 0.518 . . . . 0.0 111.135 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.4 pt -125.39 161.63 29.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 CA-C-N 115.183 -0.917 . . . . 0.0 108.576 -179.323 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.527 ' HE3' ' HB3' ' A' ' 78' ' ' ASP . 59.6 mtmt -101.29 143.08 31.79 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-O 120.999 0.428 . . . . 0.0 110.535 177.176 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 75.9 mt -124.3 126.67 72.43 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.152 174.597 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 31.0 mtmt -94.83 104.46 16.36 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 177.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.651 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 97.5 t -85.26 112.05 21.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -179.274 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.468 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 5.2 p -115.62 123.41 71.01 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 CA-C-O 121.461 0.648 . . . . 0.0 110.331 179.505 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -85.96 176.68 49.16 Favored Glycine 0 N--CA 1.435 -1.387 0 CA-C-N 115.223 -0.899 . . . . 0.0 112.095 -178.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.576 ' NE2' ' HA ' ' A' ' 84' ' ' TYR . 78.4 mt-30 -77.36 -13.1 60.0 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.382 0.611 . . . . 0.0 111.333 -177.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -87.95 13.51 10.79 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.18 174.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 46.5 m 66.06 32.79 8.05 Favored 'General case' 0 C--N 1.343 0.294 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.378 179.084 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.434 ' O ' ' HA ' ' A' ' 20' ' ' VAL . 94.4 m-20 -105.47 111.71 24.52 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.952 179.255 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.651 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 31.2 tt0 -108.78 132.97 53.46 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.399 -179.389 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.2 p -134.36 143.36 38.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.196 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 27.4 m170 -101.98 113.28 26.36 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.403 0.621 . . . . 0.0 112.105 -175.484 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -111.18 148.86 31.86 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.072 175.641 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -111.8 123.82 51.04 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.901 178.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 32.9 m -136.99 174.3 12.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.229 -179.439 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.456 ' O ' ' HB ' ' A' ' 35' ' ' THR . 35.4 ttmt -89.73 160.95 16.31 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 -179.573 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -54.65 -38.69 67.19 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 120.918 0.39 . . . . 0.0 110.365 177.016 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -100.77 21.92 41.8 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 116.066 -0.516 . . . . 0.0 112.826 -178.502 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.499 HG23 ' HB2' ' A' ' 39' ' ' LYS . 0.9 OUTLIER -60.53 143.08 54.45 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-O 121.376 0.607 . . . . 0.0 112.552 179.8 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 56.1 m -85.97 157.03 20.22 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.285 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.704 ' SD ' ' HA ' ' A' ' 65' ' ' ASN . 25.5 ptm -53.27 -32.73 50.0 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -178.66 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.34 -37.04 84.1 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -178.373 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.499 ' HB2' HG23 ' A' ' 35' ' ' THR . 49.7 mmtm -59.15 -40.65 86.22 Favored 'General case' 0 C--O 1.206 -1.222 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.25 -175.805 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.503 HD23 ' H ' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -86.42 -43.68 12.62 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -179.163 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.408 ' HA ' ' CE1' ' A' ' 57' ' ' PHE . 25.0 mtpp -62.15 -46.97 86.61 Favored 'General case' 0 CA--C 1.502 -0.873 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.05 -177.843 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.434 ' HA ' HG22 ' A' ' 52' ' ' VAL . 29.6 ttpp -63.64 -40.08 95.96 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.136 0.493 . . . . 0.0 110.003 178.302 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 50.9 m -63.66 -49.72 72.08 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.591 -0.732 . . . . 0.0 112.352 -178.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.51 ' CB ' ' HZ ' ' A' ' 57' ' ' PHE . 44.0 t80 -71.86 -45.59 60.86 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.743 0.306 . . . . 0.0 111.611 -179.681 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.572 ' HB1' ' O ' ' A' ' 50' ' ' VAL . . . -58.27 -32.49 68.45 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.133 -178.142 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -62.88 -45.0 94.6 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.353 -0.839 . . . . 0.0 112.223 -179.156 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.478 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 24.0 ptt180 -69.54 -25.17 63.89 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.202 0.525 . . . . 0.0 110.779 -176.647 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.431 HG22 ' O ' ' A' ' 44' ' ' TYR . 7.9 t -102.59 -7.26 21.96 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -174.881 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 68.76 28.31 73.2 Favored Glycine 0 N--CA 1.46 0.268 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.237 178.56 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.572 ' O ' ' HB1' ' A' ' 45' ' ' ALA . 86.9 t -106.53 146.52 12.96 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 C-N-CA 122.613 0.365 . . . . 0.0 110.167 -178.216 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.407 ' HB3' ' HB2' ' A' ' 54' ' ' SER . . . -52.52 133.54 35.62 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 176.778 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.434 HG22 ' HA ' ' A' ' 42' ' ' LYS . 76.9 t -60.48 -43.99 95.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.79 -177.087 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -66.08 -32.4 73.83 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.166 179.406 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.426 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 68.0 m -76.06 -10.81 59.72 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.446 -178.467 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.558 HD12 ' CE1' ' A' ' 57' ' ' PHE . 0.1 OUTLIER -92.68 123.38 35.92 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -179.947 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 28.0 mmm180 -104.47 110.74 23.13 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.757 -170.411 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.558 ' CE1' HD12 ' A' ' 55' ' ' LEU . 69.2 m-85 -110.48 126.95 54.9 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-O 121.043 0.449 . . . . 0.0 110.622 175.507 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.556 HD22 ' CE1' ' A' ' 84' ' ' TYR . 7.7 mp -129.1 144.94 51.37 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.184 178.777 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.74 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 62.5 t80 -111.41 116.46 30.96 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.054 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 58.71 18.7 6.15 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 122.673 0.389 . . . . 0.0 111.907 -179.116 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 98.98 6.72 55.9 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.774 -0.727 . . . . 0.0 113.234 178.624 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.74 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.1 OUTLIER -118.33 146.6 44.24 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.01 0.433 . . . . 0.0 110.06 176.815 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.507 ' HA ' ' HG ' ' A' ' 58' ' ' LEU . 38.9 mtp180 -68.4 134.96 51.01 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.525 -0.762 . . . . 0.0 112.51 -174.302 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 90.8 mt -91.15 119.86 39.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 115.399 -0.819 . . . . 0.0 108.828 178.022 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.704 ' HA ' ' SD ' ' A' ' 37' ' ' MET . 65.5 m-80 -118.6 159.36 23.73 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.635 -178.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -71.07 -12.96 61.81 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.191 0.52 . . . . 0.0 110.433 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -83.62 -19.45 35.43 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.097 -179.055 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -62.31 145.25 54.31 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.316 0.579 . . . . 0.0 112.263 -177.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.431 ' O ' HG22 ' A' ' 72' ' ' THR . 69.4 p -103.38 158.06 32.57 Favored Pre-proline 0 N--CA 1.44 -0.951 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.18 179.221 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -61.63 -21.59 72.42 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.578 2.185 . . . . 0.0 112.51 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.62 -22.47 32.21 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.437 -178.029 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.431 HG22 ' O ' ' A' ' 69' ' ' THR . 4.7 t -95.35 -32.77 12.79 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -179.579 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 96.1 mt -71.99 -25.96 62.05 Favored 'General case' 0 C--O 1.218 -0.554 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.025 177.793 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 48.74 33.34 4.22 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 176.395 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 65.2 mtt -87.21 158.88 19.02 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.293 -179.029 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -149.58 -179.42 7.08 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 177.635 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.402 ' HA ' ' H ' ' A' ' 16' ' ' LYS . 38.1 t70 -56.33 127.88 33.09 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.259 0.552 . . . . 0.0 112.123 -176.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.527 ' HB3' ' HE3' ' A' ' 16' ' ' LYS . 1.0 OUTLIER 67.27 32.63 5.88 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.591 1.556 . . . . 0.0 114.117 174.204 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -78.78 178.68 7.72 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 176.55 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.6 m -112.35 151.71 14.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 CA-C-O 121.271 0.558 . . . . 0.0 111.784 -174.453 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.482 HG22 ' HA ' ' A' ' 19' ' ' VAL . 1.0 OUTLIER -131.44 144.81 36.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 CA-C-N 115.453 -0.794 . . . . 0.0 108.878 178.023 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -104.55 139.29 39.65 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.964 -178.566 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 87.4 t -121.31 130.42 74.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 CA-C-O 121.235 0.54 . . . . 0.0 110.958 -179.591 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.576 ' HA ' ' NE2' ' A' ' 22' ' ' GLN . 77.4 m-85 -101.11 168.5 9.55 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.198 178.024 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 80.9 mm-40 -67.83 133.52 49.34 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.608 0.718 . . . . 0.0 111.821 -171.671 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.426 ' HA ' ' O ' ' A' ' 54' ' ' SER . 3.2 pm0 -79.85 157.52 26.97 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.488 -1.233 . . . . 0.0 112.224 -176.489 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -79.32 -52.18 8.45 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -177.266 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.43 ' HB3' HG13 ' A' ' 50' ' ' VAL . 56.4 tp . . . . . 0 C--N 1.33 -0.274 0 CA-C-O 120.876 0.37 . . . . 0.0 111.432 -178.056 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 . . . . . 0 N--CA 1.432 -1.358 0 CA-C-O 121.338 0.59 . . . . 0.0 110.496 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.416 ' O ' ' HD3' ' A' ' 30' ' ' ARG . 9.0 pt -110.5 161.54 8.83 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.048 -174.292 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.51 ' HB2' ' NH1' ' A' ' 30' ' ' ARG . 34.5 ttpt -109.1 144.22 37.43 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -179.231 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.637 HG21 HD12 ' A' ' 81' ' ' ILE . 82.2 mt -132.33 133.61 59.96 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.161 0 CA-C-O 120.775 0.322 . . . . 0.0 111.598 178.142 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.8 mtmt -94.87 105.23 17.14 Favored 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.127 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.698 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 75.0 t -82.28 117.64 28.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 175.36 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.536 ' HA ' ' O ' ' A' ' 25' ' ' ASN . 7.6 p -122.05 122.11 65.77 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 CA-C-O 121.727 0.775 . . . . 0.0 111.453 179.529 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.453 ' HA2' ' HB ' ' A' ' 83' ' ' VAL . . . -91.2 171.98 35.99 Favored Glycine 0 N--CA 1.436 -1.355 0 CA-C-N 114.867 -1.06 . . . . 0.0 111.535 179.451 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.453 ' C ' ' H ' ' A' ' 24' ' ' SER . 88.1 mm-40 -70.76 -27.32 63.85 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 120.933 0.397 . . . . 0.0 111.895 -176.143 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -79.63 21.84 0.5 Allowed 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.362 175.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.453 ' H ' ' C ' ' A' ' 22' ' ' GLN . 21.2 m 68.59 27.09 6.19 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.687 176.685 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.536 ' O ' ' HA ' ' A' ' 20' ' ' VAL . 58.2 t30 -93.85 102.09 14.2 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 119.895 -0.722 . . . . 0.0 111.167 -179.65 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.698 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 35.6 tt0 -112.84 127.49 56.19 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.47 177.723 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.7 p -136.4 145.0 31.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.712 -177.388 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 63.5 m170 -92.41 117.59 30.07 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.308 0.575 . . . . 0.0 111.917 -178.407 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -109.5 141.76 41.49 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.805 174.155 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.51 ' NH1' ' HB2' ' A' ' 16' ' ' LYS . 23.9 tpp180 -102.57 116.35 32.42 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 177.019 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.545 HG21 HD12 ' A' ' 17' ' ' ILE . 34.5 m -134.43 174.86 12.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.212 -176.641 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.469 ' O ' ' HB ' ' A' ' 35' ' ' THR . 38.0 ttmt -88.54 158.83 18.18 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.451 ' HB3' ' HB3' ' A' ' 70' ' ' PRO . 98.4 m-85 -55.43 -40.57 71.66 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 174.227 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -101.99 33.81 6.21 Favored Glycine 0 N--CA 1.449 -0.462 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.163 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.482 ' OG1' ' HB ' ' A' ' 31' ' ' VAL . 0.6 OUTLIER -65.69 140.32 58.46 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 121.317 0.58 . . . . 0.0 111.936 179.356 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.511 ' OG ' ' HG2' ' A' ' 39' ' ' LYS . 85.9 p -81.08 160.03 24.59 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.137 178.77 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.606 ' SD ' ' HA ' ' A' ' 65' ' ' ASN . 26.5 ptt? -60.82 -32.49 71.87 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.933 0.397 . . . . 0.0 110.687 178.096 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.74 -36.27 80.49 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.45 -177.749 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.511 ' HG2' ' OG ' ' A' ' 36' ' ' SER . 75.6 mmtt -59.63 -41.82 91.31 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.999 -176.615 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.501 HD23 ' H ' ' A' ' 40' ' ' LEU . 0.5 OUTLIER -89.42 -47.87 7.72 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -179.738 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.627 ' HG2' ' CD1' ' A' ' 57' ' ' PHE . 61.8 mtpt -62.37 -47.93 82.02 Favored 'General case' 0 CA--C 1.492 -1.271 0 CA-C-N 116.282 -0.417 . . . . 0.0 112.09 -174.524 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -61.69 -43.3 99.12 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 178.078 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 42.7 t -64.98 -51.51 61.31 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.371 -0.832 . . . . 0.0 111.294 -176.16 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.511 ' O ' HG22 ' A' ' 48' ' ' THR . 62.9 t80 -65.99 -49.06 69.12 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.937 -179.486 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.497 ' HB1' ' O ' ' A' ' 50' ' ' VAL . . . -59.74 -35.17 74.04 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.521 0.676 . . . . 0.0 109.788 -178.324 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -65.31 -47.0 78.08 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.248 -178.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.422 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 14.2 ptm180 -68.35 -26.39 65.57 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.568 -178.035 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.511 HG22 ' O ' ' A' ' 44' ' ' TYR . 8.8 t -96.71 -3.51 42.42 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -178.194 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 68.51 35.56 81.66 Favored Glycine 0 C--N 1.335 0.5 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.706 178.525 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.574 HG11 ' HG3' ' A' ' 86' ' ' GLU . 78.2 t -118.83 144.54 26.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 C-N-CA 122.406 0.282 . . . . 0.0 111.346 -177.671 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.467 ' HB3' ' HB2' ' A' ' 54' ' ' SER . . . -51.25 129.31 24.32 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.968 176.008 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 77.0 t -61.42 -43.94 97.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.019 -177.509 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -65.75 -32.43 73.96 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.016 -179.432 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.468 ' HB3' ' HB3' ' A' ' 87' ' ' GLN . 51.5 m -83.57 -6.17 59.37 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.687 -178.285 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.521 HD12 ' CE1' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -96.43 121.17 37.95 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 176.617 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.21 126.47 52.26 Favored 'General case' 0 CA--C 1.499 -1.012 0 C-N-CA 120.112 -0.635 . . . . 0.0 110.834 -176.621 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.627 ' CD1' ' HG2' ' A' ' 41' ' ' LYS . 22.2 m-85 -106.98 131.04 54.5 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 176.77 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.524 HD13 ' HA ' ' A' ' 63' ' ' ARG . 2.9 mm? -120.88 155.06 34.96 Favored 'General case' 0 N--CA 1.417 -2.075 0 CA-C-O 122.29 1.043 . . . . 0.0 113.068 -174.74 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.627 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 54.1 t80 -122.79 105.99 10.52 Favored 'General case' 0 C--N 1.282 -2.339 0 CA-C-N 113.289 -1.778 . . . . 0.0 108.103 174.536 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 54.26 28.46 9.24 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.805 -176.58 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 96.4 -7.83 66.43 Favored Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.543 -0.753 . . . . 0.0 113.117 177.554 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.627 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 4.1 ppt_? -104.34 147.15 27.84 Favored 'General case' 0 N--CA 1.438 -1.034 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.078 179.287 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.524 ' HA ' HD13 ' A' ' 58' ' ' LEU . 0.1 OUTLIER -67.9 143.77 55.56 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -171.4 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 81.9 mt -102.87 121.42 54.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.273 -0.876 . . . . 0.0 108.709 174.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.606 ' HA ' ' SD ' ' A' ' 37' ' ' MET . 66.4 m-80 -121.41 172.41 8.07 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 120.916 0.389 . . . . 0.0 110.997 -178.177 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -70.21 -13.21 62.08 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.076 0.465 . . . . 0.0 110.96 -178.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -82.29 -14.82 54.8 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.011 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.431 ' CG ' HH12 ' A' ' 62' ' ' ARG . 4.6 m-20 -65.17 153.73 40.07 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 -177.048 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.42 ' HB ' ' HD2' ' A' ' 70' ' ' PRO . 70.2 p -126.28 159.35 63.11 Favored Pre-proline 0 N--CA 1.435 -1.206 0 CA-C-N 114.156 -1.384 . . . . 0.0 109.54 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.451 ' HB3' ' HB3' ' A' ' 33' ' ' TYR . 33.3 Cg_endo -63.71 -19.49 67.33 Favored 'Trans proline' 0 C--O 1.224 -0.183 0 C-N-CA 122.515 2.143 . . . . 0.0 112.688 -179.556 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.49 -26.99 37.88 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-O 120.81 0.338 . . . . 0.0 111.143 -178.219 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.404 HG22 ' H ' ' A' ' 69' ' ' THR . 12.3 t -94.82 -36.75 11.54 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 120.861 0.362 . . . . 0.0 110.181 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 95.8 mt -75.33 -23.14 57.22 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 175.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 52.94 29.03 7.22 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.728 178.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.437 ' HA ' ' OD2' ' A' ' 79' ' ' ASP . 66.2 mtt -85.71 157.18 20.36 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.166 -178.081 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.48 ' H ' ' HB2' ' A' ' 79' ' ' ASP . 14.0 pt-20 -152.79 -173.57 4.62 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.157 -178.072 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.445 ' HA ' ' H ' ' A' ' 16' ' ' LYS . 28.3 t70 -57.66 120.84 9.05 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.709 0.766 . . . . 0.0 112.569 -176.303 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.485 ' OD1' ' HE3' ' A' ' 16' ' ' LYS . 29.5 t70 65.86 34.16 7.49 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.442 1.497 . . . . 0.0 111.054 178.464 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.48 ' HB2' ' H ' ' A' ' 76' ' ' GLU . 31.9 t0 -75.06 176.3 7.37 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.413 177.343 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 35.3 m -111.87 143.24 22.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 CA-C-O 121.847 0.832 . . . . 0.0 112.883 -174.571 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.637 HD12 HG21 ' A' ' 17' ' ' ILE . 3.3 mt -128.47 134.15 65.27 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 CA-C-N 114.234 -1.348 . . . . 0.0 109.425 176.026 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -101.7 138.16 39.06 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.105 0.478 . . . . 0.0 110.677 -177.129 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.453 ' HB ' ' HA2' ' A' ' 21' ' ' GLY . 88.6 t -123.5 133.76 68.26 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.644 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.481 ' CD1' HD23 ' A' ' 58' ' ' LEU . 53.7 m-85 -99.5 152.48 19.95 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 175.279 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 10.5 mm100 -68.32 129.24 39.34 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 122.004 0.907 . . . . 0.0 112.568 -169.302 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.574 ' HG3' HG11 ' A' ' 50' ' ' VAL . 1.4 pm0 -64.05 160.87 17.12 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 113.473 -1.694 . . . . 0.0 113.548 -172.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.468 ' HB3' ' HB3' ' A' ' 54' ' ' SER . 6.6 tp-100 -64.96 -48.72 73.01 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.404 -178.212 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.5 HD23 ' HA ' ' A' ' 50' ' ' VAL . 56.7 tp . . . . . 0 C--N 1.322 -0.604 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.868 -179.05 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 . . . . . 0 N--CA 1.439 -1.021 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.423 ' HB ' ' HA ' ' A' ' 77' ' ' ASP . 18.3 pt -127.16 161.95 33.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -177.477 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.536 ' HE3' ' HB2' ' A' ' 78' ' ' ASP . 59.3 mtmt -97.55 146.47 25.23 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-O 121.045 0.45 . . . . 0.0 110.599 176.521 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.672 HG21 HD12 ' A' ' 81' ' ' ILE . 40.7 mm -128.1 127.37 67.64 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 CA-C-N 115.498 -0.773 . . . . 0.0 109.833 174.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.9 mtmt -96.75 104.77 16.8 Favored 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 177.47 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.7 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 98.8 t -82.21 116.88 27.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.6 t -113.03 117.61 55.82 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-O 121.082 0.467 . . . . 0.0 110.738 -178.434 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -88.49 168.58 36.59 Favored Glycine 0 N--CA 1.436 -1.317 0 C-N-CA 120.431 -0.89 . . . . 0.0 111.378 177.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -67.89 -23.78 65.15 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.191 0.52 . . . . 0.0 111.902 -178.421 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -79.5 11.27 3.14 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.124 178.075 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.1 m 69.0 27.29 5.44 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.811 -178.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -95.66 104.63 16.55 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.737 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.7 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 37.7 tt0 -105.02 135.37 46.48 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.673 178.751 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.1 p -137.17 140.22 42.74 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.457 178.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 55.1 m170 -99.05 113.14 25.18 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 121.307 0.575 . . . . 0.0 111.156 -176.123 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -110.65 145.38 38.04 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.718 176.467 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 11.1 tpt180 -99.95 118.07 35.59 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.249 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.48 ' HB ' HG21 ' A' ' 35' ' ' THR . 33.3 m -133.56 167.75 25.69 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -178.807 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 46.0 tttm -90.82 162.96 14.61 Favored 'General case' 0 C--N 1.284 -2.247 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.275 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.512 ' O ' ' HB3' ' A' ' 70' ' ' PRO . 94.2 m-85 -55.09 -39.18 69.01 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 176.579 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.477 ' HA2' ' HG3' ' A' ' 70' ' ' PRO . . . -96.38 19.26 55.35 Favored Glycine 0 N--CA 1.444 -0.805 0 CA-C-N 115.728 -0.669 . . . . 0.0 113.337 -177.135 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.48 HG21 ' HB ' ' A' ' 31' ' ' VAL . 1.3 m -67.47 136.69 55.03 Favored 'General case' 0 N--CA 1.428 -1.535 0 CA-C-O 121.125 0.488 . . . . 0.0 111.73 179.088 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.572 ' HA ' ' O ' ' A' ' 65' ' ' ASN . 47.0 m -86.28 151.97 23.16 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.497 -178.063 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.476 ' HG2' ' HB2' ' A' ' 66' ' ' ASP . 24.2 ptt? -50.01 -32.27 14.84 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -179.161 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.95 -35.96 78.12 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -178.338 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -59.44 -40.89 88.24 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.083 0.468 . . . . 0.0 110.137 -177.598 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.659 HD12 ' CD2' ' A' ' 57' ' ' PHE . 0.2 OUTLIER -86.8 -43.96 12.1 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.544 -177.684 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 61.6 mtpt -62.79 -47.03 85.24 Favored 'General case' 0 CA--C 1.491 -1.293 0 N-CA-C 111.868 0.321 . . . . 0.0 111.868 -177.195 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -63.72 -40.68 97.35 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.034 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 46.6 t -63.73 -48.77 75.69 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.03 -179.153 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.709 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 43.1 t80 -70.18 -44.84 67.93 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.874 -179.108 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.427 ' CB ' ' HA ' ' A' ' 52' ' ' VAL . . . -59.47 -34.57 72.71 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.229 0.538 . . . . 0.0 109.822 179.348 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -66.43 -45.81 78.6 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.331 -0.849 . . . . 0.0 111.613 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.709 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 10.9 ptm85 -65.59 -28.71 69.33 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.898 -178.353 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.499 HG22 ' O ' ' A' ' 44' ' ' TYR . 9.9 t -93.23 -5.82 49.07 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.718 179.627 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 66.92 35.4 89.46 Favored Glycine 0 C--N 1.335 0.483 0 CA-C-N 116.036 -0.529 . . . . 0.0 113.277 177.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.708 HG21 ' HG3' ' A' ' 86' ' ' GLU . 1.5 p -121.54 166.16 16.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 116.927 0.364 . . . . 0.0 110.967 -177.483 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.413 ' HB3' ' HB2' ' A' ' 54' ' ' SER . . . -57.46 128.72 38.47 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.51 179.081 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.427 ' HA ' ' CB ' ' A' ' 45' ' ' ALA . 73.4 t -61.36 -46.24 96.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.553 -0.748 . . . . 0.0 111.585 -177.037 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -77.33 -14.76 59.67 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.987 -176.804 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.455 ' HB3' ' HB3' ' A' ' 87' ' ' GLN . 70.0 m -85.43 -15.6 42.47 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.528 178.511 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.452 HD13 ' N ' ' A' ' 56' ' ' ARG . 0.8 OUTLIER -95.03 135.03 37.06 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.452 ' N ' HD13 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -130.43 141.42 50.53 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 120.132 -0.627 . . . . 0.0 111.404 -175.203 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.659 ' CD2' HD12 ' A' ' 40' ' ' LEU . 13.7 m-85 -115.5 136.71 52.8 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-N 115.21 -0.904 . . . . 0.0 108.95 177.228 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.757 HD23 ' CD1' ' A' ' 84' ' ' TYR . 0.9 OUTLIER -129.99 151.12 50.9 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-O 121.589 0.709 . . . . 0.0 111.268 178.773 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.719 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 49.5 t80 -113.89 103.47 11.2 Favored 'General case' 0 C--N 1.284 -2.265 0 CA-C-N 114.921 -1.036 . . . . 0.0 108.713 175.866 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.7 t70 54.92 24.29 5.72 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.748 -177.53 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 102.34 -5.7 52.47 Favored Glycine 0 C--N 1.333 0.4 0 CA-C-N 115.601 -0.727 . . . . 0.0 113.663 177.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.719 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.2 OUTLIER -108.4 150.16 27.75 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 117.362 0.581 . . . . 0.0 109.856 178.578 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.493 ' HA ' ' CD1' ' A' ' 58' ' ' LEU . 11.8 mpt_? -66.96 142.86 57.11 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -171.053 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.42 HG21 HD11 ' A' ' 40' ' ' LEU . 44.1 mm -74.59 144.9 11.77 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 CA-C-N 114.816 -1.084 . . . . 0.0 109.502 176.076 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.572 ' O ' ' HA ' ' A' ' 36' ' ' SER . 1.0 OUTLIER -68.35 106.12 2.39 Favored 'General case' 0 N--CA 1.406 -2.655 0 N-CA-C 115.089 1.515 . . . . 0.0 115.089 -170.415 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.476 ' HB2' ' HG2' ' A' ' 37' ' ' MET . 4.1 t70 -91.07 -39.65 12.06 Favored 'General case' 0 C--N 1.257 -3.453 0 N-CA-C 102.834 -3.024 . . . . 0.0 102.834 153.494 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -117.7 -17.9 9.78 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 110.82 -2.9 . . . . 0.0 110.927 -176.387 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.569 ' HB2' ' HA ' ' A' ' 65' ' ' ASN . 2.7 m-20 -72.76 168.58 18.5 Favored 'General case' 0 C--N 1.342 0.269 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.964 -176.073 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.683 ' O ' HG22 ' A' ' 72' ' ' THR . 88.8 m -97.47 130.49 29.23 Favored Pre-proline 0 C--N 1.306 -1.324 0 C-N-CA 120.799 -0.361 . . . . 0.0 110.687 -172.416 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.512 ' HB3' ' O ' ' A' ' 33' ' ' TYR . 88.6 Cg_exo -52.62 -37.68 74.93 Favored 'Trans proline' 0 CA--C 1.53 0.295 0 C-N-CA 122.756 2.304 . . . . 0.0 112.127 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.02 -25.06 37.49 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.554 179.672 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.683 HG22 ' O ' ' A' ' 69' ' ' THR . 2.1 t -70.15 -32.81 70.96 Favored 'General case' 0 C--N 1.347 0.473 0 C-N-CA 120.026 -0.67 . . . . 0.0 109.47 178.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 60.4 mt -72.2 -24.99 61.49 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.185 174.004 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 57.22 40.52 27.93 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.359 179.329 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 24.7 mmt -72.55 155.62 39.87 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.834 -179.632 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -151.59 175.75 12.03 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 176.325 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.423 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 37.6 t70 -58.26 121.35 10.54 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.456 0.646 . . . . 0.0 112.335 -178.057 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.536 ' HB2' ' HE3' ' A' ' 16' ' ' LYS . 13.5 t70 74.19 34.28 0.85 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.351 1.461 . . . . 0.0 111.982 176.797 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -75.71 177.51 6.79 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.597 -0.441 . . . . 0.0 109.984 177.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 33.1 m -110.23 147.63 14.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 CA-C-O 121.546 0.689 . . . . 0.0 112.28 -173.675 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.672 HD12 HG21 ' A' ' 17' ' ' ILE . 0.3 OUTLIER -140.61 144.82 26.61 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.302 -179.85 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -110.28 143.08 40.99 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.169 -175.39 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 86.6 t -125.4 132.43 71.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.131 0.491 . . . . 0.0 111.479 179.238 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.757 ' CD1' HD23 ' A' ' 58' ' ' LEU . 90.5 m-85 -100.44 162.49 12.91 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.784 177.165 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 53.3 tp60 -69.45 143.97 53.42 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -176.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.708 ' HG3' HG21 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -90.0 171.15 9.77 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 112.991 0.738 . . . . 0.0 112.991 -175.12 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.455 ' HB3' ' HB3' ' A' ' 54' ' ' SER . 51.9 tt0 -62.06 -50.01 73.69 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.044 -0.98 . . . . 0.0 112.613 -178.5 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.8 mp . . . . . 0 C--N 1.32 -0.712 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.022 -178.009 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.456 ' HB2' ' HG3' ' A' ' 30' ' ' ARG . 90.7 m-85 . . . . . 0 N--CA 1.442 -0.871 0 CA-C-O 121.098 0.475 . . . . 0.0 111.769 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.856 HD12 ' HA ' ' A' ' 76' ' ' GLU . 17.1 pt -109.56 163.62 6.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.326 -174.526 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.538 ' C ' HD12 ' A' ' 17' ' ' ILE . 38.0 mtmm -90.28 145.88 24.65 Favored 'General case' 0 CA--C 1.5 -0.95 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.654 HD13 ' CG2' ' A' ' 31' ' ' VAL . 1.5 mp -135.18 137.04 50.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.632 173.179 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 18.6 mtmm -97.29 104.53 16.56 Favored 'General case' 0 N--CA 1.437 -1.083 0 C-N-CA 119.979 -0.688 . . . . 0.0 109.191 178.73 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.627 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 85.3 t -82.64 116.17 26.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.422 179.309 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.8 t -107.69 118.85 56.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-O 120.833 0.349 . . . . 0.0 110.077 179.62 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.484 ' HA2' ' HB ' ' A' ' 83' ' ' VAL . . . -87.97 177.06 46.13 Favored Glycine 0 C--N 1.314 -0.663 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.414 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.514 ' C ' ' H ' ' A' ' 24' ' ' SER . 91.0 mm-40 -65.62 -36.75 84.63 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -178.102 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.64 18.85 0.22 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.954 0.407 . . . . 0.0 109.99 176.719 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.514 ' H ' ' C ' ' A' ' 22' ' ' GLN . 51.0 m 62.12 30.41 17.77 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.153 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -92.06 107.07 18.94 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.947 -178.702 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.627 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 32.2 tt0 -97.4 132.3 43.25 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.892 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.417 HG13 ' HB ' ' A' ' 19' ' ' VAL . 7.4 p -135.76 139.82 45.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.522 178.834 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 61.7 m170 -95.91 114.0 25.68 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 121.17 0.51 . . . . 0.0 110.916 -176.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -110.37 153.41 24.98 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.583 177.623 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.456 ' HG3' ' HB2' ' A' ' 14' ' ' TYR . 11.7 tpp180 -108.74 115.59 30.39 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.66 179.3 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.654 ' CG2' HD13 ' A' ' 17' ' ' ILE . 30.3 m -140.36 -178.94 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.412 -178.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.536 ' O ' ' HB ' ' A' ' 35' ' ' THR . 83.6 tttt -88.68 155.22 19.72 Favored 'General case' 0 C--N 1.313 -1.001 0 O-C-N 122.361 -0.212 . . . . 0.0 110.674 -177.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -51.79 -45.41 63.83 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-O 121.381 0.61 . . . . 0.0 110.123 176.498 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -109.84 35.43 4.88 Favored Glycine 0 N--CA 1.441 -1.012 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.967 179.417 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.655 ' O ' HD13 ' A' ' 73' ' ' LEU . 0.5 OUTLIER -57.19 143.43 39.12 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 121.475 0.655 . . . . 0.0 110.893 -177.164 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 59.3 m -79.85 150.02 30.79 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.757 -179.244 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.69 ' HA ' HD21 ' A' ' 40' ' ' LEU . 26.6 ptt? -49.64 -32.31 12.79 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -177.541 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.24 -36.07 82.42 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -179.601 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -59.19 -41.48 88.59 Favored 'General case' 0 C--O 1.217 -0.65 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.165 -175.645 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.719 HD23 ' H ' ' A' ' 40' ' ' LEU . 0.5 OUTLIER -86.25 -45.64 11.09 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.168 -176.87 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -62.45 -47.92 81.92 Favored 'General case' 0 CA--C 1.492 -1.257 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.761 -176.552 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -65.72 -39.67 91.41 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.166 178.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 44.9 t -64.35 -51.45 63.27 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.34 -178.355 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.613 ' O ' ' HG3' ' A' ' 47' ' ' ARG . 47.6 t80 -66.82 -44.0 82.3 Favored 'General case' 0 CA--C 1.499 -1.002 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.45 179.53 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.442 ' HA ' HG12 ' A' ' 50' ' ' VAL . . . -58.58 -36.16 73.53 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.01 0.434 . . . . 0.0 109.855 -179.202 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -67.58 -44.79 77.33 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.778 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.613 ' HG3' ' O ' ' A' ' 44' ' ' TYR . 2.1 ppt_? -64.33 -25.87 68.23 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.65 -178.05 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.534 HG22 ' O ' ' A' ' 44' ' ' TYR . 10.1 t -104.17 -9.33 18.76 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.815 -178.148 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 68.92 39.56 85.14 Favored Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.737 -0.744 . . . . 0.0 113.036 179.027 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.523 HG21 ' HG3' ' A' ' 86' ' ' GLU . 5.2 p -118.21 164.32 14.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 120.981 0.419 . . . . 0.0 111.026 -178.01 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.596 ' HB3' ' OG ' ' A' ' 54' ' ' SER . . . -59.99 128.55 37.39 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.991 175.769 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 73.4 t -64.39 -40.96 90.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 121.131 0.491 . . . . 0.0 110.401 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 32.2 p-10 -67.24 -27.83 67.55 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.36 -177.757 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.596 ' OG ' ' HB3' ' A' ' 51' ' ' ALA . 88.4 p -97.58 1.18 48.55 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.079 0.466 . . . . 0.0 111.618 179.314 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -96.85 133.49 41.4 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 175.192 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.75 144.16 35.35 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -174.711 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.652 ' CG ' HD12 ' A' ' 40' ' ' LEU . 63.4 m-85 -119.14 142.86 47.56 Favored 'General case' 0 CA--C 1.501 -0.921 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.618 176.419 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.639 HD22 ' CE1' ' A' ' 84' ' ' TYR . 8.1 mp -130.84 133.87 46.31 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.628 178.248 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.778 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 0.3 OUTLIER -109.33 114.63 28.47 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.945 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 38.7 t70 66.27 22.48 10.91 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 122.044 0.926 . . . . 0.0 110.674 -177.083 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 89.9 9.53 65.86 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.41 -0.814 . . . . 0.0 113.055 176.101 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.778 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.2 OUTLIER -117.62 148.62 41.77 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.753 179.588 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.474 ' HD3' HD11 ' A' ' 58' ' ' LEU . 26.1 mmt85 -65.41 133.26 50.96 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.245 -175.736 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.486 HD12 ' HB3' ' A' ' 57' ' ' PHE . 87.9 mt -93.67 120.55 43.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.213 -178.317 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.652 ' HA ' ' SD ' ' A' ' 37' ' ' MET . 22.1 m120 -115.83 162.48 17.25 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.773 177.019 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -70.1 -15.0 62.92 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.214 0.53 . . . . 0.0 110.573 -179.171 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -84.12 -18.83 35.52 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.701 -178.568 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.65 ' CG ' HH12 ' A' ' 62' ' ' ARG . 65.9 m-20 -71.21 171.49 10.95 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 115.413 1.635 . . . . 0.0 115.413 -172.808 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.69 ' O ' ' HG ' ' A' ' 73' ' ' LEU . 71.8 p -93.57 156.39 39.76 Favored Pre-proline 0 C--N 1.346 0.449 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.352 -172.036 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.739 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 9.6 Cg_endo -49.77 -26.51 13.6 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 123.352 2.702 . . . . 0.0 113.793 -175.047 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.85 ' HA ' ' CG ' ' A' ' 75' ' ' MET . 0.0 OUTLIER -74.04 -24.35 59.53 Favored 'General case' 0 C--O 1.214 -0.775 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 -179.558 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.563 ' CG2' ' HB3' ' A' ' 68' ' ' ASP . 0.5 OUTLIER -101.85 -6.8 23.12 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 176.126 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.739 ' HB2' ' HA ' ' A' ' 70' ' ' PRO . 0.7 OUTLIER -101.44 24.58 9.43 Favored 'General case' 0 CA--C 1.444 -3.098 0 CA-C-N 111.807 -2.451 . . . . 0.0 115.409 -172.661 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.734 ' HB2' ' O ' ' A' ' 73' ' ' LEU . 35.7 mt-10 76.26 65.62 0.05 Allowed 'General case' 0 C--N 1.303 -1.413 0 CA-C-O 122.903 1.335 . . . . 0.0 111.35 174.448 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.85 ' CG ' ' HA ' ' A' ' 71' ' ' LYS . 90.1 mtp -39.58 -179.31 0.0 OUTLIER 'General case' 0 C--N 1.267 -2.984 0 CA-C-N 111.812 -2.449 . . . . 0.0 116.201 171.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.856 ' HA ' HD12 ' A' ' 15' ' ' ILE . 14.9 pt-20 -71.74 -178.05 2.14 Favored 'General case' 0 CA--C 1.486 -1.508 0 C-N-CA 124.812 1.245 . . . . 0.0 113.13 -156.488 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -35.34 99.76 0.02 OUTLIER 'General case' 0 CA--C 1.506 -0.74 0 O-C-N 124.862 1.351 . . . . 0.0 113.932 -168.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 14.0 t70 82.42 33.23 0.08 Allowed 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 112.181 -2.281 . . . . 0.0 112.566 171.462 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -70.44 178.9 2.71 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 119.828 -0.749 . . . . 0.0 109.57 172.117 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 29.3 m -110.92 151.02 13.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -172.032 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.487 HG13 ' HG2' ' A' ' 74' ' ' GLU . 1.3 mm -138.87 145.93 26.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.017 -0.992 . . . . 0.0 111.674 -178.48 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -112.16 138.8 48.34 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 116.114 -0.493 . . . . 0.0 109.83 178.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.484 ' HB ' ' HA2' ' A' ' 21' ' ' GLY . 78.3 t -125.83 132.8 70.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 CA-C-O 121.063 0.459 . . . . 0.0 111.092 179.54 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.639 ' CE1' HD22 ' A' ' 58' ' ' LEU . 70.7 m-85 -98.84 140.88 32.35 Favored 'General case' 0 N--CA 1.418 -2.056 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 174.263 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -68.15 127.12 31.75 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 121.806 0.812 . . . . 0.0 112.152 -164.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.523 ' HG3' HG21 ' A' ' 50' ' ' VAL . 13.2 pm0 -64.54 157.44 26.82 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 113.84 -1.527 . . . . 0.0 113.029 -175.262 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 57.9 tp60 -66.23 -45.22 81.42 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.999 -1.001 . . . . 0.0 112.928 -174.212 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 93.4 mt . . . . . 0 C--N 1.315 -0.898 0 CA-C-N 116.13 -0.487 . . . . 0.0 112.292 -174.656 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 . . . . . 0 CA--C 1.511 -0.549 0 CA-C-O 121.51 0.672 . . . . 0.0 112.343 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 18.2 pt -126.89 162.89 30.62 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.285 -175.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.412 ' HB2' ' N ' ' A' ' 78' ' ' ASP . 28.3 mtpp -92.27 145.35 24.55 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.048 178.548 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.406 ' CG2' HD13 ' A' ' 81' ' ' ILE . 31.2 mm -135.02 129.8 51.26 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 CA-C-O 120.856 0.36 . . . . 0.0 111.305 175.288 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 22.3 mtmt -100.34 108.13 20.09 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 177.576 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.648 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 77.5 t -81.69 117.76 28.25 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 177.873 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 59.4 t -112.29 118.78 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 CA-C-O 121.189 0.519 . . . . 0.0 110.571 -178.41 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.415 ' HA2' ' HB ' ' A' ' 83' ' ' VAL . . . -86.89 168.24 39.11 Favored Glycine 0 N--CA 1.436 -1.344 0 C-N-CA 120.494 -0.86 . . . . 0.0 111.44 177.384 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.453 ' HG2' ' O ' ' A' ' 83' ' ' VAL . 87.7 mm-40 -70.87 -20.29 62.54 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.566 0.698 . . . . 0.0 111.498 -178.134 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -84.46 13.84 5.09 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.354 178.233 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.9 m 67.18 28.73 8.06 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.083 -178.299 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -95.58 103.28 15.15 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.063 -179.56 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.648 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 35.4 tt0 -104.03 135.44 45.53 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.03 179.545 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.2 p -135.64 142.38 39.52 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.389 178.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 27.9 m170 -102.08 117.61 35.17 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 121.252 0.548 . . . . 0.0 112.285 -175.355 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.433 ' HZ ' ' CD ' ' A' ' 47' ' ' ARG . 81.0 m-85 -116.33 146.87 42.1 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.49 175.714 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 49.5 ttp180 -104.45 123.02 46.72 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 174.489 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 33.4 m -133.43 174.34 13.37 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.374 -175.541 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.4 ttpp -88.41 157.7 18.6 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -178.298 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.498 ' O ' ' HB3' ' A' ' 70' ' ' PRO . 90.8 m-85 -52.3 -41.22 62.74 Favored 'General case' 0 C--O 1.224 -0.268 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 175.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -104.97 32.31 7.64 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.954 -178.018 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.536 HG23 ' HB2' ' A' ' 39' ' ' LYS . 1.1 m -67.76 134.57 51.25 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 121.28 0.562 . . . . 0.0 111.913 178.438 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.544 ' HB3' ' HA ' ' A' ' 66' ' ' ASP . 69.9 m -91.26 156.31 17.91 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.528 -179.688 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.434 ' HB3' HG22 ' A' ' 64' ' ' ILE . 24.9 ptt? -45.67 -35.75 4.38 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -178.025 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.69 -37.74 85.22 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -176.272 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.536 ' HB2' HG23 ' A' ' 35' ' ' THR . 76.0 mmtt -59.99 -39.87 87.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.778 0.323 . . . . 0.0 110.205 -175.848 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.58 HD12 ' CD1' ' A' ' 57' ' ' PHE . 0.4 OUTLIER -87.58 -42.79 12.47 Favored 'General case' 0 C--O 1.217 -0.629 0 N-CA-C 112.665 0.616 . . . . 0.0 112.665 -177.545 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.479 ' HA ' ' HE1' ' A' ' 57' ' ' PHE . 61.3 mtpt -62.88 -46.24 88.8 Favored 'General case' 0 CA--C 1.493 -1.22 0 CA-C-O 120.574 0.226 . . . . 0.0 111.514 -178.599 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.532 ' O ' ' HB2' ' A' ' 46' ' ' ASP . 40.5 ttpt -62.81 -41.28 99.24 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.638 176.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 46.9 t -69.08 -52.19 30.97 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.63 -177.195 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.669 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 40.3 t80 -64.4 -47.83 77.73 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-O 120.694 0.283 . . . . 0.0 110.935 -178.8 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.443 ' CB ' ' HA ' ' A' ' 52' ' ' VAL . . . -60.13 -33.68 72.48 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.397 0.617 . . . . 0.0 109.968 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.532 ' HB2' ' O ' ' A' ' 42' ' ' LYS . 20.4 t70 -64.02 -47.15 81.36 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.214 -178.842 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.669 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 7.8 ptm180 -69.76 -29.25 66.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.392 -177.163 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.525 HG22 ' O ' ' A' ' 44' ' ' TYR . 7.6 t -88.44 -12.75 42.23 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.965 0.412 . . . . 0.0 110.425 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 69.76 31.58 70.34 Favored Glycine 0 CA--C 1.505 -0.558 0 C-N-CA 121.003 -0.618 . . . . 0.0 111.906 179.226 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.86 HG11 ' HB2' ' A' ' 87' ' ' GLN . 0.5 OUTLIER -115.2 175.12 2.73 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 CA-C-O 120.435 0.16 . . . . 0.0 110.605 -176.064 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.531 ' HB3' ' HB2' ' A' ' 54' ' ' SER . . . -59.16 125.64 24.45 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.912 179.021 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.443 ' HA ' ' CB ' ' A' ' 45' ' ' ALA . 70.2 t -67.1 -44.14 88.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.284 0.564 . . . . 0.0 110.253 178.856 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -66.16 -34.23 77.57 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.847 -178.665 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.531 ' HB2' ' HB3' ' A' ' 51' ' ' ALA . 59.2 m -84.98 -13.83 49.4 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.885 -175.751 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.837 HD23 ' HB3' ' A' ' 87' ' ' GLN . 2.7 tm? -92.98 123.2 36.06 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 179.01 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.409 ' HG3' ' C ' ' A' ' 55' ' ' LEU . 20.4 mtt180 -135.74 146.09 47.3 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.117 -170.091 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.58 ' CD1' HD12 ' A' ' 40' ' ' LEU . 95.2 m-85 -119.97 148.11 43.94 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.965 -179.329 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.415 HD22 ' CE1' ' A' ' 84' ' ' TYR . 7.3 mp -129.07 148.31 51.01 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.517 176.237 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.659 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 18.0 t80 -121.88 120.81 35.59 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 177.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 33.6 t70 61.04 24.05 14.18 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 121.517 0.675 . . . . 0.0 110.707 179.255 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 87.92 8.38 72.77 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.846 179.049 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.659 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 6.0 ppt_? -120.44 152.59 37.77 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 120.356 -0.538 . . . . 0.0 111.274 178.844 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 18.0 mmm180 -65.3 133.95 52.54 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.458 -176.019 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.434 HG22 ' HB3' ' A' ' 37' ' ' MET . 87.0 mt -85.18 129.37 37.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 173.142 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -109.96 162.23 14.72 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.25 0.547 . . . . 0.0 111.034 -172.139 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.544 ' HA ' ' HB3' ' A' ' 36' ' ' SER . 10.9 p-10 -83.47 -7.67 59.5 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.178 0.513 . . . . 0.0 109.688 174.048 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -102.81 -13.02 17.17 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 115.361 -0.836 . . . . 0.0 112.324 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.412 ' OD2' HD21 ' A' ' 73' ' ' LEU . 35.9 p30 -71.62 167.08 20.55 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 113.034 0.754 . . . . 0.0 113.034 -174.713 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.486 ' HB ' ' HD2' ' A' ' 70' ' ' PRO . 53.0 p -120.59 160.23 45.03 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.012 -176.83 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.498 ' HB3' ' O ' ' A' ' 33' ' ' TYR . 12.7 Cg_endo -56.84 -31.34 88.52 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.125 2.55 . . . . 0.0 113.701 -177.129 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.412 ' HE2' ' HB3' ' A' ' 71' ' ' LYS . 2.8 ptpt -70.18 -48.77 55.77 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.645 0.259 . . . . 0.0 111.066 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.42 HG22 ' H ' ' A' ' 69' ' ' THR . 10.0 t -70.87 -27.87 64.14 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 121.007 0.432 . . . . 0.0 109.928 178.181 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.498 ' HB3' ' HG3' ' A' ' 75' ' ' MET . 74.9 mt -70.84 -27.42 63.84 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 174.286 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 53.84 29.38 9.67 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.223 176.174 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.498 ' HG3' ' HB3' ' A' ' 73' ' ' LEU . 88.2 mtp -81.9 150.85 27.55 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.411 -177.605 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -146.73 178.65 8.15 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 177.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -60.58 123.49 17.55 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.729 0.775 . . . . 0.0 112.224 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.412 ' N ' ' HB2' ' A' ' 16' ' ' LYS . 15.4 t70 64.8 33.93 9.8 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 113.865 -1.516 . . . . 0.0 111.033 176.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -76.98 177.84 7.43 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 175.528 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.0 m -114.43 148.6 17.12 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 CA-C-O 121.742 0.782 . . . . 0.0 112.382 -174.571 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.406 HD13 ' CG2' ' A' ' 17' ' ' ILE . 1.1 mp -125.75 136.74 59.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 CA-C-N 114.508 -1.224 . . . . 0.0 108.232 177.811 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -99.97 139.4 35.69 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.143 0.497 . . . . 0.0 110.892 -176.415 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.559 HG22 ' CD2' ' A' ' 57' ' ' PHE . 86.6 t -123.36 130.45 74.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.114 178.294 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.415 ' CE1' HD22 ' A' ' 58' ' ' LEU . 84.1 m-85 -99.28 149.07 23.5 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 174.101 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -69.31 107.26 3.2 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 121.553 0.692 . . . . 0.0 111.017 -171.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.483 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 1.3 mm-40 176.04 114.65 0.02 OUTLIER 'General case' 0 CA--C 1.476 -1.901 0 C-N-CA 125.984 1.714 . . . . 0.0 110.966 -174.198 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.86 ' HB2' HG11 ' A' ' 50' ' ' VAL . 27.8 pt20 -157.18 13.35 0.24 Allowed 'General case' 0 N--CA 1.384 -3.768 0 CA-C-N 113.425 -1.716 . . . . 0.0 108.337 176.692 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 52.3 tp . . . . . 0 C--N 1.309 -1.167 0 CA-C-N 112.857 -1.974 . . . . 0.0 107.624 -170.036 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 . . . . . 0 N--CA 1.444 -0.758 0 CA-C-O 120.947 0.403 . . . . 0.0 111.072 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.759 HD12 ' HA ' ' A' ' 76' ' ' GLU . 11.7 pt -109.05 163.01 6.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-O 121.49 0.662 . . . . 0.0 111.369 -173.107 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.528 ' HD3' ' OD2' ' A' ' 77' ' ' ASP . 42.5 mtpt -92.1 147.67 22.77 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.727 -178.624 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.669 HG13 ' HB3' ' A' ' 74' ' ' GLU . 8.4 mm -139.5 139.34 38.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.613 175.781 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.5 mtmt -101.92 105.25 16.03 Favored 'General case' 0 N--CA 1.431 -1.388 0 C-N-CA 120.105 -0.638 . . . . 0.0 109.638 177.773 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.637 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 76.0 t -80.71 114.06 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 176.347 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 59.2 t -109.34 118.65 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.013 0 CA-C-O 121.154 0.502 . . . . 0.0 110.482 -178.141 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -84.62 173.34 49.35 Favored Glycine 0 N--CA 1.436 -1.318 0 C-N-CA 120.321 -0.942 . . . . 0.0 111.013 176.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 86.7 mm-40 -73.36 -19.18 61.07 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.368 0.604 . . . . 0.0 111.83 -176.74 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -85.5 12.53 8.33 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.161 176.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 51.0 m 67.3 27.13 8.36 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.063 -177.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -89.31 103.4 16.03 Favored 'General case' 0 CA--C 1.495 -1.14 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.876 179.295 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.637 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 36.3 tt0 -104.89 133.44 49.69 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.978 -177.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.3 p -136.57 141.9 39.73 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.466 178.169 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.407 ' HA ' ' O ' ' A' ' 17' ' ' ILE . 63.5 m170 -95.37 119.04 33.19 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 121.405 0.622 . . . . 0.0 111.429 -176.697 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -109.51 150.74 27.69 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.508 175.562 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 17.1 tpp180 -103.36 118.09 35.97 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 176.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.56 ' O ' HG12 ' A' ' 15' ' ' ILE . 34.6 m -136.75 173.13 14.08 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.715 -175.381 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -90.13 156.76 18.12 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.129 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -55.49 -38.86 69.71 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 121.327 0.584 . . . . 0.0 109.518 175.152 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -104.45 33.69 6.37 Favored Glycine 0 N--CA 1.44 -1.037 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.395 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.558 ' O ' HD13 ' A' ' 73' ' ' LEU . 0.9 OUTLIER -63.77 131.7 48.67 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-O 121.695 0.759 . . . . 0.0 111.833 179.568 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 69.9 m -81.15 151.88 28.03 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.254 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.671 ' SD ' ' HA ' ' A' ' 65' ' ' ASN . 27.3 ptt? -48.34 -33.5 9.07 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -178.499 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.52 -36.53 82.87 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 112.203 0.445 . . . . 0.0 112.203 -178.444 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.52 ' HB2' HG23 ' A' ' 35' ' ' THR . 75.8 mmtt -60.74 -41.19 94.87 Favored 'General case' 0 C--O 1.217 -0.622 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.822 -174.416 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.794 HD23 ' H ' ' A' ' 40' ' ' LEU . 0.9 OUTLIER -87.71 -45.14 10.63 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -178.2 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.444 ' HA ' ' HE1' ' A' ' 57' ' ' PHE . 61.1 mtpt -62.65 -46.09 89.84 Favored 'General case' 0 CA--C 1.494 -1.175 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -177.055 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 41.7 ttmt -62.76 -41.49 99.25 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 121.231 0.539 . . . . 0.0 109.593 176.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 58.8 m -69.16 -51.91 33.4 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -177.041 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.602 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 43.4 t80 -66.41 -47.51 73.04 Favored 'General case' 0 CA--C 1.505 -0.776 0 N-CA-C 111.779 0.289 . . . . 0.0 111.779 -179.118 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.415 ' CB ' ' HA ' ' A' ' 52' ' ' VAL . . . -59.98 -35.47 75.07 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.318 0.58 . . . . 0.0 110.347 -178.419 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -66.15 -47.1 75.16 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.517 -178.643 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.602 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 10.6 ptm85 -68.91 -25.72 64.73 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.242 -176.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.455 HG22 ' O ' ' A' ' 44' ' ' TYR . 10.2 t -93.04 -9.9 38.08 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 120.956 0.408 . . . . 0.0 111.123 -179.693 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.6 40.14 59.6 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.975 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.739 HG21 ' HG3' ' A' ' 86' ' ' GLU . 2.7 p -126.4 162.46 30.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.476 ' HB3' ' OG ' ' A' ' 54' ' ' SER . . . -59.81 130.67 47.92 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 178.877 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.415 ' HA ' ' CB ' ' A' ' 45' ' ' ALA . 74.8 t -61.63 -44.64 99.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.694 -177.858 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -66.37 -33.21 75.2 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.673 -178.704 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.51 ' HB2' ' H ' ' A' ' 87' ' ' GLN . 90.5 p -76.72 -14.45 59.94 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.68 -178.423 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.489 HD13 ' N ' ' A' ' 56' ' ' ARG . 1.0 OUTLIER -95.89 136.97 35.62 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -179.509 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.489 ' N ' HD13 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -140.99 145.48 36.01 Favored 'General case' 0 N--CA 1.436 -1.129 0 C-N-CA 119.853 -0.739 . . . . 0.0 111.509 -176.798 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.497 ' CG ' HD12 ' A' ' 40' ' ' LEU . 92.8 m-85 -118.84 140.96 49.11 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 114.922 -1.035 . . . . 0.0 109.267 176.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.601 HD22 ' CE1' ' A' ' 84' ' ' TYR . 9.2 mp -126.26 145.54 50.37 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.856 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.704 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 0.4 OUTLIER -128.84 117.38 20.96 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 177.157 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 68.13 24.14 7.77 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.387 0.613 . . . . 0.0 110.987 -175.194 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.1 14.08 77.77 Favored Glycine 0 N--CA 1.438 -1.185 0 CA-C-N 115.414 -0.812 . . . . 0.0 113.001 176.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.704 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.1 OUTLIER -124.2 146.45 48.69 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.232 179.462 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 10.9 mpt_? -67.6 130.1 41.97 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.836 -176.339 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 83.9 mt -80.09 125.86 39.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.384 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.671 ' HA ' ' SD ' ' A' ' 37' ' ' MET . 20.7 m120 -116.69 171.18 8.04 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 123.343 0.657 . . . . 0.0 109.489 177.255 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -78.8 -8.76 59.07 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -175.128 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -114.97 16.62 17.14 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 120.229 -0.588 . . . . 0.0 112.162 -178.317 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.65 ' HB2' HD21 ' A' ' 73' ' ' LEU . 72.0 m-20 -84.22 172.06 12.22 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.579 ' O ' ' HG ' ' A' ' 73' ' ' LEU . 69.2 p -82.91 156.13 67.5 Favored Pre-proline 0 CA--C 1.509 -0.599 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -173.362 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.727 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 17.4 Cg_endo -54.84 -18.68 16.93 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 123.131 2.554 . . . . 0.0 112.61 -176.427 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.862 ' HA ' ' CG ' ' A' ' 75' ' ' MET . 2.1 tmmm? -70.5 -40.54 73.51 Favored 'General case' 0 N--CA 1.413 -2.312 0 C-N-CA 122.888 0.475 . . . . 0.0 111.812 -179.447 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.476 ' CG2' ' HB3' ' A' ' 68' ' ' ASP . 1.4 t -96.72 -6.84 35.45 Favored 'General case' 0 CA--C 1.477 -1.839 0 CA-C-O 123.34 1.543 . . . . 0.0 107.021 -178.887 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.767 ' O ' ' HB2' ' A' ' 74' ' ' GLU . 0.3 OUTLIER -96.53 24.97 5.42 Favored 'General case' 0 CA--C 1.432 -3.587 0 CA-C-N 111.514 -2.585 . . . . 0.0 114.407 -176.761 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.767 ' HB2' ' O ' ' A' ' 73' ' ' LEU . 32.7 mt-10 76.23 66.04 0.06 Allowed 'General case' 0 C--N 1.305 -1.327 0 O-C-N 124.747 1.28 . . . . 0.0 111.66 173.067 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.862 ' CG ' ' HA ' ' A' ' 71' ' ' LYS . 76.4 mtm -39.84 -179.32 0.0 OUTLIER 'General case' 0 C--N 1.269 -2.897 0 CA-C-N 112.418 -2.174 . . . . 0.0 116.764 172.46 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.759 ' HA ' HD12 ' A' ' 15' ' ' ILE . 13.6 pt-20 -72.18 178.75 3.68 Favored 'General case' 0 CA--C 1.478 -1.819 0 C-N-CA 124.369 1.068 . . . . 0.0 112.295 -157.052 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.528 ' OD2' ' HD3' ' A' ' 16' ' ' LYS . 7.0 t70 -25.67 97.74 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.705 0 O-C-N 125.392 1.683 . . . . 0.0 114.269 -171.023 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.9 t70 80.23 33.04 0.17 Allowed 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 112.05 -2.341 . . . . 0.0 113.076 168.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -72.04 178.27 3.88 Favored 'General case' 0 C--N 1.36 1.056 0 C-N-CA 119.193 -1.003 . . . . 0.0 109.489 171.774 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 29.8 m -107.76 152.19 9.56 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -170.562 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.416 HD13 ' HA ' ' A' ' 81' ' ' ILE . 4.7 mm -135.91 138.88 46.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.499 -179.679 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -103.34 140.41 37.46 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.198 -179.183 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 95.6 t -125.69 133.72 68.41 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-O 120.975 0.417 . . . . 0.0 111.227 178.424 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.601 ' CE1' HD22 ' A' ' 58' ' ' LEU . 79.0 m-85 -107.59 159.3 16.55 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.604 176.207 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 37.5 tp60 -68.62 144.05 54.62 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.19 0.519 . . . . 0.0 111.649 -170.449 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.739 ' HG3' HG21 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -95.87 161.41 14.02 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.547 -175.589 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.51 ' H ' ' HB2' ' A' ' 54' ' ' SER . 58.3 tp60 -66.75 -44.39 81.56 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.379 -0.828 . . . . 0.0 113.232 -177.48 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.2 mm? . . . . . 0 C--N 1.32 -0.708 0 CA-C-O 120.881 0.372 . . . . 0.0 111.958 -175.795 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.7 mtp . . . . . 0 N--CA 1.474 0.762 0 N-CA-C 110.421 -0.214 . . . . 0.0 110.421 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.98 149.67 46.42 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.35 178.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -60.89 141.59 57.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.199 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -62.11 -40.98 97.74 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.143 -176.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 62.64 11.79 5.07 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.484 178.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 66.91 126.29 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.516 0.726 . . . . 0.0 112.341 178.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 19.4 pm0 -69.29 165.14 21.25 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.206 178.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.47 -40.77 97.74 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.567 -178.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 89.3 -6.86 83.1 Favored Glycine 0 N--CA 1.445 -0.759 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 -178.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -84.55 83.09 8.13 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 114.469 -0.865 . . . . 0.0 109.681 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 31.1 p30 -162.89 178.39 8.44 Favored 'General case' 0 N--CA 1.424 -1.768 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -177.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -165.84 -74.41 0.03 OUTLIER 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.006 177.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -110.96 -13.68 14.07 Favored 'General case' 0 CA--C 1.496 -1.108 0 CA-C-O 122.303 1.049 . . . . 0.0 109.701 177.017 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -137.73 160.66 38.62 Favored 'General case' 0 C--N 1.28 -2.443 0 CA-C-N 113.41 -1.723 . . . . 0.0 110.481 -177.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.497 HG12 ' O ' ' A' ' 31' ' ' VAL . 11.9 pt -116.93 163.33 14.18 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.662 -176.086 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.465 ' HE2' ' HB3' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -96.31 141.54 29.53 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.2 179.644 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.508 HD12 ' CG2' ' A' ' 31' ' ' VAL . 83.7 mt -140.35 137.62 36.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.504 175.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 13.8 mtmm -102.02 106.32 17.2 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.608 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 92.8 t -82.45 119.87 32.82 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.62 178.428 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 59.1 t -110.81 118.77 58.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-O 120.91 0.386 . . . . 0.0 110.025 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.586 ' HA2' ' HB ' ' A' ' 83' ' ' VAL . . . -90.15 169.41 34.82 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.346 -0.93 . . . . 0.0 112.549 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.472 ' HG2' ' O ' ' A' ' 83' ' ' VAL . 89.8 mm-40 -69.16 -24.38 64.07 Favored 'General case' 0 CA--C 1.504 -0.799 0 CA-C-O 121.39 0.614 . . . . 0.0 110.689 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -69.85 1.6 4.25 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.644 175.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.428 ' H ' ' C ' ' A' ' 22' ' ' GLN . 47.4 m 69.49 27.82 4.8 Favored 'General case' 0 C--N 1.351 0.656 0 CA-C-O 121.994 0.902 . . . . 0.0 109.134 -176.461 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -98.86 107.1 19.45 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.354 -1.294 . . . . 0.0 111.049 -178.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.608 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 33.7 tt0 -99.3 133.27 43.83 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.418 177.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.6 p -133.8 139.78 47.9 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-N 115.91 -0.587 . . . . 0.0 109.88 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.415 ' HB3' ' HE3' ' A' ' 16' ' ' LYS . 19.0 m170 -96.48 113.28 24.85 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.345 0.593 . . . . 0.0 111.582 -176.502 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -111.99 150.4 30.63 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.473 179.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.485 ' HD3' ' O ' ' A' ' 15' ' ' ILE . 22.4 tpp180 -107.35 116.95 32.84 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 175.346 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.508 ' CG2' HD12 ' A' ' 17' ' ' ILE . 35.0 m -138.66 169.02 18.53 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.304 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -178.414 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 53.9 tttp -89.33 160.1 17.03 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 -177.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -55.38 -38.29 68.66 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.016 0.436 . . . . 0.0 110.126 175.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -102.35 22.65 36.94 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.931 -0.577 . . . . 0.0 113.051 -178.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -62.39 142.36 57.87 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-O 121.323 0.582 . . . . 0.0 112.001 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 69.2 m -91.14 153.47 20.03 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.604 -179.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.407 ' HA ' HD21 ' A' ' 40' ' ' LEU . 27.3 ptt? -49.96 -33.19 16.92 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 112.897 0.702 . . . . 0.0 112.897 -177.194 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.46 -36.78 81.37 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -178.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -60.13 -40.04 88.41 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.91 0.386 . . . . 0.0 110.766 -176.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.567 HD12 ' CD2' ' A' ' 57' ' ' PHE . 0.2 OUTLIER -86.62 -45.49 10.98 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.928 -177.993 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.554 ' HG2' ' CD1' ' A' ' 57' ' ' PHE . 63.2 mtpt -63.83 -45.44 89.54 Favored 'General case' 0 CA--C 1.498 -1.024 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.639 -177.054 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -60.55 -44.37 96.19 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 176.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 39.5 t -64.96 -50.22 67.24 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.775 -176.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.554 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 48.8 t80 -68.18 -45.63 72.91 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.517 -179.073 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.486 ' HB1' ' O ' ' A' ' 50' ' ' VAL . . . -59.24 -36.27 75.15 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.413 0.625 . . . . 0.0 109.725 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -67.01 -47.01 72.74 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.413 -178.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.554 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 10.5 ptm85 -66.3 -24.74 66.6 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.334 -178.487 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.485 HG22 ' O ' ' A' ' 44' ' ' TYR . 14.6 t -99.36 -5.36 29.73 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.833 -178.212 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 69.3 30.94 71.38 Favored Glycine 0 C--N 1.336 0.53 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.762 178.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.486 ' O ' ' HB1' ' A' ' 45' ' ' ALA . 83.2 t -118.75 150.19 21.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 C-N-CA 122.445 0.298 . . . . 0.0 110.803 -177.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.497 ' HB3' ' OG ' ' A' ' 54' ' ' SER . . . -51.34 134.72 27.89 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.296 176.059 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 74.7 t -61.63 -43.28 96.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.602 -178.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -71.82 -15.93 62.16 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.703 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.52 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 73.6 m -81.55 -12.62 58.73 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.645 178.302 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.495 ' C ' ' HD3' ' A' ' 56' ' ' ARG . 2.6 mm? -94.37 134.84 36.44 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.112 176.526 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.495 ' HD3' ' C ' ' A' ' 55' ' ' LEU . 0.7 OUTLIER -126.07 114.42 18.39 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.971 -177.658 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.567 ' CD2' HD12 ' A' ' 40' ' ' LEU . 20.0 m-85 -106.12 132.27 52.4 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.172 0.511 . . . . 0.0 111.856 -178.577 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.564 ' HG ' ' HA ' ' A' ' 63' ' ' ARG . 6.6 mp -129.3 139.98 51.58 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.701 178.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.724 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 88.9 t80 -111.14 121.89 46.46 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 177.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 19.4 t70 55.19 23.56 5.53 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 121.484 0.659 . . . . 0.0 111.544 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 94.85 8.46 59.23 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.793 -0.717 . . . . 0.0 113.16 177.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.724 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.1 OUTLIER -124.79 141.44 52.11 Favored 'General case' 0 CA--C 1.505 -0.758 0 CA-C-O 121.147 0.498 . . . . 0.0 109.759 176.456 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.564 ' HA ' ' HG ' ' A' ' 58' ' ' LEU . 29.5 ptt180 -68.23 139.38 56.03 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -174.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.439 HD12 ' HB3' ' A' ' 57' ' ' PHE . 83.7 mt -88.97 122.42 40.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-N 114.548 -1.206 . . . . 0.0 109.886 -178.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 -109.01 163.99 12.82 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.68 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -81.39 -7.7 59.62 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.142 0.496 . . . . 0.0 109.767 177.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -94.51 -19.25 20.7 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.164 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.514 ' CG ' HH12 ' A' ' 62' ' ' ARG . 39.3 m-20 -62.73 138.19 58.45 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-O 121.179 0.514 . . . . 0.0 111.746 -177.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.442 ' HB ' ' HD2' ' A' ' 70' ' ' PRO . 82.7 p -91.26 162.71 31.48 Favored Pre-proline 0 C--N 1.312 -1.039 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.195 -179.009 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.442 ' HD2' ' HB ' ' A' ' 69' ' ' THR . 17.9 Cg_endo -59.79 -25.99 80.9 Favored 'Trans proline' 0 CA--C 1.535 0.542 0 C-N-CA 122.107 1.871 . . . . 0.0 111.6 176.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.441 ' N ' ' HE2' ' A' ' 71' ' ' LYS . 0.2 OUTLIER -63.7 -47.01 82.87 Favored 'General case' 0 CA--C 1.483 -1.629 0 CA-C-O 121.96 0.886 . . . . 0.0 110.164 178.69 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.7 t -84.32 -27.14 27.98 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 113.975 -1.466 . . . . 0.0 112.09 -174.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 96.4 mt -82.77 -22.74 34.19 Favored 'General case' 0 C--O 1.216 -0.702 0 C-N-CA 120.289 -0.564 . . . . 0.0 110.798 177.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 38.08 34.27 0.06 Allowed 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 124.833 1.253 . . . . 0.0 113.616 178.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 64.9 mtt -75.35 150.57 38.39 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -152.54 -174.03 4.76 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -178.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -48.94 118.06 2.41 Favored 'General case' 0 C--N 1.32 -0.707 0 O-C-N 123.885 0.74 . . . . 0.0 112.763 -176.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.5 t70 58.42 34.55 24.07 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.23 -1.35 . . . . 0.0 111.479 173.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -69.89 178.13 2.81 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.3 m -114.77 148.77 17.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 CA-C-O 121.594 0.711 . . . . 0.0 112.092 -174.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.483 HD12 HG21 ' A' ' 17' ' ' ILE . 2.6 mt -131.85 137.79 54.17 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.1 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -105.1 133.88 49.13 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -178.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.586 ' HB ' ' HA2' ' A' ' 21' ' ' GLY . 92.6 t -124.08 136.43 60.38 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.874 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.554 ' CD1' HD13 ' A' ' 58' ' ' LEU . 69.8 m-85 -96.78 164.11 12.7 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 58.5 tp60 -67.24 128.7 37.39 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.304 0.573 . . . . 0.0 110.581 -171.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.52 ' HA ' ' O ' ' A' ' 54' ' ' SER . 13.7 pm0 -64.92 151.14 46.49 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 114.935 -1.029 . . . . 0.0 112.256 -177.002 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 61.8 tp60 -63.42 -50.91 67.95 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.366 -174.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 88.3 mt -72.79 -34.54 66.99 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.67 -0.696 . . . . 0.0 112.798 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -62.14 -42.28 99.72 Favored Glycine 0 CA--C 1.516 0.109 0 C-N-CA 120.215 -0.993 . . . . 0.0 112.16 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.563 0 CA-C-O 118.622 -1.099 . . . . 0.0 112.385 178.403 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.3 tpp . . . . . 0 N--CA 1.471 0.593 0 CA-C-O 120.616 0.246 . . . . 0.0 110.485 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.64 150.12 31.68 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.655 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -82.58 133.49 35.18 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.79 177.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -65.82 -19.45 65.89 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -178.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 76.56 17.69 1.84 Allowed 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.85 0.86 . . . . 0.0 109.915 -176.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -143.81 134.1 24.5 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 177.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 67.3 mm-40 -116.52 178.07 4.47 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 -176.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.7 -40.82 93.66 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.959 0.409 . . . . 0.0 110.254 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -87.39 -48.07 4.41 Favored Glycine 0 N--CA 1.438 -1.202 0 C-N-CA 120.426 -0.893 . . . . 0.0 110.91 175.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 28.1 t70 56.82 33.31 22.86 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.585 0.754 . . . . 0.0 111.147 178.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 31.7 p-10 -111.93 26.14 10.91 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.564 0.697 . . . . 0.0 110.325 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -143.6 148.69 36.26 Favored 'General case' 0 N--CA 1.418 -2.043 0 CA-C-N 115.034 -0.984 . . . . 0.0 109.195 -177.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.57 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 23.5 mt-10 -125.55 38.3 4.2 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.665 -176.404 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -129.39 160.32 33.45 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 115.747 -0.66 . . . . 0.0 112.466 -173.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.493 ' O ' ' HD2' ' A' ' 30' ' ' ARG . 13.9 pt -124.25 164.17 22.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 114.535 -1.211 . . . . 0.0 108.035 -178.595 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.441 ' HB2' HH11 ' A' ' 30' ' ' ARG . 17.7 ttpp -99.69 143.41 29.95 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 119.997 -0.681 . . . . 0.0 110.202 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.562 HG21 HD12 ' A' ' 81' ' ' ILE . 74.3 mt -135.75 134.42 51.32 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 CA-C-O 120.87 0.367 . . . . 0.0 111.113 175.337 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 18.4 mtmt -96.04 107.18 19.45 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.655 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 71.4 t -81.29 117.38 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 177.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.3 t -110.75 118.11 56.5 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -82.52 178.53 53.33 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 120.5 -0.857 . . . . 0.0 111.747 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.511 ' C ' ' H ' ' A' ' 24' ' ' SER . 97.9 mt-30 -66.18 -37.02 84.61 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -178.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -79.29 22.19 0.44 Allowed 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.618 0.723 . . . . 0.0 109.294 177.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.511 ' H ' ' C ' ' A' ' 22' ' ' GLN . 85.0 p 58.97 30.43 20.22 Favored 'General case' 0 CA--C 1.512 -0.517 0 C-N-CA 124.807 1.243 . . . . 0.0 111.201 -179.093 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -83.6 105.68 14.72 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 114.836 -1.075 . . . . 0.0 109.866 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.655 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 36.5 tt0 -103.67 130.88 51.21 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.699 -177.184 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.5 p -135.79 140.75 43.7 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.091 177.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 18.4 m170 -96.24 117.13 30.17 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 121.525 0.679 . . . . 0.0 111.935 -175.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.406 ' HZ ' ' CD ' ' A' ' 47' ' ' ARG . 45.6 m-85 -109.6 149.21 30.0 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.604 -1.18 . . . . 0.0 111.039 177.018 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.493 ' HD2' ' O ' ' A' ' 15' ' ' ILE . 22.8 tpt180 -108.98 117.02 33.11 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 177.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.443 ' O ' HG12 ' A' ' 15' ' ' ILE . 33.0 m -137.69 170.5 17.33 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.35 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.008 -177.356 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.57 ' HG3' ' O ' ' A' ' 13' ' ' GLU . 38.5 ttmt -89.83 156.29 18.59 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 110.453 -0.203 . . . . 0.0 110.453 -177.619 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -56.4 -38.91 72.16 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 121.142 0.496 . . . . 0.0 109.691 174.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -98.06 24.76 30.41 Favored Glycine 0 N--CA 1.443 -0.868 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.452 -178.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.48 HG23 ' HB2' ' A' ' 39' ' ' LYS . 1.0 OUTLIER -65.83 140.51 58.39 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-O 121.426 0.631 . . . . 0.0 112.193 179.232 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 66.5 m -91.99 157.19 16.94 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.975 179.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.694 ' SD ' ' HA ' ' A' ' 65' ' ' ASN . 26.4 ptt? -51.47 -31.88 25.03 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -176.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.75 -38.06 86.6 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.198 -0.456 . . . . 0.0 112.097 -177.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.48 ' HB2' HG23 ' A' ' 35' ' ' THR . 75.5 mmtt -60.66 -38.25 84.25 Favored 'General case' 0 C--O 1.217 -0.645 0 CA-C-O 120.672 0.273 . . . . 0.0 111.183 -175.228 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.514 HD12 ' CG ' ' A' ' 57' ' ' PHE . 0.2 OUTLIER -86.59 -47.32 9.31 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.741 -178.528 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.441 ' HA ' ' HE1' ' A' ' 57' ' ' PHE . 94.3 mttt -62.95 -47.2 84.23 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.99 -177.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -64.27 -38.74 92.11 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.014 178.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 47.5 t -69.07 -53.55 19.75 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.68 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.705 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 45.3 t80 -65.89 -47.22 75.56 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-N 116.227 -0.442 . . . . 0.0 112.18 -178.214 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.75 -35.68 75.09 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.38 0.609 . . . . 0.0 109.895 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -65.99 -47.15 75.48 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.725 -178.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.705 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 8.7 ptm180 -65.9 -27.94 68.58 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.065 -178.252 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.517 HG22 ' O ' ' A' ' 44' ' ' TYR . 9.3 t -93.19 -6.74 47.07 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.072 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 69.67 33.16 71.17 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.902 178.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.421 HG22 ' H ' ' A' ' 51' ' ' ALA . 1.6 p -117.7 167.29 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 CA-C-O 120.693 0.282 . . . . 0.0 110.827 -177.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.543 ' HB3' ' OG ' ' A' ' 54' ' ' SER . . . -61.48 128.22 35.25 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.389 178.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 77.2 t -64.24 -43.99 97.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.777 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -67.47 -29.67 69.18 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.708 -177.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.543 ' OG ' ' HB3' ' A' ' 51' ' ' ALA . 88.5 p -82.76 -17.16 45.18 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 119.891 -0.723 . . . . 0.0 111.135 -179.056 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.503 HD13 ' N ' ' A' ' 56' ' ' ARG . 0.9 OUTLIER -92.59 135.2 34.28 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 -177.183 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.509 ' NH1' ' HA ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -140.96 149.58 42.0 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-O 121.486 0.66 . . . . 0.0 111.693 -177.106 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.514 ' CG ' HD12 ' A' ' 40' ' ' LEU . 58.0 m-85 -117.94 138.8 51.92 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 114.554 -1.203 . . . . 0.0 109.824 179.117 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.602 HD22 ' CE1' ' A' ' 84' ' ' TYR . 9.2 mp -125.3 137.95 54.07 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.765 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.782 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 23.1 t80 -105.5 114.48 28.68 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 38.0 t70 53.86 29.29 9.57 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-O 121.697 0.761 . . . . 0.0 111.602 -177.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.416 ' O ' HD23 ' A' ' 58' ' ' LEU . . . 95.07 -4.19 67.54 Favored Glycine 0 C--N 1.313 -0.704 0 CA-C-N 115.859 -0.609 . . . . 0.0 113.408 177.439 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.782 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.1 OUTLIER -106.5 138.88 41.88 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.355 0.598 . . . . 0.0 110.385 178.58 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.507 ' HA ' ' HG ' ' A' ' 58' ' ' LEU . 32.2 mtp-105 -69.01 135.64 51.21 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.882 -174.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 79.3 mt -93.3 121.52 44.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.985 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.694 ' HA ' ' SD ' ' A' ' 37' ' ' MET . 65.0 m-80 -117.31 161.72 19.06 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.486 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -71.75 -13.34 61.68 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.159 0.504 . . . . 0.0 109.826 178.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -76.74 -21.47 55.2 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.65 177.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.415 ' CG ' HH12 ' A' ' 62' ' ' ARG . 66.0 m-20 -71.48 139.9 49.77 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 121.47 0.653 . . . . 0.0 111.444 -179.201 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.545 ' HB ' ' HD2' ' A' ' 70' ' ' PRO . 47.8 p -101.99 163.95 16.75 Favored Pre-proline 0 C--N 1.304 -1.396 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.92 -178.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.545 ' HD2' ' HB ' ' A' ' 69' ' ' THR . 12.7 Cg_endo -56.39 -37.44 97.07 Favored 'Trans proline' 0 C--N 1.357 1.024 0 C-N-CA 122.427 2.085 . . . . 0.0 113.436 -177.018 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.446 ' HD3' ' N ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -74.49 -19.5 60.34 Favored 'General case' 0 C--O 1.221 -0.438 0 CA-C-O 121.057 0.456 . . . . 0.0 112.028 179.277 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.446 ' N ' ' HD3' ' A' ' 71' ' ' LYS . 52.1 m -85.0 -45.17 12.4 Favored 'General case' 0 N--CA 1.408 -2.546 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.966 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 98.9 mt -71.2 -25.25 62.43 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.526 178.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 51.57 30.27 6.33 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.836 177.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 20.2 ptp -73.88 162.77 28.74 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.995 0.426 . . . . 0.0 111.464 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -151.56 175.41 12.36 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.724 -177.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -65.9 118.93 10.42 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 121.692 0.758 . . . . 0.0 111.634 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 21.5 t70 70.65 33.91 2.22 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 126.095 1.758 . . . . 0.0 111.587 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -77.86 178.72 7.2 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 176.081 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.1 m -113.36 146.79 17.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-O 121.7 0.762 . . . . 0.0 111.9 -175.054 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.562 HD12 HG21 ' A' ' 17' ' ' ILE . 1.2 mt -134.15 141.99 42.25 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.962 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -107.54 146.53 31.73 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.834 0.349 . . . . 0.0 111.473 -176.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.428 ' O ' ' HG3' ' A' ' 22' ' ' GLN . 97.5 t -125.31 132.41 71.13 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.66 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.102 179.278 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.602 ' CE1' HD22 ' A' ' 58' ' ' LEU . 63.6 m-85 -100.62 143.98 30.15 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.766 175.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -69.85 134.64 48.71 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -176.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.509 ' HA ' ' NH1' ' A' ' 56' ' ' ARG . 1.3 pp20? -94.3 -155.79 0.47 Allowed 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -171.226 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -82.95 -55.94 4.1 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -171.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.406 HD12 ' H ' ' A' ' 51' ' ' ALA . 85.3 mt -65.49 -39.65 92.14 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -174.215 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -103.72 5.19 47.1 Favored Glycine 0 C--N 1.307 -1.075 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.087 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.416 ' HA3' ' O ' ' A' ' 86' ' ' GLU . . . . . . . . 0 N--CA 1.439 -1.119 0 CA-C-O 118.763 -1.02 . . . . 0.0 112.571 -178.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.5 ttp . . . . . 0 N--CA 1.476 0.87 0 CA-C-O 120.813 0.34 . . . . 0.0 110.758 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -141.93 126.07 17.41 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.374 178.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -85.22 106.7 16.84 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -60.81 -49.54 77.07 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.997 -176.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 53.26 25.83 4.71 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 177.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -125.44 137.02 53.98 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 121.006 0.432 . . . . 0.0 110.457 -178.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -132.29 144.92 50.93 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.629 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.6 -24.55 62.77 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.108 0.48 . . . . 0.0 110.392 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 78.81 15.67 80.33 Favored Glycine 0 CA--C 1.497 -1.043 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -179.231 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -132.89 97.74 4.11 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 114.964 -0.618 . . . . 0.0 110.186 -178.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -105.88 100.62 10.16 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 177.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -150.47 153.25 35.54 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.892 -176.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.465 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 40.4 mt-10 -123.59 44.38 2.71 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 121.617 0.722 . . . . 0.0 112.026 -176.396 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -120.36 157.25 29.64 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.171 177.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.5 pt -125.39 162.34 28.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.442 -176.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.484 ' HE2' ' HB2' ' A' ' 78' ' ' ASP . 38.1 mtmm -97.42 144.47 27.13 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.963 176.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.669 HG21 HD12 ' A' ' 81' ' ' ILE . 45.2 mm -128.08 129.53 69.52 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.979 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.02 178.565 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 27.5 mtmt -96.67 104.58 16.58 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 174.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.557 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 89.6 t -81.95 111.92 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.863 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 177.208 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.0 t -108.49 117.72 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.414 ' HA2' ' HB ' ' A' ' 83' ' ' VAL . . . -93.84 164.79 26.58 Favored Glycine 0 N--CA 1.435 -1.42 0 C-N-CA 120.489 -0.862 . . . . 0.0 111.449 178.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.455 ' C ' ' H ' ' A' ' 24' ' ' SER . 98.3 mt-30 -67.95 -23.94 65.11 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.374 0.607 . . . . 0.0 110.44 179.525 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -70.87 8.92 0.77 Allowed 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.919 175.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.455 ' H ' ' C ' ' A' ' 22' ' ' GLN . 44.5 m 68.96 25.27 6.04 Favored 'General case' 0 C--N 1.348 0.531 0 C-N-CA 123.753 0.821 . . . . 0.0 110.315 -179.352 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 54.0 t-20 -96.03 107.27 19.54 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.946 -178.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.557 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 28.7 tt0 -105.46 125.77 51.37 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.426 175.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.2 p -137.65 140.94 40.45 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-O 121.099 0.476 . . . . 0.0 111.126 -179.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 62.5 m170 -89.83 118.65 29.58 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.066 -178.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -118.43 143.64 46.53 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.296 171.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 52.9 ttp180 -106.44 121.51 44.4 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 121.528 0.68 . . . . 0.0 110.466 177.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 33.8 m -136.57 172.58 15.02 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 CA-C-N 114.82 -1.082 . . . . 0.0 108.911 -177.194 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' A' ' 13' ' ' GLU . 50.3 tttm -89.55 160.58 16.63 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -179.195 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.409 ' C ' ' HB3' ' A' ' 70' ' ' PRO . 95.7 m-85 -54.08 -41.21 67.97 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.976 0.417 . . . . 0.0 110.228 176.531 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -97.65 22.33 41.38 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.844 -177.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.436 ' HB ' ' O ' ' A' ' 32' ' ' LYS . 0.9 OUTLIER -61.63 143.82 55.48 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-O 121.181 0.515 . . . . 0.0 112.109 179.222 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 65.5 m -91.59 150.72 21.05 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.967 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -49.56 -33.03 13.83 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -177.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.88 -37.12 81.08 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.93 -177.089 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -61.32 -40.28 93.61 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.853 0.358 . . . . 0.0 110.646 -175.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.514 HD12 ' CD2' ' A' ' 57' ' ' PHE . 0.4 OUTLIER -87.26 -45.28 10.77 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.075 -0.512 . . . . 0.0 112.08 -179.269 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.572 ' HG2' ' CD1' ' A' ' 57' ' ' PHE . 61.4 mtpt -63.01 -45.98 89.8 Favored 'General case' 0 CA--C 1.496 -1.119 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.752 -177.185 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -62.13 -40.96 97.68 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.165 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 48.0 t -66.41 -51.34 57.96 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.168 -0.923 . . . . 0.0 111.326 -178.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.689 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 49.2 t80 -66.64 -45.82 77.78 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.85 -178.158 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.443 ' HB1' ' O ' ' A' ' 50' ' ' VAL . . . -59.25 -36.03 74.75 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.502 0.668 . . . . 0.0 109.757 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -66.49 -46.34 76.62 Favored 'General case' 0 C--N 1.311 -1.109 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.193 -178.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.689 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 11.4 ptm85 -65.39 -26.84 68.17 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.176 -177.494 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.528 HG22 ' O ' ' A' ' 44' ' ' TYR . 10.1 t -95.55 -7.42 37.96 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.222 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.81 32.04 66.98 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.406 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.456 HG13 ' HB3' ' A' ' 88' ' ' LEU . 84.5 t -117.74 150.25 19.9 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 C-N-CA 122.6 0.36 . . . . 0.0 110.859 -177.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.443 ' HB3' ' OG ' ' A' ' 54' ' ' SER . . . -52.58 137.05 31.36 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.396 176.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 74.3 t -61.23 -42.97 95.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.14 -179.186 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -67.26 -25.04 65.87 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.118 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.45 ' HB3' ' H ' ' A' ' 87' ' ' GLN . 74.0 m -74.76 -16.03 60.74 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.88 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -96.44 134.13 40.0 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.238 0.542 . . . . 0.0 110.823 177.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -132.93 125.29 29.51 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.626 178.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.572 ' CD1' ' HG2' ' A' ' 41' ' ' LYS . 12.3 m-85 -108.44 135.15 50.2 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.966 -179.376 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.58 HD13 ' CD1' ' A' ' 84' ' ' TYR . 6.2 mp -124.05 147.45 47.84 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.98 -178.525 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.652 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 31.2 t80 -128.96 128.83 44.51 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 176.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 34.7 t70 59.5 27.18 16.28 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 121.653 0.74 . . . . 0.0 110.4 179.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 78.51 17.97 76.69 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.667 178.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.652 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -130.87 151.73 50.97 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.91 178.587 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.449 ' HA ' ' HG ' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -68.06 135.64 52.55 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.807 -175.438 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 86.0 mt -88.1 117.47 31.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 177.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -107.36 153.85 22.16 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.499 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -68.98 -10.94 60.01 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.873 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -85.78 -19.01 31.38 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.036 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.442 ' CG ' HH12 ' A' ' 62' ' ' ARG . 36.9 m-20 -67.43 148.74 51.17 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -175.274 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.461 ' HB ' ' HD2' ' A' ' 70' ' ' PRO . 31.7 p -96.9 162.29 23.49 Favored Pre-proline 0 N--CA 1.444 -0.755 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.212 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.461 ' HD2' ' HB ' ' A' ' 69' ' ' THR . 19.2 Cg_endo -59.28 -31.51 95.25 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.519 2.146 . . . . 0.0 113.06 -178.503 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.564 ' HG3' ' N ' ' A' ' 72' ' ' THR . 15.2 ptmt -70.46 -38.83 74.51 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -179.017 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.564 ' N ' ' HG3' ' A' ' 71' ' ' LYS . 13.4 t -82.09 -29.82 31.58 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 120.971 0.415 . . . . 0.0 110.437 -177.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 96.1 mt -73.25 -22.2 60.46 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 174.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 52.91 28.75 6.87 Favored 'General case' 0 C--N 1.348 0.509 0 O-C-N 124.037 0.836 . . . . 0.0 112.5 175.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 70.8 mtm -85.23 150.36 24.85 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.113 0.483 . . . . 0.0 111.834 -176.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -151.67 -176.61 5.69 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 176.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.438 ' HA ' ' H ' ' A' ' 16' ' ' LYS . 1.3 m-20 -57.33 119.5 6.55 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -177.287 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.484 ' HB2' ' HE2' ' A' ' 16' ' ' LYS . 18.5 t70 63.22 35.41 12.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 113.972 -1.467 . . . . 0.0 111.082 175.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -76.78 177.66 7.44 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.269 177.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 30.9 m -108.96 138.48 35.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 CA-C-O 121.772 0.796 . . . . 0.0 112.455 -174.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.669 HD12 HG21 ' A' ' 17' ' ' ILE . 1.6 mt -132.36 134.01 59.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.974 178.238 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -98.18 144.28 27.8 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.245 -174.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.414 ' HB ' ' HA2' ' A' ' 21' ' ' GLY . 84.6 t -129.13 133.98 64.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.993 178.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.58 ' CD1' HD13 ' A' ' 58' ' ' LEU . 57.4 m-85 -98.13 156.71 16.54 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.288 177.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 43.6 tp60 -68.0 133.14 48.53 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.195 0.522 . . . . 0.0 111.097 -171.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.676 ' HG2' ' H ' ' A' ' 89' ' ' GLY . 4.2 pm0 -65.6 158.0 28.34 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.434 -0.803 . . . . 0.0 113.12 -174.582 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.45 ' H ' ' HB3' ' A' ' 54' ' ' SER . 82.7 mm-40 -72.53 -48.33 41.11 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.992 -177.542 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.456 ' HB3' HG13 ' A' ' 50' ' ' VAL . 60.5 tp -66.89 -43.26 83.93 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 114.708 -1.133 . . . . 0.0 111.758 -177.454 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.676 ' H ' ' HG2' ' A' ' 86' ' ' GLU . . . -65.3 -41.62 96.58 Favored Glycine 0 C--N 1.318 -0.438 0 CA-C-N 115.644 -0.707 . . . . 0.0 113.446 -178.633 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.67 -1.072 . . . . 0.0 112.426 -179.886 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 79.9 mtm . . . . . 0 N--CA 1.476 0.831 0 N-CA-C 110.291 -0.263 . . . . 0.0 110.291 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 59.5 34.84 22.65 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.649 0.737 . . . . 0.0 110.338 -177.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -143.7 -177.3 5.34 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.219 -177.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -64.24 -37.47 87.59 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -74.04 -4.35 34.88 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 121.119 0.485 . . . . 0.0 110.831 -178.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -81.55 116.88 21.53 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.433 178.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -150.07 158.71 44.45 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.442 -177.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -72.54 -23.28 60.97 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.41 0.624 . . . . 0.0 110.045 178.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 100.79 -20.26 48.75 Favored Glycine 0 N--CA 1.437 -1.251 0 CA-C-N 115.157 -0.929 . . . . 0.0 112.073 178.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 31.2 t70 55.26 40.98 31.74 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.922 0.867 . . . . 0.0 109.871 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -158.15 91.71 1.12 Allowed 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -177.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -81.13 159.55 24.64 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.37 -175.145 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 72.9 29.98 1.77 Allowed 'General case' 0 CA--C 1.508 -0.669 0 C-N-CA 124.174 0.99 . . . . 0.0 110.205 -177.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -132.78 160.21 37.51 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 113.789 -1.551 . . . . 0.0 109.699 178.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.3 pt -120.12 162.46 18.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -176.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.499 ' HD2' ' CG ' ' A' ' 78' ' ' ASP . 38.9 ttmt -101.0 143.55 31.01 Favored 'General case' 0 C--N 1.286 -2.172 0 CA-C-O 121.006 0.432 . . . . 0.0 110.733 179.257 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.719 HG21 HD12 ' A' ' 81' ' ' ILE . 41.7 mm -127.58 129.56 70.33 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.783 177.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.5 mtmt -100.1 104.16 15.7 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 176.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.723 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 96.7 t -82.41 118.38 30.03 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.52 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.6 t -113.76 118.25 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 CA-C-O 120.927 0.394 . . . . 0.0 109.967 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.414 ' HA2' ' HB ' ' A' ' 83' ' ' VAL . . . -90.86 175.35 40.08 Favored Glycine 0 C--N 1.314 -0.693 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.49 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.498 ' C ' ' H ' ' A' ' 24' ' ' SER . 98.8 mt-30 -64.51 -34.18 77.63 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 121.235 0.541 . . . . 0.0 110.896 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -70.0 8.69 0.68 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.956 176.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.498 ' H ' ' C ' ' A' ' 22' ' ' GLN . 49.9 m 65.96 27.88 10.68 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.859 0.838 . . . . 0.0 109.059 -176.253 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -87.06 104.87 16.74 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.468 -177.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.723 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 42.6 tt0 -104.61 131.88 51.51 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.588 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.4 p -138.05 137.83 44.15 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.598 179.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 37.7 m170 -97.1 111.18 23.52 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.185 0.516 . . . . 0.0 111.644 -176.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -110.57 149.59 30.16 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.818 176.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 18.4 tpt180 -103.34 121.54 42.96 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.406 HG22 HG12 ' A' ' 17' ' ' ILE . 30.9 m -134.86 174.27 13.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.35 -177.44 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -88.11 155.28 19.87 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -52.98 -39.0 62.69 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 175.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.52 ' CA ' ' HG3' ' A' ' 70' ' ' PRO . . . -106.86 33.2 6.59 Favored Glycine 0 C--N 1.334 0.44 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.744 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.605 HG23 ' HB2' ' A' ' 39' ' ' LYS . 0.9 OUTLIER -64.38 136.5 57.18 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-O 121.526 0.679 . . . . 0.0 112.442 179.22 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 69.6 m -85.61 155.11 21.27 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.091 -0.958 . . . . 0.0 109.875 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.498 ' HA ' HD21 ' A' ' 40' ' ' LEU . 25.7 ptt? -50.87 -30.49 14.68 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -176.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.49 -37.96 85.56 Favored 'General case' 0 C--O 1.217 -0.642 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 -178.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.605 ' HB2' HG23 ' A' ' 35' ' ' THR . 31.1 mmmt -60.6 -40.03 90.31 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.049 -176.444 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.498 HD21 ' HA ' ' A' ' 37' ' ' MET . 0.2 OUTLIER -86.49 -46.05 10.54 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.782 -178.465 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 46.4 mttp -62.02 -46.61 88.41 Favored 'General case' 0 C--O 1.212 -0.892 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.43 -178.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.461 ' HA ' HG22 ' A' ' 52' ' ' VAL . 25.0 ttmm -62.47 -42.53 99.55 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.079 0.466 . . . . 0.0 110.058 177.027 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 45.7 t -62.98 -50.07 72.2 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.289 -176.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.655 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 42.0 t80 -71.43 -43.81 66.01 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.787 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.605 ' HB1' ' O ' ' A' ' 50' ' ' VAL . . . -57.82 -33.26 68.42 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.364 0.602 . . . . 0.0 109.741 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -63.05 -47.72 81.78 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.188 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.655 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 3.5 ptm180 -68.62 -27.84 66.38 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.411 -177.197 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.459 HG22 ' O ' ' A' ' 44' ' ' TYR . 8.9 t -96.64 -10.77 26.33 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -177.257 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.56 35.26 67.75 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.248 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.625 HG13 ' HB3' ' A' ' 88' ' ' LEU . 73.7 t -119.32 149.65 21.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 C-N-CA 122.713 0.405 . . . . 0.0 110.891 -177.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.456 ' HB3' ' OG ' ' A' ' 54' ' ' SER . . . -51.81 136.19 28.33 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.347 176.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.461 HG22 ' HA ' ' A' ' 42' ' ' LYS . 76.8 t -60.9 -44.3 97.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.277 -177.031 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -77.14 -10.01 59.12 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.093 0.473 . . . . 0.0 110.954 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.456 ' OG ' ' HB3' ' A' ' 51' ' ' ALA . 74.9 m -87.36 -10.51 51.95 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.18 176.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -96.34 130.05 43.53 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 177.307 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.473 ' HD3' ' O ' ' A' ' 85' ' ' GLN . 0.0 OUTLIER -122.49 117.06 25.04 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 121.423 0.63 . . . . 0.0 111.334 -176.696 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.576 ' HZ ' ' CB ' ' A' ' 44' ' ' TYR . 32.6 m-85 -106.14 128.36 53.84 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.529 178.426 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.534 ' HG ' ' HA ' ' A' ' 63' ' ' ARG . 7.8 mp -121.6 136.12 54.96 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.423 179.274 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.587 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 83.8 t80 -105.3 116.0 31.22 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 178.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 55.44 23.18 5.59 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.848 -0.614 . . . . 0.0 112.393 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 102.06 2.29 51.68 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 121.089 -0.577 . . . . 0.0 113.514 176.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.587 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -120.29 140.93 50.5 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 117.175 0.488 . . . . 0.0 109.98 176.702 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.534 ' HA ' ' HG ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -68.44 137.56 54.58 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.282 0.563 . . . . 0.0 112.05 -175.347 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.404 HD12 ' HB3' ' A' ' 57' ' ' PHE . 87.1 mt -82.66 125.16 39.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.581 -179.252 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -99.21 162.94 12.77 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.495 -177.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.415 ' HB3' ' HG2' ' A' ' 37' ' ' MET . 7.1 p-10 -81.79 -6.52 59.14 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 174.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -101.65 -6.28 23.98 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.332 -178.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -62.2 148.77 43.62 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.253 0.549 . . . . 0.0 112.149 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.403 ' H ' HG22 ' A' ' 72' ' ' THR . 49.9 p -113.87 159.53 35.6 Favored Pre-proline 0 C--N 1.319 -0.749 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.531 -179.253 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.52 ' HG3' ' CA ' ' A' ' 34' ' ' GLY . 77.8 Cg_exo -55.33 -39.38 91.29 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.904 2.403 . . . . 0.0 112.407 -178.521 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.507 ' HG3' ' H ' ' A' ' 72' ' ' THR . 17.3 ptmt -69.01 -46.76 67.2 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -177.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.507 ' H ' ' HG3' ' A' ' 71' ' ' LYS . 9.0 t -67.19 -27.01 66.91 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-O 120.924 0.393 . . . . 0.0 110.875 -177.263 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 93.7 mt -90.95 -22.55 20.8 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.676 178.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 43.4 47.8 5.91 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.927 -177.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 74.2 mtm -85.24 161.12 19.7 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.913 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -147.65 -178.39 6.23 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.376 178.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.484 ' HA ' ' H ' ' A' ' 16' ' ' LYS . 34.3 t70 -65.42 120.1 12.22 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.028 0.442 . . . . 0.0 111.357 -178.321 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.499 ' CG ' ' HD2' ' A' ' 16' ' ' LYS . 3.0 m-20 74.9 33.2 0.77 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.19 1.396 . . . . 0.0 111.783 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -70.43 176.4 4.05 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 177.083 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.9 t -118.36 136.66 54.84 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 CA-C-O 121.431 0.634 . . . . 0.0 111.163 -174.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.719 HD12 HG21 ' A' ' 17' ' ' ILE . 1.8 mt -131.64 138.85 51.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.307 -177.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -102.85 145.47 29.74 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.255 -173.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.414 ' HB ' ' HA2' ' A' ' 21' ' ' GLY . 90.7 t -126.59 131.01 71.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.26 178.431 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.465 ' CE1' HD22 ' A' ' 58' ' ' LEU . 78.6 m-85 -99.72 168.56 9.84 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.684 177.014 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.473 ' O ' ' HD3' ' A' ' 56' ' ' ARG . 43.9 tp60 -66.88 129.9 41.39 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.394 0.616 . . . . 0.0 111.188 -170.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.683 ' HG2' ' H ' ' A' ' 89' ' ' GLY . 4.1 pm0 -65.66 154.1 39.8 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.958 -1.019 . . . . 0.0 112.714 -177.079 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.425 ' HB3' ' CB ' ' A' ' 54' ' ' SER . 61.0 tp60 -72.11 -42.76 65.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.98 -176.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.625 ' HB3' HG13 ' A' ' 50' ' ' VAL . 57.1 tp -67.43 -39.54 85.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.009 -178.213 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.683 ' H ' ' HG2' ' A' ' 86' ' ' GLU . . . -87.03 -105.03 0.83 Allowed Glycine 0 C--N 1.315 -0.601 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.521 -178.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.92 -0.933 . . . . 0.0 111.399 -178.875 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 79.4 mtm . . . . . 0 N--CA 1.471 0.615 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.17 135.09 55.09 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 120.924 0.392 . . . . 0.0 111.324 -177.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -95.38 110.11 22.18 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.176 178.005 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -62.08 -36.18 80.91 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.609 178.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 73.29 25.34 2.23 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.403 -179.097 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 61.43 67.42 0.78 Allowed 'General case' 0 C--O 1.246 0.902 0 CA-C-N 114.876 -1.056 . . . . 0.0 111.821 179.066 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 59.35 -161.86 0.26 Allowed 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.71 177.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -82.02 -0.93 46.54 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.023 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 128.06 47.95 0.17 Allowed Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -178.219 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -115.14 122.35 45.82 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.665 -0.267 . . . . 0.0 110.607 -177.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -108.29 100.9 10.15 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.031 0.443 . . . . 0.0 109.979 177.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.574 ' HB1' ' HD1' ' A' ' 14' ' ' TYR . . . -153.11 -49.16 0.1 Allowed 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.772 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 63.84 49.36 2.9 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 114.84 -1.073 . . . . 0.0 112.33 176.2 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.574 ' HD1' ' HB1' ' A' ' 12' ' ' ALA . 98.4 m-85 -110.54 154.97 22.95 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 121.544 0.687 . . . . 0.0 111.438 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.475 ' HA ' ' OD1' ' A' ' 77' ' ' ASP . 21.8 pt -132.21 162.6 39.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 CA-C-N 114.588 -1.187 . . . . 0.0 108.552 -178.157 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.468 ' H ' ' HA ' ' A' ' 77' ' ' ASP . 56.5 mtmt -92.88 147.36 22.91 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 121.059 0.457 . . . . 0.0 110.664 175.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.652 HD12 HG21 ' A' ' 31' ' ' VAL . 9.4 mt -128.34 131.75 68.79 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.449 173.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.416 ' HD3' ' OD2' ' A' ' 78' ' ' ASP . 27.4 mtmt -98.93 104.71 16.78 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 176.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.632 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 98.5 t -82.29 115.54 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.1 t -106.06 116.56 50.09 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.495 ' HA2' ' HB ' ' A' ' 83' ' ' VAL . . . -85.16 174.3 49.13 Favored Glycine 0 C--N 1.309 -0.951 0 C-N-CA 120.191 -1.004 . . . . 0.0 112.0 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.425 ' HG3' ' O ' ' A' ' 83' ' ' VAL . 98.3 mt-30 -70.11 -21.88 63.07 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-O 121.447 0.641 . . . . 0.0 110.371 178.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -74.62 0.78 13.91 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.28 174.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.6 t 69.32 26.63 5.28 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -176.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -90.86 106.74 18.73 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-N 114.687 -1.142 . . . . 0.0 110.281 -179.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.632 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 29.4 tt0 -98.83 125.99 44.35 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.453 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.1 p -129.5 139.94 50.39 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.887 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 60.6 m170 -97.67 115.75 28.54 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.441 -175.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -111.55 148.39 33.36 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.706 175.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 26.2 tpt180 -99.22 120.27 39.25 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.652 HG21 HD12 ' A' ' 17' ' ' ILE . 33.0 m -135.86 172.45 15.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.537 -176.194 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 14' ' ' TYR . 36.9 tttm -90.38 160.76 15.92 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -54.21 -38.42 65.65 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-O 120.996 0.427 . . . . 0.0 110.275 175.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.65 ' CA ' ' HG3' ' A' ' 70' ' ' PRO . . . -98.82 25.88 26.36 Favored Glycine 0 CA--C 1.492 -1.389 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.858 -178.058 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.756 HG23 ' HB2' ' A' ' 39' ' ' LYS . 1.1 m -68.48 124.7 24.27 Favored 'General case' 0 N--CA 1.41 -2.457 0 CA-C-O 121.673 0.749 . . . . 0.0 111.773 178.491 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.583 ' HB3' ' HA ' ' A' ' 66' ' ' ASP . 41.2 m -91.82 167.53 12.08 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 114.482 -1.235 . . . . 0.0 109.537 178.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.456 ' HB2' ' CD ' ' A' ' 41' ' ' LYS . 25.2 ptt? -47.32 -39.32 14.53 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -175.323 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.84 -37.33 81.7 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -175.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.756 ' HB2' HG23 ' A' ' 35' ' ' THR . 29.9 mmmt -60.47 -41.64 94.61 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.273 -176.01 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.543 HD23 ' H ' ' A' ' 40' ' ' LEU . 0.5 OUTLIER -88.95 -44.08 10.69 Favored 'General case' 0 C--O 1.22 -0.489 0 N-CA-C 112.438 0.532 . . . . 0.0 112.438 -178.964 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.629 ' HE3' ' O ' ' A' ' 55' ' ' LEU . 60.8 mtpt -61.74 -46.79 88.09 Favored 'General case' 0 CA--C 1.488 -1.439 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.798 -176.317 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.496 ' HA ' HG22 ' A' ' 52' ' ' VAL . 39.0 ttpt -62.12 -40.8 97.14 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.14 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 66.6 m -65.59 -49.05 70.22 Favored 'General case' 0 CA--C 1.552 1.021 0 CA-C-N 115.215 -0.902 . . . . 0.0 112.407 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.649 ' O ' ' HG3' ' A' ' 47' ' ' ARG . 59.7 t80 -71.08 -45.13 64.32 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.949 -179.309 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.635 ' HB1' ' O ' ' A' ' 50' ' ' VAL . . . -58.48 -34.19 70.63 Favored 'General case' 0 CA--C 1.501 -0.914 0 CA-C-O 121.443 0.639 . . . . 0.0 109.585 -178.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -63.08 -48.14 79.92 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.046 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.649 ' HG3' ' O ' ' A' ' 44' ' ' TYR . 0.0 OUTLIER -69.25 -22.66 63.83 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.967 -0.56 . . . . 0.0 112.19 -176.324 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.466 HG22 ' O ' ' A' ' 44' ' ' TYR . 8.8 t -103.3 -7.27 21.24 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.909 0.385 . . . . 0.0 111.939 -177.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.25 31.99 65.75 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.544 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.635 ' O ' ' HB1' ' A' ' 45' ' ' ALA . 80.6 t -113.53 147.29 17.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 C-N-CA 122.886 0.474 . . . . 0.0 110.343 -178.391 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.588 ' HB3' ' OG ' ' A' ' 54' ' ' SER . . . -56.49 136.52 54.09 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.316 -0.402 . . . . 0.0 109.995 176.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.496 HG22 ' HA ' ' A' ' 42' ' ' LYS . 73.1 t -62.12 -44.4 98.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.469 -176.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -69.29 -31.42 69.9 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.522 -177.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.588 ' OG ' ' HB3' ' A' ' 51' ' ' ALA . 89.8 p -87.42 2.82 49.35 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 120.664 -0.414 . . . . 0.0 111.481 -179.097 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.713 HD22 ' HG2' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -94.83 121.73 36.72 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 174.147 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -117.15 117.89 30.83 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 119.875 -0.73 . . . . 0.0 112.343 -173.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.517 ' CD1' ' HG2' ' A' ' 41' ' ' LYS . 45.7 m-85 -108.91 130.03 55.43 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.595 176.407 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.575 HD13 ' CD1' ' A' ' 84' ' ' TYR . 8.0 mp -122.61 144.65 48.98 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 121.466 0.65 . . . . 0.0 111.226 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.676 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 64.5 t80 -118.37 115.1 23.99 Favored 'General case' 0 N--CA 1.426 -1.674 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.081 178.462 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 53.38 29.15 8.31 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.426 -178.137 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 96.01 -1.55 63.17 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.958 -0.564 . . . . 0.0 113.435 176.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.676 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -113.62 136.44 52.82 Favored 'General case' 0 CA--C 1.491 -1.326 0 CA-C-O 121.289 0.566 . . . . 0.0 109.672 177.5 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.508 ' HA ' ' HG ' ' A' ' 58' ' ' LEU . 30.1 ptt180 -72.38 133.74 45.08 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.168 -177.121 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.503 HD11 HD12 ' A' ' 81' ' ' ILE . 68.7 mt -75.61 132.83 32.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 CA-C-N 114.462 -1.244 . . . . 0.0 108.856 -178.056 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -109.57 169.82 8.46 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.09 0.471 . . . . 0.0 110.758 -175.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.583 ' HA ' ' HB3' ' A' ' 36' ' ' SER . 7.2 p-10 -82.9 -6.33 59.41 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.159 0.504 . . . . 0.0 109.667 175.421 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -101.3 -16.63 16.88 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.419 -0.809 . . . . 0.0 113.157 -175.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.6 p30 -68.78 161.57 28.18 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -175.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.454 ' HB ' ' HD2' ' A' ' 70' ' ' PRO . 72.0 p -129.9 166.72 24.19 Favored Pre-proline 0 CA--C 1.548 0.901 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.415 -174.03 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.65 ' HG3' ' CA ' ' A' ' 34' ' ' GLY . 57.2 Cg_exo -54.46 -39.91 85.71 Favored 'Trans proline' 0 C--N 1.369 1.623 0 C-N-CA 123.108 2.539 . . . . 0.0 113.318 -176.52 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.509 ' HD3' ' N ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -70.27 -23.77 62.94 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 -176.175 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.509 ' N ' ' HD3' ' A' ' 71' ' ' LYS . 5.1 t -95.34 -25.42 16.31 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.194 0.521 . . . . 0.0 110.117 -177.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.471 ' HB3' ' HG3' ' A' ' 75' ' ' MET . 92.7 mt -89.79 -24.34 21.49 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.936 178.487 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 46.5 30.96 1.19 Allowed 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.555 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.471 ' HG3' ' HB3' ' A' ' 73' ' ' LEU . 66.7 mtt -79.03 153.0 30.58 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.006 -179.016 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -150.54 -174.81 4.87 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.475 ' OD1' ' HA ' ' A' ' 15' ' ' ILE . 20.0 m-20 -55.0 126.1 23.16 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 -177.084 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.442 ' HB2' ' HE3' ' A' ' 16' ' ' LYS . 9.0 t70 67.21 35.42 4.47 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 113.882 -1.508 . . . . 0.0 111.489 173.466 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -70.63 176.38 4.19 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.845 177.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 30.7 m -110.11 136.52 45.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-O 121.588 0.708 . . . . 0.0 111.858 -175.083 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.503 HD12 HD11 ' A' ' 64' ' ' ILE . 10.8 mm -131.99 137.61 54.42 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.09 -178.153 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -107.33 142.75 36.63 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.361 -177.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.495 ' HB ' ' HA2' ' A' ' 21' ' ' GLY . 93.4 t -124.55 133.5 69.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-O 121.009 0.433 . . . . 0.0 111.29 178.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.575 ' CD1' HD13 ' A' ' 58' ' ' LEU . 46.7 m-85 -100.23 167.69 10.27 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.492 178.476 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -67.85 124.65 23.92 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.496 0.665 . . . . 0.0 110.691 -173.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.713 ' HG2' HD22 ' A' ' 55' ' ' LEU . 2.2 mp0 -82.59 162.02 22.07 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.6 -177.072 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -69.03 -40.09 78.82 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.105 177.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.532 ' HB2' HG13 ' A' ' 50' ' ' VAL . 10.9 mp -102.74 3.97 37.5 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.713 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -92.26 -163.6 37.94 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.56 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.357 0 CA-C-O 118.66 -1.078 . . . . 0.0 111.86 179.457 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.9 tpp . . . . . 0 N--CA 1.471 0.6 0 CA-C-O 121.13 0.491 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -154.27 158.02 39.57 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.266 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -79.63 176.61 9.55 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -69.31 -34.37 74.58 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.792 0.329 . . . . 0.0 110.825 -178.206 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 61.41 30.48 18.96 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.549 178.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -96.65 131.43 43.32 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.64 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 26.5 pt20 -146.99 161.42 40.84 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.877 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.56 -37.22 85.3 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.43 0.633 . . . . 0.0 110.305 177.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 97.28 -7.66 64.23 Favored Glycine 0 CA--C 1.497 -1.036 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.455 -179.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -62.93 -39.35 94.34 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.229 -0.486 . . . . 0.0 110.707 178.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 65.2 t30 55.92 47.3 20.33 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-O 122.264 1.03 . . . . 0.0 108.656 -175.047 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -114.66 179.43 3.95 Favored 'General case' 0 N--CA 1.399 -3.002 0 CA-C-N 114.288 -1.324 . . . . 0.0 108.54 -175.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -105.71 27.87 8.04 Favored 'General case' 0 C--N 1.281 -2.394 0 CA-C-O 121.395 0.617 . . . . 0.0 111.448 -175.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -133.06 155.67 48.78 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.689 -178.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.499 ' O ' ' HD2' ' A' ' 30' ' ' ARG . 23.7 pt -122.45 163.14 21.32 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.414 -176.116 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.434 ' HZ2' ' CG ' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -91.53 144.93 25.04 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.253 178.042 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.52 HD12 HG21 ' A' ' 31' ' ' VAL . 67.8 mt -139.12 133.9 40.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-O 120.87 0.367 . . . . 0.0 111.32 172.653 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 18.4 mtmt -96.43 106.15 18.34 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.647 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 81.1 t -81.25 116.76 26.1 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 176.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 59.9 t -112.63 117.76 56.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 120.929 0.395 . . . . 0.0 110.095 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.529 ' HA2' ' HB ' ' A' ' 83' ' ' VAL . . . -92.25 171.24 33.66 Favored Glycine 0 C--N 1.314 -0.665 0 C-N-CA 120.434 -0.888 . . . . 0.0 112.588 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.437 ' C ' ' H ' ' A' ' 24' ' ' SER . 97.7 mt-30 -66.45 -27.45 67.82 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 121.232 0.539 . . . . 0.0 110.674 179.35 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -69.86 4.17 2.17 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.917 175.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.437 ' H ' ' C ' ' A' ' 22' ' ' GLN . 50.9 m 67.54 27.79 7.76 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.878 0.847 . . . . 0.0 109.12 -176.656 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -91.95 104.83 17.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-N 114.576 -1.193 . . . . 0.0 110.952 -178.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.647 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 30.6 tt0 -100.73 129.53 46.64 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.851 176.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.411 ' CG1' ' HB ' ' A' ' 19' ' ' VAL . 7.5 p -133.26 140.18 47.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.041 179.049 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 51.4 m170 -94.73 112.87 24.59 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.164 -176.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -110.64 147.36 34.44 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.425 177.256 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.499 ' HD2' ' O ' ' A' ' 15' ' ' ILE . 12.4 tpt180 -105.17 116.0 31.21 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 175.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.52 HG21 HD12 ' A' ' 17' ' ' ILE . 35.3 m -137.86 172.72 13.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.918 -176.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -89.33 159.92 17.13 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 -177.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -55.04 -38.3 67.79 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.073 0.463 . . . . 0.0 109.753 173.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -100.04 25.92 26.44 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.767 -177.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.594 HG23 ' HB2' ' A' ' 39' ' ' LYS . 1.2 m -71.39 128.44 35.87 Favored 'General case' 0 N--CA 1.425 -1.682 0 CA-C-O 121.529 0.681 . . . . 0.0 112.418 179.102 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.535 ' HB3' ' HA ' ' A' ' 66' ' ' ASP . 66.9 m -93.11 164.15 13.37 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 114.759 -1.11 . . . . 0.0 111.045 -179.15 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.541 ' SD ' ' HA ' ' A' ' 65' ' ' ASN . 24.3 ptt? -47.14 -39.21 13.09 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -174.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.76 -37.18 80.94 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -175.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.594 ' HB2' HG23 ' A' ' 35' ' ' THR . 75.8 mmtt -61.1 -40.51 94.03 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.52 -176.106 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.559 HD12 ' CD2' ' A' ' 57' ' ' PHE . 0.3 OUTLIER -88.06 -44.49 10.92 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.376 -178.618 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.546 ' HG2' ' CD1' ' A' ' 57' ' ' PHE . 61.6 mtpt -62.87 -45.3 93.22 Favored 'General case' 0 CA--C 1.489 -1.376 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.71 -176.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.407 ' O ' ' HB2' ' A' ' 46' ' ' ASP . 24.4 ttmm -61.22 -43.3 99.1 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 176.31 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 44.5 t -65.78 -51.44 59.11 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.426 -0.806 . . . . 0.0 112.1 -176.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.521 ' O ' HG22 ' A' ' 48' ' ' THR . 41.9 t80 -66.85 -46.57 74.65 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 120.769 0.319 . . . . 0.0 111.488 -179.191 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.57 -35.08 75.19 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.413 0.625 . . . . 0.0 109.883 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' A' ' 42' ' ' LYS . 32.3 t70 -64.5 -47.37 79.16 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.343 -178.155 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.518 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 15.4 ptm180 -65.72 -28.5 69.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.539 -177.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.521 HG22 ' O ' ' A' ' 44' ' ' TYR . 7.0 t -93.57 -8.24 41.83 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.234 -179.428 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.12 30.99 69.33 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.941 -0.647 . . . . 0.0 113.12 178.137 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.412 HG12 HG23 ' A' ' 48' ' ' THR . 2.5 p -115.09 169.28 6.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -178.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.428 ' HB3' ' HB3' ' A' ' 54' ' ' SER . . . -60.41 136.81 58.16 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.775 0.321 . . . . 0.0 110.666 178.046 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 79.7 t -61.96 -44.24 98.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-O 121.396 0.617 . . . . 0.0 109.857 179.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -71.33 -21.74 62.01 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.827 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.509 ' HB2' ' HB3' ' A' ' 87' ' ' GLN . 85.2 p -75.75 -12.59 60.21 Favored 'General case' 0 CA--C 1.52 -0.189 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.533 179.276 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.532 HD12 ' CE1' ' A' ' 57' ' ' PHE . 0.1 OUTLIER -94.45 132.72 38.8 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 177.469 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.72 120.11 25.85 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.125 0.488 . . . . 0.0 110.524 -179.288 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.559 ' CD2' HD12 ' A' ' 40' ' ' LEU . 32.9 m-85 -110.29 134.3 52.4 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.46 -179.482 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.534 HD13 ' CD1' ' A' ' 84' ' ' TYR . 7.1 mp -126.75 145.54 50.57 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.906 178.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.785 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 89.2 t80 -117.41 118.32 31.9 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 176.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 30.8 t70 54.05 29.74 10.73 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.738 0.78 . . . . 0.0 111.56 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 90.26 6.08 69.23 Favored Glycine 0 C--N 1.313 -0.741 0 CA-C-N 115.612 -0.722 . . . . 0.0 113.539 176.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.785 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -116.9 143.88 45.18 Favored 'General case' 0 CA--C 1.503 -0.838 0 CA-C-O 121.12 0.486 . . . . 0.0 109.752 177.102 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.491 ' HA ' ' HG ' ' A' ' 58' ' ' LEU . 34.6 mtp-105 -73.14 128.47 35.57 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.001 -175.39 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 74.6 mt -79.61 129.57 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 177.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.541 ' HA ' ' SD ' ' A' ' 37' ' ' MET . 93.7 m-20 -125.23 176.62 6.62 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 121.169 0.509 . . . . 0.0 111.443 -173.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.535 ' HA ' ' HB3' ' A' ' 36' ' ' SER . 8.9 p-10 -82.98 -6.58 59.54 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.571 177.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -102.16 -13.22 17.54 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.314 -176.287 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.444 ' HB3' HH22 ' A' ' 62' ' ' ARG . 20.2 p30 -70.97 165.29 23.73 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -176.103 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.474 ' O ' HG22 ' A' ' 72' ' ' THR . 42.5 p -123.56 159.63 54.47 Favored Pre-proline 0 N--CA 1.443 -0.78 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.056 -175.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.47 ' HD2' ' HB ' ' A' ' 69' ' ' THR . 19.3 Cg_endo -58.61 -31.15 94.04 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.927 2.418 . . . . 0.0 114.097 -176.584 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.68 -28.55 36.74 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 119.586 -0.845 . . . . 0.0 111.87 -177.635 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.474 HG22 ' O ' ' A' ' 69' ' ' THR . 12.1 t -79.24 -30.78 43.35 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 120.071 -0.652 . . . . 0.0 109.308 178.257 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.432 ' HB3' ' HG3' ' A' ' 75' ' ' MET . 94.9 mt -76.65 -23.16 53.3 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.262 175.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 46.21 34.24 2.08 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.119 177.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.432 ' HG3' ' HB3' ' A' ' 73' ' ' LEU . 61.6 mtt -72.36 154.11 41.1 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.774 -177.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -151.13 175.22 12.34 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.222 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.434 ' CG ' ' HZ2' ' A' ' 16' ' ' LYS . 38.7 t70 -58.7 122.07 12.61 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.801 0.81 . . . . 0.0 112.76 -177.258 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.6 t70 66.45 34.74 6.01 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 113.788 -1.551 . . . . 0.0 111.701 177.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -74.8 178.45 5.48 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 175.308 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 36.0 m -117.26 147.77 20.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 CA-C-O 121.763 0.792 . . . . 0.0 112.87 -175.005 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.498 HD12 HG21 ' A' ' 17' ' ' ILE . 7.6 mt -128.73 138.25 55.1 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-N 114.318 -1.31 . . . . 0.0 110.164 178.333 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -104.52 140.45 37.96 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.813 0.34 . . . . 0.0 110.613 -176.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.529 ' HB ' ' HA2' ' A' ' 21' ' ' GLY . 98.4 t -126.42 134.37 66.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-O 121.221 0.534 . . . . 0.0 111.938 -178.483 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.534 ' CD1' HD13 ' A' ' 58' ' ' LEU . 78.3 m-85 -99.38 168.69 9.84 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.739 177.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.485 ' HG3' ' HA2' ' A' ' 90' ' ' GLY . 64.1 tt0 -66.4 133.01 49.59 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.367 0.603 . . . . 0.0 111.499 -172.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -61.68 151.89 32.44 Favored 'General case' 0 CA--C 1.497 -1.079 0 CA-C-N 115.125 -0.943 . . . . 0.0 112.021 -177.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.509 ' HB3' ' HB2' ' A' ' 54' ' ' SER . 60.5 tp60 -69.19 -40.06 78.29 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.533 179.36 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -111.62 -1.5 15.73 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.212 -179.115 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -103.2 -123.41 5.27 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.485 ' HA2' ' HG3' ' A' ' 85' ' ' GLN . . . . . . . . 0 N--CA 1.435 -1.415 0 CA-C-O 118.515 -1.158 . . . . 0.0 112.354 178.281 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 N--CA 1.475 0.785 0 CA-C-O 120.772 0.32 . . . . 0.0 110.487 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -110.67 123.4 49.95 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 177.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -68.38 -26.07 65.38 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -62.35 -42.45 99.4 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.724 174.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 62.79 74.21 0.44 Allowed 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.099 -0.955 . . . . 0.0 112.055 178.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -81.21 112.52 18.62 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 58.47 -176.39 0.08 Allowed 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.586 -176.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -105.53 -3.22 22.67 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.939 177.026 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 107.15 73.79 0.85 Allowed Glycine 0 N--CA 1.443 -0.878 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -178.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -133.64 163.0 30.41 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -176.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -119.07 12.12 12.62 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 120.805 0.336 . . . . 0.0 111.426 -178.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -144.98 162.4 37.0 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.337 -179.105 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -130.5 124.68 32.49 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-O 121.661 0.744 . . . . 0.0 111.996 -177.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -129.39 157.24 42.5 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.82 178.096 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.5 pt -114.98 161.44 13.73 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -176.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.403 ' H ' ' HA ' ' A' ' 77' ' ' ASP . 23.0 ttmm -103.61 142.82 33.64 Favored 'General case' 0 C--N 1.282 -2.326 0 C-N-CA 120.572 -0.451 . . . . 0.0 109.958 179.398 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.629 HG21 HD12 ' A' ' 81' ' ' ILE . 41.0 mm -123.59 127.99 74.32 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.169 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.799 177.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.1 mtmt -101.6 103.69 14.52 Favored 'General case' 0 N--CA 1.423 -1.802 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 177.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.776 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 91.3 t -81.69 121.98 35.9 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.87 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 62.0 t -109.99 121.48 62.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.16 0.505 . . . . 0.0 110.285 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -90.97 -174.11 43.94 Favored Glycine 0 CA--C 1.52 0.371 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.937 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -63.75 -38.59 91.68 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -177.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.614 ' HB2' ' OD1' ' A' ' 25' ' ' ASN . 16.0 m-20 -87.33 22.06 2.26 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 178.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 48.9 m 65.35 31.76 10.23 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.863 -178.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.614 ' OD1' ' HB2' ' A' ' 23' ' ' ASP . 14.9 m120 -78.67 106.74 10.86 Favored 'General case' 0 CA--C 1.501 -0.924 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.755 -178.439 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.776 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 36.6 tt0 -103.08 134.63 46.18 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-O 121.195 0.521 . . . . 0.0 111.279 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.7 p -136.12 141.92 40.2 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.198 178.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 35.6 m170 -101.69 115.14 29.86 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.264 0.554 . . . . 0.0 111.817 -176.026 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -115.51 148.07 39.92 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.37 175.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 21.4 tpp180 -103.11 120.56 40.91 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 177.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.424 HG22 HG12 ' A' ' 17' ' ' ILE . 32.5 m -134.58 172.22 16.5 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.449 -178.158 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -89.99 162.56 15.32 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.411 ' C ' ' HB3' ' A' ' 70' ' ' PRO . 83.3 m-85 -56.37 -39.85 73.59 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 175.009 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -101.22 33.06 6.77 Favored Glycine 0 N--CA 1.446 -0.651 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.388 -179.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.508 HG23 ' HB2' ' A' ' 39' ' ' LYS . 0.9 OUTLIER -68.75 133.42 48.35 Favored 'General case' 0 N--CA 1.428 -1.537 0 CA-C-O 121.47 0.652 . . . . 0.0 111.953 177.908 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.459 ' OG ' ' HG2' ' A' ' 39' ' ' LYS . 86.7 p -78.44 161.6 26.99 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.293 -179.359 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.638 ' SD ' ' HA ' ' A' ' 65' ' ' ASN . 26.2 ptt? -59.61 -32.29 70.27 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.898 0.38 . . . . 0.0 111.004 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.17 -36.87 83.19 Favored 'General case' 0 C--O 1.219 -0.537 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.628 -177.289 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.508 ' HB2' HG23 ' A' ' 35' ' ' THR . 32.4 mmmt -59.97 -40.86 90.56 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.609 -175.588 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.513 HD23 ' H ' ' A' ' 40' ' ' LEU . 0.4 OUTLIER -87.82 -45.87 9.93 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -179.534 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -62.65 -45.32 93.36 Favored 'General case' 0 CA--C 1.501 -0.93 0 N-CA-C 111.798 0.295 . . . . 0.0 111.798 -176.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.531 ' O ' ' HB2' ' A' ' 46' ' ' ASP . 40.0 ttpt -61.95 -42.12 98.75 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.614 176.776 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.448 ' O ' ' HB3' ' A' ' 46' ' ' ASP . 38.2 t -68.75 -51.17 44.13 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.286 -176.196 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.487 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 48.7 t80 -68.3 -48.01 66.1 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.9 -178.166 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.21 -29.34 68.67 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 121.631 0.729 . . . . 0.0 109.679 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.531 ' HB2' ' O ' ' A' ' 42' ' ' LYS . 22.2 t70 -63.16 -46.74 85.76 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.749 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.487 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 25.9 ptt180 -69.09 -30.47 68.79 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.008 0.432 . . . . 0.0 110.926 -175.579 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.595 HG23 HG12 ' A' ' 50' ' ' VAL . 4.8 t -92.46 -21.53 20.11 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.83 -175.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.3 23.32 57.08 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.39 -0.909 . . . . 0.0 112.985 179.163 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.72 HG11 HD23 ' A' ' 55' ' ' LEU . 7.8 p -98.74 158.94 3.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.002 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.543 ' HB3' ' OG ' ' A' ' 54' ' ' SER . . . -59.96 132.72 54.83 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 177.703 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 71.1 t -61.3 -44.19 97.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.158 0.504 . . . . 0.0 110.598 -178.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -66.63 -32.92 74.55 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.015 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.543 ' OG ' ' HB3' ' A' ' 51' ' ' ALA . 83.1 p -76.25 -13.21 60.17 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.302 -0.408 . . . . 0.0 112.066 -178.374 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.72 HD23 HG11 ' A' ' 50' ' ' VAL . 0.6 OUTLIER -95.56 128.5 42.47 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -178.196 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -121.82 126.86 49.74 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.906 -175.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.546 ' CE1' HD12 ' A' ' 55' ' ' LEU . 65.8 m-85 -106.14 129.83 54.14 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.094 173.423 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.514 ' HG ' ' HA ' ' A' ' 63' ' ' ARG . 8.1 mp -126.47 147.24 49.85 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 121.21 0.529 . . . . 0.0 111.103 -179.169 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.75 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 45.1 t80 -118.06 114.39 23.05 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 55.89 29.7 14.62 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.097 0.475 . . . . 0.0 112.258 -177.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 92.35 6.78 64.22 Favored Glycine 0 C--N 1.313 -0.717 0 C-N-CA 120.902 -0.666 . . . . 0.0 113.776 175.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.75 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.1 OUTLIER -120.84 136.6 54.87 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 117.204 0.502 . . . . 0.0 109.677 176.708 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.514 ' HA ' ' HG ' ' A' ' 58' ' ' LEU . 5.7 ptm180 -66.92 141.84 57.49 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.309 -0.86 . . . . 0.0 112.542 -175.674 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 77.7 mt -95.28 120.52 44.8 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.228 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.638 ' HA ' ' SD ' ' A' ' 37' ' ' MET . 21.3 m120 -119.56 164.75 15.37 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.065 0.459 . . . . 0.0 111.376 -178.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -70.66 -12.19 61.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.797 179.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -81.51 -21.01 38.91 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.083 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.458 ' CG ' HH12 ' A' ' 62' ' ' ARG . 66.0 m-20 -74.78 143.54 43.97 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -175.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.447 ' HB ' ' HD2' ' A' ' 70' ' ' PRO . 82.8 p -91.55 161.4 34.41 Favored Pre-proline 0 C--N 1.318 -0.792 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.872 177.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.447 ' HD2' ' HB ' ' A' ' 69' ' ' THR . 19.1 Cg_endo -60.04 -26.69 83.12 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.485 2.124 . . . . 0.0 111.766 177.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.07 -40.44 38.53 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.206 -177.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.1 t -75.83 -31.34 59.31 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.676 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.405 ' HB3' ' HE3' ' A' ' 75' ' ' MET . 97.4 mt -71.98 -25.52 61.88 Favored 'General case' 0 C--O 1.213 -0.837 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.36 177.338 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 52.19 24.2 2.68 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 123.58 0.752 . . . . 0.0 112.926 174.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.405 ' HE3' ' HB3' ' A' ' 73' ' ' LEU . 23.4 ptp -79.62 161.1 26.1 Favored 'General case' 0 C--N 1.321 -0.643 0 O-C-N 122.123 -0.36 . . . . 0.0 110.982 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -143.74 -178.9 6.14 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -178.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.403 ' HA ' ' H ' ' A' ' 16' ' ' LYS . 34.2 t70 -66.46 118.51 10.19 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.304 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 17.9 t70 71.27 33.54 1.95 Allowed 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.715 1.206 . . . . 0.0 110.475 178.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -84.02 177.36 8.3 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 176.305 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.5 m -110.47 149.27 13.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 CA-C-O 121.539 0.685 . . . . 0.0 111.836 -174.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.629 HD12 HG21 ' A' ' 17' ' ' ILE . 1.0 OUTLIER -137.61 138.93 44.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 CA-C-N 114.763 -1.108 . . . . 0.0 109.905 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -100.24 146.18 27.2 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.993 0.425 . . . . 0.0 111.499 -174.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 84.0 t -118.62 129.22 75.18 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.252 175.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.503 ' CE1' HD22 ' A' ' 58' ' ' LEU . 60.2 m-85 -100.55 169.42 9.07 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.224 177.478 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -67.36 148.81 51.14 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.439 0.637 . . . . 0.0 111.536 -173.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.685 ' HG2' ' H ' ' A' ' 89' ' ' GLY . 0.7 OUTLIER -94.55 157.1 16.14 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 114.82 -1.082 . . . . 0.0 112.335 -175.052 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.537 ' H ' ' HB2' ' A' ' 54' ' ' SER . 53.1 tt0 -66.19 -41.78 89.78 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.112 178.472 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.41 ' HB3' HG23 ' A' ' 50' ' ' VAL . 58.8 tp -63.08 -40.55 97.99 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 178.446 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.685 ' H ' ' HG2' ' A' ' 86' ' ' GLU . . . 103.24 154.95 24.56 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.89 177.169 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.102 0 CA-C-O 119.041 -0.866 . . . . 0.0 111.08 178.687 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 ptp . . . . . 0 N--CA 1.471 0.587 0 CA-C-O 120.892 0.377 . . . . 0.0 111.046 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -109.15 128.04 54.69 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 174.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 31.6 t70 67.01 -179.75 0.22 Allowed 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -174.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -66.35 -37.42 85.27 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.325 -0.55 . . . . 0.0 109.719 177.089 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 55.42 33.68 21.39 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.411 177.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.58 87.8 5.73 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-O 121.543 0.687 . . . . 0.0 109.703 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -91.5 162.74 14.42 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.429 -177.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -94.3 125.4 38.91 Favored 'General case' 0 N--CA 1.425 -1.725 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 174.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -71.99 61.29 1.35 Allowed Glycine 0 C--N 1.308 -1.004 0 C-N-CA 120.613 -0.803 . . . . 0.0 113.98 -176.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -85.77 66.82 9.81 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.577 0.703 . . . . 0.0 109.807 177.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -171.34 42.26 0.02 OUTLIER 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.336 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.27 162.08 26.79 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.662 -1.154 . . . . 0.0 111.163 -178.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 70.4 35.67 1.94 Allowed 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 122.3 1.048 . . . . 0.0 110.23 -177.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -132.21 167.51 19.67 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 113.644 -1.617 . . . . 0.0 109.417 178.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.424 ' O ' ' HD3' ' A' ' 30' ' ' ARG . 4.3 pt -109.06 161.07 7.58 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -176.52 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.559 ' HE3' ' OD1' ' A' ' 78' ' ' ASP . 34.3 ttpt -109.82 144.69 37.9 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 -177.628 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.761 HG21 HD12 ' A' ' 81' ' ' ILE . 82.4 mt -130.29 133.04 64.61 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.183 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.395 178.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.0 mtmt -96.33 105.56 17.65 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 175.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.739 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 88.1 t -81.33 117.58 27.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.061 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.4 t -112.94 120.02 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 O-C-N 123.504 0.503 . . . . 0.0 109.769 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.405 ' HA2' ' HB ' ' A' ' 83' ' ' VAL . . . -86.42 -175.45 49.63 Favored Glycine 0 C--N 1.311 -0.821 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.746 -179.531 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -62.68 -37.58 87.0 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -178.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -88.9 22.57 2.65 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 178.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 54.6 m 64.16 38.53 8.19 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.942 -178.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -79.91 102.34 9.11 Favored 'General case' 0 C--O 1.215 -0.739 0 CA-C-N 115.0 -1.0 . . . . 0.0 108.974 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.739 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 27.7 tt0 -104.35 128.41 52.18 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 120.986 0.422 . . . . 0.0 112.107 -176.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.6 p -141.65 144.07 26.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.283 177.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 61.0 m170 -91.43 117.64 29.86 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -178.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -111.76 144.95 40.21 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.859 172.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.424 ' HD3' ' O ' ' A' ' 15' ' ' ILE . 15.1 tpp180 -108.8 119.88 40.84 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.251 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 33.6 m -138.13 174.77 10.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.606 -178.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.513 ' O ' ' HB ' ' A' ' 35' ' ' THR . 36.1 ttpt -88.29 160.4 17.67 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.267 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.641 ' O ' ' HB3' ' A' ' 70' ' ' PRO . 96.7 m-85 -57.18 -44.11 83.27 Favored 'General case' 0 C--O 1.224 -0.244 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 176.379 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -93.18 21.04 42.37 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.464 -177.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.513 ' HB ' ' O ' ' A' ' 32' ' ' LYS . 0.9 OUTLIER -60.27 139.6 57.52 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-O 121.637 0.732 . . . . 0.0 112.154 179.363 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.9 m -91.35 158.42 16.55 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.433 178.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.405 ' HG2' ' HB3' ' A' ' 66' ' ' ASP . 25.3 ptt? -52.16 -33.35 39.98 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -176.63 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.42 -35.97 79.03 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -177.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.505 ' HB2' HG23 ' A' ' 35' ' ' THR . 75.1 mmtt -59.15 -41.3 88.01 Favored 'General case' 0 C--O 1.215 -0.749 0 CA-C-O 120.846 0.355 . . . . 0.0 110.691 -175.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.519 HD23 ' H ' ' A' ' 40' ' ' LEU . 0.4 OUTLIER -88.56 -44.19 10.84 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -179.575 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.624 ' HE3' ' O ' ' A' ' 55' ' ' LEU . 61.6 mtpt -62.52 -45.33 93.47 Favored 'General case' 0 CA--C 1.492 -1.279 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.803 -176.464 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.502 ' HA ' HG22 ' A' ' 52' ' ' VAL . 40.4 ttmt -61.2 -43.58 98.65 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 176.358 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 58.0 m -62.84 -49.19 75.88 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.309 -176.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.479 ' CB ' ' HZ ' ' A' ' 57' ' ' PHE . 47.7 t80 -71.54 -45.93 60.97 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.735 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.532 ' HB1' ' O ' ' A' ' 50' ' ' VAL . . . -59.0 -33.36 70.62 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 121.301 0.572 . . . . 0.0 109.845 -178.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -63.02 -46.46 87.48 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.415 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 -70.84 -24.78 62.6 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.902 0.382 . . . . 0.0 111.616 -177.185 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.429 HG22 ' O ' ' A' ' 44' ' ' TYR . 9.9 t -97.29 -5.31 36.99 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.788 -178.409 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 68.52 30.56 73.13 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.312 178.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.712 HG11 ' HG3' ' A' ' 86' ' ' GLU . 70.6 t -112.81 146.93 16.87 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 C-N-CA 122.628 0.371 . . . . 0.0 110.392 -178.443 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.561 ' H ' HD12 ' A' ' 88' ' ' LEU . . . -54.47 133.08 45.77 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.974 177.117 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.502 HG22 ' HA ' ' A' ' 42' ' ' LYS . 72.7 t -61.6 -42.86 95.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.991 -176.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 32.4 p-10 -73.73 -16.77 61.17 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.675 -177.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.547 ' HB2' ' HB3' ' A' ' 87' ' ' GLN . 96.8 p -93.82 -5.8 47.32 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.846 -0.342 . . . . 0.0 111.442 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.624 ' O ' ' HE3' ' A' ' 41' ' ' LYS . 0.1 OUTLIER -94.47 135.18 36.2 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.687 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.479 ' HD2' ' N ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -130.36 126.61 37.55 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 120.002 -0.679 . . . . 0.0 111.849 -175.844 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.498 ' CE1' HD12 ' A' ' 55' ' ' LEU . 36.4 m-85 -110.27 133.14 53.54 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.39 177.297 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.518 HD22 ' CE1' ' A' ' 84' ' ' TYR . 9.8 mp -122.52 146.05 47.76 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.123 0.487 . . . . 0.0 111.113 -179.156 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.72 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 74.0 t80 -118.74 117.54 29.18 Favored 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 175.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 33.9 t70 58.17 28.3 16.3 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.741 0.781 . . . . 0.0 111.225 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 92.39 5.17 65.54 Favored Glycine 0 C--N 1.315 -0.585 0 CA-C-N 115.382 -0.826 . . . . 0.0 113.721 177.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.72 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.2 OUTLIER -122.37 134.47 54.63 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.313 0.578 . . . . 0.0 109.888 177.716 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.487 ' HA ' ' HG ' ' A' ' 58' ' ' LEU . 28.8 ptt180 -66.16 139.84 58.16 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 115.206 -0.906 . . . . 0.0 112.63 -175.498 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 76.5 mt -89.48 118.05 34.0 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.977 -178.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -105.71 159.85 15.67 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.514 -178.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.405 ' HB3' ' HG2' ' A' ' 37' ' ' MET . 6.9 p-10 -73.97 -14.47 61.04 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.244 0.545 . . . . 0.0 109.731 177.311 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -81.72 -19.16 42.06 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.78 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -72.88 147.47 45.32 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.197 0.522 . . . . 0.0 111.863 -178.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.431 ' HB ' ' HD2' ' A' ' 70' ' ' PRO . 23.3 p -97.12 160.74 28.3 Favored Pre-proline 0 N--CA 1.439 -1.013 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.545 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.641 ' HB3' ' O ' ' A' ' 33' ' ' TYR . 14.3 Cg_endo -58.21 -32.9 96.87 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.566 2.177 . . . . 0.0 112.535 -178.352 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.598 ' HG3' ' N ' ' A' ' 72' ' ' THR . 19.8 ptmt -69.0 -43.47 74.77 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.956 -0.565 . . . . 0.0 112.334 -179.376 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.598 ' N ' ' HG3' ' A' ' 71' ' ' LYS . 12.5 t -76.08 -28.75 57.71 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-O 121.248 0.547 . . . . 0.0 109.667 -178.219 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 96.1 mt -75.58 -21.59 57.71 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.681 175.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.519 ' HG2' ' O ' ' A' ' 71' ' ' LYS . 8.7 mm-40 52.4 34.03 14.25 Favored 'General case' 0 C--N 1.348 0.524 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 175.04 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 67.8 mtm -88.34 155.47 19.69 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 120.984 0.421 . . . . 0.0 111.526 -178.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -153.16 -175.19 5.23 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 177.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.444 ' HA ' ' H ' ' A' ' 16' ' ' LYS . 3.5 p-10 -63.85 125.25 23.76 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.758 0.79 . . . . 0.0 112.366 -176.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.559 ' OD1' ' HE3' ' A' ' 16' ' ' LYS . 24.2 t70 64.24 33.39 11.68 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.005 -1.452 . . . . 0.0 110.98 177.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -78.06 177.31 8.42 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.135 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.3 m -108.83 144.72 16.75 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 CA-C-O 121.547 0.689 . . . . 0.0 111.948 -174.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.761 HD12 HG21 ' A' ' 17' ' ' ILE . 1.2 mt -137.98 140.76 40.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.27 179.335 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -102.72 146.02 28.84 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.309 -175.46 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.405 ' HB ' ' HA2' ' A' ' 21' ' ' GLY . 97.4 t -126.44 132.37 70.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 121.081 0.467 . . . . 0.0 110.996 177.491 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.518 ' CE1' HD22 ' A' ' 58' ' ' LEU . 79.3 m-85 -108.47 168.75 9.1 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.452 178.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -68.05 141.66 56.11 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.7 0.762 . . . . 0.0 111.697 -173.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.712 ' HG3' HG11 ' A' ' 50' ' ' VAL . 0.5 OUTLIER -104.24 167.16 9.93 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 114.389 -1.278 . . . . 0.0 112.474 -172.621 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.547 ' HB3' ' HB2' ' A' ' 54' ' ' SER . 64.6 tt0 -64.14 -47.65 79.1 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.003 -177.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.561 HD12 ' H ' ' A' ' 51' ' ' ALA . 92.0 mt -91.02 -2.4 57.68 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.165 -0.47 . . . . 0.0 112.24 -177.196 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.491 ' H ' ' HG2' ' A' ' 86' ' ' GLU . . . -106.55 -110.12 3.45 Favored Glycine 0 N--CA 1.442 -0.951 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 176.438 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.213 0 CA-C-O 118.44 -1.2 . . . . 0.0 111.633 -179.916 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.0 mtm . . . . . 0 N--CA 1.474 0.74 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.69 97.33 7.87 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-O 120.868 0.366 . . . . 0.0 111.123 -178.111 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -90.19 5.72 45.8 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.602 0.715 . . . . 0.0 109.204 177.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -61.36 -36.57 80.58 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.507 -1.224 . . . . 0.0 110.44 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 71.89 20.23 4.54 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.882 178.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.431 ' O ' ' HB2' ' A' ' 7' ' ' GLN . . . -65.46 138.26 57.99 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 176.569 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.431 ' HB2' ' O ' ' A' ' 6' ' ' ALA . 98.8 mt-30 68.2 125.14 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.535 0.734 . . . . 0.0 110.742 -175.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.36 -40.57 94.75 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.099 0.476 . . . . 0.0 110.623 -178.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -178.69 29.6 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.839 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 177.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -63.79 -40.7 97.29 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -176.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -125.73 116.14 21.16 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-O 121.568 0.699 . . . . 0.0 111.227 -173.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -138.45 148.59 44.56 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.575 178.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 61.94 42.34 10.33 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.759 0.79 . . . . 0.0 109.659 -175.333 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -110.75 164.75 12.44 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.1 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.2 pt -129.08 162.25 36.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.127 -177.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.539 ' HE3' ' HB2' ' A' ' 78' ' ' ASP . 55.7 mtmt -98.7 147.42 24.87 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-O 121.0 0.429 . . . . 0.0 110.308 176.425 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.56 HD12 HG21 ' A' ' 31' ' ' VAL . 61.3 mt -130.76 128.82 63.45 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.099 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.604 174.229 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.3 mtmt -95.61 104.45 16.36 Favored 'General case' 0 N--CA 1.426 -1.639 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 176.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.673 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 85.8 t -82.38 110.97 18.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.467 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 5.5 p -121.66 121.68 65.04 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 CA-C-O 121.783 0.802 . . . . 0.0 111.385 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.48 ' HA2' ' HB ' ' A' ' 83' ' ' VAL . . . -91.26 169.03 32.81 Favored Glycine 0 N--CA 1.432 -1.595 0 CA-C-N 114.723 -1.126 . . . . 0.0 112.149 -179.213 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.475 ' C ' ' H ' ' A' ' 24' ' ' SER . 20.6 pt20 -68.15 -23.14 64.85 Favored 'General case' 0 CA--C 1.494 -1.179 0 CA-C-O 121.857 0.837 . . . . 0.0 110.859 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -70.23 7.52 0.98 Allowed 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 114.163 -1.38 . . . . 0.0 109.907 175.001 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.475 ' H ' ' C ' ' A' ' 22' ' ' GLN . 49.0 m 66.32 29.94 9.21 Favored 'General case' 0 C--N 1.347 0.463 0 C-N-CA 123.559 0.744 . . . . 0.0 110.363 -178.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.458 ' O ' ' HA ' ' A' ' 20' ' ' VAL . 54.7 t30 -104.59 105.57 15.73 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.564 -178.674 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.673 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 39.8 tt0 -108.0 132.73 53.21 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.437 0.637 . . . . 0.0 111.112 178.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.3 p -136.14 142.77 37.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.651 179.09 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 53.8 m170 -100.18 115.61 30.26 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 121.293 0.568 . . . . 0.0 111.791 -175.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -115.48 151.28 35.09 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.724 176.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 53.2 ttp180 -111.23 123.46 50.24 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 173.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.56 HG21 HD12 ' A' ' 17' ' ' ILE . 31.3 m -135.7 174.02 13.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.102 -176.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 24.4 ttpp -88.49 156.67 18.97 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.472 ' C ' ' HB3' ' A' ' 70' ' ' PRO . 90.1 m-85 -51.28 -41.36 60.38 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 176.371 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -100.27 25.49 28.11 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.844 -0.617 . . . . 0.0 113.244 -177.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.518 HG23 ' HB2' ' A' ' 39' ' ' LYS . 1.1 m -65.26 136.47 56.64 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 121.284 0.564 . . . . 0.0 111.855 178.507 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.463 ' HB3' ' HA ' ' A' ' 66' ' ' ASP . 49.3 m -84.85 153.95 22.61 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.06 -178.498 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.462 ' SD ' ' HA ' ' A' ' 65' ' ' ASN . 24.7 ptt? -48.2 -32.32 6.95 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.17 -37.79 84.18 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -176.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.518 ' HB2' HG23 ' A' ' 35' ' ' THR . 75.3 mmtt -62.16 -39.23 91.95 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.767 0.318 . . . . 0.0 110.972 -175.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.523 HD12 ' CD2' ' A' ' 57' ' ' PHE . 0.3 OUTLIER -86.88 -46.04 10.28 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 116.163 -0.471 . . . . 0.0 112.088 -178.564 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.467 ' HG2' ' CD1' ' A' ' 57' ' ' PHE . 59.0 mtpt -62.64 -48.53 78.96 Favored 'General case' 0 CA--C 1.496 -1.104 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 -177.364 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -63.04 -40.42 97.66 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.006 179.001 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 47.3 t -66.01 -51.4 58.66 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.078 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.471 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 45.2 t80 -65.34 -46.92 78.29 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.838 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.427 ' HB1' ' O ' ' A' ' 50' ' ' VAL . . . -58.53 -36.68 74.22 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-O 121.374 0.606 . . . . 0.0 109.805 -177.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -66.51 -47.94 71.37 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.227 -178.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.471 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 15.8 ptm180 -71.25 -24.35 62.16 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.73 -177.578 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.439 HG22 ' O ' ' A' ' 44' ' ' TYR . 12.9 t -95.67 -8.36 34.93 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.579 -178.459 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.73 30.94 65.5 Favored Glycine 0 C--N 1.336 0.552 0 C-N-CA 121.298 -0.477 . . . . 0.0 113.54 178.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.456 HG11 ' HG2' ' A' ' 86' ' ' GLU . 96.8 t -119.44 150.39 21.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 -178.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.446 ' HB3' ' OG ' ' A' ' 54' ' ' SER . . . -52.26 135.83 31.71 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.242 176.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 72.2 t -61.6 -43.41 96.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.243 -178.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -66.59 -27.24 67.56 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.52 178.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.455 ' OG ' ' HB3' ' A' ' 87' ' ' GLN . 74.2 m -75.09 -12.15 60.25 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.237 179.103 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.412 HD13 ' HA ' ' A' ' 55' ' ' LEU . 1.4 mm? -94.8 135.42 36.32 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.081 0.467 . . . . 0.0 110.28 177.035 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.46 119.25 17.23 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.127 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.523 ' CD2' HD12 ' A' ' 40' ' ' LEU . 11.0 m-85 -109.37 132.24 54.31 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.39 -179.351 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.523 ' HG ' ' HA ' ' A' ' 63' ' ' ARG . 9.1 mp -124.8 147.76 48.54 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 121.356 0.598 . . . . 0.0 111.654 -177.489 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.794 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 49.2 t80 -126.92 126.35 43.1 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 175.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 22.6 t70 58.78 24.56 12.46 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.719 0.771 . . . . 0.0 110.931 -179.018 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.07 5.83 87.16 Favored Glycine 0 C--N 1.312 -0.795 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.863 179.095 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.794 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.1 OUTLIER -113.97 144.47 43.03 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 178.046 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.523 ' HA ' ' HG ' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -71.65 132.1 44.11 Favored 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.699 -176.478 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 82.1 mt -74.68 130.72 35.88 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 N-CA-C 107.429 -1.322 . . . . 0.0 107.429 176.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.462 ' HA ' ' SD ' ' A' ' 37' ' ' MET . 15.6 m120 -112.9 165.74 12.04 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 121.236 0.541 . . . . 0.0 111.1 -173.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.463 ' HA ' ' HB3' ' A' ' 36' ' ' SER . 7.2 p-10 -82.66 -6.71 59.52 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 176.214 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -112.53 -2.4 14.65 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.668 -175.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 31.5 p30 -76.82 167.76 21.27 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.297 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.559 ' O ' HG22 ' A' ' 72' ' ' THR . 41.0 p -116.99 155.25 49.55 Favored Pre-proline 0 C--N 1.316 -0.857 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.702 -178.022 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.472 ' HB3' ' C ' ' A' ' 33' ' ' TYR . 18.5 Cg_endo -59.52 -31.22 94.23 Favored 'Trans proline' 0 C--O 1.217 -0.548 0 C-N-CA 122.375 2.05 . . . . 0.0 112.417 -178.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.56 ' HD3' ' N ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -75.53 -29.26 59.38 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -179.266 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.56 ' N ' ' HD3' ' A' ' 71' ' ' LYS . 4.9 t -76.08 -29.7 58.06 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.076 -0.65 . . . . 0.0 110.174 -178.725 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.552 HD21 ' NH1' ' A' ' 62' ' ' ARG . 97.7 mt -92.96 -23.72 18.62 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.355 177.484 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 40.19 59.14 2.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.506 -175.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 75.6 mtm -84.21 149.02 26.41 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.731 178.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -137.96 -179.29 5.68 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -178.077 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -64.17 118.19 8.22 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.528 0.68 . . . . 0.0 112.542 -175.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.539 ' HB2' ' HE3' ' A' ' 16' ' ' LYS . 11.8 t70 73.27 34.32 1.03 Allowed 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 113.951 -1.477 . . . . 0.0 111.17 176.214 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -74.84 177.22 6.39 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.638 177.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.8 t -111.85 130.69 65.0 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 CA-C-O 121.201 0.524 . . . . 0.0 110.939 -173.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.447 HD13 HG23 ' A' ' 17' ' ' ILE . 1.2 mp -118.69 135.1 60.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.434 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -97.59 135.86 38.81 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.589 -175.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.48 ' HB ' ' HA2' ' A' ' 21' ' ' GLY . 93.1 t -126.8 133.52 68.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 CA-C-O 121.163 0.506 . . . . 0.0 110.572 178.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -107.1 168.99 8.82 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.437 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -64.67 136.99 57.56 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-O 121.91 0.862 . . . . 0.0 111.64 -173.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.456 ' HG2' HG11 ' A' ' 50' ' ' VAL . 31.7 mp0 -70.7 156.56 39.33 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 114.169 -1.378 . . . . 0.0 112.286 -174.312 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.455 ' HB3' ' OG ' ' A' ' 54' ' ' SER . 61.7 tt0 -64.83 -43.98 91.31 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.015 175.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 52.8 tp -93.35 -30.47 15.1 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.101 -179.143 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.416 ' H ' ' HB2' ' A' ' 86' ' ' GLU . . . -89.92 0.09 78.78 Favored Glycine 0 C--O 1.236 0.251 0 C-N-CA 121.094 -0.574 . . . . 0.0 113.497 -177.184 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.581 -1.122 . . . . 0.0 111.391 179.009 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.7 ttt . . . . . 0 N--CA 1.47 0.559 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -118.34 133.77 55.61 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 120.649 0.262 . . . . 0.0 110.312 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.539 ' OD1' ' HB2' ' A' ' 6' ' ' ALA . 35.6 t70 -81.38 110.39 16.77 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.008 0.432 . . . . 0.0 111.29 -178.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -65.42 -40.97 93.98 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.8 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -170.76 -30.99 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -177.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.539 ' HB2' ' OD1' ' A' ' 3' ' ' ASP . . . 58.3 39.26 25.74 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.062 -178.625 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -94.91 146.8 23.98 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.46 -178.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -84.85 -6.35 59.35 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.234 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 143.22 -22.25 2.25 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.345 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 22.1 t70 64.48 27.23 13.49 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.494 0.664 . . . . 0.0 111.114 178.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -101.11 -1.17 34.74 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.36 0.6 . . . . 0.0 110.11 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.65 -44.07 97.2 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 115.222 1.564 . . . . 0.0 115.222 -173.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -117.18 16.26 14.92 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 115.002 1.482 . . . . 0.0 115.002 -171.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -138.05 159.83 40.99 Favored 'General case' 0 C--N 1.283 -2.305 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.47 ' HB ' ' HA ' ' A' ' 77' ' ' ASP . 12.1 pt -116.49 160.76 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.21 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.247 -177.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.402 ' H ' ' HA ' ' A' ' 77' ' ' ASP . 58.8 mtpt -101.21 147.3 26.43 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.652 178.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.423 HG12 HG22 ' A' ' 31' ' ' VAL . 42.8 mm -127.13 126.47 68.13 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.312 176.695 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.7 mtmt -96.79 103.67 15.6 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 176.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.653 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 94.3 t -82.69 116.07 26.27 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.265 178.339 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 64.1 t -109.0 118.55 56.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -92.94 179.65 39.77 Favored Glycine 0 C--N 1.312 -0.805 0 C-N-CA 120.207 -0.997 . . . . 0.0 113.062 -178.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 90.9 mm-40 -72.31 -20.2 61.53 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 121.468 0.651 . . . . 0.0 111.714 -178.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -83.37 10.77 7.94 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.324 -0.853 . . . . 0.0 108.963 176.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 40.8 m 63.65 28.47 15.03 Favored 'General case' 0 C--N 1.347 0.498 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -176.224 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 55.9 t-20 -93.32 106.94 18.84 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.513 -1.221 . . . . 0.0 110.42 -177.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.653 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 29.9 tt0 -99.28 132.02 44.9 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.13 177.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.7 p -136.74 139.94 43.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.461 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 60.1 m170 -98.66 114.55 27.08 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 121.376 0.608 . . . . 0.0 111.709 -176.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -110.63 145.31 38.13 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.284 174.121 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 57.6 ttp180 -105.33 125.71 51.29 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.1 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.423 HG22 HG12 ' A' ' 17' ' ' ILE . 32.6 m -136.44 175.7 9.72 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.516 -177.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.476 ' O ' ' HB ' ' A' ' 35' ' ' THR . 59.0 tttp -88.37 157.42 18.72 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.075 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.418 ' O ' ' HB3' ' A' ' 70' ' ' PRO . 66.2 m-85 -55.9 -41.08 73.95 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 173.684 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -97.98 31.57 7.79 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.141 -178.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.522 HG23 ' HB2' ' A' ' 39' ' ' LYS . 0.9 OUTLIER -68.63 138.79 55.31 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-O 121.503 0.668 . . . . 0.0 112.378 179.009 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.415 ' OG ' ' HG2' ' A' ' 39' ' ' LYS . 87.7 p -83.09 163.55 20.83 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.705 177.44 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.703 ' SD ' ' HA ' ' A' ' 65' ' ' ASN . 25.3 ptt? -60.61 -31.89 71.04 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.748 0.309 . . . . 0.0 111.189 -179.598 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.63 -37.16 82.94 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.244 -178.087 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.522 ' HB2' HG23 ' A' ' 35' ' ' THR . 75.9 mmtt -59.93 -40.39 88.74 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.192 -175.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.506 HD23 ' H ' ' A' ' 40' ' ' LEU . 0.4 OUTLIER -87.96 -44.13 11.25 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 179.737 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.4 ' HG2' ' HD1' ' A' ' 57' ' ' PHE . 61.3 mtpt -62.68 -45.29 93.45 Favored 'General case' 0 CA--C 1.493 -1.213 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.188 -177.518 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.422 ' O ' ' HB2' ' A' ' 46' ' ' ASP . 24.9 ttmm -62.98 -41.6 99.6 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 176.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 52.4 m -63.95 -46.19 85.82 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.202 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.707 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 45.6 t80 -71.11 -45.25 64.02 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.97 0.415 . . . . 0.0 110.871 178.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.47 -28.14 69.07 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.155 0.502 . . . . 0.0 110.008 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.422 ' HB2' ' O ' ' A' ' 42' ' ' LYS . 25.8 t70 -63.91 -45.95 87.0 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.374 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.707 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 15.3 ptm180 -65.82 -28.0 68.67 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.018 0.437 . . . . 0.0 111.047 -178.34 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.501 HG22 ' O ' ' A' ' 44' ' ' TYR . 2.0 t -97.27 -17.71 19.64 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.467 -178.516 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.04 30.36 67.82 Favored Glycine 0 C--O 1.236 0.23 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.04 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.872 HG11 ' HB2' ' A' ' 87' ' ' GLN . 2.4 p -108.76 176.46 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-O 120.676 0.274 . . . . 0.0 110.553 -177.173 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.626 ' H ' HG22 ' A' ' 50' ' ' VAL . . . -58.79 125.92 25.52 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.396 176.31 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 71.6 t -65.99 -45.46 90.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.379 0.609 . . . . 0.0 110.97 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -68.72 -31.74 71.03 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.456 -177.179 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.567 ' HB2' ' HB3' ' A' ' 51' ' ' ALA . 50.2 m -81.74 -4.44 56.31 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.979 -175.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.651 HD12 ' CE1' ' A' ' 57' ' ' PHE . 0.3 OUTLIER -90.14 128.71 36.41 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 177.108 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.465 ' HD3' ' CB ' ' A' ' 86' ' ' GLU . 3.2 mpt_? -106.12 118.95 37.95 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -173.436 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.651 ' CE1' HD12 ' A' ' 55' ' ' LEU . 61.0 m-85 -111.08 134.84 52.37 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.124 171.632 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.723 HD23 ' HD1' ' A' ' 84' ' ' TYR . 2.9 mm? -127.76 155.2 44.41 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.937 0.875 . . . . 0.0 111.746 -178.502 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.746 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 58.6 t80 -122.46 108.54 13.3 Favored 'General case' 0 C--N 1.286 -2.171 0 CA-C-N 113.941 -1.481 . . . . 0.0 108.264 176.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 55.19 22.52 4.72 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.183 0.516 . . . . 0.0 110.74 -174.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 93.85 -7.95 73.66 Favored Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.561 -179.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.746 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.1 OUTLIER -91.57 142.15 27.95 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.391 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.548 ' HA ' ' CD1' ' A' ' 58' ' ' LEU . 0.7 OUTLIER -64.81 139.2 58.74 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -174.795 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 78.9 mt -103.93 117.77 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 174.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.703 ' HA ' ' SD ' ' A' ' 37' ' ' MET . 48.0 m-80 -121.57 166.84 13.61 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 120.92 0.39 . . . . 0.0 110.6 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -70.61 -15.32 62.74 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.532 -177.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -92.12 -0.42 57.44 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 116.705 -0.225 . . . . 0.0 111.523 -179.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -80.33 140.58 36.06 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 120.906 0.384 . . . . 0.0 111.112 178.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.437 ' HB ' ' HD2' ' A' ' 70' ' ' PRO . 82.2 p -87.87 160.07 47.54 Favored Pre-proline 0 C--N 1.314 -0.97 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.993 -178.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.437 ' HD2' ' HB ' ' A' ' 69' ' ' THR . 21.0 Cg_endo -62.22 -25.61 76.99 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.626 2.217 . . . . 0.0 111.713 177.402 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.5 tmtt? -82.14 -37.65 25.9 Favored 'General case' 0 N--CA 1.423 -1.82 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.128 -177.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.7 t -74.07 -33.51 63.69 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 120.456 -0.497 . . . . 0.0 110.432 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 97.2 mt -79.06 -22.84 44.76 Favored 'General case' 0 C--O 1.217 -0.614 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.517 177.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 51.73 34.57 13.25 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.043 175.013 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 75.7 mtm -76.25 155.94 33.95 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 121.009 0.433 . . . . 0.0 111.342 -178.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -141.23 176.33 8.93 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.47 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 35.7 t70 -66.49 121.16 14.71 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 120.955 0.407 . . . . 0.0 111.089 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 24.5 t70 71.24 34.68 1.72 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.618 -1.174 . . . . 0.0 110.291 177.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -74.81 176.26 7.22 Favored 'General case' 0 N--CA 1.457 -0.09 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.95 178.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 24.5 m -106.97 138.38 33.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-O 121.57 0.7 . . . . 0.0 111.58 -176.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.412 HD13 ' HA ' ' A' ' 81' ' ' ILE . 6.8 mm -134.81 136.6 52.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.422 -177.479 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 53.6 mm-40 -101.88 141.88 34.05 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.862 -174.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 74.3 t -129.18 134.36 64.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-O 120.972 0.415 . . . . 0.0 110.953 177.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.723 ' HD1' HD23 ' A' ' 58' ' ' LEU . 74.4 m-85 -99.98 151.76 20.98 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 175.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.523 ' O ' ' HG3' ' A' ' 86' ' ' GLU . 63.9 tt0 -71.51 96.45 1.52 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.219 0.533 . . . . 0.0 110.226 -176.39 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.577 ' O ' HD22 ' A' ' 55' ' ' LEU . 30.6 mt-10 -167.99 142.34 3.5 Favored 'General case' 0 CA--C 1.501 -0.929 0 C-N-CA 125.592 1.557 . . . . 0.0 109.486 -177.437 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.872 ' HB2' HG11 ' A' ' 50' ' ' VAL . 27.6 pt20 177.33 -29.41 0.0 OUTLIER 'General case' 0 N--CA 1.389 -3.483 0 C-N-CA 125.284 1.434 . . . . 0.0 108.315 -176.692 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 60.0 tp 178.44 -37.6 0.01 OUTLIER 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 103.696 -2.705 . . . . 0.0 103.696 -179.212 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 141.05 95.18 0.25 Allowed Glycine 0 N--CA 1.44 -1.077 0 CA-C-N 113.182 -1.826 . . . . 0.0 112.047 172.291 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.469 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 -179.065 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.9 mtt . . . . . 0 N--CA 1.474 0.747 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -133.37 154.78 50.45 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.321 -178.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -70.77 160.31 32.94 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.167 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -63.13 -34.33 77.38 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 175.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 77.63 -71.96 0.1 Allowed 'General case' 0 CA--C 1.508 -0.641 0 CA-C-N 114.756 -1.111 . . . . 0.0 112.77 176.045 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -121.45 116.81 25.42 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-O 121.056 0.455 . . . . 0.0 112.208 -177.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -137.27 158.67 43.92 Favored 'General case' 0 CA--C 1.496 -1.122 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.07 175.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -106.85 120.98 43.49 Favored 'General case' 0 N--CA 1.413 -2.294 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 175.19 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -66.91 -12.71 60.39 Favored Glycine 0 CA--C 1.496 -1.141 0 C-N-CA 120.522 -0.847 . . . . 0.0 111.364 -178.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 27.7 t70 53.23 67.03 1.06 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.734 0.778 . . . . 0.0 109.772 -179.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -93.84 13.1 23.56 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.663 -174.343 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -146.8 144.92 29.7 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.115 -178.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -129.88 15.7 5.8 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.928 0.871 . . . . 0.0 110.449 -178.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -136.89 159.83 40.69 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 114.301 -1.318 . . . . 0.0 110.744 -177.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.411 ' O ' ' HD2' ' A' ' 30' ' ' ARG . 12.1 pt -126.21 163.04 28.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -179.117 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.535 ' H ' ' HA ' ' A' ' 77' ' ' ASP . 37.0 ttpt -106.55 140.05 40.05 Favored 'General case' 0 C--N 1.282 -2.353 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.621 HG21 HD12 ' A' ' 81' ' ' ILE . 83.5 mt -133.5 132.97 57.69 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.118 0 CA-C-O 120.814 0.34 . . . . 0.0 111.29 177.608 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.3 mtmt -97.62 105.81 18.02 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.148 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.61 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 97.7 t -82.42 120.38 33.75 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 178.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 59.9 t -111.02 118.22 56.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 120.998 0.428 . . . . 0.0 110.11 179.248 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.534 ' HA2' ' HB ' ' A' ' 83' ' ' VAL . . . -87.27 169.51 39.83 Favored Glycine 0 N--CA 1.445 -0.764 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.704 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.493 ' HG2' ' O ' ' A' ' 83' ' ' VAL . 15.9 mm100 -68.71 -26.82 65.46 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 120.961 0.41 . . . . 0.0 111.92 -177.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -83.34 13.88 4.02 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.055 178.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 27.4 t 74.17 24.45 1.94 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.428 178.277 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -91.57 104.53 17.0 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.811 -178.176 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.61 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 30.4 tt0 -98.77 130.82 45.24 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.693 176.637 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.423 ' CG1' ' HB ' ' A' ' 19' ' ' VAL . 7.1 p -131.06 141.35 46.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.131 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 50.7 m170 -98.98 108.74 21.5 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 121.067 0.46 . . . . 0.0 110.702 -175.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -110.05 147.13 34.15 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.868 179.239 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.411 ' HD2' ' O ' ' A' ' 15' ' ' ILE . 23.4 tpt180 -108.38 118.74 37.56 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 176.344 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.497 HG21 HD12 ' A' ' 17' ' ' ILE . 33.7 m -133.21 171.6 17.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.767 -177.684 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.422 ' O ' ' HB ' ' A' ' 35' ' ' THR . 38.1 ttpt -88.83 156.93 18.65 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 -178.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -55.61 -39.58 70.97 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 174.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -97.42 24.6 30.77 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.56 -178.335 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.422 ' HB ' ' O ' ' A' ' 32' ' ' LYS . 1.0 OUTLIER -67.05 138.09 56.92 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-O 121.367 0.603 . . . . 0.0 112.068 179.032 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.8 m -92.1 158.89 15.95 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.685 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 25.9 ptt? -52.78 -34.38 53.01 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -176.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.55 -36.27 80.12 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.332 0.494 . . . . 0.0 112.332 -176.489 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -59.98 -40.91 90.76 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.664 0.268 . . . . 0.0 110.711 -174.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.501 HD23 ' H ' ' A' ' 40' ' ' LEU . 0.4 OUTLIER -87.79 -45.81 10.0 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.213 -0.448 . . . . 0.0 112.0 -179.094 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.672 ' HG2' ' CD1' ' A' ' 57' ' ' PHE . 62.3 mtpt -62.83 -45.9 90.45 Favored 'General case' 0 CA--C 1.493 -1.22 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.501 -175.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -61.85 -41.68 98.12 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 177.249 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 47.9 t -63.98 -51.0 66.35 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.227 -178.052 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.596 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 46.6 t80 -70.21 -46.59 64.21 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.345 -179.089 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.437 ' HB1' ' O ' ' A' ' 50' ' ' VAL . . . -60.05 -36.76 78.02 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.393 0.616 . . . . 0.0 110.016 -178.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -66.03 -46.16 78.86 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.14 -178.34 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.596 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 14.6 ptm180 -68.07 -24.73 65.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.453 -177.668 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.459 HG22 ' O ' ' A' ' 44' ' ' TYR . 12.4 t -96.02 -8.61 33.16 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 120.769 0.318 . . . . 0.0 111.619 -179.126 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.72 31.2 60.73 Favored Glycine 0 C--N 1.339 0.727 0 C-N-CA 121.004 -0.617 . . . . 0.0 113.222 178.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.443 HG11 ' HG3' ' A' ' 86' ' ' GLU . 94.7 t -119.47 148.76 22.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 C-N-CA 122.539 0.336 . . . . 0.0 110.806 -178.409 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.417 ' HB3' ' OG ' ' A' ' 54' ' ' SER . . . -51.76 134.24 30.8 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.456 176.355 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 74.0 t -61.05 -44.62 98.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.001 -177.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -70.56 -22.44 62.59 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.187 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.484 ' HB3' ' HB3' ' A' ' 87' ' ' GLN . 68.0 m -80.24 -10.96 59.77 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.169 179.129 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.08 129.3 40.67 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 177.554 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -117.94 115.12 24.27 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 120.999 0.428 . . . . 0.0 110.856 -177.465 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.672 ' CD1' ' HG2' ' A' ' 41' ' ' LYS . 27.6 m-85 -106.06 127.76 53.4 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.937 177.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.556 HD22 ' CE1' ' A' ' 84' ' ' TYR . 9.2 mp -124.59 140.22 53.15 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.922 -179.353 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.767 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 76.7 t80 -105.95 117.08 33.09 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 177.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 29.1 t70 56.53 19.84 4.46 Favored 'General case' 0 CA--C 1.548 0.879 0 CA-C-O 121.29 0.567 . . . . 0.0 111.625 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.94 1.32 51.95 Favored Glycine 0 CA--C 1.521 0.451 0 C-N-CA 121.081 -0.58 . . . . 0.0 113.224 178.435 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.767 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.2 OUTLIER -113.68 142.38 46.08 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 117.097 0.448 . . . . 0.0 109.866 177.668 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.553 ' HA ' ' HG ' ' A' ' 58' ' ' LEU . 9.7 mpt_? -65.45 139.09 58.49 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -175.671 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 80.5 mt -94.49 119.02 41.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.294 178.284 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -110.66 160.99 16.19 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.193 -178.707 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -72.18 -18.29 61.87 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.304 0.573 . . . . 0.0 109.718 176.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -81.4 -19.45 42.57 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.031 -179.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.522 ' CG ' HH12 ' A' ' 62' ' ' ARG . 47.3 m-20 -68.21 140.23 56.07 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 121.391 0.615 . . . . 0.0 111.854 -179.327 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.488 ' HB ' ' HD2' ' A' ' 70' ' ' PRO . 18.8 p -100.66 163.45 18.08 Favored Pre-proline 0 C--N 1.311 -1.065 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.909 -178.277 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.488 ' HD2' ' HB ' ' A' ' 69' ' ' THR . 17.1 Cg_endo -58.32 -28.86 86.16 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 122.703 2.269 . . . . 0.0 112.687 -178.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.554 ' HG3' ' H ' ' A' ' 72' ' ' THR . 15.2 ptmt -72.41 -49.82 30.92 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.554 ' H ' ' HG3' ' A' ' 71' ' ' LYS . 15.1 t -67.64 -34.26 76.61 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.981 0.42 . . . . 0.0 110.735 -177.402 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 97.5 mt -79.41 -22.84 43.74 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.541 177.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 36.35 36.52 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 124.639 1.176 . . . . 0.0 113.835 -179.009 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 65.9 mtt -75.42 151.81 38.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.47 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -147.98 -176.4 5.26 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.819 -178.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.535 ' HA ' ' H ' ' A' ' 16' ' ' LYS . 6.4 p-10 -59.42 121.91 12.66 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -174.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.459 ' OD1' ' HE3' ' A' ' 16' ' ' LYS . 26.5 t70 71.01 32.45 2.31 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 113.635 -1.621 . . . . 0.0 111.553 175.321 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -79.23 178.05 8.36 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 175.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 35.1 m -115.13 150.5 17.05 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 CA-C-O 121.815 0.817 . . . . 0.0 112.336 -174.068 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.621 HD12 HG21 ' A' ' 17' ' ' ILE . 1.6 mt -134.26 134.92 54.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.854 178.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -101.81 139.63 37.19 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.897 -178.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.534 ' HB ' ' HA2' ' A' ' 21' ' ' GLY . 95.2 t -122.11 130.94 74.15 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.548 177.092 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.556 ' CE1' HD22 ' A' ' 58' ' ' LEU . 66.8 m-85 -99.21 167.29 10.77 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.474 178.405 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -67.06 137.11 56.18 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.538 0.685 . . . . 0.0 110.677 -173.052 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.507 ' HG2' ' HA3' ' A' ' 89' ' ' GLY . 0.9 OUTLIER -83.9 156.55 22.34 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.979 -1.009 . . . . 0.0 112.955 -171.574 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.484 ' HB3' ' HB3' ' A' ' 54' ' ' SER . 64.2 tt0 -66.36 -42.83 87.46 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.892 -1.049 . . . . 0.0 112.777 -177.74 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.476 HD23 ' OG ' ' A' ' 54' ' ' SER . 4.6 mm? -91.56 -15.58 28.44 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -178.084 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.507 ' HA3' ' HG2' ' A' ' 86' ' ' GLU . . . -62.67 -41.82 99.77 Favored Glycine 0 CA--C 1.509 -0.327 0 C-N-CA 120.249 -0.977 . . . . 0.0 111.645 178.663 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.124 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 176.686 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.5 mtp . . . . . 0 N--CA 1.474 0.771 0 CA-C-O 120.958 0.409 . . . . 0.0 110.711 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -135.47 162.18 33.37 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -78.2 179.63 6.78 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.149 -178.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -65.07 -40.12 94.23 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.641 0.258 . . . . 0.0 111.652 -176.594 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 63.23 23.48 13.87 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.543 0.737 . . . . 0.0 112.682 178.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -145.36 148.26 33.18 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.265 178.198 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 54.34 -159.2 0.17 Allowed 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.33 0.586 . . . . 0.0 111.415 179.405 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -71.53 -18.57 62.26 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.662 177.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 90.53 -7.77 80.85 Favored Glycine 0 CA--C 1.501 -0.821 0 N-CA-C 111.138 -0.785 . . . . 0.0 111.138 -178.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -115.21 145.62 42.24 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.825 -0.688 . . . . 0.0 111.144 -179.332 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 -155.51 96.14 1.75 Allowed 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -79.68 -70.39 0.52 Allowed 'General case' 0 N--CA 1.428 -1.562 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.518 ' C ' ' HD1' ' A' ' 14' ' ' TYR . 11.1 pt-20 -174.2 -55.36 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.266 0 CA-C-O 121.463 0.649 . . . . 0.0 111.227 173.368 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.518 ' HD1' ' C ' ' A' ' 13' ' ' GLU . 2.0 m-85 -122.43 155.98 34.98 Favored 'General case' 0 C--N 1.273 -2.735 0 CA-C-N 115.122 -0.944 . . . . 0.0 112.783 -177.43 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.6 pt -134.01 162.73 38.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-N 114.152 -1.386 . . . . 0.0 107.931 -179.021 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.456 ' HD2' ' NH1' ' A' ' 30' ' ' ARG . 3.5 mppt? -99.99 148.67 24.26 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 121.147 0.499 . . . . 0.0 111.616 179.197 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.468 HG23 ' CG1' ' A' ' 81' ' ' ILE . 67.8 mt -124.96 131.83 72.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.796 176.151 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.0 mtmt -101.54 102.74 13.53 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 172.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.701 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 92.3 t -82.87 117.7 29.27 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.614 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 57.9 t -106.85 114.72 46.69 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.513 ' HA2' ' HB ' ' A' ' 83' ' ' VAL . . . -88.96 171.49 39.12 Favored Glycine 0 C--N 1.313 -0.721 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.597 -179.239 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 90.8 mm-40 -73.89 -11.83 60.48 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-O 121.719 0.771 . . . . 0.0 110.652 179.385 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -83.6 7.16 18.18 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 114.57 -1.195 . . . . 0.0 108.86 174.19 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.5 m 65.41 27.59 11.82 Favored 'General case' 0 C--N 1.347 0.46 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.002 -176.242 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -97.11 105.74 17.94 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.704 -177.086 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.701 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 39.0 tt0 -98.09 129.7 44.9 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.713 176.183 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.2 p -139.54 141.82 34.25 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.988 -178.524 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 31.7 m170 -88.65 116.91 27.24 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.747 -179.132 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -113.68 136.88 52.35 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 114.993 -1.003 . . . . 0.0 108.701 170.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.456 ' NH1' ' HD2' ' A' ' 16' ' ' LYS . 35.9 ttt85 -104.91 125.64 51.13 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.57 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.503 ' HB ' ' OG1' ' A' ' 35' ' ' THR . 22.7 m -135.12 -179.76 3.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.227 -174.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -89.77 157.04 18.12 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 178.478 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.422 ' O ' ' HB3' ' A' ' 70' ' ' PRO . 90.6 m-85 -53.93 -39.79 66.17 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 173.725 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -102.07 33.39 6.55 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.355 -179.037 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.503 ' OG1' ' HB ' ' A' ' 31' ' ' VAL . 0.9 OUTLIER -66.7 138.52 57.46 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 121.614 0.721 . . . . 0.0 112.2 179.263 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.507 ' HB3' ' HB2' ' A' ' 66' ' ' ASP . 67.2 m -82.87 151.99 25.77 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.94 178.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.612 ' SD ' ' HA ' ' A' ' 65' ' ' ASN . 26.7 ptt? -54.1 -30.58 49.16 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.935 0.398 . . . . 0.0 111.047 -179.44 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.17 -36.75 80.69 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.781 -178.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -60.14 -40.83 91.18 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.791 0.329 . . . . 0.0 111.149 -176.245 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.491 HD23 ' H ' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -86.87 -45.52 10.78 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 116.056 -0.52 . . . . 0.0 112.0 -179.787 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.426 ' HA ' ' CE1' ' A' ' 57' ' ' PHE . 24.8 mtpp -61.78 -47.32 85.68 Favored 'General case' 0 CA--C 1.5 -0.972 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.351 -177.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.489 ' HA ' HG22 ' A' ' 52' ' ' VAL . 40.6 ttpt -62.79 -42.07 99.54 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.072 0.463 . . . . 0.0 109.986 178.546 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 44.7 t -66.35 -50.88 62.07 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.866 -176.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.592 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 49.6 t80 -70.71 -45.53 64.78 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.142 -178.035 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.525 ' HB1' ' O ' ' A' ' 50' ' ' VAL . . . -59.13 -35.63 73.8 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.409 0.623 . . . . 0.0 109.77 -179.094 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -64.35 -47.16 80.4 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.531 -179.347 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.592 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 14.5 ptm180 -71.17 -21.91 62.1 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.671 -177.671 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.466 HG22 ' O ' ' A' ' 44' ' ' TYR . 13.7 t -101.13 -2.73 30.67 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-O 120.855 0.36 . . . . 0.0 111.699 -178.753 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 69.8 37.08 75.45 Favored Glycine 0 C--N 1.335 0.486 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.013 178.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.525 ' O ' ' HB1' ' A' ' 45' ' ' ALA . 91.3 t -122.62 147.67 26.69 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 C-N-CA 122.825 0.45 . . . . 0.0 110.811 -178.008 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.456 ' HB3' ' HB2' ' A' ' 54' ' ' SER . . . -54.77 135.02 47.87 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 175.319 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.489 HG22 ' HA ' ' A' ' 42' ' ' LYS . 76.6 t -61.1 -45.86 97.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.312 -175.358 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -71.41 -27.79 63.55 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.356 -178.524 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.456 ' HB2' ' HB3' ' A' ' 51' ' ' ALA . 49.1 m -82.68 -5.43 58.85 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.464 -178.68 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.485 HD12 ' CE1' ' A' ' 57' ' ' PHE . 0.2 OUTLIER -95.34 122.42 38.03 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 177.414 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -108.02 117.39 34.01 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 120.33 -0.548 . . . . 0.0 112.222 -174.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.494 ' HZ ' ' CB ' ' A' ' 44' ' ' TYR . 44.3 m-85 -100.63 128.68 46.6 Favored 'General case' 0 CA--C 1.498 -1.058 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.569 174.024 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.595 HD13 ' HA ' ' A' ' 63' ' ' ARG . 4.2 mm? -119.06 155.89 30.66 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.384 -177.115 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.764 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 63.0 t80 -133.75 109.94 9.48 Favored 'General case' 0 C--N 1.279 -2.466 0 CA-C-N 114.289 -1.323 . . . . 0.0 109.385 174.245 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 27.9 t70 52.81 29.9 8.27 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.565 0.698 . . . . 0.0 111.562 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 94.58 4.98 61.87 Favored Glycine 0 C--N 1.31 -0.886 0 C-N-CA 120.856 -0.688 . . . . 0.0 113.65 176.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.764 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.2 OUTLIER -122.8 133.49 54.45 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 177.159 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.595 ' HA ' HD13 ' A' ' 58' ' ' LEU . 30.4 ptt180 -72.75 145.91 46.77 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.783 -172.716 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.448 HD11 HD12 ' A' ' 81' ' ' ILE . 73.6 mt -91.21 121.76 41.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.4 -176.57 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.612 ' HA ' ' SD ' ' A' ' 37' ' ' MET . 50.7 m-80 -111.09 157.54 19.88 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.769 -178.548 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.507 ' HB2' ' HB3' ' A' ' 36' ' ' SER . 4.8 p-10 -74.79 -11.98 60.28 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-O 121.179 0.514 . . . . 0.0 109.819 178.1 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -81.62 -20.37 39.86 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.913 179.193 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.461 ' CG ' HH12 ' A' ' 62' ' ' ARG . 50.5 m-20 -67.14 149.41 50.55 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.294 0.569 . . . . 0.0 112.087 -178.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.404 ' HB ' ' HD2' ' A' ' 70' ' ' PRO . 76.4 p -108.68 159.77 29.69 Favored Pre-proline 0 C--N 1.315 -0.933 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.634 178.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.422 ' HB3' ' O ' ' A' ' 33' ' ' TYR . 19.3 Cg_endo -60.49 -28.68 87.13 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.448 2.099 . . . . 0.0 111.721 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.738 ' C ' ' HD2' ' A' ' 71' ' ' LYS . 0.1 OUTLIER -65.6 -44.04 87.81 Favored 'General case' 0 N--CA 1.415 -2.176 0 CA-C-O 121.615 0.721 . . . . 0.0 109.496 178.819 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -80.22 -40.06 27.85 Favored 'General case' 0 N--CA 1.414 -2.265 0 CA-C-N 114.848 -1.069 . . . . 0.0 111.152 -174.463 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 98.6 mt -71.32 -23.24 61.9 Favored 'General case' 0 N--CA 1.44 -0.975 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 175.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.425 ' HG3' ' O ' ' A' ' 71' ' ' LYS . 38.5 mt-10 50.79 28.7 3.79 Favored 'General case' 0 C--N 1.349 0.553 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.462 -179.038 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.441 ' HE1' HD11 ' A' ' 17' ' ' ILE . 21.5 ptm -81.32 164.64 22.03 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.241 -178.369 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -151.37 -175.21 5.09 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-O 120.743 0.306 . . . . 0.0 110.252 -176.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -63.96 119.92 10.99 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.211 -179.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 33.1 t70 67.06 35.58 4.55 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.196 177.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -78.43 175.63 10.12 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.082 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 29.1 m -98.42 133.57 40.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 CA-C-O 121.807 0.813 . . . . 0.0 111.611 -176.052 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.468 ' CG1' HG23 ' A' ' 17' ' ' ILE . 18.1 mm -129.78 130.53 66.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 CA-C-N 114.634 -1.166 . . . . 0.0 109.86 179.137 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -102.56 148.25 25.77 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.094 0.473 . . . . 0.0 111.645 -175.059 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.513 ' HB ' ' HA2' ' A' ' 21' ' ' GLY . 79.4 t -123.34 129.86 74.57 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.858 174.603 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -101.77 170.84 7.9 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.571 178.472 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -64.51 136.94 57.56 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.776 0.798 . . . . 0.0 110.988 -172.111 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.523 ' CD ' ' H ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -108.93 160.21 16.19 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 114.512 -1.222 . . . . 0.0 111.614 -173.224 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.423 ' HB3' ' HB3' ' A' ' 54' ' ' SER . 64.3 tt0 -65.02 -46.14 82.57 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -175.771 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.473 ' HB2' HG13 ' A' ' 50' ' ' VAL . 3.3 mm? -98.24 3.48 48.86 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -175.363 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.516 ' H ' ' HG2' ' A' ' 86' ' ' GLU . . . -101.05 -155.72 27.05 Favored Glycine 0 C--N 1.313 -0.709 0 C-N-CA 120.193 -1.003 . . . . 0.0 112.934 -178.084 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.362 0 CA-C-O 118.536 -1.147 . . . . 0.0 111.547 -178.174 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.8 mtp . . . . . 0 N--CA 1.469 0.52 0 CA-C-O 120.95 0.405 . . . . 0.0 110.597 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.71 153.58 37.17 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.479 179.163 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 43.4 m-20 -81.65 157.35 24.69 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 177.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -61.0 -40.73 94.63 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.71 -179.493 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 54.99 30.55 14.34 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.512 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -105.75 135.43 47.18 Favored 'General case' 0 N--CA 1.426 -1.633 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.868 -177.389 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -125.18 160.88 28.1 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.34 -39.4 92.96 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 121.415 0.626 . . . . 0.0 109.537 -178.026 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 87.54 -10.7 68.53 Favored Glycine 0 CA--C 1.485 -1.814 0 N-CA-C 109.971 -1.251 . . . . 0.0 109.971 -178.416 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 25.6 t70 50.08 45.24 25.65 Favored 'General case' 0 C--O 1.216 -0.66 0 CA-C-N 114.112 -1.044 . . . . 0.0 108.909 -179.185 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 32.3 p-10 -88.42 11.57 16.57 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.34 -1.3 . . . . 0.0 112.422 -172.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.58 -40.63 95.46 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.267 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -110.58 25.95 11.22 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.333 0.587 . . . . 0.0 111.324 -178.361 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -133.5 157.34 45.89 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.479 -178.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.464 ' O ' ' HD3' ' A' ' 30' ' ' ARG . 8.3 pt -111.27 163.08 8.33 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 -178.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.656 ' HE2' ' OD1' ' A' ' 78' ' ' ASP . 34.9 ttpt -113.78 145.33 41.55 Favored 'General case' 0 C--N 1.291 -1.955 0 C-N-CA 118.882 -1.127 . . . . 0.0 111.687 -179.221 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 84.6 mt -122.21 127.84 75.34 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.489 177.009 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.2 mtmt -99.19 104.68 16.66 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 176.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.668 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 96.1 t -82.55 119.2 31.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.989 -178.218 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.9 t -105.27 112.84 40.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.328 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -91.09 177.27 41.25 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.072 -1.061 . . . . 0.0 112.611 -178.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -82.54 -10.1 59.13 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 121.434 0.635 . . . . 0.0 111.621 -178.347 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -85.04 11.12 10.2 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 115.075 -0.966 . . . . 0.0 108.801 174.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.2 m 62.86 33.25 15.3 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.437 -178.095 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 -111.55 108.94 18.61 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.438 -179.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.668 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 30.0 tt0 -94.18 128.67 40.75 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.331 -0.849 . . . . 0.0 108.932 174.694 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.3 p -132.58 139.38 49.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -178.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 23.9 m170 -100.94 117.17 34.48 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.314 0.578 . . . . 0.0 111.963 -174.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -109.62 144.39 38.03 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.058 -0.973 . . . . 0.0 110.137 175.688 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.464 ' HD3' ' O ' ' A' ' 15' ' ' ILE . 20.2 tpp180 -103.2 119.32 38.66 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.217 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.401 ' HB ' HG21 ' A' ' 35' ' ' THR . 32.9 m -134.63 167.99 24.7 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.803 -178.062 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.403 ' O ' ' HB ' ' A' ' 35' ' ' THR . 46.5 tttm -91.22 163.33 14.29 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 178.561 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -57.36 -38.67 74.53 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.752 174.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -93.94 19.0 55.55 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 121.175 -0.536 . . . . 0.0 112.428 -178.063 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.403 ' HB ' ' O ' ' A' ' 32' ' ' LYS . 1.1 m -63.85 136.81 57.69 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-O 121.394 0.616 . . . . 0.0 111.802 179.035 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 68.3 m -92.91 156.79 16.72 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.307 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.414 ' SD ' ' HA ' ' A' ' 65' ' ' ASN . 26.7 ptt? -51.38 -32.34 25.59 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -176.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.19 -37.39 82.8 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 -177.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 49.3 mmtm -60.21 -39.98 88.48 Favored 'General case' 0 C--O 1.216 -0.696 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.08 -176.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.678 HD12 ' CD1' ' A' ' 57' ' ' PHE . 0.2 OUTLIER -87.24 -44.06 11.73 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -178.848 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.496 ' HA ' ' HE1' ' A' ' 57' ' ' PHE . 57.3 mtpt -62.83 -45.63 91.72 Favored 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -178.239 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 28.9 ttpp -62.31 -41.98 98.98 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 177.409 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.429 ' O ' ' HB3' ' A' ' 46' ' ' ASP . 58.4 m -66.26 -48.17 71.34 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.73 -178.475 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.664 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 38.9 t80 -71.72 -44.25 64.46 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -179.584 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.35 -29.7 66.17 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 121.286 0.565 . . . . 0.0 109.809 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.429 ' HB3' ' O ' ' A' ' 43' ' ' SER . 31.3 t70 -62.72 -48.56 78.73 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.789 178.489 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.664 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 7.5 ptm180 -69.79 -24.16 63.45 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.192 -176.353 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.47 HG23 HG12 ' A' ' 50' ' ' VAL . 7.3 t -100.66 -8.98 22.34 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.234 -0.439 . . . . 0.0 112.132 -178.333 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 67.43 40.6 91.39 Favored Glycine 0 C--N 1.336 0.531 0 C-N-CA 120.676 -0.774 . . . . 0.0 113.029 178.403 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.471 HG21 ' HG3' ' A' ' 86' ' ' GLU . 3.6 p -125.3 166.74 20.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 O-C-N 122.728 -0.277 . . . . 0.0 110.72 -177.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.441 ' HB3' ' OG ' ' A' ' 54' ' ' SER . . . -59.18 137.36 58.0 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 116.329 -0.396 . . . . 0.0 109.994 176.693 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 75.6 t -60.51 -44.04 95.65 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.57 -176.034 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -84.06 -12.15 55.57 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -179.108 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.512 ' HB2' ' HB3' ' A' ' 87' ' ' GLN . 85.5 p -79.75 -14.26 58.86 Favored 'General case' 0 CA--C 1.514 -0.417 0 C-N-CA 119.924 -0.711 . . . . 0.0 109.091 176.687 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.423 HD13 ' N ' ' A' ' 56' ' ' ARG . 1.9 tm? -99.61 129.59 45.77 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 177.061 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.423 ' N ' HD13 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -135.48 137.61 42.32 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 119.747 -0.781 . . . . 0.0 111.767 -176.599 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.678 ' CD1' HD12 ' A' ' 40' ' ' LEU . 96.3 m-85 -106.95 139.96 40.52 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.382 176.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.557 HD13 ' CD1' ' A' ' 84' ' ' TYR . 6.6 mp -128.68 139.7 52.11 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.703 176.517 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.675 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 34.4 t80 -107.78 119.04 38.32 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.129 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 32.5 t70 51.93 33.61 11.97 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.507 0.67 . . . . 0.0 111.395 179.53 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.19 13.8 73.25 Favored Glycine 0 CA--C 1.522 0.528 0 CA-C-N 115.647 -0.706 . . . . 0.0 113.739 177.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.675 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.2 OUTLIER -123.71 149.83 45.05 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 117.163 0.481 . . . . 0.0 110.406 178.822 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 63' ' ' ARG . 10.2 mmm180 -67.88 139.7 56.5 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -176.142 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 75.5 mt -103.43 111.29 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 173.19 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.414 ' HA ' ' SD ' ' A' ' 37' ' ' MET . 95.1 m-20 -114.38 170.22 8.46 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-O 121.094 0.473 . . . . 0.0 111.439 -178.179 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 15.3 p-10 -72.25 -14.07 61.68 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.571 -178.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -94.15 -13.16 27.02 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.397 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.443 ' HB3' ' HG ' ' A' ' 73' ' ' LEU . 30.2 m-20 -72.56 149.62 43.86 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.269 0.557 . . . . 0.0 112.187 -178.724 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.459 ' HB ' ' HD2' ' A' ' 70' ' ' PRO . 81.8 p -108.88 161.45 23.62 Favored Pre-proline 0 C--N 1.315 -0.907 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.691 -179.509 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.459 ' HD2' ' HB ' ' A' ' 69' ' ' THR . 24.2 Cg_endo -61.34 -22.95 75.98 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.455 2.104 . . . . 0.0 111.639 178.736 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.695 ' C ' ' HD2' ' A' ' 71' ' ' LYS . 0.0 OUTLIER -67.65 -44.52 77.7 Favored 'General case' 0 N--CA 1.41 -2.441 0 C-N-CA 123.651 0.78 . . . . 0.0 109.635 -179.755 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.6 t -90.0 -32.57 16.72 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.927 -175.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.443 ' HG ' ' HB3' ' A' ' 68' ' ' ASP . 96.0 mt -72.7 -22.95 60.82 Favored 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 174.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 52.89 32.9 13.3 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 114.846 -1.07 . . . . 0.0 112.25 176.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.406 ' HG3' ' HB3' ' A' ' 73' ' ' LEU . 69.1 mtm -83.54 156.99 22.52 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.372 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -154.44 -176.04 5.7 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -58.48 122.6 13.75 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.949 0.88 . . . . 0.0 112.605 -177.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.656 ' OD1' ' HE2' ' A' ' 16' ' ' LYS . 1.4 m-20 63.14 33.61 14.31 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 113.884 -1.507 . . . . 0.0 111.614 176.495 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -74.92 176.74 6.85 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 178.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 31.5 m -112.71 144.26 20.78 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 CA-C-O 121.459 0.647 . . . . 0.0 111.335 -175.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -129.12 143.97 39.6 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.65 -179.204 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -107.7 141.44 39.23 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 120.817 0.342 . . . . 0.0 110.651 -177.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.438 HG22 ' CD2' ' A' ' 57' ' ' PHE . 99.5 t -117.13 133.44 63.88 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-O 121.096 0.474 . . . . 0.0 111.293 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.557 ' CD1' HD13 ' A' ' 58' ' ' LEU . 53.6 m-85 -98.91 168.45 10.1 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 115.366 -0.833 . . . . 0.0 109.669 176.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 60.1 tp60 -66.68 132.65 48.58 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.311 0.577 . . . . 0.0 111.766 -171.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.571 ' HG2' ' H ' ' A' ' 89' ' ' GLY . 19.5 pm0 -82.2 144.72 30.49 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.43 -179.142 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.512 ' HB3' ' HB2' ' A' ' 54' ' ' SER . 6.8 tp-100 -64.6 -45.61 86.19 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -174.46 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.436 HD12 ' HB2' ' A' ' 51' ' ' ALA . 87.8 mt -92.48 -13.03 30.5 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -175.668 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.571 ' H ' ' HG2' ' A' ' 86' ' ' GLU . . . -65.72 -43.43 94.2 Favored Glycine 0 CA--C 1.503 -0.703 0 C-N-CA 120.056 -1.069 . . . . 0.0 111.822 178.798 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.383 0 CA-C-O 118.731 -1.038 . . . . 0.0 111.563 177.871 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.1 mtt . . . . . 0 N--CA 1.475 0.793 0 CA-C-O 120.641 0.258 . . . . 0.0 110.586 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.33 150.41 43.53 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.94 177.505 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -81.05 111.01 17.13 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 120.947 0.403 . . . . 0.0 111.034 -179.07 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -75.06 -26.46 59.4 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.77 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 59.24 63.47 1.58 Allowed 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.416 -178.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -88.85 108.09 19.34 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.949 -178.254 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 56.9 -172.09 0.08 Allowed 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.452 0.701 . . . . 0.0 112.229 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.11 -39.72 94.66 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.487 -179.041 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 79.7 14.52 80.97 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 110.436 -1.066 . . . . 0.0 110.436 -176.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -110.19 133.22 53.45 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 114.587 -0.807 . . . . 0.0 109.716 -179.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 31.8 p30 -119.76 19.11 12.55 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -176.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -150.85 152.02 33.09 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.491 -178.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -99.55 23.56 9.31 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.453 0.644 . . . . 0.0 111.198 -179.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -100.8 155.31 18.0 Favored 'General case' 0 C--N 1.284 -2.259 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.624 -178.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.427 ' O ' ' HD3' ' A' ' 30' ' ' ARG . 11.6 pt -114.03 160.84 13.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.091 -175.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.458 ' H ' ' HA ' ' A' ' 77' ' ' ASP . 23.4 ttmt -100.76 145.39 28.56 Favored 'General case' 0 C--N 1.283 -2.324 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.622 -179.175 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.678 HG21 HD12 ' A' ' 81' ' ' ILE . 39.7 mm -126.21 127.57 70.89 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.357 175.137 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.451 ' HE2' HG22 ' A' ' 80' ' ' VAL . 15.1 mtmt -96.36 104.98 16.98 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 176.415 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.656 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 85.0 t -81.7 109.45 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.591 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.223 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.1 t -112.24 118.36 57.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -178.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.48 ' HA2' ' HB ' ' A' ' 83' ' ' VAL . . . -96.28 160.47 22.13 Favored Glycine 0 C--N 1.304 -1.196 0 C-N-CA 120.074 -1.06 . . . . 0.0 112.293 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.468 ' C ' ' H ' ' A' ' 24' ' ' SER . 16.4 pt20 -66.52 -20.35 66.01 Favored 'General case' 0 CA--C 1.495 -1.163 0 CA-C-O 122.427 1.108 . . . . 0.0 109.67 177.277 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -69.33 5.41 1.31 Allowed 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 113.122 -1.853 . . . . 0.0 109.507 173.377 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.468 ' H ' ' C ' ' A' ' 22' ' ' GLN . 50.2 m 63.13 31.59 15.68 Favored 'General case' 0 C--N 1.35 0.625 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.154 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -110.39 108.07 17.99 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 114.843 -1.071 . . . . 0.0 111.042 -177.286 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.656 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 30.8 tt0 -103.82 133.85 48.11 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.522 175.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.3 p -139.23 139.39 39.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-N 115.663 -0.698 . . . . 0.0 109.52 177.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 63.6 m170 -98.04 117.17 31.8 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.205 0.526 . . . . 0.0 111.433 -176.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -112.73 146.52 38.61 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.298 175.102 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.427 ' HD3' ' O ' ' A' ' 15' ' ' ILE . 23.8 tpp180 -103.31 120.53 40.94 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.458 ' HB ' ' OG1' ' A' ' 35' ' ' THR . 29.0 m -132.07 167.82 25.5 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -177.449 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.57 ' O ' ' HB ' ' A' ' 35' ' ' THR . 43.0 tttm -91.06 161.38 15.14 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.644 ' O ' ' HB3' ' A' ' 70' ' ' PRO . 97.1 m-85 -58.96 -38.23 78.6 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 171.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.626 ' HA2' ' CG ' ' A' ' 70' ' ' PRO . . . -85.64 21.81 13.13 Favored Glycine 0 N--CA 1.433 -1.547 0 CA-C-N 114.621 -1.172 . . . . 0.0 112.167 -178.105 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.57 ' HB ' ' O ' ' A' ' 32' ' ' LYS . 0.9 OUTLIER -68.56 141.01 55.61 Favored 'General case' 0 N--CA 1.425 -1.699 0 CA-C-O 121.384 0.611 . . . . 0.0 111.684 179.775 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.477 ' HB3' ' HE1' ' A' ' 37' ' ' MET . 48.7 m -88.47 143.37 27.02 Favored 'General case' 0 N--CA 1.416 -2.148 0 CA-C-N 115.405 -0.816 . . . . 0.0 108.939 177.381 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.807 ' SD ' ' HA ' ' A' ' 66' ' ' ASP . 0.2 OUTLIER -51.65 -40.1 59.37 Favored 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 123.575 0.75 . . . . 0.0 111.482 179.647 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.505 ' N ' ' HG2' ' A' ' 37' ' ' MET . . . -62.35 -27.02 68.77 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.152 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -60.47 -40.43 91.21 Favored 'General case' 0 C--O 1.21 -0.995 0 C-N-CA 121.111 -0.235 . . . . 0.0 110.84 -178.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.508 HD23 ' H ' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -85.47 -39.12 17.84 Favored 'General case' 0 C--N 1.309 -1.183 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.889 -176.764 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.492 ' HA ' ' HE1' ' A' ' 57' ' ' PHE . 61.7 mtpt -65.49 -44.86 85.79 Favored 'General case' 0 CA--C 1.493 -1.225 0 CA-C-O 120.728 0.299 . . . . 0.0 110.773 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.604 ' HD3' HG21 ' A' ' 52' ' ' VAL . 15.5 tppt? -62.97 -43.23 99.35 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 176.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 58.1 m -69.53 -50.25 46.79 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.366 -0.833 . . . . 0.0 113.196 -176.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.62 ' O ' ' HG3' ' A' ' 47' ' ' ARG . 62.4 t80 -64.67 -47.23 79.18 Favored 'General case' 0 CA--C 1.496 -1.116 0 CA-C-O 120.674 0.273 . . . . 0.0 111.233 -179.143 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.25 -36.5 77.91 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 121.367 0.603 . . . . 0.0 109.471 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -66.21 -45.59 80.22 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.315 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.62 ' HG3' ' O ' ' A' ' 44' ' ' TYR . 5.1 ppt_? -67.27 -25.01 65.85 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.347 -178.099 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.544 HG22 ' O ' ' A' ' 44' ' ' TYR . 10.2 t -99.07 -17.81 18.06 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 120.815 0.341 . . . . 0.0 111.61 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.1 32.59 35.22 Favored Glycine 0 C--O 1.227 -0.298 0 C-N-CA 120.471 -0.871 . . . . 0.0 113.021 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.579 HG21 ' HG3' ' A' ' 86' ' ' GLU . 4.3 p -115.13 160.96 14.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 O-C-N 122.555 -0.379 . . . . 0.0 110.292 -179.49 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.488 ' HB3' ' OG ' ' A' ' 54' ' ' SER . . . -57.91 129.31 41.34 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 178.126 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.604 HG21 ' HD3' ' A' ' 42' ' ' LYS . 78.6 t -61.53 -43.65 97.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.648 -178.27 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -64.53 -33.98 77.18 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.541 -179.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.488 ' OG ' ' HB3' ' A' ' 51' ' ' ALA . 90.6 p -78.82 -12.56 60.03 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.96 0.41 . . . . 0.0 110.975 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.405 HD13 ' N ' ' A' ' 56' ' ' ARG . 2.8 tm? -95.86 132.8 40.74 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -178.753 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.405 ' N ' HD13 ' A' ' 55' ' ' LEU . 5.6 ptt180 -144.33 145.8 32.19 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-O 121.259 0.552 . . . . 0.0 112.351 -173.375 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.524 ' CD2' HG22 ' A' ' 83' ' ' VAL . 95.7 m-85 -119.06 147.2 44.38 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.737 176.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 6.7 mp -124.31 138.24 54.4 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.792 175.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.594 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 32.2 t80 -117.84 125.93 51.46 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 179.147 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 33.4 t70 58.74 26.86 15.19 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.888 0.852 . . . . 0.0 110.163 -179.427 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 81.33 15.77 75.69 Favored Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.735 177.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.594 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 4.4 ppt_? -132.08 155.32 48.3 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-O 121.277 0.56 . . . . 0.0 112.042 179.242 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 16.4 mmm180 -58.68 137.59 57.5 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -175.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.487 HD11 ' HB2' ' A' ' 59' ' ' PHE . 75.7 mt -102.09 109.0 25.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 168.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.536 ' C ' ' HG3' ' A' ' 37' ' ' MET . 88.6 m-20 -120.53 161.59 21.04 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 120.638 0.256 . . . . 0.0 111.039 -174.332 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.807 ' HA ' ' SD ' ' A' ' 37' ' ' MET . 4.7 t70 -58.38 -9.75 1.73 Allowed 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 179.355 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -84.14 -15.49 47.03 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.242 177.06 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -71.86 149.78 44.87 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -175.468 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.53 ' O ' HG22 ' A' ' 72' ' ' THR . 35.3 p -117.69 155.29 50.78 Favored Pre-proline 0 N--CA 1.437 -1.11 0 CA-C-N 114.439 -1.255 . . . . 0.0 109.358 177.529 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.644 ' HB3' ' O ' ' A' ' 33' ' ' TYR . 58.5 Cg_exo -54.83 -40.56 84.54 Favored 'Trans proline' 0 N--CA 1.477 0.502 0 C-N-CA 122.803 2.335 . . . . 0.0 113.75 -176.483 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.599 ' C ' ' HD2' ' A' ' 71' ' ' LYS . 0.0 OUTLIER -70.92 -30.0 66.21 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -177.482 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.583 ' N ' ' HD2' ' A' ' 71' ' ' LYS . 4.7 t -81.69 -28.64 33.4 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.484 -177.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 97.9 mt -70.26 -24.78 63.12 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 176.178 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 47.11 30.35 1.33 Allowed 'General case' 0 CA--C 1.551 1.016 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.488 177.262 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 20.5 ptp -75.49 160.23 30.43 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.938 0.399 . . . . 0.0 111.513 -179.401 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -147.52 -177.64 5.81 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.588 -178.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.458 ' HA ' ' H ' ' A' ' 16' ' ' LYS . 36.8 t70 -66.14 120.16 12.72 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -176.737 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 20.4 t70 69.19 33.66 3.24 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 114.381 -1.282 . . . . 0.0 110.441 177.157 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.4 ' O ' ' HG3' ' A' ' 18' ' ' LYS . 4.6 t70 -78.19 177.36 8.44 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.612 177.453 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.451 HG22 ' HE2' ' A' ' 18' ' ' LYS . 16.9 t -110.0 135.06 50.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 CA-C-O 121.481 0.658 . . . . 0.0 111.686 -171.5 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.678 HD12 HG21 ' A' ' 17' ' ' ILE . 1.8 mt -132.57 132.46 60.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.703 178.305 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -98.79 141.93 30.96 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.442 -174.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.524 HG22 ' CD2' ' A' ' 57' ' ' PHE . 87.6 t -125.88 129.14 72.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-O 121.346 0.593 . . . . 0.0 110.57 177.605 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -107.75 169.18 8.76 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.869 178.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -64.8 138.31 58.3 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.411 0.625 . . . . 0.0 111.303 -172.035 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.579 ' HG3' HG21 ' A' ' 50' ' ' VAL . 0.2 OUTLIER -96.93 160.74 14.18 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.706 -178.496 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.47 ' H ' ' HB2' ' A' ' 54' ' ' SER . 6.5 tp-100 -61.22 -46.02 92.17 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.025 0.441 . . . . 0.0 112.063 -174.296 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 87.4 mt -91.7 -7.23 50.42 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.892 -176.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.551 ' H ' ' HG2' ' A' ' 86' ' ' GLU . . . -65.89 -40.34 95.41 Favored Glycine 0 CA--C 1.509 -0.291 0 C-N-CA 120.848 -0.691 . . . . 0.0 111.988 178.015 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.236 0 CA-C-O 118.161 -1.355 . . . . 0.0 111.147 179.898 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.2 mtp . . . . . 0 N--CA 1.47 0.547 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.26 112.21 18.77 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.88 0.371 . . . . 0.0 110.306 178.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -86.5 -5.0 59.26 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.612 -179.452 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -64.93 -39.89 94.2 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -178.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 56.21 64.31 1.74 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.25 0.548 . . . . 0.0 109.586 -176.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -64.13 114.29 4.09 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.55 -175.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 57.46 102.91 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.981 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -76.61 -3.61 38.65 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.772 -176.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 82.04 21.3 61.32 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.924 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -81.72 112.82 19.24 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 -179.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -118.5 -1.95 11.12 Favored 'General case' 0 CA--C 1.498 -1.019 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -178.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 67.17 178.69 0.23 Allowed 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.794 -176.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.612 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 45.0 mt-10 68.49 40.92 1.85 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.339 0.59 . . . . 0.0 111.548 -177.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -131.67 158.65 40.54 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.135 178.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.4 pt -125.39 161.63 29.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 CA-C-N 115.183 -0.917 . . . . 0.0 108.576 -179.323 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.527 ' HE3' ' HB3' ' A' ' 78' ' ' ASP . 59.6 mtmt -101.29 143.08 31.79 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-O 120.999 0.428 . . . . 0.0 110.535 177.176 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 75.9 mt -124.3 126.67 72.43 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.152 174.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 31.0 mtmt -94.83 104.46 16.36 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 177.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.651 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 97.5 t -85.26 112.05 21.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -179.274 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.468 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 5.2 p -115.62 123.41 71.01 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 CA-C-O 121.461 0.648 . . . . 0.0 110.331 179.505 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -85.96 176.68 49.16 Favored Glycine 0 N--CA 1.435 -1.387 0 CA-C-N 115.223 -0.899 . . . . 0.0 112.095 -178.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.576 ' NE2' ' HA ' ' A' ' 84' ' ' TYR . 78.4 mt-30 -77.36 -13.1 60.0 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.382 0.611 . . . . 0.0 111.333 -177.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -87.95 13.51 10.79 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.18 174.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 46.5 m 66.06 32.79 8.05 Favored 'General case' 0 C--N 1.343 0.294 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.378 179.084 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.434 ' O ' ' HA ' ' A' ' 20' ' ' VAL . 94.4 m-20 -105.47 111.71 24.52 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.952 179.255 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.651 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 31.2 tt0 -108.78 132.97 53.46 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.399 -179.389 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.2 p -134.36 143.36 38.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.196 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 27.4 m170 -101.98 113.28 26.36 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.403 0.621 . . . . 0.0 112.105 -175.484 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -111.18 148.86 31.86 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.072 175.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -111.8 123.82 51.04 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.901 178.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 32.9 m -136.99 174.3 12.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.229 -179.439 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.612 ' HG3' ' O ' ' A' ' 13' ' ' GLU . 35.4 ttmt -89.73 160.95 16.31 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 -179.573 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -54.65 -38.69 67.19 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 120.918 0.39 . . . . 0.0 110.365 177.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -100.77 21.92 41.8 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 116.066 -0.516 . . . . 0.0 112.826 -178.502 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.499 HG23 ' HB2' ' A' ' 39' ' ' LYS . 0.9 OUTLIER -60.53 143.08 54.45 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-O 121.376 0.607 . . . . 0.0 112.552 179.8 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 56.1 m -85.97 157.03 20.22 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.285 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.704 ' SD ' ' HA ' ' A' ' 65' ' ' ASN . 25.5 ptm -53.27 -32.73 50.0 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -178.66 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.34 -37.04 84.1 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -178.373 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.499 ' HB2' HG23 ' A' ' 35' ' ' THR . 49.7 mmtm -59.15 -40.65 86.22 Favored 'General case' 0 C--O 1.206 -1.222 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.25 -175.805 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.503 HD23 ' H ' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -86.42 -43.68 12.62 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -179.163 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.408 ' HA ' ' CE1' ' A' ' 57' ' ' PHE . 25.0 mtpp -62.15 -46.97 86.61 Favored 'General case' 0 CA--C 1.502 -0.873 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.05 -177.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.434 ' HA ' HG22 ' A' ' 52' ' ' VAL . 29.6 ttpp -63.64 -40.08 95.96 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.136 0.493 . . . . 0.0 110.003 178.302 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 50.9 m -63.66 -49.72 72.08 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.591 -0.732 . . . . 0.0 112.352 -178.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.51 ' CB ' ' HZ ' ' A' ' 57' ' ' PHE . 44.0 t80 -71.86 -45.59 60.86 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.743 0.306 . . . . 0.0 111.611 -179.681 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.572 ' HB1' ' O ' ' A' ' 50' ' ' VAL . . . -58.27 -32.49 68.45 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.133 -178.142 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -62.88 -45.0 94.6 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.353 -0.839 . . . . 0.0 112.223 -179.156 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.478 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 24.0 ptt180 -69.54 -25.17 63.89 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.202 0.525 . . . . 0.0 110.779 -176.647 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.431 HG22 ' O ' ' A' ' 44' ' ' TYR . 7.9 t -102.59 -7.26 21.96 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -174.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 68.76 28.31 73.2 Favored Glycine 0 N--CA 1.46 0.268 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.237 178.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.572 ' O ' ' HB1' ' A' ' 45' ' ' ALA . 86.9 t -106.53 146.52 12.96 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 C-N-CA 122.613 0.365 . . . . 0.0 110.167 -178.216 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.407 ' HB3' ' HB2' ' A' ' 54' ' ' SER . . . -52.52 133.54 35.62 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 176.778 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.434 HG22 ' HA ' ' A' ' 42' ' ' LYS . 76.9 t -60.48 -43.99 95.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.79 -177.087 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -66.08 -32.4 73.83 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.166 179.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.426 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 68.0 m -76.06 -10.81 59.72 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.446 -178.467 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.558 HD12 ' CE1' ' A' ' 57' ' ' PHE . 0.1 OUTLIER -92.68 123.38 35.92 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -179.947 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 28.0 mmm180 -104.47 110.74 23.13 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.757 -170.411 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.558 ' CE1' HD12 ' A' ' 55' ' ' LEU . 69.2 m-85 -110.48 126.95 54.9 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-O 121.043 0.449 . . . . 0.0 110.622 175.507 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.556 HD22 ' CE1' ' A' ' 84' ' ' TYR . 7.7 mp -129.1 144.94 51.37 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.184 178.777 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.74 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 62.5 t80 -111.41 116.46 30.96 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.054 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 58.71 18.7 6.15 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 122.673 0.389 . . . . 0.0 111.907 -179.116 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 98.98 6.72 55.9 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.774 -0.727 . . . . 0.0 113.234 178.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.74 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.1 OUTLIER -118.33 146.6 44.24 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.01 0.433 . . . . 0.0 110.06 176.815 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.507 ' HA ' ' HG ' ' A' ' 58' ' ' LEU . 38.9 mtp180 -68.4 134.96 51.01 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.525 -0.762 . . . . 0.0 112.51 -174.302 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 90.8 mt -91.15 119.86 39.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 115.399 -0.819 . . . . 0.0 108.828 178.022 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.704 ' HA ' ' SD ' ' A' ' 37' ' ' MET . 65.5 m-80 -118.6 159.36 23.73 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.635 -178.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -71.07 -12.96 61.81 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.191 0.52 . . . . 0.0 110.433 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -83.62 -19.45 35.43 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.097 -179.055 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -62.31 145.25 54.31 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.316 0.579 . . . . 0.0 112.263 -177.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.431 ' O ' HG22 ' A' ' 72' ' ' THR . 69.4 p -103.38 158.06 32.57 Favored Pre-proline 0 N--CA 1.44 -0.951 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.18 179.221 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -61.63 -21.59 72.42 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.578 2.185 . . . . 0.0 112.51 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.62 -22.47 32.21 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.437 -178.029 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.431 HG22 ' O ' ' A' ' 69' ' ' THR . 4.7 t -95.35 -32.77 12.79 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -179.579 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 96.1 mt -71.99 -25.96 62.05 Favored 'General case' 0 C--O 1.218 -0.554 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.025 177.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 48.74 33.34 4.22 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 176.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 65.2 mtt -87.21 158.88 19.02 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.293 -179.029 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -149.58 -179.42 7.08 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 177.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.402 ' HA ' ' H ' ' A' ' 16' ' ' LYS . 38.1 t70 -56.33 127.88 33.09 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.259 0.552 . . . . 0.0 112.123 -176.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.527 ' HB3' ' HE3' ' A' ' 16' ' ' LYS . 1.0 OUTLIER 67.27 32.63 5.88 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.591 1.556 . . . . 0.0 114.117 174.204 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -78.78 178.68 7.72 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 176.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.6 m -112.35 151.71 14.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 CA-C-O 121.271 0.558 . . . . 0.0 111.784 -174.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.482 HG22 ' HA ' ' A' ' 19' ' ' VAL . 1.0 OUTLIER -131.44 144.81 36.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 CA-C-N 115.453 -0.794 . . . . 0.0 108.878 178.023 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -104.55 139.29 39.65 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.964 -178.566 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 87.4 t -121.31 130.42 74.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 CA-C-O 121.235 0.54 . . . . 0.0 110.958 -179.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.576 ' HA ' ' NE2' ' A' ' 22' ' ' GLN . 77.4 m-85 -101.11 168.5 9.55 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.198 178.024 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 80.9 mm-40 -67.83 133.52 49.34 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.608 0.718 . . . . 0.0 111.821 -171.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.529 ' HG2' ' H ' ' A' ' 89' ' ' GLY . 3.2 pm0 -79.85 157.52 26.97 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.488 -1.233 . . . . 0.0 112.224 -176.489 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -79.32 -52.18 8.45 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -177.266 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.43 ' HB3' HG13 ' A' ' 50' ' ' VAL . 56.4 tp -65.04 -40.7 95.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.876 0.37 . . . . 0.0 111.432 -178.056 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.529 ' H ' ' HG2' ' A' ' 86' ' ' GLU . . . 114.77 119.08 3.31 Favored Glycine 0 C--N 1.319 -0.387 0 C-N-CA 120.518 -0.849 . . . . 0.0 113.0 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.787 0 CA-C-O 118.839 -0.978 . . . . 0.0 111.862 178.985 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 75.7 mtm . . . . . 0 N--CA 1.478 0.962 0 CA-C-O 120.915 0.388 . . . . 0.0 110.99 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.33 159.9 29.21 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.807 -179.607 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -78.52 -2.65 39.71 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.208 0.528 . . . . 0.0 109.745 179.154 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -62.91 -38.1 89.61 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.194 175.327 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 77.72 -24.87 0.21 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.431 1.092 . . . . 0.0 111.597 -177.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 54.95 84.53 0.07 Allowed 'General case' 0 C--O 1.238 0.485 0 O-C-N 123.852 0.72 . . . . 0.0 111.749 178.305 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.405 ' HB3' ' H ' ' A' ' 9' ' ' GLY . 1.8 mm-40 61.49 -171.12 0.15 Allowed 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.329 -178.057 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -92.1 -4.63 54.08 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.405 ' H ' ' HB3' ' A' ' 7' ' ' GLN . . . 71.79 19.0 77.84 Favored Glycine 0 N--CA 1.436 -1.331 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -176.049 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 27.5 t70 55.07 51.62 13.11 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.949 0.88 . . . . 0.0 109.078 -175.075 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 12.5 t30 -62.4 -45.18 94.28 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-N 114.649 -1.159 . . . . 0.0 109.482 -177.517 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 56.9 -160.41 0.23 Allowed 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.7 178.236 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 52.03 68.31 0.83 Allowed 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.226 0.536 . . . . 0.0 112.106 177.073 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -100.66 151.15 21.97 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-O 121.338 0.59 . . . . 0.0 110.496 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.416 ' O ' ' HD3' ' A' ' 30' ' ' ARG . 9.0 pt -110.5 161.54 8.83 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.048 -174.292 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.51 ' HB2' ' NH1' ' A' ' 30' ' ' ARG . 34.5 ttpt -109.1 144.22 37.43 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -179.231 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.637 HG21 HD12 ' A' ' 81' ' ' ILE . 82.2 mt -132.33 133.61 59.96 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.161 0 CA-C-O 120.775 0.322 . . . . 0.0 111.598 178.142 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.8 mtmt -94.87 105.23 17.14 Favored 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.127 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.698 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 75.0 t -82.28 117.64 28.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 175.36 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.536 ' HA ' ' O ' ' A' ' 25' ' ' ASN . 7.6 p -122.05 122.11 65.77 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 CA-C-O 121.727 0.775 . . . . 0.0 111.453 179.529 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.453 ' HA2' ' HB ' ' A' ' 83' ' ' VAL . . . -91.2 171.98 35.99 Favored Glycine 0 N--CA 1.436 -1.355 0 CA-C-N 114.867 -1.06 . . . . 0.0 111.535 179.451 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.453 ' C ' ' H ' ' A' ' 24' ' ' SER . 88.1 mm-40 -70.76 -27.32 63.85 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 120.933 0.397 . . . . 0.0 111.895 -176.143 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -79.63 21.84 0.5 Allowed 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.362 175.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.453 ' H ' ' C ' ' A' ' 22' ' ' GLN . 21.2 m 68.59 27.09 6.19 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.687 176.685 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.536 ' O ' ' HA ' ' A' ' 20' ' ' VAL . 58.2 t30 -93.85 102.09 14.2 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 119.895 -0.722 . . . . 0.0 111.167 -179.65 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.698 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 35.6 tt0 -112.84 127.49 56.19 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.47 177.723 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.7 p -136.4 145.0 31.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.712 -177.388 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 63.5 m170 -92.41 117.59 30.07 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.308 0.575 . . . . 0.0 111.917 -178.407 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -109.5 141.76 41.49 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.805 174.155 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.51 ' NH1' ' HB2' ' A' ' 16' ' ' LYS . 23.9 tpp180 -102.57 116.35 32.42 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 177.019 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.545 HG21 HD12 ' A' ' 17' ' ' ILE . 34.5 m -134.43 174.86 12.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.212 -176.641 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.469 ' O ' ' HB ' ' A' ' 35' ' ' THR . 38.0 ttmt -88.54 158.83 18.18 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.451 ' HB3' ' HB3' ' A' ' 70' ' ' PRO . 98.4 m-85 -55.43 -40.57 71.66 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 174.227 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -101.99 33.81 6.21 Favored Glycine 0 N--CA 1.449 -0.462 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.163 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.482 ' OG1' ' HB ' ' A' ' 31' ' ' VAL . 0.6 OUTLIER -65.69 140.32 58.46 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 121.317 0.58 . . . . 0.0 111.936 179.356 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.511 ' OG ' ' HG2' ' A' ' 39' ' ' LYS . 85.9 p -81.08 160.03 24.59 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.137 178.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.606 ' SD ' ' HA ' ' A' ' 65' ' ' ASN . 26.5 ptt? -60.82 -32.49 71.87 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.933 0.397 . . . . 0.0 110.687 178.096 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.74 -36.27 80.49 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.45 -177.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.511 ' HG2' ' OG ' ' A' ' 36' ' ' SER . 75.6 mmtt -59.63 -41.82 91.31 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.999 -176.615 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.501 HD23 ' H ' ' A' ' 40' ' ' LEU . 0.5 OUTLIER -89.42 -47.87 7.72 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -179.738 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.627 ' HG2' ' CD1' ' A' ' 57' ' ' PHE . 61.8 mtpt -62.37 -47.93 82.02 Favored 'General case' 0 CA--C 1.492 -1.271 0 CA-C-N 116.282 -0.417 . . . . 0.0 112.09 -174.524 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -61.69 -43.3 99.12 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 178.078 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 42.7 t -64.98 -51.51 61.31 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.371 -0.832 . . . . 0.0 111.294 -176.16 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.511 ' O ' HG22 ' A' ' 48' ' ' THR . 62.9 t80 -65.99 -49.06 69.12 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.937 -179.486 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.497 ' HB1' ' O ' ' A' ' 50' ' ' VAL . . . -59.74 -35.17 74.04 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.521 0.676 . . . . 0.0 109.788 -178.324 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -65.31 -47.0 78.08 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.248 -178.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.422 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 14.2 ptm180 -68.35 -26.39 65.57 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.568 -178.035 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.511 HG22 ' O ' ' A' ' 44' ' ' TYR . 8.8 t -96.71 -3.51 42.42 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -178.194 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 68.51 35.56 81.66 Favored Glycine 0 C--N 1.335 0.5 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.706 178.525 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.574 HG11 ' HG3' ' A' ' 86' ' ' GLU . 78.2 t -118.83 144.54 26.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 C-N-CA 122.406 0.282 . . . . 0.0 111.346 -177.671 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.467 ' HB3' ' HB2' ' A' ' 54' ' ' SER . . . -51.25 129.31 24.32 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.968 176.008 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 77.0 t -61.42 -43.94 97.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.019 -177.509 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -65.75 -32.43 73.96 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.016 -179.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.468 ' HB3' ' HB3' ' A' ' 87' ' ' GLN . 51.5 m -83.57 -6.17 59.37 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.687 -178.285 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.521 HD12 ' CE1' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -96.43 121.17 37.95 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 176.617 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.21 126.47 52.26 Favored 'General case' 0 CA--C 1.499 -1.012 0 C-N-CA 120.112 -0.635 . . . . 0.0 110.834 -176.621 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.627 ' CD1' ' HG2' ' A' ' 41' ' ' LYS . 22.2 m-85 -106.98 131.04 54.5 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 176.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.524 HD13 ' HA ' ' A' ' 63' ' ' ARG . 2.9 mm? -120.88 155.06 34.96 Favored 'General case' 0 N--CA 1.417 -2.075 0 CA-C-O 122.29 1.043 . . . . 0.0 113.068 -174.74 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.627 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 54.1 t80 -122.79 105.99 10.52 Favored 'General case' 0 C--N 1.282 -2.339 0 CA-C-N 113.289 -1.778 . . . . 0.0 108.103 174.536 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 54.26 28.46 9.24 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.805 -176.58 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 96.4 -7.83 66.43 Favored Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.543 -0.753 . . . . 0.0 113.117 177.554 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.627 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 4.1 ppt_? -104.34 147.15 27.84 Favored 'General case' 0 N--CA 1.438 -1.034 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.078 179.287 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.524 ' HA ' HD13 ' A' ' 58' ' ' LEU . 0.1 OUTLIER -67.9 143.77 55.56 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -171.4 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 81.9 mt -102.87 121.42 54.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.273 -0.876 . . . . 0.0 108.709 174.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.606 ' HA ' ' SD ' ' A' ' 37' ' ' MET . 66.4 m-80 -121.41 172.41 8.07 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 120.916 0.389 . . . . 0.0 110.997 -178.177 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -70.21 -13.21 62.08 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.076 0.465 . . . . 0.0 110.96 -178.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -82.29 -14.82 54.8 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.011 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.431 ' CG ' HH12 ' A' ' 62' ' ' ARG . 4.6 m-20 -65.17 153.73 40.07 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 -177.048 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.42 ' HB ' ' HD2' ' A' ' 70' ' ' PRO . 70.2 p -126.28 159.35 63.11 Favored Pre-proline 0 N--CA 1.435 -1.206 0 CA-C-N 114.156 -1.384 . . . . 0.0 109.54 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.451 ' HB3' ' HB3' ' A' ' 33' ' ' TYR . 33.3 Cg_endo -63.71 -19.49 67.33 Favored 'Trans proline' 0 C--O 1.224 -0.183 0 C-N-CA 122.515 2.143 . . . . 0.0 112.688 -179.556 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.49 -26.99 37.88 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-O 120.81 0.338 . . . . 0.0 111.143 -178.219 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.404 HG22 ' H ' ' A' ' 69' ' ' THR . 12.3 t -94.82 -36.75 11.54 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 120.861 0.362 . . . . 0.0 110.181 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 95.8 mt -75.33 -23.14 57.22 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 175.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 52.94 29.03 7.22 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.728 178.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.437 ' HA ' ' OD2' ' A' ' 79' ' ' ASP . 66.2 mtt -85.71 157.18 20.36 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.166 -178.081 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.48 ' H ' ' HB2' ' A' ' 79' ' ' ASP . 14.0 pt-20 -152.79 -173.57 4.62 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.157 -178.072 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.445 ' HA ' ' H ' ' A' ' 16' ' ' LYS . 28.3 t70 -57.66 120.84 9.05 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.709 0.766 . . . . 0.0 112.569 -176.303 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.485 ' OD1' ' HE3' ' A' ' 16' ' ' LYS . 29.5 t70 65.86 34.16 7.49 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.442 1.497 . . . . 0.0 111.054 178.464 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.48 ' HB2' ' H ' ' A' ' 76' ' ' GLU . 31.9 t0 -75.06 176.3 7.37 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.413 177.343 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 35.3 m -111.87 143.24 22.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 CA-C-O 121.847 0.832 . . . . 0.0 112.883 -174.571 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.637 HD12 HG21 ' A' ' 17' ' ' ILE . 3.3 mt -128.47 134.15 65.27 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 CA-C-N 114.234 -1.348 . . . . 0.0 109.425 176.026 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -101.7 138.16 39.06 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.105 0.478 . . . . 0.0 110.677 -177.129 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.453 ' HB ' ' HA2' ' A' ' 21' ' ' GLY . 88.6 t -123.5 133.76 68.26 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.644 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.481 ' CD1' HD23 ' A' ' 58' ' ' LEU . 53.7 m-85 -99.5 152.48 19.95 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 175.279 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 10.5 mm100 -68.32 129.24 39.34 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 122.004 0.907 . . . . 0.0 112.568 -169.302 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.574 ' HG3' HG11 ' A' ' 50' ' ' VAL . 1.4 pm0 -64.05 160.87 17.12 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 113.473 -1.694 . . . . 0.0 113.548 -172.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.468 ' HB3' ' HB3' ' A' ' 54' ' ' SER . 6.6 tp-100 -64.96 -48.72 73.01 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.404 -178.212 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.5 HD23 ' HA ' ' A' ' 50' ' ' VAL . 56.7 tp -68.91 -39.89 79.43 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.868 -179.05 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.484 ' H ' ' HG2' ' A' ' 86' ' ' GLU . . . 104.18 133.98 8.0 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.55 -178.325 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.541 -1.144 . . . . 0.0 111.858 -178.854 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.9 ttp . . . . . 0 N--CA 1.471 0.595 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -142.17 172.72 12.31 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.002 -177.401 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -65.98 122.85 18.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.228 179.267 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -70.91 -38.26 72.96 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.511 -179.42 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 74.21 -52.66 0.69 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.125 0.97 . . . . 0.0 110.571 -176.096 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -104.91 112.06 25.04 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.483 177.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -133.05 146.49 51.75 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.485 -179.381 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.04 -46.31 81.81 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.435 177.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -70.57 -43.51 60.56 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.739 177.437 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 25.0 t70 66.74 -54.8 0.43 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.472 1.109 . . . . 0.0 113.736 177.108 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -65.25 -38.98 92.02 Favored 'General case' 0 CA--C 1.488 -1.431 0 CA-C-O 121.485 0.659 . . . . 0.0 111.041 -178.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -113.07 125.13 54.04 Favored 'General case' 0 N--CA 1.398 -3.033 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.565 -176.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -114.37 3.07 14.9 Favored 'General case' 0 C--N 1.282 -2.339 0 CA-C-O 122.344 1.069 . . . . 0.0 110.622 -175.55 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -140.13 159.46 42.14 Favored 'General case' 0 C--N 1.282 -2.338 0 CA-C-N 113.353 -1.749 . . . . 0.0 108.457 177.459 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.423 ' HB ' ' HA ' ' A' ' 77' ' ' ASP . 18.3 pt -127.16 161.95 33.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -177.477 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.536 ' HE3' ' HB2' ' A' ' 78' ' ' ASP . 59.3 mtmt -97.55 146.47 25.23 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-O 121.045 0.45 . . . . 0.0 110.599 176.521 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.672 HG21 HD12 ' A' ' 81' ' ' ILE . 40.7 mm -128.1 127.37 67.64 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 CA-C-N 115.498 -0.773 . . . . 0.0 109.833 174.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.9 mtmt -96.75 104.77 16.8 Favored 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 177.47 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.7 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 98.8 t -82.21 116.88 27.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.6 t -113.03 117.61 55.82 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-O 121.082 0.467 . . . . 0.0 110.738 -178.434 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -88.49 168.58 36.59 Favored Glycine 0 N--CA 1.436 -1.317 0 C-N-CA 120.431 -0.89 . . . . 0.0 111.378 177.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -67.89 -23.78 65.15 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.191 0.52 . . . . 0.0 111.902 -178.421 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -79.5 11.27 3.14 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.124 178.075 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.1 m 69.0 27.29 5.44 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.811 -178.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -95.66 104.63 16.55 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.737 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.7 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 37.7 tt0 -105.02 135.37 46.48 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.673 178.751 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.1 p -137.17 140.22 42.74 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.457 178.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 55.1 m170 -99.05 113.14 25.18 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 121.307 0.575 . . . . 0.0 111.156 -176.123 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -110.65 145.38 38.04 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.718 176.467 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 11.1 tpt180 -99.95 118.07 35.59 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.249 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.48 ' HB ' HG21 ' A' ' 35' ' ' THR . 33.3 m -133.56 167.75 25.69 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -178.807 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 46.0 tttm -90.82 162.96 14.61 Favored 'General case' 0 C--N 1.284 -2.247 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.275 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.512 ' O ' ' HB3' ' A' ' 70' ' ' PRO . 94.2 m-85 -55.09 -39.18 69.01 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 176.579 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.477 ' HA2' ' HG3' ' A' ' 70' ' ' PRO . . . -96.38 19.26 55.35 Favored Glycine 0 N--CA 1.444 -0.805 0 CA-C-N 115.728 -0.669 . . . . 0.0 113.337 -177.135 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.48 HG21 ' HB ' ' A' ' 31' ' ' VAL . 1.3 m -67.47 136.69 55.03 Favored 'General case' 0 N--CA 1.428 -1.535 0 CA-C-O 121.125 0.488 . . . . 0.0 111.73 179.088 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.572 ' HA ' ' O ' ' A' ' 65' ' ' ASN . 47.0 m -86.28 151.97 23.16 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.497 -178.063 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.476 ' HG2' ' HB2' ' A' ' 66' ' ' ASP . 24.2 ptt? -50.01 -32.27 14.84 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -179.161 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.95 -35.96 78.12 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -178.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -59.44 -40.89 88.24 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.083 0.468 . . . . 0.0 110.137 -177.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.659 HD12 ' CD2' ' A' ' 57' ' ' PHE . 0.2 OUTLIER -86.8 -43.96 12.1 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.544 -177.684 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 61.6 mtpt -62.79 -47.03 85.24 Favored 'General case' 0 CA--C 1.491 -1.293 0 N-CA-C 111.868 0.321 . . . . 0.0 111.868 -177.195 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -63.72 -40.68 97.35 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.034 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 46.6 t -63.73 -48.77 75.69 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.03 -179.153 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.709 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 43.1 t80 -70.18 -44.84 67.93 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.874 -179.108 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.427 ' CB ' ' HA ' ' A' ' 52' ' ' VAL . . . -59.47 -34.57 72.71 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.229 0.538 . . . . 0.0 109.822 179.348 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -66.43 -45.81 78.6 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.331 -0.849 . . . . 0.0 111.613 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.709 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 10.9 ptm85 -65.59 -28.71 69.33 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.898 -178.353 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.499 HG22 ' O ' ' A' ' 44' ' ' TYR . 9.9 t -93.23 -5.82 49.07 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.718 179.627 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 66.92 35.4 89.46 Favored Glycine 0 C--N 1.335 0.483 0 CA-C-N 116.036 -0.529 . . . . 0.0 113.277 177.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.708 HG21 ' HG3' ' A' ' 86' ' ' GLU . 1.5 p -121.54 166.16 16.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 116.927 0.364 . . . . 0.0 110.967 -177.483 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.413 ' HB3' ' HB2' ' A' ' 54' ' ' SER . . . -57.46 128.72 38.47 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.51 179.081 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.427 ' HA ' ' CB ' ' A' ' 45' ' ' ALA . 73.4 t -61.36 -46.24 96.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.553 -0.748 . . . . 0.0 111.585 -177.037 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -77.33 -14.76 59.67 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.987 -176.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.455 ' HB3' ' HB3' ' A' ' 87' ' ' GLN . 70.0 m -85.43 -15.6 42.47 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.528 178.511 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.452 HD13 ' N ' ' A' ' 56' ' ' ARG . 0.8 OUTLIER -95.03 135.03 37.06 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.452 ' N ' HD13 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -130.43 141.42 50.53 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 120.132 -0.627 . . . . 0.0 111.404 -175.203 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.659 ' CD2' HD12 ' A' ' 40' ' ' LEU . 13.7 m-85 -115.5 136.71 52.8 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-N 115.21 -0.904 . . . . 0.0 108.95 177.228 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.757 HD23 ' CD1' ' A' ' 84' ' ' TYR . 0.9 OUTLIER -129.99 151.12 50.9 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-O 121.589 0.709 . . . . 0.0 111.268 178.773 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.719 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 49.5 t80 -113.89 103.47 11.2 Favored 'General case' 0 C--N 1.284 -2.265 0 CA-C-N 114.921 -1.036 . . . . 0.0 108.713 175.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.7 t70 54.92 24.29 5.72 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.748 -177.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 102.34 -5.7 52.47 Favored Glycine 0 C--N 1.333 0.4 0 CA-C-N 115.601 -0.727 . . . . 0.0 113.663 177.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.719 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.2 OUTLIER -108.4 150.16 27.75 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 117.362 0.581 . . . . 0.0 109.856 178.578 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.493 ' HA ' ' CD1' ' A' ' 58' ' ' LEU . 11.8 mpt_? -66.96 142.86 57.11 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -171.053 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.42 HG21 HD11 ' A' ' 40' ' ' LEU . 44.1 mm -74.59 144.9 11.77 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 CA-C-N 114.816 -1.084 . . . . 0.0 109.502 176.076 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.572 ' O ' ' HA ' ' A' ' 36' ' ' SER . 1.0 OUTLIER -68.35 106.12 2.39 Favored 'General case' 0 N--CA 1.406 -2.655 0 N-CA-C 115.089 1.515 . . . . 0.0 115.089 -170.415 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.476 ' HB2' ' HG2' ' A' ' 37' ' ' MET . 4.1 t70 -91.07 -39.65 12.06 Favored 'General case' 0 C--N 1.257 -3.453 0 N-CA-C 102.834 -3.024 . . . . 0.0 102.834 153.494 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -117.7 -17.9 9.78 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 110.82 -2.9 . . . . 0.0 110.927 -176.387 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.569 ' HB2' ' HA ' ' A' ' 65' ' ' ASN . 2.7 m-20 -72.76 168.58 18.5 Favored 'General case' 0 C--N 1.342 0.269 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.964 -176.073 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.683 ' O ' HG22 ' A' ' 72' ' ' THR . 88.8 m -97.47 130.49 29.23 Favored Pre-proline 0 C--N 1.306 -1.324 0 C-N-CA 120.799 -0.361 . . . . 0.0 110.687 -172.416 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.512 ' HB3' ' O ' ' A' ' 33' ' ' TYR . 88.6 Cg_exo -52.62 -37.68 74.93 Favored 'Trans proline' 0 CA--C 1.53 0.295 0 C-N-CA 122.756 2.304 . . . . 0.0 112.127 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.02 -25.06 37.49 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.554 179.672 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.683 HG22 ' O ' ' A' ' 69' ' ' THR . 2.1 t -70.15 -32.81 70.96 Favored 'General case' 0 C--N 1.347 0.473 0 C-N-CA 120.026 -0.67 . . . . 0.0 109.47 178.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 60.4 mt -72.2 -24.99 61.49 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.185 174.004 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 57.22 40.52 27.93 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.359 179.329 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 24.7 mmt -72.55 155.62 39.87 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.834 -179.632 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -151.59 175.75 12.03 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 176.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.423 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 37.6 t70 -58.26 121.35 10.54 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.456 0.646 . . . . 0.0 112.335 -178.057 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.536 ' HB2' ' HE3' ' A' ' 16' ' ' LYS . 13.5 t70 74.19 34.28 0.85 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.351 1.461 . . . . 0.0 111.982 176.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -75.71 177.51 6.79 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.597 -0.441 . . . . 0.0 109.984 177.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 33.1 m -110.23 147.63 14.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 CA-C-O 121.546 0.689 . . . . 0.0 112.28 -173.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.672 HD12 HG21 ' A' ' 17' ' ' ILE . 0.3 OUTLIER -140.61 144.82 26.61 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.302 -179.85 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -110.28 143.08 40.99 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.169 -175.39 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 86.6 t -125.4 132.43 71.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.131 0.491 . . . . 0.0 111.479 179.238 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.757 ' CD1' HD23 ' A' ' 58' ' ' LEU . 90.5 m-85 -100.44 162.49 12.91 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.784 177.165 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 53.3 tp60 -69.45 143.97 53.42 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -176.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.708 ' HG3' HG21 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -90.0 171.15 9.77 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 112.991 0.738 . . . . 0.0 112.991 -175.12 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.455 ' HB3' ' HB3' ' A' ' 54' ' ' SER . 51.9 tt0 -62.06 -50.01 73.69 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.044 -0.98 . . . . 0.0 112.613 -178.5 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.8 mp -68.56 -36.63 79.03 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.022 -178.009 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.576 ' H ' ' HG2' ' A' ' 86' ' ' GLU . . . -63.34 -41.12 99.55 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.953 -0.642 . . . . 0.0 113.05 -178.479 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.054 0 CA-C-O 118.555 -1.136 . . . . 0.0 111.644 179.445 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.9 tpt . . . . . 0 N--CA 1.475 0.784 0 CA-C-O 120.725 0.298 . . . . 0.0 110.359 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -88.02 87.42 7.33 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.106 0.479 . . . . 0.0 110.787 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -88.2 -172.65 3.89 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.502 178.534 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -61.15 -40.26 93.19 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.771 -178.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 54.34 36.84 26.27 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.101 0.476 . . . . 0.0 110.444 -176.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -160.04 159.59 32.19 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.115 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 26.6 pt20 -124.6 146.68 48.92 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.838 0.352 . . . . 0.0 110.374 178.466 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.81 -40.24 96.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.573 -175.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.0 16.84 73.78 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.501 -0.857 . . . . 0.0 111.401 -177.589 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -85.52 99.87 11.53 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.033 -0.583 . . . . 0.0 109.632 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.66 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 10.2 p30 -143.12 20.98 1.93 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -175.771 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.51 -45.99 91.76 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -177.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -115.37 60.34 0.7 Allowed 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 120.995 0.426 . . . . 0.0 110.264 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.66 ' CD1' ' HA ' ' A' ' 11' ' ' ASN . 90.7 m-85 -134.45 167.85 20.0 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.769 -175.436 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.856 HD12 ' HA ' ' A' ' 76' ' ' GLU . 17.1 pt -109.56 163.62 6.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.326 -174.526 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.538 ' C ' HD12 ' A' ' 17' ' ' ILE . 38.0 mtmm -90.28 145.88 24.65 Favored 'General case' 0 CA--C 1.5 -0.95 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.654 HD13 ' CG2' ' A' ' 31' ' ' VAL . 1.5 mp -135.18 137.04 50.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.632 173.179 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 18.6 mtmm -97.29 104.53 16.56 Favored 'General case' 0 N--CA 1.437 -1.083 0 C-N-CA 119.979 -0.688 . . . . 0.0 109.191 178.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.627 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 85.3 t -82.64 116.17 26.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.422 179.309 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.8 t -107.69 118.85 56.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-O 120.833 0.349 . . . . 0.0 110.077 179.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.484 ' HA2' ' HB ' ' A' ' 83' ' ' VAL . . . -87.97 177.06 46.13 Favored Glycine 0 C--N 1.314 -0.663 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.414 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.514 ' C ' ' H ' ' A' ' 24' ' ' SER . 91.0 mm-40 -65.62 -36.75 84.63 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -178.102 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.64 18.85 0.22 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.954 0.407 . . . . 0.0 109.99 176.719 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.514 ' H ' ' C ' ' A' ' 22' ' ' GLN . 51.0 m 62.12 30.41 17.77 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.153 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -92.06 107.07 18.94 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.947 -178.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.627 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 32.2 tt0 -97.4 132.3 43.25 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.892 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.417 HG13 ' HB ' ' A' ' 19' ' ' VAL . 7.4 p -135.76 139.82 45.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.522 178.834 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 61.7 m170 -95.91 114.0 25.68 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 121.17 0.51 . . . . 0.0 110.916 -176.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -110.37 153.41 24.98 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.583 177.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.468 ' HG2' ' HB2' ' A' ' 11' ' ' ASN . 11.7 tpp180 -108.74 115.59 30.39 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.66 179.3 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.654 ' CG2' HD13 ' A' ' 17' ' ' ILE . 30.3 m -140.36 -178.94 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.412 -178.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.536 ' O ' ' HB ' ' A' ' 35' ' ' THR . 83.6 tttt -88.68 155.22 19.72 Favored 'General case' 0 C--N 1.313 -1.001 0 O-C-N 122.361 -0.212 . . . . 0.0 110.674 -177.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -51.79 -45.41 63.83 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-O 121.381 0.61 . . . . 0.0 110.123 176.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -109.84 35.43 4.88 Favored Glycine 0 N--CA 1.441 -1.012 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.967 179.417 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.655 ' O ' HD13 ' A' ' 73' ' ' LEU . 0.5 OUTLIER -57.19 143.43 39.12 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 121.475 0.655 . . . . 0.0 110.893 -177.164 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 59.3 m -79.85 150.02 30.79 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.757 -179.244 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.69 ' HA ' HD21 ' A' ' 40' ' ' LEU . 26.6 ptt? -49.64 -32.31 12.79 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -177.541 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.24 -36.07 82.42 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -179.601 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -59.19 -41.48 88.59 Favored 'General case' 0 C--O 1.217 -0.65 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.165 -175.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.719 HD23 ' H ' ' A' ' 40' ' ' LEU . 0.5 OUTLIER -86.25 -45.64 11.09 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.168 -176.87 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -62.45 -47.92 81.92 Favored 'General case' 0 CA--C 1.492 -1.257 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.761 -176.552 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -65.72 -39.67 91.41 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.166 178.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 44.9 t -64.35 -51.45 63.27 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.34 -178.355 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.613 ' O ' ' HG3' ' A' ' 47' ' ' ARG . 47.6 t80 -66.82 -44.0 82.3 Favored 'General case' 0 CA--C 1.499 -1.002 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.45 179.53 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.442 ' HA ' HG12 ' A' ' 50' ' ' VAL . . . -58.58 -36.16 73.53 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.01 0.434 . . . . 0.0 109.855 -179.202 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -67.58 -44.79 77.33 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.778 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.613 ' HG3' ' O ' ' A' ' 44' ' ' TYR . 2.1 ppt_? -64.33 -25.87 68.23 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.65 -178.05 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.534 HG22 ' O ' ' A' ' 44' ' ' TYR . 10.1 t -104.17 -9.33 18.76 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.815 -178.148 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 68.92 39.56 85.14 Favored Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.737 -0.744 . . . . 0.0 113.036 179.027 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.523 HG21 ' HG3' ' A' ' 86' ' ' GLU . 5.2 p -118.21 164.32 14.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 120.981 0.419 . . . . 0.0 111.026 -178.01 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.596 ' HB3' ' OG ' ' A' ' 54' ' ' SER . . . -59.99 128.55 37.39 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.991 175.769 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 73.4 t -64.39 -40.96 90.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 121.131 0.491 . . . . 0.0 110.401 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 32.2 p-10 -67.24 -27.83 67.55 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.36 -177.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.596 ' OG ' ' HB3' ' A' ' 51' ' ' ALA . 88.4 p -97.58 1.18 48.55 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.079 0.466 . . . . 0.0 111.618 179.314 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -96.85 133.49 41.4 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 175.192 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.75 144.16 35.35 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -174.711 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.652 ' CG ' HD12 ' A' ' 40' ' ' LEU . 63.4 m-85 -119.14 142.86 47.56 Favored 'General case' 0 CA--C 1.501 -0.921 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.618 176.419 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.639 HD22 ' CE1' ' A' ' 84' ' ' TYR . 8.1 mp -130.84 133.87 46.31 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.628 178.248 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.778 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 0.3 OUTLIER -109.33 114.63 28.47 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.945 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 38.7 t70 66.27 22.48 10.91 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 122.044 0.926 . . . . 0.0 110.674 -177.083 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 89.9 9.53 65.86 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.41 -0.814 . . . . 0.0 113.055 176.101 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.778 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.2 OUTLIER -117.62 148.62 41.77 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.753 179.588 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.474 ' HD3' HD11 ' A' ' 58' ' ' LEU . 26.1 mmt85 -65.41 133.26 50.96 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.245 -175.736 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.486 HD12 ' HB3' ' A' ' 57' ' ' PHE . 87.9 mt -93.67 120.55 43.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.213 -178.317 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.652 ' HA ' ' SD ' ' A' ' 37' ' ' MET . 22.1 m120 -115.83 162.48 17.25 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.773 177.019 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -70.1 -15.0 62.92 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.214 0.53 . . . . 0.0 110.573 -179.171 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -84.12 -18.83 35.52 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.701 -178.568 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.65 ' CG ' HH12 ' A' ' 62' ' ' ARG . 65.9 m-20 -71.21 171.49 10.95 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 115.413 1.635 . . . . 0.0 115.413 -172.808 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.69 ' O ' ' HG ' ' A' ' 73' ' ' LEU . 71.8 p -93.57 156.39 39.76 Favored Pre-proline 0 C--N 1.346 0.449 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.352 -172.036 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.739 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 9.6 Cg_endo -49.77 -26.51 13.6 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 123.352 2.702 . . . . 0.0 113.793 -175.047 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.85 ' HA ' ' CG ' ' A' ' 75' ' ' MET . 0.0 OUTLIER -74.04 -24.35 59.53 Favored 'General case' 0 C--O 1.214 -0.775 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 -179.558 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.563 ' CG2' ' HB3' ' A' ' 68' ' ' ASP . 0.5 OUTLIER -101.85 -6.8 23.12 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 176.126 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.739 ' HB2' ' HA ' ' A' ' 70' ' ' PRO . 0.7 OUTLIER -101.44 24.58 9.43 Favored 'General case' 0 CA--C 1.444 -3.098 0 CA-C-N 111.807 -2.451 . . . . 0.0 115.409 -172.661 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.734 ' HB2' ' O ' ' A' ' 73' ' ' LEU . 35.7 mt-10 76.26 65.62 0.05 Allowed 'General case' 0 C--N 1.303 -1.413 0 CA-C-O 122.903 1.335 . . . . 0.0 111.35 174.448 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.85 ' CG ' ' HA ' ' A' ' 71' ' ' LYS . 90.1 mtp -39.58 -179.31 0.0 OUTLIER 'General case' 0 C--N 1.267 -2.984 0 CA-C-N 111.812 -2.449 . . . . 0.0 116.201 171.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.856 ' HA ' HD12 ' A' ' 15' ' ' ILE . 14.9 pt-20 -71.74 -178.05 2.14 Favored 'General case' 0 CA--C 1.486 -1.508 0 C-N-CA 124.812 1.245 . . . . 0.0 113.13 -156.488 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -35.34 99.76 0.02 OUTLIER 'General case' 0 CA--C 1.506 -0.74 0 O-C-N 124.862 1.351 . . . . 0.0 113.932 -168.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 14.0 t70 82.42 33.23 0.08 Allowed 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 112.181 -2.281 . . . . 0.0 112.566 171.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -70.44 178.9 2.71 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 119.828 -0.749 . . . . 0.0 109.57 172.117 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 29.3 m -110.92 151.02 13.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -172.032 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.487 HG13 ' HG2' ' A' ' 74' ' ' GLU . 1.3 mm -138.87 145.93 26.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.017 -0.992 . . . . 0.0 111.674 -178.48 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -112.16 138.8 48.34 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 116.114 -0.493 . . . . 0.0 109.83 178.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.484 ' HB ' ' HA2' ' A' ' 21' ' ' GLY . 78.3 t -125.83 132.8 70.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 CA-C-O 121.063 0.459 . . . . 0.0 111.092 179.54 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.639 ' CE1' HD22 ' A' ' 58' ' ' LEU . 70.7 m-85 -98.84 140.88 32.35 Favored 'General case' 0 N--CA 1.418 -2.056 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 174.263 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -68.15 127.12 31.75 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 121.806 0.812 . . . . 0.0 112.152 -164.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.523 ' HG3' HG21 ' A' ' 50' ' ' VAL . 13.2 pm0 -64.54 157.44 26.82 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 113.84 -1.527 . . . . 0.0 113.029 -175.262 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 57.9 tp60 -66.23 -45.22 81.42 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.999 -1.001 . . . . 0.0 112.928 -174.212 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 93.4 mt -105.89 4.14 29.32 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 116.13 -0.487 . . . . 0.0 112.292 -174.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -121.99 -144.49 6.82 Favored Glycine 0 C--N 1.31 -0.873 0 C-N-CA 120.382 -0.914 . . . . 0.0 111.858 -178.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.494 0 CA-C-O 118.461 -1.188 . . . . 0.0 111.709 -179.796 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.4 tpp . . . . . 0 N--CA 1.476 0.843 0 CA-C-O 120.526 0.203 . . . . 0.0 111.403 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 51.02 44.69 28.48 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.338 0.655 . . . . 0.0 112.504 177.16 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.5 t70 53.99 53.31 11.36 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.47 0.653 . . . . 0.0 111.581 -179.004 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -62.27 -39.81 94.17 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.484 176.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 67.52 36.47 3.76 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.927 178.02 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -66.04 125.44 25.48 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 175.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.7 mp0 53.53 87.65 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 121.943 0.878 . . . . 0.0 110.771 -173.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -79.14 0.03 29.86 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 114.834 -1.076 . . . . 0.0 111.232 -177.013 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 123.54 -8.71 8.82 Favored Glycine 0 CA--C 1.498 -0.974 0 N-CA-C 111.476 -0.65 . . . . 0.0 111.476 -178.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -147.1 172.95 12.97 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -100.85 10.9 40.57 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.537 0.684 . . . . 0.0 110.099 -179.175 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -154.1 159.58 41.56 Favored 'General case' 0 N--CA 1.422 -1.84 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.701 -179.013 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.451 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 1.3 pm0 -95.31 47.91 1.14 Allowed 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.685 -176.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -123.92 153.36 41.29 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.51 0.672 . . . . 0.0 112.343 -178.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 18.2 pt -126.89 162.89 30.62 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.285 -175.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.412 ' HB2' ' N ' ' A' ' 78' ' ' ASP . 28.3 mtpp -92.27 145.35 24.55 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.048 178.548 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.406 ' CG2' HD13 ' A' ' 81' ' ' ILE . 31.2 mm -135.02 129.8 51.26 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 CA-C-O 120.856 0.36 . . . . 0.0 111.305 175.288 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 22.3 mtmt -100.34 108.13 20.09 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 177.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.648 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 77.5 t -81.69 117.76 28.25 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 177.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 59.4 t -112.29 118.78 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 CA-C-O 121.189 0.519 . . . . 0.0 110.571 -178.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.415 ' HA2' ' HB ' ' A' ' 83' ' ' VAL . . . -86.89 168.24 39.11 Favored Glycine 0 N--CA 1.436 -1.344 0 C-N-CA 120.494 -0.86 . . . . 0.0 111.44 177.384 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.453 ' HG2' ' O ' ' A' ' 83' ' ' VAL . 87.7 mm-40 -70.87 -20.29 62.54 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.566 0.698 . . . . 0.0 111.498 -178.134 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -84.46 13.84 5.09 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.354 178.233 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.9 m 67.18 28.73 8.06 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.083 -178.299 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -95.58 103.28 15.15 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.063 -179.56 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.648 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 35.4 tt0 -104.03 135.44 45.53 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.03 179.545 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.2 p -135.64 142.38 39.52 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.389 178.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 27.9 m170 -102.08 117.61 35.17 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 121.252 0.548 . . . . 0.0 112.285 -175.355 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.433 ' HZ ' ' CD ' ' A' ' 47' ' ' ARG . 81.0 m-85 -116.33 146.87 42.1 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.49 175.714 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 49.5 ttp180 -104.45 123.02 46.72 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 174.489 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 33.4 m -133.43 174.34 13.37 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.374 -175.541 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.451 ' HG3' ' O ' ' A' ' 13' ' ' GLU . 22.4 ttpp -88.41 157.7 18.6 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -178.298 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.498 ' O ' ' HB3' ' A' ' 70' ' ' PRO . 90.8 m-85 -52.3 -41.22 62.74 Favored 'General case' 0 C--O 1.224 -0.268 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 175.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -104.97 32.31 7.64 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.954 -178.018 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.536 HG23 ' HB2' ' A' ' 39' ' ' LYS . 1.1 m -67.76 134.57 51.25 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 121.28 0.562 . . . . 0.0 111.913 178.438 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.544 ' HB3' ' HA ' ' A' ' 66' ' ' ASP . 69.9 m -91.26 156.31 17.91 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.528 -179.688 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.434 ' HB3' HG22 ' A' ' 64' ' ' ILE . 24.9 ptt? -45.67 -35.75 4.38 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -178.025 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.69 -37.74 85.22 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -176.272 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.536 ' HB2' HG23 ' A' ' 35' ' ' THR . 76.0 mmtt -59.99 -39.87 87.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.778 0.323 . . . . 0.0 110.205 -175.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.58 HD12 ' CD1' ' A' ' 57' ' ' PHE . 0.4 OUTLIER -87.58 -42.79 12.47 Favored 'General case' 0 C--O 1.217 -0.629 0 N-CA-C 112.665 0.616 . . . . 0.0 112.665 -177.545 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.479 ' HA ' ' HE1' ' A' ' 57' ' ' PHE . 61.3 mtpt -62.88 -46.24 88.8 Favored 'General case' 0 CA--C 1.493 -1.22 0 CA-C-O 120.574 0.226 . . . . 0.0 111.514 -178.599 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.532 ' O ' ' HB2' ' A' ' 46' ' ' ASP . 40.5 ttpt -62.81 -41.28 99.24 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.638 176.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 46.9 t -69.08 -52.19 30.97 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.63 -177.195 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.669 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 40.3 t80 -64.4 -47.83 77.73 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-O 120.694 0.283 . . . . 0.0 110.935 -178.8 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.443 ' CB ' ' HA ' ' A' ' 52' ' ' VAL . . . -60.13 -33.68 72.48 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.397 0.617 . . . . 0.0 109.968 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.532 ' HB2' ' O ' ' A' ' 42' ' ' LYS . 20.4 t70 -64.02 -47.15 81.36 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.214 -178.842 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.669 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 7.8 ptm180 -69.76 -29.25 66.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.392 -177.163 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.525 HG22 ' O ' ' A' ' 44' ' ' TYR . 7.6 t -88.44 -12.75 42.23 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.965 0.412 . . . . 0.0 110.425 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 69.76 31.58 70.34 Favored Glycine 0 CA--C 1.505 -0.558 0 C-N-CA 121.003 -0.618 . . . . 0.0 111.906 179.226 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.86 HG11 ' HB2' ' A' ' 87' ' ' GLN . 0.5 OUTLIER -115.2 175.12 2.73 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 CA-C-O 120.435 0.16 . . . . 0.0 110.605 -176.064 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.531 ' HB3' ' HB2' ' A' ' 54' ' ' SER . . . -59.16 125.64 24.45 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.912 179.021 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.443 ' HA ' ' CB ' ' A' ' 45' ' ' ALA . 70.2 t -67.1 -44.14 88.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.284 0.564 . . . . 0.0 110.253 178.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -66.16 -34.23 77.57 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.847 -178.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.531 ' HB2' ' HB3' ' A' ' 51' ' ' ALA . 59.2 m -84.98 -13.83 49.4 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.885 -175.751 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.837 HD23 ' HB3' ' A' ' 87' ' ' GLN . 2.7 tm? -92.98 123.2 36.06 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 179.01 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.409 ' HG3' ' C ' ' A' ' 55' ' ' LEU . 20.4 mtt180 -135.74 146.09 47.3 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.117 -170.091 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.58 ' CD1' HD12 ' A' ' 40' ' ' LEU . 95.2 m-85 -119.97 148.11 43.94 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.965 -179.329 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.415 HD22 ' CE1' ' A' ' 84' ' ' TYR . 7.3 mp -129.07 148.31 51.01 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.517 176.237 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.659 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 18.0 t80 -121.88 120.81 35.59 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 177.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 33.6 t70 61.04 24.05 14.18 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 121.517 0.675 . . . . 0.0 110.707 179.255 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 87.92 8.38 72.77 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.846 179.049 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.659 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 6.0 ppt_? -120.44 152.59 37.77 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 120.356 -0.538 . . . . 0.0 111.274 178.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 18.0 mmm180 -65.3 133.95 52.54 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.458 -176.019 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.434 HG22 ' HB3' ' A' ' 37' ' ' MET . 87.0 mt -85.18 129.37 37.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 173.142 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -109.96 162.23 14.72 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.25 0.547 . . . . 0.0 111.034 -172.139 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.544 ' HA ' ' HB3' ' A' ' 36' ' ' SER . 10.9 p-10 -83.47 -7.67 59.5 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.178 0.513 . . . . 0.0 109.688 174.048 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -102.81 -13.02 17.17 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 115.361 -0.836 . . . . 0.0 112.324 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.412 ' OD2' HD21 ' A' ' 73' ' ' LEU . 35.9 p30 -71.62 167.08 20.55 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 113.034 0.754 . . . . 0.0 113.034 -174.713 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.486 ' HB ' ' HD2' ' A' ' 70' ' ' PRO . 53.0 p -120.59 160.23 45.03 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.012 -176.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.498 ' HB3' ' O ' ' A' ' 33' ' ' TYR . 12.7 Cg_endo -56.84 -31.34 88.52 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.125 2.55 . . . . 0.0 113.701 -177.129 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.412 ' HE2' ' HB3' ' A' ' 71' ' ' LYS . 2.8 ptpt -70.18 -48.77 55.77 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.645 0.259 . . . . 0.0 111.066 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.42 HG22 ' H ' ' A' ' 69' ' ' THR . 10.0 t -70.87 -27.87 64.14 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 121.007 0.432 . . . . 0.0 109.928 178.181 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.498 ' HB3' ' HG3' ' A' ' 75' ' ' MET . 74.9 mt -70.84 -27.42 63.84 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 174.286 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 53.84 29.38 9.67 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.223 176.174 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.498 ' HG3' ' HB3' ' A' ' 73' ' ' LEU . 88.2 mtp -81.9 150.85 27.55 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.411 -177.605 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -146.73 178.65 8.15 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 177.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -60.58 123.49 17.55 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.729 0.775 . . . . 0.0 112.224 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.412 ' N ' ' HB2' ' A' ' 16' ' ' LYS . 15.4 t70 64.8 33.93 9.8 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 113.865 -1.516 . . . . 0.0 111.033 176.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -76.98 177.84 7.43 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 175.528 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.0 m -114.43 148.6 17.12 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 CA-C-O 121.742 0.782 . . . . 0.0 112.382 -174.571 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.406 HD13 ' CG2' ' A' ' 17' ' ' ILE . 1.1 mp -125.75 136.74 59.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 CA-C-N 114.508 -1.224 . . . . 0.0 108.232 177.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -99.97 139.4 35.69 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.143 0.497 . . . . 0.0 110.892 -176.415 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.559 HG22 ' CD2' ' A' ' 57' ' ' PHE . 86.6 t -123.36 130.45 74.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.114 178.294 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.415 ' CE1' HD22 ' A' ' 58' ' ' LEU . 84.1 m-85 -99.28 149.07 23.5 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 174.101 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -69.31 107.26 3.2 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 121.553 0.692 . . . . 0.0 111.017 -171.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.483 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 1.3 mm-40 176.04 114.65 0.02 OUTLIER 'General case' 0 CA--C 1.476 -1.901 0 C-N-CA 125.984 1.714 . . . . 0.0 110.966 -174.198 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.86 ' HB2' HG11 ' A' ' 50' ' ' VAL . 27.8 pt20 -157.18 13.35 0.24 Allowed 'General case' 0 N--CA 1.384 -3.768 0 CA-C-N 113.425 -1.716 . . . . 0.0 108.337 176.692 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 52.3 tp 90.44 -7.21 0.32 Allowed 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 112.857 -1.974 . . . . 0.0 107.624 -170.036 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.429 ' H ' ' HG3' ' A' ' 87' ' ' GLN . . . -60.78 -41.39 99.09 Favored Glycine 0 N--CA 1.441 -0.989 0 CA-C-N 114.416 -1.265 . . . . 0.0 111.656 174.152 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.895 0 CA-C-O 118.227 -1.318 . . . . 0.0 111.449 178.584 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.9 ttm . . . . . 0 N--CA 1.472 0.672 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.84 102.77 10.24 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 177.473 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -83.98 -172.91 4.42 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.551 -178.269 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -60.55 -38.44 84.52 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.098 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 62.44 29.74 17.18 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.198 0.523 . . . . 0.0 110.535 -178.296 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -152.4 157.94 41.96 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.45 -179.063 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -124.45 151.38 44.61 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.06 -37.95 86.92 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.786 0.327 . . . . 0.0 110.94 -178.689 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 82.05 19.06 65.87 Favored Glycine 0 CA--C 1.5 -0.903 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 -177.458 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -81.96 -178.54 7.04 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 114.524 -0.838 . . . . 0.0 109.804 -178.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 56.32 44.51 24.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.824 0.821 . . . . 0.0 110.158 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.7 -37.18 80.79 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.338 -1.301 . . . . 0.0 111.735 -178.378 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -86.59 26.64 1.06 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.644 0.735 . . . . 0.0 110.824 -179.116 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -125.32 168.67 13.2 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 115.076 -0.965 . . . . 0.0 111.072 -177.456 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.759 HD12 ' HA ' ' A' ' 76' ' ' GLU . 11.7 pt -109.05 163.01 6.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-O 121.49 0.662 . . . . 0.0 111.369 -173.107 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.528 ' HD3' ' OD2' ' A' ' 77' ' ' ASP . 42.5 mtpt -92.1 147.67 22.77 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.727 -178.624 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.669 HG13 ' HB3' ' A' ' 74' ' ' GLU . 8.4 mm -139.5 139.34 38.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.613 175.781 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.5 mtmt -101.92 105.25 16.03 Favored 'General case' 0 N--CA 1.431 -1.388 0 C-N-CA 120.105 -0.638 . . . . 0.0 109.638 177.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.637 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 76.0 t -80.71 114.06 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 176.347 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 59.2 t -109.34 118.65 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.013 0 CA-C-O 121.154 0.502 . . . . 0.0 110.482 -178.141 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -84.62 173.34 49.35 Favored Glycine 0 N--CA 1.436 -1.318 0 C-N-CA 120.321 -0.942 . . . . 0.0 111.013 176.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 86.7 mm-40 -73.36 -19.18 61.07 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.368 0.604 . . . . 0.0 111.83 -176.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -85.5 12.53 8.33 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.161 176.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 51.0 m 67.3 27.13 8.36 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.063 -177.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -89.31 103.4 16.03 Favored 'General case' 0 CA--C 1.495 -1.14 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.876 179.295 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.637 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 36.3 tt0 -104.89 133.44 49.69 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.978 -177.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.3 p -136.57 141.9 39.73 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.466 178.169 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.407 ' HA ' ' O ' ' A' ' 17' ' ' ILE . 63.5 m170 -95.37 119.04 33.19 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 121.405 0.622 . . . . 0.0 111.429 -176.697 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -109.51 150.74 27.69 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.508 175.562 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 17.1 tpp180 -103.36 118.09 35.97 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 176.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.56 ' O ' HG12 ' A' ' 15' ' ' ILE . 34.6 m -136.75 173.13 14.08 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.715 -175.381 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -90.13 156.76 18.12 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.129 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -55.49 -38.86 69.71 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 121.327 0.584 . . . . 0.0 109.518 175.152 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -104.45 33.69 6.37 Favored Glycine 0 N--CA 1.44 -1.037 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.395 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.558 ' O ' HD13 ' A' ' 73' ' ' LEU . 0.9 OUTLIER -63.77 131.7 48.67 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-O 121.695 0.759 . . . . 0.0 111.833 179.568 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 69.9 m -81.15 151.88 28.03 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.254 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.671 ' SD ' ' HA ' ' A' ' 65' ' ' ASN . 27.3 ptt? -48.34 -33.5 9.07 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -178.499 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.52 -36.53 82.87 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 112.203 0.445 . . . . 0.0 112.203 -178.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.52 ' HB2' HG23 ' A' ' 35' ' ' THR . 75.8 mmtt -60.74 -41.19 94.87 Favored 'General case' 0 C--O 1.217 -0.622 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.822 -174.416 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.794 HD23 ' H ' ' A' ' 40' ' ' LEU . 0.9 OUTLIER -87.71 -45.14 10.63 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -178.2 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.444 ' HA ' ' HE1' ' A' ' 57' ' ' PHE . 61.1 mtpt -62.65 -46.09 89.84 Favored 'General case' 0 CA--C 1.494 -1.175 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -177.055 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 41.7 ttmt -62.76 -41.49 99.25 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 121.231 0.539 . . . . 0.0 109.593 176.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 58.8 m -69.16 -51.91 33.4 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -177.041 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.602 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 43.4 t80 -66.41 -47.51 73.04 Favored 'General case' 0 CA--C 1.505 -0.776 0 N-CA-C 111.779 0.289 . . . . 0.0 111.779 -179.118 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.415 ' CB ' ' HA ' ' A' ' 52' ' ' VAL . . . -59.98 -35.47 75.07 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.318 0.58 . . . . 0.0 110.347 -178.419 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -66.15 -47.1 75.16 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.517 -178.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.602 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 10.6 ptm85 -68.91 -25.72 64.73 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.242 -176.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.455 HG22 ' O ' ' A' ' 44' ' ' TYR . 10.2 t -93.04 -9.9 38.08 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 120.956 0.408 . . . . 0.0 111.123 -179.693 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.6 40.14 59.6 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.975 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.739 HG21 ' HG3' ' A' ' 86' ' ' GLU . 2.7 p -126.4 162.46 30.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.476 ' HB3' ' OG ' ' A' ' 54' ' ' SER . . . -59.81 130.67 47.92 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 178.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.415 ' HA ' ' CB ' ' A' ' 45' ' ' ALA . 74.8 t -61.63 -44.64 99.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.694 -177.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -66.37 -33.21 75.2 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.673 -178.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.51 ' HB2' ' H ' ' A' ' 87' ' ' GLN . 90.5 p -76.72 -14.45 59.94 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.68 -178.423 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.489 HD13 ' N ' ' A' ' 56' ' ' ARG . 1.0 OUTLIER -95.89 136.97 35.62 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -179.509 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.489 ' N ' HD13 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -140.99 145.48 36.01 Favored 'General case' 0 N--CA 1.436 -1.129 0 C-N-CA 119.853 -0.739 . . . . 0.0 111.509 -176.798 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.497 ' CG ' HD12 ' A' ' 40' ' ' LEU . 92.8 m-85 -118.84 140.96 49.11 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 114.922 -1.035 . . . . 0.0 109.267 176.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.601 HD22 ' CE1' ' A' ' 84' ' ' TYR . 9.2 mp -126.26 145.54 50.37 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.856 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.704 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 0.4 OUTLIER -128.84 117.38 20.96 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 177.157 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 68.13 24.14 7.77 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.387 0.613 . . . . 0.0 110.987 -175.194 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.1 14.08 77.77 Favored Glycine 0 N--CA 1.438 -1.185 0 CA-C-N 115.414 -0.812 . . . . 0.0 113.001 176.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.704 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.1 OUTLIER -124.2 146.45 48.69 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.232 179.462 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 10.9 mpt_? -67.6 130.1 41.97 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.836 -176.339 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 83.9 mt -80.09 125.86 39.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.384 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.671 ' HA ' ' SD ' ' A' ' 37' ' ' MET . 20.7 m120 -116.69 171.18 8.04 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 123.343 0.657 . . . . 0.0 109.489 177.255 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -78.8 -8.76 59.07 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -175.128 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -114.97 16.62 17.14 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 120.229 -0.588 . . . . 0.0 112.162 -178.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.65 ' HB2' HD21 ' A' ' 73' ' ' LEU . 72.0 m-20 -84.22 172.06 12.22 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.579 ' O ' ' HG ' ' A' ' 73' ' ' LEU . 69.2 p -82.91 156.13 67.5 Favored Pre-proline 0 CA--C 1.509 -0.599 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -173.362 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.727 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 17.4 Cg_endo -54.84 -18.68 16.93 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 123.131 2.554 . . . . 0.0 112.61 -176.427 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.862 ' HA ' ' CG ' ' A' ' 75' ' ' MET . 2.1 tmmm? -70.5 -40.54 73.51 Favored 'General case' 0 N--CA 1.413 -2.312 0 C-N-CA 122.888 0.475 . . . . 0.0 111.812 -179.447 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.476 ' CG2' ' HB3' ' A' ' 68' ' ' ASP . 1.4 t -96.72 -6.84 35.45 Favored 'General case' 0 CA--C 1.477 -1.839 0 CA-C-O 123.34 1.543 . . . . 0.0 107.021 -178.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.767 ' O ' ' HB2' ' A' ' 74' ' ' GLU . 0.3 OUTLIER -96.53 24.97 5.42 Favored 'General case' 0 CA--C 1.432 -3.587 0 CA-C-N 111.514 -2.585 . . . . 0.0 114.407 -176.761 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.767 ' HB2' ' O ' ' A' ' 73' ' ' LEU . 32.7 mt-10 76.23 66.04 0.06 Allowed 'General case' 0 C--N 1.305 -1.327 0 O-C-N 124.747 1.28 . . . . 0.0 111.66 173.067 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.862 ' CG ' ' HA ' ' A' ' 71' ' ' LYS . 76.4 mtm -39.84 -179.32 0.0 OUTLIER 'General case' 0 C--N 1.269 -2.897 0 CA-C-N 112.418 -2.174 . . . . 0.0 116.764 172.46 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.759 ' HA ' HD12 ' A' ' 15' ' ' ILE . 13.6 pt-20 -72.18 178.75 3.68 Favored 'General case' 0 CA--C 1.478 -1.819 0 C-N-CA 124.369 1.068 . . . . 0.0 112.295 -157.052 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.528 ' OD2' ' HD3' ' A' ' 16' ' ' LYS . 7.0 t70 -25.67 97.74 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.705 0 O-C-N 125.392 1.683 . . . . 0.0 114.269 -171.023 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.9 t70 80.23 33.04 0.17 Allowed 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 112.05 -2.341 . . . . 0.0 113.076 168.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -72.04 178.27 3.88 Favored 'General case' 0 C--N 1.36 1.056 0 C-N-CA 119.193 -1.003 . . . . 0.0 109.489 171.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 29.8 m -107.76 152.19 9.56 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -170.562 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.416 HD13 ' HA ' ' A' ' 81' ' ' ILE . 4.7 mm -135.91 138.88 46.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.499 -179.679 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -103.34 140.41 37.46 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.198 -179.183 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 95.6 t -125.69 133.72 68.41 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-O 120.975 0.417 . . . . 0.0 111.227 178.424 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.601 ' CE1' HD22 ' A' ' 58' ' ' LEU . 79.0 m-85 -107.59 159.3 16.55 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.604 176.207 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 37.5 tp60 -68.62 144.05 54.62 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.19 0.519 . . . . 0.0 111.649 -170.449 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.739 ' HG3' HG21 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -95.87 161.41 14.02 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.547 -175.589 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.51 ' H ' ' HB2' ' A' ' 54' ' ' SER . 58.3 tp60 -66.75 -44.39 81.56 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.379 -0.828 . . . . 0.0 113.232 -177.48 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -85.98 -7.06 58.92 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.881 0.372 . . . . 0.0 111.958 -175.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.517 ' H ' ' HG2' ' A' ' 86' ' ' GLU . . . -101.68 -84.4 1.8 Allowed Glycine 0 N--CA 1.436 -1.352 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 178.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.048 0 CA-C-O 118.692 -1.06 . . . . 0.0 112.481 178.447 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 . . . . . 0 N--CA 1.441 -0.908 0 CA-C-O 120.979 0.419 . . . . 0.0 110.481 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.497 HG12 ' O ' ' A' ' 31' ' ' VAL . 11.9 pt -116.93 163.33 14.18 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.662 -176.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.465 ' HE2' ' HB3' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -96.31 141.54 29.53 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.2 179.644 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.508 HD12 ' CG2' ' A' ' 31' ' ' VAL . 83.7 mt -140.35 137.62 36.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.504 175.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 13.8 mtmm -102.02 106.32 17.2 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.608 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 92.8 t -82.45 119.87 32.82 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.62 178.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 59.1 t -110.81 118.77 58.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-O 120.91 0.386 . . . . 0.0 110.025 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.586 ' HA2' ' HB ' ' A' ' 83' ' ' VAL . . . -90.15 169.41 34.82 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.346 -0.93 . . . . 0.0 112.549 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.472 ' HG2' ' O ' ' A' ' 83' ' ' VAL . 89.8 mm-40 -69.16 -24.38 64.07 Favored 'General case' 0 CA--C 1.504 -0.799 0 CA-C-O 121.39 0.614 . . . . 0.0 110.689 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -69.85 1.6 4.25 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.644 175.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.428 ' H ' ' C ' ' A' ' 22' ' ' GLN . 47.4 m 69.49 27.82 4.8 Favored 'General case' 0 C--N 1.351 0.656 0 CA-C-O 121.994 0.902 . . . . 0.0 109.134 -176.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -98.86 107.1 19.45 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.354 -1.294 . . . . 0.0 111.049 -178.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.608 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 33.7 tt0 -99.3 133.27 43.83 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.418 177.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.6 p -133.8 139.78 47.9 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-N 115.91 -0.587 . . . . 0.0 109.88 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.415 ' HB3' ' HE3' ' A' ' 16' ' ' LYS . 19.0 m170 -96.48 113.28 24.85 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.345 0.593 . . . . 0.0 111.582 -176.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -111.99 150.4 30.63 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.473 179.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.485 ' HD3' ' O ' ' A' ' 15' ' ' ILE . 22.4 tpp180 -107.35 116.95 32.84 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 175.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.508 ' CG2' HD12 ' A' ' 17' ' ' ILE . 35.0 m -138.66 169.02 18.53 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.304 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -178.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 53.9 tttp -89.33 160.1 17.03 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 -177.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -55.38 -38.29 68.66 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.016 0.436 . . . . 0.0 110.126 175.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -102.35 22.65 36.94 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.931 -0.577 . . . . 0.0 113.051 -178.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -62.39 142.36 57.87 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-O 121.323 0.582 . . . . 0.0 112.001 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 69.2 m -91.14 153.47 20.03 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.604 -179.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.407 ' HA ' HD21 ' A' ' 40' ' ' LEU . 27.3 ptt? -49.96 -33.19 16.92 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 112.897 0.702 . . . . 0.0 112.897 -177.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.46 -36.78 81.37 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -178.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -60.13 -40.04 88.41 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.91 0.386 . . . . 0.0 110.766 -176.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.567 HD12 ' CD2' ' A' ' 57' ' ' PHE . 0.2 OUTLIER -86.62 -45.49 10.98 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.928 -177.993 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.554 ' HG2' ' CD1' ' A' ' 57' ' ' PHE . 63.2 mtpt -63.83 -45.44 89.54 Favored 'General case' 0 CA--C 1.498 -1.024 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.639 -177.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -60.55 -44.37 96.19 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 176.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 39.5 t -64.96 -50.22 67.24 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.775 -176.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.554 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 48.8 t80 -68.18 -45.63 72.91 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.517 -179.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.486 ' HB1' ' O ' ' A' ' 50' ' ' VAL . . . -59.24 -36.27 75.15 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.413 0.625 . . . . 0.0 109.725 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -67.01 -47.01 72.74 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.413 -178.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.554 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 10.5 ptm85 -66.3 -24.74 66.6 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.334 -178.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.485 HG22 ' O ' ' A' ' 44' ' ' TYR . 14.6 t -99.36 -5.36 29.73 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.833 -178.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 69.3 30.94 71.38 Favored Glycine 0 C--N 1.336 0.53 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.762 178.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.486 ' O ' ' HB1' ' A' ' 45' ' ' ALA . 83.2 t -118.75 150.19 21.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 C-N-CA 122.445 0.298 . . . . 0.0 110.803 -177.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.497 ' HB3' ' OG ' ' A' ' 54' ' ' SER . . . -51.34 134.72 27.89 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.296 176.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 74.7 t -61.63 -43.28 96.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.602 -178.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -71.82 -15.93 62.16 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.703 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.52 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 73.6 m -81.55 -12.62 58.73 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.645 178.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.495 ' C ' ' HD3' ' A' ' 56' ' ' ARG . 2.6 mm? -94.37 134.84 36.44 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.112 176.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.495 ' HD3' ' C ' ' A' ' 55' ' ' LEU . 0.7 OUTLIER -126.07 114.42 18.39 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.971 -177.658 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.567 ' CD2' HD12 ' A' ' 40' ' ' LEU . 20.0 m-85 -106.12 132.27 52.4 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.172 0.511 . . . . 0.0 111.856 -178.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.564 ' HG ' ' HA ' ' A' ' 63' ' ' ARG . 6.6 mp -129.3 139.98 51.58 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.701 178.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.724 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 88.9 t80 -111.14 121.89 46.46 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 177.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 19.4 t70 55.19 23.56 5.53 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 121.484 0.659 . . . . 0.0 111.544 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 94.85 8.46 59.23 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.793 -0.717 . . . . 0.0 113.16 177.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.724 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.1 OUTLIER -124.79 141.44 52.11 Favored 'General case' 0 CA--C 1.505 -0.758 0 CA-C-O 121.147 0.498 . . . . 0.0 109.759 176.456 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.564 ' HA ' ' HG ' ' A' ' 58' ' ' LEU . 29.5 ptt180 -68.23 139.38 56.03 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -174.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.439 HD12 ' HB3' ' A' ' 57' ' ' PHE . 83.7 mt -88.97 122.42 40.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-N 114.548 -1.206 . . . . 0.0 109.886 -178.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 -109.01 163.99 12.82 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.68 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -81.39 -7.7 59.62 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.142 0.496 . . . . 0.0 109.767 177.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -94.51 -19.25 20.7 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.164 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.514 ' CG ' HH12 ' A' ' 62' ' ' ARG . 39.3 m-20 -62.73 138.19 58.45 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-O 121.179 0.514 . . . . 0.0 111.746 -177.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.442 ' HB ' ' HD2' ' A' ' 70' ' ' PRO . 82.7 p -91.26 162.71 31.48 Favored Pre-proline 0 C--N 1.312 -1.039 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.195 -179.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.442 ' HD2' ' HB ' ' A' ' 69' ' ' THR . 17.9 Cg_endo -59.79 -25.99 80.9 Favored 'Trans proline' 0 CA--C 1.535 0.542 0 C-N-CA 122.107 1.871 . . . . 0.0 111.6 176.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.441 ' HE2' ' N ' ' A' ' 71' ' ' LYS . 0.2 OUTLIER -63.7 -47.01 82.87 Favored 'General case' 0 CA--C 1.483 -1.629 0 CA-C-O 121.96 0.886 . . . . 0.0 110.164 178.69 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.7 t -84.32 -27.14 27.98 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 113.975 -1.466 . . . . 0.0 112.09 -174.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 96.4 mt -82.77 -22.74 34.19 Favored 'General case' 0 C--O 1.216 -0.702 0 C-N-CA 120.289 -0.564 . . . . 0.0 110.798 177.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 38.08 34.27 0.06 Allowed 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 124.833 1.253 . . . . 0.0 113.616 178.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 64.9 mtt -75.35 150.57 38.39 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -152.54 -174.03 4.76 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -178.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -48.94 118.06 2.41 Favored 'General case' 0 C--N 1.32 -0.707 0 O-C-N 123.885 0.74 . . . . 0.0 112.763 -176.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.5 t70 58.42 34.55 24.07 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.23 -1.35 . . . . 0.0 111.479 173.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -69.89 178.13 2.81 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.3 m -114.77 148.77 17.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 CA-C-O 121.594 0.711 . . . . 0.0 112.092 -174.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.483 HD12 HG21 ' A' ' 17' ' ' ILE . 2.6 mt -131.85 137.79 54.17 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.1 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -105.1 133.88 49.13 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -178.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.586 ' HB ' ' HA2' ' A' ' 21' ' ' GLY . 92.6 t -124.08 136.43 60.38 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.874 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.554 ' CD1' HD13 ' A' ' 58' ' ' LEU . 69.8 m-85 -96.78 164.11 12.7 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 58.5 tp60 -67.24 128.7 37.39 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.304 0.573 . . . . 0.0 110.581 -171.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.52 ' HA ' ' O ' ' A' ' 54' ' ' SER . 13.7 pm0 -64.92 151.14 46.49 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 114.935 -1.029 . . . . 0.0 112.256 -177.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 61.8 tp60 -63.42 -50.91 67.95 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.366 -174.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 88.3 mt . . . . . 0 C--N 1.322 -0.609 0 CA-C-N 115.67 -0.696 . . . . 0.0 112.798 -179.873 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 . . . . . 0 N--CA 1.442 -0.869 0 CA-C-O 121.402 0.62 . . . . 0.0 112.466 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.493 ' O ' ' HD2' ' A' ' 30' ' ' ARG . 13.9 pt -124.25 164.17 22.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 114.535 -1.211 . . . . 0.0 108.035 -178.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.441 ' HB2' HH11 ' A' ' 30' ' ' ARG . 17.7 ttpp -99.69 143.41 29.95 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 119.997 -0.681 . . . . 0.0 110.202 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.562 HG21 HD12 ' A' ' 81' ' ' ILE . 74.3 mt -135.75 134.42 51.32 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 CA-C-O 120.87 0.367 . . . . 0.0 111.113 175.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 18.4 mtmt -96.04 107.18 19.45 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.655 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 71.4 t -81.29 117.38 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 177.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.3 t -110.75 118.11 56.5 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -82.52 178.53 53.33 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 120.5 -0.857 . . . . 0.0 111.747 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.511 ' C ' ' H ' ' A' ' 24' ' ' SER . 97.9 mt-30 -66.18 -37.02 84.61 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -178.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -79.29 22.19 0.44 Allowed 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.618 0.723 . . . . 0.0 109.294 177.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.511 ' H ' ' C ' ' A' ' 22' ' ' GLN . 85.0 p 58.97 30.43 20.22 Favored 'General case' 0 CA--C 1.512 -0.517 0 C-N-CA 124.807 1.243 . . . . 0.0 111.201 -179.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -83.6 105.68 14.72 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 114.836 -1.075 . . . . 0.0 109.866 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.655 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 36.5 tt0 -103.67 130.88 51.21 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.699 -177.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.5 p -135.79 140.75 43.7 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.091 177.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 18.4 m170 -96.24 117.13 30.17 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 121.525 0.679 . . . . 0.0 111.935 -175.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.406 ' HZ ' ' CD ' ' A' ' 47' ' ' ARG . 45.6 m-85 -109.6 149.21 30.0 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.604 -1.18 . . . . 0.0 111.039 177.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.493 ' HD2' ' O ' ' A' ' 15' ' ' ILE . 22.8 tpt180 -108.98 117.02 33.11 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 177.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.443 ' O ' HG12 ' A' ' 15' ' ' ILE . 33.0 m -137.69 170.5 17.33 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.35 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.008 -177.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.432 ' O ' ' HB ' ' A' ' 35' ' ' THR . 38.5 ttmt -89.83 156.29 18.59 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 110.453 -0.203 . . . . 0.0 110.453 -177.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -56.4 -38.91 72.16 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 121.142 0.496 . . . . 0.0 109.691 174.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -98.06 24.76 30.41 Favored Glycine 0 N--CA 1.443 -0.868 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.452 -178.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.48 HG23 ' HB2' ' A' ' 39' ' ' LYS . 1.0 OUTLIER -65.83 140.51 58.39 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-O 121.426 0.631 . . . . 0.0 112.193 179.232 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 66.5 m -91.99 157.19 16.94 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.975 179.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.694 ' SD ' ' HA ' ' A' ' 65' ' ' ASN . 26.4 ptt? -51.47 -31.88 25.03 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -176.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.75 -38.06 86.6 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.198 -0.456 . . . . 0.0 112.097 -177.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.48 ' HB2' HG23 ' A' ' 35' ' ' THR . 75.5 mmtt -60.66 -38.25 84.25 Favored 'General case' 0 C--O 1.217 -0.645 0 CA-C-O 120.672 0.273 . . . . 0.0 111.183 -175.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.514 HD12 ' CG ' ' A' ' 57' ' ' PHE . 0.2 OUTLIER -86.59 -47.32 9.31 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.741 -178.528 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.441 ' HA ' ' HE1' ' A' ' 57' ' ' PHE . 94.3 mttt -62.95 -47.2 84.23 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.99 -177.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -64.27 -38.74 92.11 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.014 178.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 47.5 t -69.07 -53.55 19.75 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.68 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.705 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 45.3 t80 -65.89 -47.22 75.56 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-N 116.227 -0.442 . . . . 0.0 112.18 -178.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.75 -35.68 75.09 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.38 0.609 . . . . 0.0 109.895 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -65.99 -47.15 75.48 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.725 -178.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.705 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 8.7 ptm180 -65.9 -27.94 68.58 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.065 -178.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.517 HG22 ' O ' ' A' ' 44' ' ' TYR . 9.3 t -93.19 -6.74 47.07 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.072 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 69.67 33.16 71.17 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.902 178.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.421 HG22 ' H ' ' A' ' 51' ' ' ALA . 1.6 p -117.7 167.29 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 CA-C-O 120.693 0.282 . . . . 0.0 110.827 -177.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.543 ' HB3' ' OG ' ' A' ' 54' ' ' SER . . . -61.48 128.22 35.25 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.389 178.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 77.2 t -64.24 -43.99 97.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.777 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -67.47 -29.67 69.18 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.708 -177.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.543 ' OG ' ' HB3' ' A' ' 51' ' ' ALA . 88.5 p -82.76 -17.16 45.18 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 119.891 -0.723 . . . . 0.0 111.135 -179.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.503 HD13 ' N ' ' A' ' 56' ' ' ARG . 0.9 OUTLIER -92.59 135.2 34.28 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 -177.183 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.509 ' NH1' ' HA ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -140.96 149.58 42.0 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-O 121.486 0.66 . . . . 0.0 111.693 -177.106 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.514 ' CG ' HD12 ' A' ' 40' ' ' LEU . 58.0 m-85 -117.94 138.8 51.92 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 114.554 -1.203 . . . . 0.0 109.824 179.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.602 HD22 ' CE1' ' A' ' 84' ' ' TYR . 9.2 mp -125.3 137.95 54.07 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.765 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.782 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 23.1 t80 -105.5 114.48 28.68 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 38.0 t70 53.86 29.29 9.57 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-O 121.697 0.761 . . . . 0.0 111.602 -177.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.416 ' O ' HD23 ' A' ' 58' ' ' LEU . . . 95.07 -4.19 67.54 Favored Glycine 0 C--N 1.313 -0.704 0 CA-C-N 115.859 -0.609 . . . . 0.0 113.408 177.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.782 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.1 OUTLIER -106.5 138.88 41.88 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.355 0.598 . . . . 0.0 110.385 178.58 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.507 ' HA ' ' HG ' ' A' ' 58' ' ' LEU . 32.2 mtp-105 -69.01 135.64 51.21 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.882 -174.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 79.3 mt -93.3 121.52 44.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.985 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.694 ' HA ' ' SD ' ' A' ' 37' ' ' MET . 65.0 m-80 -117.31 161.72 19.06 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.486 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -71.75 -13.34 61.68 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.159 0.504 . . . . 0.0 109.826 178.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -76.74 -21.47 55.2 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.65 177.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.415 ' CG ' HH12 ' A' ' 62' ' ' ARG . 66.0 m-20 -71.48 139.9 49.77 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 121.47 0.653 . . . . 0.0 111.444 -179.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.545 ' HB ' ' HD2' ' A' ' 70' ' ' PRO . 47.8 p -101.99 163.95 16.75 Favored Pre-proline 0 C--N 1.304 -1.396 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.92 -178.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.545 ' HD2' ' HB ' ' A' ' 69' ' ' THR . 12.7 Cg_endo -56.39 -37.44 97.07 Favored 'Trans proline' 0 C--N 1.357 1.024 0 C-N-CA 122.427 2.085 . . . . 0.0 113.436 -177.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.446 ' HD3' ' N ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -74.49 -19.5 60.34 Favored 'General case' 0 C--O 1.221 -0.438 0 CA-C-O 121.057 0.456 . . . . 0.0 112.028 179.277 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.446 ' N ' ' HD3' ' A' ' 71' ' ' LYS . 52.1 m -85.0 -45.17 12.4 Favored 'General case' 0 N--CA 1.408 -2.546 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.966 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 98.9 mt -71.2 -25.25 62.43 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.526 178.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 51.57 30.27 6.33 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.836 177.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 20.2 ptp -73.88 162.77 28.74 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.995 0.426 . . . . 0.0 111.464 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -151.56 175.41 12.36 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.724 -177.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -65.9 118.93 10.42 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 121.692 0.758 . . . . 0.0 111.634 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 21.5 t70 70.65 33.91 2.22 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 126.095 1.758 . . . . 0.0 111.587 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -77.86 178.72 7.2 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 176.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.1 m -113.36 146.79 17.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-O 121.7 0.762 . . . . 0.0 111.9 -175.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.562 HD12 HG21 ' A' ' 17' ' ' ILE . 1.2 mt -134.15 141.99 42.25 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.962 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -107.54 146.53 31.73 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.834 0.349 . . . . 0.0 111.473 -176.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.428 ' O ' ' HG3' ' A' ' 22' ' ' GLN . 97.5 t -125.31 132.41 71.13 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.66 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.102 179.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.602 ' CE1' HD22 ' A' ' 58' ' ' LEU . 63.6 m-85 -100.62 143.98 30.15 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.766 175.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 58.7 tp60 -69.85 134.64 48.71 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -176.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.509 ' HA ' ' NH1' ' A' ' 56' ' ' ARG . 1.3 pp20? -94.3 -155.79 0.47 Allowed 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -171.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -82.95 -55.94 4.1 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -171.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.406 HD12 ' H ' ' A' ' 51' ' ' ALA . 85.3 mt . . . . . 0 C--N 1.321 -0.665 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -174.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 . . . . . 0 N--CA 1.442 -0.844 0 CA-C-O 120.818 0.342 . . . . 0.0 110.171 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.5 pt -125.39 162.34 28.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.442 -176.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.484 ' HE2' ' HB2' ' A' ' 78' ' ' ASP . 38.1 mtmm -97.42 144.47 27.13 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.963 176.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.669 HG21 HD12 ' A' ' 81' ' ' ILE . 45.2 mm -128.08 129.53 69.52 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.979 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.02 178.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 27.5 mtmt -96.67 104.58 16.58 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 174.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.557 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 89.6 t -81.95 111.92 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.863 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 177.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.0 t -108.49 117.72 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.414 ' HA2' ' HB ' ' A' ' 83' ' ' VAL . . . -93.84 164.79 26.58 Favored Glycine 0 N--CA 1.435 -1.42 0 C-N-CA 120.489 -0.862 . . . . 0.0 111.449 178.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.455 ' C ' ' H ' ' A' ' 24' ' ' SER . 98.3 mt-30 -67.95 -23.94 65.11 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.374 0.607 . . . . 0.0 110.44 179.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -70.87 8.92 0.77 Allowed 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.919 175.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.455 ' H ' ' C ' ' A' ' 22' ' ' GLN . 44.5 m 68.96 25.27 6.04 Favored 'General case' 0 C--N 1.348 0.531 0 C-N-CA 123.753 0.821 . . . . 0.0 110.315 -179.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 54.0 t-20 -96.03 107.27 19.54 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.946 -178.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.557 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 28.7 tt0 -105.46 125.77 51.37 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.426 175.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.2 p -137.65 140.94 40.45 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-O 121.099 0.476 . . . . 0.0 111.126 -179.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 62.5 m170 -89.83 118.65 29.58 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.066 -178.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -118.43 143.64 46.53 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.296 171.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 52.9 ttp180 -106.44 121.51 44.4 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 121.528 0.68 . . . . 0.0 110.466 177.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 33.8 m -136.57 172.58 15.02 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 CA-C-N 114.82 -1.082 . . . . 0.0 108.911 -177.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.436 ' O ' ' HB ' ' A' ' 35' ' ' THR . 50.3 tttm -89.55 160.58 16.63 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -179.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.409 ' C ' ' HB3' ' A' ' 70' ' ' PRO . 95.7 m-85 -54.08 -41.21 67.97 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.976 0.417 . . . . 0.0 110.228 176.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -97.65 22.33 41.38 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.844 -177.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.436 ' HB ' ' O ' ' A' ' 32' ' ' LYS . 0.9 OUTLIER -61.63 143.82 55.48 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-O 121.181 0.515 . . . . 0.0 112.109 179.222 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 65.5 m -91.59 150.72 21.05 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.967 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -49.56 -33.03 13.83 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -177.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.88 -37.12 81.08 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.93 -177.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -61.32 -40.28 93.61 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.853 0.358 . . . . 0.0 110.646 -175.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.514 HD12 ' CD2' ' A' ' 57' ' ' PHE . 0.4 OUTLIER -87.26 -45.28 10.77 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.075 -0.512 . . . . 0.0 112.08 -179.269 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.572 ' HG2' ' CD1' ' A' ' 57' ' ' PHE . 61.4 mtpt -63.01 -45.98 89.8 Favored 'General case' 0 CA--C 1.496 -1.119 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.752 -177.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -62.13 -40.96 97.68 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 48.0 t -66.41 -51.34 57.96 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.168 -0.923 . . . . 0.0 111.326 -178.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.689 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 49.2 t80 -66.64 -45.82 77.78 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.85 -178.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.443 ' HB1' ' O ' ' A' ' 50' ' ' VAL . . . -59.25 -36.03 74.75 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.502 0.668 . . . . 0.0 109.757 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -66.49 -46.34 76.62 Favored 'General case' 0 C--N 1.311 -1.109 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.193 -178.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.689 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 11.4 ptm85 -65.39 -26.84 68.17 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.176 -177.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.528 HG22 ' O ' ' A' ' 44' ' ' TYR . 10.1 t -95.55 -7.42 37.96 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.222 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.81 32.04 66.98 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.406 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.456 HG13 ' HB3' ' A' ' 88' ' ' LEU . 84.5 t -117.74 150.25 19.9 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 C-N-CA 122.6 0.36 . . . . 0.0 110.859 -177.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.443 ' HB3' ' OG ' ' A' ' 54' ' ' SER . . . -52.58 137.05 31.36 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.396 176.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 74.3 t -61.23 -42.97 95.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.14 -179.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -67.26 -25.04 65.87 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.118 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.45 ' HB3' ' H ' ' A' ' 87' ' ' GLN . 74.0 m -74.76 -16.03 60.74 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.88 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -96.44 134.13 40.0 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.238 0.542 . . . . 0.0 110.823 177.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -132.93 125.29 29.51 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.626 178.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.572 ' CD1' ' HG2' ' A' ' 41' ' ' LYS . 12.3 m-85 -108.44 135.15 50.2 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.966 -179.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.58 HD13 ' CD1' ' A' ' 84' ' ' TYR . 6.2 mp -124.05 147.45 47.84 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.98 -178.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.652 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 31.2 t80 -128.96 128.83 44.51 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 176.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 34.7 t70 59.5 27.18 16.28 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 121.653 0.74 . . . . 0.0 110.4 179.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 78.51 17.97 76.69 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.667 178.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.652 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -130.87 151.73 50.97 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.91 178.587 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.449 ' HA ' ' HG ' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -68.06 135.64 52.55 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.807 -175.438 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 86.0 mt -88.1 117.47 31.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 177.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -107.36 153.85 22.16 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.499 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -68.98 -10.94 60.01 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.873 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -85.78 -19.01 31.38 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.036 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.442 ' CG ' HH12 ' A' ' 62' ' ' ARG . 36.9 m-20 -67.43 148.74 51.17 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -175.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.461 ' HB ' ' HD2' ' A' ' 70' ' ' PRO . 31.7 p -96.9 162.29 23.49 Favored Pre-proline 0 N--CA 1.444 -0.755 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.212 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.461 ' HD2' ' HB ' ' A' ' 69' ' ' THR . 19.2 Cg_endo -59.28 -31.51 95.25 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.519 2.146 . . . . 0.0 113.06 -178.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.564 ' HG3' ' N ' ' A' ' 72' ' ' THR . 15.2 ptmt -70.46 -38.83 74.51 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -179.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.564 ' N ' ' HG3' ' A' ' 71' ' ' LYS . 13.4 t -82.09 -29.82 31.58 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 120.971 0.415 . . . . 0.0 110.437 -177.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 96.1 mt -73.25 -22.2 60.46 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 174.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 52.91 28.75 6.87 Favored 'General case' 0 C--N 1.348 0.509 0 O-C-N 124.037 0.836 . . . . 0.0 112.5 175.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 70.8 mtm -85.23 150.36 24.85 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.113 0.483 . . . . 0.0 111.834 -176.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -151.67 -176.61 5.69 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 176.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.438 ' HA ' ' H ' ' A' ' 16' ' ' LYS . 1.3 m-20 -57.33 119.5 6.55 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -177.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.484 ' HB2' ' HE2' ' A' ' 16' ' ' LYS . 18.5 t70 63.22 35.41 12.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 113.972 -1.467 . . . . 0.0 111.082 175.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -76.78 177.66 7.44 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.269 177.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 30.9 m -108.96 138.48 35.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 CA-C-O 121.772 0.796 . . . . 0.0 112.455 -174.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.669 HD12 HG21 ' A' ' 17' ' ' ILE . 1.6 mt -132.36 134.01 59.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.974 178.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -98.18 144.28 27.8 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.245 -174.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.414 ' HB ' ' HA2' ' A' ' 21' ' ' GLY . 84.6 t -129.13 133.98 64.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.993 178.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.58 ' CD1' HD13 ' A' ' 58' ' ' LEU . 57.4 m-85 -98.13 156.71 16.54 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.288 177.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 43.6 tp60 -68.0 133.14 48.53 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.195 0.522 . . . . 0.0 111.097 -171.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.418 ' HB2' HG11 ' A' ' 50' ' ' VAL . 4.2 pm0 -65.6 158.0 28.34 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.434 -0.803 . . . . 0.0 113.12 -174.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.45 ' H ' ' HB3' ' A' ' 54' ' ' SER . 82.7 mm-40 -72.53 -48.33 41.11 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.992 -177.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.456 ' HB3' HG13 ' A' ' 50' ' ' VAL . 60.5 tp . . . . . 0 C--N 1.312 -1.046 0 CA-C-N 114.708 -1.133 . . . . 0.0 111.758 -177.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 . . . . . 0 CA--C 1.5 -0.956 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.3 pt -120.12 162.46 18.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -176.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.499 ' HD2' ' CG ' ' A' ' 78' ' ' ASP . 38.9 ttmt -101.0 143.55 31.01 Favored 'General case' 0 C--N 1.286 -2.172 0 CA-C-O 121.006 0.432 . . . . 0.0 110.733 179.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.719 HG21 HD12 ' A' ' 81' ' ' ILE . 41.7 mm -127.58 129.56 70.33 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.783 177.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.5 mtmt -100.1 104.16 15.7 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 176.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.723 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 96.7 t -82.41 118.38 30.03 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.52 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.6 t -113.76 118.25 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 CA-C-O 120.927 0.394 . . . . 0.0 109.967 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.414 ' HA2' ' HB ' ' A' ' 83' ' ' VAL . . . -90.86 175.35 40.08 Favored Glycine 0 C--N 1.314 -0.693 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.49 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.498 ' C ' ' H ' ' A' ' 24' ' ' SER . 98.8 mt-30 -64.51 -34.18 77.63 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 121.235 0.541 . . . . 0.0 110.896 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -70.0 8.69 0.68 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.956 176.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.498 ' H ' ' C ' ' A' ' 22' ' ' GLN . 49.9 m 65.96 27.88 10.68 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.859 0.838 . . . . 0.0 109.059 -176.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -87.06 104.87 16.74 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.468 -177.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.723 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 42.6 tt0 -104.61 131.88 51.51 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.588 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.4 p -138.05 137.83 44.15 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.598 179.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 37.7 m170 -97.1 111.18 23.52 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.185 0.516 . . . . 0.0 111.644 -176.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -110.57 149.59 30.16 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.818 176.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 18.4 tpt180 -103.34 121.54 42.96 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.406 HG22 HG12 ' A' ' 17' ' ' ILE . 30.9 m -134.86 174.27 13.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.35 -177.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -88.11 155.28 19.87 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -52.98 -39.0 62.69 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 175.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.52 ' CA ' ' HG3' ' A' ' 70' ' ' PRO . . . -106.86 33.2 6.59 Favored Glycine 0 C--N 1.334 0.44 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.744 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.605 HG23 ' HB2' ' A' ' 39' ' ' LYS . 0.9 OUTLIER -64.38 136.5 57.18 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-O 121.526 0.679 . . . . 0.0 112.442 179.22 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 69.6 m -85.61 155.11 21.27 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.091 -0.958 . . . . 0.0 109.875 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.498 ' HA ' HD21 ' A' ' 40' ' ' LEU . 25.7 ptt? -50.87 -30.49 14.68 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -176.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.49 -37.96 85.56 Favored 'General case' 0 C--O 1.217 -0.642 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 -178.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.605 ' HB2' HG23 ' A' ' 35' ' ' THR . 31.1 mmmt -60.6 -40.03 90.31 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.049 -176.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.498 HD21 ' HA ' ' A' ' 37' ' ' MET . 0.2 OUTLIER -86.49 -46.05 10.54 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.782 -178.465 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 46.4 mttp -62.02 -46.61 88.41 Favored 'General case' 0 C--O 1.212 -0.892 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.43 -178.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.461 ' HA ' HG22 ' A' ' 52' ' ' VAL . 25.0 ttmm -62.47 -42.53 99.55 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.079 0.466 . . . . 0.0 110.058 177.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 45.7 t -62.98 -50.07 72.2 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.289 -176.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.655 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 42.0 t80 -71.43 -43.81 66.01 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.787 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.605 ' HB1' ' O ' ' A' ' 50' ' ' VAL . . . -57.82 -33.26 68.42 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.364 0.602 . . . . 0.0 109.741 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -63.05 -47.72 81.78 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.188 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.655 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 3.5 ptm180 -68.62 -27.84 66.38 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.411 -177.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.459 HG22 ' O ' ' A' ' 44' ' ' TYR . 8.9 t -96.64 -10.77 26.33 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -177.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.56 35.26 67.75 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.248 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.625 HG13 ' HB3' ' A' ' 88' ' ' LEU . 73.7 t -119.32 149.65 21.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 C-N-CA 122.713 0.405 . . . . 0.0 110.891 -177.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.456 ' HB3' ' OG ' ' A' ' 54' ' ' SER . . . -51.81 136.19 28.33 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.347 176.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.461 HG22 ' HA ' ' A' ' 42' ' ' LYS . 76.8 t -60.9 -44.3 97.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.277 -177.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -77.14 -10.01 59.12 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.093 0.473 . . . . 0.0 110.954 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.456 ' OG ' ' HB3' ' A' ' 51' ' ' ALA . 74.9 m -87.36 -10.51 51.95 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.18 176.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -96.34 130.05 43.53 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 177.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.473 ' HD3' ' O ' ' A' ' 85' ' ' GLN . 0.0 OUTLIER -122.49 117.06 25.04 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 121.423 0.63 . . . . 0.0 111.334 -176.696 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.576 ' HZ ' ' CB ' ' A' ' 44' ' ' TYR . 32.6 m-85 -106.14 128.36 53.84 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.529 178.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.534 ' HG ' ' HA ' ' A' ' 63' ' ' ARG . 7.8 mp -121.6 136.12 54.96 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.423 179.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.587 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 83.8 t80 -105.3 116.0 31.22 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 178.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 55.44 23.18 5.59 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.848 -0.614 . . . . 0.0 112.393 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 102.06 2.29 51.68 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 121.089 -0.577 . . . . 0.0 113.514 176.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.587 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -120.29 140.93 50.5 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 117.175 0.488 . . . . 0.0 109.98 176.702 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.534 ' HA ' ' HG ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -68.44 137.56 54.58 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.282 0.563 . . . . 0.0 112.05 -175.347 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.404 HD12 ' HB3' ' A' ' 57' ' ' PHE . 87.1 mt -82.66 125.16 39.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.581 -179.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -99.21 162.94 12.77 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.495 -177.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.415 ' HB3' ' HG2' ' A' ' 37' ' ' MET . 7.1 p-10 -81.79 -6.52 59.14 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 174.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -101.65 -6.28 23.98 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.332 -178.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -62.2 148.77 43.62 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.253 0.549 . . . . 0.0 112.149 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.403 ' H ' HG22 ' A' ' 72' ' ' THR . 49.9 p -113.87 159.53 35.6 Favored Pre-proline 0 C--N 1.319 -0.749 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.531 -179.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.52 ' HG3' ' CA ' ' A' ' 34' ' ' GLY . 77.8 Cg_exo -55.33 -39.38 91.29 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.904 2.403 . . . . 0.0 112.407 -178.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.507 ' HG3' ' H ' ' A' ' 72' ' ' THR . 17.3 ptmt -69.01 -46.76 67.2 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -177.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.507 ' H ' ' HG3' ' A' ' 71' ' ' LYS . 9.0 t -67.19 -27.01 66.91 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-O 120.924 0.393 . . . . 0.0 110.875 -177.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 93.7 mt -90.95 -22.55 20.8 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.676 178.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 43.4 47.8 5.91 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.927 -177.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 74.2 mtm -85.24 161.12 19.7 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.913 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -147.65 -178.39 6.23 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.376 178.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.484 ' HA ' ' H ' ' A' ' 16' ' ' LYS . 34.3 t70 -65.42 120.1 12.22 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.028 0.442 . . . . 0.0 111.357 -178.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.499 ' CG ' ' HD2' ' A' ' 16' ' ' LYS . 3.0 m-20 74.9 33.2 0.77 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.19 1.396 . . . . 0.0 111.783 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -70.43 176.4 4.05 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 177.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.9 t -118.36 136.66 54.84 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 CA-C-O 121.431 0.634 . . . . 0.0 111.163 -174.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.719 HD12 HG21 ' A' ' 17' ' ' ILE . 1.8 mt -131.64 138.85 51.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.307 -177.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -102.85 145.47 29.74 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.255 -173.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.414 ' HB ' ' HA2' ' A' ' 21' ' ' GLY . 90.7 t -126.59 131.01 71.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.26 178.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.465 ' CE1' HD22 ' A' ' 58' ' ' LEU . 78.6 m-85 -99.72 168.56 9.84 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.684 177.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.473 ' O ' ' HD3' ' A' ' 56' ' ' ARG . 43.9 tp60 -66.88 129.9 41.39 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.394 0.616 . . . . 0.0 111.188 -170.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.473 ' HB2' HG11 ' A' ' 50' ' ' VAL . 4.1 pm0 -65.66 154.1 39.8 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.958 -1.019 . . . . 0.0 112.714 -177.079 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.425 ' HB3' ' CB ' ' A' ' 54' ' ' SER . 61.0 tp60 -72.11 -42.76 65.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.98 -176.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.625 ' HB3' HG13 ' A' ' 50' ' ' VAL . 57.1 tp . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.009 -178.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 32' ' ' LYS . 98.4 m-85 . . . . . 0 N--CA 1.435 -1.184 0 CA-C-O 121.544 0.687 . . . . 0.0 111.438 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.475 ' HA ' ' OD1' ' A' ' 77' ' ' ASP . 21.8 pt -132.21 162.6 39.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 CA-C-N 114.588 -1.187 . . . . 0.0 108.552 -178.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.468 ' H ' ' HA ' ' A' ' 77' ' ' ASP . 56.5 mtmt -92.88 147.36 22.91 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 121.059 0.457 . . . . 0.0 110.664 175.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.652 HD12 HG21 ' A' ' 31' ' ' VAL . 9.4 mt -128.34 131.75 68.79 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.449 173.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.416 ' HD3' ' OD2' ' A' ' 78' ' ' ASP . 27.4 mtmt -98.93 104.71 16.78 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 176.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.632 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 98.5 t -82.29 115.54 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.1 t -106.06 116.56 50.09 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.495 ' HA2' ' HB ' ' A' ' 83' ' ' VAL . . . -85.16 174.3 49.13 Favored Glycine 0 C--N 1.309 -0.951 0 C-N-CA 120.191 -1.004 . . . . 0.0 112.0 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.425 ' HG3' ' O ' ' A' ' 83' ' ' VAL . 98.3 mt-30 -70.11 -21.88 63.07 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-O 121.447 0.641 . . . . 0.0 110.371 178.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -74.62 0.78 13.91 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.28 174.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.6 t 69.32 26.63 5.28 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -176.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -90.86 106.74 18.73 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-N 114.687 -1.142 . . . . 0.0 110.281 -179.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.632 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 29.4 tt0 -98.83 125.99 44.35 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.453 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.1 p -129.5 139.94 50.39 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.887 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 60.6 m170 -97.67 115.75 28.54 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.441 -175.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -111.55 148.39 33.36 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.706 175.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 26.2 tpt180 -99.22 120.27 39.25 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.652 HG21 HD12 ' A' ' 17' ' ' ILE . 33.0 m -135.86 172.45 15.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.537 -176.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 14' ' ' TYR . 36.9 tttm -90.38 160.76 15.92 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -54.21 -38.42 65.65 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-O 120.996 0.427 . . . . 0.0 110.275 175.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.65 ' CA ' ' HG3' ' A' ' 70' ' ' PRO . . . -98.82 25.88 26.36 Favored Glycine 0 CA--C 1.492 -1.389 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.858 -178.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.756 HG23 ' HB2' ' A' ' 39' ' ' LYS . 1.1 m -68.48 124.7 24.27 Favored 'General case' 0 N--CA 1.41 -2.457 0 CA-C-O 121.673 0.749 . . . . 0.0 111.773 178.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.583 ' HB3' ' HA ' ' A' ' 66' ' ' ASP . 41.2 m -91.82 167.53 12.08 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 114.482 -1.235 . . . . 0.0 109.537 178.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.456 ' HB2' ' CD ' ' A' ' 41' ' ' LYS . 25.2 ptt? -47.32 -39.32 14.53 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -175.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.84 -37.33 81.7 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -175.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.756 ' HB2' HG23 ' A' ' 35' ' ' THR . 29.9 mmmt -60.47 -41.64 94.61 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.273 -176.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.543 HD23 ' H ' ' A' ' 40' ' ' LEU . 0.5 OUTLIER -88.95 -44.08 10.69 Favored 'General case' 0 C--O 1.22 -0.489 0 N-CA-C 112.438 0.532 . . . . 0.0 112.438 -178.964 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.629 ' HE3' ' O ' ' A' ' 55' ' ' LEU . 60.8 mtpt -61.74 -46.79 88.09 Favored 'General case' 0 CA--C 1.488 -1.439 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.798 -176.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.496 ' HA ' HG22 ' A' ' 52' ' ' VAL . 39.0 ttpt -62.12 -40.8 97.14 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 66.6 m -65.59 -49.05 70.22 Favored 'General case' 0 CA--C 1.552 1.021 0 CA-C-N 115.215 -0.902 . . . . 0.0 112.407 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.649 ' O ' ' HG3' ' A' ' 47' ' ' ARG . 59.7 t80 -71.08 -45.13 64.32 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.949 -179.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.635 ' HB1' ' O ' ' A' ' 50' ' ' VAL . . . -58.48 -34.19 70.63 Favored 'General case' 0 CA--C 1.501 -0.914 0 CA-C-O 121.443 0.639 . . . . 0.0 109.585 -178.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -63.08 -48.14 79.92 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.046 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.649 ' HG3' ' O ' ' A' ' 44' ' ' TYR . 0.0 OUTLIER -69.25 -22.66 63.83 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.967 -0.56 . . . . 0.0 112.19 -176.324 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.466 HG22 ' O ' ' A' ' 44' ' ' TYR . 8.8 t -103.3 -7.27 21.24 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.909 0.385 . . . . 0.0 111.939 -177.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.25 31.99 65.75 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.544 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.635 ' O ' ' HB1' ' A' ' 45' ' ' ALA . 80.6 t -113.53 147.29 17.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 C-N-CA 122.886 0.474 . . . . 0.0 110.343 -178.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.588 ' HB3' ' OG ' ' A' ' 54' ' ' SER . . . -56.49 136.52 54.09 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.316 -0.402 . . . . 0.0 109.995 176.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.496 HG22 ' HA ' ' A' ' 42' ' ' LYS . 73.1 t -62.12 -44.4 98.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.469 -176.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -69.29 -31.42 69.9 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.522 -177.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.588 ' OG ' ' HB3' ' A' ' 51' ' ' ALA . 89.8 p -87.42 2.82 49.35 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 120.664 -0.414 . . . . 0.0 111.481 -179.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.713 HD22 ' HG2' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -94.83 121.73 36.72 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 174.147 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -117.15 117.89 30.83 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 119.875 -0.73 . . . . 0.0 112.343 -173.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.517 ' CD1' ' HG2' ' A' ' 41' ' ' LYS . 45.7 m-85 -108.91 130.03 55.43 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.595 176.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.575 HD13 ' CD1' ' A' ' 84' ' ' TYR . 8.0 mp -122.61 144.65 48.98 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 121.466 0.65 . . . . 0.0 111.226 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.676 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 64.5 t80 -118.37 115.1 23.99 Favored 'General case' 0 N--CA 1.426 -1.674 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.081 178.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 53.38 29.15 8.31 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.426 -178.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 96.01 -1.55 63.17 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.958 -0.564 . . . . 0.0 113.435 176.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.676 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -113.62 136.44 52.82 Favored 'General case' 0 CA--C 1.491 -1.326 0 CA-C-O 121.289 0.566 . . . . 0.0 109.672 177.5 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.508 ' HA ' ' HG ' ' A' ' 58' ' ' LEU . 30.1 ptt180 -72.38 133.74 45.08 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.168 -177.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.503 HD11 HD12 ' A' ' 81' ' ' ILE . 68.7 mt -75.61 132.83 32.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 CA-C-N 114.462 -1.244 . . . . 0.0 108.856 -178.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -109.57 169.82 8.46 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.09 0.471 . . . . 0.0 110.758 -175.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.583 ' HA ' ' HB3' ' A' ' 36' ' ' SER . 7.2 p-10 -82.9 -6.33 59.41 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.159 0.504 . . . . 0.0 109.667 175.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -101.3 -16.63 16.88 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.419 -0.809 . . . . 0.0 113.157 -175.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.6 p30 -68.78 161.57 28.18 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -175.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.454 ' HB ' ' HD2' ' A' ' 70' ' ' PRO . 72.0 p -129.9 166.72 24.19 Favored Pre-proline 0 CA--C 1.548 0.901 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.415 -174.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.65 ' HG3' ' CA ' ' A' ' 34' ' ' GLY . 57.2 Cg_exo -54.46 -39.91 85.71 Favored 'Trans proline' 0 C--N 1.369 1.623 0 C-N-CA 123.108 2.539 . . . . 0.0 113.318 -176.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.509 ' HD3' ' N ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -70.27 -23.77 62.94 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 -176.175 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.509 ' N ' ' HD3' ' A' ' 71' ' ' LYS . 5.1 t -95.34 -25.42 16.31 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.194 0.521 . . . . 0.0 110.117 -177.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.471 ' HB3' ' HG3' ' A' ' 75' ' ' MET . 92.7 mt -89.79 -24.34 21.49 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.936 178.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 46.5 30.96 1.19 Allowed 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.555 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.471 ' HG3' ' HB3' ' A' ' 73' ' ' LEU . 66.7 mtt -79.03 153.0 30.58 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.006 -179.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -150.54 -174.81 4.87 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.475 ' OD1' ' HA ' ' A' ' 15' ' ' ILE . 20.0 m-20 -55.0 126.1 23.16 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 -177.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.442 ' HB2' ' HE3' ' A' ' 16' ' ' LYS . 9.0 t70 67.21 35.42 4.47 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 113.882 -1.508 . . . . 0.0 111.489 173.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -70.63 176.38 4.19 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.845 177.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 30.7 m -110.11 136.52 45.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-O 121.588 0.708 . . . . 0.0 111.858 -175.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.503 HD12 HD11 ' A' ' 64' ' ' ILE . 10.8 mm -131.99 137.61 54.42 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.09 -178.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -107.33 142.75 36.63 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.361 -177.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.495 ' HB ' ' HA2' ' A' ' 21' ' ' GLY . 93.4 t -124.55 133.5 69.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-O 121.009 0.433 . . . . 0.0 111.29 178.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.575 ' CD1' HD13 ' A' ' 58' ' ' LEU . 46.7 m-85 -100.23 167.69 10.27 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.492 178.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -67.85 124.65 23.92 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.496 0.665 . . . . 0.0 110.691 -173.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.713 ' HG2' HD22 ' A' ' 55' ' ' LEU . 2.2 mp0 -82.59 162.02 22.07 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.6 -177.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -69.03 -40.09 78.82 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.105 177.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.532 ' HB2' HG13 ' A' ' 50' ' ' VAL . 10.9 mp . . . . . 0 C--N 1.332 -0.169 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.713 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 . . . . . 0 N--CA 1.45 -0.437 0 CA-C-O 121.19 0.519 . . . . 0.0 111.689 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.499 ' O ' ' HD2' ' A' ' 30' ' ' ARG . 23.7 pt -122.45 163.14 21.32 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.414 -176.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.434 ' HZ2' ' CG ' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -91.53 144.93 25.04 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.253 178.042 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.52 HD12 HG21 ' A' ' 31' ' ' VAL . 67.8 mt -139.12 133.9 40.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-O 120.87 0.367 . . . . 0.0 111.32 172.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 18.4 mtmt -96.43 106.15 18.34 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.647 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 81.1 t -81.25 116.76 26.1 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 176.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 59.9 t -112.63 117.76 56.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 120.929 0.395 . . . . 0.0 110.095 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.529 ' HA2' ' HB ' ' A' ' 83' ' ' VAL . . . -92.25 171.24 33.66 Favored Glycine 0 C--N 1.314 -0.665 0 C-N-CA 120.434 -0.888 . . . . 0.0 112.588 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.437 ' C ' ' H ' ' A' ' 24' ' ' SER . 97.7 mt-30 -66.45 -27.45 67.82 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 121.232 0.539 . . . . 0.0 110.674 179.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -69.86 4.17 2.17 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.917 175.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.437 ' H ' ' C ' ' A' ' 22' ' ' GLN . 50.9 m 67.54 27.79 7.76 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.878 0.847 . . . . 0.0 109.12 -176.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -91.95 104.83 17.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-N 114.576 -1.193 . . . . 0.0 110.952 -178.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.647 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 30.6 tt0 -100.73 129.53 46.64 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.851 176.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.411 ' CG1' ' HB ' ' A' ' 19' ' ' VAL . 7.5 p -133.26 140.18 47.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.041 179.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 51.4 m170 -94.73 112.87 24.59 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.164 -176.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -110.64 147.36 34.44 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.425 177.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.499 ' HD2' ' O ' ' A' ' 15' ' ' ILE . 12.4 tpt180 -105.17 116.0 31.21 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 175.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.52 HG21 HD12 ' A' ' 17' ' ' ILE . 35.3 m -137.86 172.72 13.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.918 -176.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -89.33 159.92 17.13 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 -177.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -55.04 -38.3 67.79 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.073 0.463 . . . . 0.0 109.753 173.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -100.04 25.92 26.44 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.767 -177.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.594 HG23 ' HB2' ' A' ' 39' ' ' LYS . 1.2 m -71.39 128.44 35.87 Favored 'General case' 0 N--CA 1.425 -1.682 0 CA-C-O 121.529 0.681 . . . . 0.0 112.418 179.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.535 ' HB3' ' HA ' ' A' ' 66' ' ' ASP . 66.9 m -93.11 164.15 13.37 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 114.759 -1.11 . . . . 0.0 111.045 -179.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.541 ' SD ' ' HA ' ' A' ' 65' ' ' ASN . 24.3 ptt? -47.14 -39.21 13.09 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -174.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.76 -37.18 80.94 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -175.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.594 ' HB2' HG23 ' A' ' 35' ' ' THR . 75.8 mmtt -61.1 -40.51 94.03 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.52 -176.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.559 HD12 ' CD2' ' A' ' 57' ' ' PHE . 0.3 OUTLIER -88.06 -44.49 10.92 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.376 -178.618 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.546 ' HG2' ' CD1' ' A' ' 57' ' ' PHE . 61.6 mtpt -62.87 -45.3 93.22 Favored 'General case' 0 CA--C 1.489 -1.376 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.71 -176.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.407 ' O ' ' HB2' ' A' ' 46' ' ' ASP . 24.4 ttmm -61.22 -43.3 99.1 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 176.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 44.5 t -65.78 -51.44 59.11 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.426 -0.806 . . . . 0.0 112.1 -176.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.521 ' O ' HG22 ' A' ' 48' ' ' THR . 41.9 t80 -66.85 -46.57 74.65 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 120.769 0.319 . . . . 0.0 111.488 -179.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.57 -35.08 75.19 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.413 0.625 . . . . 0.0 109.883 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' A' ' 42' ' ' LYS . 32.3 t70 -64.5 -47.37 79.16 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.343 -178.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.518 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 15.4 ptm180 -65.72 -28.5 69.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.539 -177.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.521 HG22 ' O ' ' A' ' 44' ' ' TYR . 7.0 t -93.57 -8.24 41.83 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.234 -179.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.12 30.99 69.33 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.941 -0.647 . . . . 0.0 113.12 178.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.412 HG12 HG23 ' A' ' 48' ' ' THR . 2.5 p -115.09 169.28 6.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -178.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.428 ' HB3' ' HB3' ' A' ' 54' ' ' SER . . . -60.41 136.81 58.16 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.775 0.321 . . . . 0.0 110.666 178.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 79.7 t -61.96 -44.24 98.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-O 121.396 0.617 . . . . 0.0 109.857 179.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -71.33 -21.74 62.01 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.827 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.509 ' HB2' ' HB3' ' A' ' 87' ' ' GLN . 85.2 p -75.75 -12.59 60.21 Favored 'General case' 0 CA--C 1.52 -0.189 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.533 179.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.532 HD12 ' CE1' ' A' ' 57' ' ' PHE . 0.1 OUTLIER -94.45 132.72 38.8 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 177.469 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.72 120.11 25.85 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.125 0.488 . . . . 0.0 110.524 -179.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.559 ' CD2' HD12 ' A' ' 40' ' ' LEU . 32.9 m-85 -110.29 134.3 52.4 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.46 -179.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.534 HD13 ' CD1' ' A' ' 84' ' ' TYR . 7.1 mp -126.75 145.54 50.57 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.906 178.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.785 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 89.2 t80 -117.41 118.32 31.9 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 176.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 30.8 t70 54.05 29.74 10.73 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.738 0.78 . . . . 0.0 111.56 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 90.26 6.08 69.23 Favored Glycine 0 C--N 1.313 -0.741 0 CA-C-N 115.612 -0.722 . . . . 0.0 113.539 176.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.785 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -116.9 143.88 45.18 Favored 'General case' 0 CA--C 1.503 -0.838 0 CA-C-O 121.12 0.486 . . . . 0.0 109.752 177.102 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.491 ' HA ' ' HG ' ' A' ' 58' ' ' LEU . 34.6 mtp-105 -73.14 128.47 35.57 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.001 -175.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 74.6 mt -79.61 129.57 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 177.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.541 ' HA ' ' SD ' ' A' ' 37' ' ' MET . 93.7 m-20 -125.23 176.62 6.62 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 121.169 0.509 . . . . 0.0 111.443 -173.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.535 ' HA ' ' HB3' ' A' ' 36' ' ' SER . 8.9 p-10 -82.98 -6.58 59.54 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.571 177.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -102.16 -13.22 17.54 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.314 -176.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.444 ' HB3' HH22 ' A' ' 62' ' ' ARG . 20.2 p30 -70.97 165.29 23.73 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -176.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.474 ' O ' HG22 ' A' ' 72' ' ' THR . 42.5 p -123.56 159.63 54.47 Favored Pre-proline 0 N--CA 1.443 -0.78 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.056 -175.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.47 ' HD2' ' HB ' ' A' ' 69' ' ' THR . 19.3 Cg_endo -58.61 -31.15 94.04 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.927 2.418 . . . . 0.0 114.097 -176.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.68 -28.55 36.74 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 119.586 -0.845 . . . . 0.0 111.87 -177.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.474 HG22 ' O ' ' A' ' 69' ' ' THR . 12.1 t -79.24 -30.78 43.35 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 120.071 -0.652 . . . . 0.0 109.308 178.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.432 ' HB3' ' HG3' ' A' ' 75' ' ' MET . 94.9 mt -76.65 -23.16 53.3 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.262 175.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 46.21 34.24 2.08 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.119 177.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.432 ' HG3' ' HB3' ' A' ' 73' ' ' LEU . 61.6 mtt -72.36 154.11 41.1 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.774 -177.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -151.13 175.22 12.34 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.434 ' CG ' ' HZ2' ' A' ' 16' ' ' LYS . 38.7 t70 -58.7 122.07 12.61 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.801 0.81 . . . . 0.0 112.76 -177.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.6 t70 66.45 34.74 6.01 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 113.788 -1.551 . . . . 0.0 111.701 177.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -74.8 178.45 5.48 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 175.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 36.0 m -117.26 147.77 20.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 CA-C-O 121.763 0.792 . . . . 0.0 112.87 -175.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.498 HD12 HG21 ' A' ' 17' ' ' ILE . 7.6 mt -128.73 138.25 55.1 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-N 114.318 -1.31 . . . . 0.0 110.164 178.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -104.52 140.45 37.96 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.813 0.34 . . . . 0.0 110.613 -176.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.529 ' HB ' ' HA2' ' A' ' 21' ' ' GLY . 98.4 t -126.42 134.37 66.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-O 121.221 0.534 . . . . 0.0 111.938 -178.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.534 ' CD1' HD13 ' A' ' 58' ' ' LEU . 78.3 m-85 -99.38 168.69 9.84 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.739 177.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -66.4 133.01 49.59 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.367 0.603 . . . . 0.0 111.499 -172.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -61.68 151.89 32.44 Favored 'General case' 0 CA--C 1.497 -1.079 0 CA-C-N 115.125 -0.943 . . . . 0.0 112.021 -177.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.509 ' HB3' ' HB2' ' A' ' 54' ' ' SER . 60.5 tp60 -69.19 -40.06 78.29 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.533 179.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.0 mm? . . . . . 0 C--O 1.226 -0.184 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.212 -179.115 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 . . . . . 0 N--CA 1.439 -0.997 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.5 pt -114.98 161.44 13.73 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -176.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.403 ' H ' ' HA ' ' A' ' 77' ' ' ASP . 23.0 ttmm -103.61 142.82 33.64 Favored 'General case' 0 C--N 1.282 -2.326 0 C-N-CA 120.572 -0.451 . . . . 0.0 109.958 179.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.629 HG21 HD12 ' A' ' 81' ' ' ILE . 41.0 mm -123.59 127.99 74.32 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.169 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.799 177.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.1 mtmt -101.6 103.69 14.52 Favored 'General case' 0 N--CA 1.423 -1.802 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 177.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.776 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 91.3 t -81.69 121.98 35.9 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.87 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 62.0 t -109.99 121.48 62.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.16 0.505 . . . . 0.0 110.285 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -90.97 -174.11 43.94 Favored Glycine 0 CA--C 1.52 0.371 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.937 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -63.75 -38.59 91.68 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -177.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.614 ' HB2' ' OD1' ' A' ' 25' ' ' ASN . 16.0 m-20 -87.33 22.06 2.26 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 178.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 48.9 m 65.35 31.76 10.23 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.863 -178.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.614 ' OD1' ' HB2' ' A' ' 23' ' ' ASP . 14.9 m120 -78.67 106.74 10.86 Favored 'General case' 0 CA--C 1.501 -0.924 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.755 -178.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.776 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 36.6 tt0 -103.08 134.63 46.18 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-O 121.195 0.521 . . . . 0.0 111.279 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.7 p -136.12 141.92 40.2 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.198 178.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 35.6 m170 -101.69 115.14 29.86 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.264 0.554 . . . . 0.0 111.817 -176.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -115.51 148.07 39.92 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.37 175.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 21.4 tpp180 -103.11 120.56 40.91 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 177.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.424 HG22 HG12 ' A' ' 17' ' ' ILE . 32.5 m -134.58 172.22 16.5 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.449 -178.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -89.99 162.56 15.32 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.411 ' C ' ' HB3' ' A' ' 70' ' ' PRO . 83.3 m-85 -56.37 -39.85 73.59 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 175.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -101.22 33.06 6.77 Favored Glycine 0 N--CA 1.446 -0.651 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.388 -179.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.508 HG23 ' HB2' ' A' ' 39' ' ' LYS . 0.9 OUTLIER -68.75 133.42 48.35 Favored 'General case' 0 N--CA 1.428 -1.537 0 CA-C-O 121.47 0.652 . . . . 0.0 111.953 177.908 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.459 ' OG ' ' HG2' ' A' ' 39' ' ' LYS . 86.7 p -78.44 161.6 26.99 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.293 -179.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.638 ' SD ' ' HA ' ' A' ' 65' ' ' ASN . 26.2 ptt? -59.61 -32.29 70.27 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.898 0.38 . . . . 0.0 111.004 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.17 -36.87 83.19 Favored 'General case' 0 C--O 1.219 -0.537 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.628 -177.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.508 ' HB2' HG23 ' A' ' 35' ' ' THR . 32.4 mmmt -59.97 -40.86 90.56 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.609 -175.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.513 HD23 ' H ' ' A' ' 40' ' ' LEU . 0.4 OUTLIER -87.82 -45.87 9.93 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -179.534 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -62.65 -45.32 93.36 Favored 'General case' 0 CA--C 1.501 -0.93 0 N-CA-C 111.798 0.295 . . . . 0.0 111.798 -176.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.531 ' O ' ' HB2' ' A' ' 46' ' ' ASP . 40.0 ttpt -61.95 -42.12 98.75 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.614 176.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.448 ' O ' ' HB3' ' A' ' 46' ' ' ASP . 38.2 t -68.75 -51.17 44.13 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.286 -176.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.487 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 48.7 t80 -68.3 -48.01 66.1 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.9 -178.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.21 -29.34 68.67 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 121.631 0.729 . . . . 0.0 109.679 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.531 ' HB2' ' O ' ' A' ' 42' ' ' LYS . 22.2 t70 -63.16 -46.74 85.76 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.749 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.487 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 25.9 ptt180 -69.09 -30.47 68.79 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.008 0.432 . . . . 0.0 110.926 -175.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.595 HG23 HG12 ' A' ' 50' ' ' VAL . 4.8 t -92.46 -21.53 20.11 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.83 -175.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.3 23.32 57.08 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.39 -0.909 . . . . 0.0 112.985 179.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.72 HG11 HD23 ' A' ' 55' ' ' LEU . 7.8 p -98.74 158.94 3.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.002 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.543 ' HB3' ' OG ' ' A' ' 54' ' ' SER . . . -59.96 132.72 54.83 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 177.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 71.1 t -61.3 -44.19 97.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.158 0.504 . . . . 0.0 110.598 -178.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -66.63 -32.92 74.55 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.015 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.543 ' OG ' ' HB3' ' A' ' 51' ' ' ALA . 83.1 p -76.25 -13.21 60.17 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.302 -0.408 . . . . 0.0 112.066 -178.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.72 HD23 HG11 ' A' ' 50' ' ' VAL . 0.6 OUTLIER -95.56 128.5 42.47 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -178.196 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -121.82 126.86 49.74 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.906 -175.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.546 ' CE1' HD12 ' A' ' 55' ' ' LEU . 65.8 m-85 -106.14 129.83 54.14 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.094 173.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.514 ' HG ' ' HA ' ' A' ' 63' ' ' ARG . 8.1 mp -126.47 147.24 49.85 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 121.21 0.529 . . . . 0.0 111.103 -179.169 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.75 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 45.1 t80 -118.06 114.39 23.05 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 55.89 29.7 14.62 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.097 0.475 . . . . 0.0 112.258 -177.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 92.35 6.78 64.22 Favored Glycine 0 C--N 1.313 -0.717 0 C-N-CA 120.902 -0.666 . . . . 0.0 113.776 175.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.75 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.1 OUTLIER -120.84 136.6 54.87 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 117.204 0.502 . . . . 0.0 109.677 176.708 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.514 ' HA ' ' HG ' ' A' ' 58' ' ' LEU . 5.7 ptm180 -66.92 141.84 57.49 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.309 -0.86 . . . . 0.0 112.542 -175.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 77.7 mt -95.28 120.52 44.8 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.228 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.638 ' HA ' ' SD ' ' A' ' 37' ' ' MET . 21.3 m120 -119.56 164.75 15.37 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.065 0.459 . . . . 0.0 111.376 -178.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -70.66 -12.19 61.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.797 179.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -81.51 -21.01 38.91 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.083 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.458 ' CG ' HH12 ' A' ' 62' ' ' ARG . 66.0 m-20 -74.78 143.54 43.97 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -175.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.447 ' HB ' ' HD2' ' A' ' 70' ' ' PRO . 82.8 p -91.55 161.4 34.41 Favored Pre-proline 0 C--N 1.318 -0.792 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.872 177.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.447 ' HD2' ' HB ' ' A' ' 69' ' ' THR . 19.1 Cg_endo -60.04 -26.69 83.12 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.485 2.124 . . . . 0.0 111.766 177.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.07 -40.44 38.53 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.206 -177.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.1 t -75.83 -31.34 59.31 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.676 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.405 ' HB3' ' HE3' ' A' ' 75' ' ' MET . 97.4 mt -71.98 -25.52 61.88 Favored 'General case' 0 C--O 1.213 -0.837 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.36 177.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 52.19 24.2 2.68 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 123.58 0.752 . . . . 0.0 112.926 174.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.405 ' HE3' ' HB3' ' A' ' 73' ' ' LEU . 23.4 ptp -79.62 161.1 26.1 Favored 'General case' 0 C--N 1.321 -0.643 0 O-C-N 122.123 -0.36 . . . . 0.0 110.982 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -143.74 -178.9 6.14 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -178.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.403 ' HA ' ' H ' ' A' ' 16' ' ' LYS . 34.2 t70 -66.46 118.51 10.19 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.304 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 17.9 t70 71.27 33.54 1.95 Allowed 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.715 1.206 . . . . 0.0 110.475 178.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -84.02 177.36 8.3 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 176.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.5 m -110.47 149.27 13.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 CA-C-O 121.539 0.685 . . . . 0.0 111.836 -174.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.629 HD12 HG21 ' A' ' 17' ' ' ILE . 1.0 OUTLIER -137.61 138.93 44.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 CA-C-N 114.763 -1.108 . . . . 0.0 109.905 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -100.24 146.18 27.2 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.993 0.425 . . . . 0.0 111.499 -174.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 84.0 t -118.62 129.22 75.18 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.252 175.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.503 ' CE1' HD22 ' A' ' 58' ' ' LEU . 60.2 m-85 -100.55 169.42 9.07 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.224 177.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -67.36 148.81 51.14 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.439 0.637 . . . . 0.0 111.536 -173.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.549 ' HG3' HG21 ' A' ' 50' ' ' VAL . 0.7 OUTLIER -94.55 157.1 16.14 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 114.82 -1.082 . . . . 0.0 112.335 -175.052 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.537 ' H ' ' HB2' ' A' ' 54' ' ' SER . 53.1 tt0 -66.19 -41.78 89.78 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.112 178.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.41 ' HB3' HG23 ' A' ' 50' ' ' VAL . 58.8 tp . . . . . 0 C--N 1.328 -0.333 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 178.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 . . . . . 0 N--CA 1.443 -0.797 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.424 ' O ' ' HD3' ' A' ' 30' ' ' ARG . 4.3 pt -109.06 161.07 7.58 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -176.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.559 ' HE3' ' OD1' ' A' ' 78' ' ' ASP . 34.3 ttpt -109.82 144.69 37.9 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 -177.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.761 HG21 HD12 ' A' ' 81' ' ' ILE . 82.4 mt -130.29 133.04 64.61 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.183 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.395 178.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.0 mtmt -96.33 105.56 17.65 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 175.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.739 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 88.1 t -81.33 117.58 27.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.4 t -112.94 120.02 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 O-C-N 123.504 0.503 . . . . 0.0 109.769 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.405 ' HA2' ' HB ' ' A' ' 83' ' ' VAL . . . -86.42 -175.45 49.63 Favored Glycine 0 C--N 1.311 -0.821 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.746 -179.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -62.68 -37.58 87.0 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -178.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -88.9 22.57 2.65 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 178.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 54.6 m 64.16 38.53 8.19 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.942 -178.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -79.91 102.34 9.11 Favored 'General case' 0 C--O 1.215 -0.739 0 CA-C-N 115.0 -1.0 . . . . 0.0 108.974 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.739 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 27.7 tt0 -104.35 128.41 52.18 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 120.986 0.422 . . . . 0.0 112.107 -176.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.6 p -141.65 144.07 26.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.283 177.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 61.0 m170 -91.43 117.64 29.86 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -178.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -111.76 144.95 40.21 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.859 172.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.424 ' HD3' ' O ' ' A' ' 15' ' ' ILE . 15.1 tpp180 -108.8 119.88 40.84 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 33.6 m -138.13 174.77 10.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.606 -178.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.513 ' O ' ' HB ' ' A' ' 35' ' ' THR . 36.1 ttpt -88.29 160.4 17.67 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.267 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.641 ' O ' ' HB3' ' A' ' 70' ' ' PRO . 96.7 m-85 -57.18 -44.11 83.27 Favored 'General case' 0 C--O 1.224 -0.244 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 176.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -93.18 21.04 42.37 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.464 -177.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.513 ' HB ' ' O ' ' A' ' 32' ' ' LYS . 0.9 OUTLIER -60.27 139.6 57.52 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-O 121.637 0.732 . . . . 0.0 112.154 179.363 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.9 m -91.35 158.42 16.55 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.433 178.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.405 ' HG2' ' HB3' ' A' ' 66' ' ' ASP . 25.3 ptt? -52.16 -33.35 39.98 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -176.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.42 -35.97 79.03 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -177.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.505 ' HB2' HG23 ' A' ' 35' ' ' THR . 75.1 mmtt -59.15 -41.3 88.01 Favored 'General case' 0 C--O 1.215 -0.749 0 CA-C-O 120.846 0.355 . . . . 0.0 110.691 -175.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.519 HD23 ' H ' ' A' ' 40' ' ' LEU . 0.4 OUTLIER -88.56 -44.19 10.84 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -179.575 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.624 ' HE3' ' O ' ' A' ' 55' ' ' LEU . 61.6 mtpt -62.52 -45.33 93.47 Favored 'General case' 0 CA--C 1.492 -1.279 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.803 -176.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.502 ' HA ' HG22 ' A' ' 52' ' ' VAL . 40.4 ttmt -61.2 -43.58 98.65 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 176.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 58.0 m -62.84 -49.19 75.88 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.309 -176.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.479 ' CB ' ' HZ ' ' A' ' 57' ' ' PHE . 47.7 t80 -71.54 -45.93 60.97 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.735 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.532 ' HB1' ' O ' ' A' ' 50' ' ' VAL . . . -59.0 -33.36 70.62 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 121.301 0.572 . . . . 0.0 109.845 -178.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -63.02 -46.46 87.48 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.415 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 -70.84 -24.78 62.6 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.902 0.382 . . . . 0.0 111.616 -177.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.429 HG22 ' O ' ' A' ' 44' ' ' TYR . 9.9 t -97.29 -5.31 36.99 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.788 -178.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 68.52 30.56 73.13 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.312 178.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.712 HG11 ' HG3' ' A' ' 86' ' ' GLU . 70.6 t -112.81 146.93 16.87 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 C-N-CA 122.628 0.371 . . . . 0.0 110.392 -178.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.561 ' H ' HD12 ' A' ' 88' ' ' LEU . . . -54.47 133.08 45.77 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.974 177.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.502 HG22 ' HA ' ' A' ' 42' ' ' LYS . 72.7 t -61.6 -42.86 95.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.991 -176.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 32.4 p-10 -73.73 -16.77 61.17 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.675 -177.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.547 ' HB2' ' HB3' ' A' ' 87' ' ' GLN . 96.8 p -93.82 -5.8 47.32 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.846 -0.342 . . . . 0.0 111.442 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.624 ' O ' ' HE3' ' A' ' 41' ' ' LYS . 0.1 OUTLIER -94.47 135.18 36.2 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.687 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.479 ' N ' ' HD2' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -130.36 126.61 37.55 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 120.002 -0.679 . . . . 0.0 111.849 -175.844 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.498 ' CE1' HD12 ' A' ' 55' ' ' LEU . 36.4 m-85 -110.27 133.14 53.54 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.39 177.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.518 HD22 ' CE1' ' A' ' 84' ' ' TYR . 9.8 mp -122.52 146.05 47.76 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.123 0.487 . . . . 0.0 111.113 -179.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.72 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 74.0 t80 -118.74 117.54 29.18 Favored 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 175.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 33.9 t70 58.17 28.3 16.3 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.741 0.781 . . . . 0.0 111.225 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 92.39 5.17 65.54 Favored Glycine 0 C--N 1.315 -0.585 0 CA-C-N 115.382 -0.826 . . . . 0.0 113.721 177.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.72 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.2 OUTLIER -122.37 134.47 54.63 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.313 0.578 . . . . 0.0 109.888 177.716 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.487 ' HA ' ' HG ' ' A' ' 58' ' ' LEU . 28.8 ptt180 -66.16 139.84 58.16 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 115.206 -0.906 . . . . 0.0 112.63 -175.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 76.5 mt -89.48 118.05 34.0 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.977 -178.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -105.71 159.85 15.67 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.514 -178.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.405 ' HB3' ' HG2' ' A' ' 37' ' ' MET . 6.9 p-10 -73.97 -14.47 61.04 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.244 0.545 . . . . 0.0 109.731 177.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -81.72 -19.16 42.06 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.78 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -72.88 147.47 45.32 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.197 0.522 . . . . 0.0 111.863 -178.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.431 ' HB ' ' HD2' ' A' ' 70' ' ' PRO . 23.3 p -97.12 160.74 28.3 Favored Pre-proline 0 N--CA 1.439 -1.013 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.545 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.641 ' HB3' ' O ' ' A' ' 33' ' ' TYR . 14.3 Cg_endo -58.21 -32.9 96.87 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.566 2.177 . . . . 0.0 112.535 -178.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.598 ' HG3' ' N ' ' A' ' 72' ' ' THR . 19.8 ptmt -69.0 -43.47 74.77 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.956 -0.565 . . . . 0.0 112.334 -179.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.598 ' N ' ' HG3' ' A' ' 71' ' ' LYS . 12.5 t -76.08 -28.75 57.71 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-O 121.248 0.547 . . . . 0.0 109.667 -178.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 96.1 mt -75.58 -21.59 57.71 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.681 175.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.519 ' HG2' ' O ' ' A' ' 71' ' ' LYS . 8.7 mm-40 52.4 34.03 14.25 Favored 'General case' 0 C--N 1.348 0.524 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 175.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 67.8 mtm -88.34 155.47 19.69 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 120.984 0.421 . . . . 0.0 111.526 -178.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -153.16 -175.19 5.23 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 177.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.444 ' HA ' ' H ' ' A' ' 16' ' ' LYS . 3.5 p-10 -63.85 125.25 23.76 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.758 0.79 . . . . 0.0 112.366 -176.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.559 ' OD1' ' HE3' ' A' ' 16' ' ' LYS . 24.2 t70 64.24 33.39 11.68 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.005 -1.452 . . . . 0.0 110.98 177.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -78.06 177.31 8.42 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.3 m -108.83 144.72 16.75 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 CA-C-O 121.547 0.689 . . . . 0.0 111.948 -174.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.761 HD12 HG21 ' A' ' 17' ' ' ILE . 1.2 mt -137.98 140.76 40.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.27 179.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -102.72 146.02 28.84 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.309 -175.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.405 ' HB ' ' HA2' ' A' ' 21' ' ' GLY . 97.4 t -126.44 132.37 70.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 121.081 0.467 . . . . 0.0 110.996 177.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.518 ' CE1' HD22 ' A' ' 58' ' ' LEU . 79.3 m-85 -108.47 168.75 9.1 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.452 178.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -68.05 141.66 56.11 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.7 0.762 . . . . 0.0 111.697 -173.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.712 ' HG3' HG11 ' A' ' 50' ' ' VAL . 0.5 OUTLIER -104.24 167.16 9.93 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 114.389 -1.278 . . . . 0.0 112.474 -172.621 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.547 ' HB3' ' HB2' ' A' ' 54' ' ' SER . 64.6 tt0 -64.14 -47.65 79.1 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.003 -177.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.561 HD12 ' H ' ' A' ' 51' ' ' ALA . 92.0 mt . . . . . 0 C--N 1.317 -0.813 0 CA-C-N 116.165 -0.47 . . . . 0.0 112.24 -177.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 . . . . . 0 CA--C 1.514 -0.424 0 CA-C-O 121.309 0.576 . . . . 0.0 111.1 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.2 pt -129.08 162.25 36.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.127 -177.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.539 ' HE3' ' HB2' ' A' ' 78' ' ' ASP . 55.7 mtmt -98.7 147.42 24.87 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-O 121.0 0.429 . . . . 0.0 110.308 176.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.56 HD12 HG21 ' A' ' 31' ' ' VAL . 61.3 mt -130.76 128.82 63.45 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.099 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.604 174.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.3 mtmt -95.61 104.45 16.36 Favored 'General case' 0 N--CA 1.426 -1.639 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 176.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.673 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 85.8 t -82.38 110.97 18.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.467 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 5.5 p -121.66 121.68 65.04 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 CA-C-O 121.783 0.802 . . . . 0.0 111.385 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.48 ' HA2' ' HB ' ' A' ' 83' ' ' VAL . . . -91.26 169.03 32.81 Favored Glycine 0 N--CA 1.432 -1.595 0 CA-C-N 114.723 -1.126 . . . . 0.0 112.149 -179.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.475 ' C ' ' H ' ' A' ' 24' ' ' SER . 20.6 pt20 -68.15 -23.14 64.85 Favored 'General case' 0 CA--C 1.494 -1.179 0 CA-C-O 121.857 0.837 . . . . 0.0 110.859 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -70.23 7.52 0.98 Allowed 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 114.163 -1.38 . . . . 0.0 109.907 175.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.475 ' H ' ' C ' ' A' ' 22' ' ' GLN . 49.0 m 66.32 29.94 9.21 Favored 'General case' 0 C--N 1.347 0.463 0 C-N-CA 123.559 0.744 . . . . 0.0 110.363 -178.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.458 ' O ' ' HA ' ' A' ' 20' ' ' VAL . 54.7 t30 -104.59 105.57 15.73 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.564 -178.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.673 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 39.8 tt0 -108.0 132.73 53.21 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.437 0.637 . . . . 0.0 111.112 178.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.3 p -136.14 142.77 37.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.651 179.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 53.8 m170 -100.18 115.61 30.26 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 121.293 0.568 . . . . 0.0 111.791 -175.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -115.48 151.28 35.09 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.724 176.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 53.2 ttp180 -111.23 123.46 50.24 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 173.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.56 HG21 HD12 ' A' ' 17' ' ' ILE . 31.3 m -135.7 174.02 13.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.102 -176.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 24.4 ttpp -88.49 156.67 18.97 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.472 ' C ' ' HB3' ' A' ' 70' ' ' PRO . 90.1 m-85 -51.28 -41.36 60.38 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 176.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -100.27 25.49 28.11 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.844 -0.617 . . . . 0.0 113.244 -177.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.518 HG23 ' HB2' ' A' ' 39' ' ' LYS . 1.1 m -65.26 136.47 56.64 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 121.284 0.564 . . . . 0.0 111.855 178.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.463 ' HB3' ' HA ' ' A' ' 66' ' ' ASP . 49.3 m -84.85 153.95 22.61 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.06 -178.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.462 ' SD ' ' HA ' ' A' ' 65' ' ' ASN . 24.7 ptt? -48.2 -32.32 6.95 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.17 -37.79 84.18 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -176.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.518 ' HB2' HG23 ' A' ' 35' ' ' THR . 75.3 mmtt -62.16 -39.23 91.95 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.767 0.318 . . . . 0.0 110.972 -175.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.523 HD12 ' CD2' ' A' ' 57' ' ' PHE . 0.3 OUTLIER -86.88 -46.04 10.28 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 116.163 -0.471 . . . . 0.0 112.088 -178.564 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.467 ' HG2' ' CD1' ' A' ' 57' ' ' PHE . 59.0 mtpt -62.64 -48.53 78.96 Favored 'General case' 0 CA--C 1.496 -1.104 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 -177.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -63.04 -40.42 97.66 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.006 179.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 47.3 t -66.01 -51.4 58.66 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.078 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.471 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 45.2 t80 -65.34 -46.92 78.29 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.838 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.427 ' HB1' ' O ' ' A' ' 50' ' ' VAL . . . -58.53 -36.68 74.22 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-O 121.374 0.606 . . . . 0.0 109.805 -177.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -66.51 -47.94 71.37 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.227 -178.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.471 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 15.8 ptm180 -71.25 -24.35 62.16 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.73 -177.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.439 HG22 ' O ' ' A' ' 44' ' ' TYR . 12.9 t -95.67 -8.36 34.93 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.579 -178.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.73 30.94 65.5 Favored Glycine 0 C--N 1.336 0.552 0 C-N-CA 121.298 -0.477 . . . . 0.0 113.54 178.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.456 HG11 ' HG2' ' A' ' 86' ' ' GLU . 96.8 t -119.44 150.39 21.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 -178.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.446 ' HB3' ' OG ' ' A' ' 54' ' ' SER . . . -52.26 135.83 31.71 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.242 176.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 72.2 t -61.6 -43.41 96.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.243 -178.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -66.59 -27.24 67.56 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.52 178.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.455 ' OG ' ' HB3' ' A' ' 87' ' ' GLN . 74.2 m -75.09 -12.15 60.25 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.237 179.103 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.412 HD13 ' HA ' ' A' ' 55' ' ' LEU . 1.4 mm? -94.8 135.42 36.32 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.081 0.467 . . . . 0.0 110.28 177.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.46 119.25 17.23 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.127 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.523 ' CD2' HD12 ' A' ' 40' ' ' LEU . 11.0 m-85 -109.37 132.24 54.31 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.39 -179.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.523 ' HG ' ' HA ' ' A' ' 63' ' ' ARG . 9.1 mp -124.8 147.76 48.54 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 121.356 0.598 . . . . 0.0 111.654 -177.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.794 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 49.2 t80 -126.92 126.35 43.1 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 175.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 22.6 t70 58.78 24.56 12.46 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.719 0.771 . . . . 0.0 110.931 -179.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.07 5.83 87.16 Favored Glycine 0 C--N 1.312 -0.795 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.863 179.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.794 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.1 OUTLIER -113.97 144.47 43.03 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 178.046 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.523 ' HA ' ' HG ' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -71.65 132.1 44.11 Favored 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.699 -176.478 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 82.1 mt -74.68 130.72 35.88 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 N-CA-C 107.429 -1.322 . . . . 0.0 107.429 176.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.462 ' HA ' ' SD ' ' A' ' 37' ' ' MET . 15.6 m120 -112.9 165.74 12.04 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 121.236 0.541 . . . . 0.0 111.1 -173.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.463 ' HA ' ' HB3' ' A' ' 36' ' ' SER . 7.2 p-10 -82.66 -6.71 59.52 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 176.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -112.53 -2.4 14.65 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.668 -175.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 31.5 p30 -76.82 167.76 21.27 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.297 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.559 ' O ' HG22 ' A' ' 72' ' ' THR . 41.0 p -116.99 155.25 49.55 Favored Pre-proline 0 C--N 1.316 -0.857 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.702 -178.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.472 ' HB3' ' C ' ' A' ' 33' ' ' TYR . 18.5 Cg_endo -59.52 -31.22 94.23 Favored 'Trans proline' 0 C--O 1.217 -0.548 0 C-N-CA 122.375 2.05 . . . . 0.0 112.417 -178.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.56 ' HD3' ' N ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -75.53 -29.26 59.38 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -179.266 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.56 ' N ' ' HD3' ' A' ' 71' ' ' LYS . 4.9 t -76.08 -29.7 58.06 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.076 -0.65 . . . . 0.0 110.174 -178.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.552 HD21 ' NH1' ' A' ' 62' ' ' ARG . 97.7 mt -92.96 -23.72 18.62 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.355 177.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 40.19 59.14 2.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.506 -175.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 75.6 mtm -84.21 149.02 26.41 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.731 178.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -137.96 -179.29 5.68 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -178.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -64.17 118.19 8.22 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.528 0.68 . . . . 0.0 112.542 -175.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.539 ' HB2' ' HE3' ' A' ' 16' ' ' LYS . 11.8 t70 73.27 34.32 1.03 Allowed 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 113.951 -1.477 . . . . 0.0 111.17 176.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -74.84 177.22 6.39 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.638 177.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.8 t -111.85 130.69 65.0 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 CA-C-O 121.201 0.524 . . . . 0.0 110.939 -173.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.447 HD13 HG23 ' A' ' 17' ' ' ILE . 1.2 mp -118.69 135.1 60.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.434 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -97.59 135.86 38.81 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.589 -175.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.48 ' HB ' ' HA2' ' A' ' 21' ' ' GLY . 93.1 t -126.8 133.52 68.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 CA-C-O 121.163 0.506 . . . . 0.0 110.572 178.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -107.1 168.99 8.82 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.437 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -64.67 136.99 57.56 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-O 121.91 0.862 . . . . 0.0 111.64 -173.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.456 ' HG2' HG11 ' A' ' 50' ' ' VAL . 31.7 mp0 -70.7 156.56 39.33 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 114.169 -1.378 . . . . 0.0 112.286 -174.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.455 ' HB3' ' OG ' ' A' ' 54' ' ' SER . 61.7 tt0 -64.83 -43.98 91.31 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.015 175.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 52.8 tp . . . . . 0 N--CA 1.445 -0.721 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.101 -179.143 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 . . . . . 0 CA--C 1.495 -1.14 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.47 ' HB ' ' HA ' ' A' ' 77' ' ' ASP . 12.1 pt -116.49 160.76 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.21 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.247 -177.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.402 ' H ' ' HA ' ' A' ' 77' ' ' ASP . 58.8 mtpt -101.21 147.3 26.43 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.652 178.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.423 HG12 HG22 ' A' ' 31' ' ' VAL . 42.8 mm -127.13 126.47 68.13 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.312 176.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.7 mtmt -96.79 103.67 15.6 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 176.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.653 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 94.3 t -82.69 116.07 26.27 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.265 178.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 64.1 t -109.0 118.55 56.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -92.94 179.65 39.77 Favored Glycine 0 C--N 1.312 -0.805 0 C-N-CA 120.207 -0.997 . . . . 0.0 113.062 -178.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 90.9 mm-40 -72.31 -20.2 61.53 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 121.468 0.651 . . . . 0.0 111.714 -178.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -83.37 10.77 7.94 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.324 -0.853 . . . . 0.0 108.963 176.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 40.8 m 63.65 28.47 15.03 Favored 'General case' 0 C--N 1.347 0.498 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -176.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 55.9 t-20 -93.32 106.94 18.84 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.513 -1.221 . . . . 0.0 110.42 -177.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.653 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 29.9 tt0 -99.28 132.02 44.9 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.13 177.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.7 p -136.74 139.94 43.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.461 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 60.1 m170 -98.66 114.55 27.08 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 121.376 0.608 . . . . 0.0 111.709 -176.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -110.63 145.31 38.13 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.284 174.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 57.6 ttp180 -105.33 125.71 51.29 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.1 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.423 HG22 HG12 ' A' ' 17' ' ' ILE . 32.6 m -136.44 175.7 9.72 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.516 -177.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.476 ' O ' ' HB ' ' A' ' 35' ' ' THR . 59.0 tttp -88.37 157.42 18.72 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.418 ' O ' ' HB3' ' A' ' 70' ' ' PRO . 66.2 m-85 -55.9 -41.08 73.95 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 173.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -97.98 31.57 7.79 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.141 -178.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.522 HG23 ' HB2' ' A' ' 39' ' ' LYS . 0.9 OUTLIER -68.63 138.79 55.31 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-O 121.503 0.668 . . . . 0.0 112.378 179.009 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.415 ' OG ' ' HG2' ' A' ' 39' ' ' LYS . 87.7 p -83.09 163.55 20.83 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.705 177.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.703 ' SD ' ' HA ' ' A' ' 65' ' ' ASN . 25.3 ptt? -60.61 -31.89 71.04 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.748 0.309 . . . . 0.0 111.189 -179.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.63 -37.16 82.94 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.244 -178.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.522 ' HB2' HG23 ' A' ' 35' ' ' THR . 75.9 mmtt -59.93 -40.39 88.74 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.192 -175.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.506 HD23 ' H ' ' A' ' 40' ' ' LEU . 0.4 OUTLIER -87.96 -44.13 11.25 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 179.737 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.4 ' HG2' ' HD1' ' A' ' 57' ' ' PHE . 61.3 mtpt -62.68 -45.29 93.45 Favored 'General case' 0 CA--C 1.493 -1.213 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.188 -177.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.422 ' O ' ' HB2' ' A' ' 46' ' ' ASP . 24.9 ttmm -62.98 -41.6 99.6 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 176.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 52.4 m -63.95 -46.19 85.82 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.202 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.707 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 45.6 t80 -71.11 -45.25 64.02 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.97 0.415 . . . . 0.0 110.871 178.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.47 -28.14 69.07 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.155 0.502 . . . . 0.0 110.008 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.422 ' HB2' ' O ' ' A' ' 42' ' ' LYS . 25.8 t70 -63.91 -45.95 87.0 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.374 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.707 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 15.3 ptm180 -65.82 -28.0 68.67 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.018 0.437 . . . . 0.0 111.047 -178.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.501 HG22 ' O ' ' A' ' 44' ' ' TYR . 2.0 t -97.27 -17.71 19.64 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.467 -178.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.04 30.36 67.82 Favored Glycine 0 C--O 1.236 0.23 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.04 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.872 HG11 ' HB2' ' A' ' 87' ' ' GLN . 2.4 p -108.76 176.46 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-O 120.676 0.274 . . . . 0.0 110.553 -177.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.626 ' H ' HG22 ' A' ' 50' ' ' VAL . . . -58.79 125.92 25.52 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.396 176.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 71.6 t -65.99 -45.46 90.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.379 0.609 . . . . 0.0 110.97 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -68.72 -31.74 71.03 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.456 -177.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.567 ' HB2' ' HB3' ' A' ' 51' ' ' ALA . 50.2 m -81.74 -4.44 56.31 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.979 -175.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.651 HD12 ' CE1' ' A' ' 57' ' ' PHE . 0.3 OUTLIER -90.14 128.71 36.41 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 177.108 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.465 ' HD3' ' CB ' ' A' ' 86' ' ' GLU . 3.2 mpt_? -106.12 118.95 37.95 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -173.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.651 ' CE1' HD12 ' A' ' 55' ' ' LEU . 61.0 m-85 -111.08 134.84 52.37 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.124 171.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.723 HD23 ' HD1' ' A' ' 84' ' ' TYR . 2.9 mm? -127.76 155.2 44.41 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.937 0.875 . . . . 0.0 111.746 -178.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.746 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 58.6 t80 -122.46 108.54 13.3 Favored 'General case' 0 C--N 1.286 -2.171 0 CA-C-N 113.941 -1.481 . . . . 0.0 108.264 176.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 55.19 22.52 4.72 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.183 0.516 . . . . 0.0 110.74 -174.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 93.85 -7.95 73.66 Favored Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.561 -179.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.746 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.1 OUTLIER -91.57 142.15 27.95 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.391 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.548 ' HA ' ' CD1' ' A' ' 58' ' ' LEU . 0.7 OUTLIER -64.81 139.2 58.74 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -174.795 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 78.9 mt -103.93 117.77 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 174.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.703 ' HA ' ' SD ' ' A' ' 37' ' ' MET . 48.0 m-80 -121.57 166.84 13.61 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 120.92 0.39 . . . . 0.0 110.6 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -70.61 -15.32 62.74 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.532 -177.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -92.12 -0.42 57.44 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 116.705 -0.225 . . . . 0.0 111.523 -179.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -80.33 140.58 36.06 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 120.906 0.384 . . . . 0.0 111.112 178.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.437 ' HB ' ' HD2' ' A' ' 70' ' ' PRO . 82.2 p -87.87 160.07 47.54 Favored Pre-proline 0 C--N 1.314 -0.97 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.993 -178.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.437 ' HD2' ' HB ' ' A' ' 69' ' ' THR . 21.0 Cg_endo -62.22 -25.61 76.99 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.626 2.217 . . . . 0.0 111.713 177.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.5 tmtt? -82.14 -37.65 25.9 Favored 'General case' 0 N--CA 1.423 -1.82 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.128 -177.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.7 t -74.07 -33.51 63.69 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 120.456 -0.497 . . . . 0.0 110.432 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 97.2 mt -79.06 -22.84 44.76 Favored 'General case' 0 C--O 1.217 -0.614 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.517 177.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 51.73 34.57 13.25 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.043 175.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 75.7 mtm -76.25 155.94 33.95 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 121.009 0.433 . . . . 0.0 111.342 -178.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -141.23 176.33 8.93 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.47 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 35.7 t70 -66.49 121.16 14.71 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 120.955 0.407 . . . . 0.0 111.089 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 24.5 t70 71.24 34.68 1.72 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.618 -1.174 . . . . 0.0 110.291 177.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -74.81 176.26 7.22 Favored 'General case' 0 N--CA 1.457 -0.09 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.95 178.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 24.5 m -106.97 138.38 33.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-O 121.57 0.7 . . . . 0.0 111.58 -176.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.412 HD13 ' HA ' ' A' ' 81' ' ' ILE . 6.8 mm -134.81 136.6 52.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.422 -177.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 53.6 mm-40 -101.88 141.88 34.05 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.862 -174.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 74.3 t -129.18 134.36 64.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-O 120.972 0.415 . . . . 0.0 110.953 177.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.723 ' HD1' HD23 ' A' ' 58' ' ' LEU . 74.4 m-85 -99.98 151.76 20.98 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 175.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.523 ' O ' ' HG3' ' A' ' 86' ' ' GLU . 63.9 tt0 -71.51 96.45 1.52 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.219 0.533 . . . . 0.0 110.226 -176.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.577 ' O ' HD22 ' A' ' 55' ' ' LEU . 30.6 mt-10 -167.99 142.34 3.5 Favored 'General case' 0 CA--C 1.501 -0.929 0 C-N-CA 125.592 1.557 . . . . 0.0 109.486 -177.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.872 ' HB2' HG11 ' A' ' 50' ' ' VAL . 27.6 pt20 177.33 -29.41 0.0 OUTLIER 'General case' 0 N--CA 1.389 -3.483 0 C-N-CA 125.284 1.434 . . . . 0.0 108.315 -176.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 60.0 tp . . . . . 0 N--CA 1.428 -1.551 0 N-CA-C 103.696 -2.705 . . . . 0.0 103.696 -179.212 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 . . . . . 0 N--CA 1.433 -1.279 0 CA-C-O 121.163 0.506 . . . . 0.0 110.744 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.411 ' O ' ' HD2' ' A' ' 30' ' ' ARG . 12.1 pt -126.21 163.04 28.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -179.117 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.535 ' H ' ' HA ' ' A' ' 77' ' ' ASP . 37.0 ttpt -106.55 140.05 40.05 Favored 'General case' 0 C--N 1.282 -2.353 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.621 HG21 HD12 ' A' ' 81' ' ' ILE . 83.5 mt -133.5 132.97 57.69 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.118 0 CA-C-O 120.814 0.34 . . . . 0.0 111.29 177.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.3 mtmt -97.62 105.81 18.02 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.61 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 97.7 t -82.42 120.38 33.75 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 178.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 59.9 t -111.02 118.22 56.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 120.998 0.428 . . . . 0.0 110.11 179.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.534 ' HA2' ' HB ' ' A' ' 83' ' ' VAL . . . -87.27 169.51 39.83 Favored Glycine 0 N--CA 1.445 -0.764 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.704 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.493 ' HG2' ' O ' ' A' ' 83' ' ' VAL . 15.9 mm100 -68.71 -26.82 65.46 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 120.961 0.41 . . . . 0.0 111.92 -177.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -83.34 13.88 4.02 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.055 178.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 27.4 t 74.17 24.45 1.94 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.428 178.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -91.57 104.53 17.0 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.811 -178.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.61 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 30.4 tt0 -98.77 130.82 45.24 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.693 176.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.423 ' CG1' ' HB ' ' A' ' 19' ' ' VAL . 7.1 p -131.06 141.35 46.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 50.7 m170 -98.98 108.74 21.5 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 121.067 0.46 . . . . 0.0 110.702 -175.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -110.05 147.13 34.15 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.868 179.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.411 ' HD2' ' O ' ' A' ' 15' ' ' ILE . 23.4 tpt180 -108.38 118.74 37.56 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 176.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.497 HG21 HD12 ' A' ' 17' ' ' ILE . 33.7 m -133.21 171.6 17.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.767 -177.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.422 ' O ' ' HB ' ' A' ' 35' ' ' THR . 38.1 ttpt -88.83 156.93 18.65 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 -178.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -55.61 -39.58 70.97 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 174.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -97.42 24.6 30.77 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.56 -178.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.422 ' HB ' ' O ' ' A' ' 32' ' ' LYS . 1.0 OUTLIER -67.05 138.09 56.92 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-O 121.367 0.603 . . . . 0.0 112.068 179.032 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.8 m -92.1 158.89 15.95 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.685 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 25.9 ptt? -52.78 -34.38 53.01 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -176.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.55 -36.27 80.12 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.332 0.494 . . . . 0.0 112.332 -176.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -59.98 -40.91 90.76 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.664 0.268 . . . . 0.0 110.711 -174.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.501 HD23 ' H ' ' A' ' 40' ' ' LEU . 0.4 OUTLIER -87.79 -45.81 10.0 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.213 -0.448 . . . . 0.0 112.0 -179.094 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.672 ' HG2' ' CD1' ' A' ' 57' ' ' PHE . 62.3 mtpt -62.83 -45.9 90.45 Favored 'General case' 0 CA--C 1.493 -1.22 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.501 -175.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -61.85 -41.68 98.12 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 177.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 47.9 t -63.98 -51.0 66.35 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.227 -178.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.596 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 46.6 t80 -70.21 -46.59 64.21 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.345 -179.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.437 ' HB1' ' O ' ' A' ' 50' ' ' VAL . . . -60.05 -36.76 78.02 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.393 0.616 . . . . 0.0 110.016 -178.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -66.03 -46.16 78.86 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.14 -178.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.596 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 14.6 ptm180 -68.07 -24.73 65.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.453 -177.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.459 HG22 ' O ' ' A' ' 44' ' ' TYR . 12.4 t -96.02 -8.61 33.16 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 120.769 0.318 . . . . 0.0 111.619 -179.126 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.72 31.2 60.73 Favored Glycine 0 C--N 1.339 0.727 0 C-N-CA 121.004 -0.617 . . . . 0.0 113.222 178.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.443 HG11 ' HG3' ' A' ' 86' ' ' GLU . 94.7 t -119.47 148.76 22.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 C-N-CA 122.539 0.336 . . . . 0.0 110.806 -178.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.417 ' HB3' ' OG ' ' A' ' 54' ' ' SER . . . -51.76 134.24 30.8 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.456 176.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 74.0 t -61.05 -44.62 98.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.001 -177.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -70.56 -22.44 62.59 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.187 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.484 ' HB3' ' HB3' ' A' ' 87' ' ' GLN . 68.0 m -80.24 -10.96 59.77 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.169 179.129 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.08 129.3 40.67 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 177.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -117.94 115.12 24.27 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 120.999 0.428 . . . . 0.0 110.856 -177.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.672 ' CD1' ' HG2' ' A' ' 41' ' ' LYS . 27.6 m-85 -106.06 127.76 53.4 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.937 177.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.556 HD22 ' CE1' ' A' ' 84' ' ' TYR . 9.2 mp -124.59 140.22 53.15 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.922 -179.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.767 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 76.7 t80 -105.95 117.08 33.09 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 177.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 29.1 t70 56.53 19.84 4.46 Favored 'General case' 0 CA--C 1.548 0.879 0 CA-C-O 121.29 0.567 . . . . 0.0 111.625 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.94 1.32 51.95 Favored Glycine 0 CA--C 1.521 0.451 0 C-N-CA 121.081 -0.58 . . . . 0.0 113.224 178.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.767 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.2 OUTLIER -113.68 142.38 46.08 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 117.097 0.448 . . . . 0.0 109.866 177.668 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.553 ' HA ' ' HG ' ' A' ' 58' ' ' LEU . 9.7 mpt_? -65.45 139.09 58.49 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -175.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 80.5 mt -94.49 119.02 41.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.294 178.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -110.66 160.99 16.19 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.193 -178.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -72.18 -18.29 61.87 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.304 0.573 . . . . 0.0 109.718 176.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -81.4 -19.45 42.57 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.031 -179.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.522 ' CG ' HH12 ' A' ' 62' ' ' ARG . 47.3 m-20 -68.21 140.23 56.07 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 121.391 0.615 . . . . 0.0 111.854 -179.327 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.488 ' HB ' ' HD2' ' A' ' 70' ' ' PRO . 18.8 p -100.66 163.45 18.08 Favored Pre-proline 0 C--N 1.311 -1.065 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.909 -178.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.488 ' HD2' ' HB ' ' A' ' 69' ' ' THR . 17.1 Cg_endo -58.32 -28.86 86.16 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 122.703 2.269 . . . . 0.0 112.687 -178.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.554 ' HG3' ' H ' ' A' ' 72' ' ' THR . 15.2 ptmt -72.41 -49.82 30.92 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.554 ' H ' ' HG3' ' A' ' 71' ' ' LYS . 15.1 t -67.64 -34.26 76.61 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.981 0.42 . . . . 0.0 110.735 -177.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 97.5 mt -79.41 -22.84 43.74 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.541 177.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 36.35 36.52 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 124.639 1.176 . . . . 0.0 113.835 -179.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 65.9 mtt -75.42 151.81 38.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.47 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -147.98 -176.4 5.26 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.819 -178.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.535 ' HA ' ' H ' ' A' ' 16' ' ' LYS . 6.4 p-10 -59.42 121.91 12.66 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -174.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.459 ' OD1' ' HE3' ' A' ' 16' ' ' LYS . 26.5 t70 71.01 32.45 2.31 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 113.635 -1.621 . . . . 0.0 111.553 175.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -79.23 178.05 8.36 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 175.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 35.1 m -115.13 150.5 17.05 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 CA-C-O 121.815 0.817 . . . . 0.0 112.336 -174.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.621 HD12 HG21 ' A' ' 17' ' ' ILE . 1.6 mt -134.26 134.92 54.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.854 178.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -101.81 139.63 37.19 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.897 -178.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.534 ' HB ' ' HA2' ' A' ' 21' ' ' GLY . 95.2 t -122.11 130.94 74.15 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.548 177.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.556 ' CE1' HD22 ' A' ' 58' ' ' LEU . 66.8 m-85 -99.21 167.29 10.77 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.474 178.405 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -67.06 137.11 56.18 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.538 0.685 . . . . 0.0 110.677 -173.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.493 ' H ' ' CD ' ' A' ' 86' ' ' GLU . 0.9 OUTLIER -83.9 156.55 22.34 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.979 -1.009 . . . . 0.0 112.955 -171.574 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.484 ' HB3' ' HB3' ' A' ' 54' ' ' SER . 64.2 tt0 -66.36 -42.83 87.46 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.892 -1.049 . . . . 0.0 112.777 -177.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.476 HD23 ' OG ' ' A' ' 54' ' ' SER . 4.6 mm? . . . . . 0 C--N 1.322 -0.608 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -178.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 . . . . . 0 CA--C 1.505 -0.753 0 CA-C-O 121.87 0.843 . . . . 0.0 112.783 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.6 pt -134.01 162.73 38.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-N 114.152 -1.386 . . . . 0.0 107.931 -179.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.456 ' HD2' ' NH1' ' A' ' 30' ' ' ARG . 3.5 mppt? -99.99 148.67 24.26 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 121.147 0.499 . . . . 0.0 111.616 179.197 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.468 HG23 ' CG1' ' A' ' 81' ' ' ILE . 67.8 mt -124.96 131.83 72.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.796 176.151 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.0 mtmt -101.54 102.74 13.53 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 172.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.701 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 92.3 t -82.87 117.7 29.27 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 57.9 t -106.85 114.72 46.69 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.513 ' HA2' ' HB ' ' A' ' 83' ' ' VAL . . . -88.96 171.49 39.12 Favored Glycine 0 C--N 1.313 -0.721 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.597 -179.239 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 90.8 mm-40 -73.89 -11.83 60.48 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-O 121.719 0.771 . . . . 0.0 110.652 179.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -83.6 7.16 18.18 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 114.57 -1.195 . . . . 0.0 108.86 174.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.5 m 65.41 27.59 11.82 Favored 'General case' 0 C--N 1.347 0.46 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.002 -176.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -97.11 105.74 17.94 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.704 -177.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.701 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 39.0 tt0 -98.09 129.7 44.9 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.713 176.183 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.2 p -139.54 141.82 34.25 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.988 -178.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 31.7 m170 -88.65 116.91 27.24 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.747 -179.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -113.68 136.88 52.35 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 114.993 -1.003 . . . . 0.0 108.701 170.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.456 ' NH1' ' HD2' ' A' ' 16' ' ' LYS . 35.9 ttt85 -104.91 125.64 51.13 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.503 ' HB ' ' OG1' ' A' ' 35' ' ' THR . 22.7 m -135.12 -179.76 3.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.227 -174.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -89.77 157.04 18.12 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 178.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.422 ' O ' ' HB3' ' A' ' 70' ' ' PRO . 90.6 m-85 -53.93 -39.79 66.17 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 173.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -102.07 33.39 6.55 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.355 -179.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.503 ' OG1' ' HB ' ' A' ' 31' ' ' VAL . 0.9 OUTLIER -66.7 138.52 57.46 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 121.614 0.721 . . . . 0.0 112.2 179.263 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.507 ' HB3' ' HB2' ' A' ' 66' ' ' ASP . 67.2 m -82.87 151.99 25.77 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.94 178.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.612 ' SD ' ' HA ' ' A' ' 65' ' ' ASN . 26.7 ptt? -54.1 -30.58 49.16 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.935 0.398 . . . . 0.0 111.047 -179.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.17 -36.75 80.69 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.781 -178.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -60.14 -40.83 91.18 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.791 0.329 . . . . 0.0 111.149 -176.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.491 HD23 ' H ' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -86.87 -45.52 10.78 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 116.056 -0.52 . . . . 0.0 112.0 -179.787 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.426 ' HA ' ' CE1' ' A' ' 57' ' ' PHE . 24.8 mtpp -61.78 -47.32 85.68 Favored 'General case' 0 CA--C 1.5 -0.972 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.351 -177.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.489 ' HA ' HG22 ' A' ' 52' ' ' VAL . 40.6 ttpt -62.79 -42.07 99.54 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.072 0.463 . . . . 0.0 109.986 178.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 44.7 t -66.35 -50.88 62.07 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.866 -176.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.592 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 49.6 t80 -70.71 -45.53 64.78 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.142 -178.035 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.525 ' HB1' ' O ' ' A' ' 50' ' ' VAL . . . -59.13 -35.63 73.8 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.409 0.623 . . . . 0.0 109.77 -179.094 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -64.35 -47.16 80.4 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.531 -179.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.592 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 14.5 ptm180 -71.17 -21.91 62.1 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.671 -177.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.466 HG22 ' O ' ' A' ' 44' ' ' TYR . 13.7 t -101.13 -2.73 30.67 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-O 120.855 0.36 . . . . 0.0 111.699 -178.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 69.8 37.08 75.45 Favored Glycine 0 C--N 1.335 0.486 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.013 178.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.525 ' O ' ' HB1' ' A' ' 45' ' ' ALA . 91.3 t -122.62 147.67 26.69 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 C-N-CA 122.825 0.45 . . . . 0.0 110.811 -178.008 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.456 ' HB3' ' HB2' ' A' ' 54' ' ' SER . . . -54.77 135.02 47.87 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 175.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.489 HG22 ' HA ' ' A' ' 42' ' ' LYS . 76.6 t -61.1 -45.86 97.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.312 -175.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -71.41 -27.79 63.55 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.356 -178.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.456 ' HB2' ' HB3' ' A' ' 51' ' ' ALA . 49.1 m -82.68 -5.43 58.85 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.464 -178.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.485 HD12 ' CE1' ' A' ' 57' ' ' PHE . 0.2 OUTLIER -95.34 122.42 38.03 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 177.414 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -108.02 117.39 34.01 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 120.33 -0.548 . . . . 0.0 112.222 -174.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.494 ' HZ ' ' CB ' ' A' ' 44' ' ' TYR . 44.3 m-85 -100.63 128.68 46.6 Favored 'General case' 0 CA--C 1.498 -1.058 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.569 174.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.595 HD13 ' HA ' ' A' ' 63' ' ' ARG . 4.2 mm? -119.06 155.89 30.66 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.384 -177.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.764 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 63.0 t80 -133.75 109.94 9.48 Favored 'General case' 0 C--N 1.279 -2.466 0 CA-C-N 114.289 -1.323 . . . . 0.0 109.385 174.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 27.9 t70 52.81 29.9 8.27 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.565 0.698 . . . . 0.0 111.562 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 94.58 4.98 61.87 Favored Glycine 0 C--N 1.31 -0.886 0 C-N-CA 120.856 -0.688 . . . . 0.0 113.65 176.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.764 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.2 OUTLIER -122.8 133.49 54.45 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 177.159 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.595 ' HA ' HD13 ' A' ' 58' ' ' LEU . 30.4 ptt180 -72.75 145.91 46.77 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.783 -172.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.448 HD11 HD12 ' A' ' 81' ' ' ILE . 73.6 mt -91.21 121.76 41.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.4 -176.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.612 ' HA ' ' SD ' ' A' ' 37' ' ' MET . 50.7 m-80 -111.09 157.54 19.88 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.769 -178.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.507 ' HB2' ' HB3' ' A' ' 36' ' ' SER . 4.8 p-10 -74.79 -11.98 60.28 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-O 121.179 0.514 . . . . 0.0 109.819 178.1 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -81.62 -20.37 39.86 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.913 179.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.461 ' CG ' HH12 ' A' ' 62' ' ' ARG . 50.5 m-20 -67.14 149.41 50.55 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.294 0.569 . . . . 0.0 112.087 -178.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.404 ' HB ' ' HD2' ' A' ' 70' ' ' PRO . 76.4 p -108.68 159.77 29.69 Favored Pre-proline 0 C--N 1.315 -0.933 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.634 178.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.422 ' HB3' ' O ' ' A' ' 33' ' ' TYR . 19.3 Cg_endo -60.49 -28.68 87.13 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.448 2.099 . . . . 0.0 111.721 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.738 ' HD2' ' C ' ' A' ' 71' ' ' LYS . 0.1 OUTLIER -65.6 -44.04 87.81 Favored 'General case' 0 N--CA 1.415 -2.176 0 CA-C-O 121.615 0.721 . . . . 0.0 109.496 178.819 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -80.22 -40.06 27.85 Favored 'General case' 0 N--CA 1.414 -2.265 0 CA-C-N 114.848 -1.069 . . . . 0.0 111.152 -174.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 98.6 mt -71.32 -23.24 61.9 Favored 'General case' 0 N--CA 1.44 -0.975 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 175.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.425 ' HG3' ' O ' ' A' ' 71' ' ' LYS . 38.5 mt-10 50.79 28.7 3.79 Favored 'General case' 0 C--N 1.349 0.553 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.462 -179.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.441 ' HE1' HD11 ' A' ' 17' ' ' ILE . 21.5 ptm -81.32 164.64 22.03 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.241 -178.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -151.37 -175.21 5.09 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-O 120.743 0.306 . . . . 0.0 110.252 -176.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -63.96 119.92 10.99 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.211 -179.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 33.1 t70 67.06 35.58 4.55 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.196 177.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -78.43 175.63 10.12 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 29.1 m -98.42 133.57 40.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 CA-C-O 121.807 0.813 . . . . 0.0 111.611 -176.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.468 ' CG1' HG23 ' A' ' 17' ' ' ILE . 18.1 mm -129.78 130.53 66.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 CA-C-N 114.634 -1.166 . . . . 0.0 109.86 179.137 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -102.56 148.25 25.77 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.094 0.473 . . . . 0.0 111.645 -175.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.513 ' HB ' ' HA2' ' A' ' 21' ' ' GLY . 79.4 t -123.34 129.86 74.57 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.858 174.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -101.77 170.84 7.9 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.571 178.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -64.51 136.94 57.56 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.776 0.798 . . . . 0.0 110.988 -172.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.523 ' H ' ' CD ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -108.93 160.21 16.19 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 114.512 -1.222 . . . . 0.0 111.614 -173.224 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.423 ' HB3' ' HB3' ' A' ' 54' ' ' SER . 64.3 tt0 -65.02 -46.14 82.57 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -175.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.473 ' HB2' HG13 ' A' ' 50' ' ' VAL . 3.3 mm? . . . . . 0 C--N 1.321 -0.666 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -175.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 . . . . . 0 CA--C 1.515 -0.382 0 CA-C-O 121.334 0.587 . . . . 0.0 111.479 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.464 ' O ' ' HD3' ' A' ' 30' ' ' ARG . 8.3 pt -111.27 163.08 8.33 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 -178.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.656 ' HE2' ' OD1' ' A' ' 78' ' ' ASP . 34.9 ttpt -113.78 145.33 41.55 Favored 'General case' 0 C--N 1.291 -1.955 0 C-N-CA 118.882 -1.127 . . . . 0.0 111.687 -179.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 84.6 mt -122.21 127.84 75.34 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.489 177.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.2 mtmt -99.19 104.68 16.66 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 176.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.668 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 96.1 t -82.55 119.2 31.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.989 -178.218 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.9 t -105.27 112.84 40.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -91.09 177.27 41.25 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.072 -1.061 . . . . 0.0 112.611 -178.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -82.54 -10.1 59.13 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 121.434 0.635 . . . . 0.0 111.621 -178.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -85.04 11.12 10.2 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 115.075 -0.966 . . . . 0.0 108.801 174.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.2 m 62.86 33.25 15.3 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.437 -178.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 -111.55 108.94 18.61 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.438 -179.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.668 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 30.0 tt0 -94.18 128.67 40.75 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.331 -0.849 . . . . 0.0 108.932 174.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.3 p -132.58 139.38 49.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -178.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 23.9 m170 -100.94 117.17 34.48 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.314 0.578 . . . . 0.0 111.963 -174.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -109.62 144.39 38.03 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.058 -0.973 . . . . 0.0 110.137 175.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.464 ' HD3' ' O ' ' A' ' 15' ' ' ILE . 20.2 tpp180 -103.2 119.32 38.66 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.401 ' HB ' HG21 ' A' ' 35' ' ' THR . 32.9 m -134.63 167.99 24.7 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.803 -178.062 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.403 ' O ' ' HB ' ' A' ' 35' ' ' THR . 46.5 tttm -91.22 163.33 14.29 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 178.561 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -57.36 -38.67 74.53 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.752 174.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -93.94 19.0 55.55 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 121.175 -0.536 . . . . 0.0 112.428 -178.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.403 ' HB ' ' O ' ' A' ' 32' ' ' LYS . 1.1 m -63.85 136.81 57.69 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-O 121.394 0.616 . . . . 0.0 111.802 179.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 68.3 m -92.91 156.79 16.72 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.307 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.414 ' SD ' ' HA ' ' A' ' 65' ' ' ASN . 26.7 ptt? -51.38 -32.34 25.59 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -176.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.19 -37.39 82.8 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 -177.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 49.3 mmtm -60.21 -39.98 88.48 Favored 'General case' 0 C--O 1.216 -0.696 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.08 -176.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.678 HD12 ' CD1' ' A' ' 57' ' ' PHE . 0.2 OUTLIER -87.24 -44.06 11.73 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -178.848 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.496 ' HA ' ' HE1' ' A' ' 57' ' ' PHE . 57.3 mtpt -62.83 -45.63 91.72 Favored 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -178.239 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 28.9 ttpp -62.31 -41.98 98.98 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 177.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.429 ' O ' ' HB3' ' A' ' 46' ' ' ASP . 58.4 m -66.26 -48.17 71.34 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.73 -178.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.664 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 38.9 t80 -71.72 -44.25 64.46 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -179.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.35 -29.7 66.17 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 121.286 0.565 . . . . 0.0 109.809 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.429 ' HB3' ' O ' ' A' ' 43' ' ' SER . 31.3 t70 -62.72 -48.56 78.73 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.789 178.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.664 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 7.5 ptm180 -69.79 -24.16 63.45 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.192 -176.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.47 HG23 HG12 ' A' ' 50' ' ' VAL . 7.3 t -100.66 -8.98 22.34 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.234 -0.439 . . . . 0.0 112.132 -178.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 67.43 40.6 91.39 Favored Glycine 0 C--N 1.336 0.531 0 C-N-CA 120.676 -0.774 . . . . 0.0 113.029 178.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.471 HG21 ' HG3' ' A' ' 86' ' ' GLU . 3.6 p -125.3 166.74 20.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 O-C-N 122.728 -0.277 . . . . 0.0 110.72 -177.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.441 ' HB3' ' OG ' ' A' ' 54' ' ' SER . . . -59.18 137.36 58.0 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 116.329 -0.396 . . . . 0.0 109.994 176.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 75.6 t -60.51 -44.04 95.65 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.57 -176.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -84.06 -12.15 55.57 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -179.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.512 ' HB2' ' HB3' ' A' ' 87' ' ' GLN . 85.5 p -79.75 -14.26 58.86 Favored 'General case' 0 CA--C 1.514 -0.417 0 C-N-CA 119.924 -0.711 . . . . 0.0 109.091 176.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.423 HD13 ' N ' ' A' ' 56' ' ' ARG . 1.9 tm? -99.61 129.59 45.77 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 177.061 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.423 ' N ' HD13 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -135.48 137.61 42.32 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 119.747 -0.781 . . . . 0.0 111.767 -176.599 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.678 ' CD1' HD12 ' A' ' 40' ' ' LEU . 96.3 m-85 -106.95 139.96 40.52 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.382 176.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.557 HD13 ' CD1' ' A' ' 84' ' ' TYR . 6.6 mp -128.68 139.7 52.11 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.703 176.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.675 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 34.4 t80 -107.78 119.04 38.32 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.129 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 32.5 t70 51.93 33.61 11.97 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.507 0.67 . . . . 0.0 111.395 179.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.19 13.8 73.25 Favored Glycine 0 CA--C 1.522 0.528 0 CA-C-N 115.647 -0.706 . . . . 0.0 113.739 177.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.675 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.2 OUTLIER -123.71 149.83 45.05 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 117.163 0.481 . . . . 0.0 110.406 178.822 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 63' ' ' ARG . 10.2 mmm180 -67.88 139.7 56.5 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -176.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 75.5 mt -103.43 111.29 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 173.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.414 ' HA ' ' SD ' ' A' ' 37' ' ' MET . 95.1 m-20 -114.38 170.22 8.46 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-O 121.094 0.473 . . . . 0.0 111.439 -178.179 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 15.3 p-10 -72.25 -14.07 61.68 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.571 -178.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -94.15 -13.16 27.02 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.397 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.443 ' HB3' ' HG ' ' A' ' 73' ' ' LEU . 30.2 m-20 -72.56 149.62 43.86 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.269 0.557 . . . . 0.0 112.187 -178.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.459 ' HB ' ' HD2' ' A' ' 70' ' ' PRO . 81.8 p -108.88 161.45 23.62 Favored Pre-proline 0 C--N 1.315 -0.907 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.691 -179.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.459 ' HD2' ' HB ' ' A' ' 69' ' ' THR . 24.2 Cg_endo -61.34 -22.95 75.98 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.455 2.104 . . . . 0.0 111.639 178.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.695 ' HD2' ' C ' ' A' ' 71' ' ' LYS . 0.0 OUTLIER -67.65 -44.52 77.7 Favored 'General case' 0 N--CA 1.41 -2.441 0 C-N-CA 123.651 0.78 . . . . 0.0 109.635 -179.755 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.6 t -90.0 -32.57 16.72 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.927 -175.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.443 ' HG ' ' HB3' ' A' ' 68' ' ' ASP . 96.0 mt -72.7 -22.95 60.82 Favored 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 174.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 52.89 32.9 13.3 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 114.846 -1.07 . . . . 0.0 112.25 176.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.406 ' HG3' ' HB3' ' A' ' 73' ' ' LEU . 69.1 mtm -83.54 156.99 22.52 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.372 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -154.44 -176.04 5.7 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -58.48 122.6 13.75 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.949 0.88 . . . . 0.0 112.605 -177.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.656 ' OD1' ' HE2' ' A' ' 16' ' ' LYS . 1.4 m-20 63.14 33.61 14.31 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 113.884 -1.507 . . . . 0.0 111.614 176.495 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -74.92 176.74 6.85 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 178.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 31.5 m -112.71 144.26 20.78 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 CA-C-O 121.459 0.647 . . . . 0.0 111.335 -175.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -129.12 143.97 39.6 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.65 -179.204 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -107.7 141.44 39.23 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 120.817 0.342 . . . . 0.0 110.651 -177.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.438 HG22 ' CD2' ' A' ' 57' ' ' PHE . 99.5 t -117.13 133.44 63.88 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-O 121.096 0.474 . . . . 0.0 111.293 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.557 ' CD1' HD13 ' A' ' 58' ' ' LEU . 53.6 m-85 -98.91 168.45 10.1 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 115.366 -0.833 . . . . 0.0 109.669 176.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 60.1 tp60 -66.68 132.65 48.58 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.311 0.577 . . . . 0.0 111.766 -171.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.489 ' HA ' ' O ' ' A' ' 54' ' ' SER . 19.5 pm0 -82.2 144.72 30.49 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.43 -179.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.512 ' HB3' ' HB2' ' A' ' 54' ' ' SER . 6.8 tp-100 -64.6 -45.61 86.19 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -174.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.436 HD12 ' HB2' ' A' ' 51' ' ' ALA . 87.8 mt . . . . . 0 C--N 1.315 -0.914 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -175.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 . . . . . 0 N--CA 1.441 -0.88 0 CA-C-O 121.11 0.481 . . . . 0.0 110.624 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.427 ' O ' ' HD3' ' A' ' 30' ' ' ARG . 11.6 pt -114.03 160.84 13.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.091 -175.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.458 ' H ' ' HA ' ' A' ' 77' ' ' ASP . 23.4 ttmt -100.76 145.39 28.56 Favored 'General case' 0 C--N 1.283 -2.324 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.622 -179.175 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.678 HG21 HD12 ' A' ' 81' ' ' ILE . 39.7 mm -126.21 127.57 70.89 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.357 175.137 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.451 ' HE2' HG22 ' A' ' 80' ' ' VAL . 15.1 mtmt -96.36 104.98 16.98 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 176.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.656 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 85.0 t -81.7 109.45 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.591 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.223 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.1 t -112.24 118.36 57.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -178.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.48 ' HA2' ' HB ' ' A' ' 83' ' ' VAL . . . -96.28 160.47 22.13 Favored Glycine 0 C--N 1.304 -1.196 0 C-N-CA 120.074 -1.06 . . . . 0.0 112.293 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.468 ' C ' ' H ' ' A' ' 24' ' ' SER . 16.4 pt20 -66.52 -20.35 66.01 Favored 'General case' 0 CA--C 1.495 -1.163 0 CA-C-O 122.427 1.108 . . . . 0.0 109.67 177.277 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -69.33 5.41 1.31 Allowed 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 113.122 -1.853 . . . . 0.0 109.507 173.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.468 ' H ' ' C ' ' A' ' 22' ' ' GLN . 50.2 m 63.13 31.59 15.68 Favored 'General case' 0 C--N 1.35 0.625 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.154 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -110.39 108.07 17.99 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 114.843 -1.071 . . . . 0.0 111.042 -177.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.656 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 30.8 tt0 -103.82 133.85 48.11 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.522 175.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.3 p -139.23 139.39 39.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-N 115.663 -0.698 . . . . 0.0 109.52 177.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 63.6 m170 -98.04 117.17 31.8 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.205 0.526 . . . . 0.0 111.433 -176.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -112.73 146.52 38.61 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.298 175.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.427 ' HD3' ' O ' ' A' ' 15' ' ' ILE . 23.8 tpp180 -103.31 120.53 40.94 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.458 ' HB ' ' OG1' ' A' ' 35' ' ' THR . 29.0 m -132.07 167.82 25.5 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -177.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.57 ' O ' ' HB ' ' A' ' 35' ' ' THR . 43.0 tttm -91.06 161.38 15.14 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.644 ' O ' ' HB3' ' A' ' 70' ' ' PRO . 97.1 m-85 -58.96 -38.23 78.6 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 171.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.626 ' HA2' ' CG ' ' A' ' 70' ' ' PRO . . . -85.64 21.81 13.13 Favored Glycine 0 N--CA 1.433 -1.547 0 CA-C-N 114.621 -1.172 . . . . 0.0 112.167 -178.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.57 ' HB ' ' O ' ' A' ' 32' ' ' LYS . 0.9 OUTLIER -68.56 141.01 55.61 Favored 'General case' 0 N--CA 1.425 -1.699 0 CA-C-O 121.384 0.611 . . . . 0.0 111.684 179.775 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.477 ' HB3' ' HE1' ' A' ' 37' ' ' MET . 48.7 m -88.47 143.37 27.02 Favored 'General case' 0 N--CA 1.416 -2.148 0 CA-C-N 115.405 -0.816 . . . . 0.0 108.939 177.381 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.807 ' SD ' ' HA ' ' A' ' 66' ' ' ASP . 0.2 OUTLIER -51.65 -40.1 59.37 Favored 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 123.575 0.75 . . . . 0.0 111.482 179.647 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.505 ' N ' ' HG2' ' A' ' 37' ' ' MET . . . -62.35 -27.02 68.77 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.152 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -60.47 -40.43 91.21 Favored 'General case' 0 C--O 1.21 -0.995 0 C-N-CA 121.111 -0.235 . . . . 0.0 110.84 -178.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.508 HD23 ' H ' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -85.47 -39.12 17.84 Favored 'General case' 0 C--N 1.309 -1.183 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.889 -176.764 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.492 ' HA ' ' HE1' ' A' ' 57' ' ' PHE . 61.7 mtpt -65.49 -44.86 85.79 Favored 'General case' 0 CA--C 1.493 -1.225 0 CA-C-O 120.728 0.299 . . . . 0.0 110.773 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.604 ' HD3' HG21 ' A' ' 52' ' ' VAL . 15.5 tppt? -62.97 -43.23 99.35 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 176.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 58.1 m -69.53 -50.25 46.79 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.366 -0.833 . . . . 0.0 113.196 -176.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.62 ' O ' ' HG3' ' A' ' 47' ' ' ARG . 62.4 t80 -64.67 -47.23 79.18 Favored 'General case' 0 CA--C 1.496 -1.116 0 CA-C-O 120.674 0.273 . . . . 0.0 111.233 -179.143 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.25 -36.5 77.91 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 121.367 0.603 . . . . 0.0 109.471 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -66.21 -45.59 80.22 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.315 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.62 ' HG3' ' O ' ' A' ' 44' ' ' TYR . 5.1 ppt_? -67.27 -25.01 65.85 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.347 -178.099 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.544 HG22 ' O ' ' A' ' 44' ' ' TYR . 10.2 t -99.07 -17.81 18.06 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 120.815 0.341 . . . . 0.0 111.61 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.1 32.59 35.22 Favored Glycine 0 C--O 1.227 -0.298 0 C-N-CA 120.471 -0.871 . . . . 0.0 113.021 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.579 HG21 ' HG3' ' A' ' 86' ' ' GLU . 4.3 p -115.13 160.96 14.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 O-C-N 122.555 -0.379 . . . . 0.0 110.292 -179.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.488 ' HB3' ' OG ' ' A' ' 54' ' ' SER . . . -57.91 129.31 41.34 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 178.126 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.604 HG21 ' HD3' ' A' ' 42' ' ' LYS . 78.6 t -61.53 -43.65 97.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.648 -178.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -64.53 -33.98 77.18 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.541 -179.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.488 ' OG ' ' HB3' ' A' ' 51' ' ' ALA . 90.6 p -78.82 -12.56 60.03 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.96 0.41 . . . . 0.0 110.975 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.405 HD13 ' N ' ' A' ' 56' ' ' ARG . 2.8 tm? -95.86 132.8 40.74 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -178.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.405 ' N ' HD13 ' A' ' 55' ' ' LEU . 5.6 ptt180 -144.33 145.8 32.19 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-O 121.259 0.552 . . . . 0.0 112.351 -173.375 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.524 ' CD2' HG22 ' A' ' 83' ' ' VAL . 95.7 m-85 -119.06 147.2 44.38 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.737 176.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 6.7 mp -124.31 138.24 54.4 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.792 175.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.594 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 32.2 t80 -117.84 125.93 51.46 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 179.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 33.4 t70 58.74 26.86 15.19 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.888 0.852 . . . . 0.0 110.163 -179.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 81.33 15.77 75.69 Favored Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.735 177.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.594 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 4.4 ppt_? -132.08 155.32 48.3 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-O 121.277 0.56 . . . . 0.0 112.042 179.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 16.4 mmm180 -58.68 137.59 57.5 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -175.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.487 HD11 ' HB2' ' A' ' 59' ' ' PHE . 75.7 mt -102.09 109.0 25.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 168.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.536 ' C ' ' HG3' ' A' ' 37' ' ' MET . 88.6 m-20 -120.53 161.59 21.04 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 120.638 0.256 . . . . 0.0 111.039 -174.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.807 ' HA ' ' SD ' ' A' ' 37' ' ' MET . 4.7 t70 -58.38 -9.75 1.73 Allowed 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 179.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -84.14 -15.49 47.03 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.242 177.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -71.86 149.78 44.87 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -175.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.53 ' O ' HG22 ' A' ' 72' ' ' THR . 35.3 p -117.69 155.29 50.78 Favored Pre-proline 0 N--CA 1.437 -1.11 0 CA-C-N 114.439 -1.255 . . . . 0.0 109.358 177.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.644 ' HB3' ' O ' ' A' ' 33' ' ' TYR . 58.5 Cg_exo -54.83 -40.56 84.54 Favored 'Trans proline' 0 N--CA 1.477 0.502 0 C-N-CA 122.803 2.335 . . . . 0.0 113.75 -176.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.599 ' HD2' ' C ' ' A' ' 71' ' ' LYS . 0.0 OUTLIER -70.92 -30.0 66.21 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -177.482 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.583 ' N ' ' HD2' ' A' ' 71' ' ' LYS . 4.7 t -81.69 -28.64 33.4 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.484 -177.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 97.9 mt -70.26 -24.78 63.12 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 176.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 47.11 30.35 1.33 Allowed 'General case' 0 CA--C 1.551 1.016 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.488 177.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 20.5 ptp -75.49 160.23 30.43 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.938 0.399 . . . . 0.0 111.513 -179.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -147.52 -177.64 5.81 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.588 -178.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.458 ' HA ' ' H ' ' A' ' 16' ' ' LYS . 36.8 t70 -66.14 120.16 12.72 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -176.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 20.4 t70 69.19 33.66 3.24 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 114.381 -1.282 . . . . 0.0 110.441 177.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.4 ' O ' ' HG3' ' A' ' 18' ' ' LYS . 4.6 t70 -78.19 177.36 8.44 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.612 177.453 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.451 HG22 ' HE2' ' A' ' 18' ' ' LYS . 16.9 t -110.0 135.06 50.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 CA-C-O 121.481 0.658 . . . . 0.0 111.686 -171.5 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.678 HD12 HG21 ' A' ' 17' ' ' ILE . 1.8 mt -132.57 132.46 60.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.703 178.305 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -98.79 141.93 30.96 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.442 -174.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.524 HG22 ' CD2' ' A' ' 57' ' ' PHE . 87.6 t -125.88 129.14 72.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-O 121.346 0.593 . . . . 0.0 110.57 177.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -107.75 169.18 8.76 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.869 178.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -64.8 138.31 58.3 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.411 0.625 . . . . 0.0 111.303 -172.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.579 ' HG3' HG21 ' A' ' 50' ' ' VAL . 0.2 OUTLIER -96.93 160.74 14.18 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.706 -178.496 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.47 ' H ' ' HB2' ' A' ' 54' ' ' SER . 6.5 tp-100 -61.22 -46.02 92.17 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.025 0.441 . . . . 0.0 112.063 -174.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 87.4 mt . . . . . 0 C--N 1.31 -1.146 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.892 -176.781 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 . . . . . 0 CA--C 1.507 -0.696 0 CA-C-O 121.189 0.518 . . . . 0.0 111.135 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.4 pt -125.39 161.63 29.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 CA-C-N 115.183 -0.917 . . . . 0.0 108.576 -179.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.527 ' HE3' ' HB3' ' A' ' 78' ' ' ASP . 59.6 mtmt -101.29 143.08 31.79 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-O 120.999 0.428 . . . . 0.0 110.535 177.176 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 75.9 mt -124.3 126.67 72.43 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.152 174.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 31.0 mtmt -94.83 104.46 16.36 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 177.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.651 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 97.5 t -85.26 112.05 21.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -179.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.468 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 5.2 p -115.62 123.41 71.01 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 CA-C-O 121.461 0.648 . . . . 0.0 110.331 179.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -85.96 176.68 49.16 Favored Glycine 0 N--CA 1.435 -1.387 0 CA-C-N 115.223 -0.899 . . . . 0.0 112.095 -178.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.576 ' NE2' ' HA ' ' A' ' 84' ' ' TYR . 78.4 mt-30 -77.36 -13.1 60.0 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.382 0.611 . . . . 0.0 111.333 -177.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -87.95 13.51 10.79 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.18 174.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 46.5 m 66.06 32.79 8.05 Favored 'General case' 0 C--N 1.343 0.294 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.378 179.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.434 ' O ' ' HA ' ' A' ' 20' ' ' VAL . 94.4 m-20 -105.47 111.71 24.52 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.952 179.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.651 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 31.2 tt0 -108.78 132.97 53.46 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.399 -179.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.2 p -134.36 143.36 38.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.196 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 27.4 m170 -101.98 113.28 26.36 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.403 0.621 . . . . 0.0 112.105 -175.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -111.18 148.86 31.86 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.072 175.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -111.8 123.82 51.04 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.901 178.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 32.9 m -136.99 174.3 12.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.229 -179.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.456 ' O ' ' HB ' ' A' ' 35' ' ' THR . 35.4 ttmt -89.73 160.95 16.31 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 -179.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -54.65 -38.69 67.19 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 120.918 0.39 . . . . 0.0 110.365 177.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -100.77 21.92 41.8 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 116.066 -0.516 . . . . 0.0 112.826 -178.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.499 HG23 ' HB2' ' A' ' 39' ' ' LYS . 0.9 OUTLIER -60.53 143.08 54.45 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-O 121.376 0.607 . . . . 0.0 112.552 179.8 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 56.1 m -85.97 157.03 20.22 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.285 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.704 ' SD ' ' HA ' ' A' ' 65' ' ' ASN . 25.5 ptm -53.27 -32.73 50.0 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -178.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.34 -37.04 84.1 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -178.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.499 ' HB2' HG23 ' A' ' 35' ' ' THR . 49.7 mmtm -59.15 -40.65 86.22 Favored 'General case' 0 C--O 1.206 -1.222 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.25 -175.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.503 HD23 ' H ' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -86.42 -43.68 12.62 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -179.163 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.408 ' HA ' ' CE1' ' A' ' 57' ' ' PHE . 25.0 mtpp -62.15 -46.97 86.61 Favored 'General case' 0 CA--C 1.502 -0.873 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.05 -177.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.434 ' HA ' HG22 ' A' ' 52' ' ' VAL . 29.6 ttpp -63.64 -40.08 95.96 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.136 0.493 . . . . 0.0 110.003 178.302 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 50.9 m -63.66 -49.72 72.08 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.591 -0.732 . . . . 0.0 112.352 -178.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.51 ' CB ' ' HZ ' ' A' ' 57' ' ' PHE . 44.0 t80 -71.86 -45.59 60.86 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.743 0.306 . . . . 0.0 111.611 -179.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.572 ' HB1' ' O ' ' A' ' 50' ' ' VAL . . . -58.27 -32.49 68.45 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.133 -178.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -62.88 -45.0 94.6 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.353 -0.839 . . . . 0.0 112.223 -179.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.478 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 24.0 ptt180 -69.54 -25.17 63.89 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.202 0.525 . . . . 0.0 110.779 -176.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.431 HG22 ' O ' ' A' ' 44' ' ' TYR . 7.9 t -102.59 -7.26 21.96 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -174.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 68.76 28.31 73.2 Favored Glycine 0 N--CA 1.46 0.268 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.237 178.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.572 ' O ' ' HB1' ' A' ' 45' ' ' ALA . 86.9 t -106.53 146.52 12.96 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 C-N-CA 122.613 0.365 . . . . 0.0 110.167 -178.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.407 ' HB3' ' HB2' ' A' ' 54' ' ' SER . . . -52.52 133.54 35.62 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 176.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.434 HG22 ' HA ' ' A' ' 42' ' ' LYS . 76.9 t -60.48 -43.99 95.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.79 -177.087 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -66.08 -32.4 73.83 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.166 179.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.426 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 68.0 m -76.06 -10.81 59.72 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.446 -178.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.558 HD12 ' CE1' ' A' ' 57' ' ' PHE . 0.1 OUTLIER -92.68 123.38 35.92 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -179.947 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 28.0 mmm180 -104.47 110.74 23.13 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.757 -170.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.558 ' CE1' HD12 ' A' ' 55' ' ' LEU . 69.2 m-85 -110.48 126.95 54.9 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-O 121.043 0.449 . . . . 0.0 110.622 175.507 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.556 HD22 ' CE1' ' A' ' 84' ' ' TYR . 7.7 mp -129.1 144.94 51.37 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.184 178.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.74 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 62.5 t80 -111.41 116.46 30.96 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.054 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 58.71 18.7 6.15 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 122.673 0.389 . . . . 0.0 111.907 -179.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 98.98 6.72 55.9 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.774 -0.727 . . . . 0.0 113.234 178.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.74 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.1 OUTLIER -118.33 146.6 44.24 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.01 0.433 . . . . 0.0 110.06 176.815 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.507 ' HA ' ' HG ' ' A' ' 58' ' ' LEU . 38.9 mtp180 -68.4 134.96 51.01 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.525 -0.762 . . . . 0.0 112.51 -174.302 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 90.8 mt -91.15 119.86 39.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 115.399 -0.819 . . . . 0.0 108.828 178.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.704 ' HA ' ' SD ' ' A' ' 37' ' ' MET . 65.5 m-80 -118.6 159.36 23.73 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.635 -178.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -71.07 -12.96 61.81 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.191 0.52 . . . . 0.0 110.433 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -83.62 -19.45 35.43 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.097 -179.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -62.31 145.25 54.31 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.316 0.579 . . . . 0.0 112.263 -177.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.431 ' O ' HG22 ' A' ' 72' ' ' THR . 69.4 p -103.38 158.06 32.57 Favored Pre-proline 0 N--CA 1.44 -0.951 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.18 179.221 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -61.63 -21.59 72.42 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.578 2.185 . . . . 0.0 112.51 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.62 -22.47 32.21 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.437 -178.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.431 HG22 ' O ' ' A' ' 69' ' ' THR . 4.7 t -95.35 -32.77 12.79 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -179.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 96.1 mt -71.99 -25.96 62.05 Favored 'General case' 0 C--O 1.218 -0.554 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.025 177.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 48.74 33.34 4.22 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 176.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 65.2 mtt -87.21 158.88 19.02 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.293 -179.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -149.58 -179.42 7.08 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 177.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.402 ' HA ' ' H ' ' A' ' 16' ' ' LYS . 38.1 t70 -56.33 127.88 33.09 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.259 0.552 . . . . 0.0 112.123 -176.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.527 ' HB3' ' HE3' ' A' ' 16' ' ' LYS . 1.0 OUTLIER 67.27 32.63 5.88 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.591 1.556 . . . . 0.0 114.117 174.204 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -78.78 178.68 7.72 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 176.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.6 m -112.35 151.71 14.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 CA-C-O 121.271 0.558 . . . . 0.0 111.784 -174.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.482 HG22 ' HA ' ' A' ' 19' ' ' VAL . 1.0 OUTLIER -131.44 144.81 36.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 CA-C-N 115.453 -0.794 . . . . 0.0 108.878 178.023 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -104.55 139.29 39.65 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.964 -178.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 87.4 t -121.31 130.42 74.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 CA-C-O 121.235 0.54 . . . . 0.0 110.958 -179.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.576 ' HA ' ' NE2' ' A' ' 22' ' ' GLN . 77.4 m-85 -101.11 168.5 9.55 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.198 178.024 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 80.9 mm-40 -67.83 133.52 49.34 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.608 0.718 . . . . 0.0 111.821 -171.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.426 ' HA ' ' O ' ' A' ' 54' ' ' SER . 3.2 pm0 -79.85 157.52 26.97 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.488 -1.233 . . . . 0.0 112.224 -176.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -79.32 -52.18 8.45 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -177.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.43 ' HB3' HG13 ' A' ' 50' ' ' VAL . 56.4 tp . . . . . 0 C--N 1.33 -0.274 0 CA-C-O 120.876 0.37 . . . . 0.0 111.432 -178.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 . . . . . 0 N--CA 1.432 -1.358 0 CA-C-O 121.338 0.59 . . . . 0.0 110.496 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.416 ' O ' ' HD3' ' A' ' 30' ' ' ARG . 9.0 pt -110.5 161.54 8.83 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.048 -174.292 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.51 ' HB2' ' NH1' ' A' ' 30' ' ' ARG . 34.5 ttpt -109.1 144.22 37.43 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -179.231 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.637 HG21 HD12 ' A' ' 81' ' ' ILE . 82.2 mt -132.33 133.61 59.96 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.161 0 CA-C-O 120.775 0.322 . . . . 0.0 111.598 178.142 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.8 mtmt -94.87 105.23 17.14 Favored 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.698 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 75.0 t -82.28 117.64 28.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 175.36 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.536 ' HA ' ' O ' ' A' ' 25' ' ' ASN . 7.6 p -122.05 122.11 65.77 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 CA-C-O 121.727 0.775 . . . . 0.0 111.453 179.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.453 ' HA2' ' HB ' ' A' ' 83' ' ' VAL . . . -91.2 171.98 35.99 Favored Glycine 0 N--CA 1.436 -1.355 0 CA-C-N 114.867 -1.06 . . . . 0.0 111.535 179.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.453 ' C ' ' H ' ' A' ' 24' ' ' SER . 88.1 mm-40 -70.76 -27.32 63.85 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 120.933 0.397 . . . . 0.0 111.895 -176.143 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -79.63 21.84 0.5 Allowed 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.362 175.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.453 ' H ' ' C ' ' A' ' 22' ' ' GLN . 21.2 m 68.59 27.09 6.19 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.687 176.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.536 ' O ' ' HA ' ' A' ' 20' ' ' VAL . 58.2 t30 -93.85 102.09 14.2 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 119.895 -0.722 . . . . 0.0 111.167 -179.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.698 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 35.6 tt0 -112.84 127.49 56.19 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.47 177.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.7 p -136.4 145.0 31.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.712 -177.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 63.5 m170 -92.41 117.59 30.07 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.308 0.575 . . . . 0.0 111.917 -178.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -109.5 141.76 41.49 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.805 174.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.51 ' NH1' ' HB2' ' A' ' 16' ' ' LYS . 23.9 tpp180 -102.57 116.35 32.42 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 177.019 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.545 HG21 HD12 ' A' ' 17' ' ' ILE . 34.5 m -134.43 174.86 12.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.212 -176.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.469 ' O ' ' HB ' ' A' ' 35' ' ' THR . 38.0 ttmt -88.54 158.83 18.18 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.451 ' HB3' ' HB3' ' A' ' 70' ' ' PRO . 98.4 m-85 -55.43 -40.57 71.66 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 174.227 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -101.99 33.81 6.21 Favored Glycine 0 N--CA 1.449 -0.462 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.163 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.482 ' OG1' ' HB ' ' A' ' 31' ' ' VAL . 0.6 OUTLIER -65.69 140.32 58.46 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 121.317 0.58 . . . . 0.0 111.936 179.356 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.511 ' OG ' ' HG2' ' A' ' 39' ' ' LYS . 85.9 p -81.08 160.03 24.59 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.137 178.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.606 ' SD ' ' HA ' ' A' ' 65' ' ' ASN . 26.5 ptt? -60.82 -32.49 71.87 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.933 0.397 . . . . 0.0 110.687 178.096 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.74 -36.27 80.49 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.45 -177.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.511 ' HG2' ' OG ' ' A' ' 36' ' ' SER . 75.6 mmtt -59.63 -41.82 91.31 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.999 -176.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.501 HD23 ' H ' ' A' ' 40' ' ' LEU . 0.5 OUTLIER -89.42 -47.87 7.72 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -179.738 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.627 ' HG2' ' CD1' ' A' ' 57' ' ' PHE . 61.8 mtpt -62.37 -47.93 82.02 Favored 'General case' 0 CA--C 1.492 -1.271 0 CA-C-N 116.282 -0.417 . . . . 0.0 112.09 -174.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -61.69 -43.3 99.12 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 178.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 42.7 t -64.98 -51.51 61.31 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.371 -0.832 . . . . 0.0 111.294 -176.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.511 ' O ' HG22 ' A' ' 48' ' ' THR . 62.9 t80 -65.99 -49.06 69.12 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.937 -179.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.497 ' HB1' ' O ' ' A' ' 50' ' ' VAL . . . -59.74 -35.17 74.04 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.521 0.676 . . . . 0.0 109.788 -178.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -65.31 -47.0 78.08 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.248 -178.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.422 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 14.2 ptm180 -68.35 -26.39 65.57 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.568 -178.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.511 HG22 ' O ' ' A' ' 44' ' ' TYR . 8.8 t -96.71 -3.51 42.42 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -178.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 68.51 35.56 81.66 Favored Glycine 0 C--N 1.335 0.5 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.706 178.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.574 HG11 ' HG3' ' A' ' 86' ' ' GLU . 78.2 t -118.83 144.54 26.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 C-N-CA 122.406 0.282 . . . . 0.0 111.346 -177.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.467 ' HB3' ' HB2' ' A' ' 54' ' ' SER . . . -51.25 129.31 24.32 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.968 176.008 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 77.0 t -61.42 -43.94 97.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.019 -177.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -65.75 -32.43 73.96 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.016 -179.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.468 ' HB3' ' HB3' ' A' ' 87' ' ' GLN . 51.5 m -83.57 -6.17 59.37 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.687 -178.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.521 HD12 ' CE1' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -96.43 121.17 37.95 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 176.617 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.21 126.47 52.26 Favored 'General case' 0 CA--C 1.499 -1.012 0 C-N-CA 120.112 -0.635 . . . . 0.0 110.834 -176.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.627 ' CD1' ' HG2' ' A' ' 41' ' ' LYS . 22.2 m-85 -106.98 131.04 54.5 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 176.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.524 HD13 ' HA ' ' A' ' 63' ' ' ARG . 2.9 mm? -120.88 155.06 34.96 Favored 'General case' 0 N--CA 1.417 -2.075 0 CA-C-O 122.29 1.043 . . . . 0.0 113.068 -174.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.627 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 54.1 t80 -122.79 105.99 10.52 Favored 'General case' 0 C--N 1.282 -2.339 0 CA-C-N 113.289 -1.778 . . . . 0.0 108.103 174.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 54.26 28.46 9.24 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.805 -176.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 96.4 -7.83 66.43 Favored Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.543 -0.753 . . . . 0.0 113.117 177.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.627 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 4.1 ppt_? -104.34 147.15 27.84 Favored 'General case' 0 N--CA 1.438 -1.034 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.078 179.287 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.524 ' HA ' HD13 ' A' ' 58' ' ' LEU . 0.1 OUTLIER -67.9 143.77 55.56 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -171.4 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 81.9 mt -102.87 121.42 54.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.273 -0.876 . . . . 0.0 108.709 174.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.606 ' HA ' ' SD ' ' A' ' 37' ' ' MET . 66.4 m-80 -121.41 172.41 8.07 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 120.916 0.389 . . . . 0.0 110.997 -178.177 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -70.21 -13.21 62.08 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.076 0.465 . . . . 0.0 110.96 -178.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -82.29 -14.82 54.8 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.011 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.431 ' CG ' HH12 ' A' ' 62' ' ' ARG . 4.6 m-20 -65.17 153.73 40.07 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 -177.048 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.42 ' HB ' ' HD2' ' A' ' 70' ' ' PRO . 70.2 p -126.28 159.35 63.11 Favored Pre-proline 0 N--CA 1.435 -1.206 0 CA-C-N 114.156 -1.384 . . . . 0.0 109.54 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.451 ' HB3' ' HB3' ' A' ' 33' ' ' TYR . 33.3 Cg_endo -63.71 -19.49 67.33 Favored 'Trans proline' 0 C--O 1.224 -0.183 0 C-N-CA 122.515 2.143 . . . . 0.0 112.688 -179.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.49 -26.99 37.88 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-O 120.81 0.338 . . . . 0.0 111.143 -178.219 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.404 HG22 ' H ' ' A' ' 69' ' ' THR . 12.3 t -94.82 -36.75 11.54 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 120.861 0.362 . . . . 0.0 110.181 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 95.8 mt -75.33 -23.14 57.22 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 175.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 52.94 29.03 7.22 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.728 178.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.437 ' HA ' ' OD2' ' A' ' 79' ' ' ASP . 66.2 mtt -85.71 157.18 20.36 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.166 -178.081 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.48 ' H ' ' HB2' ' A' ' 79' ' ' ASP . 14.0 pt-20 -152.79 -173.57 4.62 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.157 -178.072 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.445 ' HA ' ' H ' ' A' ' 16' ' ' LYS . 28.3 t70 -57.66 120.84 9.05 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.709 0.766 . . . . 0.0 112.569 -176.303 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.485 ' OD1' ' HE3' ' A' ' 16' ' ' LYS . 29.5 t70 65.86 34.16 7.49 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.442 1.497 . . . . 0.0 111.054 178.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.48 ' HB2' ' H ' ' A' ' 76' ' ' GLU . 31.9 t0 -75.06 176.3 7.37 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.413 177.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 35.3 m -111.87 143.24 22.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 CA-C-O 121.847 0.832 . . . . 0.0 112.883 -174.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.637 HD12 HG21 ' A' ' 17' ' ' ILE . 3.3 mt -128.47 134.15 65.27 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 CA-C-N 114.234 -1.348 . . . . 0.0 109.425 176.026 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -101.7 138.16 39.06 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.105 0.478 . . . . 0.0 110.677 -177.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.453 ' HB ' ' HA2' ' A' ' 21' ' ' GLY . 88.6 t -123.5 133.76 68.26 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.644 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.481 ' CD1' HD23 ' A' ' 58' ' ' LEU . 53.7 m-85 -99.5 152.48 19.95 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 175.279 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 10.5 mm100 -68.32 129.24 39.34 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 122.004 0.907 . . . . 0.0 112.568 -169.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.574 ' HG3' HG11 ' A' ' 50' ' ' VAL . 1.4 pm0 -64.05 160.87 17.12 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 113.473 -1.694 . . . . 0.0 113.548 -172.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.468 ' HB3' ' HB3' ' A' ' 54' ' ' SER . 6.6 tp-100 -64.96 -48.72 73.01 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.404 -178.212 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.5 HD23 ' HA ' ' A' ' 50' ' ' VAL . 56.7 tp . . . . . 0 C--N 1.322 -0.604 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.868 -179.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 . . . . . 0 N--CA 1.439 -1.021 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.423 ' HB ' ' HA ' ' A' ' 77' ' ' ASP . 18.3 pt -127.16 161.95 33.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -177.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.536 ' HE3' ' HB2' ' A' ' 78' ' ' ASP . 59.3 mtmt -97.55 146.47 25.23 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-O 121.045 0.45 . . . . 0.0 110.599 176.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.672 HG21 HD12 ' A' ' 81' ' ' ILE . 40.7 mm -128.1 127.37 67.64 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 CA-C-N 115.498 -0.773 . . . . 0.0 109.833 174.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.9 mtmt -96.75 104.77 16.8 Favored 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 177.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.7 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 98.8 t -82.21 116.88 27.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.6 t -113.03 117.61 55.82 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-O 121.082 0.467 . . . . 0.0 110.738 -178.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -88.49 168.58 36.59 Favored Glycine 0 N--CA 1.436 -1.317 0 C-N-CA 120.431 -0.89 . . . . 0.0 111.378 177.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.462 HE21 ' HA ' ' A' ' 84' ' ' TYR . 78.5 mt-30 -67.89 -23.78 65.15 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.191 0.52 . . . . 0.0 111.902 -178.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -79.5 11.27 3.14 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.124 178.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.1 m 69.0 27.29 5.44 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.811 -178.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -95.66 104.63 16.55 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.737 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.7 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 37.7 tt0 -105.02 135.37 46.48 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.673 178.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.1 p -137.17 140.22 42.74 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.457 178.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 55.1 m170 -99.05 113.14 25.18 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 121.307 0.575 . . . . 0.0 111.156 -176.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -110.65 145.38 38.04 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.718 176.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 11.1 tpt180 -99.95 118.07 35.59 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.48 ' HB ' HG21 ' A' ' 35' ' ' THR . 33.3 m -133.56 167.75 25.69 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -178.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 46.0 tttm -90.82 162.96 14.61 Favored 'General case' 0 C--N 1.284 -2.247 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.512 ' O ' ' HB3' ' A' ' 70' ' ' PRO . 94.2 m-85 -55.09 -39.18 69.01 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 176.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.477 ' HA2' ' HG3' ' A' ' 70' ' ' PRO . . . -96.38 19.26 55.35 Favored Glycine 0 N--CA 1.444 -0.805 0 CA-C-N 115.728 -0.669 . . . . 0.0 113.337 -177.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.48 HG21 ' HB ' ' A' ' 31' ' ' VAL . 1.3 m -67.47 136.69 55.03 Favored 'General case' 0 N--CA 1.428 -1.535 0 CA-C-O 121.125 0.488 . . . . 0.0 111.73 179.088 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.572 ' HA ' ' O ' ' A' ' 65' ' ' ASN . 47.0 m -86.28 151.97 23.16 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.497 -178.063 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.476 ' HG2' ' HB2' ' A' ' 66' ' ' ASP . 24.2 ptt? -50.01 -32.27 14.84 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -179.161 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.95 -35.96 78.12 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -178.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -59.44 -40.89 88.24 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.083 0.468 . . . . 0.0 110.137 -177.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.659 HD12 ' CD2' ' A' ' 57' ' ' PHE . 0.2 OUTLIER -86.8 -43.96 12.1 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.544 -177.684 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 61.6 mtpt -62.79 -47.03 85.24 Favored 'General case' 0 CA--C 1.491 -1.293 0 N-CA-C 111.868 0.321 . . . . 0.0 111.868 -177.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -63.72 -40.68 97.35 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 46.6 t -63.73 -48.77 75.69 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.03 -179.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.709 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 43.1 t80 -70.18 -44.84 67.93 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.874 -179.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.427 ' CB ' ' HA ' ' A' ' 52' ' ' VAL . . . -59.47 -34.57 72.71 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.229 0.538 . . . . 0.0 109.822 179.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -66.43 -45.81 78.6 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.331 -0.849 . . . . 0.0 111.613 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.709 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 10.9 ptm85 -65.59 -28.71 69.33 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.898 -178.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.499 HG22 ' O ' ' A' ' 44' ' ' TYR . 9.9 t -93.23 -5.82 49.07 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.718 179.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 66.92 35.4 89.46 Favored Glycine 0 C--N 1.335 0.483 0 CA-C-N 116.036 -0.529 . . . . 0.0 113.277 177.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.708 HG21 ' HG3' ' A' ' 86' ' ' GLU . 1.5 p -121.54 166.16 16.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 116.927 0.364 . . . . 0.0 110.967 -177.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.413 ' HB3' ' HB2' ' A' ' 54' ' ' SER . . . -57.46 128.72 38.47 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.51 179.081 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.427 ' HA ' ' CB ' ' A' ' 45' ' ' ALA . 73.4 t -61.36 -46.24 96.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.553 -0.748 . . . . 0.0 111.585 -177.037 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -77.33 -14.76 59.67 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.987 -176.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.455 ' HB3' ' HB3' ' A' ' 87' ' ' GLN . 70.0 m -85.43 -15.6 42.47 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.528 178.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.452 HD13 ' N ' ' A' ' 56' ' ' ARG . 0.8 OUTLIER -95.03 135.03 37.06 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.452 ' N ' HD13 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -130.43 141.42 50.53 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 120.132 -0.627 . . . . 0.0 111.404 -175.203 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.659 ' CD2' HD12 ' A' ' 40' ' ' LEU . 13.7 m-85 -115.5 136.71 52.8 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-N 115.21 -0.904 . . . . 0.0 108.95 177.228 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.757 HD23 ' CD1' ' A' ' 84' ' ' TYR . 0.9 OUTLIER -129.99 151.12 50.9 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-O 121.589 0.709 . . . . 0.0 111.268 178.773 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.719 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 49.5 t80 -113.89 103.47 11.2 Favored 'General case' 0 C--N 1.284 -2.265 0 CA-C-N 114.921 -1.036 . . . . 0.0 108.713 175.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.7 t70 54.92 24.29 5.72 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.748 -177.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 102.34 -5.7 52.47 Favored Glycine 0 C--N 1.333 0.4 0 CA-C-N 115.601 -0.727 . . . . 0.0 113.663 177.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.719 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.2 OUTLIER -108.4 150.16 27.75 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 117.362 0.581 . . . . 0.0 109.856 178.578 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.493 ' HA ' ' CD1' ' A' ' 58' ' ' LEU . 11.8 mpt_? -66.96 142.86 57.11 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -171.053 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.42 HG21 HD11 ' A' ' 40' ' ' LEU . 44.1 mm -74.59 144.9 11.77 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 CA-C-N 114.816 -1.084 . . . . 0.0 109.502 176.076 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.572 ' O ' ' HA ' ' A' ' 36' ' ' SER . 1.0 OUTLIER -68.35 106.12 2.39 Favored 'General case' 0 N--CA 1.406 -2.655 0 N-CA-C 115.089 1.515 . . . . 0.0 115.089 -170.415 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.476 ' HB2' ' HG2' ' A' ' 37' ' ' MET . 4.1 t70 -91.07 -39.65 12.06 Favored 'General case' 0 C--N 1.257 -3.453 0 N-CA-C 102.834 -3.024 . . . . 0.0 102.834 153.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -117.7 -17.9 9.78 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 110.82 -2.9 . . . . 0.0 110.927 -176.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.569 ' HB2' ' HA ' ' A' ' 65' ' ' ASN . 2.7 m-20 -72.76 168.58 18.5 Favored 'General case' 0 C--N 1.342 0.269 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.964 -176.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.683 ' O ' HG22 ' A' ' 72' ' ' THR . 88.8 m -97.47 130.49 29.23 Favored Pre-proline 0 C--N 1.306 -1.324 0 C-N-CA 120.799 -0.361 . . . . 0.0 110.687 -172.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.512 ' HB3' ' O ' ' A' ' 33' ' ' TYR . 88.6 Cg_exo -52.62 -37.68 74.93 Favored 'Trans proline' 0 CA--C 1.53 0.295 0 C-N-CA 122.756 2.304 . . . . 0.0 112.127 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.02 -25.06 37.49 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.554 179.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.683 HG22 ' O ' ' A' ' 69' ' ' THR . 2.1 t -70.15 -32.81 70.96 Favored 'General case' 0 C--N 1.347 0.473 0 C-N-CA 120.026 -0.67 . . . . 0.0 109.47 178.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 60.4 mt -72.2 -24.99 61.49 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.185 174.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 57.22 40.52 27.93 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.359 179.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 24.7 mmt -72.55 155.62 39.87 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.834 -179.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -151.59 175.75 12.03 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 176.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.423 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 37.6 t70 -58.26 121.35 10.54 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.456 0.646 . . . . 0.0 112.335 -178.057 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.536 ' HB2' ' HE3' ' A' ' 16' ' ' LYS . 13.5 t70 74.19 34.28 0.85 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.351 1.461 . . . . 0.0 111.982 176.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -75.71 177.51 6.79 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.597 -0.441 . . . . 0.0 109.984 177.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 33.1 m -110.23 147.63 14.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 CA-C-O 121.546 0.689 . . . . 0.0 112.28 -173.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.672 HD12 HG21 ' A' ' 17' ' ' ILE . 0.3 OUTLIER -140.61 144.82 26.61 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.302 -179.85 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -110.28 143.08 40.99 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.169 -175.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 86.6 t -125.4 132.43 71.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.131 0.491 . . . . 0.0 111.479 179.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.757 ' CD1' HD23 ' A' ' 58' ' ' LEU . 90.5 m-85 -100.44 162.49 12.91 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.784 177.165 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 53.3 tp60 -69.45 143.97 53.42 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -176.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.708 ' HG3' HG21 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -90.0 171.15 9.77 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 112.991 0.738 . . . . 0.0 112.991 -175.12 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.455 ' HB3' ' HB3' ' A' ' 54' ' ' SER . 51.9 tt0 -62.06 -50.01 73.69 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.044 -0.98 . . . . 0.0 112.613 -178.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.8 mp . . . . . 0 C--N 1.32 -0.712 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.022 -178.009 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.456 ' HB2' ' HG3' ' A' ' 30' ' ' ARG . 90.7 m-85 . . . . . 0 N--CA 1.442 -0.871 0 CA-C-O 121.098 0.475 . . . . 0.0 111.769 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.856 HD12 ' HA ' ' A' ' 76' ' ' GLU . 17.1 pt -109.56 163.62 6.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.326 -174.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.538 ' C ' HD12 ' A' ' 17' ' ' ILE . 38.0 mtmm -90.28 145.88 24.65 Favored 'General case' 0 CA--C 1.5 -0.95 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.654 HD13 ' CG2' ' A' ' 31' ' ' VAL . 1.5 mp -135.18 137.04 50.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.632 173.179 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 18.6 mtmm -97.29 104.53 16.56 Favored 'General case' 0 N--CA 1.437 -1.083 0 C-N-CA 119.979 -0.688 . . . . 0.0 109.191 178.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.627 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 85.3 t -82.64 116.17 26.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.422 179.309 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.8 t -107.69 118.85 56.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-O 120.833 0.349 . . . . 0.0 110.077 179.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.484 ' HA2' ' HB ' ' A' ' 83' ' ' VAL . . . -87.97 177.06 46.13 Favored Glycine 0 C--N 1.314 -0.663 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.414 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.514 ' C ' ' H ' ' A' ' 24' ' ' SER . 91.0 mm-40 -65.62 -36.75 84.63 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -178.102 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.64 18.85 0.22 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.954 0.407 . . . . 0.0 109.99 176.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.514 ' H ' ' C ' ' A' ' 22' ' ' GLN . 51.0 m 62.12 30.41 17.77 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.153 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -92.06 107.07 18.94 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.947 -178.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.627 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 32.2 tt0 -97.4 132.3 43.25 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.892 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.417 HG13 ' HB ' ' A' ' 19' ' ' VAL . 7.4 p -135.76 139.82 45.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.522 178.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 61.7 m170 -95.91 114.0 25.68 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 121.17 0.51 . . . . 0.0 110.916 -176.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -110.37 153.41 24.98 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.583 177.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.456 ' HG3' ' HB2' ' A' ' 14' ' ' TYR . 11.7 tpp180 -108.74 115.59 30.39 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.66 179.3 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.654 ' CG2' HD13 ' A' ' 17' ' ' ILE . 30.3 m -140.36 -178.94 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.412 -178.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.536 ' O ' ' HB ' ' A' ' 35' ' ' THR . 83.6 tttt -88.68 155.22 19.72 Favored 'General case' 0 C--N 1.313 -1.001 0 O-C-N 122.361 -0.212 . . . . 0.0 110.674 -177.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -51.79 -45.41 63.83 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-O 121.381 0.61 . . . . 0.0 110.123 176.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -109.84 35.43 4.88 Favored Glycine 0 N--CA 1.441 -1.012 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.967 179.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.655 ' O ' HD13 ' A' ' 73' ' ' LEU . 0.5 OUTLIER -57.19 143.43 39.12 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 121.475 0.655 . . . . 0.0 110.893 -177.164 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 59.3 m -79.85 150.02 30.79 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.757 -179.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.69 ' HA ' HD21 ' A' ' 40' ' ' LEU . 26.6 ptt? -49.64 -32.31 12.79 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -177.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.24 -36.07 82.42 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -179.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -59.19 -41.48 88.59 Favored 'General case' 0 C--O 1.217 -0.65 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.165 -175.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.719 HD23 ' H ' ' A' ' 40' ' ' LEU . 0.5 OUTLIER -86.25 -45.64 11.09 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.168 -176.87 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -62.45 -47.92 81.92 Favored 'General case' 0 CA--C 1.492 -1.257 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.761 -176.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -65.72 -39.67 91.41 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.166 178.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 44.9 t -64.35 -51.45 63.27 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.34 -178.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.613 ' O ' ' HG3' ' A' ' 47' ' ' ARG . 47.6 t80 -66.82 -44.0 82.3 Favored 'General case' 0 CA--C 1.499 -1.002 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.45 179.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.442 ' HA ' HG12 ' A' ' 50' ' ' VAL . . . -58.58 -36.16 73.53 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.01 0.434 . . . . 0.0 109.855 -179.202 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -67.58 -44.79 77.33 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.778 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.613 ' HG3' ' O ' ' A' ' 44' ' ' TYR . 2.1 ppt_? -64.33 -25.87 68.23 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.65 -178.05 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.534 HG22 ' O ' ' A' ' 44' ' ' TYR . 10.1 t -104.17 -9.33 18.76 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.815 -178.148 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 68.92 39.56 85.14 Favored Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.737 -0.744 . . . . 0.0 113.036 179.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.523 HG21 ' HG3' ' A' ' 86' ' ' GLU . 5.2 p -118.21 164.32 14.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 120.981 0.419 . . . . 0.0 111.026 -178.01 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.596 ' HB3' ' OG ' ' A' ' 54' ' ' SER . . . -59.99 128.55 37.39 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.991 175.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 73.4 t -64.39 -40.96 90.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 121.131 0.491 . . . . 0.0 110.401 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 32.2 p-10 -67.24 -27.83 67.55 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.36 -177.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.596 ' OG ' ' HB3' ' A' ' 51' ' ' ALA . 88.4 p -97.58 1.18 48.55 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.079 0.466 . . . . 0.0 111.618 179.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -96.85 133.49 41.4 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 175.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.75 144.16 35.35 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -174.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.652 ' CG ' HD12 ' A' ' 40' ' ' LEU . 63.4 m-85 -119.14 142.86 47.56 Favored 'General case' 0 CA--C 1.501 -0.921 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.618 176.419 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.639 HD22 ' CE1' ' A' ' 84' ' ' TYR . 8.1 mp -130.84 133.87 46.31 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.628 178.248 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.778 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 0.3 OUTLIER -109.33 114.63 28.47 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.945 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 38.7 t70 66.27 22.48 10.91 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 122.044 0.926 . . . . 0.0 110.674 -177.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 89.9 9.53 65.86 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.41 -0.814 . . . . 0.0 113.055 176.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.778 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.2 OUTLIER -117.62 148.62 41.77 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.753 179.588 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.474 ' HD3' HD11 ' A' ' 58' ' ' LEU . 26.1 mmt85 -65.41 133.26 50.96 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.245 -175.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.486 HD12 ' HB3' ' A' ' 57' ' ' PHE . 87.9 mt -93.67 120.55 43.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.213 -178.317 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.652 ' HA ' ' SD ' ' A' ' 37' ' ' MET . 22.1 m120 -115.83 162.48 17.25 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.773 177.019 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -70.1 -15.0 62.92 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.214 0.53 . . . . 0.0 110.573 -179.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -84.12 -18.83 35.52 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.701 -178.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.65 ' CG ' HH12 ' A' ' 62' ' ' ARG . 65.9 m-20 -71.21 171.49 10.95 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 115.413 1.635 . . . . 0.0 115.413 -172.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.69 ' O ' ' HG ' ' A' ' 73' ' ' LEU . 71.8 p -93.57 156.39 39.76 Favored Pre-proline 0 C--N 1.346 0.449 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.352 -172.036 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.739 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 9.6 Cg_endo -49.77 -26.51 13.6 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 123.352 2.702 . . . . 0.0 113.793 -175.047 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.85 ' HA ' ' CG ' ' A' ' 75' ' ' MET . 0.0 OUTLIER -74.04 -24.35 59.53 Favored 'General case' 0 C--O 1.214 -0.775 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 -179.558 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.563 ' CG2' ' HB3' ' A' ' 68' ' ' ASP . 0.5 OUTLIER -101.85 -6.8 23.12 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 176.126 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.739 ' HB2' ' HA ' ' A' ' 70' ' ' PRO . 0.7 OUTLIER -101.44 24.58 9.43 Favored 'General case' 0 CA--C 1.444 -3.098 0 CA-C-N 111.807 -2.451 . . . . 0.0 115.409 -172.661 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.734 ' HB2' ' O ' ' A' ' 73' ' ' LEU . 35.7 mt-10 76.26 65.62 0.05 Allowed 'General case' 0 C--N 1.303 -1.413 0 CA-C-O 122.903 1.335 . . . . 0.0 111.35 174.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.85 ' CG ' ' HA ' ' A' ' 71' ' ' LYS . 90.1 mtp -39.58 -179.31 0.0 OUTLIER 'General case' 0 C--N 1.267 -2.984 0 CA-C-N 111.812 -2.449 . . . . 0.0 116.201 171.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.856 ' HA ' HD12 ' A' ' 15' ' ' ILE . 14.9 pt-20 -71.74 -178.05 2.14 Favored 'General case' 0 CA--C 1.486 -1.508 0 C-N-CA 124.812 1.245 . . . . 0.0 113.13 -156.488 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -35.34 99.76 0.02 OUTLIER 'General case' 0 CA--C 1.506 -0.74 0 O-C-N 124.862 1.351 . . . . 0.0 113.932 -168.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 14.0 t70 82.42 33.23 0.08 Allowed 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 112.181 -2.281 . . . . 0.0 112.566 171.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -70.44 178.9 2.71 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 119.828 -0.749 . . . . 0.0 109.57 172.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 29.3 m -110.92 151.02 13.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -172.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.487 HG13 ' HG2' ' A' ' 74' ' ' GLU . 1.3 mm -138.87 145.93 26.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.017 -0.992 . . . . 0.0 111.674 -178.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -112.16 138.8 48.34 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 116.114 -0.493 . . . . 0.0 109.83 178.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.484 ' HB ' ' HA2' ' A' ' 21' ' ' GLY . 78.3 t -125.83 132.8 70.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 CA-C-O 121.063 0.459 . . . . 0.0 111.092 179.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.639 ' CE1' HD22 ' A' ' 58' ' ' LEU . 70.7 m-85 -98.84 140.88 32.35 Favored 'General case' 0 N--CA 1.418 -2.056 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 174.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -68.15 127.12 31.75 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 121.806 0.812 . . . . 0.0 112.152 -164.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.523 ' HG3' HG21 ' A' ' 50' ' ' VAL . 13.2 pm0 -64.54 157.44 26.82 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 113.84 -1.527 . . . . 0.0 113.029 -175.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 57.9 tp60 -66.23 -45.22 81.42 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.999 -1.001 . . . . 0.0 112.928 -174.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 93.4 mt . . . . . 0 C--N 1.315 -0.898 0 CA-C-N 116.13 -0.487 . . . . 0.0 112.292 -174.656 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 . . . . . 0 CA--C 1.511 -0.549 0 CA-C-O 121.51 0.672 . . . . 0.0 112.343 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 18.2 pt -126.89 162.89 30.62 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.285 -175.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.412 ' HB2' ' N ' ' A' ' 78' ' ' ASP . 28.3 mtpp -92.27 145.35 24.55 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.048 178.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.406 ' CG2' HD13 ' A' ' 81' ' ' ILE . 31.2 mm -135.02 129.8 51.26 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 CA-C-O 120.856 0.36 . . . . 0.0 111.305 175.288 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 22.3 mtmt -100.34 108.13 20.09 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 177.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.648 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 77.5 t -81.69 117.76 28.25 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 177.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 59.4 t -112.29 118.78 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 CA-C-O 121.189 0.519 . . . . 0.0 110.571 -178.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.415 ' HA2' ' HB ' ' A' ' 83' ' ' VAL . . . -86.89 168.24 39.11 Favored Glycine 0 N--CA 1.436 -1.344 0 C-N-CA 120.494 -0.86 . . . . 0.0 111.44 177.384 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.453 ' HG2' ' O ' ' A' ' 83' ' ' VAL . 87.7 mm-40 -70.87 -20.29 62.54 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.566 0.698 . . . . 0.0 111.498 -178.134 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -84.46 13.84 5.09 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.354 178.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.9 m 67.18 28.73 8.06 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.083 -178.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -95.58 103.28 15.15 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.063 -179.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.648 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 35.4 tt0 -104.03 135.44 45.53 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.03 179.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.2 p -135.64 142.38 39.52 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.389 178.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 27.9 m170 -102.08 117.61 35.17 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 121.252 0.548 . . . . 0.0 112.285 -175.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.433 ' HZ ' ' CD ' ' A' ' 47' ' ' ARG . 81.0 m-85 -116.33 146.87 42.1 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.49 175.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 49.5 ttp180 -104.45 123.02 46.72 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 174.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 33.4 m -133.43 174.34 13.37 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.374 -175.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.4 ttpp -88.41 157.7 18.6 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -178.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.498 ' O ' ' HB3' ' A' ' 70' ' ' PRO . 90.8 m-85 -52.3 -41.22 62.74 Favored 'General case' 0 C--O 1.224 -0.268 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 175.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -104.97 32.31 7.64 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.954 -178.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.536 HG23 ' HB2' ' A' ' 39' ' ' LYS . 1.1 m -67.76 134.57 51.25 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 121.28 0.562 . . . . 0.0 111.913 178.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.544 ' HB3' ' HA ' ' A' ' 66' ' ' ASP . 69.9 m -91.26 156.31 17.91 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.528 -179.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.434 ' HB3' HG22 ' A' ' 64' ' ' ILE . 24.9 ptt? -45.67 -35.75 4.38 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -178.025 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.69 -37.74 85.22 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -176.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.536 ' HB2' HG23 ' A' ' 35' ' ' THR . 76.0 mmtt -59.99 -39.87 87.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.778 0.323 . . . . 0.0 110.205 -175.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.58 HD12 ' CD1' ' A' ' 57' ' ' PHE . 0.4 OUTLIER -87.58 -42.79 12.47 Favored 'General case' 0 C--O 1.217 -0.629 0 N-CA-C 112.665 0.616 . . . . 0.0 112.665 -177.545 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.479 ' HA ' ' HE1' ' A' ' 57' ' ' PHE . 61.3 mtpt -62.88 -46.24 88.8 Favored 'General case' 0 CA--C 1.493 -1.22 0 CA-C-O 120.574 0.226 . . . . 0.0 111.514 -178.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.532 ' O ' ' HB2' ' A' ' 46' ' ' ASP . 40.5 ttpt -62.81 -41.28 99.24 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.638 176.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 46.9 t -69.08 -52.19 30.97 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.63 -177.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.669 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 40.3 t80 -64.4 -47.83 77.73 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-O 120.694 0.283 . . . . 0.0 110.935 -178.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.443 ' CB ' ' HA ' ' A' ' 52' ' ' VAL . . . -60.13 -33.68 72.48 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.397 0.617 . . . . 0.0 109.968 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.532 ' HB2' ' O ' ' A' ' 42' ' ' LYS . 20.4 t70 -64.02 -47.15 81.36 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.214 -178.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.669 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 7.8 ptm180 -69.76 -29.25 66.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.392 -177.163 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.525 HG22 ' O ' ' A' ' 44' ' ' TYR . 7.6 t -88.44 -12.75 42.23 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.965 0.412 . . . . 0.0 110.425 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 69.76 31.58 70.34 Favored Glycine 0 CA--C 1.505 -0.558 0 C-N-CA 121.003 -0.618 . . . . 0.0 111.906 179.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.86 HG11 ' HB2' ' A' ' 87' ' ' GLN . 0.5 OUTLIER -115.2 175.12 2.73 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 CA-C-O 120.435 0.16 . . . . 0.0 110.605 -176.064 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.531 ' HB3' ' HB2' ' A' ' 54' ' ' SER . . . -59.16 125.64 24.45 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.912 179.021 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.443 ' HA ' ' CB ' ' A' ' 45' ' ' ALA . 70.2 t -67.1 -44.14 88.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.284 0.564 . . . . 0.0 110.253 178.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -66.16 -34.23 77.57 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.847 -178.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.531 ' HB2' ' HB3' ' A' ' 51' ' ' ALA . 59.2 m -84.98 -13.83 49.4 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.885 -175.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.837 HD23 ' HB3' ' A' ' 87' ' ' GLN . 2.7 tm? -92.98 123.2 36.06 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 179.01 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.409 ' HG3' ' C ' ' A' ' 55' ' ' LEU . 20.4 mtt180 -135.74 146.09 47.3 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.117 -170.091 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.58 ' CD1' HD12 ' A' ' 40' ' ' LEU . 95.2 m-85 -119.97 148.11 43.94 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.965 -179.329 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.415 HD22 ' CE1' ' A' ' 84' ' ' TYR . 7.3 mp -129.07 148.31 51.01 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.517 176.237 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.659 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 18.0 t80 -121.88 120.81 35.59 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 177.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 33.6 t70 61.04 24.05 14.18 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 121.517 0.675 . . . . 0.0 110.707 179.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 87.92 8.38 72.77 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.846 179.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.659 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 6.0 ppt_? -120.44 152.59 37.77 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 120.356 -0.538 . . . . 0.0 111.274 178.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 18.0 mmm180 -65.3 133.95 52.54 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.458 -176.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.434 HG22 ' HB3' ' A' ' 37' ' ' MET . 87.0 mt -85.18 129.37 37.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 173.142 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -109.96 162.23 14.72 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.25 0.547 . . . . 0.0 111.034 -172.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.544 ' HA ' ' HB3' ' A' ' 36' ' ' SER . 10.9 p-10 -83.47 -7.67 59.5 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.178 0.513 . . . . 0.0 109.688 174.048 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -102.81 -13.02 17.17 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 115.361 -0.836 . . . . 0.0 112.324 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.412 ' OD2' HD21 ' A' ' 73' ' ' LEU . 35.9 p30 -71.62 167.08 20.55 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 113.034 0.754 . . . . 0.0 113.034 -174.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.486 ' HB ' ' HD2' ' A' ' 70' ' ' PRO . 53.0 p -120.59 160.23 45.03 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.012 -176.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.498 ' HB3' ' O ' ' A' ' 33' ' ' TYR . 12.7 Cg_endo -56.84 -31.34 88.52 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.125 2.55 . . . . 0.0 113.701 -177.129 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.412 ' HE2' ' HB3' ' A' ' 71' ' ' LYS . 2.8 ptpt -70.18 -48.77 55.77 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.645 0.259 . . . . 0.0 111.066 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.42 HG22 ' H ' ' A' ' 69' ' ' THR . 10.0 t -70.87 -27.87 64.14 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 121.007 0.432 . . . . 0.0 109.928 178.181 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.498 ' HB3' ' HG3' ' A' ' 75' ' ' MET . 74.9 mt -70.84 -27.42 63.84 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 174.286 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 53.84 29.38 9.67 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.223 176.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.498 ' HG3' ' HB3' ' A' ' 73' ' ' LEU . 88.2 mtp -81.9 150.85 27.55 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.411 -177.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -146.73 178.65 8.15 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 177.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -60.58 123.49 17.55 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.729 0.775 . . . . 0.0 112.224 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.412 ' N ' ' HB2' ' A' ' 16' ' ' LYS . 15.4 t70 64.8 33.93 9.8 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 113.865 -1.516 . . . . 0.0 111.033 176.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -76.98 177.84 7.43 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 175.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.0 m -114.43 148.6 17.12 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 CA-C-O 121.742 0.782 . . . . 0.0 112.382 -174.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.406 HD13 ' CG2' ' A' ' 17' ' ' ILE . 1.1 mp -125.75 136.74 59.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 CA-C-N 114.508 -1.224 . . . . 0.0 108.232 177.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -99.97 139.4 35.69 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.143 0.497 . . . . 0.0 110.892 -176.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.559 HG22 ' CD2' ' A' ' 57' ' ' PHE . 86.6 t -123.36 130.45 74.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.114 178.294 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.415 ' CE1' HD22 ' A' ' 58' ' ' LEU . 84.1 m-85 -99.28 149.07 23.5 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 174.101 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -69.31 107.26 3.2 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 121.553 0.692 . . . . 0.0 111.017 -171.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.483 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 1.3 mm-40 176.04 114.65 0.02 OUTLIER 'General case' 0 CA--C 1.476 -1.901 0 C-N-CA 125.984 1.714 . . . . 0.0 110.966 -174.198 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.86 ' HB2' HG11 ' A' ' 50' ' ' VAL . 27.8 pt20 -157.18 13.35 0.24 Allowed 'General case' 0 N--CA 1.384 -3.768 0 CA-C-N 113.425 -1.716 . . . . 0.0 108.337 176.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 52.3 tp . . . . . 0 C--N 1.309 -1.167 0 CA-C-N 112.857 -1.974 . . . . 0.0 107.624 -170.036 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 . . . . . 0 N--CA 1.444 -0.758 0 CA-C-O 120.947 0.403 . . . . 0.0 111.072 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.759 HD12 ' HA ' ' A' ' 76' ' ' GLU . 11.7 pt -109.05 163.01 6.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-O 121.49 0.662 . . . . 0.0 111.369 -173.107 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.528 ' HD3' ' OD2' ' A' ' 77' ' ' ASP . 42.5 mtpt -92.1 147.67 22.77 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.727 -178.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.669 HG13 ' HB3' ' A' ' 74' ' ' GLU . 8.4 mm -139.5 139.34 38.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.613 175.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.5 mtmt -101.92 105.25 16.03 Favored 'General case' 0 N--CA 1.431 -1.388 0 C-N-CA 120.105 -0.638 . . . . 0.0 109.638 177.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.637 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 76.0 t -80.71 114.06 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 176.347 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 59.2 t -109.34 118.65 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.013 0 CA-C-O 121.154 0.502 . . . . 0.0 110.482 -178.141 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -84.62 173.34 49.35 Favored Glycine 0 N--CA 1.436 -1.318 0 C-N-CA 120.321 -0.942 . . . . 0.0 111.013 176.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 86.7 mm-40 -73.36 -19.18 61.07 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.368 0.604 . . . . 0.0 111.83 -176.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -85.5 12.53 8.33 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.161 176.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 51.0 m 67.3 27.13 8.36 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.063 -177.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -89.31 103.4 16.03 Favored 'General case' 0 CA--C 1.495 -1.14 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.876 179.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.637 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 36.3 tt0 -104.89 133.44 49.69 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.978 -177.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.3 p -136.57 141.9 39.73 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.466 178.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.407 ' HA ' ' O ' ' A' ' 17' ' ' ILE . 63.5 m170 -95.37 119.04 33.19 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 121.405 0.622 . . . . 0.0 111.429 -176.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -109.51 150.74 27.69 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.508 175.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 17.1 tpp180 -103.36 118.09 35.97 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 176.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.56 ' O ' HG12 ' A' ' 15' ' ' ILE . 34.6 m -136.75 173.13 14.08 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.715 -175.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -90.13 156.76 18.12 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -55.49 -38.86 69.71 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 121.327 0.584 . . . . 0.0 109.518 175.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -104.45 33.69 6.37 Favored Glycine 0 N--CA 1.44 -1.037 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.395 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.558 ' O ' HD13 ' A' ' 73' ' ' LEU . 0.9 OUTLIER -63.77 131.7 48.67 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-O 121.695 0.759 . . . . 0.0 111.833 179.568 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 69.9 m -81.15 151.88 28.03 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.254 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.671 ' SD ' ' HA ' ' A' ' 65' ' ' ASN . 27.3 ptt? -48.34 -33.5 9.07 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -178.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.52 -36.53 82.87 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 112.203 0.445 . . . . 0.0 112.203 -178.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.52 ' HB2' HG23 ' A' ' 35' ' ' THR . 75.8 mmtt -60.74 -41.19 94.87 Favored 'General case' 0 C--O 1.217 -0.622 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.822 -174.416 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.794 HD23 ' H ' ' A' ' 40' ' ' LEU . 0.9 OUTLIER -87.71 -45.14 10.63 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -178.2 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.444 ' HA ' ' HE1' ' A' ' 57' ' ' PHE . 61.1 mtpt -62.65 -46.09 89.84 Favored 'General case' 0 CA--C 1.494 -1.175 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -177.055 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 41.7 ttmt -62.76 -41.49 99.25 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 121.231 0.539 . . . . 0.0 109.593 176.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 58.8 m -69.16 -51.91 33.4 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -177.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.602 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 43.4 t80 -66.41 -47.51 73.04 Favored 'General case' 0 CA--C 1.505 -0.776 0 N-CA-C 111.779 0.289 . . . . 0.0 111.779 -179.118 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.415 ' CB ' ' HA ' ' A' ' 52' ' ' VAL . . . -59.98 -35.47 75.07 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.318 0.58 . . . . 0.0 110.347 -178.419 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -66.15 -47.1 75.16 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.517 -178.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.602 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 10.6 ptm85 -68.91 -25.72 64.73 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.242 -176.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.455 HG22 ' O ' ' A' ' 44' ' ' TYR . 10.2 t -93.04 -9.9 38.08 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 120.956 0.408 . . . . 0.0 111.123 -179.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.6 40.14 59.6 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.975 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.739 HG21 ' HG3' ' A' ' 86' ' ' GLU . 2.7 p -126.4 162.46 30.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.476 ' HB3' ' OG ' ' A' ' 54' ' ' SER . . . -59.81 130.67 47.92 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 178.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.415 ' HA ' ' CB ' ' A' ' 45' ' ' ALA . 74.8 t -61.63 -44.64 99.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.694 -177.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -66.37 -33.21 75.2 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.673 -178.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.51 ' HB2' ' H ' ' A' ' 87' ' ' GLN . 90.5 p -76.72 -14.45 59.94 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.68 -178.423 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.489 HD13 ' N ' ' A' ' 56' ' ' ARG . 1.0 OUTLIER -95.89 136.97 35.62 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -179.509 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.489 ' N ' HD13 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -140.99 145.48 36.01 Favored 'General case' 0 N--CA 1.436 -1.129 0 C-N-CA 119.853 -0.739 . . . . 0.0 111.509 -176.798 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.497 ' CG ' HD12 ' A' ' 40' ' ' LEU . 92.8 m-85 -118.84 140.96 49.11 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 114.922 -1.035 . . . . 0.0 109.267 176.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.601 HD22 ' CE1' ' A' ' 84' ' ' TYR . 9.2 mp -126.26 145.54 50.37 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.856 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.704 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 0.4 OUTLIER -128.84 117.38 20.96 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 177.157 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 68.13 24.14 7.77 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.387 0.613 . . . . 0.0 110.987 -175.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.1 14.08 77.77 Favored Glycine 0 N--CA 1.438 -1.185 0 CA-C-N 115.414 -0.812 . . . . 0.0 113.001 176.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.704 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.1 OUTLIER -124.2 146.45 48.69 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.232 179.462 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 10.9 mpt_? -67.6 130.1 41.97 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.836 -176.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 83.9 mt -80.09 125.86 39.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.384 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.671 ' HA ' ' SD ' ' A' ' 37' ' ' MET . 20.7 m120 -116.69 171.18 8.04 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 123.343 0.657 . . . . 0.0 109.489 177.255 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -78.8 -8.76 59.07 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -175.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -114.97 16.62 17.14 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 120.229 -0.588 . . . . 0.0 112.162 -178.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.65 ' HB2' HD21 ' A' ' 73' ' ' LEU . 72.0 m-20 -84.22 172.06 12.22 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.579 ' O ' ' HG ' ' A' ' 73' ' ' LEU . 69.2 p -82.91 156.13 67.5 Favored Pre-proline 0 CA--C 1.509 -0.599 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -173.362 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.727 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 17.4 Cg_endo -54.84 -18.68 16.93 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 123.131 2.554 . . . . 0.0 112.61 -176.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.862 ' HA ' ' CG ' ' A' ' 75' ' ' MET . 2.1 tmmm? -70.5 -40.54 73.51 Favored 'General case' 0 N--CA 1.413 -2.312 0 C-N-CA 122.888 0.475 . . . . 0.0 111.812 -179.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.476 ' CG2' ' HB3' ' A' ' 68' ' ' ASP . 1.4 t -96.72 -6.84 35.45 Favored 'General case' 0 CA--C 1.477 -1.839 0 CA-C-O 123.34 1.543 . . . . 0.0 107.021 -178.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.767 ' O ' ' HB2' ' A' ' 74' ' ' GLU . 0.3 OUTLIER -96.53 24.97 5.42 Favored 'General case' 0 CA--C 1.432 -3.587 0 CA-C-N 111.514 -2.585 . . . . 0.0 114.407 -176.761 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.767 ' HB2' ' O ' ' A' ' 73' ' ' LEU . 32.7 mt-10 76.23 66.04 0.06 Allowed 'General case' 0 C--N 1.305 -1.327 0 O-C-N 124.747 1.28 . . . . 0.0 111.66 173.067 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.862 ' CG ' ' HA ' ' A' ' 71' ' ' LYS . 76.4 mtm -39.84 -179.32 0.0 OUTLIER 'General case' 0 C--N 1.269 -2.897 0 CA-C-N 112.418 -2.174 . . . . 0.0 116.764 172.46 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.759 ' HA ' HD12 ' A' ' 15' ' ' ILE . 13.6 pt-20 -72.18 178.75 3.68 Favored 'General case' 0 CA--C 1.478 -1.819 0 C-N-CA 124.369 1.068 . . . . 0.0 112.295 -157.052 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.528 ' OD2' ' HD3' ' A' ' 16' ' ' LYS . 7.0 t70 -25.67 97.74 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.705 0 O-C-N 125.392 1.683 . . . . 0.0 114.269 -171.023 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.9 t70 80.23 33.04 0.17 Allowed 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 112.05 -2.341 . . . . 0.0 113.076 168.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -72.04 178.27 3.88 Favored 'General case' 0 C--N 1.36 1.056 0 C-N-CA 119.193 -1.003 . . . . 0.0 109.489 171.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 29.8 m -107.76 152.19 9.56 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -170.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.416 ' HA ' HD13 ' A' ' 81' ' ' ILE . 4.7 mm -135.91 138.88 46.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.499 -179.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -103.34 140.41 37.46 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.198 -179.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 95.6 t -125.69 133.72 68.41 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-O 120.975 0.417 . . . . 0.0 111.227 178.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.601 ' CE1' HD22 ' A' ' 58' ' ' LEU . 79.0 m-85 -107.59 159.3 16.55 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.604 176.207 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 37.5 tp60 -68.62 144.05 54.62 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.19 0.519 . . . . 0.0 111.649 -170.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.739 ' HG3' HG21 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -95.87 161.41 14.02 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.547 -175.589 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.51 ' H ' ' HB2' ' A' ' 54' ' ' SER . 58.3 tp60 -66.75 -44.39 81.56 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.379 -0.828 . . . . 0.0 113.232 -177.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.2 mm? . . . . . 0 C--N 1.32 -0.708 0 CA-C-O 120.881 0.372 . . . . 0.0 111.958 -175.795 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.7 mtp . . . . . 0 N--CA 1.474 0.762 0 N-CA-C 110.421 -0.214 . . . . 0.0 110.421 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.98 149.67 46.42 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.35 178.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -60.89 141.59 57.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.199 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -62.11 -40.98 97.74 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.143 -176.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 62.64 11.79 5.07 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.484 178.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 66.91 126.29 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.516 0.726 . . . . 0.0 112.341 178.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 19.4 pm0 -69.29 165.14 21.25 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.206 178.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.47 -40.77 97.74 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.567 -178.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 89.3 -6.86 83.1 Favored Glycine 0 N--CA 1.445 -0.759 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 -178.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -84.55 83.09 8.13 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 114.469 -0.865 . . . . 0.0 109.681 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 31.1 p30 -162.89 178.39 8.44 Favored 'General case' 0 N--CA 1.424 -1.768 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -177.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -165.84 -74.41 0.03 OUTLIER 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.006 177.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -110.96 -13.68 14.07 Favored 'General case' 0 CA--C 1.496 -1.108 0 CA-C-O 122.303 1.049 . . . . 0.0 109.701 177.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -137.73 160.66 38.62 Favored 'General case' 0 C--N 1.28 -2.443 0 CA-C-N 113.41 -1.723 . . . . 0.0 110.481 -177.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.497 HG12 ' O ' ' A' ' 31' ' ' VAL . 11.9 pt -116.93 163.33 14.18 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.662 -176.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.465 ' HE2' ' HB3' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -96.31 141.54 29.53 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.2 179.644 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.508 HD12 ' CG2' ' A' ' 31' ' ' VAL . 83.7 mt -140.35 137.62 36.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.504 175.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 13.8 mtmm -102.02 106.32 17.2 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.608 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 92.8 t -82.45 119.87 32.82 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.62 178.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 59.1 t -110.81 118.77 58.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-O 120.91 0.386 . . . . 0.0 110.025 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.586 ' HA2' ' HB ' ' A' ' 83' ' ' VAL . . . -90.15 169.41 34.82 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.346 -0.93 . . . . 0.0 112.549 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.472 ' HG2' ' O ' ' A' ' 83' ' ' VAL . 89.8 mm-40 -69.16 -24.38 64.07 Favored 'General case' 0 CA--C 1.504 -0.799 0 CA-C-O 121.39 0.614 . . . . 0.0 110.689 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -69.85 1.6 4.25 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.644 175.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.428 ' H ' ' C ' ' A' ' 22' ' ' GLN . 47.4 m 69.49 27.82 4.8 Favored 'General case' 0 C--N 1.351 0.656 0 CA-C-O 121.994 0.902 . . . . 0.0 109.134 -176.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -98.86 107.1 19.45 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.354 -1.294 . . . . 0.0 111.049 -178.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.608 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 33.7 tt0 -99.3 133.27 43.83 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.418 177.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.6 p -133.8 139.78 47.9 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-N 115.91 -0.587 . . . . 0.0 109.88 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.415 ' HB3' ' HE3' ' A' ' 16' ' ' LYS . 19.0 m170 -96.48 113.28 24.85 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.345 0.593 . . . . 0.0 111.582 -176.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -111.99 150.4 30.63 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.473 179.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.485 ' HD3' ' O ' ' A' ' 15' ' ' ILE . 22.4 tpp180 -107.35 116.95 32.84 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 175.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.508 ' CG2' HD12 ' A' ' 17' ' ' ILE . 35.0 m -138.66 169.02 18.53 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.304 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -178.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 53.9 tttp -89.33 160.1 17.03 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 -177.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -55.38 -38.29 68.66 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.016 0.436 . . . . 0.0 110.126 175.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -102.35 22.65 36.94 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.931 -0.577 . . . . 0.0 113.051 -178.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -62.39 142.36 57.87 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-O 121.323 0.582 . . . . 0.0 112.001 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 69.2 m -91.14 153.47 20.03 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.604 -179.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.407 ' HA ' HD21 ' A' ' 40' ' ' LEU . 27.3 ptt? -49.96 -33.19 16.92 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 112.897 0.702 . . . . 0.0 112.897 -177.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.46 -36.78 81.37 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -178.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -60.13 -40.04 88.41 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.91 0.386 . . . . 0.0 110.766 -176.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.567 HD12 ' CD2' ' A' ' 57' ' ' PHE . 0.2 OUTLIER -86.62 -45.49 10.98 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.928 -177.993 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.554 ' HG2' ' CD1' ' A' ' 57' ' ' PHE . 63.2 mtpt -63.83 -45.44 89.54 Favored 'General case' 0 CA--C 1.498 -1.024 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.639 -177.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -60.55 -44.37 96.19 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 176.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 39.5 t -64.96 -50.22 67.24 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.775 -176.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.554 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 48.8 t80 -68.18 -45.63 72.91 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.517 -179.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.486 ' HB1' ' O ' ' A' ' 50' ' ' VAL . . . -59.24 -36.27 75.15 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.413 0.625 . . . . 0.0 109.725 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -67.01 -47.01 72.74 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.413 -178.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.554 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 10.5 ptm85 -66.3 -24.74 66.6 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.334 -178.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.485 HG22 ' O ' ' A' ' 44' ' ' TYR . 14.6 t -99.36 -5.36 29.73 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.833 -178.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 69.3 30.94 71.38 Favored Glycine 0 C--N 1.336 0.53 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.762 178.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.486 ' O ' ' HB1' ' A' ' 45' ' ' ALA . 83.2 t -118.75 150.19 21.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 C-N-CA 122.445 0.298 . . . . 0.0 110.803 -177.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.497 ' HB3' ' OG ' ' A' ' 54' ' ' SER . . . -51.34 134.72 27.89 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.296 176.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 74.7 t -61.63 -43.28 96.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.602 -178.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -71.82 -15.93 62.16 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.703 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.52 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 73.6 m -81.55 -12.62 58.73 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.645 178.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.495 ' C ' ' HD3' ' A' ' 56' ' ' ARG . 2.6 mm? -94.37 134.84 36.44 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.112 176.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.495 ' HD3' ' C ' ' A' ' 55' ' ' LEU . 0.7 OUTLIER -126.07 114.42 18.39 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.971 -177.658 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.567 ' CD2' HD12 ' A' ' 40' ' ' LEU . 20.0 m-85 -106.12 132.27 52.4 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.172 0.511 . . . . 0.0 111.856 -178.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.564 ' HG ' ' HA ' ' A' ' 63' ' ' ARG . 6.6 mp -129.3 139.98 51.58 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.701 178.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.724 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 88.9 t80 -111.14 121.89 46.46 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 177.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 19.4 t70 55.19 23.56 5.53 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 121.484 0.659 . . . . 0.0 111.544 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 94.85 8.46 59.23 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.793 -0.717 . . . . 0.0 113.16 177.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.724 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.1 OUTLIER -124.79 141.44 52.11 Favored 'General case' 0 CA--C 1.505 -0.758 0 CA-C-O 121.147 0.498 . . . . 0.0 109.759 176.456 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.564 ' HA ' ' HG ' ' A' ' 58' ' ' LEU . 29.5 ptt180 -68.23 139.38 56.03 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -174.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.439 HD12 ' HB3' ' A' ' 57' ' ' PHE . 83.7 mt -88.97 122.42 40.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-N 114.548 -1.206 . . . . 0.0 109.886 -178.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 -109.01 163.99 12.82 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.68 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -81.39 -7.7 59.62 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.142 0.496 . . . . 0.0 109.767 177.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -94.51 -19.25 20.7 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.164 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.514 ' CG ' HH12 ' A' ' 62' ' ' ARG . 39.3 m-20 -62.73 138.19 58.45 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-O 121.179 0.514 . . . . 0.0 111.746 -177.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.442 ' HB ' ' HD2' ' A' ' 70' ' ' PRO . 82.7 p -91.26 162.71 31.48 Favored Pre-proline 0 C--N 1.312 -1.039 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.195 -179.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.442 ' HD2' ' HB ' ' A' ' 69' ' ' THR . 17.9 Cg_endo -59.79 -25.99 80.9 Favored 'Trans proline' 0 CA--C 1.535 0.542 0 C-N-CA 122.107 1.871 . . . . 0.0 111.6 176.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.441 ' HE2' ' N ' ' A' ' 71' ' ' LYS . 0.2 OUTLIER -63.7 -47.01 82.87 Favored 'General case' 0 CA--C 1.483 -1.629 0 CA-C-O 121.96 0.886 . . . . 0.0 110.164 178.69 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.7 t -84.32 -27.14 27.98 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 113.975 -1.466 . . . . 0.0 112.09 -174.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 96.4 mt -82.77 -22.74 34.19 Favored 'General case' 0 C--O 1.216 -0.702 0 C-N-CA 120.289 -0.564 . . . . 0.0 110.798 177.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 38.08 34.27 0.06 Allowed 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 124.833 1.253 . . . . 0.0 113.616 178.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 64.9 mtt -75.35 150.57 38.39 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -152.54 -174.03 4.76 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -178.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -48.94 118.06 2.41 Favored 'General case' 0 C--N 1.32 -0.707 0 O-C-N 123.885 0.74 . . . . 0.0 112.763 -176.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.5 t70 58.42 34.55 24.07 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.23 -1.35 . . . . 0.0 111.479 173.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -69.89 178.13 2.81 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.3 m -114.77 148.77 17.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 CA-C-O 121.594 0.711 . . . . 0.0 112.092 -174.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.483 HD12 HG21 ' A' ' 17' ' ' ILE . 2.6 mt -131.85 137.79 54.17 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.1 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -105.1 133.88 49.13 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -178.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.586 ' HB ' ' HA2' ' A' ' 21' ' ' GLY . 92.6 t -124.08 136.43 60.38 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.874 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.554 ' CD1' HD13 ' A' ' 58' ' ' LEU . 69.8 m-85 -96.78 164.11 12.7 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 58.5 tp60 -67.24 128.7 37.39 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.304 0.573 . . . . 0.0 110.581 -171.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.52 ' HA ' ' O ' ' A' ' 54' ' ' SER . 13.7 pm0 -64.92 151.14 46.49 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 114.935 -1.029 . . . . 0.0 112.256 -177.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 61.8 tp60 -63.42 -50.91 67.95 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.366 -174.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 88.3 mt -72.79 -34.54 66.99 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.67 -0.696 . . . . 0.0 112.798 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -62.14 -42.28 99.72 Favored Glycine 0 CA--C 1.516 0.109 0 C-N-CA 120.215 -0.993 . . . . 0.0 112.16 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.563 0 CA-C-O 118.622 -1.099 . . . . 0.0 112.385 178.403 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.3 tpp . . . . . 0 N--CA 1.471 0.593 0 CA-C-O 120.616 0.246 . . . . 0.0 110.485 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.64 150.12 31.68 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.655 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -82.58 133.49 35.18 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.79 177.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -65.82 -19.45 65.89 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -178.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 76.56 17.69 1.84 Allowed 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.85 0.86 . . . . 0.0 109.915 -176.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -143.81 134.1 24.5 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 177.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 67.3 mm-40 -116.52 178.07 4.47 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 -176.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.7 -40.82 93.66 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.959 0.409 . . . . 0.0 110.254 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -87.39 -48.07 4.41 Favored Glycine 0 N--CA 1.438 -1.202 0 C-N-CA 120.426 -0.893 . . . . 0.0 110.91 175.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 28.1 t70 56.82 33.31 22.86 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.585 0.754 . . . . 0.0 111.147 178.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 31.7 p-10 -111.93 26.14 10.91 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.564 0.697 . . . . 0.0 110.325 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -143.6 148.69 36.26 Favored 'General case' 0 N--CA 1.418 -2.043 0 CA-C-N 115.034 -0.984 . . . . 0.0 109.195 -177.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.57 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 23.5 mt-10 -125.55 38.3 4.2 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.665 -176.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -129.39 160.32 33.45 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 115.747 -0.66 . . . . 0.0 112.466 -173.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.493 ' O ' ' HD2' ' A' ' 30' ' ' ARG . 13.9 pt -124.25 164.17 22.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 114.535 -1.211 . . . . 0.0 108.035 -178.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.441 ' HB2' HH11 ' A' ' 30' ' ' ARG . 17.7 ttpp -99.69 143.41 29.95 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 119.997 -0.681 . . . . 0.0 110.202 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.562 HG21 HD12 ' A' ' 81' ' ' ILE . 74.3 mt -135.75 134.42 51.32 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 CA-C-O 120.87 0.367 . . . . 0.0 111.113 175.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 18.4 mtmt -96.04 107.18 19.45 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.655 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 71.4 t -81.29 117.38 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 177.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.3 t -110.75 118.11 56.5 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -82.52 178.53 53.33 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 120.5 -0.857 . . . . 0.0 111.747 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.511 ' C ' ' H ' ' A' ' 24' ' ' SER . 97.9 mt-30 -66.18 -37.02 84.61 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -178.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -79.29 22.19 0.44 Allowed 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.618 0.723 . . . . 0.0 109.294 177.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.511 ' H ' ' C ' ' A' ' 22' ' ' GLN . 85.0 p 58.97 30.43 20.22 Favored 'General case' 0 CA--C 1.512 -0.517 0 C-N-CA 124.807 1.243 . . . . 0.0 111.201 -179.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -83.6 105.68 14.72 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 114.836 -1.075 . . . . 0.0 109.866 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.655 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 36.5 tt0 -103.67 130.88 51.21 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.699 -177.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.5 p -135.79 140.75 43.7 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.091 177.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 18.4 m170 -96.24 117.13 30.17 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 121.525 0.679 . . . . 0.0 111.935 -175.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.406 ' HZ ' ' CD ' ' A' ' 47' ' ' ARG . 45.6 m-85 -109.6 149.21 30.0 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.604 -1.18 . . . . 0.0 111.039 177.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.493 ' HD2' ' O ' ' A' ' 15' ' ' ILE . 22.8 tpt180 -108.98 117.02 33.11 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 177.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.443 ' O ' HG12 ' A' ' 15' ' ' ILE . 33.0 m -137.69 170.5 17.33 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.35 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.008 -177.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.57 ' HG3' ' O ' ' A' ' 13' ' ' GLU . 38.5 ttmt -89.83 156.29 18.59 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 110.453 -0.203 . . . . 0.0 110.453 -177.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -56.4 -38.91 72.16 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 121.142 0.496 . . . . 0.0 109.691 174.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -98.06 24.76 30.41 Favored Glycine 0 N--CA 1.443 -0.868 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.452 -178.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.48 HG23 ' HB2' ' A' ' 39' ' ' LYS . 1.0 OUTLIER -65.83 140.51 58.39 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-O 121.426 0.631 . . . . 0.0 112.193 179.232 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 66.5 m -91.99 157.19 16.94 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.975 179.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.694 ' SD ' ' HA ' ' A' ' 65' ' ' ASN . 26.4 ptt? -51.47 -31.88 25.03 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -176.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.75 -38.06 86.6 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.198 -0.456 . . . . 0.0 112.097 -177.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.48 ' HB2' HG23 ' A' ' 35' ' ' THR . 75.5 mmtt -60.66 -38.25 84.25 Favored 'General case' 0 C--O 1.217 -0.645 0 CA-C-O 120.672 0.273 . . . . 0.0 111.183 -175.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.514 HD12 ' CG ' ' A' ' 57' ' ' PHE . 0.2 OUTLIER -86.59 -47.32 9.31 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.741 -178.528 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.441 ' HA ' ' HE1' ' A' ' 57' ' ' PHE . 94.3 mttt -62.95 -47.2 84.23 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.99 -177.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -64.27 -38.74 92.11 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.014 178.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 47.5 t -69.07 -53.55 19.75 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.68 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.705 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 45.3 t80 -65.89 -47.22 75.56 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-N 116.227 -0.442 . . . . 0.0 112.18 -178.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.75 -35.68 75.09 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.38 0.609 . . . . 0.0 109.895 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -65.99 -47.15 75.48 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.725 -178.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.705 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 8.7 ptm180 -65.9 -27.94 68.58 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.065 -178.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.517 HG22 ' O ' ' A' ' 44' ' ' TYR . 9.3 t -93.19 -6.74 47.07 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.072 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 69.67 33.16 71.17 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.902 178.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.421 HG22 ' H ' ' A' ' 51' ' ' ALA . 1.6 p -117.7 167.29 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 CA-C-O 120.693 0.282 . . . . 0.0 110.827 -177.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.543 ' HB3' ' OG ' ' A' ' 54' ' ' SER . . . -61.48 128.22 35.25 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.389 178.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 77.2 t -64.24 -43.99 97.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.777 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -67.47 -29.67 69.18 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.708 -177.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.543 ' OG ' ' HB3' ' A' ' 51' ' ' ALA . 88.5 p -82.76 -17.16 45.18 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 119.891 -0.723 . . . . 0.0 111.135 -179.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.503 HD13 ' N ' ' A' ' 56' ' ' ARG . 0.9 OUTLIER -92.59 135.2 34.28 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 -177.183 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.509 ' NH1' ' HA ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -140.96 149.58 42.0 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-O 121.486 0.66 . . . . 0.0 111.693 -177.106 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.514 ' CG ' HD12 ' A' ' 40' ' ' LEU . 58.0 m-85 -117.94 138.8 51.92 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 114.554 -1.203 . . . . 0.0 109.824 179.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.602 HD22 ' CE1' ' A' ' 84' ' ' TYR . 9.2 mp -125.3 137.95 54.07 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.765 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.782 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 23.1 t80 -105.5 114.48 28.68 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 38.0 t70 53.86 29.29 9.57 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-O 121.697 0.761 . . . . 0.0 111.602 -177.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.416 ' O ' HD23 ' A' ' 58' ' ' LEU . . . 95.07 -4.19 67.54 Favored Glycine 0 C--N 1.313 -0.704 0 CA-C-N 115.859 -0.609 . . . . 0.0 113.408 177.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.782 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.1 OUTLIER -106.5 138.88 41.88 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.355 0.598 . . . . 0.0 110.385 178.58 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.507 ' HA ' ' HG ' ' A' ' 58' ' ' LEU . 32.2 mtp-105 -69.01 135.64 51.21 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.882 -174.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 79.3 mt -93.3 121.52 44.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.985 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.694 ' HA ' ' SD ' ' A' ' 37' ' ' MET . 65.0 m-80 -117.31 161.72 19.06 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.486 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -71.75 -13.34 61.68 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.159 0.504 . . . . 0.0 109.826 178.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -76.74 -21.47 55.2 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.65 177.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.415 ' CG ' HH12 ' A' ' 62' ' ' ARG . 66.0 m-20 -71.48 139.9 49.77 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 121.47 0.653 . . . . 0.0 111.444 -179.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.545 ' HB ' ' HD2' ' A' ' 70' ' ' PRO . 47.8 p -101.99 163.95 16.75 Favored Pre-proline 0 C--N 1.304 -1.396 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.92 -178.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.545 ' HD2' ' HB ' ' A' ' 69' ' ' THR . 12.7 Cg_endo -56.39 -37.44 97.07 Favored 'Trans proline' 0 C--N 1.357 1.024 0 C-N-CA 122.427 2.085 . . . . 0.0 113.436 -177.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.446 ' HD3' ' N ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -74.49 -19.5 60.34 Favored 'General case' 0 C--O 1.221 -0.438 0 CA-C-O 121.057 0.456 . . . . 0.0 112.028 179.277 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.446 ' N ' ' HD3' ' A' ' 71' ' ' LYS . 52.1 m -85.0 -45.17 12.4 Favored 'General case' 0 N--CA 1.408 -2.546 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.966 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 98.9 mt -71.2 -25.25 62.43 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.526 178.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 51.57 30.27 6.33 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.836 177.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 20.2 ptp -73.88 162.77 28.74 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.995 0.426 . . . . 0.0 111.464 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -151.56 175.41 12.36 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.724 -177.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -65.9 118.93 10.42 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 121.692 0.758 . . . . 0.0 111.634 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 21.5 t70 70.65 33.91 2.22 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 126.095 1.758 . . . . 0.0 111.587 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -77.86 178.72 7.2 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 176.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.1 m -113.36 146.79 17.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-O 121.7 0.762 . . . . 0.0 111.9 -175.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.562 HD12 HG21 ' A' ' 17' ' ' ILE . 1.2 mt -134.15 141.99 42.25 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.962 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -107.54 146.53 31.73 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.834 0.349 . . . . 0.0 111.473 -176.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.428 ' O ' ' HG3' ' A' ' 22' ' ' GLN . 97.5 t -125.31 132.41 71.13 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.66 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.102 179.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.602 ' CE1' HD22 ' A' ' 58' ' ' LEU . 63.6 m-85 -100.62 143.98 30.15 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.766 175.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 58.7 tp60 -69.85 134.64 48.71 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -176.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.509 ' HA ' ' NH1' ' A' ' 56' ' ' ARG . 1.3 pp20? -94.3 -155.79 0.47 Allowed 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -171.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -82.95 -55.94 4.1 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -171.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.406 HD12 ' H ' ' A' ' 51' ' ' ALA . 85.3 mt -65.49 -39.65 92.14 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -174.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -103.72 5.19 47.1 Favored Glycine 0 C--N 1.307 -1.075 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.087 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.416 ' HA3' ' O ' ' A' ' 86' ' ' GLU . . . . . . . . 0 N--CA 1.439 -1.119 0 CA-C-O 118.763 -1.02 . . . . 0.0 112.571 -178.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.5 ttp . . . . . 0 N--CA 1.476 0.87 0 CA-C-O 120.813 0.34 . . . . 0.0 110.758 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -141.93 126.07 17.41 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.374 178.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -85.22 106.7 16.84 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -60.81 -49.54 77.07 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.997 -176.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 53.26 25.83 4.71 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 177.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -125.44 137.02 53.98 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 121.006 0.432 . . . . 0.0 110.457 -178.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -132.29 144.92 50.93 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.629 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.6 -24.55 62.77 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.108 0.48 . . . . 0.0 110.392 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 78.81 15.67 80.33 Favored Glycine 0 CA--C 1.497 -1.043 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -179.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -132.89 97.74 4.11 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 114.964 -0.618 . . . . 0.0 110.186 -178.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -105.88 100.62 10.16 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 177.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -150.47 153.25 35.54 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.892 -176.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.465 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 40.4 mt-10 -123.59 44.38 2.71 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 121.617 0.722 . . . . 0.0 112.026 -176.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -120.36 157.25 29.64 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.171 177.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.5 pt -125.39 162.34 28.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.442 -176.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.484 ' HE2' ' HB2' ' A' ' 78' ' ' ASP . 38.1 mtmm -97.42 144.47 27.13 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.963 176.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.669 HG21 HD12 ' A' ' 81' ' ' ILE . 45.2 mm -128.08 129.53 69.52 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.979 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.02 178.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 27.5 mtmt -96.67 104.58 16.58 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 174.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.557 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 89.6 t -81.95 111.92 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.863 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 177.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.0 t -108.49 117.72 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.414 ' HA2' ' HB ' ' A' ' 83' ' ' VAL . . . -93.84 164.79 26.58 Favored Glycine 0 N--CA 1.435 -1.42 0 C-N-CA 120.489 -0.862 . . . . 0.0 111.449 178.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.455 ' C ' ' H ' ' A' ' 24' ' ' SER . 98.3 mt-30 -67.95 -23.94 65.11 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.374 0.607 . . . . 0.0 110.44 179.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -70.87 8.92 0.77 Allowed 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.919 175.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.455 ' H ' ' C ' ' A' ' 22' ' ' GLN . 44.5 m 68.96 25.27 6.04 Favored 'General case' 0 C--N 1.348 0.531 0 C-N-CA 123.753 0.821 . . . . 0.0 110.315 -179.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 54.0 t-20 -96.03 107.27 19.54 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.946 -178.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.557 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 28.7 tt0 -105.46 125.77 51.37 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.426 175.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.2 p -137.65 140.94 40.45 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-O 121.099 0.476 . . . . 0.0 111.126 -179.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 62.5 m170 -89.83 118.65 29.58 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.066 -178.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -118.43 143.64 46.53 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.296 171.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 52.9 ttp180 -106.44 121.51 44.4 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 121.528 0.68 . . . . 0.0 110.466 177.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 33.8 m -136.57 172.58 15.02 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 CA-C-N 114.82 -1.082 . . . . 0.0 108.911 -177.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' A' ' 13' ' ' GLU . 50.3 tttm -89.55 160.58 16.63 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -179.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.409 ' C ' ' HB3' ' A' ' 70' ' ' PRO . 95.7 m-85 -54.08 -41.21 67.97 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.976 0.417 . . . . 0.0 110.228 176.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -97.65 22.33 41.38 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.844 -177.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.436 ' HB ' ' O ' ' A' ' 32' ' ' LYS . 0.9 OUTLIER -61.63 143.82 55.48 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-O 121.181 0.515 . . . . 0.0 112.109 179.222 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 65.5 m -91.59 150.72 21.05 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.967 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -49.56 -33.03 13.83 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -177.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.88 -37.12 81.08 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.93 -177.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -61.32 -40.28 93.61 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.853 0.358 . . . . 0.0 110.646 -175.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.514 HD12 ' CD2' ' A' ' 57' ' ' PHE . 0.4 OUTLIER -87.26 -45.28 10.77 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.075 -0.512 . . . . 0.0 112.08 -179.269 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.572 ' HG2' ' CD1' ' A' ' 57' ' ' PHE . 61.4 mtpt -63.01 -45.98 89.8 Favored 'General case' 0 CA--C 1.496 -1.119 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.752 -177.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -62.13 -40.96 97.68 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 48.0 t -66.41 -51.34 57.96 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.168 -0.923 . . . . 0.0 111.326 -178.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.689 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 49.2 t80 -66.64 -45.82 77.78 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.85 -178.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.443 ' HB1' ' O ' ' A' ' 50' ' ' VAL . . . -59.25 -36.03 74.75 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.502 0.668 . . . . 0.0 109.757 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -66.49 -46.34 76.62 Favored 'General case' 0 C--N 1.311 -1.109 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.193 -178.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.689 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 11.4 ptm85 -65.39 -26.84 68.17 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.176 -177.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.528 HG22 ' O ' ' A' ' 44' ' ' TYR . 10.1 t -95.55 -7.42 37.96 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.222 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.81 32.04 66.98 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.406 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.456 HG13 ' HB3' ' A' ' 88' ' ' LEU . 84.5 t -117.74 150.25 19.9 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 C-N-CA 122.6 0.36 . . . . 0.0 110.859 -177.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.443 ' HB3' ' OG ' ' A' ' 54' ' ' SER . . . -52.58 137.05 31.36 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.396 176.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 74.3 t -61.23 -42.97 95.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.14 -179.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -67.26 -25.04 65.87 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.118 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.45 ' HB3' ' H ' ' A' ' 87' ' ' GLN . 74.0 m -74.76 -16.03 60.74 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.88 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -96.44 134.13 40.0 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.238 0.542 . . . . 0.0 110.823 177.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -132.93 125.29 29.51 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.626 178.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.572 ' CD1' ' HG2' ' A' ' 41' ' ' LYS . 12.3 m-85 -108.44 135.15 50.2 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.966 -179.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.58 HD13 ' CD1' ' A' ' 84' ' ' TYR . 6.2 mp -124.05 147.45 47.84 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.98 -178.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.652 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 31.2 t80 -128.96 128.83 44.51 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 176.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 34.7 t70 59.5 27.18 16.28 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 121.653 0.74 . . . . 0.0 110.4 179.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 78.51 17.97 76.69 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.667 178.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.652 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -130.87 151.73 50.97 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.91 178.587 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.449 ' HA ' ' HG ' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -68.06 135.64 52.55 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.807 -175.438 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 86.0 mt -88.1 117.47 31.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 177.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -107.36 153.85 22.16 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.499 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -68.98 -10.94 60.01 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.873 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -85.78 -19.01 31.38 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.036 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.442 ' CG ' HH12 ' A' ' 62' ' ' ARG . 36.9 m-20 -67.43 148.74 51.17 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -175.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.461 ' HB ' ' HD2' ' A' ' 70' ' ' PRO . 31.7 p -96.9 162.29 23.49 Favored Pre-proline 0 N--CA 1.444 -0.755 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.212 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.461 ' HD2' ' HB ' ' A' ' 69' ' ' THR . 19.2 Cg_endo -59.28 -31.51 95.25 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.519 2.146 . . . . 0.0 113.06 -178.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.564 ' HG3' ' N ' ' A' ' 72' ' ' THR . 15.2 ptmt -70.46 -38.83 74.51 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -179.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.564 ' N ' ' HG3' ' A' ' 71' ' ' LYS . 13.4 t -82.09 -29.82 31.58 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 120.971 0.415 . . . . 0.0 110.437 -177.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 96.1 mt -73.25 -22.2 60.46 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 174.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 52.91 28.75 6.87 Favored 'General case' 0 C--N 1.348 0.509 0 O-C-N 124.037 0.836 . . . . 0.0 112.5 175.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 70.8 mtm -85.23 150.36 24.85 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.113 0.483 . . . . 0.0 111.834 -176.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -151.67 -176.61 5.69 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 176.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.438 ' HA ' ' H ' ' A' ' 16' ' ' LYS . 1.3 m-20 -57.33 119.5 6.55 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -177.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.484 ' HB2' ' HE2' ' A' ' 16' ' ' LYS . 18.5 t70 63.22 35.41 12.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 113.972 -1.467 . . . . 0.0 111.082 175.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -76.78 177.66 7.44 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.269 177.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 30.9 m -108.96 138.48 35.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 CA-C-O 121.772 0.796 . . . . 0.0 112.455 -174.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.669 HD12 HG21 ' A' ' 17' ' ' ILE . 1.6 mt -132.36 134.01 59.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.974 178.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -98.18 144.28 27.8 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.245 -174.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.414 ' HB ' ' HA2' ' A' ' 21' ' ' GLY . 84.6 t -129.13 133.98 64.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.993 178.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.58 ' CD1' HD13 ' A' ' 58' ' ' LEU . 57.4 m-85 -98.13 156.71 16.54 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.288 177.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 43.6 tp60 -68.0 133.14 48.53 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.195 0.522 . . . . 0.0 111.097 -171.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.676 ' HG2' ' H ' ' A' ' 89' ' ' GLY . 4.2 pm0 -65.6 158.0 28.34 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.434 -0.803 . . . . 0.0 113.12 -174.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.45 ' H ' ' HB3' ' A' ' 54' ' ' SER . 82.7 mm-40 -72.53 -48.33 41.11 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.992 -177.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.456 ' HB3' HG13 ' A' ' 50' ' ' VAL . 60.5 tp -66.89 -43.26 83.93 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 114.708 -1.133 . . . . 0.0 111.758 -177.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.676 ' H ' ' HG2' ' A' ' 86' ' ' GLU . . . -65.3 -41.62 96.58 Favored Glycine 0 C--N 1.318 -0.438 0 CA-C-N 115.644 -0.707 . . . . 0.0 113.446 -178.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.67 -1.072 . . . . 0.0 112.426 -179.886 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 79.9 mtm . . . . . 0 N--CA 1.476 0.831 0 N-CA-C 110.291 -0.263 . . . . 0.0 110.291 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 59.5 34.84 22.65 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.649 0.737 . . . . 0.0 110.338 -177.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -143.7 -177.3 5.34 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.219 -177.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -64.24 -37.47 87.59 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -74.04 -4.35 34.88 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 121.119 0.485 . . . . 0.0 110.831 -178.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -81.55 116.88 21.53 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.433 178.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -150.07 158.71 44.45 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.442 -177.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -72.54 -23.28 60.97 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.41 0.624 . . . . 0.0 110.045 178.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 100.79 -20.26 48.75 Favored Glycine 0 N--CA 1.437 -1.251 0 CA-C-N 115.157 -0.929 . . . . 0.0 112.073 178.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 31.2 t70 55.26 40.98 31.74 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.922 0.867 . . . . 0.0 109.871 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -158.15 91.71 1.12 Allowed 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -177.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -81.13 159.55 24.64 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.37 -175.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 72.9 29.98 1.77 Allowed 'General case' 0 CA--C 1.508 -0.669 0 C-N-CA 124.174 0.99 . . . . 0.0 110.205 -177.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -132.78 160.21 37.51 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 113.789 -1.551 . . . . 0.0 109.699 178.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.3 pt -120.12 162.46 18.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -176.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.499 ' HD2' ' CG ' ' A' ' 78' ' ' ASP . 38.9 ttmt -101.0 143.55 31.01 Favored 'General case' 0 C--N 1.286 -2.172 0 CA-C-O 121.006 0.432 . . . . 0.0 110.733 179.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.719 HG21 HD12 ' A' ' 81' ' ' ILE . 41.7 mm -127.58 129.56 70.33 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.783 177.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.5 mtmt -100.1 104.16 15.7 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 176.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.723 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 96.7 t -82.41 118.38 30.03 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.52 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.6 t -113.76 118.25 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 CA-C-O 120.927 0.394 . . . . 0.0 109.967 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.414 ' HA2' ' HB ' ' A' ' 83' ' ' VAL . . . -90.86 175.35 40.08 Favored Glycine 0 C--N 1.314 -0.693 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.49 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.498 ' C ' ' H ' ' A' ' 24' ' ' SER . 98.8 mt-30 -64.51 -34.18 77.63 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 121.235 0.541 . . . . 0.0 110.896 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -70.0 8.69 0.68 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.956 176.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.498 ' H ' ' C ' ' A' ' 22' ' ' GLN . 49.9 m 65.96 27.88 10.68 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.859 0.838 . . . . 0.0 109.059 -176.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -87.06 104.87 16.74 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.468 -177.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.723 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 42.6 tt0 -104.61 131.88 51.51 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.588 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.4 p -138.05 137.83 44.15 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.598 179.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 37.7 m170 -97.1 111.18 23.52 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.185 0.516 . . . . 0.0 111.644 -176.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -110.57 149.59 30.16 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.818 176.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 18.4 tpt180 -103.34 121.54 42.96 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.406 HG22 HG12 ' A' ' 17' ' ' ILE . 30.9 m -134.86 174.27 13.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.35 -177.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -88.11 155.28 19.87 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -52.98 -39.0 62.69 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 175.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.52 ' CA ' ' HG3' ' A' ' 70' ' ' PRO . . . -106.86 33.2 6.59 Favored Glycine 0 C--N 1.334 0.44 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.744 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.605 HG23 ' HB2' ' A' ' 39' ' ' LYS . 0.9 OUTLIER -64.38 136.5 57.18 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-O 121.526 0.679 . . . . 0.0 112.442 179.22 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 69.6 m -85.61 155.11 21.27 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.091 -0.958 . . . . 0.0 109.875 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.498 ' HA ' HD21 ' A' ' 40' ' ' LEU . 25.7 ptt? -50.87 -30.49 14.68 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -176.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.49 -37.96 85.56 Favored 'General case' 0 C--O 1.217 -0.642 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 -178.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.605 ' HB2' HG23 ' A' ' 35' ' ' THR . 31.1 mmmt -60.6 -40.03 90.31 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.049 -176.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.498 HD21 ' HA ' ' A' ' 37' ' ' MET . 0.2 OUTLIER -86.49 -46.05 10.54 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.782 -178.465 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 46.4 mttp -62.02 -46.61 88.41 Favored 'General case' 0 C--O 1.212 -0.892 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.43 -178.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.461 ' HA ' HG22 ' A' ' 52' ' ' VAL . 25.0 ttmm -62.47 -42.53 99.55 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.079 0.466 . . . . 0.0 110.058 177.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 45.7 t -62.98 -50.07 72.2 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.289 -176.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.655 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 42.0 t80 -71.43 -43.81 66.01 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.787 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.605 ' HB1' ' O ' ' A' ' 50' ' ' VAL . . . -57.82 -33.26 68.42 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.364 0.602 . . . . 0.0 109.741 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -63.05 -47.72 81.78 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.188 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.655 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 3.5 ptm180 -68.62 -27.84 66.38 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.411 -177.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.459 HG22 ' O ' ' A' ' 44' ' ' TYR . 8.9 t -96.64 -10.77 26.33 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -177.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.56 35.26 67.75 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.248 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.625 HG13 ' HB3' ' A' ' 88' ' ' LEU . 73.7 t -119.32 149.65 21.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 C-N-CA 122.713 0.405 . . . . 0.0 110.891 -177.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.456 ' HB3' ' OG ' ' A' ' 54' ' ' SER . . . -51.81 136.19 28.33 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.347 176.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.461 HG22 ' HA ' ' A' ' 42' ' ' LYS . 76.8 t -60.9 -44.3 97.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.277 -177.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -77.14 -10.01 59.12 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.093 0.473 . . . . 0.0 110.954 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.456 ' OG ' ' HB3' ' A' ' 51' ' ' ALA . 74.9 m -87.36 -10.51 51.95 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.18 176.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -96.34 130.05 43.53 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 177.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.473 ' HD3' ' O ' ' A' ' 85' ' ' GLN . 0.0 OUTLIER -122.49 117.06 25.04 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 121.423 0.63 . . . . 0.0 111.334 -176.696 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.576 ' HZ ' ' CB ' ' A' ' 44' ' ' TYR . 32.6 m-85 -106.14 128.36 53.84 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.529 178.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.534 ' HG ' ' HA ' ' A' ' 63' ' ' ARG . 7.8 mp -121.6 136.12 54.96 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.423 179.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.587 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 83.8 t80 -105.3 116.0 31.22 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 178.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 55.44 23.18 5.59 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.848 -0.614 . . . . 0.0 112.393 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 102.06 2.29 51.68 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 121.089 -0.577 . . . . 0.0 113.514 176.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.587 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -120.29 140.93 50.5 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 117.175 0.488 . . . . 0.0 109.98 176.702 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.534 ' HA ' ' HG ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -68.44 137.56 54.58 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.282 0.563 . . . . 0.0 112.05 -175.347 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.404 HD12 ' HB3' ' A' ' 57' ' ' PHE . 87.1 mt -82.66 125.16 39.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.581 -179.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -99.21 162.94 12.77 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.495 -177.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.415 ' HB3' ' HG2' ' A' ' 37' ' ' MET . 7.1 p-10 -81.79 -6.52 59.14 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 174.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -101.65 -6.28 23.98 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.332 -178.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -62.2 148.77 43.62 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.253 0.549 . . . . 0.0 112.149 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.403 ' H ' HG22 ' A' ' 72' ' ' THR . 49.9 p -113.87 159.53 35.6 Favored Pre-proline 0 C--N 1.319 -0.749 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.531 -179.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.52 ' HG3' ' CA ' ' A' ' 34' ' ' GLY . 77.8 Cg_exo -55.33 -39.38 91.29 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.904 2.403 . . . . 0.0 112.407 -178.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.507 ' HG3' ' H ' ' A' ' 72' ' ' THR . 17.3 ptmt -69.01 -46.76 67.2 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -177.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.507 ' H ' ' HG3' ' A' ' 71' ' ' LYS . 9.0 t -67.19 -27.01 66.91 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-O 120.924 0.393 . . . . 0.0 110.875 -177.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 93.7 mt -90.95 -22.55 20.8 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.676 178.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 43.4 47.8 5.91 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.927 -177.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 74.2 mtm -85.24 161.12 19.7 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.913 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -147.65 -178.39 6.23 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.376 178.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.484 ' HA ' ' H ' ' A' ' 16' ' ' LYS . 34.3 t70 -65.42 120.1 12.22 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.028 0.442 . . . . 0.0 111.357 -178.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.499 ' CG ' ' HD2' ' A' ' 16' ' ' LYS . 3.0 m-20 74.9 33.2 0.77 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.19 1.396 . . . . 0.0 111.783 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -70.43 176.4 4.05 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 177.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.9 t -118.36 136.66 54.84 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 CA-C-O 121.431 0.634 . . . . 0.0 111.163 -174.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.719 HD12 HG21 ' A' ' 17' ' ' ILE . 1.8 mt -131.64 138.85 51.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.307 -177.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -102.85 145.47 29.74 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.255 -173.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.414 ' HB ' ' HA2' ' A' ' 21' ' ' GLY . 90.7 t -126.59 131.01 71.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.26 178.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.465 ' CE1' HD22 ' A' ' 58' ' ' LEU . 78.6 m-85 -99.72 168.56 9.84 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.684 177.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.473 ' O ' ' HD3' ' A' ' 56' ' ' ARG . 43.9 tp60 -66.88 129.9 41.39 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.394 0.616 . . . . 0.0 111.188 -170.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.683 ' HG2' ' H ' ' A' ' 89' ' ' GLY . 4.1 pm0 -65.66 154.1 39.8 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.958 -1.019 . . . . 0.0 112.714 -177.079 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.425 ' HB3' ' CB ' ' A' ' 54' ' ' SER . 61.0 tp60 -72.11 -42.76 65.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.98 -176.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.625 ' HB3' HG13 ' A' ' 50' ' ' VAL . 57.1 tp -67.43 -39.54 85.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.009 -178.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.683 ' H ' ' HG2' ' A' ' 86' ' ' GLU . . . -87.03 -105.03 0.83 Allowed Glycine 0 C--N 1.315 -0.601 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.521 -178.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.92 -0.933 . . . . 0.0 111.399 -178.875 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 79.4 mtm . . . . . 0 N--CA 1.471 0.615 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.17 135.09 55.09 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 120.924 0.392 . . . . 0.0 111.324 -177.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -95.38 110.11 22.18 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.176 178.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -62.08 -36.18 80.91 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.609 178.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 73.29 25.34 2.23 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.403 -179.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 61.43 67.42 0.78 Allowed 'General case' 0 C--O 1.246 0.902 0 CA-C-N 114.876 -1.056 . . . . 0.0 111.821 179.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 59.35 -161.86 0.26 Allowed 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.71 177.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -82.02 -0.93 46.54 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.023 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 128.06 47.95 0.17 Allowed Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -178.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -115.14 122.35 45.82 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.665 -0.267 . . . . 0.0 110.607 -177.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -108.29 100.9 10.15 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.031 0.443 . . . . 0.0 109.979 177.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.574 ' HB1' ' HD1' ' A' ' 14' ' ' TYR . . . -153.11 -49.16 0.1 Allowed 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.772 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 63.84 49.36 2.9 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 114.84 -1.073 . . . . 0.0 112.33 176.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.574 ' HD1' ' HB1' ' A' ' 12' ' ' ALA . 98.4 m-85 -110.54 154.97 22.95 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 121.544 0.687 . . . . 0.0 111.438 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.475 ' HA ' ' OD1' ' A' ' 77' ' ' ASP . 21.8 pt -132.21 162.6 39.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 CA-C-N 114.588 -1.187 . . . . 0.0 108.552 -178.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.468 ' H ' ' HA ' ' A' ' 77' ' ' ASP . 56.5 mtmt -92.88 147.36 22.91 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 121.059 0.457 . . . . 0.0 110.664 175.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.652 HD12 HG21 ' A' ' 31' ' ' VAL . 9.4 mt -128.34 131.75 68.79 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.449 173.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.416 ' HD3' ' OD2' ' A' ' 78' ' ' ASP . 27.4 mtmt -98.93 104.71 16.78 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 176.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.632 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 98.5 t -82.29 115.54 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.1 t -106.06 116.56 50.09 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.495 ' HA2' ' HB ' ' A' ' 83' ' ' VAL . . . -85.16 174.3 49.13 Favored Glycine 0 C--N 1.309 -0.951 0 C-N-CA 120.191 -1.004 . . . . 0.0 112.0 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.425 ' HG3' ' O ' ' A' ' 83' ' ' VAL . 98.3 mt-30 -70.11 -21.88 63.07 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-O 121.447 0.641 . . . . 0.0 110.371 178.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -74.62 0.78 13.91 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.28 174.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.6 t 69.32 26.63 5.28 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -176.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -90.86 106.74 18.73 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-N 114.687 -1.142 . . . . 0.0 110.281 -179.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.632 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 29.4 tt0 -98.83 125.99 44.35 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.453 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.1 p -129.5 139.94 50.39 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.887 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 60.6 m170 -97.67 115.75 28.54 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.441 -175.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -111.55 148.39 33.36 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.706 175.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 26.2 tpt180 -99.22 120.27 39.25 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.652 HG21 HD12 ' A' ' 17' ' ' ILE . 33.0 m -135.86 172.45 15.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.537 -176.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 14' ' ' TYR . 36.9 tttm -90.38 160.76 15.92 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -54.21 -38.42 65.65 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-O 120.996 0.427 . . . . 0.0 110.275 175.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.65 ' CA ' ' HG3' ' A' ' 70' ' ' PRO . . . -98.82 25.88 26.36 Favored Glycine 0 CA--C 1.492 -1.389 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.858 -178.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.756 HG23 ' HB2' ' A' ' 39' ' ' LYS . 1.1 m -68.48 124.7 24.27 Favored 'General case' 0 N--CA 1.41 -2.457 0 CA-C-O 121.673 0.749 . . . . 0.0 111.773 178.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.583 ' HB3' ' HA ' ' A' ' 66' ' ' ASP . 41.2 m -91.82 167.53 12.08 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 114.482 -1.235 . . . . 0.0 109.537 178.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.456 ' HB2' ' CD ' ' A' ' 41' ' ' LYS . 25.2 ptt? -47.32 -39.32 14.53 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -175.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.84 -37.33 81.7 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -175.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.756 ' HB2' HG23 ' A' ' 35' ' ' THR . 29.9 mmmt -60.47 -41.64 94.61 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.273 -176.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.543 HD23 ' H ' ' A' ' 40' ' ' LEU . 0.5 OUTLIER -88.95 -44.08 10.69 Favored 'General case' 0 C--O 1.22 -0.489 0 N-CA-C 112.438 0.532 . . . . 0.0 112.438 -178.964 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.629 ' HE3' ' O ' ' A' ' 55' ' ' LEU . 60.8 mtpt -61.74 -46.79 88.09 Favored 'General case' 0 CA--C 1.488 -1.439 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.798 -176.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.496 ' HA ' HG22 ' A' ' 52' ' ' VAL . 39.0 ttpt -62.12 -40.8 97.14 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 66.6 m -65.59 -49.05 70.22 Favored 'General case' 0 CA--C 1.552 1.021 0 CA-C-N 115.215 -0.902 . . . . 0.0 112.407 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.649 ' O ' ' HG3' ' A' ' 47' ' ' ARG . 59.7 t80 -71.08 -45.13 64.32 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.949 -179.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.635 ' HB1' ' O ' ' A' ' 50' ' ' VAL . . . -58.48 -34.19 70.63 Favored 'General case' 0 CA--C 1.501 -0.914 0 CA-C-O 121.443 0.639 . . . . 0.0 109.585 -178.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -63.08 -48.14 79.92 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.046 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.649 ' HG3' ' O ' ' A' ' 44' ' ' TYR . 0.0 OUTLIER -69.25 -22.66 63.83 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.967 -0.56 . . . . 0.0 112.19 -176.324 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.466 HG22 ' O ' ' A' ' 44' ' ' TYR . 8.8 t -103.3 -7.27 21.24 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.909 0.385 . . . . 0.0 111.939 -177.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.25 31.99 65.75 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.544 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.635 ' O ' ' HB1' ' A' ' 45' ' ' ALA . 80.6 t -113.53 147.29 17.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 C-N-CA 122.886 0.474 . . . . 0.0 110.343 -178.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.588 ' HB3' ' OG ' ' A' ' 54' ' ' SER . . . -56.49 136.52 54.09 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.316 -0.402 . . . . 0.0 109.995 176.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.496 HG22 ' HA ' ' A' ' 42' ' ' LYS . 73.1 t -62.12 -44.4 98.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.469 -176.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -69.29 -31.42 69.9 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.522 -177.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.588 ' OG ' ' HB3' ' A' ' 51' ' ' ALA . 89.8 p -87.42 2.82 49.35 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 120.664 -0.414 . . . . 0.0 111.481 -179.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.713 HD22 ' HG2' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -94.83 121.73 36.72 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 174.147 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -117.15 117.89 30.83 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 119.875 -0.73 . . . . 0.0 112.343 -173.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.517 ' CD1' ' HG2' ' A' ' 41' ' ' LYS . 45.7 m-85 -108.91 130.03 55.43 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.595 176.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.575 HD13 ' CD1' ' A' ' 84' ' ' TYR . 8.0 mp -122.61 144.65 48.98 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 121.466 0.65 . . . . 0.0 111.226 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.676 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 64.5 t80 -118.37 115.1 23.99 Favored 'General case' 0 N--CA 1.426 -1.674 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.081 178.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 53.38 29.15 8.31 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.426 -178.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 96.01 -1.55 63.17 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.958 -0.564 . . . . 0.0 113.435 176.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.676 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -113.62 136.44 52.82 Favored 'General case' 0 CA--C 1.491 -1.326 0 CA-C-O 121.289 0.566 . . . . 0.0 109.672 177.5 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.508 ' HA ' ' HG ' ' A' ' 58' ' ' LEU . 30.1 ptt180 -72.38 133.74 45.08 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.168 -177.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.503 HD11 HD12 ' A' ' 81' ' ' ILE . 68.7 mt -75.61 132.83 32.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 CA-C-N 114.462 -1.244 . . . . 0.0 108.856 -178.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -109.57 169.82 8.46 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.09 0.471 . . . . 0.0 110.758 -175.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.583 ' HA ' ' HB3' ' A' ' 36' ' ' SER . 7.2 p-10 -82.9 -6.33 59.41 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.159 0.504 . . . . 0.0 109.667 175.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -101.3 -16.63 16.88 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.419 -0.809 . . . . 0.0 113.157 -175.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.6 p30 -68.78 161.57 28.18 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -175.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.454 ' HB ' ' HD2' ' A' ' 70' ' ' PRO . 72.0 p -129.9 166.72 24.19 Favored Pre-proline 0 CA--C 1.548 0.901 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.415 -174.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.65 ' HG3' ' CA ' ' A' ' 34' ' ' GLY . 57.2 Cg_exo -54.46 -39.91 85.71 Favored 'Trans proline' 0 C--N 1.369 1.623 0 C-N-CA 123.108 2.539 . . . . 0.0 113.318 -176.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.509 ' HD3' ' N ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -70.27 -23.77 62.94 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 -176.175 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.509 ' N ' ' HD3' ' A' ' 71' ' ' LYS . 5.1 t -95.34 -25.42 16.31 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.194 0.521 . . . . 0.0 110.117 -177.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.471 ' HB3' ' HG3' ' A' ' 75' ' ' MET . 92.7 mt -89.79 -24.34 21.49 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.936 178.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 46.5 30.96 1.19 Allowed 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.555 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.471 ' HG3' ' HB3' ' A' ' 73' ' ' LEU . 66.7 mtt -79.03 153.0 30.58 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.006 -179.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -150.54 -174.81 4.87 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.475 ' OD1' ' HA ' ' A' ' 15' ' ' ILE . 20.0 m-20 -55.0 126.1 23.16 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 -177.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.442 ' HB2' ' HE3' ' A' ' 16' ' ' LYS . 9.0 t70 67.21 35.42 4.47 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 113.882 -1.508 . . . . 0.0 111.489 173.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -70.63 176.38 4.19 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.845 177.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 30.7 m -110.11 136.52 45.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-O 121.588 0.708 . . . . 0.0 111.858 -175.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.503 HD12 HD11 ' A' ' 64' ' ' ILE . 10.8 mm -131.99 137.61 54.42 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.09 -178.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -107.33 142.75 36.63 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.361 -177.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.495 ' HB ' ' HA2' ' A' ' 21' ' ' GLY . 93.4 t -124.55 133.5 69.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-O 121.009 0.433 . . . . 0.0 111.29 178.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.575 ' CD1' HD13 ' A' ' 58' ' ' LEU . 46.7 m-85 -100.23 167.69 10.27 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.492 178.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -67.85 124.65 23.92 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.496 0.665 . . . . 0.0 110.691 -173.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.713 ' HG2' HD22 ' A' ' 55' ' ' LEU . 2.2 mp0 -82.59 162.02 22.07 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.6 -177.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -69.03 -40.09 78.82 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.105 177.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.532 ' HB2' HG13 ' A' ' 50' ' ' VAL . 10.9 mp -102.74 3.97 37.5 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.713 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -92.26 -163.6 37.94 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.56 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.357 0 CA-C-O 118.66 -1.078 . . . . 0.0 111.86 179.457 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.9 tpp . . . . . 0 N--CA 1.471 0.6 0 CA-C-O 121.13 0.491 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -154.27 158.02 39.57 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.266 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -79.63 176.61 9.55 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -69.31 -34.37 74.58 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.792 0.329 . . . . 0.0 110.825 -178.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 61.41 30.48 18.96 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.549 178.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -96.65 131.43 43.32 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.64 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 26.5 pt20 -146.99 161.42 40.84 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.877 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.56 -37.22 85.3 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.43 0.633 . . . . 0.0 110.305 177.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 97.28 -7.66 64.23 Favored Glycine 0 CA--C 1.497 -1.036 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.455 -179.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -62.93 -39.35 94.34 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.229 -0.486 . . . . 0.0 110.707 178.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 65.2 t30 55.92 47.3 20.33 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-O 122.264 1.03 . . . . 0.0 108.656 -175.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -114.66 179.43 3.95 Favored 'General case' 0 N--CA 1.399 -3.002 0 CA-C-N 114.288 -1.324 . . . . 0.0 108.54 -175.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -105.71 27.87 8.04 Favored 'General case' 0 C--N 1.281 -2.394 0 CA-C-O 121.395 0.617 . . . . 0.0 111.448 -175.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -133.06 155.67 48.78 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.689 -178.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.499 ' O ' ' HD2' ' A' ' 30' ' ' ARG . 23.7 pt -122.45 163.14 21.32 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.414 -176.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.434 ' HZ2' ' CG ' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -91.53 144.93 25.04 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.253 178.042 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.52 HD12 HG21 ' A' ' 31' ' ' VAL . 67.8 mt -139.12 133.9 40.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-O 120.87 0.367 . . . . 0.0 111.32 172.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 18.4 mtmt -96.43 106.15 18.34 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.647 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 81.1 t -81.25 116.76 26.1 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 176.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 59.9 t -112.63 117.76 56.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 120.929 0.395 . . . . 0.0 110.095 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.529 ' HA2' ' HB ' ' A' ' 83' ' ' VAL . . . -92.25 171.24 33.66 Favored Glycine 0 C--N 1.314 -0.665 0 C-N-CA 120.434 -0.888 . . . . 0.0 112.588 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.437 ' C ' ' H ' ' A' ' 24' ' ' SER . 97.7 mt-30 -66.45 -27.45 67.82 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 121.232 0.539 . . . . 0.0 110.674 179.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -69.86 4.17 2.17 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.917 175.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.437 ' H ' ' C ' ' A' ' 22' ' ' GLN . 50.9 m 67.54 27.79 7.76 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.878 0.847 . . . . 0.0 109.12 -176.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -91.95 104.83 17.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-N 114.576 -1.193 . . . . 0.0 110.952 -178.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.647 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 30.6 tt0 -100.73 129.53 46.64 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.851 176.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.411 ' CG1' ' HB ' ' A' ' 19' ' ' VAL . 7.5 p -133.26 140.18 47.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.041 179.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 51.4 m170 -94.73 112.87 24.59 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.164 -176.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -110.64 147.36 34.44 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.425 177.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.499 ' HD2' ' O ' ' A' ' 15' ' ' ILE . 12.4 tpt180 -105.17 116.0 31.21 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 175.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.52 HG21 HD12 ' A' ' 17' ' ' ILE . 35.3 m -137.86 172.72 13.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.918 -176.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -89.33 159.92 17.13 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 -177.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -55.04 -38.3 67.79 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.073 0.463 . . . . 0.0 109.753 173.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -100.04 25.92 26.44 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.767 -177.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.594 HG23 ' HB2' ' A' ' 39' ' ' LYS . 1.2 m -71.39 128.44 35.87 Favored 'General case' 0 N--CA 1.425 -1.682 0 CA-C-O 121.529 0.681 . . . . 0.0 112.418 179.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.535 ' HB3' ' HA ' ' A' ' 66' ' ' ASP . 66.9 m -93.11 164.15 13.37 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 114.759 -1.11 . . . . 0.0 111.045 -179.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.541 ' SD ' ' HA ' ' A' ' 65' ' ' ASN . 24.3 ptt? -47.14 -39.21 13.09 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -174.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.76 -37.18 80.94 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -175.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.594 ' HB2' HG23 ' A' ' 35' ' ' THR . 75.8 mmtt -61.1 -40.51 94.03 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.52 -176.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.559 HD12 ' CD2' ' A' ' 57' ' ' PHE . 0.3 OUTLIER -88.06 -44.49 10.92 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.376 -178.618 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.546 ' HG2' ' CD1' ' A' ' 57' ' ' PHE . 61.6 mtpt -62.87 -45.3 93.22 Favored 'General case' 0 CA--C 1.489 -1.376 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.71 -176.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.407 ' O ' ' HB2' ' A' ' 46' ' ' ASP . 24.4 ttmm -61.22 -43.3 99.1 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 176.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 44.5 t -65.78 -51.44 59.11 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.426 -0.806 . . . . 0.0 112.1 -176.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.521 ' O ' HG22 ' A' ' 48' ' ' THR . 41.9 t80 -66.85 -46.57 74.65 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 120.769 0.319 . . . . 0.0 111.488 -179.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.57 -35.08 75.19 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.413 0.625 . . . . 0.0 109.883 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' A' ' 42' ' ' LYS . 32.3 t70 -64.5 -47.37 79.16 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.343 -178.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.518 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 15.4 ptm180 -65.72 -28.5 69.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.539 -177.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.521 HG22 ' O ' ' A' ' 44' ' ' TYR . 7.0 t -93.57 -8.24 41.83 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.234 -179.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.12 30.99 69.33 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.941 -0.647 . . . . 0.0 113.12 178.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.412 HG12 HG23 ' A' ' 48' ' ' THR . 2.5 p -115.09 169.28 6.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -178.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.428 ' HB3' ' HB3' ' A' ' 54' ' ' SER . . . -60.41 136.81 58.16 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.775 0.321 . . . . 0.0 110.666 178.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 79.7 t -61.96 -44.24 98.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-O 121.396 0.617 . . . . 0.0 109.857 179.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -71.33 -21.74 62.01 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.827 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.509 ' HB2' ' HB3' ' A' ' 87' ' ' GLN . 85.2 p -75.75 -12.59 60.21 Favored 'General case' 0 CA--C 1.52 -0.189 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.533 179.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.532 HD12 ' CE1' ' A' ' 57' ' ' PHE . 0.1 OUTLIER -94.45 132.72 38.8 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 177.469 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.72 120.11 25.85 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.125 0.488 . . . . 0.0 110.524 -179.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.559 ' CD2' HD12 ' A' ' 40' ' ' LEU . 32.9 m-85 -110.29 134.3 52.4 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.46 -179.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.534 HD13 ' CD1' ' A' ' 84' ' ' TYR . 7.1 mp -126.75 145.54 50.57 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.906 178.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.785 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 89.2 t80 -117.41 118.32 31.9 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 176.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 30.8 t70 54.05 29.74 10.73 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.738 0.78 . . . . 0.0 111.56 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 90.26 6.08 69.23 Favored Glycine 0 C--N 1.313 -0.741 0 CA-C-N 115.612 -0.722 . . . . 0.0 113.539 176.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.785 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -116.9 143.88 45.18 Favored 'General case' 0 CA--C 1.503 -0.838 0 CA-C-O 121.12 0.486 . . . . 0.0 109.752 177.102 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.491 ' HA ' ' HG ' ' A' ' 58' ' ' LEU . 34.6 mtp-105 -73.14 128.47 35.57 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.001 -175.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 74.6 mt -79.61 129.57 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 177.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.541 ' HA ' ' SD ' ' A' ' 37' ' ' MET . 93.7 m-20 -125.23 176.62 6.62 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 121.169 0.509 . . . . 0.0 111.443 -173.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.535 ' HA ' ' HB3' ' A' ' 36' ' ' SER . 8.9 p-10 -82.98 -6.58 59.54 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.571 177.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -102.16 -13.22 17.54 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.314 -176.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.444 ' HB3' HH22 ' A' ' 62' ' ' ARG . 20.2 p30 -70.97 165.29 23.73 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -176.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.474 ' O ' HG22 ' A' ' 72' ' ' THR . 42.5 p -123.56 159.63 54.47 Favored Pre-proline 0 N--CA 1.443 -0.78 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.056 -175.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.47 ' HD2' ' HB ' ' A' ' 69' ' ' THR . 19.3 Cg_endo -58.61 -31.15 94.04 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.927 2.418 . . . . 0.0 114.097 -176.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.68 -28.55 36.74 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 119.586 -0.845 . . . . 0.0 111.87 -177.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.474 HG22 ' O ' ' A' ' 69' ' ' THR . 12.1 t -79.24 -30.78 43.35 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 120.071 -0.652 . . . . 0.0 109.308 178.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.432 ' HB3' ' HG3' ' A' ' 75' ' ' MET . 94.9 mt -76.65 -23.16 53.3 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.262 175.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 46.21 34.24 2.08 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.119 177.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.432 ' HG3' ' HB3' ' A' ' 73' ' ' LEU . 61.6 mtt -72.36 154.11 41.1 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.774 -177.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -151.13 175.22 12.34 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.434 ' CG ' ' HZ2' ' A' ' 16' ' ' LYS . 38.7 t70 -58.7 122.07 12.61 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.801 0.81 . . . . 0.0 112.76 -177.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.6 t70 66.45 34.74 6.01 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 113.788 -1.551 . . . . 0.0 111.701 177.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -74.8 178.45 5.48 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 175.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 36.0 m -117.26 147.77 20.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 CA-C-O 121.763 0.792 . . . . 0.0 112.87 -175.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.498 HD12 HG21 ' A' ' 17' ' ' ILE . 7.6 mt -128.73 138.25 55.1 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-N 114.318 -1.31 . . . . 0.0 110.164 178.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -104.52 140.45 37.96 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.813 0.34 . . . . 0.0 110.613 -176.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.529 ' HB ' ' HA2' ' A' ' 21' ' ' GLY . 98.4 t -126.42 134.37 66.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-O 121.221 0.534 . . . . 0.0 111.938 -178.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.534 ' CD1' HD13 ' A' ' 58' ' ' LEU . 78.3 m-85 -99.38 168.69 9.84 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.739 177.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.485 ' HG3' ' HA2' ' A' ' 90' ' ' GLY . 64.1 tt0 -66.4 133.01 49.59 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.367 0.603 . . . . 0.0 111.499 -172.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -61.68 151.89 32.44 Favored 'General case' 0 CA--C 1.497 -1.079 0 CA-C-N 115.125 -0.943 . . . . 0.0 112.021 -177.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.509 ' HB3' ' HB2' ' A' ' 54' ' ' SER . 60.5 tp60 -69.19 -40.06 78.29 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.533 179.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -111.62 -1.5 15.73 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.212 -179.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -103.2 -123.41 5.27 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.485 ' HA2' ' HG3' ' A' ' 85' ' ' GLN . . . . . . . . 0 N--CA 1.435 -1.415 0 CA-C-O 118.515 -1.158 . . . . 0.0 112.354 178.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 N--CA 1.475 0.785 0 CA-C-O 120.772 0.32 . . . . 0.0 110.487 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -110.67 123.4 49.95 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 177.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -68.38 -26.07 65.38 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -62.35 -42.45 99.4 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.724 174.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 62.79 74.21 0.44 Allowed 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.099 -0.955 . . . . 0.0 112.055 178.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -81.21 112.52 18.62 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 58.47 -176.39 0.08 Allowed 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.586 -176.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -105.53 -3.22 22.67 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.939 177.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 107.15 73.79 0.85 Allowed Glycine 0 N--CA 1.443 -0.878 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -178.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -133.64 163.0 30.41 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -176.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -119.07 12.12 12.62 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 120.805 0.336 . . . . 0.0 111.426 -178.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -144.98 162.4 37.0 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.337 -179.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -130.5 124.68 32.49 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-O 121.661 0.744 . . . . 0.0 111.996 -177.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -129.39 157.24 42.5 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.82 178.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.5 pt -114.98 161.44 13.73 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -176.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.403 ' H ' ' HA ' ' A' ' 77' ' ' ASP . 23.0 ttmm -103.61 142.82 33.64 Favored 'General case' 0 C--N 1.282 -2.326 0 C-N-CA 120.572 -0.451 . . . . 0.0 109.958 179.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.629 HG21 HD12 ' A' ' 81' ' ' ILE . 41.0 mm -123.59 127.99 74.32 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.169 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.799 177.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.1 mtmt -101.6 103.69 14.52 Favored 'General case' 0 N--CA 1.423 -1.802 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 177.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.776 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 91.3 t -81.69 121.98 35.9 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.87 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 62.0 t -109.99 121.48 62.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.16 0.505 . . . . 0.0 110.285 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -90.97 -174.11 43.94 Favored Glycine 0 CA--C 1.52 0.371 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.937 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -63.75 -38.59 91.68 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -177.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.614 ' HB2' ' OD1' ' A' ' 25' ' ' ASN . 16.0 m-20 -87.33 22.06 2.26 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 178.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 48.9 m 65.35 31.76 10.23 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.863 -178.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.614 ' OD1' ' HB2' ' A' ' 23' ' ' ASP . 14.9 m120 -78.67 106.74 10.86 Favored 'General case' 0 CA--C 1.501 -0.924 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.755 -178.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.776 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 36.6 tt0 -103.08 134.63 46.18 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-O 121.195 0.521 . . . . 0.0 111.279 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.7 p -136.12 141.92 40.2 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.198 178.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 35.6 m170 -101.69 115.14 29.86 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.264 0.554 . . . . 0.0 111.817 -176.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -115.51 148.07 39.92 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.37 175.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 21.4 tpp180 -103.11 120.56 40.91 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 177.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.424 HG22 HG12 ' A' ' 17' ' ' ILE . 32.5 m -134.58 172.22 16.5 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.449 -178.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -89.99 162.56 15.32 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.411 ' C ' ' HB3' ' A' ' 70' ' ' PRO . 83.3 m-85 -56.37 -39.85 73.59 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 175.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -101.22 33.06 6.77 Favored Glycine 0 N--CA 1.446 -0.651 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.388 -179.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.508 HG23 ' HB2' ' A' ' 39' ' ' LYS . 0.9 OUTLIER -68.75 133.42 48.35 Favored 'General case' 0 N--CA 1.428 -1.537 0 CA-C-O 121.47 0.652 . . . . 0.0 111.953 177.908 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.459 ' OG ' ' HG2' ' A' ' 39' ' ' LYS . 86.7 p -78.44 161.6 26.99 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.293 -179.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.638 ' SD ' ' HA ' ' A' ' 65' ' ' ASN . 26.2 ptt? -59.61 -32.29 70.27 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.898 0.38 . . . . 0.0 111.004 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.17 -36.87 83.19 Favored 'General case' 0 C--O 1.219 -0.537 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.628 -177.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.508 ' HB2' HG23 ' A' ' 35' ' ' THR . 32.4 mmmt -59.97 -40.86 90.56 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.609 -175.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.513 HD23 ' H ' ' A' ' 40' ' ' LEU . 0.4 OUTLIER -87.82 -45.87 9.93 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -179.534 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -62.65 -45.32 93.36 Favored 'General case' 0 CA--C 1.501 -0.93 0 N-CA-C 111.798 0.295 . . . . 0.0 111.798 -176.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.531 ' O ' ' HB2' ' A' ' 46' ' ' ASP . 40.0 ttpt -61.95 -42.12 98.75 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.614 176.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.448 ' O ' ' HB3' ' A' ' 46' ' ' ASP . 38.2 t -68.75 -51.17 44.13 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.286 -176.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.487 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 48.7 t80 -68.3 -48.01 66.1 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.9 -178.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.21 -29.34 68.67 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 121.631 0.729 . . . . 0.0 109.679 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.531 ' HB2' ' O ' ' A' ' 42' ' ' LYS . 22.2 t70 -63.16 -46.74 85.76 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.749 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.487 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 25.9 ptt180 -69.09 -30.47 68.79 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.008 0.432 . . . . 0.0 110.926 -175.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.595 HG23 HG12 ' A' ' 50' ' ' VAL . 4.8 t -92.46 -21.53 20.11 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.83 -175.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.3 23.32 57.08 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.39 -0.909 . . . . 0.0 112.985 179.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.72 HG11 HD23 ' A' ' 55' ' ' LEU . 7.8 p -98.74 158.94 3.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.002 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.543 ' HB3' ' OG ' ' A' ' 54' ' ' SER . . . -59.96 132.72 54.83 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 177.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 71.1 t -61.3 -44.19 97.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.158 0.504 . . . . 0.0 110.598 -178.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -66.63 -32.92 74.55 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.015 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.543 ' OG ' ' HB3' ' A' ' 51' ' ' ALA . 83.1 p -76.25 -13.21 60.17 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.302 -0.408 . . . . 0.0 112.066 -178.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.72 HD23 HG11 ' A' ' 50' ' ' VAL . 0.6 OUTLIER -95.56 128.5 42.47 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -178.196 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -121.82 126.86 49.74 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.906 -175.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.546 ' CE1' HD12 ' A' ' 55' ' ' LEU . 65.8 m-85 -106.14 129.83 54.14 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.094 173.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.514 ' HG ' ' HA ' ' A' ' 63' ' ' ARG . 8.1 mp -126.47 147.24 49.85 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 121.21 0.529 . . . . 0.0 111.103 -179.169 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.75 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 45.1 t80 -118.06 114.39 23.05 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 55.89 29.7 14.62 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.097 0.475 . . . . 0.0 112.258 -177.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 92.35 6.78 64.22 Favored Glycine 0 C--N 1.313 -0.717 0 C-N-CA 120.902 -0.666 . . . . 0.0 113.776 175.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.75 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.1 OUTLIER -120.84 136.6 54.87 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 117.204 0.502 . . . . 0.0 109.677 176.708 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.514 ' HA ' ' HG ' ' A' ' 58' ' ' LEU . 5.7 ptm180 -66.92 141.84 57.49 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.309 -0.86 . . . . 0.0 112.542 -175.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 77.7 mt -95.28 120.52 44.8 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.228 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.638 ' HA ' ' SD ' ' A' ' 37' ' ' MET . 21.3 m120 -119.56 164.75 15.37 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.065 0.459 . . . . 0.0 111.376 -178.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -70.66 -12.19 61.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.797 179.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -81.51 -21.01 38.91 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.083 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.458 ' CG ' HH12 ' A' ' 62' ' ' ARG . 66.0 m-20 -74.78 143.54 43.97 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -175.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.447 ' HB ' ' HD2' ' A' ' 70' ' ' PRO . 82.8 p -91.55 161.4 34.41 Favored Pre-proline 0 C--N 1.318 -0.792 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.872 177.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.447 ' HD2' ' HB ' ' A' ' 69' ' ' THR . 19.1 Cg_endo -60.04 -26.69 83.12 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.485 2.124 . . . . 0.0 111.766 177.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.07 -40.44 38.53 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.206 -177.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.1 t -75.83 -31.34 59.31 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.676 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.405 ' HB3' ' HE3' ' A' ' 75' ' ' MET . 97.4 mt -71.98 -25.52 61.88 Favored 'General case' 0 C--O 1.213 -0.837 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.36 177.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 52.19 24.2 2.68 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 123.58 0.752 . . . . 0.0 112.926 174.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.405 ' HE3' ' HB3' ' A' ' 73' ' ' LEU . 23.4 ptp -79.62 161.1 26.1 Favored 'General case' 0 C--N 1.321 -0.643 0 O-C-N 122.123 -0.36 . . . . 0.0 110.982 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -143.74 -178.9 6.14 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -178.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.403 ' HA ' ' H ' ' A' ' 16' ' ' LYS . 34.2 t70 -66.46 118.51 10.19 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.304 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 17.9 t70 71.27 33.54 1.95 Allowed 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.715 1.206 . . . . 0.0 110.475 178.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -84.02 177.36 8.3 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 176.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.5 m -110.47 149.27 13.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 CA-C-O 121.539 0.685 . . . . 0.0 111.836 -174.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.629 HD12 HG21 ' A' ' 17' ' ' ILE . 1.0 OUTLIER -137.61 138.93 44.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 CA-C-N 114.763 -1.108 . . . . 0.0 109.905 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -100.24 146.18 27.2 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.993 0.425 . . . . 0.0 111.499 -174.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 84.0 t -118.62 129.22 75.18 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.252 175.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.503 ' CE1' HD22 ' A' ' 58' ' ' LEU . 60.2 m-85 -100.55 169.42 9.07 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.224 177.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -67.36 148.81 51.14 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.439 0.637 . . . . 0.0 111.536 -173.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.685 ' HG2' ' H ' ' A' ' 89' ' ' GLY . 0.7 OUTLIER -94.55 157.1 16.14 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 114.82 -1.082 . . . . 0.0 112.335 -175.052 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.537 ' H ' ' HB2' ' A' ' 54' ' ' SER . 53.1 tt0 -66.19 -41.78 89.78 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.112 178.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.41 ' HB3' HG23 ' A' ' 50' ' ' VAL . 58.8 tp -63.08 -40.55 97.99 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 178.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.685 ' H ' ' HG2' ' A' ' 86' ' ' GLU . . . 103.24 154.95 24.56 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.89 177.169 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.102 0 CA-C-O 119.041 -0.866 . . . . 0.0 111.08 178.687 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 ptp . . . . . 0 N--CA 1.471 0.587 0 CA-C-O 120.892 0.377 . . . . 0.0 111.046 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -109.15 128.04 54.69 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 174.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 31.6 t70 67.01 -179.75 0.22 Allowed 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -174.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -66.35 -37.42 85.27 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.325 -0.55 . . . . 0.0 109.719 177.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 55.42 33.68 21.39 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.411 177.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.58 87.8 5.73 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-O 121.543 0.687 . . . . 0.0 109.703 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -91.5 162.74 14.42 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.429 -177.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -94.3 125.4 38.91 Favored 'General case' 0 N--CA 1.425 -1.725 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 174.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -71.99 61.29 1.35 Allowed Glycine 0 C--N 1.308 -1.004 0 C-N-CA 120.613 -0.803 . . . . 0.0 113.98 -176.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -85.77 66.82 9.81 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.577 0.703 . . . . 0.0 109.807 177.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -171.34 42.26 0.02 OUTLIER 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.27 162.08 26.79 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.662 -1.154 . . . . 0.0 111.163 -178.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 70.4 35.67 1.94 Allowed 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 122.3 1.048 . . . . 0.0 110.23 -177.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -132.21 167.51 19.67 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 113.644 -1.617 . . . . 0.0 109.417 178.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.424 ' O ' ' HD3' ' A' ' 30' ' ' ARG . 4.3 pt -109.06 161.07 7.58 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -176.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.559 ' HE3' ' OD1' ' A' ' 78' ' ' ASP . 34.3 ttpt -109.82 144.69 37.9 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 -177.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.761 HG21 HD12 ' A' ' 81' ' ' ILE . 82.4 mt -130.29 133.04 64.61 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.183 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.395 178.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.0 mtmt -96.33 105.56 17.65 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 175.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.739 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 88.1 t -81.33 117.58 27.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.4 t -112.94 120.02 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 O-C-N 123.504 0.503 . . . . 0.0 109.769 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.405 ' HA2' ' HB ' ' A' ' 83' ' ' VAL . . . -86.42 -175.45 49.63 Favored Glycine 0 C--N 1.311 -0.821 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.746 -179.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -62.68 -37.58 87.0 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -178.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -88.9 22.57 2.65 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 178.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 54.6 m 64.16 38.53 8.19 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.942 -178.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -79.91 102.34 9.11 Favored 'General case' 0 C--O 1.215 -0.739 0 CA-C-N 115.0 -1.0 . . . . 0.0 108.974 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.739 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 27.7 tt0 -104.35 128.41 52.18 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 120.986 0.422 . . . . 0.0 112.107 -176.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.6 p -141.65 144.07 26.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.283 177.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 61.0 m170 -91.43 117.64 29.86 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -178.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -111.76 144.95 40.21 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.859 172.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.424 ' HD3' ' O ' ' A' ' 15' ' ' ILE . 15.1 tpp180 -108.8 119.88 40.84 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 33.6 m -138.13 174.77 10.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.606 -178.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.513 ' O ' ' HB ' ' A' ' 35' ' ' THR . 36.1 ttpt -88.29 160.4 17.67 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.267 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.641 ' O ' ' HB3' ' A' ' 70' ' ' PRO . 96.7 m-85 -57.18 -44.11 83.27 Favored 'General case' 0 C--O 1.224 -0.244 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 176.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -93.18 21.04 42.37 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.464 -177.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.513 ' HB ' ' O ' ' A' ' 32' ' ' LYS . 0.9 OUTLIER -60.27 139.6 57.52 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-O 121.637 0.732 . . . . 0.0 112.154 179.363 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.9 m -91.35 158.42 16.55 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.433 178.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.405 ' HG2' ' HB3' ' A' ' 66' ' ' ASP . 25.3 ptt? -52.16 -33.35 39.98 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -176.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.42 -35.97 79.03 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -177.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.505 ' HB2' HG23 ' A' ' 35' ' ' THR . 75.1 mmtt -59.15 -41.3 88.01 Favored 'General case' 0 C--O 1.215 -0.749 0 CA-C-O 120.846 0.355 . . . . 0.0 110.691 -175.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.519 HD23 ' H ' ' A' ' 40' ' ' LEU . 0.4 OUTLIER -88.56 -44.19 10.84 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -179.575 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.624 ' HE3' ' O ' ' A' ' 55' ' ' LEU . 61.6 mtpt -62.52 -45.33 93.47 Favored 'General case' 0 CA--C 1.492 -1.279 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.803 -176.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.502 ' HA ' HG22 ' A' ' 52' ' ' VAL . 40.4 ttmt -61.2 -43.58 98.65 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 176.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 58.0 m -62.84 -49.19 75.88 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.309 -176.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.479 ' CB ' ' HZ ' ' A' ' 57' ' ' PHE . 47.7 t80 -71.54 -45.93 60.97 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.735 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.532 ' HB1' ' O ' ' A' ' 50' ' ' VAL . . . -59.0 -33.36 70.62 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 121.301 0.572 . . . . 0.0 109.845 -178.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -63.02 -46.46 87.48 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.415 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 -70.84 -24.78 62.6 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.902 0.382 . . . . 0.0 111.616 -177.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.429 HG22 ' O ' ' A' ' 44' ' ' TYR . 9.9 t -97.29 -5.31 36.99 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.788 -178.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 68.52 30.56 73.13 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.312 178.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.712 HG11 ' HG3' ' A' ' 86' ' ' GLU . 70.6 t -112.81 146.93 16.87 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 C-N-CA 122.628 0.371 . . . . 0.0 110.392 -178.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.561 ' H ' HD12 ' A' ' 88' ' ' LEU . . . -54.47 133.08 45.77 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.974 177.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.502 HG22 ' HA ' ' A' ' 42' ' ' LYS . 72.7 t -61.6 -42.86 95.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.991 -176.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 32.4 p-10 -73.73 -16.77 61.17 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.675 -177.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.547 ' HB2' ' HB3' ' A' ' 87' ' ' GLN . 96.8 p -93.82 -5.8 47.32 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.846 -0.342 . . . . 0.0 111.442 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.624 ' O ' ' HE3' ' A' ' 41' ' ' LYS . 0.1 OUTLIER -94.47 135.18 36.2 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.687 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.479 ' N ' ' HD2' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -130.36 126.61 37.55 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 120.002 -0.679 . . . . 0.0 111.849 -175.844 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.498 ' CE1' HD12 ' A' ' 55' ' ' LEU . 36.4 m-85 -110.27 133.14 53.54 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.39 177.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.518 HD22 ' CE1' ' A' ' 84' ' ' TYR . 9.8 mp -122.52 146.05 47.76 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.123 0.487 . . . . 0.0 111.113 -179.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.72 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 74.0 t80 -118.74 117.54 29.18 Favored 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 175.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 33.9 t70 58.17 28.3 16.3 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.741 0.781 . . . . 0.0 111.225 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 92.39 5.17 65.54 Favored Glycine 0 C--N 1.315 -0.585 0 CA-C-N 115.382 -0.826 . . . . 0.0 113.721 177.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.72 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.2 OUTLIER -122.37 134.47 54.63 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.313 0.578 . . . . 0.0 109.888 177.716 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.487 ' HA ' ' HG ' ' A' ' 58' ' ' LEU . 28.8 ptt180 -66.16 139.84 58.16 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 115.206 -0.906 . . . . 0.0 112.63 -175.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 76.5 mt -89.48 118.05 34.0 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.977 -178.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -105.71 159.85 15.67 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.514 -178.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.405 ' HB3' ' HG2' ' A' ' 37' ' ' MET . 6.9 p-10 -73.97 -14.47 61.04 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.244 0.545 . . . . 0.0 109.731 177.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -81.72 -19.16 42.06 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.78 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -72.88 147.47 45.32 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.197 0.522 . . . . 0.0 111.863 -178.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.431 ' HB ' ' HD2' ' A' ' 70' ' ' PRO . 23.3 p -97.12 160.74 28.3 Favored Pre-proline 0 N--CA 1.439 -1.013 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.545 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.641 ' HB3' ' O ' ' A' ' 33' ' ' TYR . 14.3 Cg_endo -58.21 -32.9 96.87 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.566 2.177 . . . . 0.0 112.535 -178.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.598 ' HG3' ' N ' ' A' ' 72' ' ' THR . 19.8 ptmt -69.0 -43.47 74.77 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.956 -0.565 . . . . 0.0 112.334 -179.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.598 ' N ' ' HG3' ' A' ' 71' ' ' LYS . 12.5 t -76.08 -28.75 57.71 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-O 121.248 0.547 . . . . 0.0 109.667 -178.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 96.1 mt -75.58 -21.59 57.71 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.681 175.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.519 ' HG2' ' O ' ' A' ' 71' ' ' LYS . 8.7 mm-40 52.4 34.03 14.25 Favored 'General case' 0 C--N 1.348 0.524 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 175.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 67.8 mtm -88.34 155.47 19.69 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 120.984 0.421 . . . . 0.0 111.526 -178.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -153.16 -175.19 5.23 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 177.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.444 ' HA ' ' H ' ' A' ' 16' ' ' LYS . 3.5 p-10 -63.85 125.25 23.76 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.758 0.79 . . . . 0.0 112.366 -176.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.559 ' OD1' ' HE3' ' A' ' 16' ' ' LYS . 24.2 t70 64.24 33.39 11.68 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.005 -1.452 . . . . 0.0 110.98 177.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -78.06 177.31 8.42 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.3 m -108.83 144.72 16.75 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 CA-C-O 121.547 0.689 . . . . 0.0 111.948 -174.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.761 HD12 HG21 ' A' ' 17' ' ' ILE . 1.2 mt -137.98 140.76 40.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.27 179.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -102.72 146.02 28.84 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.309 -175.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.405 ' HB ' ' HA2' ' A' ' 21' ' ' GLY . 97.4 t -126.44 132.37 70.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 121.081 0.467 . . . . 0.0 110.996 177.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.518 ' CE1' HD22 ' A' ' 58' ' ' LEU . 79.3 m-85 -108.47 168.75 9.1 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.452 178.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -68.05 141.66 56.11 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.7 0.762 . . . . 0.0 111.697 -173.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.712 ' HG3' HG11 ' A' ' 50' ' ' VAL . 0.5 OUTLIER -104.24 167.16 9.93 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 114.389 -1.278 . . . . 0.0 112.474 -172.621 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.547 ' HB3' ' HB2' ' A' ' 54' ' ' SER . 64.6 tt0 -64.14 -47.65 79.1 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.003 -177.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.561 HD12 ' H ' ' A' ' 51' ' ' ALA . 92.0 mt -91.02 -2.4 57.68 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.165 -0.47 . . . . 0.0 112.24 -177.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.491 ' H ' ' HG2' ' A' ' 86' ' ' GLU . . . -106.55 -110.12 3.45 Favored Glycine 0 N--CA 1.442 -0.951 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 176.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.213 0 CA-C-O 118.44 -1.2 . . . . 0.0 111.633 -179.916 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.0 mtm . . . . . 0 N--CA 1.474 0.74 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.69 97.33 7.87 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-O 120.868 0.366 . . . . 0.0 111.123 -178.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -90.19 5.72 45.8 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.602 0.715 . . . . 0.0 109.204 177.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -61.36 -36.57 80.58 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.507 -1.224 . . . . 0.0 110.44 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 71.89 20.23 4.54 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.882 178.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.431 ' O ' ' HB2' ' A' ' 7' ' ' GLN . . . -65.46 138.26 57.99 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 176.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.431 ' HB2' ' O ' ' A' ' 6' ' ' ALA . 98.8 mt-30 68.2 125.14 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.535 0.734 . . . . 0.0 110.742 -175.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.36 -40.57 94.75 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.099 0.476 . . . . 0.0 110.623 -178.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -178.69 29.6 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.839 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 177.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -63.79 -40.7 97.29 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -176.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -125.73 116.14 21.16 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-O 121.568 0.699 . . . . 0.0 111.227 -173.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -138.45 148.59 44.56 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.575 178.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 61.94 42.34 10.33 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.759 0.79 . . . . 0.0 109.659 -175.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -110.75 164.75 12.44 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.1 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.2 pt -129.08 162.25 36.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.127 -177.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.539 ' HE3' ' HB2' ' A' ' 78' ' ' ASP . 55.7 mtmt -98.7 147.42 24.87 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-O 121.0 0.429 . . . . 0.0 110.308 176.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.56 HD12 HG21 ' A' ' 31' ' ' VAL . 61.3 mt -130.76 128.82 63.45 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.099 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.604 174.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.3 mtmt -95.61 104.45 16.36 Favored 'General case' 0 N--CA 1.426 -1.639 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 176.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.673 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 85.8 t -82.38 110.97 18.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.467 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 5.5 p -121.66 121.68 65.04 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 CA-C-O 121.783 0.802 . . . . 0.0 111.385 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.48 ' HA2' ' HB ' ' A' ' 83' ' ' VAL . . . -91.26 169.03 32.81 Favored Glycine 0 N--CA 1.432 -1.595 0 CA-C-N 114.723 -1.126 . . . . 0.0 112.149 -179.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.475 ' C ' ' H ' ' A' ' 24' ' ' SER . 20.6 pt20 -68.15 -23.14 64.85 Favored 'General case' 0 CA--C 1.494 -1.179 0 CA-C-O 121.857 0.837 . . . . 0.0 110.859 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -70.23 7.52 0.98 Allowed 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 114.163 -1.38 . . . . 0.0 109.907 175.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.475 ' H ' ' C ' ' A' ' 22' ' ' GLN . 49.0 m 66.32 29.94 9.21 Favored 'General case' 0 C--N 1.347 0.463 0 C-N-CA 123.559 0.744 . . . . 0.0 110.363 -178.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.458 ' O ' ' HA ' ' A' ' 20' ' ' VAL . 54.7 t30 -104.59 105.57 15.73 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.564 -178.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.673 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 39.8 tt0 -108.0 132.73 53.21 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.437 0.637 . . . . 0.0 111.112 178.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.3 p -136.14 142.77 37.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.651 179.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 53.8 m170 -100.18 115.61 30.26 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 121.293 0.568 . . . . 0.0 111.791 -175.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -115.48 151.28 35.09 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.724 176.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 53.2 ttp180 -111.23 123.46 50.24 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 173.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.56 HG21 HD12 ' A' ' 17' ' ' ILE . 31.3 m -135.7 174.02 13.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.102 -176.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 24.4 ttpp -88.49 156.67 18.97 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.472 ' C ' ' HB3' ' A' ' 70' ' ' PRO . 90.1 m-85 -51.28 -41.36 60.38 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 176.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -100.27 25.49 28.11 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.844 -0.617 . . . . 0.0 113.244 -177.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.518 HG23 ' HB2' ' A' ' 39' ' ' LYS . 1.1 m -65.26 136.47 56.64 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 121.284 0.564 . . . . 0.0 111.855 178.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.463 ' HB3' ' HA ' ' A' ' 66' ' ' ASP . 49.3 m -84.85 153.95 22.61 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.06 -178.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.462 ' SD ' ' HA ' ' A' ' 65' ' ' ASN . 24.7 ptt? -48.2 -32.32 6.95 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.17 -37.79 84.18 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -176.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.518 ' HB2' HG23 ' A' ' 35' ' ' THR . 75.3 mmtt -62.16 -39.23 91.95 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.767 0.318 . . . . 0.0 110.972 -175.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.523 HD12 ' CD2' ' A' ' 57' ' ' PHE . 0.3 OUTLIER -86.88 -46.04 10.28 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 116.163 -0.471 . . . . 0.0 112.088 -178.564 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.467 ' HG2' ' CD1' ' A' ' 57' ' ' PHE . 59.0 mtpt -62.64 -48.53 78.96 Favored 'General case' 0 CA--C 1.496 -1.104 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 -177.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -63.04 -40.42 97.66 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.006 179.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 47.3 t -66.01 -51.4 58.66 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.078 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.471 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 45.2 t80 -65.34 -46.92 78.29 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.838 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.427 ' HB1' ' O ' ' A' ' 50' ' ' VAL . . . -58.53 -36.68 74.22 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-O 121.374 0.606 . . . . 0.0 109.805 -177.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -66.51 -47.94 71.37 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.227 -178.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.471 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 15.8 ptm180 -71.25 -24.35 62.16 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.73 -177.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.439 HG22 ' O ' ' A' ' 44' ' ' TYR . 12.9 t -95.67 -8.36 34.93 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.579 -178.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.73 30.94 65.5 Favored Glycine 0 C--N 1.336 0.552 0 C-N-CA 121.298 -0.477 . . . . 0.0 113.54 178.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.456 HG11 ' HG2' ' A' ' 86' ' ' GLU . 96.8 t -119.44 150.39 21.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 -178.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.446 ' HB3' ' OG ' ' A' ' 54' ' ' SER . . . -52.26 135.83 31.71 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.242 176.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 72.2 t -61.6 -43.41 96.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.243 -178.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -66.59 -27.24 67.56 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.52 178.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.455 ' OG ' ' HB3' ' A' ' 87' ' ' GLN . 74.2 m -75.09 -12.15 60.25 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.237 179.103 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.412 HD13 ' HA ' ' A' ' 55' ' ' LEU . 1.4 mm? -94.8 135.42 36.32 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.081 0.467 . . . . 0.0 110.28 177.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.46 119.25 17.23 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.127 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.523 ' CD2' HD12 ' A' ' 40' ' ' LEU . 11.0 m-85 -109.37 132.24 54.31 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.39 -179.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.523 ' HG ' ' HA ' ' A' ' 63' ' ' ARG . 9.1 mp -124.8 147.76 48.54 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 121.356 0.598 . . . . 0.0 111.654 -177.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.794 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 49.2 t80 -126.92 126.35 43.1 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 175.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 22.6 t70 58.78 24.56 12.46 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.719 0.771 . . . . 0.0 110.931 -179.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.07 5.83 87.16 Favored Glycine 0 C--N 1.312 -0.795 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.863 179.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.794 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.1 OUTLIER -113.97 144.47 43.03 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 178.046 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.523 ' HA ' ' HG ' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -71.65 132.1 44.11 Favored 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.699 -176.478 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 82.1 mt -74.68 130.72 35.88 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 N-CA-C 107.429 -1.322 . . . . 0.0 107.429 176.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.462 ' HA ' ' SD ' ' A' ' 37' ' ' MET . 15.6 m120 -112.9 165.74 12.04 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 121.236 0.541 . . . . 0.0 111.1 -173.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.463 ' HA ' ' HB3' ' A' ' 36' ' ' SER . 7.2 p-10 -82.66 -6.71 59.52 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 176.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -112.53 -2.4 14.65 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.668 -175.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 31.5 p30 -76.82 167.76 21.27 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.297 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.559 ' O ' HG22 ' A' ' 72' ' ' THR . 41.0 p -116.99 155.25 49.55 Favored Pre-proline 0 C--N 1.316 -0.857 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.702 -178.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.472 ' HB3' ' C ' ' A' ' 33' ' ' TYR . 18.5 Cg_endo -59.52 -31.22 94.23 Favored 'Trans proline' 0 C--O 1.217 -0.548 0 C-N-CA 122.375 2.05 . . . . 0.0 112.417 -178.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.56 ' HD3' ' N ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -75.53 -29.26 59.38 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -179.266 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.56 ' N ' ' HD3' ' A' ' 71' ' ' LYS . 4.9 t -76.08 -29.7 58.06 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.076 -0.65 . . . . 0.0 110.174 -178.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.552 HD21 ' NH1' ' A' ' 62' ' ' ARG . 97.7 mt -92.96 -23.72 18.62 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.355 177.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 40.19 59.14 2.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.506 -175.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 75.6 mtm -84.21 149.02 26.41 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.731 178.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -137.96 -179.29 5.68 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -178.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -64.17 118.19 8.22 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.528 0.68 . . . . 0.0 112.542 -175.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.539 ' HB2' ' HE3' ' A' ' 16' ' ' LYS . 11.8 t70 73.27 34.32 1.03 Allowed 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 113.951 -1.477 . . . . 0.0 111.17 176.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -74.84 177.22 6.39 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.638 177.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.8 t -111.85 130.69 65.0 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 CA-C-O 121.201 0.524 . . . . 0.0 110.939 -173.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.447 HD13 HG23 ' A' ' 17' ' ' ILE . 1.2 mp -118.69 135.1 60.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.434 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -97.59 135.86 38.81 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.589 -175.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.48 ' HB ' ' HA2' ' A' ' 21' ' ' GLY . 93.1 t -126.8 133.52 68.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 CA-C-O 121.163 0.506 . . . . 0.0 110.572 178.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -107.1 168.99 8.82 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.437 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -64.67 136.99 57.56 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-O 121.91 0.862 . . . . 0.0 111.64 -173.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.456 ' HG2' HG11 ' A' ' 50' ' ' VAL . 31.7 mp0 -70.7 156.56 39.33 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 114.169 -1.378 . . . . 0.0 112.286 -174.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.455 ' HB3' ' OG ' ' A' ' 54' ' ' SER . 61.7 tt0 -64.83 -43.98 91.31 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.015 175.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 52.8 tp -93.35 -30.47 15.1 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.101 -179.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.416 ' H ' ' HB2' ' A' ' 86' ' ' GLU . . . -89.92 0.09 78.78 Favored Glycine 0 C--O 1.236 0.251 0 C-N-CA 121.094 -0.574 . . . . 0.0 113.497 -177.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.581 -1.122 . . . . 0.0 111.391 179.009 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.7 ttt . . . . . 0 N--CA 1.47 0.559 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -118.34 133.77 55.61 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 120.649 0.262 . . . . 0.0 110.312 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.539 ' OD1' ' HB2' ' A' ' 6' ' ' ALA . 35.6 t70 -81.38 110.39 16.77 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.008 0.432 . . . . 0.0 111.29 -178.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -65.42 -40.97 93.98 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.8 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -170.76 -30.99 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -177.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.539 ' HB2' ' OD1' ' A' ' 3' ' ' ASP . . . 58.3 39.26 25.74 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.062 -178.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -94.91 146.8 23.98 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.46 -178.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -84.85 -6.35 59.35 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.234 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 143.22 -22.25 2.25 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.345 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 22.1 t70 64.48 27.23 13.49 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.494 0.664 . . . . 0.0 111.114 178.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -101.11 -1.17 34.74 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.36 0.6 . . . . 0.0 110.11 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.65 -44.07 97.2 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 115.222 1.564 . . . . 0.0 115.222 -173.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -117.18 16.26 14.92 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 115.002 1.482 . . . . 0.0 115.002 -171.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -138.05 159.83 40.99 Favored 'General case' 0 C--N 1.283 -2.305 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.47 ' HB ' ' HA ' ' A' ' 77' ' ' ASP . 12.1 pt -116.49 160.76 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.21 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.247 -177.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.402 ' H ' ' HA ' ' A' ' 77' ' ' ASP . 58.8 mtpt -101.21 147.3 26.43 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.652 178.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.423 HG12 HG22 ' A' ' 31' ' ' VAL . 42.8 mm -127.13 126.47 68.13 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.312 176.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.7 mtmt -96.79 103.67 15.6 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 176.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.653 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 94.3 t -82.69 116.07 26.27 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.265 178.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 64.1 t -109.0 118.55 56.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -92.94 179.65 39.77 Favored Glycine 0 C--N 1.312 -0.805 0 C-N-CA 120.207 -0.997 . . . . 0.0 113.062 -178.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 90.9 mm-40 -72.31 -20.2 61.53 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 121.468 0.651 . . . . 0.0 111.714 -178.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -83.37 10.77 7.94 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.324 -0.853 . . . . 0.0 108.963 176.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 40.8 m 63.65 28.47 15.03 Favored 'General case' 0 C--N 1.347 0.498 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -176.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 55.9 t-20 -93.32 106.94 18.84 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.513 -1.221 . . . . 0.0 110.42 -177.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.653 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 29.9 tt0 -99.28 132.02 44.9 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.13 177.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.7 p -136.74 139.94 43.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.461 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 60.1 m170 -98.66 114.55 27.08 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 121.376 0.608 . . . . 0.0 111.709 -176.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -110.63 145.31 38.13 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.284 174.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 57.6 ttp180 -105.33 125.71 51.29 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.1 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.423 HG22 HG12 ' A' ' 17' ' ' ILE . 32.6 m -136.44 175.7 9.72 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.516 -177.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.476 ' O ' ' HB ' ' A' ' 35' ' ' THR . 59.0 tttp -88.37 157.42 18.72 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.418 ' O ' ' HB3' ' A' ' 70' ' ' PRO . 66.2 m-85 -55.9 -41.08 73.95 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 173.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -97.98 31.57 7.79 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.141 -178.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.522 HG23 ' HB2' ' A' ' 39' ' ' LYS . 0.9 OUTLIER -68.63 138.79 55.31 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-O 121.503 0.668 . . . . 0.0 112.378 179.009 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.415 ' OG ' ' HG2' ' A' ' 39' ' ' LYS . 87.7 p -83.09 163.55 20.83 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.705 177.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.703 ' SD ' ' HA ' ' A' ' 65' ' ' ASN . 25.3 ptt? -60.61 -31.89 71.04 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.748 0.309 . . . . 0.0 111.189 -179.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.63 -37.16 82.94 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.244 -178.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.522 ' HB2' HG23 ' A' ' 35' ' ' THR . 75.9 mmtt -59.93 -40.39 88.74 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.192 -175.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.506 HD23 ' H ' ' A' ' 40' ' ' LEU . 0.4 OUTLIER -87.96 -44.13 11.25 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 179.737 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.4 ' HG2' ' HD1' ' A' ' 57' ' ' PHE . 61.3 mtpt -62.68 -45.29 93.45 Favored 'General case' 0 CA--C 1.493 -1.213 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.188 -177.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.422 ' O ' ' HB2' ' A' ' 46' ' ' ASP . 24.9 ttmm -62.98 -41.6 99.6 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 176.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 52.4 m -63.95 -46.19 85.82 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.202 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.707 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 45.6 t80 -71.11 -45.25 64.02 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.97 0.415 . . . . 0.0 110.871 178.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.47 -28.14 69.07 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.155 0.502 . . . . 0.0 110.008 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.422 ' HB2' ' O ' ' A' ' 42' ' ' LYS . 25.8 t70 -63.91 -45.95 87.0 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.374 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.707 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 15.3 ptm180 -65.82 -28.0 68.67 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.018 0.437 . . . . 0.0 111.047 -178.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.501 HG22 ' O ' ' A' ' 44' ' ' TYR . 2.0 t -97.27 -17.71 19.64 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.467 -178.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.04 30.36 67.82 Favored Glycine 0 C--O 1.236 0.23 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.04 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.872 HG11 ' HB2' ' A' ' 87' ' ' GLN . 2.4 p -108.76 176.46 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-O 120.676 0.274 . . . . 0.0 110.553 -177.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.626 ' H ' HG22 ' A' ' 50' ' ' VAL . . . -58.79 125.92 25.52 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.396 176.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 71.6 t -65.99 -45.46 90.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.379 0.609 . . . . 0.0 110.97 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -68.72 -31.74 71.03 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.456 -177.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.567 ' HB2' ' HB3' ' A' ' 51' ' ' ALA . 50.2 m -81.74 -4.44 56.31 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.979 -175.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.651 HD12 ' CE1' ' A' ' 57' ' ' PHE . 0.3 OUTLIER -90.14 128.71 36.41 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 177.108 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.465 ' HD3' ' CB ' ' A' ' 86' ' ' GLU . 3.2 mpt_? -106.12 118.95 37.95 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -173.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.651 ' CE1' HD12 ' A' ' 55' ' ' LEU . 61.0 m-85 -111.08 134.84 52.37 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.124 171.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.723 HD23 ' HD1' ' A' ' 84' ' ' TYR . 2.9 mm? -127.76 155.2 44.41 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.937 0.875 . . . . 0.0 111.746 -178.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.746 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 58.6 t80 -122.46 108.54 13.3 Favored 'General case' 0 C--N 1.286 -2.171 0 CA-C-N 113.941 -1.481 . . . . 0.0 108.264 176.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 55.19 22.52 4.72 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.183 0.516 . . . . 0.0 110.74 -174.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 93.85 -7.95 73.66 Favored Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.561 -179.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.746 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.1 OUTLIER -91.57 142.15 27.95 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.391 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.548 ' HA ' ' CD1' ' A' ' 58' ' ' LEU . 0.7 OUTLIER -64.81 139.2 58.74 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -174.795 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 78.9 mt -103.93 117.77 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 174.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.703 ' HA ' ' SD ' ' A' ' 37' ' ' MET . 48.0 m-80 -121.57 166.84 13.61 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 120.92 0.39 . . . . 0.0 110.6 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -70.61 -15.32 62.74 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.532 -177.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -92.12 -0.42 57.44 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 116.705 -0.225 . . . . 0.0 111.523 -179.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -80.33 140.58 36.06 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 120.906 0.384 . . . . 0.0 111.112 178.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.437 ' HB ' ' HD2' ' A' ' 70' ' ' PRO . 82.2 p -87.87 160.07 47.54 Favored Pre-proline 0 C--N 1.314 -0.97 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.993 -178.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.437 ' HD2' ' HB ' ' A' ' 69' ' ' THR . 21.0 Cg_endo -62.22 -25.61 76.99 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.626 2.217 . . . . 0.0 111.713 177.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.5 tmtt? -82.14 -37.65 25.9 Favored 'General case' 0 N--CA 1.423 -1.82 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.128 -177.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.7 t -74.07 -33.51 63.69 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 120.456 -0.497 . . . . 0.0 110.432 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 97.2 mt -79.06 -22.84 44.76 Favored 'General case' 0 C--O 1.217 -0.614 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.517 177.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 51.73 34.57 13.25 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.043 175.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 75.7 mtm -76.25 155.94 33.95 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 121.009 0.433 . . . . 0.0 111.342 -178.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -141.23 176.33 8.93 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.47 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 35.7 t70 -66.49 121.16 14.71 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 120.955 0.407 . . . . 0.0 111.089 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 24.5 t70 71.24 34.68 1.72 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.618 -1.174 . . . . 0.0 110.291 177.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -74.81 176.26 7.22 Favored 'General case' 0 N--CA 1.457 -0.09 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.95 178.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 24.5 m -106.97 138.38 33.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-O 121.57 0.7 . . . . 0.0 111.58 -176.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.412 HD13 ' HA ' ' A' ' 81' ' ' ILE . 6.8 mm -134.81 136.6 52.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.422 -177.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 53.6 mm-40 -101.88 141.88 34.05 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.862 -174.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 74.3 t -129.18 134.36 64.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-O 120.972 0.415 . . . . 0.0 110.953 177.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.723 ' HD1' HD23 ' A' ' 58' ' ' LEU . 74.4 m-85 -99.98 151.76 20.98 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 175.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.523 ' O ' ' HG3' ' A' ' 86' ' ' GLU . 63.9 tt0 -71.51 96.45 1.52 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.219 0.533 . . . . 0.0 110.226 -176.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.577 ' O ' HD22 ' A' ' 55' ' ' LEU . 30.6 mt-10 -167.99 142.34 3.5 Favored 'General case' 0 CA--C 1.501 -0.929 0 C-N-CA 125.592 1.557 . . . . 0.0 109.486 -177.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.872 ' HB2' HG11 ' A' ' 50' ' ' VAL . 27.6 pt20 177.33 -29.41 0.0 OUTLIER 'General case' 0 N--CA 1.389 -3.483 0 C-N-CA 125.284 1.434 . . . . 0.0 108.315 -176.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 60.0 tp 178.44 -37.6 0.01 OUTLIER 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 103.696 -2.705 . . . . 0.0 103.696 -179.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 141.05 95.18 0.25 Allowed Glycine 0 N--CA 1.44 -1.077 0 CA-C-N 113.182 -1.826 . . . . 0.0 112.047 172.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.469 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 -179.065 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.9 mtt . . . . . 0 N--CA 1.474 0.747 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -133.37 154.78 50.45 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.321 -178.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -70.77 160.31 32.94 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.167 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -63.13 -34.33 77.38 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 175.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 77.63 -71.96 0.1 Allowed 'General case' 0 CA--C 1.508 -0.641 0 CA-C-N 114.756 -1.111 . . . . 0.0 112.77 176.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -121.45 116.81 25.42 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-O 121.056 0.455 . . . . 0.0 112.208 -177.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -137.27 158.67 43.92 Favored 'General case' 0 CA--C 1.496 -1.122 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.07 175.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -106.85 120.98 43.49 Favored 'General case' 0 N--CA 1.413 -2.294 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 175.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -66.91 -12.71 60.39 Favored Glycine 0 CA--C 1.496 -1.141 0 C-N-CA 120.522 -0.847 . . . . 0.0 111.364 -178.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 27.7 t70 53.23 67.03 1.06 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.734 0.778 . . . . 0.0 109.772 -179.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -93.84 13.1 23.56 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.663 -174.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -146.8 144.92 29.7 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.115 -178.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -129.88 15.7 5.8 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.928 0.871 . . . . 0.0 110.449 -178.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -136.89 159.83 40.69 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 114.301 -1.318 . . . . 0.0 110.744 -177.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.411 ' O ' ' HD2' ' A' ' 30' ' ' ARG . 12.1 pt -126.21 163.04 28.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -179.117 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.535 ' H ' ' HA ' ' A' ' 77' ' ' ASP . 37.0 ttpt -106.55 140.05 40.05 Favored 'General case' 0 C--N 1.282 -2.353 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.621 HG21 HD12 ' A' ' 81' ' ' ILE . 83.5 mt -133.5 132.97 57.69 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.118 0 CA-C-O 120.814 0.34 . . . . 0.0 111.29 177.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.3 mtmt -97.62 105.81 18.02 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.61 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 97.7 t -82.42 120.38 33.75 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 178.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 59.9 t -111.02 118.22 56.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 120.998 0.428 . . . . 0.0 110.11 179.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.534 ' HA2' ' HB ' ' A' ' 83' ' ' VAL . . . -87.27 169.51 39.83 Favored Glycine 0 N--CA 1.445 -0.764 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.704 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.493 ' HG2' ' O ' ' A' ' 83' ' ' VAL . 15.9 mm100 -68.71 -26.82 65.46 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 120.961 0.41 . . . . 0.0 111.92 -177.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -83.34 13.88 4.02 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.055 178.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 27.4 t 74.17 24.45 1.94 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.428 178.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -91.57 104.53 17.0 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.811 -178.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.61 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 30.4 tt0 -98.77 130.82 45.24 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.693 176.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.423 ' CG1' ' HB ' ' A' ' 19' ' ' VAL . 7.1 p -131.06 141.35 46.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 50.7 m170 -98.98 108.74 21.5 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 121.067 0.46 . . . . 0.0 110.702 -175.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -110.05 147.13 34.15 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.868 179.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.411 ' HD2' ' O ' ' A' ' 15' ' ' ILE . 23.4 tpt180 -108.38 118.74 37.56 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 176.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.497 HG21 HD12 ' A' ' 17' ' ' ILE . 33.7 m -133.21 171.6 17.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.767 -177.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.422 ' O ' ' HB ' ' A' ' 35' ' ' THR . 38.1 ttpt -88.83 156.93 18.65 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 -178.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -55.61 -39.58 70.97 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 174.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -97.42 24.6 30.77 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.56 -178.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.422 ' HB ' ' O ' ' A' ' 32' ' ' LYS . 1.0 OUTLIER -67.05 138.09 56.92 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-O 121.367 0.603 . . . . 0.0 112.068 179.032 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.8 m -92.1 158.89 15.95 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.685 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 25.9 ptt? -52.78 -34.38 53.01 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -176.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.55 -36.27 80.12 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.332 0.494 . . . . 0.0 112.332 -176.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -59.98 -40.91 90.76 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.664 0.268 . . . . 0.0 110.711 -174.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.501 HD23 ' H ' ' A' ' 40' ' ' LEU . 0.4 OUTLIER -87.79 -45.81 10.0 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.213 -0.448 . . . . 0.0 112.0 -179.094 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.672 ' HG2' ' CD1' ' A' ' 57' ' ' PHE . 62.3 mtpt -62.83 -45.9 90.45 Favored 'General case' 0 CA--C 1.493 -1.22 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.501 -175.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -61.85 -41.68 98.12 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 177.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 47.9 t -63.98 -51.0 66.35 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.227 -178.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.596 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 46.6 t80 -70.21 -46.59 64.21 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.345 -179.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.437 ' HB1' ' O ' ' A' ' 50' ' ' VAL . . . -60.05 -36.76 78.02 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.393 0.616 . . . . 0.0 110.016 -178.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -66.03 -46.16 78.86 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.14 -178.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.596 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 14.6 ptm180 -68.07 -24.73 65.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.453 -177.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.459 HG22 ' O ' ' A' ' 44' ' ' TYR . 12.4 t -96.02 -8.61 33.16 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 120.769 0.318 . . . . 0.0 111.619 -179.126 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.72 31.2 60.73 Favored Glycine 0 C--N 1.339 0.727 0 C-N-CA 121.004 -0.617 . . . . 0.0 113.222 178.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.443 HG11 ' HG3' ' A' ' 86' ' ' GLU . 94.7 t -119.47 148.76 22.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 C-N-CA 122.539 0.336 . . . . 0.0 110.806 -178.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.417 ' HB3' ' OG ' ' A' ' 54' ' ' SER . . . -51.76 134.24 30.8 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.456 176.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 74.0 t -61.05 -44.62 98.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.001 -177.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -70.56 -22.44 62.59 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.187 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.484 ' HB3' ' HB3' ' A' ' 87' ' ' GLN . 68.0 m -80.24 -10.96 59.77 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.169 179.129 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.08 129.3 40.67 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 177.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -117.94 115.12 24.27 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 120.999 0.428 . . . . 0.0 110.856 -177.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.672 ' CD1' ' HG2' ' A' ' 41' ' ' LYS . 27.6 m-85 -106.06 127.76 53.4 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.937 177.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.556 HD22 ' CE1' ' A' ' 84' ' ' TYR . 9.2 mp -124.59 140.22 53.15 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.922 -179.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.767 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 76.7 t80 -105.95 117.08 33.09 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 177.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 29.1 t70 56.53 19.84 4.46 Favored 'General case' 0 CA--C 1.548 0.879 0 CA-C-O 121.29 0.567 . . . . 0.0 111.625 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.94 1.32 51.95 Favored Glycine 0 CA--C 1.521 0.451 0 C-N-CA 121.081 -0.58 . . . . 0.0 113.224 178.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.767 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.2 OUTLIER -113.68 142.38 46.08 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 117.097 0.448 . . . . 0.0 109.866 177.668 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.553 ' HA ' ' HG ' ' A' ' 58' ' ' LEU . 9.7 mpt_? -65.45 139.09 58.49 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -175.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 80.5 mt -94.49 119.02 41.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.294 178.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -110.66 160.99 16.19 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.193 -178.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -72.18 -18.29 61.87 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.304 0.573 . . . . 0.0 109.718 176.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -81.4 -19.45 42.57 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.031 -179.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.522 ' CG ' HH12 ' A' ' 62' ' ' ARG . 47.3 m-20 -68.21 140.23 56.07 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 121.391 0.615 . . . . 0.0 111.854 -179.327 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.488 ' HB ' ' HD2' ' A' ' 70' ' ' PRO . 18.8 p -100.66 163.45 18.08 Favored Pre-proline 0 C--N 1.311 -1.065 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.909 -178.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.488 ' HD2' ' HB ' ' A' ' 69' ' ' THR . 17.1 Cg_endo -58.32 -28.86 86.16 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 122.703 2.269 . . . . 0.0 112.687 -178.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.554 ' HG3' ' H ' ' A' ' 72' ' ' THR . 15.2 ptmt -72.41 -49.82 30.92 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.554 ' H ' ' HG3' ' A' ' 71' ' ' LYS . 15.1 t -67.64 -34.26 76.61 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.981 0.42 . . . . 0.0 110.735 -177.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 97.5 mt -79.41 -22.84 43.74 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.541 177.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 36.35 36.52 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 124.639 1.176 . . . . 0.0 113.835 -179.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 65.9 mtt -75.42 151.81 38.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.47 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -147.98 -176.4 5.26 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.819 -178.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.535 ' HA ' ' H ' ' A' ' 16' ' ' LYS . 6.4 p-10 -59.42 121.91 12.66 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -174.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.459 ' OD1' ' HE3' ' A' ' 16' ' ' LYS . 26.5 t70 71.01 32.45 2.31 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 113.635 -1.621 . . . . 0.0 111.553 175.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -79.23 178.05 8.36 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 175.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 35.1 m -115.13 150.5 17.05 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 CA-C-O 121.815 0.817 . . . . 0.0 112.336 -174.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.621 HD12 HG21 ' A' ' 17' ' ' ILE . 1.6 mt -134.26 134.92 54.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.854 178.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -101.81 139.63 37.19 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.897 -178.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.534 ' HB ' ' HA2' ' A' ' 21' ' ' GLY . 95.2 t -122.11 130.94 74.15 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.548 177.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.556 ' CE1' HD22 ' A' ' 58' ' ' LEU . 66.8 m-85 -99.21 167.29 10.77 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.474 178.405 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -67.06 137.11 56.18 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.538 0.685 . . . . 0.0 110.677 -173.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.507 ' HG2' ' HA3' ' A' ' 89' ' ' GLY . 0.9 OUTLIER -83.9 156.55 22.34 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.979 -1.009 . . . . 0.0 112.955 -171.574 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.484 ' HB3' ' HB3' ' A' ' 54' ' ' SER . 64.2 tt0 -66.36 -42.83 87.46 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.892 -1.049 . . . . 0.0 112.777 -177.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.476 HD23 ' OG ' ' A' ' 54' ' ' SER . 4.6 mm? -91.56 -15.58 28.44 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -178.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.507 ' HA3' ' HG2' ' A' ' 86' ' ' GLU . . . -62.67 -41.82 99.77 Favored Glycine 0 CA--C 1.509 -0.327 0 C-N-CA 120.249 -0.977 . . . . 0.0 111.645 178.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.124 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 176.686 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.5 mtp . . . . . 0 N--CA 1.474 0.771 0 CA-C-O 120.958 0.409 . . . . 0.0 110.711 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -135.47 162.18 33.37 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -78.2 179.63 6.78 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.149 -178.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -65.07 -40.12 94.23 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.641 0.258 . . . . 0.0 111.652 -176.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 63.23 23.48 13.87 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.543 0.737 . . . . 0.0 112.682 178.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -145.36 148.26 33.18 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.265 178.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 54.34 -159.2 0.17 Allowed 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.33 0.586 . . . . 0.0 111.415 179.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -71.53 -18.57 62.26 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.662 177.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 90.53 -7.77 80.85 Favored Glycine 0 CA--C 1.501 -0.821 0 N-CA-C 111.138 -0.785 . . . . 0.0 111.138 -178.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -115.21 145.62 42.24 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.825 -0.688 . . . . 0.0 111.144 -179.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 -155.51 96.14 1.75 Allowed 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -79.68 -70.39 0.52 Allowed 'General case' 0 N--CA 1.428 -1.562 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.518 ' C ' ' HD1' ' A' ' 14' ' ' TYR . 11.1 pt-20 -174.2 -55.36 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.266 0 CA-C-O 121.463 0.649 . . . . 0.0 111.227 173.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.518 ' HD1' ' C ' ' A' ' 13' ' ' GLU . 2.0 m-85 -122.43 155.98 34.98 Favored 'General case' 0 C--N 1.273 -2.735 0 CA-C-N 115.122 -0.944 . . . . 0.0 112.783 -177.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.6 pt -134.01 162.73 38.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-N 114.152 -1.386 . . . . 0.0 107.931 -179.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.456 ' HD2' ' NH1' ' A' ' 30' ' ' ARG . 3.5 mppt? -99.99 148.67 24.26 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 121.147 0.499 . . . . 0.0 111.616 179.197 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.468 HG23 ' CG1' ' A' ' 81' ' ' ILE . 67.8 mt -124.96 131.83 72.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.796 176.151 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.0 mtmt -101.54 102.74 13.53 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 172.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.701 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 92.3 t -82.87 117.7 29.27 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 57.9 t -106.85 114.72 46.69 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.513 ' HA2' ' HB ' ' A' ' 83' ' ' VAL . . . -88.96 171.49 39.12 Favored Glycine 0 C--N 1.313 -0.721 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.597 -179.239 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 90.8 mm-40 -73.89 -11.83 60.48 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-O 121.719 0.771 . . . . 0.0 110.652 179.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -83.6 7.16 18.18 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 114.57 -1.195 . . . . 0.0 108.86 174.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.5 m 65.41 27.59 11.82 Favored 'General case' 0 C--N 1.347 0.46 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.002 -176.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -97.11 105.74 17.94 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.704 -177.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.701 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 39.0 tt0 -98.09 129.7 44.9 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.713 176.183 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.2 p -139.54 141.82 34.25 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.988 -178.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 31.7 m170 -88.65 116.91 27.24 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.747 -179.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -113.68 136.88 52.35 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 114.993 -1.003 . . . . 0.0 108.701 170.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.456 ' NH1' ' HD2' ' A' ' 16' ' ' LYS . 35.9 ttt85 -104.91 125.64 51.13 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.503 ' HB ' ' OG1' ' A' ' 35' ' ' THR . 22.7 m -135.12 -179.76 3.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.227 -174.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -89.77 157.04 18.12 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 178.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.422 ' O ' ' HB3' ' A' ' 70' ' ' PRO . 90.6 m-85 -53.93 -39.79 66.17 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 173.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -102.07 33.39 6.55 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.355 -179.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.503 ' OG1' ' HB ' ' A' ' 31' ' ' VAL . 0.9 OUTLIER -66.7 138.52 57.46 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 121.614 0.721 . . . . 0.0 112.2 179.263 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.507 ' HB3' ' HB2' ' A' ' 66' ' ' ASP . 67.2 m -82.87 151.99 25.77 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.94 178.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.612 ' SD ' ' HA ' ' A' ' 65' ' ' ASN . 26.7 ptt? -54.1 -30.58 49.16 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.935 0.398 . . . . 0.0 111.047 -179.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.17 -36.75 80.69 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.781 -178.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -60.14 -40.83 91.18 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.791 0.329 . . . . 0.0 111.149 -176.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.491 HD23 ' H ' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -86.87 -45.52 10.78 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 116.056 -0.52 . . . . 0.0 112.0 -179.787 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.426 ' HA ' ' CE1' ' A' ' 57' ' ' PHE . 24.8 mtpp -61.78 -47.32 85.68 Favored 'General case' 0 CA--C 1.5 -0.972 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.351 -177.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.489 ' HA ' HG22 ' A' ' 52' ' ' VAL . 40.6 ttpt -62.79 -42.07 99.54 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.072 0.463 . . . . 0.0 109.986 178.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 44.7 t -66.35 -50.88 62.07 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.866 -176.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.592 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 49.6 t80 -70.71 -45.53 64.78 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.142 -178.035 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.525 ' HB1' ' O ' ' A' ' 50' ' ' VAL . . . -59.13 -35.63 73.8 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.409 0.623 . . . . 0.0 109.77 -179.094 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -64.35 -47.16 80.4 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.531 -179.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.592 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 14.5 ptm180 -71.17 -21.91 62.1 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.671 -177.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.466 HG22 ' O ' ' A' ' 44' ' ' TYR . 13.7 t -101.13 -2.73 30.67 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-O 120.855 0.36 . . . . 0.0 111.699 -178.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 69.8 37.08 75.45 Favored Glycine 0 C--N 1.335 0.486 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.013 178.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.525 ' O ' ' HB1' ' A' ' 45' ' ' ALA . 91.3 t -122.62 147.67 26.69 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 C-N-CA 122.825 0.45 . . . . 0.0 110.811 -178.008 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.456 ' HB3' ' HB2' ' A' ' 54' ' ' SER . . . -54.77 135.02 47.87 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 175.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.489 HG22 ' HA ' ' A' ' 42' ' ' LYS . 76.6 t -61.1 -45.86 97.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.312 -175.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -71.41 -27.79 63.55 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.356 -178.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.456 ' HB2' ' HB3' ' A' ' 51' ' ' ALA . 49.1 m -82.68 -5.43 58.85 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.464 -178.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.485 HD12 ' CE1' ' A' ' 57' ' ' PHE . 0.2 OUTLIER -95.34 122.42 38.03 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 177.414 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -108.02 117.39 34.01 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 120.33 -0.548 . . . . 0.0 112.222 -174.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.494 ' HZ ' ' CB ' ' A' ' 44' ' ' TYR . 44.3 m-85 -100.63 128.68 46.6 Favored 'General case' 0 CA--C 1.498 -1.058 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.569 174.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.595 HD13 ' HA ' ' A' ' 63' ' ' ARG . 4.2 mm? -119.06 155.89 30.66 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.384 -177.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.764 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 63.0 t80 -133.75 109.94 9.48 Favored 'General case' 0 C--N 1.279 -2.466 0 CA-C-N 114.289 -1.323 . . . . 0.0 109.385 174.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 27.9 t70 52.81 29.9 8.27 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.565 0.698 . . . . 0.0 111.562 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 94.58 4.98 61.87 Favored Glycine 0 C--N 1.31 -0.886 0 C-N-CA 120.856 -0.688 . . . . 0.0 113.65 176.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.764 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.2 OUTLIER -122.8 133.49 54.45 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 177.159 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.595 ' HA ' HD13 ' A' ' 58' ' ' LEU . 30.4 ptt180 -72.75 145.91 46.77 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.783 -172.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.448 HD11 HD12 ' A' ' 81' ' ' ILE . 73.6 mt -91.21 121.76 41.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.4 -176.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.612 ' HA ' ' SD ' ' A' ' 37' ' ' MET . 50.7 m-80 -111.09 157.54 19.88 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.769 -178.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.507 ' HB2' ' HB3' ' A' ' 36' ' ' SER . 4.8 p-10 -74.79 -11.98 60.28 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-O 121.179 0.514 . . . . 0.0 109.819 178.1 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -81.62 -20.37 39.86 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.913 179.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.461 ' CG ' HH12 ' A' ' 62' ' ' ARG . 50.5 m-20 -67.14 149.41 50.55 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.294 0.569 . . . . 0.0 112.087 -178.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.404 ' HB ' ' HD2' ' A' ' 70' ' ' PRO . 76.4 p -108.68 159.77 29.69 Favored Pre-proline 0 C--N 1.315 -0.933 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.634 178.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.422 ' HB3' ' O ' ' A' ' 33' ' ' TYR . 19.3 Cg_endo -60.49 -28.68 87.13 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.448 2.099 . . . . 0.0 111.721 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.738 ' HD2' ' C ' ' A' ' 71' ' ' LYS . 0.1 OUTLIER -65.6 -44.04 87.81 Favored 'General case' 0 N--CA 1.415 -2.176 0 CA-C-O 121.615 0.721 . . . . 0.0 109.496 178.819 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -80.22 -40.06 27.85 Favored 'General case' 0 N--CA 1.414 -2.265 0 CA-C-N 114.848 -1.069 . . . . 0.0 111.152 -174.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 98.6 mt -71.32 -23.24 61.9 Favored 'General case' 0 N--CA 1.44 -0.975 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 175.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.425 ' HG3' ' O ' ' A' ' 71' ' ' LYS . 38.5 mt-10 50.79 28.7 3.79 Favored 'General case' 0 C--N 1.349 0.553 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.462 -179.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.441 ' HE1' HD11 ' A' ' 17' ' ' ILE . 21.5 ptm -81.32 164.64 22.03 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.241 -178.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -151.37 -175.21 5.09 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-O 120.743 0.306 . . . . 0.0 110.252 -176.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -63.96 119.92 10.99 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.211 -179.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 33.1 t70 67.06 35.58 4.55 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.196 177.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -78.43 175.63 10.12 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 29.1 m -98.42 133.57 40.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 CA-C-O 121.807 0.813 . . . . 0.0 111.611 -176.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.468 ' CG1' HG23 ' A' ' 17' ' ' ILE . 18.1 mm -129.78 130.53 66.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 CA-C-N 114.634 -1.166 . . . . 0.0 109.86 179.137 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -102.56 148.25 25.77 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.094 0.473 . . . . 0.0 111.645 -175.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.513 ' HB ' ' HA2' ' A' ' 21' ' ' GLY . 79.4 t -123.34 129.86 74.57 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.858 174.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -101.77 170.84 7.9 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.571 178.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -64.51 136.94 57.56 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.776 0.798 . . . . 0.0 110.988 -172.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.523 ' H ' ' CD ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -108.93 160.21 16.19 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 114.512 -1.222 . . . . 0.0 111.614 -173.224 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.423 ' HB3' ' HB3' ' A' ' 54' ' ' SER . 64.3 tt0 -65.02 -46.14 82.57 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -175.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.473 ' HB2' HG13 ' A' ' 50' ' ' VAL . 3.3 mm? -98.24 3.48 48.86 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -175.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.516 ' H ' ' HG2' ' A' ' 86' ' ' GLU . . . -101.05 -155.72 27.05 Favored Glycine 0 C--N 1.313 -0.709 0 C-N-CA 120.193 -1.003 . . . . 0.0 112.934 -178.084 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.362 0 CA-C-O 118.536 -1.147 . . . . 0.0 111.547 -178.174 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.8 mtp . . . . . 0 N--CA 1.469 0.52 0 CA-C-O 120.95 0.405 . . . . 0.0 110.597 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.71 153.58 37.17 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.479 179.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 43.4 m-20 -81.65 157.35 24.69 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 177.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -61.0 -40.73 94.63 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.71 -179.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 54.99 30.55 14.34 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.512 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -105.75 135.43 47.18 Favored 'General case' 0 N--CA 1.426 -1.633 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.868 -177.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -125.18 160.88 28.1 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.34 -39.4 92.96 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 121.415 0.626 . . . . 0.0 109.537 -178.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 87.54 -10.7 68.53 Favored Glycine 0 CA--C 1.485 -1.814 0 N-CA-C 109.971 -1.251 . . . . 0.0 109.971 -178.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 25.6 t70 50.08 45.24 25.65 Favored 'General case' 0 C--O 1.216 -0.66 0 CA-C-N 114.112 -1.044 . . . . 0.0 108.909 -179.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 32.3 p-10 -88.42 11.57 16.57 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.34 -1.3 . . . . 0.0 112.422 -172.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.58 -40.63 95.46 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.267 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -110.58 25.95 11.22 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.333 0.587 . . . . 0.0 111.324 -178.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -133.5 157.34 45.89 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.479 -178.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.464 ' O ' ' HD3' ' A' ' 30' ' ' ARG . 8.3 pt -111.27 163.08 8.33 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 -178.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.656 ' HE2' ' OD1' ' A' ' 78' ' ' ASP . 34.9 ttpt -113.78 145.33 41.55 Favored 'General case' 0 C--N 1.291 -1.955 0 C-N-CA 118.882 -1.127 . . . . 0.0 111.687 -179.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 84.6 mt -122.21 127.84 75.34 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.489 177.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.2 mtmt -99.19 104.68 16.66 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 176.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.668 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 96.1 t -82.55 119.2 31.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.989 -178.218 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.9 t -105.27 112.84 40.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -91.09 177.27 41.25 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.072 -1.061 . . . . 0.0 112.611 -178.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -82.54 -10.1 59.13 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 121.434 0.635 . . . . 0.0 111.621 -178.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -85.04 11.12 10.2 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 115.075 -0.966 . . . . 0.0 108.801 174.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.2 m 62.86 33.25 15.3 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.437 -178.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 -111.55 108.94 18.61 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.438 -179.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.668 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 30.0 tt0 -94.18 128.67 40.75 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.331 -0.849 . . . . 0.0 108.932 174.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.3 p -132.58 139.38 49.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -178.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 23.9 m170 -100.94 117.17 34.48 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.314 0.578 . . . . 0.0 111.963 -174.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -109.62 144.39 38.03 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.058 -0.973 . . . . 0.0 110.137 175.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.464 ' HD3' ' O ' ' A' ' 15' ' ' ILE . 20.2 tpp180 -103.2 119.32 38.66 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.401 ' HB ' HG21 ' A' ' 35' ' ' THR . 32.9 m -134.63 167.99 24.7 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.803 -178.062 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.403 ' O ' ' HB ' ' A' ' 35' ' ' THR . 46.5 tttm -91.22 163.33 14.29 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 178.561 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -57.36 -38.67 74.53 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.752 174.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -93.94 19.0 55.55 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 121.175 -0.536 . . . . 0.0 112.428 -178.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.403 ' HB ' ' O ' ' A' ' 32' ' ' LYS . 1.1 m -63.85 136.81 57.69 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-O 121.394 0.616 . . . . 0.0 111.802 179.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 68.3 m -92.91 156.79 16.72 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.307 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.414 ' SD ' ' HA ' ' A' ' 65' ' ' ASN . 26.7 ptt? -51.38 -32.34 25.59 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -176.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.19 -37.39 82.8 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 -177.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 49.3 mmtm -60.21 -39.98 88.48 Favored 'General case' 0 C--O 1.216 -0.696 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.08 -176.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.678 HD12 ' CD1' ' A' ' 57' ' ' PHE . 0.2 OUTLIER -87.24 -44.06 11.73 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -178.848 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.496 ' HA ' ' HE1' ' A' ' 57' ' ' PHE . 57.3 mtpt -62.83 -45.63 91.72 Favored 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -178.239 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 28.9 ttpp -62.31 -41.98 98.98 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 177.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.429 ' O ' ' HB3' ' A' ' 46' ' ' ASP . 58.4 m -66.26 -48.17 71.34 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.73 -178.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.664 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 38.9 t80 -71.72 -44.25 64.46 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -179.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.35 -29.7 66.17 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 121.286 0.565 . . . . 0.0 109.809 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.429 ' HB3' ' O ' ' A' ' 43' ' ' SER . 31.3 t70 -62.72 -48.56 78.73 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.789 178.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.664 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 7.5 ptm180 -69.79 -24.16 63.45 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.192 -176.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.47 HG23 HG12 ' A' ' 50' ' ' VAL . 7.3 t -100.66 -8.98 22.34 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.234 -0.439 . . . . 0.0 112.132 -178.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 67.43 40.6 91.39 Favored Glycine 0 C--N 1.336 0.531 0 C-N-CA 120.676 -0.774 . . . . 0.0 113.029 178.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.471 HG21 ' HG3' ' A' ' 86' ' ' GLU . 3.6 p -125.3 166.74 20.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 O-C-N 122.728 -0.277 . . . . 0.0 110.72 -177.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.441 ' HB3' ' OG ' ' A' ' 54' ' ' SER . . . -59.18 137.36 58.0 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 116.329 -0.396 . . . . 0.0 109.994 176.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 75.6 t -60.51 -44.04 95.65 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.57 -176.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -84.06 -12.15 55.57 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -179.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.512 ' HB2' ' HB3' ' A' ' 87' ' ' GLN . 85.5 p -79.75 -14.26 58.86 Favored 'General case' 0 CA--C 1.514 -0.417 0 C-N-CA 119.924 -0.711 . . . . 0.0 109.091 176.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.423 HD13 ' N ' ' A' ' 56' ' ' ARG . 1.9 tm? -99.61 129.59 45.77 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 177.061 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.423 ' N ' HD13 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -135.48 137.61 42.32 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 119.747 -0.781 . . . . 0.0 111.767 -176.599 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.678 ' CD1' HD12 ' A' ' 40' ' ' LEU . 96.3 m-85 -106.95 139.96 40.52 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.382 176.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.557 HD13 ' CD1' ' A' ' 84' ' ' TYR . 6.6 mp -128.68 139.7 52.11 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.703 176.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.675 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 34.4 t80 -107.78 119.04 38.32 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.129 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 32.5 t70 51.93 33.61 11.97 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.507 0.67 . . . . 0.0 111.395 179.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.19 13.8 73.25 Favored Glycine 0 CA--C 1.522 0.528 0 CA-C-N 115.647 -0.706 . . . . 0.0 113.739 177.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.675 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.2 OUTLIER -123.71 149.83 45.05 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 117.163 0.481 . . . . 0.0 110.406 178.822 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 63' ' ' ARG . 10.2 mmm180 -67.88 139.7 56.5 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -176.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 75.5 mt -103.43 111.29 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 173.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.414 ' HA ' ' SD ' ' A' ' 37' ' ' MET . 95.1 m-20 -114.38 170.22 8.46 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-O 121.094 0.473 . . . . 0.0 111.439 -178.179 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 15.3 p-10 -72.25 -14.07 61.68 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.571 -178.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -94.15 -13.16 27.02 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.397 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.443 ' HB3' ' HG ' ' A' ' 73' ' ' LEU . 30.2 m-20 -72.56 149.62 43.86 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.269 0.557 . . . . 0.0 112.187 -178.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.459 ' HB ' ' HD2' ' A' ' 70' ' ' PRO . 81.8 p -108.88 161.45 23.62 Favored Pre-proline 0 C--N 1.315 -0.907 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.691 -179.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.459 ' HD2' ' HB ' ' A' ' 69' ' ' THR . 24.2 Cg_endo -61.34 -22.95 75.98 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.455 2.104 . . . . 0.0 111.639 178.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.695 ' HD2' ' C ' ' A' ' 71' ' ' LYS . 0.0 OUTLIER -67.65 -44.52 77.7 Favored 'General case' 0 N--CA 1.41 -2.441 0 C-N-CA 123.651 0.78 . . . . 0.0 109.635 -179.755 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.6 t -90.0 -32.57 16.72 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.927 -175.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.443 ' HG ' ' HB3' ' A' ' 68' ' ' ASP . 96.0 mt -72.7 -22.95 60.82 Favored 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 174.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 52.89 32.9 13.3 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 114.846 -1.07 . . . . 0.0 112.25 176.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.406 ' HG3' ' HB3' ' A' ' 73' ' ' LEU . 69.1 mtm -83.54 156.99 22.52 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.372 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -154.44 -176.04 5.7 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -58.48 122.6 13.75 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.949 0.88 . . . . 0.0 112.605 -177.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.656 ' OD1' ' HE2' ' A' ' 16' ' ' LYS . 1.4 m-20 63.14 33.61 14.31 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 113.884 -1.507 . . . . 0.0 111.614 176.495 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -74.92 176.74 6.85 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 178.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 31.5 m -112.71 144.26 20.78 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 CA-C-O 121.459 0.647 . . . . 0.0 111.335 -175.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -129.12 143.97 39.6 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.65 -179.204 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -107.7 141.44 39.23 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 120.817 0.342 . . . . 0.0 110.651 -177.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.438 HG22 ' CD2' ' A' ' 57' ' ' PHE . 99.5 t -117.13 133.44 63.88 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-O 121.096 0.474 . . . . 0.0 111.293 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.557 ' CD1' HD13 ' A' ' 58' ' ' LEU . 53.6 m-85 -98.91 168.45 10.1 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 115.366 -0.833 . . . . 0.0 109.669 176.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 60.1 tp60 -66.68 132.65 48.58 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.311 0.577 . . . . 0.0 111.766 -171.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.571 ' HG2' ' H ' ' A' ' 89' ' ' GLY . 19.5 pm0 -82.2 144.72 30.49 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.43 -179.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.512 ' HB3' ' HB2' ' A' ' 54' ' ' SER . 6.8 tp-100 -64.6 -45.61 86.19 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -174.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.436 HD12 ' HB2' ' A' ' 51' ' ' ALA . 87.8 mt -92.48 -13.03 30.5 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -175.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.571 ' H ' ' HG2' ' A' ' 86' ' ' GLU . . . -65.72 -43.43 94.2 Favored Glycine 0 CA--C 1.503 -0.703 0 C-N-CA 120.056 -1.069 . . . . 0.0 111.822 178.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.383 0 CA-C-O 118.731 -1.038 . . . . 0.0 111.563 177.871 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.1 mtt . . . . . 0 N--CA 1.475 0.793 0 CA-C-O 120.641 0.258 . . . . 0.0 110.586 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.33 150.41 43.53 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.94 177.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -81.05 111.01 17.13 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 120.947 0.403 . . . . 0.0 111.034 -179.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -75.06 -26.46 59.4 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.77 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 59.24 63.47 1.58 Allowed 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.416 -178.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -88.85 108.09 19.34 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.949 -178.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 56.9 -172.09 0.08 Allowed 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.452 0.701 . . . . 0.0 112.229 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.11 -39.72 94.66 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.487 -179.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 79.7 14.52 80.97 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 110.436 -1.066 . . . . 0.0 110.436 -176.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -110.19 133.22 53.45 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 114.587 -0.807 . . . . 0.0 109.716 -179.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 31.8 p30 -119.76 19.11 12.55 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -176.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -150.85 152.02 33.09 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.491 -178.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -99.55 23.56 9.31 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.453 0.644 . . . . 0.0 111.198 -179.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -100.8 155.31 18.0 Favored 'General case' 0 C--N 1.284 -2.259 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.624 -178.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.427 ' O ' ' HD3' ' A' ' 30' ' ' ARG . 11.6 pt -114.03 160.84 13.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.091 -175.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.458 ' H ' ' HA ' ' A' ' 77' ' ' ASP . 23.4 ttmt -100.76 145.39 28.56 Favored 'General case' 0 C--N 1.283 -2.324 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.622 -179.175 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.678 HG21 HD12 ' A' ' 81' ' ' ILE . 39.7 mm -126.21 127.57 70.89 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.357 175.137 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.451 ' HE2' HG22 ' A' ' 80' ' ' VAL . 15.1 mtmt -96.36 104.98 16.98 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 176.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.656 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 85.0 t -81.7 109.45 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.591 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.223 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.1 t -112.24 118.36 57.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -178.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.48 ' HA2' ' HB ' ' A' ' 83' ' ' VAL . . . -96.28 160.47 22.13 Favored Glycine 0 C--N 1.304 -1.196 0 C-N-CA 120.074 -1.06 . . . . 0.0 112.293 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.468 ' C ' ' H ' ' A' ' 24' ' ' SER . 16.4 pt20 -66.52 -20.35 66.01 Favored 'General case' 0 CA--C 1.495 -1.163 0 CA-C-O 122.427 1.108 . . . . 0.0 109.67 177.277 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -69.33 5.41 1.31 Allowed 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 113.122 -1.853 . . . . 0.0 109.507 173.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.468 ' H ' ' C ' ' A' ' 22' ' ' GLN . 50.2 m 63.13 31.59 15.68 Favored 'General case' 0 C--N 1.35 0.625 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.154 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -110.39 108.07 17.99 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 114.843 -1.071 . . . . 0.0 111.042 -177.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.656 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 30.8 tt0 -103.82 133.85 48.11 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.522 175.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.3 p -139.23 139.39 39.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-N 115.663 -0.698 . . . . 0.0 109.52 177.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 63.6 m170 -98.04 117.17 31.8 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.205 0.526 . . . . 0.0 111.433 -176.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -112.73 146.52 38.61 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.298 175.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.427 ' HD3' ' O ' ' A' ' 15' ' ' ILE . 23.8 tpp180 -103.31 120.53 40.94 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.458 ' HB ' ' OG1' ' A' ' 35' ' ' THR . 29.0 m -132.07 167.82 25.5 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -177.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.57 ' O ' ' HB ' ' A' ' 35' ' ' THR . 43.0 tttm -91.06 161.38 15.14 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.644 ' O ' ' HB3' ' A' ' 70' ' ' PRO . 97.1 m-85 -58.96 -38.23 78.6 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 171.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.626 ' HA2' ' CG ' ' A' ' 70' ' ' PRO . . . -85.64 21.81 13.13 Favored Glycine 0 N--CA 1.433 -1.547 0 CA-C-N 114.621 -1.172 . . . . 0.0 112.167 -178.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.57 ' HB ' ' O ' ' A' ' 32' ' ' LYS . 0.9 OUTLIER -68.56 141.01 55.61 Favored 'General case' 0 N--CA 1.425 -1.699 0 CA-C-O 121.384 0.611 . . . . 0.0 111.684 179.775 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.477 ' HB3' ' HE1' ' A' ' 37' ' ' MET . 48.7 m -88.47 143.37 27.02 Favored 'General case' 0 N--CA 1.416 -2.148 0 CA-C-N 115.405 -0.816 . . . . 0.0 108.939 177.381 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.807 ' SD ' ' HA ' ' A' ' 66' ' ' ASP . 0.2 OUTLIER -51.65 -40.1 59.37 Favored 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 123.575 0.75 . . . . 0.0 111.482 179.647 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.505 ' N ' ' HG2' ' A' ' 37' ' ' MET . . . -62.35 -27.02 68.77 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.152 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -60.47 -40.43 91.21 Favored 'General case' 0 C--O 1.21 -0.995 0 C-N-CA 121.111 -0.235 . . . . 0.0 110.84 -178.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.508 HD23 ' H ' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -85.47 -39.12 17.84 Favored 'General case' 0 C--N 1.309 -1.183 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.889 -176.764 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.492 ' HA ' ' HE1' ' A' ' 57' ' ' PHE . 61.7 mtpt -65.49 -44.86 85.79 Favored 'General case' 0 CA--C 1.493 -1.225 0 CA-C-O 120.728 0.299 . . . . 0.0 110.773 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.604 ' HD3' HG21 ' A' ' 52' ' ' VAL . 15.5 tppt? -62.97 -43.23 99.35 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 176.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 58.1 m -69.53 -50.25 46.79 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.366 -0.833 . . . . 0.0 113.196 -176.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.62 ' O ' ' HG3' ' A' ' 47' ' ' ARG . 62.4 t80 -64.67 -47.23 79.18 Favored 'General case' 0 CA--C 1.496 -1.116 0 CA-C-O 120.674 0.273 . . . . 0.0 111.233 -179.143 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.25 -36.5 77.91 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 121.367 0.603 . . . . 0.0 109.471 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -66.21 -45.59 80.22 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.315 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.62 ' HG3' ' O ' ' A' ' 44' ' ' TYR . 5.1 ppt_? -67.27 -25.01 65.85 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.347 -178.099 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.544 HG22 ' O ' ' A' ' 44' ' ' TYR . 10.2 t -99.07 -17.81 18.06 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 120.815 0.341 . . . . 0.0 111.61 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.1 32.59 35.22 Favored Glycine 0 C--O 1.227 -0.298 0 C-N-CA 120.471 -0.871 . . . . 0.0 113.021 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.579 HG21 ' HG3' ' A' ' 86' ' ' GLU . 4.3 p -115.13 160.96 14.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 O-C-N 122.555 -0.379 . . . . 0.0 110.292 -179.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.488 ' HB3' ' OG ' ' A' ' 54' ' ' SER . . . -57.91 129.31 41.34 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 178.126 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.604 HG21 ' HD3' ' A' ' 42' ' ' LYS . 78.6 t -61.53 -43.65 97.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.648 -178.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -64.53 -33.98 77.18 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.541 -179.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.488 ' OG ' ' HB3' ' A' ' 51' ' ' ALA . 90.6 p -78.82 -12.56 60.03 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.96 0.41 . . . . 0.0 110.975 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.405 HD13 ' N ' ' A' ' 56' ' ' ARG . 2.8 tm? -95.86 132.8 40.74 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -178.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.405 ' N ' HD13 ' A' ' 55' ' ' LEU . 5.6 ptt180 -144.33 145.8 32.19 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-O 121.259 0.552 . . . . 0.0 112.351 -173.375 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.524 ' CD2' HG22 ' A' ' 83' ' ' VAL . 95.7 m-85 -119.06 147.2 44.38 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.737 176.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 6.7 mp -124.31 138.24 54.4 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.792 175.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.594 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 32.2 t80 -117.84 125.93 51.46 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 179.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 33.4 t70 58.74 26.86 15.19 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.888 0.852 . . . . 0.0 110.163 -179.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 81.33 15.77 75.69 Favored Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.735 177.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.594 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 4.4 ppt_? -132.08 155.32 48.3 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-O 121.277 0.56 . . . . 0.0 112.042 179.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 16.4 mmm180 -58.68 137.59 57.5 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -175.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.487 HD11 ' HB2' ' A' ' 59' ' ' PHE . 75.7 mt -102.09 109.0 25.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 168.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.536 ' C ' ' HG3' ' A' ' 37' ' ' MET . 88.6 m-20 -120.53 161.59 21.04 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 120.638 0.256 . . . . 0.0 111.039 -174.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.807 ' HA ' ' SD ' ' A' ' 37' ' ' MET . 4.7 t70 -58.38 -9.75 1.73 Allowed 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 179.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -84.14 -15.49 47.03 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.242 177.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -71.86 149.78 44.87 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -175.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.53 ' O ' HG22 ' A' ' 72' ' ' THR . 35.3 p -117.69 155.29 50.78 Favored Pre-proline 0 N--CA 1.437 -1.11 0 CA-C-N 114.439 -1.255 . . . . 0.0 109.358 177.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.644 ' HB3' ' O ' ' A' ' 33' ' ' TYR . 58.5 Cg_exo -54.83 -40.56 84.54 Favored 'Trans proline' 0 N--CA 1.477 0.502 0 C-N-CA 122.803 2.335 . . . . 0.0 113.75 -176.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.599 ' HD2' ' C ' ' A' ' 71' ' ' LYS . 0.0 OUTLIER -70.92 -30.0 66.21 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -177.482 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.583 ' N ' ' HD2' ' A' ' 71' ' ' LYS . 4.7 t -81.69 -28.64 33.4 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.484 -177.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 97.9 mt -70.26 -24.78 63.12 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 176.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 47.11 30.35 1.33 Allowed 'General case' 0 CA--C 1.551 1.016 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.488 177.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 20.5 ptp -75.49 160.23 30.43 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.938 0.399 . . . . 0.0 111.513 -179.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -147.52 -177.64 5.81 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.588 -178.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.458 ' HA ' ' H ' ' A' ' 16' ' ' LYS . 36.8 t70 -66.14 120.16 12.72 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -176.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 20.4 t70 69.19 33.66 3.24 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 114.381 -1.282 . . . . 0.0 110.441 177.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.4 ' O ' ' HG3' ' A' ' 18' ' ' LYS . 4.6 t70 -78.19 177.36 8.44 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.612 177.453 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.451 HG22 ' HE2' ' A' ' 18' ' ' LYS . 16.9 t -110.0 135.06 50.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 CA-C-O 121.481 0.658 . . . . 0.0 111.686 -171.5 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.678 HD12 HG21 ' A' ' 17' ' ' ILE . 1.8 mt -132.57 132.46 60.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.703 178.305 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -98.79 141.93 30.96 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.442 -174.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.524 HG22 ' CD2' ' A' ' 57' ' ' PHE . 87.6 t -125.88 129.14 72.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-O 121.346 0.593 . . . . 0.0 110.57 177.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -107.75 169.18 8.76 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.869 178.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -64.8 138.31 58.3 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.411 0.625 . . . . 0.0 111.303 -172.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.579 ' HG3' HG21 ' A' ' 50' ' ' VAL . 0.2 OUTLIER -96.93 160.74 14.18 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.706 -178.496 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.47 ' H ' ' HB2' ' A' ' 54' ' ' SER . 6.5 tp-100 -61.22 -46.02 92.17 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.025 0.441 . . . . 0.0 112.063 -174.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 87.4 mt -91.7 -7.23 50.42 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.892 -176.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.551 ' H ' ' HG2' ' A' ' 86' ' ' GLU . . . -65.89 -40.34 95.41 Favored Glycine 0 CA--C 1.509 -0.291 0 C-N-CA 120.848 -0.691 . . . . 0.0 111.988 178.015 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.236 0 CA-C-O 118.161 -1.355 . . . . 0.0 111.147 179.898 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.2 mtp . . . . . 0 N--CA 1.47 0.547 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.26 112.21 18.77 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.88 0.371 . . . . 0.0 110.306 178.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -86.5 -5.0 59.26 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.612 -179.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -64.93 -39.89 94.2 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -178.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 56.21 64.31 1.74 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.25 0.548 . . . . 0.0 109.586 -176.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -64.13 114.29 4.09 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.55 -175.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 57.46 102.91 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.981 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -76.61 -3.61 38.65 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.772 -176.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 82.04 21.3 61.32 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.924 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -81.72 112.82 19.24 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 -179.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -118.5 -1.95 11.12 Favored 'General case' 0 CA--C 1.498 -1.019 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -178.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 67.17 178.69 0.23 Allowed 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.794 -176.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.612 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 45.0 mt-10 68.49 40.92 1.85 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.339 0.59 . . . . 0.0 111.548 -177.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -131.67 158.65 40.54 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.135 178.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.4 pt -125.39 161.63 29.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 CA-C-N 115.183 -0.917 . . . . 0.0 108.576 -179.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.527 ' HE3' ' HB3' ' A' ' 78' ' ' ASP . 59.6 mtmt -101.29 143.08 31.79 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-O 120.999 0.428 . . . . 0.0 110.535 177.176 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 75.9 mt -124.3 126.67 72.43 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.152 174.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 31.0 mtmt -94.83 104.46 16.36 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 177.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.651 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 97.5 t -85.26 112.05 21.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -179.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.468 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 5.2 p -115.62 123.41 71.01 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 CA-C-O 121.461 0.648 . . . . 0.0 110.331 179.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -85.96 176.68 49.16 Favored Glycine 0 N--CA 1.435 -1.387 0 CA-C-N 115.223 -0.899 . . . . 0.0 112.095 -178.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.576 ' NE2' ' HA ' ' A' ' 84' ' ' TYR . 78.4 mt-30 -77.36 -13.1 60.0 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.382 0.611 . . . . 0.0 111.333 -177.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -87.95 13.51 10.79 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.18 174.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 46.5 m 66.06 32.79 8.05 Favored 'General case' 0 C--N 1.343 0.294 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.378 179.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.434 ' O ' ' HA ' ' A' ' 20' ' ' VAL . 94.4 m-20 -105.47 111.71 24.52 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.952 179.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.651 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 31.2 tt0 -108.78 132.97 53.46 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.399 -179.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.2 p -134.36 143.36 38.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.196 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 27.4 m170 -101.98 113.28 26.36 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.403 0.621 . . . . 0.0 112.105 -175.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -111.18 148.86 31.86 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.072 175.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -111.8 123.82 51.04 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.901 178.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 32.9 m -136.99 174.3 12.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.229 -179.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.612 ' HG3' ' O ' ' A' ' 13' ' ' GLU . 35.4 ttmt -89.73 160.95 16.31 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 -179.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -54.65 -38.69 67.19 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 120.918 0.39 . . . . 0.0 110.365 177.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -100.77 21.92 41.8 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 116.066 -0.516 . . . . 0.0 112.826 -178.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.499 HG23 ' HB2' ' A' ' 39' ' ' LYS . 0.9 OUTLIER -60.53 143.08 54.45 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-O 121.376 0.607 . . . . 0.0 112.552 179.8 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 56.1 m -85.97 157.03 20.22 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.285 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.704 ' SD ' ' HA ' ' A' ' 65' ' ' ASN . 25.5 ptm -53.27 -32.73 50.0 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -178.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.34 -37.04 84.1 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -178.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.499 ' HB2' HG23 ' A' ' 35' ' ' THR . 49.7 mmtm -59.15 -40.65 86.22 Favored 'General case' 0 C--O 1.206 -1.222 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.25 -175.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.503 HD23 ' H ' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -86.42 -43.68 12.62 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -179.163 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.408 ' HA ' ' CE1' ' A' ' 57' ' ' PHE . 25.0 mtpp -62.15 -46.97 86.61 Favored 'General case' 0 CA--C 1.502 -0.873 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.05 -177.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.434 ' HA ' HG22 ' A' ' 52' ' ' VAL . 29.6 ttpp -63.64 -40.08 95.96 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.136 0.493 . . . . 0.0 110.003 178.302 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 50.9 m -63.66 -49.72 72.08 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.591 -0.732 . . . . 0.0 112.352 -178.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.51 ' CB ' ' HZ ' ' A' ' 57' ' ' PHE . 44.0 t80 -71.86 -45.59 60.86 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.743 0.306 . . . . 0.0 111.611 -179.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.572 ' HB1' ' O ' ' A' ' 50' ' ' VAL . . . -58.27 -32.49 68.45 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.133 -178.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -62.88 -45.0 94.6 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.353 -0.839 . . . . 0.0 112.223 -179.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.478 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 24.0 ptt180 -69.54 -25.17 63.89 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.202 0.525 . . . . 0.0 110.779 -176.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.431 HG22 ' O ' ' A' ' 44' ' ' TYR . 7.9 t -102.59 -7.26 21.96 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -174.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 68.76 28.31 73.2 Favored Glycine 0 N--CA 1.46 0.268 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.237 178.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.572 ' O ' ' HB1' ' A' ' 45' ' ' ALA . 86.9 t -106.53 146.52 12.96 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 C-N-CA 122.613 0.365 . . . . 0.0 110.167 -178.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.407 ' HB3' ' HB2' ' A' ' 54' ' ' SER . . . -52.52 133.54 35.62 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 176.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.434 HG22 ' HA ' ' A' ' 42' ' ' LYS . 76.9 t -60.48 -43.99 95.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.79 -177.087 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -66.08 -32.4 73.83 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.166 179.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.426 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 68.0 m -76.06 -10.81 59.72 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.446 -178.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.558 HD12 ' CE1' ' A' ' 57' ' ' PHE . 0.1 OUTLIER -92.68 123.38 35.92 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -179.947 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 28.0 mmm180 -104.47 110.74 23.13 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.757 -170.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.558 ' CE1' HD12 ' A' ' 55' ' ' LEU . 69.2 m-85 -110.48 126.95 54.9 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-O 121.043 0.449 . . . . 0.0 110.622 175.507 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.556 HD22 ' CE1' ' A' ' 84' ' ' TYR . 7.7 mp -129.1 144.94 51.37 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.184 178.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.74 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 62.5 t80 -111.41 116.46 30.96 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.054 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 58.71 18.7 6.15 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 122.673 0.389 . . . . 0.0 111.907 -179.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 98.98 6.72 55.9 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.774 -0.727 . . . . 0.0 113.234 178.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.74 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.1 OUTLIER -118.33 146.6 44.24 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.01 0.433 . . . . 0.0 110.06 176.815 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.507 ' HA ' ' HG ' ' A' ' 58' ' ' LEU . 38.9 mtp180 -68.4 134.96 51.01 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.525 -0.762 . . . . 0.0 112.51 -174.302 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 90.8 mt -91.15 119.86 39.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 115.399 -0.819 . . . . 0.0 108.828 178.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.704 ' HA ' ' SD ' ' A' ' 37' ' ' MET . 65.5 m-80 -118.6 159.36 23.73 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.635 -178.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -71.07 -12.96 61.81 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.191 0.52 . . . . 0.0 110.433 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -83.62 -19.45 35.43 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.097 -179.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -62.31 145.25 54.31 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.316 0.579 . . . . 0.0 112.263 -177.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.431 ' O ' HG22 ' A' ' 72' ' ' THR . 69.4 p -103.38 158.06 32.57 Favored Pre-proline 0 N--CA 1.44 -0.951 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.18 179.221 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -61.63 -21.59 72.42 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.578 2.185 . . . . 0.0 112.51 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.62 -22.47 32.21 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.437 -178.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.431 HG22 ' O ' ' A' ' 69' ' ' THR . 4.7 t -95.35 -32.77 12.79 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -179.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 96.1 mt -71.99 -25.96 62.05 Favored 'General case' 0 C--O 1.218 -0.554 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.025 177.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 48.74 33.34 4.22 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 176.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 65.2 mtt -87.21 158.88 19.02 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.293 -179.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -149.58 -179.42 7.08 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 177.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.402 ' HA ' ' H ' ' A' ' 16' ' ' LYS . 38.1 t70 -56.33 127.88 33.09 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.259 0.552 . . . . 0.0 112.123 -176.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.527 ' HB3' ' HE3' ' A' ' 16' ' ' LYS . 1.0 OUTLIER 67.27 32.63 5.88 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.591 1.556 . . . . 0.0 114.117 174.204 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -78.78 178.68 7.72 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 176.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.6 m -112.35 151.71 14.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 CA-C-O 121.271 0.558 . . . . 0.0 111.784 -174.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.482 HG22 ' HA ' ' A' ' 19' ' ' VAL . 1.0 OUTLIER -131.44 144.81 36.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 CA-C-N 115.453 -0.794 . . . . 0.0 108.878 178.023 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -104.55 139.29 39.65 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.964 -178.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 87.4 t -121.31 130.42 74.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 CA-C-O 121.235 0.54 . . . . 0.0 110.958 -179.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.576 ' HA ' ' NE2' ' A' ' 22' ' ' GLN . 77.4 m-85 -101.11 168.5 9.55 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.198 178.024 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 80.9 mm-40 -67.83 133.52 49.34 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.608 0.718 . . . . 0.0 111.821 -171.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.529 ' HG2' ' H ' ' A' ' 89' ' ' GLY . 3.2 pm0 -79.85 157.52 26.97 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.488 -1.233 . . . . 0.0 112.224 -176.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -79.32 -52.18 8.45 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -177.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.43 ' HB3' HG13 ' A' ' 50' ' ' VAL . 56.4 tp -65.04 -40.7 95.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.876 0.37 . . . . 0.0 111.432 -178.056 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.529 ' H ' ' HG2' ' A' ' 86' ' ' GLU . . . 114.77 119.08 3.31 Favored Glycine 0 C--N 1.319 -0.387 0 C-N-CA 120.518 -0.849 . . . . 0.0 113.0 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.787 0 CA-C-O 118.839 -0.978 . . . . 0.0 111.862 178.985 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 75.7 mtm . . . . . 0 N--CA 1.478 0.962 0 CA-C-O 120.915 0.388 . . . . 0.0 110.99 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.33 159.9 29.21 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.807 -179.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -78.52 -2.65 39.71 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.208 0.528 . . . . 0.0 109.745 179.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -62.91 -38.1 89.61 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.194 175.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 77.72 -24.87 0.21 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.431 1.092 . . . . 0.0 111.597 -177.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 54.95 84.53 0.07 Allowed 'General case' 0 C--O 1.238 0.485 0 O-C-N 123.852 0.72 . . . . 0.0 111.749 178.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.405 ' HB3' ' H ' ' A' ' 9' ' ' GLY . 1.8 mm-40 61.49 -171.12 0.15 Allowed 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.329 -178.057 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -92.1 -4.63 54.08 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.405 ' H ' ' HB3' ' A' ' 7' ' ' GLN . . . 71.79 19.0 77.84 Favored Glycine 0 N--CA 1.436 -1.331 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -176.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 27.5 t70 55.07 51.62 13.11 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.949 0.88 . . . . 0.0 109.078 -175.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 12.5 t30 -62.4 -45.18 94.28 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-N 114.649 -1.159 . . . . 0.0 109.482 -177.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 56.9 -160.41 0.23 Allowed 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.7 178.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 52.03 68.31 0.83 Allowed 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.226 0.536 . . . . 0.0 112.106 177.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -100.66 151.15 21.97 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-O 121.338 0.59 . . . . 0.0 110.496 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.416 ' O ' ' HD3' ' A' ' 30' ' ' ARG . 9.0 pt -110.5 161.54 8.83 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.048 -174.292 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.51 ' HB2' ' NH1' ' A' ' 30' ' ' ARG . 34.5 ttpt -109.1 144.22 37.43 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -179.231 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.637 HG21 HD12 ' A' ' 81' ' ' ILE . 82.2 mt -132.33 133.61 59.96 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.161 0 CA-C-O 120.775 0.322 . . . . 0.0 111.598 178.142 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.8 mtmt -94.87 105.23 17.14 Favored 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.698 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 75.0 t -82.28 117.64 28.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 175.36 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.536 ' HA ' ' O ' ' A' ' 25' ' ' ASN . 7.6 p -122.05 122.11 65.77 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 CA-C-O 121.727 0.775 . . . . 0.0 111.453 179.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.453 ' HA2' ' HB ' ' A' ' 83' ' ' VAL . . . -91.2 171.98 35.99 Favored Glycine 0 N--CA 1.436 -1.355 0 CA-C-N 114.867 -1.06 . . . . 0.0 111.535 179.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.453 ' C ' ' H ' ' A' ' 24' ' ' SER . 88.1 mm-40 -70.76 -27.32 63.85 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 120.933 0.397 . . . . 0.0 111.895 -176.143 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -79.63 21.84 0.5 Allowed 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.362 175.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.453 ' H ' ' C ' ' A' ' 22' ' ' GLN . 21.2 m 68.59 27.09 6.19 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.687 176.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.536 ' O ' ' HA ' ' A' ' 20' ' ' VAL . 58.2 t30 -93.85 102.09 14.2 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 119.895 -0.722 . . . . 0.0 111.167 -179.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.698 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 35.6 tt0 -112.84 127.49 56.19 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.47 177.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.7 p -136.4 145.0 31.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.712 -177.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 63.5 m170 -92.41 117.59 30.07 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.308 0.575 . . . . 0.0 111.917 -178.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -109.5 141.76 41.49 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.805 174.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.51 ' NH1' ' HB2' ' A' ' 16' ' ' LYS . 23.9 tpp180 -102.57 116.35 32.42 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 177.019 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.545 HG21 HD12 ' A' ' 17' ' ' ILE . 34.5 m -134.43 174.86 12.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.212 -176.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.469 ' O ' ' HB ' ' A' ' 35' ' ' THR . 38.0 ttmt -88.54 158.83 18.18 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.451 ' HB3' ' HB3' ' A' ' 70' ' ' PRO . 98.4 m-85 -55.43 -40.57 71.66 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 174.227 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -101.99 33.81 6.21 Favored Glycine 0 N--CA 1.449 -0.462 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.163 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.482 ' OG1' ' HB ' ' A' ' 31' ' ' VAL . 0.6 OUTLIER -65.69 140.32 58.46 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 121.317 0.58 . . . . 0.0 111.936 179.356 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.511 ' OG ' ' HG2' ' A' ' 39' ' ' LYS . 85.9 p -81.08 160.03 24.59 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.137 178.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.606 ' SD ' ' HA ' ' A' ' 65' ' ' ASN . 26.5 ptt? -60.82 -32.49 71.87 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.933 0.397 . . . . 0.0 110.687 178.096 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.74 -36.27 80.49 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.45 -177.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.511 ' HG2' ' OG ' ' A' ' 36' ' ' SER . 75.6 mmtt -59.63 -41.82 91.31 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.999 -176.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.501 HD23 ' H ' ' A' ' 40' ' ' LEU . 0.5 OUTLIER -89.42 -47.87 7.72 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -179.738 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.627 ' HG2' ' CD1' ' A' ' 57' ' ' PHE . 61.8 mtpt -62.37 -47.93 82.02 Favored 'General case' 0 CA--C 1.492 -1.271 0 CA-C-N 116.282 -0.417 . . . . 0.0 112.09 -174.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -61.69 -43.3 99.12 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 178.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 42.7 t -64.98 -51.51 61.31 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.371 -0.832 . . . . 0.0 111.294 -176.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.511 ' O ' HG22 ' A' ' 48' ' ' THR . 62.9 t80 -65.99 -49.06 69.12 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.937 -179.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.497 ' HB1' ' O ' ' A' ' 50' ' ' VAL . . . -59.74 -35.17 74.04 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.521 0.676 . . . . 0.0 109.788 -178.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -65.31 -47.0 78.08 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.248 -178.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.422 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 14.2 ptm180 -68.35 -26.39 65.57 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.568 -178.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.511 HG22 ' O ' ' A' ' 44' ' ' TYR . 8.8 t -96.71 -3.51 42.42 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -178.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 68.51 35.56 81.66 Favored Glycine 0 C--N 1.335 0.5 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.706 178.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.574 HG11 ' HG3' ' A' ' 86' ' ' GLU . 78.2 t -118.83 144.54 26.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 C-N-CA 122.406 0.282 . . . . 0.0 111.346 -177.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.467 ' HB3' ' HB2' ' A' ' 54' ' ' SER . . . -51.25 129.31 24.32 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.968 176.008 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 77.0 t -61.42 -43.94 97.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.019 -177.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -65.75 -32.43 73.96 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.016 -179.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.468 ' HB3' ' HB3' ' A' ' 87' ' ' GLN . 51.5 m -83.57 -6.17 59.37 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.687 -178.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.521 HD12 ' CE1' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -96.43 121.17 37.95 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 176.617 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.21 126.47 52.26 Favored 'General case' 0 CA--C 1.499 -1.012 0 C-N-CA 120.112 -0.635 . . . . 0.0 110.834 -176.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.627 ' CD1' ' HG2' ' A' ' 41' ' ' LYS . 22.2 m-85 -106.98 131.04 54.5 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 176.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.524 HD13 ' HA ' ' A' ' 63' ' ' ARG . 2.9 mm? -120.88 155.06 34.96 Favored 'General case' 0 N--CA 1.417 -2.075 0 CA-C-O 122.29 1.043 . . . . 0.0 113.068 -174.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.627 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 54.1 t80 -122.79 105.99 10.52 Favored 'General case' 0 C--N 1.282 -2.339 0 CA-C-N 113.289 -1.778 . . . . 0.0 108.103 174.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 54.26 28.46 9.24 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.805 -176.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 96.4 -7.83 66.43 Favored Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.543 -0.753 . . . . 0.0 113.117 177.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.627 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 4.1 ppt_? -104.34 147.15 27.84 Favored 'General case' 0 N--CA 1.438 -1.034 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.078 179.287 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.524 ' HA ' HD13 ' A' ' 58' ' ' LEU . 0.1 OUTLIER -67.9 143.77 55.56 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -171.4 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 81.9 mt -102.87 121.42 54.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.273 -0.876 . . . . 0.0 108.709 174.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.606 ' HA ' ' SD ' ' A' ' 37' ' ' MET . 66.4 m-80 -121.41 172.41 8.07 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 120.916 0.389 . . . . 0.0 110.997 -178.177 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -70.21 -13.21 62.08 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.076 0.465 . . . . 0.0 110.96 -178.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -82.29 -14.82 54.8 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.011 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.431 ' CG ' HH12 ' A' ' 62' ' ' ARG . 4.6 m-20 -65.17 153.73 40.07 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 -177.048 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.42 ' HB ' ' HD2' ' A' ' 70' ' ' PRO . 70.2 p -126.28 159.35 63.11 Favored Pre-proline 0 N--CA 1.435 -1.206 0 CA-C-N 114.156 -1.384 . . . . 0.0 109.54 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.451 ' HB3' ' HB3' ' A' ' 33' ' ' TYR . 33.3 Cg_endo -63.71 -19.49 67.33 Favored 'Trans proline' 0 C--O 1.224 -0.183 0 C-N-CA 122.515 2.143 . . . . 0.0 112.688 -179.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.49 -26.99 37.88 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-O 120.81 0.338 . . . . 0.0 111.143 -178.219 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.404 HG22 ' H ' ' A' ' 69' ' ' THR . 12.3 t -94.82 -36.75 11.54 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 120.861 0.362 . . . . 0.0 110.181 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 95.8 mt -75.33 -23.14 57.22 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 175.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 52.94 29.03 7.22 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.728 178.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.437 ' HA ' ' OD2' ' A' ' 79' ' ' ASP . 66.2 mtt -85.71 157.18 20.36 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.166 -178.081 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.48 ' H ' ' HB2' ' A' ' 79' ' ' ASP . 14.0 pt-20 -152.79 -173.57 4.62 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.157 -178.072 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.445 ' HA ' ' H ' ' A' ' 16' ' ' LYS . 28.3 t70 -57.66 120.84 9.05 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.709 0.766 . . . . 0.0 112.569 -176.303 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.485 ' OD1' ' HE3' ' A' ' 16' ' ' LYS . 29.5 t70 65.86 34.16 7.49 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.442 1.497 . . . . 0.0 111.054 178.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.48 ' HB2' ' H ' ' A' ' 76' ' ' GLU . 31.9 t0 -75.06 176.3 7.37 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.413 177.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 35.3 m -111.87 143.24 22.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 CA-C-O 121.847 0.832 . . . . 0.0 112.883 -174.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.637 HD12 HG21 ' A' ' 17' ' ' ILE . 3.3 mt -128.47 134.15 65.27 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 CA-C-N 114.234 -1.348 . . . . 0.0 109.425 176.026 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -101.7 138.16 39.06 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.105 0.478 . . . . 0.0 110.677 -177.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.453 ' HB ' ' HA2' ' A' ' 21' ' ' GLY . 88.6 t -123.5 133.76 68.26 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.644 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.481 ' CD1' HD23 ' A' ' 58' ' ' LEU . 53.7 m-85 -99.5 152.48 19.95 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 175.279 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 10.5 mm100 -68.32 129.24 39.34 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 122.004 0.907 . . . . 0.0 112.568 -169.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.574 ' HG3' HG11 ' A' ' 50' ' ' VAL . 1.4 pm0 -64.05 160.87 17.12 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 113.473 -1.694 . . . . 0.0 113.548 -172.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.468 ' HB3' ' HB3' ' A' ' 54' ' ' SER . 6.6 tp-100 -64.96 -48.72 73.01 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.404 -178.212 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.5 HD23 ' HA ' ' A' ' 50' ' ' VAL . 56.7 tp -68.91 -39.89 79.43 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.868 -179.05 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.484 ' H ' ' HG2' ' A' ' 86' ' ' GLU . . . 104.18 133.98 8.0 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.55 -178.325 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.541 -1.144 . . . . 0.0 111.858 -178.854 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.9 ttp . . . . . 0 N--CA 1.471 0.595 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -142.17 172.72 12.31 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.002 -177.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -65.98 122.85 18.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.228 179.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -70.91 -38.26 72.96 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.511 -179.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 74.21 -52.66 0.69 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.125 0.97 . . . . 0.0 110.571 -176.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -104.91 112.06 25.04 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.483 177.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -133.05 146.49 51.75 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.485 -179.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.04 -46.31 81.81 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.435 177.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -70.57 -43.51 60.56 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.739 177.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 25.0 t70 66.74 -54.8 0.43 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.472 1.109 . . . . 0.0 113.736 177.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -65.25 -38.98 92.02 Favored 'General case' 0 CA--C 1.488 -1.431 0 CA-C-O 121.485 0.659 . . . . 0.0 111.041 -178.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -113.07 125.13 54.04 Favored 'General case' 0 N--CA 1.398 -3.033 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.565 -176.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -114.37 3.07 14.9 Favored 'General case' 0 C--N 1.282 -2.339 0 CA-C-O 122.344 1.069 . . . . 0.0 110.622 -175.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -140.13 159.46 42.14 Favored 'General case' 0 C--N 1.282 -2.338 0 CA-C-N 113.353 -1.749 . . . . 0.0 108.457 177.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.423 ' HB ' ' HA ' ' A' ' 77' ' ' ASP . 18.3 pt -127.16 161.95 33.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -177.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.536 ' HE3' ' HB2' ' A' ' 78' ' ' ASP . 59.3 mtmt -97.55 146.47 25.23 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-O 121.045 0.45 . . . . 0.0 110.599 176.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.672 HG21 HD12 ' A' ' 81' ' ' ILE . 40.7 mm -128.1 127.37 67.64 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 CA-C-N 115.498 -0.773 . . . . 0.0 109.833 174.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.9 mtmt -96.75 104.77 16.8 Favored 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 177.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.7 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 98.8 t -82.21 116.88 27.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.6 t -113.03 117.61 55.82 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-O 121.082 0.467 . . . . 0.0 110.738 -178.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -88.49 168.58 36.59 Favored Glycine 0 N--CA 1.436 -1.317 0 C-N-CA 120.431 -0.89 . . . . 0.0 111.378 177.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.462 HE21 ' HA ' ' A' ' 84' ' ' TYR . 78.5 mt-30 -67.89 -23.78 65.15 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.191 0.52 . . . . 0.0 111.902 -178.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -79.5 11.27 3.14 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.124 178.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.1 m 69.0 27.29 5.44 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.811 -178.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -95.66 104.63 16.55 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.737 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.7 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 37.7 tt0 -105.02 135.37 46.48 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.673 178.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.1 p -137.17 140.22 42.74 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.457 178.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 55.1 m170 -99.05 113.14 25.18 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 121.307 0.575 . . . . 0.0 111.156 -176.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -110.65 145.38 38.04 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.718 176.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 11.1 tpt180 -99.95 118.07 35.59 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.48 ' HB ' HG21 ' A' ' 35' ' ' THR . 33.3 m -133.56 167.75 25.69 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -178.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 46.0 tttm -90.82 162.96 14.61 Favored 'General case' 0 C--N 1.284 -2.247 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.512 ' O ' ' HB3' ' A' ' 70' ' ' PRO . 94.2 m-85 -55.09 -39.18 69.01 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 176.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.477 ' HA2' ' HG3' ' A' ' 70' ' ' PRO . . . -96.38 19.26 55.35 Favored Glycine 0 N--CA 1.444 -0.805 0 CA-C-N 115.728 -0.669 . . . . 0.0 113.337 -177.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.48 HG21 ' HB ' ' A' ' 31' ' ' VAL . 1.3 m -67.47 136.69 55.03 Favored 'General case' 0 N--CA 1.428 -1.535 0 CA-C-O 121.125 0.488 . . . . 0.0 111.73 179.088 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.572 ' HA ' ' O ' ' A' ' 65' ' ' ASN . 47.0 m -86.28 151.97 23.16 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.497 -178.063 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.476 ' HG2' ' HB2' ' A' ' 66' ' ' ASP . 24.2 ptt? -50.01 -32.27 14.84 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -179.161 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.95 -35.96 78.12 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -178.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -59.44 -40.89 88.24 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.083 0.468 . . . . 0.0 110.137 -177.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.659 HD12 ' CD2' ' A' ' 57' ' ' PHE . 0.2 OUTLIER -86.8 -43.96 12.1 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.544 -177.684 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 61.6 mtpt -62.79 -47.03 85.24 Favored 'General case' 0 CA--C 1.491 -1.293 0 N-CA-C 111.868 0.321 . . . . 0.0 111.868 -177.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -63.72 -40.68 97.35 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 46.6 t -63.73 -48.77 75.69 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.03 -179.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.709 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 43.1 t80 -70.18 -44.84 67.93 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.874 -179.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.427 ' CB ' ' HA ' ' A' ' 52' ' ' VAL . . . -59.47 -34.57 72.71 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.229 0.538 . . . . 0.0 109.822 179.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -66.43 -45.81 78.6 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.331 -0.849 . . . . 0.0 111.613 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.709 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 10.9 ptm85 -65.59 -28.71 69.33 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.898 -178.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.499 HG22 ' O ' ' A' ' 44' ' ' TYR . 9.9 t -93.23 -5.82 49.07 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.718 179.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 66.92 35.4 89.46 Favored Glycine 0 C--N 1.335 0.483 0 CA-C-N 116.036 -0.529 . . . . 0.0 113.277 177.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.708 HG21 ' HG3' ' A' ' 86' ' ' GLU . 1.5 p -121.54 166.16 16.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 116.927 0.364 . . . . 0.0 110.967 -177.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.413 ' HB3' ' HB2' ' A' ' 54' ' ' SER . . . -57.46 128.72 38.47 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.51 179.081 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.427 ' HA ' ' CB ' ' A' ' 45' ' ' ALA . 73.4 t -61.36 -46.24 96.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.553 -0.748 . . . . 0.0 111.585 -177.037 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -77.33 -14.76 59.67 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.987 -176.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.455 ' HB3' ' HB3' ' A' ' 87' ' ' GLN . 70.0 m -85.43 -15.6 42.47 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.528 178.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.452 HD13 ' N ' ' A' ' 56' ' ' ARG . 0.8 OUTLIER -95.03 135.03 37.06 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.452 ' N ' HD13 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -130.43 141.42 50.53 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 120.132 -0.627 . . . . 0.0 111.404 -175.203 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.659 ' CD2' HD12 ' A' ' 40' ' ' LEU . 13.7 m-85 -115.5 136.71 52.8 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-N 115.21 -0.904 . . . . 0.0 108.95 177.228 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.757 HD23 ' CD1' ' A' ' 84' ' ' TYR . 0.9 OUTLIER -129.99 151.12 50.9 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-O 121.589 0.709 . . . . 0.0 111.268 178.773 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.719 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 49.5 t80 -113.89 103.47 11.2 Favored 'General case' 0 C--N 1.284 -2.265 0 CA-C-N 114.921 -1.036 . . . . 0.0 108.713 175.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.7 t70 54.92 24.29 5.72 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.748 -177.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 102.34 -5.7 52.47 Favored Glycine 0 C--N 1.333 0.4 0 CA-C-N 115.601 -0.727 . . . . 0.0 113.663 177.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.719 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.2 OUTLIER -108.4 150.16 27.75 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 117.362 0.581 . . . . 0.0 109.856 178.578 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.493 ' HA ' ' CD1' ' A' ' 58' ' ' LEU . 11.8 mpt_? -66.96 142.86 57.11 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -171.053 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.42 HG21 HD11 ' A' ' 40' ' ' LEU . 44.1 mm -74.59 144.9 11.77 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 CA-C-N 114.816 -1.084 . . . . 0.0 109.502 176.076 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.572 ' O ' ' HA ' ' A' ' 36' ' ' SER . 1.0 OUTLIER -68.35 106.12 2.39 Favored 'General case' 0 N--CA 1.406 -2.655 0 N-CA-C 115.089 1.515 . . . . 0.0 115.089 -170.415 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.476 ' HB2' ' HG2' ' A' ' 37' ' ' MET . 4.1 t70 -91.07 -39.65 12.06 Favored 'General case' 0 C--N 1.257 -3.453 0 N-CA-C 102.834 -3.024 . . . . 0.0 102.834 153.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -117.7 -17.9 9.78 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 110.82 -2.9 . . . . 0.0 110.927 -176.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.569 ' HB2' ' HA ' ' A' ' 65' ' ' ASN . 2.7 m-20 -72.76 168.58 18.5 Favored 'General case' 0 C--N 1.342 0.269 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.964 -176.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.683 ' O ' HG22 ' A' ' 72' ' ' THR . 88.8 m -97.47 130.49 29.23 Favored Pre-proline 0 C--N 1.306 -1.324 0 C-N-CA 120.799 -0.361 . . . . 0.0 110.687 -172.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.512 ' HB3' ' O ' ' A' ' 33' ' ' TYR . 88.6 Cg_exo -52.62 -37.68 74.93 Favored 'Trans proline' 0 CA--C 1.53 0.295 0 C-N-CA 122.756 2.304 . . . . 0.0 112.127 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.02 -25.06 37.49 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.554 179.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.683 HG22 ' O ' ' A' ' 69' ' ' THR . 2.1 t -70.15 -32.81 70.96 Favored 'General case' 0 C--N 1.347 0.473 0 C-N-CA 120.026 -0.67 . . . . 0.0 109.47 178.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 60.4 mt -72.2 -24.99 61.49 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.185 174.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 57.22 40.52 27.93 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.359 179.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 24.7 mmt -72.55 155.62 39.87 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.834 -179.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -151.59 175.75 12.03 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 176.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.423 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 37.6 t70 -58.26 121.35 10.54 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.456 0.646 . . . . 0.0 112.335 -178.057 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.536 ' HB2' ' HE3' ' A' ' 16' ' ' LYS . 13.5 t70 74.19 34.28 0.85 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.351 1.461 . . . . 0.0 111.982 176.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -75.71 177.51 6.79 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.597 -0.441 . . . . 0.0 109.984 177.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 33.1 m -110.23 147.63 14.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 CA-C-O 121.546 0.689 . . . . 0.0 112.28 -173.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.672 HD12 HG21 ' A' ' 17' ' ' ILE . 0.3 OUTLIER -140.61 144.82 26.61 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.302 -179.85 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -110.28 143.08 40.99 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.169 -175.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 86.6 t -125.4 132.43 71.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.131 0.491 . . . . 0.0 111.479 179.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.757 ' CD1' HD23 ' A' ' 58' ' ' LEU . 90.5 m-85 -100.44 162.49 12.91 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.784 177.165 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 53.3 tp60 -69.45 143.97 53.42 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -176.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.708 ' HG3' HG21 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -90.0 171.15 9.77 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 112.991 0.738 . . . . 0.0 112.991 -175.12 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.455 ' HB3' ' HB3' ' A' ' 54' ' ' SER . 51.9 tt0 -62.06 -50.01 73.69 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.044 -0.98 . . . . 0.0 112.613 -178.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.8 mp -68.56 -36.63 79.03 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.022 -178.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.576 ' H ' ' HG2' ' A' ' 86' ' ' GLU . . . -63.34 -41.12 99.55 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.953 -0.642 . . . . 0.0 113.05 -178.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.054 0 CA-C-O 118.555 -1.136 . . . . 0.0 111.644 179.445 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.9 tpt . . . . . 0 N--CA 1.475 0.784 0 CA-C-O 120.725 0.298 . . . . 0.0 110.359 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -88.02 87.42 7.33 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.106 0.479 . . . . 0.0 110.787 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -88.2 -172.65 3.89 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.502 178.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -61.15 -40.26 93.19 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.771 -178.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 54.34 36.84 26.27 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.101 0.476 . . . . 0.0 110.444 -176.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -160.04 159.59 32.19 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.115 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 26.6 pt20 -124.6 146.68 48.92 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.838 0.352 . . . . 0.0 110.374 178.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.81 -40.24 96.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.573 -175.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.0 16.84 73.78 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.501 -0.857 . . . . 0.0 111.401 -177.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -85.52 99.87 11.53 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.033 -0.583 . . . . 0.0 109.632 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.66 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 10.2 p30 -143.12 20.98 1.93 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -175.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.51 -45.99 91.76 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -177.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -115.37 60.34 0.7 Allowed 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 120.995 0.426 . . . . 0.0 110.264 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.66 ' CD1' ' HA ' ' A' ' 11' ' ' ASN . 90.7 m-85 -134.45 167.85 20.0 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.769 -175.436 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.856 HD12 ' HA ' ' A' ' 76' ' ' GLU . 17.1 pt -109.56 163.62 6.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.326 -174.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.538 ' C ' HD12 ' A' ' 17' ' ' ILE . 38.0 mtmm -90.28 145.88 24.65 Favored 'General case' 0 CA--C 1.5 -0.95 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.654 HD13 ' CG2' ' A' ' 31' ' ' VAL . 1.5 mp -135.18 137.04 50.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.632 173.179 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 18.6 mtmm -97.29 104.53 16.56 Favored 'General case' 0 N--CA 1.437 -1.083 0 C-N-CA 119.979 -0.688 . . . . 0.0 109.191 178.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.627 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 85.3 t -82.64 116.17 26.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.422 179.309 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.8 t -107.69 118.85 56.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-O 120.833 0.349 . . . . 0.0 110.077 179.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.484 ' HA2' ' HB ' ' A' ' 83' ' ' VAL . . . -87.97 177.06 46.13 Favored Glycine 0 C--N 1.314 -0.663 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.414 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.514 ' C ' ' H ' ' A' ' 24' ' ' SER . 91.0 mm-40 -65.62 -36.75 84.63 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -178.102 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.64 18.85 0.22 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.954 0.407 . . . . 0.0 109.99 176.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.514 ' H ' ' C ' ' A' ' 22' ' ' GLN . 51.0 m 62.12 30.41 17.77 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.153 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -92.06 107.07 18.94 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.947 -178.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.627 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 32.2 tt0 -97.4 132.3 43.25 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.892 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.417 HG13 ' HB ' ' A' ' 19' ' ' VAL . 7.4 p -135.76 139.82 45.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.522 178.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 61.7 m170 -95.91 114.0 25.68 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 121.17 0.51 . . . . 0.0 110.916 -176.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -110.37 153.41 24.98 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.583 177.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.468 ' HG2' ' HB2' ' A' ' 11' ' ' ASN . 11.7 tpp180 -108.74 115.59 30.39 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.66 179.3 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.654 ' CG2' HD13 ' A' ' 17' ' ' ILE . 30.3 m -140.36 -178.94 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.412 -178.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.536 ' O ' ' HB ' ' A' ' 35' ' ' THR . 83.6 tttt -88.68 155.22 19.72 Favored 'General case' 0 C--N 1.313 -1.001 0 O-C-N 122.361 -0.212 . . . . 0.0 110.674 -177.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -51.79 -45.41 63.83 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-O 121.381 0.61 . . . . 0.0 110.123 176.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -109.84 35.43 4.88 Favored Glycine 0 N--CA 1.441 -1.012 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.967 179.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.655 ' O ' HD13 ' A' ' 73' ' ' LEU . 0.5 OUTLIER -57.19 143.43 39.12 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 121.475 0.655 . . . . 0.0 110.893 -177.164 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 59.3 m -79.85 150.02 30.79 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.757 -179.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.69 ' HA ' HD21 ' A' ' 40' ' ' LEU . 26.6 ptt? -49.64 -32.31 12.79 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -177.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.24 -36.07 82.42 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -179.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -59.19 -41.48 88.59 Favored 'General case' 0 C--O 1.217 -0.65 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.165 -175.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.719 HD23 ' H ' ' A' ' 40' ' ' LEU . 0.5 OUTLIER -86.25 -45.64 11.09 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.168 -176.87 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -62.45 -47.92 81.92 Favored 'General case' 0 CA--C 1.492 -1.257 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.761 -176.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -65.72 -39.67 91.41 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.166 178.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 44.9 t -64.35 -51.45 63.27 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.34 -178.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.613 ' O ' ' HG3' ' A' ' 47' ' ' ARG . 47.6 t80 -66.82 -44.0 82.3 Favored 'General case' 0 CA--C 1.499 -1.002 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.45 179.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.442 ' HA ' HG12 ' A' ' 50' ' ' VAL . . . -58.58 -36.16 73.53 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.01 0.434 . . . . 0.0 109.855 -179.202 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -67.58 -44.79 77.33 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.778 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.613 ' HG3' ' O ' ' A' ' 44' ' ' TYR . 2.1 ppt_? -64.33 -25.87 68.23 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.65 -178.05 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.534 HG22 ' O ' ' A' ' 44' ' ' TYR . 10.1 t -104.17 -9.33 18.76 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.815 -178.148 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 68.92 39.56 85.14 Favored Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.737 -0.744 . . . . 0.0 113.036 179.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.523 HG21 ' HG3' ' A' ' 86' ' ' GLU . 5.2 p -118.21 164.32 14.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 120.981 0.419 . . . . 0.0 111.026 -178.01 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.596 ' HB3' ' OG ' ' A' ' 54' ' ' SER . . . -59.99 128.55 37.39 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.991 175.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 73.4 t -64.39 -40.96 90.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 121.131 0.491 . . . . 0.0 110.401 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 32.2 p-10 -67.24 -27.83 67.55 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.36 -177.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.596 ' OG ' ' HB3' ' A' ' 51' ' ' ALA . 88.4 p -97.58 1.18 48.55 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.079 0.466 . . . . 0.0 111.618 179.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -96.85 133.49 41.4 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 175.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.75 144.16 35.35 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -174.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.652 ' CG ' HD12 ' A' ' 40' ' ' LEU . 63.4 m-85 -119.14 142.86 47.56 Favored 'General case' 0 CA--C 1.501 -0.921 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.618 176.419 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.639 HD22 ' CE1' ' A' ' 84' ' ' TYR . 8.1 mp -130.84 133.87 46.31 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.628 178.248 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.778 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 0.3 OUTLIER -109.33 114.63 28.47 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.945 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 38.7 t70 66.27 22.48 10.91 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 122.044 0.926 . . . . 0.0 110.674 -177.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 89.9 9.53 65.86 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.41 -0.814 . . . . 0.0 113.055 176.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.778 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.2 OUTLIER -117.62 148.62 41.77 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.753 179.588 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.474 ' HD3' HD11 ' A' ' 58' ' ' LEU . 26.1 mmt85 -65.41 133.26 50.96 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.245 -175.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.486 HD12 ' HB3' ' A' ' 57' ' ' PHE . 87.9 mt -93.67 120.55 43.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.213 -178.317 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.652 ' HA ' ' SD ' ' A' ' 37' ' ' MET . 22.1 m120 -115.83 162.48 17.25 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.773 177.019 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -70.1 -15.0 62.92 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.214 0.53 . . . . 0.0 110.573 -179.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -84.12 -18.83 35.52 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.701 -178.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.65 ' CG ' HH12 ' A' ' 62' ' ' ARG . 65.9 m-20 -71.21 171.49 10.95 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 115.413 1.635 . . . . 0.0 115.413 -172.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.69 ' O ' ' HG ' ' A' ' 73' ' ' LEU . 71.8 p -93.57 156.39 39.76 Favored Pre-proline 0 C--N 1.346 0.449 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.352 -172.036 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.739 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 9.6 Cg_endo -49.77 -26.51 13.6 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 123.352 2.702 . . . . 0.0 113.793 -175.047 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.85 ' HA ' ' CG ' ' A' ' 75' ' ' MET . 0.0 OUTLIER -74.04 -24.35 59.53 Favored 'General case' 0 C--O 1.214 -0.775 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 -179.558 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.563 ' CG2' ' HB3' ' A' ' 68' ' ' ASP . 0.5 OUTLIER -101.85 -6.8 23.12 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 176.126 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.739 ' HB2' ' HA ' ' A' ' 70' ' ' PRO . 0.7 OUTLIER -101.44 24.58 9.43 Favored 'General case' 0 CA--C 1.444 -3.098 0 CA-C-N 111.807 -2.451 . . . . 0.0 115.409 -172.661 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.734 ' HB2' ' O ' ' A' ' 73' ' ' LEU . 35.7 mt-10 76.26 65.62 0.05 Allowed 'General case' 0 C--N 1.303 -1.413 0 CA-C-O 122.903 1.335 . . . . 0.0 111.35 174.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.85 ' CG ' ' HA ' ' A' ' 71' ' ' LYS . 90.1 mtp -39.58 -179.31 0.0 OUTLIER 'General case' 0 C--N 1.267 -2.984 0 CA-C-N 111.812 -2.449 . . . . 0.0 116.201 171.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.856 ' HA ' HD12 ' A' ' 15' ' ' ILE . 14.9 pt-20 -71.74 -178.05 2.14 Favored 'General case' 0 CA--C 1.486 -1.508 0 C-N-CA 124.812 1.245 . . . . 0.0 113.13 -156.488 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -35.34 99.76 0.02 OUTLIER 'General case' 0 CA--C 1.506 -0.74 0 O-C-N 124.862 1.351 . . . . 0.0 113.932 -168.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 14.0 t70 82.42 33.23 0.08 Allowed 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 112.181 -2.281 . . . . 0.0 112.566 171.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -70.44 178.9 2.71 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 119.828 -0.749 . . . . 0.0 109.57 172.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 29.3 m -110.92 151.02 13.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -172.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.487 HG13 ' HG2' ' A' ' 74' ' ' GLU . 1.3 mm -138.87 145.93 26.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.017 -0.992 . . . . 0.0 111.674 -178.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -112.16 138.8 48.34 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 116.114 -0.493 . . . . 0.0 109.83 178.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.484 ' HB ' ' HA2' ' A' ' 21' ' ' GLY . 78.3 t -125.83 132.8 70.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 CA-C-O 121.063 0.459 . . . . 0.0 111.092 179.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.639 ' CE1' HD22 ' A' ' 58' ' ' LEU . 70.7 m-85 -98.84 140.88 32.35 Favored 'General case' 0 N--CA 1.418 -2.056 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 174.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -68.15 127.12 31.75 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 121.806 0.812 . . . . 0.0 112.152 -164.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.523 ' HG3' HG21 ' A' ' 50' ' ' VAL . 13.2 pm0 -64.54 157.44 26.82 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 113.84 -1.527 . . . . 0.0 113.029 -175.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 57.9 tp60 -66.23 -45.22 81.42 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.999 -1.001 . . . . 0.0 112.928 -174.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 93.4 mt -105.89 4.14 29.32 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 116.13 -0.487 . . . . 0.0 112.292 -174.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -121.99 -144.49 6.82 Favored Glycine 0 C--N 1.31 -0.873 0 C-N-CA 120.382 -0.914 . . . . 0.0 111.858 -178.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.494 0 CA-C-O 118.461 -1.188 . . . . 0.0 111.709 -179.796 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.4 tpp . . . . . 0 N--CA 1.476 0.843 0 CA-C-O 120.526 0.203 . . . . 0.0 111.403 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 51.02 44.69 28.48 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.338 0.655 . . . . 0.0 112.504 177.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.5 t70 53.99 53.31 11.36 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.47 0.653 . . . . 0.0 111.581 -179.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -62.27 -39.81 94.17 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.484 176.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 67.52 36.47 3.76 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.927 178.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -66.04 125.44 25.48 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 175.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.7 mp0 53.53 87.65 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 121.943 0.878 . . . . 0.0 110.771 -173.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -79.14 0.03 29.86 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 114.834 -1.076 . . . . 0.0 111.232 -177.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 123.54 -8.71 8.82 Favored Glycine 0 CA--C 1.498 -0.974 0 N-CA-C 111.476 -0.65 . . . . 0.0 111.476 -178.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -147.1 172.95 12.97 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -100.85 10.9 40.57 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.537 0.684 . . . . 0.0 110.099 -179.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -154.1 159.58 41.56 Favored 'General case' 0 N--CA 1.422 -1.84 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.701 -179.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.451 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 1.3 pm0 -95.31 47.91 1.14 Allowed 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.685 -176.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -123.92 153.36 41.29 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.51 0.672 . . . . 0.0 112.343 -178.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 18.2 pt -126.89 162.89 30.62 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.285 -175.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.412 ' HB2' ' N ' ' A' ' 78' ' ' ASP . 28.3 mtpp -92.27 145.35 24.55 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.048 178.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.406 ' CG2' HD13 ' A' ' 81' ' ' ILE . 31.2 mm -135.02 129.8 51.26 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 CA-C-O 120.856 0.36 . . . . 0.0 111.305 175.288 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 22.3 mtmt -100.34 108.13 20.09 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 177.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.648 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 77.5 t -81.69 117.76 28.25 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 177.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 59.4 t -112.29 118.78 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 CA-C-O 121.189 0.519 . . . . 0.0 110.571 -178.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.415 ' HA2' ' HB ' ' A' ' 83' ' ' VAL . . . -86.89 168.24 39.11 Favored Glycine 0 N--CA 1.436 -1.344 0 C-N-CA 120.494 -0.86 . . . . 0.0 111.44 177.384 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.453 ' HG2' ' O ' ' A' ' 83' ' ' VAL . 87.7 mm-40 -70.87 -20.29 62.54 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.566 0.698 . . . . 0.0 111.498 -178.134 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -84.46 13.84 5.09 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.354 178.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.9 m 67.18 28.73 8.06 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.083 -178.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -95.58 103.28 15.15 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.063 -179.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.648 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 35.4 tt0 -104.03 135.44 45.53 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.03 179.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.2 p -135.64 142.38 39.52 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.389 178.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 27.9 m170 -102.08 117.61 35.17 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 121.252 0.548 . . . . 0.0 112.285 -175.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.433 ' HZ ' ' CD ' ' A' ' 47' ' ' ARG . 81.0 m-85 -116.33 146.87 42.1 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.49 175.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 49.5 ttp180 -104.45 123.02 46.72 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 174.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 33.4 m -133.43 174.34 13.37 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.374 -175.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.451 ' HG3' ' O ' ' A' ' 13' ' ' GLU . 22.4 ttpp -88.41 157.7 18.6 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -178.298 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.498 ' O ' ' HB3' ' A' ' 70' ' ' PRO . 90.8 m-85 -52.3 -41.22 62.74 Favored 'General case' 0 C--O 1.224 -0.268 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 175.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -104.97 32.31 7.64 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.954 -178.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.536 HG23 ' HB2' ' A' ' 39' ' ' LYS . 1.1 m -67.76 134.57 51.25 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 121.28 0.562 . . . . 0.0 111.913 178.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.544 ' HB3' ' HA ' ' A' ' 66' ' ' ASP . 69.9 m -91.26 156.31 17.91 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.528 -179.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.434 ' HB3' HG22 ' A' ' 64' ' ' ILE . 24.9 ptt? -45.67 -35.75 4.38 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -178.025 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.69 -37.74 85.22 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -176.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.536 ' HB2' HG23 ' A' ' 35' ' ' THR . 76.0 mmtt -59.99 -39.87 87.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.778 0.323 . . . . 0.0 110.205 -175.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.58 HD12 ' CD1' ' A' ' 57' ' ' PHE . 0.4 OUTLIER -87.58 -42.79 12.47 Favored 'General case' 0 C--O 1.217 -0.629 0 N-CA-C 112.665 0.616 . . . . 0.0 112.665 -177.545 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.479 ' HA ' ' HE1' ' A' ' 57' ' ' PHE . 61.3 mtpt -62.88 -46.24 88.8 Favored 'General case' 0 CA--C 1.493 -1.22 0 CA-C-O 120.574 0.226 . . . . 0.0 111.514 -178.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.532 ' O ' ' HB2' ' A' ' 46' ' ' ASP . 40.5 ttpt -62.81 -41.28 99.24 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.638 176.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 46.9 t -69.08 -52.19 30.97 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.63 -177.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.669 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 40.3 t80 -64.4 -47.83 77.73 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-O 120.694 0.283 . . . . 0.0 110.935 -178.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.443 ' CB ' ' HA ' ' A' ' 52' ' ' VAL . . . -60.13 -33.68 72.48 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.397 0.617 . . . . 0.0 109.968 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.532 ' HB2' ' O ' ' A' ' 42' ' ' LYS . 20.4 t70 -64.02 -47.15 81.36 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.214 -178.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.669 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 7.8 ptm180 -69.76 -29.25 66.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.392 -177.163 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.525 HG22 ' O ' ' A' ' 44' ' ' TYR . 7.6 t -88.44 -12.75 42.23 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.965 0.412 . . . . 0.0 110.425 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 69.76 31.58 70.34 Favored Glycine 0 CA--C 1.505 -0.558 0 C-N-CA 121.003 -0.618 . . . . 0.0 111.906 179.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.86 HG11 ' HB2' ' A' ' 87' ' ' GLN . 0.5 OUTLIER -115.2 175.12 2.73 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 CA-C-O 120.435 0.16 . . . . 0.0 110.605 -176.064 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.531 ' HB3' ' HB2' ' A' ' 54' ' ' SER . . . -59.16 125.64 24.45 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.912 179.021 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.443 ' HA ' ' CB ' ' A' ' 45' ' ' ALA . 70.2 t -67.1 -44.14 88.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.284 0.564 . . . . 0.0 110.253 178.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -66.16 -34.23 77.57 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.847 -178.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.531 ' HB2' ' HB3' ' A' ' 51' ' ' ALA . 59.2 m -84.98 -13.83 49.4 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.885 -175.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.837 HD23 ' HB3' ' A' ' 87' ' ' GLN . 2.7 tm? -92.98 123.2 36.06 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 179.01 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.409 ' HG3' ' C ' ' A' ' 55' ' ' LEU . 20.4 mtt180 -135.74 146.09 47.3 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.117 -170.091 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.58 ' CD1' HD12 ' A' ' 40' ' ' LEU . 95.2 m-85 -119.97 148.11 43.94 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.965 -179.329 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.415 HD22 ' CE1' ' A' ' 84' ' ' TYR . 7.3 mp -129.07 148.31 51.01 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.517 176.237 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.659 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 18.0 t80 -121.88 120.81 35.59 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 177.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 33.6 t70 61.04 24.05 14.18 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 121.517 0.675 . . . . 0.0 110.707 179.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 87.92 8.38 72.77 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.846 179.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.659 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 6.0 ppt_? -120.44 152.59 37.77 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 120.356 -0.538 . . . . 0.0 111.274 178.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 18.0 mmm180 -65.3 133.95 52.54 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.458 -176.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.434 HG22 ' HB3' ' A' ' 37' ' ' MET . 87.0 mt -85.18 129.37 37.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 173.142 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -109.96 162.23 14.72 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.25 0.547 . . . . 0.0 111.034 -172.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.544 ' HA ' ' HB3' ' A' ' 36' ' ' SER . 10.9 p-10 -83.47 -7.67 59.5 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.178 0.513 . . . . 0.0 109.688 174.048 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -102.81 -13.02 17.17 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 115.361 -0.836 . . . . 0.0 112.324 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.412 ' OD2' HD21 ' A' ' 73' ' ' LEU . 35.9 p30 -71.62 167.08 20.55 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 113.034 0.754 . . . . 0.0 113.034 -174.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.486 ' HB ' ' HD2' ' A' ' 70' ' ' PRO . 53.0 p -120.59 160.23 45.03 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.012 -176.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.498 ' HB3' ' O ' ' A' ' 33' ' ' TYR . 12.7 Cg_endo -56.84 -31.34 88.52 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.125 2.55 . . . . 0.0 113.701 -177.129 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.412 ' HE2' ' HB3' ' A' ' 71' ' ' LYS . 2.8 ptpt -70.18 -48.77 55.77 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.645 0.259 . . . . 0.0 111.066 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.42 HG22 ' H ' ' A' ' 69' ' ' THR . 10.0 t -70.87 -27.87 64.14 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 121.007 0.432 . . . . 0.0 109.928 178.181 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.498 ' HB3' ' HG3' ' A' ' 75' ' ' MET . 74.9 mt -70.84 -27.42 63.84 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 174.286 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 53.84 29.38 9.67 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.223 176.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.498 ' HG3' ' HB3' ' A' ' 73' ' ' LEU . 88.2 mtp -81.9 150.85 27.55 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.411 -177.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -146.73 178.65 8.15 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 177.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -60.58 123.49 17.55 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.729 0.775 . . . . 0.0 112.224 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.412 ' N ' ' HB2' ' A' ' 16' ' ' LYS . 15.4 t70 64.8 33.93 9.8 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 113.865 -1.516 . . . . 0.0 111.033 176.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -76.98 177.84 7.43 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 175.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.0 m -114.43 148.6 17.12 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 CA-C-O 121.742 0.782 . . . . 0.0 112.382 -174.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.406 HD13 ' CG2' ' A' ' 17' ' ' ILE . 1.1 mp -125.75 136.74 59.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 CA-C-N 114.508 -1.224 . . . . 0.0 108.232 177.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -99.97 139.4 35.69 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.143 0.497 . . . . 0.0 110.892 -176.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.559 HG22 ' CD2' ' A' ' 57' ' ' PHE . 86.6 t -123.36 130.45 74.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.114 178.294 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.415 ' CE1' HD22 ' A' ' 58' ' ' LEU . 84.1 m-85 -99.28 149.07 23.5 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 174.101 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -69.31 107.26 3.2 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 121.553 0.692 . . . . 0.0 111.017 -171.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.483 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 1.3 mm-40 176.04 114.65 0.02 OUTLIER 'General case' 0 CA--C 1.476 -1.901 0 C-N-CA 125.984 1.714 . . . . 0.0 110.966 -174.198 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.86 ' HB2' HG11 ' A' ' 50' ' ' VAL . 27.8 pt20 -157.18 13.35 0.24 Allowed 'General case' 0 N--CA 1.384 -3.768 0 CA-C-N 113.425 -1.716 . . . . 0.0 108.337 176.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 52.3 tp 90.44 -7.21 0.32 Allowed 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 112.857 -1.974 . . . . 0.0 107.624 -170.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.429 ' H ' ' HG3' ' A' ' 87' ' ' GLN . . . -60.78 -41.39 99.09 Favored Glycine 0 N--CA 1.441 -0.989 0 CA-C-N 114.416 -1.265 . . . . 0.0 111.656 174.152 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.895 0 CA-C-O 118.227 -1.318 . . . . 0.0 111.449 178.584 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.9 ttm . . . . . 0 N--CA 1.472 0.672 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.84 102.77 10.24 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 177.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -83.98 -172.91 4.42 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.551 -178.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -60.55 -38.44 84.52 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.098 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 62.44 29.74 17.18 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.198 0.523 . . . . 0.0 110.535 -178.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -152.4 157.94 41.96 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.45 -179.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -124.45 151.38 44.61 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.06 -37.95 86.92 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.786 0.327 . . . . 0.0 110.94 -178.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 82.05 19.06 65.87 Favored Glycine 0 CA--C 1.5 -0.903 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 -177.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -81.96 -178.54 7.04 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 114.524 -0.838 . . . . 0.0 109.804 -178.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 56.32 44.51 24.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.824 0.821 . . . . 0.0 110.158 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.7 -37.18 80.79 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.338 -1.301 . . . . 0.0 111.735 -178.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -86.59 26.64 1.06 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.644 0.735 . . . . 0.0 110.824 -179.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -125.32 168.67 13.2 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 115.076 -0.965 . . . . 0.0 111.072 -177.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.759 HD12 ' HA ' ' A' ' 76' ' ' GLU . 11.7 pt -109.05 163.01 6.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-O 121.49 0.662 . . . . 0.0 111.369 -173.107 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.528 ' HD3' ' OD2' ' A' ' 77' ' ' ASP . 42.5 mtpt -92.1 147.67 22.77 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.727 -178.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.669 HG13 ' HB3' ' A' ' 74' ' ' GLU . 8.4 mm -139.5 139.34 38.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.613 175.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.5 mtmt -101.92 105.25 16.03 Favored 'General case' 0 N--CA 1.431 -1.388 0 C-N-CA 120.105 -0.638 . . . . 0.0 109.638 177.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.637 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 76.0 t -80.71 114.06 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 176.347 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 59.2 t -109.34 118.65 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.013 0 CA-C-O 121.154 0.502 . . . . 0.0 110.482 -178.141 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -84.62 173.34 49.35 Favored Glycine 0 N--CA 1.436 -1.318 0 C-N-CA 120.321 -0.942 . . . . 0.0 111.013 176.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 86.7 mm-40 -73.36 -19.18 61.07 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.368 0.604 . . . . 0.0 111.83 -176.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -85.5 12.53 8.33 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.161 176.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 51.0 m 67.3 27.13 8.36 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.063 -177.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -89.31 103.4 16.03 Favored 'General case' 0 CA--C 1.495 -1.14 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.876 179.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.637 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 36.3 tt0 -104.89 133.44 49.69 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.978 -177.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.3 p -136.57 141.9 39.73 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.466 178.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.407 ' HA ' ' O ' ' A' ' 17' ' ' ILE . 63.5 m170 -95.37 119.04 33.19 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 121.405 0.622 . . . . 0.0 111.429 -176.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -109.51 150.74 27.69 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.508 175.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 17.1 tpp180 -103.36 118.09 35.97 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 176.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.56 ' O ' HG12 ' A' ' 15' ' ' ILE . 34.6 m -136.75 173.13 14.08 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.715 -175.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -90.13 156.76 18.12 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -55.49 -38.86 69.71 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 121.327 0.584 . . . . 0.0 109.518 175.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -104.45 33.69 6.37 Favored Glycine 0 N--CA 1.44 -1.037 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.395 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.558 ' O ' HD13 ' A' ' 73' ' ' LEU . 0.9 OUTLIER -63.77 131.7 48.67 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-O 121.695 0.759 . . . . 0.0 111.833 179.568 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 69.9 m -81.15 151.88 28.03 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.254 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.671 ' SD ' ' HA ' ' A' ' 65' ' ' ASN . 27.3 ptt? -48.34 -33.5 9.07 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -178.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.52 -36.53 82.87 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 112.203 0.445 . . . . 0.0 112.203 -178.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.52 ' HB2' HG23 ' A' ' 35' ' ' THR . 75.8 mmtt -60.74 -41.19 94.87 Favored 'General case' 0 C--O 1.217 -0.622 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.822 -174.416 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.794 HD23 ' H ' ' A' ' 40' ' ' LEU . 0.9 OUTLIER -87.71 -45.14 10.63 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -178.2 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.444 ' HA ' ' HE1' ' A' ' 57' ' ' PHE . 61.1 mtpt -62.65 -46.09 89.84 Favored 'General case' 0 CA--C 1.494 -1.175 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -177.055 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 41.7 ttmt -62.76 -41.49 99.25 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 121.231 0.539 . . . . 0.0 109.593 176.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 58.8 m -69.16 -51.91 33.4 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -177.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.602 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 43.4 t80 -66.41 -47.51 73.04 Favored 'General case' 0 CA--C 1.505 -0.776 0 N-CA-C 111.779 0.289 . . . . 0.0 111.779 -179.118 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.415 ' CB ' ' HA ' ' A' ' 52' ' ' VAL . . . -59.98 -35.47 75.07 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.318 0.58 . . . . 0.0 110.347 -178.419 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -66.15 -47.1 75.16 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.517 -178.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.602 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 10.6 ptm85 -68.91 -25.72 64.73 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.242 -176.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.455 HG22 ' O ' ' A' ' 44' ' ' TYR . 10.2 t -93.04 -9.9 38.08 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 120.956 0.408 . . . . 0.0 111.123 -179.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.6 40.14 59.6 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.975 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.739 HG21 ' HG3' ' A' ' 86' ' ' GLU . 2.7 p -126.4 162.46 30.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.476 ' HB3' ' OG ' ' A' ' 54' ' ' SER . . . -59.81 130.67 47.92 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 178.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.415 ' HA ' ' CB ' ' A' ' 45' ' ' ALA . 74.8 t -61.63 -44.64 99.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.694 -177.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -66.37 -33.21 75.2 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.673 -178.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.51 ' HB2' ' H ' ' A' ' 87' ' ' GLN . 90.5 p -76.72 -14.45 59.94 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.68 -178.423 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.489 HD13 ' N ' ' A' ' 56' ' ' ARG . 1.0 OUTLIER -95.89 136.97 35.62 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -179.509 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.489 ' N ' HD13 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -140.99 145.48 36.01 Favored 'General case' 0 N--CA 1.436 -1.129 0 C-N-CA 119.853 -0.739 . . . . 0.0 111.509 -176.798 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.497 ' CG ' HD12 ' A' ' 40' ' ' LEU . 92.8 m-85 -118.84 140.96 49.11 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 114.922 -1.035 . . . . 0.0 109.267 176.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.601 HD22 ' CE1' ' A' ' 84' ' ' TYR . 9.2 mp -126.26 145.54 50.37 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.856 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.704 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 0.4 OUTLIER -128.84 117.38 20.96 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 177.157 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 68.13 24.14 7.77 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.387 0.613 . . . . 0.0 110.987 -175.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.1 14.08 77.77 Favored Glycine 0 N--CA 1.438 -1.185 0 CA-C-N 115.414 -0.812 . . . . 0.0 113.001 176.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.704 ' HG3' ' O ' ' A' ' 59' ' ' PHE . 0.1 OUTLIER -124.2 146.45 48.69 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.232 179.462 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 10.9 mpt_? -67.6 130.1 41.97 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.836 -176.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 83.9 mt -80.09 125.86 39.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.384 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.671 ' HA ' ' SD ' ' A' ' 37' ' ' MET . 20.7 m120 -116.69 171.18 8.04 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 123.343 0.657 . . . . 0.0 109.489 177.255 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -78.8 -8.76 59.07 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -175.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -114.97 16.62 17.14 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 120.229 -0.588 . . . . 0.0 112.162 -178.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.65 ' HB2' HD21 ' A' ' 73' ' ' LEU . 72.0 m-20 -84.22 172.06 12.22 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.579 ' O ' ' HG ' ' A' ' 73' ' ' LEU . 69.2 p -82.91 156.13 67.5 Favored Pre-proline 0 CA--C 1.509 -0.599 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -173.362 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.727 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 17.4 Cg_endo -54.84 -18.68 16.93 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 123.131 2.554 . . . . 0.0 112.61 -176.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.862 ' HA ' ' CG ' ' A' ' 75' ' ' MET . 2.1 tmmm? -70.5 -40.54 73.51 Favored 'General case' 0 N--CA 1.413 -2.312 0 C-N-CA 122.888 0.475 . . . . 0.0 111.812 -179.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.476 ' CG2' ' HB3' ' A' ' 68' ' ' ASP . 1.4 t -96.72 -6.84 35.45 Favored 'General case' 0 CA--C 1.477 -1.839 0 CA-C-O 123.34 1.543 . . . . 0.0 107.021 -178.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.767 ' O ' ' HB2' ' A' ' 74' ' ' GLU . 0.3 OUTLIER -96.53 24.97 5.42 Favored 'General case' 0 CA--C 1.432 -3.587 0 CA-C-N 111.514 -2.585 . . . . 0.0 114.407 -176.761 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.767 ' HB2' ' O ' ' A' ' 73' ' ' LEU . 32.7 mt-10 76.23 66.04 0.06 Allowed 'General case' 0 C--N 1.305 -1.327 0 O-C-N 124.747 1.28 . . . . 0.0 111.66 173.067 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.862 ' CG ' ' HA ' ' A' ' 71' ' ' LYS . 76.4 mtm -39.84 -179.32 0.0 OUTLIER 'General case' 0 C--N 1.269 -2.897 0 CA-C-N 112.418 -2.174 . . . . 0.0 116.764 172.46 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.759 ' HA ' HD12 ' A' ' 15' ' ' ILE . 13.6 pt-20 -72.18 178.75 3.68 Favored 'General case' 0 CA--C 1.478 -1.819 0 C-N-CA 124.369 1.068 . . . . 0.0 112.295 -157.052 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.528 ' OD2' ' HD3' ' A' ' 16' ' ' LYS . 7.0 t70 -25.67 97.74 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.705 0 O-C-N 125.392 1.683 . . . . 0.0 114.269 -171.023 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.9 t70 80.23 33.04 0.17 Allowed 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 112.05 -2.341 . . . . 0.0 113.076 168.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -72.04 178.27 3.88 Favored 'General case' 0 C--N 1.36 1.056 0 C-N-CA 119.193 -1.003 . . . . 0.0 109.489 171.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 29.8 m -107.76 152.19 9.56 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -170.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.416 ' HA ' HD13 ' A' ' 81' ' ' ILE . 4.7 mm -135.91 138.88 46.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.499 -179.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -103.34 140.41 37.46 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.198 -179.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 95.6 t -125.69 133.72 68.41 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-O 120.975 0.417 . . . . 0.0 111.227 178.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.601 ' CE1' HD22 ' A' ' 58' ' ' LEU . 79.0 m-85 -107.59 159.3 16.55 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.604 176.207 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 37.5 tp60 -68.62 144.05 54.62 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.19 0.519 . . . . 0.0 111.649 -170.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.739 ' HG3' HG21 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -95.87 161.41 14.02 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.547 -175.589 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.51 ' H ' ' HB2' ' A' ' 54' ' ' SER . 58.3 tp60 -66.75 -44.39 81.56 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.379 -0.828 . . . . 0.0 113.232 -177.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -85.98 -7.06 58.92 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.881 0.372 . . . . 0.0 111.958 -175.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.517 ' H ' ' HG2' ' A' ' 86' ' ' GLU . . . -101.68 -84.4 1.8 Allowed Glycine 0 N--CA 1.436 -1.352 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 178.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.048 0 CA-C-O 118.692 -1.06 . . . . 0.0 112.481 178.447 . . . . . . . . 0 0 . 1 stop_ save_